SK287312B6 - 6-Position substituted indoline, production and use thereof as a medicament - Google Patents

6-Position substituted indoline, production and use thereof as a medicament Download PDF

Info

Publication number
SK287312B6
SK287312B6 SK646-2002A SK6462002A SK287312B6 SK 287312 B6 SK287312 B6 SK 287312B6 SK 6462002 A SK6462002 A SK 6462002A SK 287312 B6 SK287312 B6 SK 287312B6
Authority
SK
Slovakia
Prior art keywords
alkyl
group
amino
phenyl
alkoxy
Prior art date
Application number
SK646-2002A
Other languages
Slovak (sk)
Other versions
SK6462002A3 (en
Inventor
Armin Heckel
Gerald J�Rgen Roth
Rainer Walter
Meel Jacobus Van
Norbert Redemann
Ulrike Tontsch-Grunt
Walter Spevak
Frank Hilberg
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26006858&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK287312(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE19949208A external-priority patent/DE19949208A1/en
Priority claimed from DE2000142696 external-priority patent/DE10042696A1/en
Application filed by Boehringer Ingelheim Pharma Gmbh & Co. Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co. Kg
Publication of SK6462002A3 publication Critical patent/SK6462002A3/en
Publication of SK287312B6 publication Critical patent/SK287312B6/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The invention relates to a 6-substituted indoline of formula (I), isomers and salts of said compound, in particular physiologically compatible salts of said compound having pharmacologically important characteristics, in particular inhibiting action on different receptor-tyrosine kinases and cyclin/CDK complexes in addition to inhibiting the proliferation of endothelial cells and different tumor cells. The invention also relates to medicaments containing said compounds and a method for the production thereof.

Description

Vynález sa týka v polohe 6 substituovaných indolinónov ich tautomérov a solí, najmä fyziologicky prípustných solí, ktoré majú cenné vlastnosti, spôsobu ich výroby a ich použitia.The invention relates to the 6-substituted indolinones of their tautomers and salts, in particular to physiologically acceptable salts having valuable properties, to a process for their preparation and to their use.

Doterajší stav technikyBACKGROUND OF THE INVENTION

Zlúčeniny všeobecného vzorca (I)Compounds of formula (I)

v ktorých R1 znamená atóm vodíka alebo prekurzorovú skupinu majú cenné farmakologické vlastnosti, najmä inhibičný účinok na rôzne kinázy, najmä na receptorové kinázy, ako sú VEGFR2, PDGFRa, PDGFRP, FGFR1, FGFR3, EGFR, HER2, IGF1R a HGFR, ako aj na komplexy od cyklínu závislých kináz (cyclin dependent kinases, CDK), ako sú CDK1, CDK2, CDK3, CDK4, CDK5, CDK6, CDK7, CDK8 a CDK9 s ich špecifickými cyklínmi (A, BI, B2, C, Dl, D2, D3, E, F, Gl, G2, H, I a K) a na vírusové cyklíny (pozri Mengtao L. v J. Virology 71(3), 1984-1991 (1977)), ďalej na proliferačne kultivované ľudské bunky, najmä na endotelové bunky, napríklad pri angiogenéze, ale aj na proliferáciu iných buniek, najmä nádorových buniek.wherein R 1 represents a hydrogen atom or a prodrug group have valuable pharmacological properties, particularly an inhibiting effect on various kinases, especially on receptor kinases such as VEGFR2, PDGFR, PDGFR, FGFR1, FGFR3, EGFR, HER2, IGF1R and HGFR, and on cyclin dependent kinases (CDKs) such as CDK1, CDK2, CDK3, CDK4, CDK5, CDK6, CDK7, CDK8 and CDK9 with their specific cyclins (A, B1, B2, C, D1, D2, D3 , E, F, G1, G2, H, I and K) and viral cyclins (see Mengtao L. in J. Virology 71 (3), 1984-1991 (1977)), further on proliferatively cultured human cells, in particular on endothelial cells, for example in angiogenesis, but also for the proliferation of other cells, especially tumor cells.

Ostatné zlúčeniny uvedeného všeobecného vzorca (I), v ktorých R1 neznamená vodík alebo prekurzorovú skupinu, sú cenné medziprodukty na prípravu uvedených zlúčenín.Other compounds of formula (I) in which R @ 1 is not hydrogen or a precursor group are valuable intermediates for the preparation of said compounds.

Podstata vynálezuSUMMARY OF THE INVENTION

Podstatou vynálezu sú indolinóny všeobecného vzorca (I),The present invention provides the indolinones of formula (I),

R3 I /R! R 3 I / R!

(I), v ktorom(I) in which

X znamená atóm kyslíka alebo síry,X is an oxygen or sulfur atom,

R1 znamená atóm vodíka alebo Ci_4-alkoxykarbonylovú alebo C2.4-alkanoylovú skupinu,R 1 is H or a C 4 -alkoxycarbonyl or C 2nd A 4- alkanoyl group,

R2 znamená karboxylovú skupinu, nerozvetvenú alebo rozvetvenú Cj.e-alkoxy-karbonylovú skupinu, C4_7-cykloalkoxy-karbonylovú skupinu alebo aryloxy-karbonylovú skupinu, nerozvetvenú alebo rozvetvenú C^-alkoxy-karbonylovú skupinu, ktorá je v koncovej alkylovej časti substituovaná fenylovou skupinou, heteroarylovou skupinou, karboxylovou skupinou, C1.3-alkoxy-karbonylovou skupinou, aminokarbonylovou skupinou, Ci.3-alkylamino-karbonylovou skupinou alebo di-(Ci_3-alkyl)-amino-karbonylovou skupinou, nerozvetvenú alebo rozvetvenú C2.6-alkoxy-karbonylovú skupinu, ktorá je v koncovej alkylovej časti substituovaná atómom chlóru alebo skupinou hydroxy-, Ci_3-alkoxy-, amino-, Ci.3-alkylamino- alebo di-(Ci_3-alkyl)-amino-skupinou, aminokarbonylovú alebo metylaminokarbonylovú skupinu, etylaminokarbonylovú skupinu voliteľne v polohe 2 skupiny etyl- substituovanú skupinou hydroxy- alebo C|.3-alkoxy-skupinou,R 2 is carboxy, straight or branched Cj.e alkoxy-carbonyl group, a C 4 _ 7 cycloalkoxy-carbonyl or aryloxy carbonyl group, a linear or branched C ^ -alkoxy-carbonyl, which is the terminal alkyl substituted with phenyl, heteroaryl, carboxyl, C 1 . A 3 -alkoxycarbonyl group, an aminocarbonyl group, a C 1-6 alkyl group; 3 -alkylamino-carbonyl or di- (C 3 alkyl) amino-carbonyl, linear or branched C 2nd A 6 -alkoxycarbonyl group which is substituted in the terminal alkyl moiety by a chlorine atom or a hydroxy-, C 1-3 -alkoxy-, amino-, C 1-6 -alkyloxy group; 3- alkylamino- or di- (C 1-3 -alkyl) -amino, aminocarbonyl or methylaminocarbonyl, ethylaminocarbonyl optionally in the 2-position of the ethyl-substituted with hydroxy- or C 1-6 -alkyl. 3- alkoxy,

R3 znamená atóm vodíka, C1.6-alkylovú skupinu, C3.7-cykloalkylovú skupinu, trifluór-metylovú skupinu alebo heteroarylovú skupinu, fenylovú alebo naftylovú skupinu, fenylovú alebo naftylovú skupinu mono- alebo di- substituovanú atómom fluóru, chlóru, brómu alebo jódu, skupinou trifluórmetyl-, Ci_3-alkyl- alebo C|_3-alkoxy-, pričom v prípade disubstitúcie môžu byť substituenty rovnaké alebo rozdielne a pričom uvedené nesubstituované, ako aj mono- a di- substituované fenylové alebo naftylové skupiny môžu byť navyše substituované skupinou hydroxy-, hydroxy-Ci_3-alkyl- alebo skupinou CI.3-alkoxy-C1.3-alkyl-, skupinou kyano-, karboxy-, karboxy-C^-alkyl-, Ci_3-alkoxykarbonyl-, amino-karbonyl-, C1.3-alkylaminokarbonyl- alebo di-(Ci_3-alkyl)-aminokarbonylovou skupinou, skupinou nitro-, skupinou amino-, C).3-alkylamino-, di-(Ci.3-alkyl)-amino alebo amino-C1.3-alkylovou skupinou, skupinou C1.3-alkylkarbonylamino-, JV-(Ci_3-alkyl)-Cl.3-alkylkarbonylamino-, C|_3-alkylkarbonylamino-C|.3-alkyl-, 7V-(Ci.3-alkyl)-Ci_3-alkylkarbonylamino-Ci_3-alkyl-, Ci^-alkylsulfonylamino-, Ci_3-alkylsulfonylamino-Cj.3-alkyl, A-(Ci_3-alkyl)-C1.3-alkylsulfonylamino-Ci_3-alkyl- alebo skupinou aryl-Ci.3-alkyl-sulfonylamino-, skupinou cykloalkylamino-, cykloalkylénimino-, cykloalkyléniminokarbonyl-, cykloalkylénimino-Ci.3-alkyl-, cykloalkyléniminokarbonyl-C].3-alkyl alebo cykloalkyléniminosulfonyl-Ci.3-alkylovou skupinou vždy so 4 až 7 členmi kruhu, pričom metylénová skupina v polohe 4 šesťčlennej alebo sedemčlennej cykloalkyléniminoskupiny môže byť nahradená atómom kyslíka alebo síry, skupinou sulfinyl-, sulfonyl-, -NH- alebo -N-(Q.s-alkyl)- skupinou, alebo môže byť substituovaná heteroarylovou skupinou alebo heteroaryl-C1.3-alkylovou skupinou,R 3 represents a hydrogen atom, C 1 . 6- alkyl, C 3 . 7- cycloalkyl, trifluoromethyl or heteroaryl, phenyl or naphthyl, phenyl or naphthyl mono- or di-substituted by fluorine, chlorine, bromine or iodine, trifluoromethyl, C 1-3 -alkyl- or C 1-3 -alkyl; 3 alkoxy-, wherein in the case of disubstitution the substituents may be the same or different and wherein the abovementioned unsubstituted as well as mono- and di-substituted phenyl or naphthyl groups may additionally be substituted by hydroxy, hydroxy-C 3 alkyl- or C I. 3 -alkoxy-C first 3 alkyl-, cyano group, carboxy, carboxy-Cl alkyl, C 3 -alkoxycarbonyl-, amino-carbonyl, C first 3- alkylaminocarbonyl- or di- (C 1-3 -alkyl) -aminocarbonyl, nitro-, amino-, C). 3- alkylamino-, di- (C 1-3 -alkyl) -amino or amino-C 1 . 3- alkyl, C 1 . 3- alkylcarbonylamino-, N - (C 1-3 -alkyl) -C 1 . 3- alkylcarbonylamino-, C 1-3 -alkylcarbonylamino-C 1-6 alkylcarbonylamino-; 3 alkyl-, 7V- (Ci. 3 alkyl) 3 -Ci_ alkylcarbonylamino-C 3 alkyl-, C ^ -alkylsulfonylamino-, C 3 -C alkylsulfonylamino. 3- alkyl, A- (C 1-3 -alkyl) -C 1 . 3- alkylsulfonylamino-C 1-3 -alkyl- or aryl-C 1-6 -alkyl; 3 -alkylsulfonylamino-, cycloalkylamino-, cycloalkylenimino-, cycloalkylenimino-carbonyl-, cycloalkylenimino-C 1 -C 3 -alkylsulfonylamino-; 3- alkyl-, cycloalkyleneiminocarbonyl-C 1. 3- alkyl or cycloalkyleneiminosulfonyl-C 1-6 alkyl; A 3- alkyl group having from 4 to 7 ring members, the methylene group in the 4-position of the 6 or 7 membered cycloalkyleneimino group being replaced by an oxygen or sulfur atom, a sulfinyl-, sulfonyl-, -NH- or -N- (C 1-6 -alkyl) - or a heteroaryl group or a heteroaryl-C 1 group . 3- alkyl,

R4 znamená C3_7-cykloalkylovú skupinu, pričom metylénová skupina v polohe 4 šesťčlennej alebo sedemčlennej cykloalkylovej skupiny môže byť nahradená skupinou amino-, C^-alkylamino- alebo skupinou di-(Ci_3-alkyl)-amino-, alebo môže byť nahradená skupinou -NH- alebo -N(Ci_3-alkyl)-, alebo znamená fenylovú skupinu substituovanú skupinou R6, pričom fenylová skupina môže byť navyše mono- alebo di- substituovaná atómom fluóru, chlóru, brómu alebo jódu, skupinou Ci_5-alkyl-, trifluórmetyl-, hydroxy-, C|.3-alkoxy-, karboxy-, Cl.3-alkoxykarbonyl-, amino-, acetylamino-, Ci.3-alkyl-sulfonyl-amino-, aminokarbonyl-, Ci_3-alkyl-aminokarbonyl-, di-(C|.3-alkyl)-aminokarbonyl-, amino-sulfonyl-, Ci.3-alkylaminosulfonyl-, di-(C]_3-alkyl)-aminosulfonyl-, nitro- alebo kyano-, pričom substituenty môžu byť rovnaké alebo rozdielne a pričom R4 is C3 _7 cycloalkyl group wherein a methylene group in the 4-position six or seven membered cycloalkyl group can be replaced by amino, C ^ -alkylamino group or a di (C 3 alkyl) amino, or may be substituted with -NH- or -N (C 1-3 -alkyl) -, or represents a phenyl group substituted with R 6 , wherein the phenyl group may additionally be mono- or di- substituted with a fluorine, chlorine, bromine or iodine atom, with a C 1-5 group - alkyl-, trifluoromethyl-, hydroxy-, C1-6alkyl- 3 -alkoxy, carboxy, C l. 3- alkoxycarbonyl-, amino-, acetylamino-; 3- alkyl-sulfonyl-amino-, aminocarbonyl-, C 1-3 -alkyl-aminocarbonyl-, di- (C 1-3 -alkyl) -aminocarbonyl-, amino-sulfonyl-, C 1-6 -alkyl-; 3- alkylaminosulfonyl-, di- (C 1-3 -alkyl) -aminosulfonyl-, nitro- or cyano-, wherein the substituents may be the same or different and wherein

R6 znamená atóm vodíka, fluóru, chlóru, brómu alebo jódu, skupinu kyano-, nitro-, amino-, Ci_5-alkyl-, C3.7-cykloalkyl-, trifluórmetyl-, fenyl-, tetrazolyl- alebo heteroarylovú skupinu, skupinu vzorcaR 6 represents a hydrogen, fluorine, chlorine, bromine or iodine atom, a cyano-, nitro-, amino-, C 1-5 -alkyl-, C 3 group . 7- cycloalkyl-, trifluoromethyl-, phenyl-, tetrazolyl- or heteroaryl, a group of the formula

v ktorom atómy vodíka viazané na dusíkovom atóme môžu byť vzájomne nezávisle od seba nahradené C33-alkylovou skupinou,wherein the hydrogen atoms attached to the nitrogen atom may be replaced independently of one another by a C 33 -alkyl group,

Cu-alkoxylovú skupinu, Ci_3-alkoxy-Ci.3-alkoxylovú skupinu, fenyl-Ci_3-alkoxylovú skupinu, amino-C2.3-alkoxylovú skupinu, C1.3-alkylamino-C2.3-alkoxylovú skupinu, di-(C|.3-alkyl)-amino-C2.3-alkoxylovú skupinu, fenyl-C].3-alkylamino-C2.3-alkoxylovú skupinu, 7V-(C|.3-alkyl)-fenyl-Ci.3-alkylamino-C2.3-alkoxylovú skupinu, C5.7-cyklo-alkylénimino-C2.3-alkoxyovú skupinu alebo skupinu C[.3-alkylmerkapto-, karboxylovú skupinu, C|.4-alkoxykarbonylovú skupinu, aminokarbonylovú skupinu, Ci.3-alkylamino-karbonylovú skupinu, N-(Cl_5-alkyl)-C|.3-alkylaminokarbonylovú skupinu, fenyl-Ci_3-alkylamino-karbonylovú skupinu, N-(Ci_3-alkyl)-fenyl-Ci.3-alkyl-aminokarbonylovú skupinu, piperazinokarbonylovú skupinu alebo /V-(C|_3-alkyl)-piperazinokarbonylovú skupinu,A C 1 -alkoxy group, a C 1-3 -alkoxy-C 1-6 alkyl group; 3- alkoxy, phenyl-C 1-3 -alkoxy, amino-C 2 . 3 -alkoxy, C first 3 -alkylamino-C 2nd 3- alkoxy, di- (C 1-3 -alkyl) -amino-C 2 . 3- alkoxy, phenyl-C 1. 3 -alkylamino-C 2nd 3- alkoxy, N - (C 1-3 -alkyl) -phenyl-C 1-6 alkyl; 3 -alkylamino-C 2nd 3 -alkoxy, C 5-7 -cycloalkyl-C-alkylene imino second A 3- alkoxy group or a C 1-6 group; 3- alkylmercapto-, carboxyl, C1-6alkyl; A 4- alkoxycarbonyl group, an aminocarbonyl group, a C 1-6 alkyl group; 3 -alkylamino-carbonyl, N- (C l _ 5 alkyl) -C |. 3- alkylaminocarbonyl, phenyl-C 1-3 -alkylamino-carbonyl, N- (C 1-3 -alkyl) -phenyl-C 1-6 -alkylaminocarbonyl; 3- alkyl-aminocarbonyl, piperazinocarbonyl or N - (C 1-3 -alkyl) piperazinocarbonyl,

Cj^-alkylaminokarbonylovú alebo /V-(Ci.5-alkyl)-C].3-alkylaminokarbonylovú skupinu, v ktorých je alkylová časť substituovaná karboxylovou skupinou alebo C[.3-alkoxykarbonylovou skupinou, alebo v polohe 2 alebo skupinou di-(Ci_3-alkyl)-amino-, skupinou piperazino-, skupinou <V-(Cl_3-alkyl)-piperazino- alebo štvorčlennou až sedemčlennou cykloalkyléniminovou skupinou,C 1-6 -alkylaminocarbonyl or N - (C 1-5 -alkyl) - C 1. A 3- alkylaminocarbonyl group in which the alkyl moiety is substituted with a carboxyl group or a C 1-6 alkyl group; 3 alkoxycarbonyl group or in the 2 or the group di- (C 3 -alkyl) -amino, piperazino group, a group <N (C l _3-alkyl) -piperazino- or a four to seven membered cykloalkyléniminovou group,

C3.7-cykloalkyl-karbonylovú skupinu, pričom metylénová skupina v polohe 4 šesťčlennej alebo sedemčlennej cykloalkylovej časti môže byť substituovaná skupinou amino-, Ci_3-alkyl-amino- alebo skupinou di-(C1.3-alkyl)-amino-, alebo nahradená skupinou -NH- alebo skupinou -Äľ(C1.3-alkyl)-, až 7 člennú cykloalkylénimínovú skupinu, ktorej s iminoskupinou viazaná metylénová skupina môže byť nahradená karbonylovou skupinou alebo sulfonylovou skupinou, ktorej cykloalkylénová časť môže byť kondenzovaná s fenylovým kruhom, alebo jeden alebo dva atómy vodíka môžu byť nahradené C]_3-alkylovou skupinou a/alebo metylénová skupina v polohe 4 šesťčlennej alebo sedemčlennej cyklo-alkylénimínovej skupiny môže byť substituovaná karboxylovou skupinou, Ci.3-alkoxykarbonylovou skupinou, aminokarbonylovou skupinou, Ci.3-alkyl-aminokarbonylovou skupinou, di-(C|j-alkyl)-aminokarbonylovou skupinou, fenyl-Ci_3-alkylamínovou skupinou alebo jV-(C|.3-alkyl)-fenyl-C|.3-alkyl-amínovou skupinou, alebo môže byť nahradená atómom kyslíka alebo síry, skupinou sulfmyl-, sulfonyl-, -NH-, -N(Ci_3-alkyl)-, -7V(fenyl)-, -V(C|.3-alkyl-karbonyl)- alebo -TV(benzoyl)-C|.4-alkylovú skupinu substituovanú skupinou R7, pričomC 3 . 7-cycloalkyl-carbonyl group, wherein the methylene group in the 4-position six or seven membered cycloalkyl moiety may be substituted by amino, C 3 -alkyl-amino group, or di- (C first 3 alkyl) amino, or substituted -NH- and -A I (c first 3 alkyl) -, up to 7 membered cykloalkylénimínovú group, the imino group is bound to the methylene group can be replaced by a carbonyl group or a sulfonyl group, wherein a cycloalkylene moiety may be fused with a phenyl ring, or one or two hydrogen atoms may be replaced by a C 1-3 -alkyl group and / or the methylene group at the 4-position of a six or seven-membered cycloalkyleneimine group may be substituted by a carboxyl group, C 1-6 -alkyl; 3- alkoxycarbonyl, aminocarbonyl, Ci. 3- alkyl-aminocarbonyl, di- (C 1-6 -alkyl) -aminocarbonyl, phenyl-C 1-3 -alkylamino or N - (C 1-3 -alkyl) -phenyl-C 1-6 -alkylamino; 3- alkyl-amino, or it may be replaced by an oxygen or sulfur atom, sulfonyl-, sulfonyl-, -NH-, -N (C 1-3 -alkyl) -, -7 N (phenyl) -, -V (C 1 -C 3 -alkyl); 3- alkyl-carbonyl) - or -TV (benzoyl) -C 1-6 alkyl. A 4- alkyl group substituted with R 7 wherein

R7 znamená C3.7-cykloalkylovú skupinu, pričom metylénová skupina v polohe 4 šesťčlennej alebo sedemčlennej cykloalkylovej skupiny môže byť substituovaná aminoskupinou, C|.3-alkylaminovou skupinou, di-(Ci_3-alkyl)-amínovou skupinou, alebo nahradená skupinou -NH- alebo skupinou -7V(Ci.3-alkyl)-, v päť až sedemčlennej cykloalkylovej skupine môže byť jedna skupina -(CH2)2- nahradená skupinou -CO-NH-, skupina -(CH2)3- skupinou -NH-CO-NH- alebo skupinou -CO-NH-CO-, alebo skupina -(CH2)4- môže byť nahradená skupinou -NH-CO-NH-CO-, pričom atóm vodíka viazaný na atóme dusíka môže byť nahradený Ci.3-alkylovou skupinou, arylovú alebo heteroarylovú skupinu, skupinu hydroxy- alebo Ci.3-alkoxy-, skupinu amino-, Ci_7-alkylamino-, di-(Ci_7-alkyl)-amino-, fenylamino-, 7/-fenyl-C| j-alkyl-amino-, fenyl-Cu-alkyl-amino-, /V-(C, j-alkylj-fenyl-Ci j-alkyl-amino- alebo di-(fenyl-Ci.3-alkyl)-amino-, skupinu a>-hydroxy-C2.3-alkylamino-, Ä,-(Ci.3-alkyl)-ro-hydroxy-C2.3-alkyl-amino-, di-(co-hydroxy-C2.3-alkyl)-amino-, di-(co-(Ci_3-alkoxy)-C2.3-alkyl)-amino- alebo V-(dioxolán-2-yl)-Ci.3-alkyl-amino-, skupinu C].3-alkylkarbonylamino-C2.3-alkyl-amino- alebo C|.3-alkylkarbonyl-amino-C2.3-alkyl-A/-(C|_3-alkyl)-amino-, skupinu Ci.3-alkylsulfonylamino-, JV-(C1.3-alkyl)-C|.3-alkyl-sulfonylamino-, C|.3-alkylsulfonylamino-C2.3-alkyl-amino- alebo Cl.3-alkylsulfonylamino-C2.3-alkyl-/V-(C1.3-alkyl)-amino-, skupinu hydroxykarbonyl-Ci.3-alkylamino- alebo jV-(Ci.3-alkyl)-hydroxy-karbonyl-Ct.3-alkyl-amino-, guanidínovú skupinu, v ktorej jeden alebo dva atómy vodíka môžu byť každý nahradený C1.3-alkylovou skupinou, skupinu vzorcaR 7 is C 3 . The 7- cycloalkyl group, wherein the methylene group at the 4-position of the 6 or 7 membered cycloalkyl group may be substituted with an amino group, C 1-6 -cycloalkyl. 3- alkylamino, di- (C 1-3 -alkyl) -amino, or replaced by -NH- or -7V (C 1-3 -alkyl) -, in the 5-7 membered cycloalkyl group there may be one - (CH 2) 12 - replaced by -CO-NH-, - (CH 2 ) 3 - by -NH-CO-NH- or -CO-NH-CO-, or - (CH 2 ) 4 - may be replaced by -NH-CO-NH-CO-, wherein the hydrogen atom attached to the nitrogen atom may be replaced by a C 1-3 -alkyl group, an aryl or heteroaryl group, a hydroxy- or C 1-6 -alkyl group. 3- alkoxy-, amino-, C 1-7 -alkylamino-, di- (C 1-7 -alkyl) -amino-, phenylamino-, 7 H -phenyl-C 1-6 -alkyloxy-; N-alkyl-amino-, phenyl-C 1-6 -alkyl-amino-, N - (C 1-6 -alkyl) -phenyl-C 1-6 -alkyl-amino- or di- (phenyl-C 1-3 -alkyl) -amino- , a> hydroxy-C2. 3 -alkylamino, R, - (Cl. 3 alkyl) -R-hydroxy-C2. 3 -alkyl-amino, di- (co-hydroxy-C2. 3-alkyl) amino, di (CO- (C 3 alkoxy) C 2. 3 alkyl) -amino or N- (dioxolan-2-yl) -C. 3 -alkyl-amino, is C]. -C 3 alkylcarbonylamino second 3 -alkyl-amino or C |. 3 -alkylcarbonyl-amino-C2. A 3-alkyl / - (C | _ 3 alkyl) amino group, no. 3 -alkylsulfonylamino-, N- (C1. 3 alkyl) C |. 3-alkyl-sulfonylamino, C |. 3 -C alkylsulfonylamino second 3 -alkyl-amino or C l. 3 - alkylsulfonylamino-C2. 3 alkyl- / N (C1. 3 alkyl) amino group, a hydroxycarbonyl-Ci.3-alkylamino or N- (Ci. 3 alkyl) hydroxy-carbonyl-C t . 3 -alkyl-amino, guanidino, wherein one or two hydrogen atoms may each be replaced by C1. 3 -alkyl, a group of formula

- N(R8) - CO - (CH2)n - R9 (II), v ktorom- N (R 8 ) - CO - (CH 2 ) n - R 9 (II) in which

R8 znamená atóm vodíka alebo Ci_3-alkylovú skupinu, n znamená číslo 0, 1,2, alebo 3,R 8 is hydrogen or C 1-3 -alkyl, n is 0, 1, 2, or 3,

R9 znamená skupinu amino-, Ci_4-alkylamino-, di-(Cl_4-alkyl)-amino-, fenyl-amino-, TV-(Ci_4-alkyl)-fenylamino-, benzylamino-, /V-(C1.4-alkyl)-benzylamino- alebo CI.4-alkoxy-, 4- až 7-člennú cykloalkylénimínovú skupinu, pričom metylénová skupina v polohe 4 šesťčlennej alebo sedemčlennej cyklo-alkylénimínovej skupiny môže byť nahradená atómom kyslíka alebo síry, skupinou sulfmyl-, sulfonyl-, -NH-, -TV(Ci.3-alkyl)-, -N(fenyl)-, -/V(C1.3-alkyl-karbonyl)- alebo -A'(benzoyl)-, alebo pokiaľ n znamená číslo 1, 2, alebo 3 môže znamenať tiež atóm vodíka, skupinu vzorcaR 9 represents an amino, a C 4 -alkylamino, di (C l _ 4 alkyl) amino, phenyl-amino, TV- (C 4 alkyl) -fenylamino-, benzylamino, / N (C1. 4 alkyl) or C -benzylamino-. A 4- alkoxy-, 4- to 7-membered cycloalkyleneimine group, wherein the methylene group at the 4-position of the six- or seven-membered cycloalkyleneimine group may be replaced by an oxygen or sulfur atom, a sulfinyl-, sulfonyl-, -NH-, -TV (Ci) . 3 alkyl) -, -N (phenyl) -, - / V (C1. 3 alkyl-carbonyl) - or -N (benzoyl) -, or when n is 1, 2, or 3 denotes also a hydrogen atom, a group of formula

-N(R10) - (CH2)m - (CO)0 - R11 (III), v ktorom-N (R 10 ) - (CH 2 ) m - (CO) O -R 11 (III) in which

R10 znamená atóm vodíka, Ci_3-alkylovú skupinu, C[.3-alkyl-karbonylovú skupinu, arylkarbonylovú skupinu, fenyl-C].3-alkyl-karbonylovú skupinu, Ci_3-alkylsulfonylovú skupinu, arylsulfonylovú skupinu alebo fenylC[.3-alkyl-sulfonylovú skupinu, m je číslo 1, 2, 3 alebo 4, o je číslo 1, alebo, pokiaľ m znamená číslo 2, 3 alebo 4, o môže byť tiež číslo 0 aR 10 represents a hydrogen atom, a C 1-3 -alkyl group, a C 1-6 alkyl group or a C 1-3 alkyl group; 3 -alkylcarbonyl, arylcarbonyl, phenyl-C 1. A 3- alkyl-carbonyl group, a C 1-3 -alkylsulfonyl group, an arylsulfonyl group or a phenylC 1-6 alkyl group; 3 -alkylsulfonyl, m is 1, 2, 3 or 4, o is 1, or, when m is 2, 3 or 4, o can also be 0 and

R11 znamená skupinu amino-, C].4-alkylamino-, di-(C1.4-alkyl)-amino-, fenyl-amino-, A/-(C|.4-aIkyl)-fenylamino-, benzylamino-, TV-(Ci.4-alkyl)-benzylamino-, C].4-alkoxy- alebo skupinu C].3-alkoxy-CI_3-alkoxy-, voliteľne skupinou Ci_3-alkyl- v polohe 1 substituovanú skupinu di- (Ci.4-alkyl)-amino-Ci.3-alkylamino- alebo 4- až 7-člennú cykloalkylén-imínovú skupinu, pričom cykloalkylénová časť môže byť kondenzovaná s fenylovým kruhom, alebo metylénová skupina v polohe 4 šesťčlennej alebo sedemčlennej cykloalkyléniminovej skupiny môže byť nahradená atómom kyslíka alebo síry, skupinou sulfmyl-, sulfonyl-, -NH-, -TV(Ci_3-alkyl)-, -N(fenyl)-, -TV(C|.3-alkyl-karbonyl)- alebo -Mbenzoyl)-, skupinu C4_7-cykloalkylamino-, C^-cykloalkyl-C^-alkylamino- alebo C^-cykloalkenylamino-, v ktorej sa poloha 1 kruhu nezúčastňuje na dvojitej väzbe a pričom uvedené skupiny môžu byť navyše substituované na amínovom atóme dusíka skupinou C5.7-cykloalkyl-, C2.4-alkenyl- alebo C].4-alkyl-, až 7 člennú cykloalkylénimínovú skupinu, ktorej cykloalkylénová časť môže byť kondenzovaná s fenylovou skupinou alebo so skupinou oxazolo-, imidazolo-, tiazolo-, pyridino-, pyrazino- alebo pyrimidino-, voliteľne substituovanými atómom fluóru, chlóru, brómu alebo jódu, skupinou nitro-, skupinou Cl 3-alkyl-, C^-alkoxy alebo aminoskupinou, a/alebo ktorej jeden alebo dva atómy vodíka môžu byť nahradené Ci_3-alkylovou skupinou, C5.7-cykloalkylovou skupinou alebo fenylovou skupinou, a/alebo ktorej metylénová skupina v polohe 3 päťčlennej cykloalkylénimínovej skupiny môže byť substituovaná hydroxyskupinou, hydroxy-Ci_3-alkylovou skupinou, skupinou C].3-alkoxy- alebo C!.3-alkoxy-Ci.3-alkylovou skupinou, ktorej metylénová skupina v polohe 3 alebo 4 šesťčlennej alebo sedemčlennej cykloalkylénimínovej skupiny môže byť substituovaná hydroxyskupinou, hydroxy-Ci_3-alkylovou skupinou, skupinou C].3-alkoxy- alebo Ci_3-alkoxy-C|.3-alkylovou skupinou, karboxylovou skupinou, skupinou C[.4-alkoxykarbonyl-, aminokarbonyl-, Ci_3-alkyl-aminokarbonyl-, di-(C1.3-alkyl)-aminokarbonyl-, fenyl-C13-alkylamino- alebo A'-(Cl_3-alkyl)fenyl-Ci.3-alkylamino-, alebo uvedená metylénová skupina môže byť nahradená atómom kyslíka alebo síry, skupinou sulfinyl-, sulfonyl-, -NH-, -/V(C[.3-alkyl)-, -X(fenyl)-, -A/(fenyl-C|.3-alkyl)-, -V(Ci_3-alkylkarbonyl)-, -A/fCj^-hydroxykarbonyl)-, -/V(C|_4-alkoxykarbonyl)-, -N(benzoyl)- alebo -V(fenyl-Ci_3-alkyl-karbonyl)-, pričom metylénová skupina, ktorá je viazaná s imínovým atómom dusíka cykloalkylénimínovej skupiny môže byť nahradená karbonylovou skupinou alebo sulfonylovou skupinou, alebo v päťčlennej až sedemčlennej monocyklickej alebo s fenylovou skupinou kondenzovanej cykloalkylénimínovej skupine obidve metylénové skupiny, viazané imínový atóm dusíka, môžu byť nahradené karbonylovou skupinou, alebo R6 znamená C1.4-alkylovú skupinu, ktorá je substituovaná karboxylovou skupinou, Ci_3-alkoxykarbonylovou skupinou, aminokarbonylovou skupinou, Ci_3-alkylaminokarbonylovou skupinou alebo di-(C|.3-alkyl)-aminokarbonylovou skupinou alebo 4 až 7 člennou cykloalkyléniminokarbonylovou skupinou, skupinu V-(C1.3-alkyl)-C2.4-alkanoylamino-, ktorá je alkylovej časti navyše substituovaná karboxylovou skupinou alebo Ci_3-alkoxykarbonylovou skupinou, skupinu vzorcaR 11 represents an amino, C] .4-alkylamino, di- (C1-4-alkyl) amino, phenyl-amino, A / - (C | .4-alkyl) -fenylamino-, benzylamino N - (C 1-4 -alkyl) -benzylamino-, C 1 -. 4- alkoxy- or C 1 . 3 -alkoxy-C I _ 3 -alkoxy, optionally a C 3 in the 1-alkyl-substituted group di- (C. 4-alkyl) amino-C. A 3- alkylamino- or 4- to 7-membered cycloalkylene-imine group, wherein the cycloalkylene moiety may be fused to the phenyl ring, or the methylene group at the 4-position of a six- or seven-membered cycloalkyleneimine group may be replaced by oxygen or sulfur; -, -NH-, -TV (C 1-3 -alkyl) -, -N (phenyl) -, -TV (C 1-3 -alkylcarbonyl) - or -Mbenzoyl) -, C 4-7 -cycloalkylamino-, C 1-4- -cycloalkyl-C 1-6 -alkylamino- or C 1-6 -cycloalkenylamino- in which the 1-position of the ring does not participate in the double bond and wherein said groups may additionally be substituted on the amino nitrogen atom by a C 5 group. 7 -cycloalkyl- C 2nd 4- alkenyl- or C 1. A 4- alkyl-, up to 7-membered cycloalkyleneimine group, the cycloalkylene moiety of which may be fused with a phenyl group or with an oxazolo-, imidazolo-, thiazolo-, pyridino-, pyrazino- or pyrimidino- group optionally substituted by a fluorine, chlorine, bromine or iodine, nitro-, C 1-3 -alkyl-, C 1-4 -alkoxy or amino, and / or whose one or two hydrogen atoms may be replaced by C 1-3 -alkyl, C 5-6 . A 7- cycloalkyl or phenyl group, and / or wherein the methylene group at the 3-position of the five-membered cycloalkylenimine group may be substituted by hydroxy, hydroxy-C 1-3 -alkyl, group C 1. 3- alkoxy- or C1-7. 3- alkoxy-Ci. A 3- alkyl group whose methylene group at the 3- or 4-position of a six or seven membered cycloalkyleneimine group may be substituted by a hydroxy group, a hydroxy-C 1-3 -alkyl group, a C 1 group. 3- alkoxy- or C 1-3 -alkoxy-C 1-6 alkyl; 3- alkyl, carboxyl, C 1-6 alkyl; 4 -alkoxycarbonyl-, aminocarbonyl-, C 3 -alkyl-aminocarbonyl, di- (C first 3 -alkyl) aminocarbonyl-, phenyl-C 13 alkylamino- or N - (C l _ 3 alkyl) phenyl -C. 3- alkylamino-, or said methylene group may be replaced by an oxygen or sulfur atom, sulfinyl-, sulfonyl-, -NH-, - N (C 1-3 -alkyl) -, -X (phenyl) -, -A / (phenyl-C |. 3 alkyl) -, -In (C 3 alkylcarbonyl) -, N / FCJ -hydroxykarbonyl ^) -, - / V (C | _ 4 alkoxycarbonyl) -, -N (benzoyl ) - or -V (phenyl-C 1-3 -alkylcarbonyl) -, wherein the methylene group attached to the imine nitrogen atom of the cycloalkyleneimine group may be replaced by a carbonyl group or a sulfonyl group, or in a 5- to 7-membered monocyclic or phenyl condensed group the cycloalkylenimine group of the two methylene groups bonded to the imine nitrogen atom may be replaced by a carbonyl group, or R 6 represents C 1 . A 4- alkyl group which is substituted by a carboxyl group, a C 1-3 -alkoxycarbonyl group, an aminocarbonyl group, a C 1-3 -alkylaminocarbonyl group or a di- (C 1-3 -alkyl) aminocarbonyl group or a 4-7 membered cycloalkyleneiminocarbonyl group, V- group; (C first 3 -alkyl) -C second 4- alkanoylamino-, which is in addition to the alkyl moiety substituted by a carboxyl group or a C 1-3 -alkoxycarbonyl group, a group of the formula

-N(R12) - CO - (CH2)p - R13 (IV), v ktorom-N (R 12 ) -CO- (CH 2 ) p -R 13 (IV) wherein

R12 znamená atóm vodíka, Ci.6-alkylovú alebo C3.7-cykloalkylovú skupinu, alebo terminálnu C]_3-alkylovú skupinu, substituovanú fenylovou skupinou, heteroarylovou skupinou, trifluórmetylovou skupinou, hydroxyskupinou, Ci_3-alkoxyskupinou, aminokarbonylovou skupinou, C|.4-alkylamino-karbonylovou skupinou, di-(C|.4-alkyl)aminokarbonylovou skupinou, Ci_3-alkyl-karbonylovou skupinou, Ci_3-alkyl-sulfonyl-amino skupinou, //-(Cu-alkylj-Ci^-alkyl-sulfonyl-amino skupinou, Ci.3-alkyl-aminosulfonylovou skupinou alebo di-(Ci_3-alkyl)-aminosulfonylovou skupinou a p je číslo 0, 1, 2 alebo 3 aR 12 represents a hydrogen atom; 6- alkyl or C 3 . 7- cycloalkyl, or terminal C 1-3 -alkyl, substituted with phenyl, heteroaryl, trifluoromethyl, hydroxy, C 1-3 -alkoxy, aminocarbonyl, C 1-6 -alkyl; 4- alkylamino-carbonyl, di- (C 1-4 -alkyl) aminocarbonyl, C 1-3 -alkyl-carbonyl, C 1-3 -alkylsulfonyl-amino, N - (C 1 -alkyl) -C 1-6 -alkyl -sulfonyl-amino, C 1-3 -alkyl-aminosulfonyl or di- (C 1-3 -alkyl) -aminosulfonyl and p is 0, 1, 2 or 3, and

R13 má rovnaký význam ako určená skupina R7, alebo, pokiaľ číslo p je 1, 2 alebo 3, R13 môže znamenať vodíkový atóm, skupinu vzorcaR 13 has the same meaning as R 7 , or, when p is 1, 2 or 3, R 13 can be hydrogen, a group of the formula

-N(R14) - (CH2)q - (CO)r - R15 (V), v ktorom-N (R 14 ) - (CH 2 ) q - (CO) r - R 15 (V) in which

R14 znamená atóm vodíka, C].4-alkylovú skupinu, C13-alkylkarbonylovú skupinu, arylkarbonylovú skupinu, fenyl-C].3-alkylkarbonylovú skupinu, heteroarylkarbonylovú skupinu, heteroaryl-C|.3-alkylkarbonylovú skupinu, Ci_4alkylsulfonylovú skupinu, arylsulfonylovú skupinu, fenyl-Ci.3-alkyl-sulfonylovú skupinu, heteroarylsulfonylovú skupinu alebo heteroaryl-Ci_3-alkyl-sulfonylovú skupinu, q je číslo 1, 2, 3 alebo 4, r je číslo 1, alebo pokiaľ q je číslo 2, 3 alebo 4, r znamená tiež číslo 0 aR 14 represents a hydrogen atom, C 1. 4- alkyl, C 13 -alkylcarbonyl, arylcarbonyl, phenyl-C 1. 3- alkylcarbonyl, heteroarylcarbonyl, heteroaryl-C 1-6 alkyl; A 3- alkylcarbonyl group, a C 1-4 alkylsulfonyl group, an arylsulfonyl group, a phenyl-C 1-6 alkyl group; 3 -alkylsulfonyl, heteroarylsulfonyl or heteroaryl-C 1-3 -alkylsulfonyl, q is 1, 2, 3 or 4, r is 1, or when q is 2, 3 or 4, r is also number 0 a

R15 má rovnaký význam ako určená skupina R7, skupinu vzorcaR 15 has the same meaning as R 7 , the group of formula

-N(R16) - SO2 - R17 (VI), v ktorom-N (R 16) - SO 2 - R 17 (VI), wherein

R16 znamená atóm vodíka alebo terminálnu C|.4-alkylovú skupinu voliteľne substituovanú skupinou kyano-, trifluórmetyl-karbonyl-amino- alebo 7V-(Ci.3-alkyl)-trifluórmetyl-karbonyl-amino- aR 16 represents a hydrogen atom or a terminal C 1. A 4- alkyl group optionally substituted by cyano-, trifluoromethyl-carbonyl-amino- or N - (C 1-3 -alkyl) -trifluoromethyl-carbonyl-amino- and

R17 znamená Ci_3-alkylovú skupinu, aminoskupinu, substituovanú skupinou di-(Ci_3-alkyl)-amino-Ci_3-alkyl-karbonyl- alebo di-(Ci_3-alkyl)-amino-Ci.3-alkyl-sulfonyl- a skupinou di-(Ci.3-alkyl)-amino-karbonyl-Ci_3-alkyl-, alebo skupinu A'XCu-alkylj-C^-alkylsulfonylamino- alebo 7V-(C].3-alkyl)-fenyl-sulfonylamino-, v ktorých alkylová časť je navyše substituovaná skupinou kyano- alebo karboxy-, pričom všetky pre R6 uvedené zvyšky obsahujúce jednoducho viazané alebo nakondenzované fenylové skupiny môžu byť mono- alebo di- substituované atómom fluóru, chlóru, brómu alebo jódu, skupinou C1.5-alkyl-, triíluórmetyl-, hydroxy-, Ci_3-alkoxy-, karboxy-, C|.3-alkoxykarbonyl-, aminokarbonyl-, Ci.4-alkylaminokarbonyl-, di-(C1.4-alkyl)-amino-karbonyl-, aminosulfonyl-, C1.3-alkyl-aminosulfonyl-, di-(Ci_3-alkyl)-aminosulfonyl-, Ci_3-alkyl-sulfonylamino-, nitro- alebo kyano-, pričom substituenty môžu byť rovnaké alebo rozdielne, alebo dva susediace vodíkové atómy fenylovej skupiny môžu byť nahradené skupinou metyléndioxy-, aR 17 is C 1-3 -alkyl, amino substituted with di- (C 1-3 -alkyl) -amino-C 1-3 -alkyl-carbonyl- or di- (C 1-3 -alkyl) -amino-C 1. 3-alkyl-sulfonyl group and a di- (Ci. 3 alkyl) aminocarbonyl-C 3 alkyl-, or a group A'XCu -alkyl is C ^ -alkylsulfonylamino- and 7V- (C]. 3 - alkyl) -phenylsulfonylamino- in which the alkyl moiety is additionally substituted by cyano- or carboxy-, wherein all of the R 6 moieties mentioned containing single bonded or fused phenyl groups may be mono- or di-substituted by fluorine, chlorine, bromine or iodine, by C first 5- alkyl-, trifluoromethyl-, hydroxy-, C 1-3 -alkoxy-, carboxy-, C 1-3 -alkyl-; 3- alkoxycarbonyl-, aminocarbonyl-, Ci. 4 alkylaminocarbonyl, di (C first 4 -alkyl) -amino-carbonyl, aminosulfonyl, C first 3- alkyl-aminosulfonyl-, di- (C 1-3 -alkyl) -aminosulfonyl-, C 1-3 -alkylsulfonylamino-, nitro- or cyano-, wherein the substituents may be the same or different, or the two adjacent hydrogen atoms of the phenyl group may be replaced by methylenedioxy-, a

R5 znamená atóm vodíka alebo Ci_3-alkylovú skupinu, pričom výrazom arylskupina sa rozumie mono- alebo di- substituovaná fenylová alebo naftylová skupina, voliteľne substituovaná atómom fluóru, chlóru, brómu alebo jódu, skupinou kyano-, trifluórmetyl-, nitro-, karboxy-, aminokarbonyl-, C]_3-alkyl- alebo Ci.3-alkoxy- a výrazom heteroarylová skupina sa rozumie monocyklická päť- alebo šesťčlenná heteroarylová skupina, v uhlíkatom zvyšku voliteľne substituovaná Cj.3-alkylovou skupinou, pričom uvedená šesťčlenná heteroarylová skupina obsahuje jeden, dva alebo tri atómy dusíka a päťčlenná heteroarylová skupina obsahuje iminoskupinu voliteľne substituovanú Ci_3-alkylovou alebo fenyl-C[.3-alkylovou skupinou, atóm kyslíka alebo síry, alebo iminoskupinu voliteľne substituovanú C[.3-alkylovou alebo fenyl-Ci_3-alkylovou skupinou, alebo atóm kyslíka alebo síry, a okrem toho atóm dusíka, alebo iminoskupinu voliteľne substituovanú Cb3-alkylovou alebo fenyl-Ci_3-alkylovou skupinou a dva atómy dusíka, a okrem uvedeného môže byť na uvedené monocyklické heterocyklické skupiny cez dva susediace atómy uhlíka nakondenzovaný fenylový kruh a nastáva väzba cez dusíkový atóm alebo cez atóm uhlíka heterocyklickej časti alebo nakondenzovaného fenylového kruhu, atómy vodíka v uvedených alkylových a alkoxylových skupinách alebo v alkylových častiach určených skupín všeobecného vzorca (I) môžu byť čiastočne alebo celkom nahradené atómami fluóru, a ktorákoľvek karboxylová skupina nachádzajúca sa v uvedených skupinách môže byť nahradená terc.butoxykarbonylovou prekurzorovou skupinou, aR 5 represents a hydrogen atom or a C 1-3 -alkyl group, the term aryl being a mono- or di-substituted phenyl or naphthyl group optionally substituted by a fluorine, chlorine, bromine or iodine atom, cyano-, trifluoromethyl-, nitro-, carboxy aminocarbonyl-, C 1-3 -alkyl- or C 1-6 -alkyl-; 3- alkoxy- and the term heteroaryl means a monocyclic five- or six-membered heteroaryl group, optionally substituted in the carbon residue by C 1-6. 3 -alkyl, wherein said six-membered heteroaryl containing one, two or three nitrogen atoms and five-membered heteroaryl group contains an imino group optionally substituted by a C 3 -alkyl or phenyl-C [. A 3- alkyl group, an oxygen or sulfur atom, or an imino group optionally substituted by C 1-6 alkyl; 3 -alkyl or phenyl-C 3 -alkyl, or O or S, and also N, or NH optionally substituted by C b3 -alkyl or phenyl-C 3 -alkyl, and two nitrogen atoms, and the addition may be to said monocyclic heterocyclic groups via two adjacent carbon atoms a fused phenyl ring and the bond occurs through the nitrogen atom or through the carbon atom of the heterocyclic moiety or the fused phenyl ring, the hydrogen atoms in said alkyl and alkoxy groups or in the alkyl moieties of designated groups of formula (I) be partially or totally replaced by fluorine atoms, and any carboxyl group present in said groups may be replaced by a tert-butoxycarbonyl precursor group, and

každý z atómov vodíka naviazaných na atóm dusíka môže byť nahradený hydroxyskupinou, benzoylovou, pyridinoylová, formylovou, acetylovou, propionylovou, butanoylovou, pentanoylovou, hexanoylovou, alyloxykarbonylovou, metoxykarbonylovou, etoxykarbonylovou, propoxykarbonylovou, izopropoxykarbonylovou, butoxykarbonylovou, terc-butoxykarbonylovou, pentoxykarbonylovou, hexyloxykarbonylovou, oktyloxykarbonylovou, nonyloxykarbonylovou, decyloxykarbonylovou, undecyloxykarbonylovou, dodecyl-oxykarbonylovou, hexadecyloxykarbonylovou, benzyloxykarbonylovou, fenyletoxykarbonylovou, fenylpropoxykarbonylová, Ci_3-alkylsulfonyl-C2.4-alkoxykarbonylovou, Ci_3-alkoxy-C2.4-alkoxy-C2.4-alkoxykarbonylovou skupinou alebo ReCO-O-(RfCRg)-O-CO- skupinou, v ktorejeach of the hydrogen atoms attached to the nitrogen atom may be replaced by hydroxy, benzoyl, pyridinoyl, formyl, acetyl, propionyl, butanoyl, pentanoyl, hexanoyl, allyloxycarbonyl, methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, isopropoxycarbonyl, isopropoxycarbonyl, isopropoxycarbonyl, , nonyloxycarbonyl, decyloxycarbonyl, undecyloxycarbonyl, dodecyloxycarbonyl, hexadecyloxycarbonyl, benzyloxycarbonyl, phenylethoxycarbonyl, phenylpropoxycarbonyl, C 1-3 -alkylsulfonyl-C 2 . 4 -alkoxycarbonyl, C 3 -C -alkoxy second 4 -alkoxy-C 2nd A 4- alkoxycarbonyl group or a R e CO-O- (R f CR g ) -O-CO- group in which

Re znamená Cj.g-alkylovú skupinu, C5.7-cykloalkylovú skupinu, fenylovú alebo fenyl-C[.3-alkylovú skupinu, Rf znamená atóm vodíka, Ci_3-alkylovú skupinu, C5.7-cykloalkylovú skupinu alebo fenylovú skupinu a R8 znamená atóm vodíka alebo C[.3-alkylovú skupinu, ich tautoméry a ich soli.R e is Cj.g-alkyl, C5-7-cycloalkyl, phenyl or phenyl-C [.3 alkyl group, R f is hydrogen, Ci_3-alkyl, C5. 7 -cycloalkyl or phenyl; and R 8 represents a hydrogen atom or a C 1-6 alkyl group. A 3- alkyl group, tautomers and salts thereof.

Pozoruhodnú podskupinu zlúčenín všeobecného vzorca (I) tvoria zlúčeniny, v ktorýchA notable sub-group of compounds of formula (I) are those in which

X, R1 a R3 až R5 sú určené skôr aX, R 1 and R 3 to R 5 are as defined above and

R2 je nerozvetvená alebo rozvetvená Ci_6-alkoxykarbonylová skupina, C4.7-cyklo-alkoxykarbonylová skupina alebo aryloxykarbonylová skupina, nerozvetvená alebo rozvetvená C1.6-alkoxykarbonylová skupina, ktorá je v alkylovom zakončení substituovaná skupinou fenyl-, heteroaryl-, karboxy-, Ci.3-alkoxykarbonyl-, aminokarbonyl-, Ci_3-alkylaminokarbonyl- alebo di-(Ci_3-alkyl)-aminokarbonyl-, nerozvetvená alebo rozvetvená C2.6-alkoxy-karbonylová skupina, ktorá je v alkylovom zakončení substituovaná atómom chlóru alebo skupinou hydroxy-, C].3-alkoxy-, amino-, Ci_3-alkylamino- alebo di-(C1_3-alkyl)-amino-, ich tautoméry a ich soli.R 2 is a straight or branched C 1-6 -alkoxycarbonyl group, C 4 . 7 cyclo-alkoxycarbonyl or aryloxycarbonyl group, straight or branched C first A 6- alkoxycarbonyl group which is substituted at the alkyl terminus with a phenyl-, heteroaryl-, carboxy-, C 1-6 -alkyl group; 3- alkoxycarbonyl-, aminocarbonyl-, C 1-3 -alkylaminocarbonyl- or di- (C 1-3 -alkyl) aminocarbonyl-, branched or branched C 2 . A 6 -alkoxycarbonyl group which is substituted in the alkyl terminus by a chlorine atom or by a hydroxy- group, C 1-6. 3 -alkoxy, amino, C 3 -alkylamino or di- (C 1 _ 3 alkyl) amino, the tautomers and the salts thereof.

Druhú pozoruhodnú podskupinu zlúčenín všeobecného vzorca (I) tvoria zlúčeniny, v ktorýchA second notable sub-group of compounds of formula (I) are those in which

X, R1 a R3 až R5 sú určené skôr aX, R 1 and R 3 to R 5 are as defined above and

R2 znamená aminokarbonylovú skupinu alebo metylaminokarbonylovú skupinu, etylaminokarbonylovú skupinu voliteľne v polohe 2 etylovej skupiny substituovanú skupinou hydroxy- alebo Ci_3-alkoxy-, alebo, pokiaľ R4 neznamená skupinu amino-sulfonyl-fenyl- alebo skupinu //-(Ci-s-alkylj-Cij-alkylaminokarbonyl-fenyl-, R2 môže znamenať tiež di-(C1.2-alkyl)-aminokarbonylovú skupinu, ich tautoméry a ich soli.R 2 represents an aminocarbonyl or methylaminocarbonyl group, an ethylaminocarbonyl group optionally at the 2-position of the ethyl group substituted with a hydroxy- or C 1-3 -alkoxy- group, or, unless R 4 is an amino-sulfonylphenyl- or a - (C 1-6-) group alkyl-C 1-6 -alkylaminocarbonyl-phenyl-, R 2 may also be a di- (C 1-2 -alkyl) -aminocarbonyl group, their tautomers and salts thereof.

Tretiu pozoruhodnú podskupinu zlúčenín všeobecného vzorca (I) tvoria zlúčeniny, v ktorýchA third notable subgroup of compounds of formula (I) are those in which:

X, R1 až R3 a R5 sú určené skôr aX, R 1 to R 3 and R 5 are as defined above and

R4 znamená R7-(Ci_4-alkyl)-fenylovú skupinu, v ktorejR 4 represents a R 7 - (C 1-4 -alkyl) -phenyl group in which

R7 znamená skupinu amino-, Ci_7-alkylamino-, di-(C[.7-alkyl)-amino-, fenyl-amino-, A,-fenyl-C.|.3-alkyl-amino-, fenyl-Ci_3-alkyl-amino-, Äľ-(C1.3-alkyl)-fenyl-Ci.3-alkylamino- alebo di-(fenyl-Cb3-alkyl)-amino-, alebo znamená fenylovú skupinu, substituovanú skupinou vzorcaR 7 is amino-, C 1-7 -alkylamino-, di- (C 1-7 -alkyl) -amino-, phenyl-amino-, N , -phenyl-C 1-3 -alkyl-amino-, phenyl-C 1-7 -alkyl- 3-alkyl-amino, and L - (C1. 3 alkyl) -phenyl-C. 3- alkylamino- or di- (phenyl-C 3-3 -alkyl) -amino-, or represents a phenyl group substituted with a group of the formula

-N(R12) - CO - (CH2)p - R13 (IV), v ktorej R12, p a R13 sú určené vpredu, ich tautoméry, diastereoméry, enantioméry, ich zmesi a ich soli.-N (R 12 ) - CO - (CH 2 ) p - R 13 (IV), wherein R 12 , p and R 13 are as defined above, their tautomers, diastereomers, enantiomers, mixtures thereof and salts thereof.

Výhodné zlúčeniny všeobecného vzorca (I) sú tie zlúčeniny, v ktorýchPreferred compounds of formula (I) are those in which

R1 a R3 sú určené skôr aR 1 and R 3 are as defined above and

X je atóm kyslíka,X is an oxygen atom,

R2 je karboxylová skupina, nerozvetvená alebo rozvetvená C[.6-alkoxy-karbonylová skupina, C5.7-cykloalkoxykarbonylová skupina alebo fenoxykarbonylová skupina, nerozvetvená alebo rozvetvená C!.3-alkoxy-karbonylová skupina, ktorá v koncovej alkylovej časti je substituovaná skupinou fenyl-, heteroaryl-, karboxy-, C(.3-alkoxy-karbonyl-, aminokarbonyl-, C^-alkylaminokarbonyl- alebo di-(C].3-alkyl)-amino-karbonylovou skupinou, nerozvetvená alebo rozvetvená C2.3-alkoxy-karbonylová skupina, ktorá je v alkylovej koncovej časti substituovaná atómom chlóru, skupinou hydroxy-, C[.3-alkoxy-, amino-, C1.3-alkylamino- alebo di-(C|.3-alkyl)-amino-, aminokarbonylová alebo metylaminokarbonylová skupina, etylaminokarbonylovú skupina voliteľne v polohe 2 etylovej skupiny substituovaná skupinou hydroxy- alebo C].3-alkoxy- alebo, pokiaľ R4 neznamená skupinu aminosulfonyl-fenyl- alebo skupinu V-(C1.5-alkyl)-Ci.3-alkylaminokarbonyl-fenyl-, R2 môže znamenať tiež di-(C1_2-alkyl)-aminokarbonylovú skupinu,R 2 is carboxy, straight or branched C [. 6 -alkoxycarbonyl, C 5 . 7- cycloalkoxycarbonyl or phenoxycarbonyl, unbranched or branched C1. 3 -alkoxycarbonyl which is substituted in the terminal alkyl moiety by phenyl, heteroaryl, carboxy, C ( 3 -alkoxycarbonyl, aminocarbonyl, C 1-6 alkylaminocarbonyl or di- (C 1) 3 ). alkyl) amino-carbonyl group, straight or branched C2. 3 -alkoxy-carbonyl group which is substituted with an alkyl end portion with chloro, hydroxy, C [. 3 -alkoxy, amino, C1. 3- alkylamino- or di- (C 1-3 -alkyl) -amino-, aminocarbonyl or methylaminocarbonyl, ethylaminocarbonyl optionally substituted at the 2-position of the ethyl group substituted with hydroxy- or C 1-3 -alkoxy- or, unless R 4 represents aminosulfonyl-phenyl- or V- (C 1-5 -alkyl) -C 1-3 -alkylaminocarbonyl-phenyl-, R 2 may also be a di- (C 1-2 -alkyl) -aminocarbonyl group,

R4 znamená C3.7-cykloalkylovú skupinu, pričom metylénová skupina v polohe 4 šesťčlennej alebo sedemčlennej cykloalkylovej skupiny môže byť nahradená skupinou amino-, Ci_3-alkyl-amino- alebo skupinou di-(Ci„3-alkyl)-amino-, alebo môže byť nahradená skupinou -NH- alebo -JV(CI.3-alkyl)-, alebo skupinou R6 substituovanú fenylovú skupinu, ktorá môže byť navyše mono- alebo di - substituovaná atómom fluóru, chlóru alebo brómu, skupinou C].3-alkyl-, trifluórmetyl-, hydroxy-, Ci.3-alkoxy-, karboxy-, Cu-alkoxykarbonyl-, amino-, acetylamino-, aminokarbonyl-, Ci_3-alkyl-aminokarbonyl-, di-(C1_3-alkyl)-amino-karbonyl-, nitro- alebo kyano-, pričom substituenty môžu byť rovnaké alebo rozdielne a pričom R6 znamená atóm vodíka, fluóru, chlóru, brómu alebo jódu, skupinu kyano-, nitro-, amino-, C].5-alkyl-, C3.7-cykloalkyl-, trifluórmetyl-, fenyl-, tetrazolyl- alebo heteroarylovú skupinu, skupinu vzorcaR 4 is C 3. A 7- cycloalkyl group, wherein the methylene group at the 4-position of a six- or seven-membered cycloalkyl group may be replaced by amino-, C 1-3 -alkyl-amino- or di- (C 1-3 -alkyl) -amino-, or may be replaced by -NH- or - J V (Ci. 3 alkyl) -, or a group R6-substituted phenyl which may additionally be mono- or di - substituted by F, Cl, Br, C]. 3- alkyl-, trifluoromethyl-, hydroxy-, C 1-6 alkyl; 3 -alkoxy, carboxy, alkoxycarbonyl Cu, amino, acetylamino, aminocarbonyl, C 3 -alkyl-aminocarbonyl, di- (C 1 _ 3 alkyl) amino-carbonyl, nitro or cyano - wherein the substituents may be the same or different and wherein R 6 represents a hydrogen, fluorine, chlorine, bromine or iodine atom, a cyano-, nitro-, amino-, C 1 - group. 5- alkyl-, C 3 . 7- cycloalkyl-, trifluoromethyl-, phenyl-, tetrazolyl- or heteroaryl, a group of the formula

v ktorom atóm vodíka, viazaný na dusíkový atóm môže byť nahradený C[.3-alkylovou skupinou, skupinu C[.3-alkoxy-, amino-C2.3-alkoxy-, Ci.3-alkylamino-, C2.3-alkoxy-, di-(Ci.3-alkyl)-amino-C2.3-alkoxy-, fenyl-Ci.3-alkylamino-C2.3-alkoxy-, 7V-(C1.3-alkyl)-fenyl-C1.3-alkylamino-C2.3-alkoxy-, pyrolidino-C2_3-alkoxy-, piperidino-C2.3-alkoxy- alebo skupinu Ci_3-alkylmerkapto-, skupinu karboxy-, Ci_4-alkoxykarbonyl-, aminokarbonyl-, C^-alkyl-amino-karbonyl-, fenyl-Ci_3-alkylamino-karbonyl- alebo TV-(Ci.3-alkyl)-fenyl-Ci.3-alkylamino-karbonyl-, skupinu C3.7-cykloalkyl-karbonyl-, pričom metylénová skupina v polohe 4 šesťčlennej alebo sedemčlennej cykloalkylovej časti môže byť nahradená skupinou -NH- alebo -TV(Ci_3- alkyl)-, až 7 člennú cykloalkylénimínovú skupinu, v ktorej môže byť metylénová skupina viazaná na iminoskupinu nahradená skupinou karbonyl- alebo sulfonyl-, alebo jeden alebo dva atómy vodíka môžu byť každý nahradené C[_3-alkylovou skupinou a/alebo metylénová skupina v polohe 4 šesť alebo sedemčlennej cykloalkylén-imínovej skupiny môže byť substituovaná karboxylovou skupinou, Ci_3-alkoxykarbonylovou skupinou, aminokarbonylovou skupinou, Ci_3-alkylamino-karbonylovou skupinou, di-(Ci_3-alkyl)-aminokarbonylovou skupinou, fenyl- Ci_3-alkylamínovou skupinou alebo 7V-(Ci.3-alkyl)-fenyl-Ci.3-alkylamínovou skupinou, alebo môže byť nahradená atómom kyslíka alebo síry, skupinou sulfmyl-, sulfonyl-, -NH- alebo -/V(Cb3-alkyl)-, terminálovú C^-alkylovú skupinu, substituovanú skupinou R7, pričomwherein the hydrogen atom bonded to the nitrogen atom may be replaced by C 1-6. 3- alkyl, C 1-6. 3- alkoxy-, amino-C2. 3- alkoxy-, Ci. 3 -alkylamino, C 2nd 3- alkoxy-, di- (C 1-3 -alkyl) -amino-C 2 . 3- alkoxy-, phenyl-C 1-6 alkyl; 3 -alkylamino-C 2nd 3 -alkoxy, 7V- (C first 3-alkyl) -phenyl-C first 3 -alkylamino-C 2nd 3 alkoxy-, pyrrolidino-C 2 _ 3 -alkoxy, piperidino-C 2nd 3- alkoxy- or C 1-3 -alkylmercapto-, carboxy-, C 1-4 -alkoxycarbonyl-, aminocarbonyl-, C 1-4 -alkylamino-carbonyl-, phenyl-C 1-3 -alkylamino-carbonyl- or N- (C 1-6 -alkyloxycarbonyl-); 3- alkyl) -phenyl-C 1-6 alkyl; 3- alkylamino-carbonyl-, group C 3 . 7- cycloalkyl-carbonyl-, wherein the methylene group at the 4-position of the 6-membered or 7-membered cycloalkyl moiety may be replaced by -NH- or -TV (C 1-3 -alkyl) -, up to a 7 membered cycloalkyleneimine group in which the methylene group may be attached to NH replaced by a carbonyl or sulfonyl, or one or two hydrogen atoms may each be replaced by a C [_ 3 -alkyl and / or the methylene group in the 4-position six or seven membered cycloalkylene-imino group may be substituted by carboxy, C 3 - alkoxycarbonyl, aminocarbonyl, C 1-3 -alkylamino-carbonyl, di- (C 1-3 -alkyl) aminocarbonyl, phenyl-C 1-3 -alkylamino or N - (C 1-3 -alkyl) -phenyl-C 1-6 alkyl; 3 an alkylamino group, or may be replaced by O or S, sulfmyl-, sulfonyl, -NH- or - / W (b3 C alkyl) -, terminal C ^ -alkyl, substituted by R 7, wherein

R7 znamená C5.7-cykloalkylovú skupinu, pričom metylénová skupina v polohe 4 šesťčlennej alebo sedemčlennej cykloalkylovej skupiny môže byť nahradená skupinou -NH- alebo -N(Ci_3-alkyl)-, alebo v päťčlennej až sedemčlennej cykloalkylovej skupine môže byť nahradená skupina -(CH2)2- skupinou -CO-NH-, skupina -(CH2)3- skupinou -NH-CO-NH-, alebo skupina -(CH2)4- skupinou -NH-CO-NH-CO-, pričom vodíkový atóm viazaný na atóme dusíka môže byť vždy nahradený C μ3-alkylovou skupinou, fenylovú alebo heteroarylovú skupinu, skupinu hydroxy- alebo C].3-alkoxy-, skupinu amino-, Ci_6-alkylamino-, di-(C|.6-alkyl)-amino-, fenylamino-, Wfenyl-C1.3-alkyl-amino-, fenyl-C].3-alkylamino-, V-(Ci.3-alkyl)-fenyl-Ci_3-alkylamino- alebo di-(fenyl-C1.3-alkyl)-amino-, skupinu o)-hydroxy-C2_3-alkylamino-, N-(C i.3-alkyl)-ra-hydroxy-C2.3-alkyl-amino-, di-((o-hydroxy-C2.3-alkyl)-amino-, di-(ro-(C].3-alkoxy)-C2.3-alkyl)-amino- alebo 7V-(dioxolán-2-yl)-C|.3-alkyl-amino-, skupinu Ci.3-alkylkarbonylamino-C2.3-alkyl-amino- alebo Ci.3-alkylkarbonyl-amino-C2.3-alkyl-Ar-(C1.3-alkyl)-amino-, skupinu Ci.3-alkylsulfonylamino-, 7V-(Ci_3-alkyl)-Ci.3-alkyl-sulfonylamino-, Ci_3-alkylsulfonylamino-C2.3-alkyl-amino- alebo C1.3-alkylsulfonylamino-C2.3-alkyl-7V-(CI.3-alkyl)-amino-, skupinu hydroxykarbonyl-Ci_3-alkylamino- alebo V-(Ci.3-alkyl)-hydroxy-karbonyl-C|.3-alkyl-amino-, guanidínovú skupinu, v ktorej jeden atóm vodíka môže byť nahradený Cμ3-alkylovou skupinou, skupinu vzorcaR 7 is C 5 .7-cycloalkyl group wherein a methylene group in the 4-position six or seven membered cycloalkyl group can be replaced by -NH- or -N (C 3 alkyl) -, or a five to seven membered cycloalkyl group may be substituted - (CH 2 ) 2 - -CO-NH-, - (CH 2 ) 3 - -NH-CO-NH-, or - (CH 2 ) 4 - -NH-CO-NH-CO - wherein the hydrogen atom bound to the nitrogen atom can in each case be replaced by a C [ beta] 3 -alkyl group, a phenyl or heteroaryl group, a hydroxy- or C1-group. 3- alkoxy-, amino-, C 1-6 -alkylamino-, di- (C 1-6 -alkyl) -amino-, phenylamino-, W-phenyl-C 1 . 3- alkyl-amino-, phenyl-C 1. 3 -alkylamino, N- (Cl. 3 alkyl) phenyl-C 3 -alkylamino or di- (phenyl-C1. 3 alkyl) amino, a group of) hydroxy-C 2 _ 3 - alkylamino-, N- (C 1-3 -alkyl) -ra-hydroxy-C 2 . 3-alkyl-amino, di - ((o-hydroxy-C2. 3 alkyl) amino, di (ro- (C]. 3 -alkoxy) -C second 3-alkyl) -amino- and 7V- (dioxolan-2-yl) C |. 3 -alkyl-amino, a C. 3 alkylcarbonylamino C-2. 3-alkyl-amino or Cl. 3 -alkylcarbonyl-amino-C 2. 3 -alkyl-N - (C1. 3 alkyl) amino, a C. 3 -alkylsulfonylamino-, 7V- (C 3 -alkyl) -C. 3-alkyl-sulfonylamino, C 3 -C alkylsulfonylamino second 3 -alkyl-amino or C1. 3 -C alkylsulfonylamino second 3-alkyl-7V- (Ci. 3 alkyl) amino group, a hydroxycarbonyl-C 3 -alkylamino or N (C ( 3- alkyl) -hydroxy-carbonyl-C 1-3 -alkyl-amino-, a guanidine group in which one hydrogen atom can be replaced by a C 1-3 -alkyl group, a group of the formula

- N(R8) - CO - (CH2)n - R9 (II), v ktorom- N (R 8 ) - CO - (CH 2 ) n - R 9 (II) in which

R8 znamená atóm vodíka alebo C[.3-alkylovú skupinu, n znamená číslo 0, 1,2, alebo 3,R 8 represents a hydrogen atom or C 1-6 alkyl; 3- alkyl, n is 0, 1, 2, or 3,

R9 znamená skupinu amino-, Ci_3-alkylamino-, di-(C1.3-alkyl)-amino-, fenylamino-, benzylamino- alebo C]_4-alkoxy-, 5- až 7-člennú cyklo-alkylén-imínovú skupinu, pričom metylénová skupina v polohe 4 šesť-člennej alebo sedemčlennej piperidínovej skupiny môže byť nahradená atómom kyslíka alebo síry, skupinou -NH-, -7ť(C].3-alkyl)-, -7V(fenyl)-, -/V(C|.3-alkyl-karbonyl)- alebo -/V(benzoyl)-, alebo pokiaľ n znamená číslo 1, 2, alebo 3 môže R9 znamenať tiež atóm vodíka, skupinu vzorcaR 9 represents an amino, a C 3 -alkylamino, di- (C first 3 -alkyl) amino, phenylamino, benzylamino or C] _ 4 -alkoxy, a 5- to 7-membered cyclo-alkylene an amino group, wherein the methylene group at the 4-position of the 6-membered or 7-membered piperidine group may be replaced by an oxygen or sulfur atom, an -NH-, -7 '(C 1-3 -alkyl) -, -7 N (phenyl) -, - N - (C 1-3 -alkylcarbonyl) - or - N - (benzoyl) -, or when n is 1, 2, or 3, R 9 can also be hydrogen, a group of the formula

-N(R10) - (CH2)m - (CO)o - R (III), v ktorom-N (R 10 ) - (CH 2 ) m - (CO) o - R (III) in which

R10 znamená atóm vodíka, C].3-alkylovú skupinu, C[.3-alkyl-karbonylovú skupinu, Ci_3-alkylasulfonylovú skupinu, m je číslo 1, 2 alebo 3, o je číslo 1 alebo, pokiaľ m znamená číslo 2 alebo 3, tiež číslo 0 aR 10 represents a hydrogen atom, C 1. 3- alkyl, C 1-6 alkyl; 3 -alkylcarbonyl, C 1-3 -alkylasulfonyl, m is 1, 2 or 3, o is 1 or, when m is 2 or 3, also 0; and

R11 znamená skupinu amino-, Ci.3-alkylamino-, di-(Ci.3-alkyl)-amino-, alebo skupinu C|_3-alkoxy-C|.3-alkoxy-, alebo 5- až 7-člennú cyklo-alkylén-imínovú skupinu, pričom metylénová skupina v polohe 4 piperidínovej skupiny môže byť nahradená atómom kyslíka alebo síry, skupinou -NH-, -MC(_3-alkyl)-, -N(fenyl)-, -/V(Ci_3-alkylkarbonyl)- alebo -/V(benzoyl)-, skupinu C4.7-cykloalkylamino- alebo C4_7-cykloalkenylamino-, v ktorej sa poloha 1 kruhu nezúčastňuje na dvojitej väzbe, až 7 člennú cykloalkylénimínovú skupinu, v ktorej cykloalkylénová časť môže byť kondenzovaná s fenylovou skupinou alebo, jeden alebo dva atómy vodíka môžu byť každý nahradené C^-alkylovou skupinou, a/alebo metylénová skupina v polohe 3 pyrolidínovej skupiny môže byť substituovaná hydroxyskupinou, skupinou Cj-3-alkoxy-, metylénová skupina v polohe 4 šesťčlennej alebo sedemčlennej cykloalkylénimínovej skupiny môže byť substituovaná hydroxy-skupinou, hydroxy-C].3-alkylovou skupinou, skupinou Ci.3-alkoxy-, karboxy-, Ci_3-al koxykarbonyl-, aminokarbonyl-, Ci_3-alkylamino-karbonyl, di-(C1_3-alkyl)-aminokarbonyl-, fenyl-Ci_3-alkylamino- alebo yV-jCij-alkylj-fényl-Cu-alkylammo-, alebo uvedená metylénová skupina môže byť nahradená atómom kyslíka alebo síry, skupinou sulfínyl-, sulfonyl-, -NH-, -A^Cu-alkyl)-, -7V(fenyl)-, -7V(fenyl-C|.3-alkyl)-, -íV(Cb3-alkylkarbonyl)-, -N(Ci_4-hydroxykarbonyl)-, -TV(C1.4-alkoxy-karbonyl)-, -jV(benzoyl)- alebo -7V(fenyl-Ci.3-alkyl-karbonyl)pričom metylénová skupina, ktorá je viazaná s imínovým atómom dusíka cykloalkylénimínovej skupiny môže byť nahradená karbonylovou skupinou alebo sulfonylovou skupinou, alebo v päťčlennej až šesťčlennej monocyklickej, alebo s fenylovou skupinou kondenzovanej cykloalkylénimínovej skupine obidve metylénové skupiny viazané na imínový atóm dusíka môžu byť každá nahradené karbonylovou skupinou, alebo R6 znamená C[.4-alkylovú skupinu, ktorá je na koncovej časti substituovaná skupinou skupinou karboxy-, C!.3-alkoxykarbonyl-, aminokarbonyl-, Ci.3-alkylamino-karbonyl- alebo di-(Ci_3-alkyl)-aminokarbonylalebo 4 až 7 člennou cykloalkylén-iminokarbonylovou skupinou, skupinu vzorcaR 11 represents amino-, C 1-6 alkyl; 3- alkylamino-, di- (C 1-3 -alkyl) -amino-, or a C 1-3 -alkoxy-C 1-4 group. A 3- alkoxy-, or 5- to 7-membered cycloalkylene-imine group, wherein the methylene group at the 4-position of the piperidine group may be replaced by an oxygen or sulfur atom, -NH-, -MC ( -3- alkyl) -, -N (phenyl) -, - / V (C 3 alkylcarbonyl) - or - / V (benzoyl) -, C 4 .7-cycloalkylamino or C 4 _7-cykloalkenylamino-, wherein the position of the ring 1 not involved in the a double bond, up to a 7 membered cycloalkyleneimine group in which the cycloalkylene moiety can be fused with a phenyl group or, one or two hydrogen atoms can each be replaced by a C 1-6 -alkyl group, and / or the methylene group at the 3-position of the pyrrolidine group can be substituted with hydroxy , the C 1-3 -alkoxy- group, the methylene group at the 4-position of a six- or seven-membered cycloalkyleneimine group may be substituted with a hydroxy group, hydroxy-C 1. A 3- alkyl group; 3 -alkoxy, carboxyl, C 3-al koxykarbonyl-, aminocarbonyl, C 3 -alkylamino-carbonyl, di- (C 1 _ 3 alkyl) aminocarbonyl-, phenyl-Ci_3-alkylamino or YV-jCij- alkyl-phenyl-C 1-6 -alkylamino-, or said methylene group may be replaced by an oxygen or sulfur atom, a sulfinyl-, a sulfonyl-, -NH-, -N (C 1-4 -alkyl) -, -7 N (phenyl) -, -7 N (phenyl-C |. 3 alkyl) -, -N (C b3 -alkylcarbonyl) -, -N (C 4 -hydroxykarbonyl) -, -TV (C1. 4 -alkoxy-carbonyl) -, -N (benzoyl - or - N - (phenyl-C 1-3 -alkylcarbonyl) wherein the methylene group attached to the imine nitrogen atom of the cycloalkyleneimine group may be replaced by a carbonyl group or a sulfonyl group, or in a 5- to 6-membered monocyclic or phenyl condensed group the cycloalkylenimine group of the two methylene groups bonded to the imine nitrogen atom may each be replaced by a carbonyl group, or R 6 is C 1-6 . A 4- alkyl group which is substituted at the terminal moiety by a carboxy-, C1-group; 3- alkoxycarbonyl-, aminocarbonyl-, Ci. A 3- alkylamino-carbonyl- or di- (C 1-3 -alkyl) -aminocarbonylamino or 4 to 7 membered cycloalkylene-iminocarbonyl group of the formula

-N(R12) - CO - (CH2)p - R13 (IV), v ktorom-N (R 12 ) -CO- (CH 2 ) p -R 13 (IV) wherein

R12 znamená atóm vodíka, Ci_3-alkylovú alebo C5.7-cykloalkylovú skupinu, fenyl-Ci_3-alkylovú alebo heteroaryl-Ci.3-alkylovú skupinu a p je číslo 0, 1, 2 alebo 3 aR 12 is hydrogen, C 1-3 -alkyl or C 5 -alkyl. 7- cycloalkyl, phenyl-C 1-3 -alkyl or heteroaryl-C 1-3 -alkyl, and p is 0, 1, 2 or 3; and

R13 má rovnaký význam ako určená skupina R7, alebo pokiaľ číslo p je 1,2 alebo 3, R13 môže tiež znamenať vodíkový atóm, skupinu vzorcaR 13 has the same meaning as R 7 , or when p is 1, 2 or 3, R 13 can also be a hydrogen atom, a group of the formula

-N(R14) - (CH2)q - (CO)r - R15 (V), v ktorom-N (R 14 ) - (CH 2 ) q - (CO) r - R 15 (V) in which

R14 znamená atóm vodíka, C1.4-alkylovú skupinu, Ci_3-alkylkarbonylovú skupinu, fenylkarbonylovú skupinu, fenyl-Ci.3-alkylkarbonylovú skupinu, heteroarylkarbonylovú skupinu, heteroaryl-C|.3-alkylkarbonylovú skupinu, C].4-alkylsulfonylovú skupinu, fenylsulfonylovú skupinu, fenyl-C^-alkyl-sulfonylovú skupinu, heteroarylsulfonylovú skupinu alebo heteroaryl-Ci_3-alkyl-sulfonylovú skupinu, q je číslo 1, 2, 3 alebo 4, r je číslo 1, alebo pokiaľ q je číslo 2, 3 alebo 4, r znamená tiež číslo 0 aR 14 represents a hydrogen atom, C 1 . 4 -alkyl, C 3 -alkylcarbonyl group, a phenylcarbonyl group, a phenyl-Ci.3-alkylcarbonyl, heteroarylcarbonyl, heteroaryl-C |. 3- alkylcarbonyl, C 1. 4- alkylsulfonyl, phenylsulfonyl, phenyl-C 1-6 -alkylsulfonyl, heteroarylsulfonyl or heteroaryl-C 1-3 -alkylsulfonyl, q is 1, 2, 3 or 4, r is 1, or when q is 2, 3 or 4, r is also 0 and

R15 má rovnaký význam ako určená skupina R7, skupinu vzorcaR 15 has the same meaning as R 7 , the group of formula

-N(R16) - SO2 - R17 (VI), v ktorom-N (R 16) - SO 2 - R 17 (VI), wherein

R16 znamená atóm vodíka alebo terminálnu Ci.4-alkylovú skupinu voliteľne substituovanú skupinou kyano-, trifluórmetyl-karbonyl-amino- alebo jV-(C|.3-alkyl)-trifluórmetyl-karbonyl-amino- aR 16 represents a hydrogen atom or a terminal C 1-6 alkyl; A 4- alkyl group optionally substituted by cyano-, trifluoromethyl-carbonyl-amino- or N - (C 1-3 -alkyl) -trifluoromethyl-carbonyl-amino-;

R17 znamená Ci.3-alkylovú skupinu, aminoskupinu, substituovanú skupinou di-(Ci_3-alkyl)-amino-Ci_3-alkyl-karbonyl- alebo di-(Ci_3-alkyl)-amino-Ci.3-alkyl-sulfonyl- a skupinou di-(C1.3-alkyl)-amino-karbonyl-C|.3-alkyl, pričom všetky pre R6 uvedené zvyšky obsahujúce jednoducho viazané alebo nakondenzované fenylové skupiny môžu byť mono- alebo di- substituované atómom fluóru, chlóru alebo brómu, skupinou Ci_3-alkyl-, trifluórmetyl-, hydroxy-, C[.3-alkoxy-, karboxy-, C1.3-alkoxykarbonyl-, aminokarbonyl-, Ci.3-alkylaminokarbonyl-, aminosulfonyl-, Ci_3-alkyl-aminosulfonyl-, nitro- alebo kyano-, pričom substituenty môžu byť rovnaké alebo rozdielne, alebo dva susediace vodíkové atómy fenylovej skupiny môžu byť nahradené skupinou metyléndioxy-, aR 17 is C 1-6. 3- alkyl, amino substituted by di- (C 1-3 -alkyl) -amino-C 1-3 -alkyl-carbonyl- or di- (C 1-3 -alkyl) -amino-C 1-3 -alkylsulfonyl-, and di- (C1. 3 alkyl) aminocarbonyl-C |. 3- alkyl, wherein all of the R 6 radicals mentioned containing single-bonded or fused phenyl groups may be mono- or di- substituted by a fluorine, chlorine or bromine atom, a C 1-3 -alkyl-, trifluoromethyl-, hydroxy-, C 1-6 -alkyl group. 3 -alkoxy, carboxy, C first 3- alkoxycarbonyl-, aminocarbonyl-, Ci. 3- alkylaminocarbonyl-, aminosulfonyl-, C 1-3 -alkyl-aminosulfonyl-, nitro- or cyano-, wherein the substituents may be the same or different, or two adjacent hydrogen atoms of the phenyl group may be replaced by a methylenedioxy- group, and

R5 znamená atóm vodíka alebo Ci_3-alkylovú skupinu, pričom uvedený výraz heteroarylová skupina znamená voliteľne v uhlíkovom skelete C!.3-alkylovou skupinou substituovanú skupinu pyridinyl-, pyrazinyl-, pyrimidinyl-, pyridazinyl-, pyrolyl-, furyl-, tienyl-, oxazolyl-, tiazolyl-, pyrazolyl-, imidazolyl- alebo triazolyl-, v ktorých jeden atóm vodíka, viazaný na dusíkový atóm môže byť nahradený Ci_3-alkylovou skupinou alebo fenyl-C|.3-alkylovou skupinou a pričom päťčlenné, najmenej jednu iminoskupinu obsahujúce heteroarylové skupiny sú viazané cez atóm uhlíka alebo dusíka, v uvedených skupinách môže byť atóm vodíka, ktorý je viazaný na atóm dusíka, nahradený in vivo odštiepite ľnou skupinou, najmä acetylovou skupinou alebo íerc-butoxykarbonylovou skupinou, v uvedených skupinách, ktoré obsahujú karboxylové skupiny, karboxylové skupiny môžu byť substituované in vivo odštiepiteľným zvyškom, napríklad vo forme terc-butoxykarbonylovej skupiny, vodíkové atómy v hore uvedených alkylových a alkoxylových skupinách, alebo v alkylových častiach určených skupín vzorca (I) môžu byť celkom alebo čiastočne nahradené atómami fluóru a hore uvedené zvyšky, ktoré obsahujú nasýtené alkylové alebo alkoxylové časti obsahujúce viac ako dva atómy uhlíka môžu byť rozvetvené alebo nerozvetvené pokiaľ nebolo uvedené inak, ich tautoméry, diastereoméry, enantioméry, ich zmesi a soli.R 5 represents a hydrogen atom or a C 1-3 -alkyl group, said heteroaryl group being optionally substituted in the carbon skeleton of a C 1-3 -alkyl group substituted by pyridinyl-, pyrazinyl-, pyrimidinyl-, pyridazinyl-, pyrrolyl-, furyl-, thienyl -, oxazolyl-, thiazolyl-, pyrazolyl-, imidazolyl- or triazolyl- in which one hydrogen atom attached to the nitrogen atom can be replaced by a C 1-3 -alkyl group or a phenyl-C 1-6 -alkyl group. 3 -alkyl, and the five-membered, at least one NH-containing heteroaryl groups are linked via a carbon or nitrogen atom, the above groups can be hydrogen bonded to the nitrogen atom, is replaced with a leaving in vivo cling group, in particular acetyl or íerc- butoxycarbonyl, in said carboxyl-containing groups, the carboxyl groups may be substituted in vivo by a leaving group, for example in the form of a tert-butoxycarbonyl group, hydrogen atoms in the above alkyl and alkoxy groups, or in the alkyl portions of the designated groups of formula (I) may be wholly or partially replaced by fluorine atoms, and the above-mentioned radicals containing saturated alkyl or alkoxy moieties containing more than two carbon atoms may be branched or unbranched unless otherwise specified, their tautomers, diastereomers, enantiomers isomers, mixtures thereof and salts thereof.

Pozoruhodná podskupina výhodných zlúčenín všeobecného vzorca (I) sú zlúčeniny, v ktorýchA notable subset of preferred compounds of formula (I) are those in which

X, R1 a R3 až R5 sú určené skôr aX, R 1 and R 3 to R 5 are as defined above and

R2 znamená nerozvetvenú alebo rozvetvenú Ci_6-alkoxy-karbonylovú skupinu, C5_7-cykloalkoxykarbonylovú skupinu alebo fenoxykarbonylovú skupinu, nerozvetvenú alebo rozvetvenú Ci.3-alkoxy-karbonylovú skupinu, ktorá je v koncovej alkylovej časti substituovaná skupinou fenyl-, karboxy-, Ci_3-alkoxy-karbonyl-, aminokarbonyl-, Ci_3-alkylaminokarbonyl- alebo di-(Ci_3-alkyl)-amino-karbonyl-, nerozvetvenú alebo rozvetvenú C2.3-alkoxy-karbonylovú skupinu, ktorá je v koncovej alkylovej časti substituovaná skupinou hydroxy-, Ci_3-alkoxy-, amino-, Ci_3-alkylamino- alebo di-(C1.3-alkyl)-amino-, ich tautoméry, diastereoméry, enantioméry, ich zmesi a soli. R2 is a linear or branched a C 6 alkoxy-carbonyl, C 5 _7-cycloalkoxycarbonyl or a phenoxycarbonyl group, a linear or branched C. A 3- alkoxy-carbonyl group which is substituted in the terminal alkyl moiety by phenyl, carboxy, C 1-3 -alkoxy-carbonyl, aminocarbonyl, C 1-3 -alkylaminocarbonyl or di- (C 1-3 -alkyl) amino-carbonyl -, unbranched or branched C2. 3 -alkoxy-carbonyl, which is the terminal alkyl substituted by hydroxy, C 3 -alkoxy, amino, C 3 -alkylamino or di- (C first 3 alkyl) amino, tautomers thereof, diastereomers, enantiomers, mixtures and salts thereof.

Druhá veľmi pozoruhodná podskupina výhodných zlúčenín všeobecného vzorca (I) sú zlúčeniny v ktorýchA second very remarkable subset of preferred compounds of formula (I) are those in which

X, R1 a R3 až R5 sú určené skôr aX, R 1 and R 3 to R 5 are as defined above and

R2 znamená aminokarbonylovú alebo metylaminokarbonylovú skupinu, etylamino-karbonylovú skupinu, ktorá môže byť voliteľne substituovaná v polohe 2 v etylovej skupine skupinou hydroxy- alebo C]_3-alkoxy-, pričom pokiaľ R4 neznamená aminosulfonyl-fenyl- alebo alkyl)-Ci.3-alkylaminokarbonyl-fenylovú skupinu, potom R2 môže znamenať aj di-(Ci.2-alkyl)-aminokarbonylovú skupinu, ich tautoméry, diastereoméry, enantioméry, ich zmesi a soli.R 2 represents an aminocarbonyl or methylaminocarbonyl group, an ethylaminocarbonyl group which may be optionally substituted at the 2-position in the ethyl group by a hydroxy- or C 1-3 -alkoxy- group, provided that R 4 is not an aminosulfonyl-phenyl- or alkyl) -C 1 group. 3-alkylaminocarbonyl-phenyl, then R 2 may also be di- (C 1-2 -alkyl) -aminocarbonyl, their tautomers, diastereomers, enantiomers, mixtures and salts thereof.

Tretia veľmi pozoruhodná podskupina výhodných zlúčenín všeobecného vzorca (I) sú zlúčeniny v ktorýchA third very remarkable subset of preferred compounds of formula (I) are those in which

X, R1 až R3 a R5 sú určené skôr aX, R 1 to R 3 and R 5 are as defined above and

R4 znamená R7-(n-CM-alkyl)-fenylovú skupinu, v ktorejR 4, R 7 - (n C M alkyl) -phenyl, wherein

R7 znamená skupinu amino-, Ci_6-alkylamino-, di-(C1.6-alkyl)-amino-, fenyl-amino-, /V-fenyl-Ci_3-alkyl-amino-, fenyl-Ci_3-alkyl-amino-, 7V-(Ci.3-alkyl)-fenyl-Ci.3-alkylamino- alebo di-(fenyl-C1.3-alkyl)-amino-, alebo fenylovú skupinu, ktorá je substituovaná skupinou vzorca (IV)R 7 represents an amino, a C 6 -alkylamino, di- (C first 6 alkyl) amino, phenyl-amino, / V-phenyl-C 3 -alkyl-amino, phenyl-C 3 - alkyl-amino- N - (C 1-3 -alkyl) -phenyl-C 1-6 alkyl; 3 -alkylamino or di- (phenyl-C first 3 alkyl) amino, or phenyl which is substituted by a group of formula (IV)

- N(R12) - CO - (CH2)p - R13 (IV), v ktorej R12, p a R13 sú určené skôr, ich tautoméry, diastereoméry, enantioméry, ich zmesi a ich soli.- N (R 12 ) - CO - (CH 2 ) p - R 13 (IV), wherein R 12 , p and R 13 are as defined above, their tautomers, diastereomers, enantiomers, mixtures thereof and salts thereof.

Veľmi výhodné zlúčeniny vzorca (I) sú tie, v ktorýchHighly preferred compounds of formula (I) are those in which

X znamená atóm kyslíka,X is an oxygen atom,

R1 znamená atóm vodíka,R 1 represents a hydrogen atom,

R2 znamená karboxylovú skupinu, nerozvetvenú alebo rozvetvenú Ci.4-alkoxy-karbonylovú skupinu alebo fenoxykarbonylovú skupinu, nerozvetvenú alebo rozvetvenú C].3-alkoxy-karbonylovú skupinu, ktorá je v koncovej alkylovej časti substituovaná fenylovou, karboxylovou, Ci_3-alkoxykarbonylovou, aminokarbonylovou, C]_3-alkylaminokarbonylovou alebo di-(Ci_3-alkyl)-amino-karbonylovou skupinou, nerozvetvenú alebo rozvetvenú C2.3-alkoxy-karbonylovú skupinu, ktorá je v koncovej alkylovej časti substituovaná skupinou hydroxy-, C].3-alkoxy-, amino-, Ci_3-alkylamino- alebo di-(C|.3-alkyl)-amino-, aminokarbonylovú alebo metylaminokarbonylovú skupinu, etylaminokarbonylovú skupinu, ktorá môže byť voliteľne substituovaná v polohe 2 v etylovej skupine skupinou hydroxy- alebo C|.3-alkoxy-, pričom pokiaľ R4 neznamená aminosulfonyl-fenylovú alebo N-(C{.5- alkyl)-Ci_3-alkylaminokarbonyl-fenylovú skupinu, potom R2 môže znamenať aj di-(C|.2-alkyl)-aminokarbonylovú skupinu,R 2 is carboxy, a linear or branched Ci.4-alkoxy-carbonyl or phenoxycarbonyl group, a linear or branched C]. A 3 -alkoxycarbonyl group which is substituted in the terminal alkyl moiety by phenyl, carboxyl, C 1-3 -alkoxycarbonyl, aminocarbonyl, C 1-3 -alkylaminocarbonyl or di- (C 1-3 -alkyl) -amino-carbonyl, straight or branched C 2 . A 3 -alkoxycarbonyl group which is substituted in the terminal alkyl moiety by a hydroxy-, C 1 - group. 3- alkoxy-, amino-, C 1-3 -alkylamino- or di- (C 1-3 -alkyl) -amino-, aminocarbonyl or methylaminocarbonyl, ethylaminocarbonyl, which may optionally be substituted at the 2-position in the ethyl group with hydroxy- or C |. 3- alkoxy-, provided that when R 4 is not an aminosulfonyl-phenyl or N- (C 1-5 -alkyl) -C 1-3 -alkylaminocarbonyl-phenyl group, then R 2 may also be a di- (C 1-2 -alkyl) aminocarbonyl group

R3 znamená Cj^-alkylovú skupinu alebo fenylovú skupinu, ktorá môže byť substituovaná atómom fluóru, chlóru alebo brómu, skupinou trifluórmetyl-, Ομ3- alkyl-, hydroxy- alebo C|_3-alkoxy-,R 3 represents a C 1-6 -alkyl or a phenyl group which may be substituted by a fluorine, chlorine or bromine atom, a trifluoromethyl-, a C 1-3 -alkyl-, a hydroxy- or a C 1-3 -alkoxy-,

R4 znamená C5.6-cykloalkylovú skupinu, pričom metylénová skupina v polohe 4 cyklohexylovej skupiny môže byť substituovaná skupinou amino-, Cj-3-alkylamino- alebo di-fCu-alkyljamino-, alebo nahradená skupinou -NH- alebo -MCl-3-alkyl)-, fenylovú skupinu, fenylovú skupinu disubstituovanú skupinou C].3-alkyl-, C|_3-alkoxy- alebo nitro-, pričom substituenty môžu byť rovnaké alebo rozdielne, alebo fenylovú skupinu substituovanú skupinou R6, pričom uvedená fenylová skupina môže byť navyše substituovaná atómom fluóru, chlóru alebo brómu alebo skupinou amino- alebo nitro-, R4 is C5, 6-cycloalkyl group wherein a methylene group in the 4-cyclohexyl may be substituted by amino, C-3-alkylamino or di-FCU-alkyljamino-, or replaced by a -NH- or -MCl- 3-alkyl) -, phenyl, phenyl disubstituted with C 1. 3- alkyl-, C 1-3 -alkoxy- or nitro-, wherein the substituents may be the same or different, or a phenyl group substituted by R 6 , wherein said phenyl group may additionally be substituted by a fluorine, chlorine or bromine atom or an amino- or nitro-,

SK 287312 Β6 pričom R6 znamená atóm fluóru, chlóru alebo brómu,Wherein R 6 represents a fluorine, chlorine or bromine atom,

C!.3-alkylovú skupinu, Cb3-alkoxylovú skupinu, nitroskupinu, aminoskupinu alebo C5.6-cykloalkylovú skupinu, prostredníctvom uhlíkového atómu viazanú pyrolylovú skupinu, pyrazolylovú skupinu, imidazolylovú skupinu, triazolylovú skupinu alebo tetrazolylovú skupinu, pričom uvedené heteroaromatické skupiny môžu byť v uhlíkovom skelete substituované C1.3-alkylovou skupinou, alebo jeden vodíkový atóm viazaný na dusíkovom atóme môže byť nahradený C^-alkylovou skupinou alebo fenyl-C|.3-alkylovou skupinou, skupinu vzorcaCl .3 alkyl, C b3 alkoxy group, a nitro group, an amino group or a C5-.6 cycloalkyl group, linked through a carbon atom of pyrrolyl, pyrazolyl, imidazolyl, triazolyl or tetrazolyl group, the said heteroaromatic groups may be C 1 -substituted in the carbon skeleton. The 3- alkyl group or one hydrogen atom bonded to the nitrogen atom may be replaced by a C 1-6 -alkyl group or a phenyl-C 1-6 -alkyl group. 3- alkyl, a group of formula

skupinu karboxy-, C1.4-alkoxykarbonyl-, fenyl-Ci.3-alkyl-amino-karbonyl- alebo C5_7-cykloalkyl-karbonyl-, päťčlennú alebo šesťčlennú cykloalkylénimínovú skupinu, pričom metylénová skupina v polohe 4 piperidínovej skupiny môže byť nahradená atómom kyslíka alebo atómom síry, skupinou -NH- alebo skupinou -/V(C)_3-alkyl)-, nerozvetvenú, Ci_3-alkylovú skupinu v koncovej časti substituovanú skupinou R7, pričomcarboxyl group, C first 4- alkoxycarbonyl-, phenyl-C 1-6 -alkyl; 3-alkyl-amino-carbonyl or a C 5 _ 7 cycloalkyl-carbonyl, a five-membered or six-membered cykloalkylénimínovú group, the methylene group at position 4 of the piperidine group can be replaced by oxygen, S, -NH- or - / A (C 1-3 -alkyl) -, unbranched, C 1-3 -alkyl group in the terminal portion substituted with R 7 , wherein:

R7 znamená C5.7-cykloalkylovú skupinu, pričom v päťčlennej alebo šesťčlennej cykloalkylovej skupine môže byť -(CH2)2- skupina nahradená skupinou -CO-NH-, skupina -(CH2)3- môže byť nahradená skupinou -NH-CO-NH-a skupina -(CH2)4- môže byť nahradená skupinou -NH-CO-NH-CO-, pričom vždy vodíkový atóm viazaný na atóme dusíka môže byť nahradený Ci.3-alkylovou skupinou, fenylovú alebo pyridinylovú skupinu, alebo prostredníctvom uhlíkového atómu alebo dusíkového atómu viazanú pyrolylovú skupinu, pyrazolylovú skupinu, imidazolylovú skupinu alebo triazolylovú skupinu, pričom uvedené heteroarylové skupiny môžu byť v uhlíkovom skelete substituované C^-alkylovou skupinou, alebo vodík viazaný na atóme dusíka môže byť nahradený Ci_3-alkylovou skupinou, skupinu hydroxy- alebo Cb3-alkoxy-, skupinu amino-, Ci_6-alkylamino-, di-(Ci_6-alkyl)-amino-, fenylamino-, A,-fenyl-Cb3-alkyl-amino-, fenyl-C,,3-alkylamino- alebo A-(C1.3-alkyl)-fenyl-C|.3-alkyl-amino-, skupinu a>-hydroxy-C2.3-alkyl-amino-, jV-(Ci_3-alkyl)-ro-hydroxy-C2.3-alkyl-amino-, di-(ú)-hydroxy-C2.3-alkyl)-amino- alebo di-(a>-(Ci j-alkoxyj-Cjj-alkylj-amino-, skupinu Ci.3-alkylkarbonylamino-C2.3-alkyl-amino- alebo Ci.3-alkylkarbonyl-amino- C2.3-alkyl-/V-(C|.3-alkyl)-amino-, skupinu Ci.3-alkylsulfonylamino-, Af-(Ci_3-alkyl)-C1.3-alkylsulfonylamino-, Ci.3-alkyl-sulfonylamino-C2.3-alkylamino-, alebo Ci_3-alkylsulfonylamino-C2.3-alkyl-N-(Ci.3-alkyl)-amino-, skupinu hydroxykarbonyl-C1.3-alkyl-amino- alebo skupinu 1V-(Cb3-alkyl)-hydroxy-karbonyl-C|.3-alkylamino-, guanidínovú skupinu, v ktorej môže byť vodík nahradený skupinou Cb3-alkyl-, skupinu vzorcaR 7 is C 5 . 7- cycloalkyl, wherein in a 5- or 6-membered cycloalkyl group the - (CH 2 ) 2 - group may be replaced by -CO-NH-, the - (CH 2 ) 3 - may be replaced by -NH-CO-NH- a - (CH 2 ) 4 - may be replaced by -NH-CO-NH-CO-, wherein the hydrogen atom bonded to the nitrogen atom may in each case be replaced by a C 1-3 -alkyl, phenyl or pyridinyl group, or by a carbon atom or a nitrogen-linked pyrrolyl, pyrazolyl, imidazolyl or triazolyl group, wherein said heteroaryl groups may be substituted in the carbon skeleton by a C 1-6 -alkyl group or the hydrogen bonded to the nitrogen atom may be replaced by a C 1-3 -alkyl group, a hydroxy- or b C 3 alkoxy, an amino, a C 6 -alkylamino, di (C 6 alkyl) amino, phenylamino, A, phenyl-C-c3-alkyl amino, phenyl-C ,, 3 alkylamino- or N- (C first 3 -alk yl) -phenyl-C 1-3 -alkyl-amino-, a? -hydroxy-C 2 group . 3- alkyl-amino- N - (C 1-3 -alkyl) -ro-hydroxy-C 2 . 3-alkyl-amino, di (s) a hydroxy-C 2nd 3-alkyl) amino or di- (i> - (C-j-alkoxyj CJJ-alkylj-amino, a C.-C 3 alkylcarbonylamino second 3 -alkyl-amino or C. 3 -alkylcarbonyl- amino-C 2 .3-alkyl / N (C |. 3 alkyl) amino, a C. -alkylsulfonylamino- 3, and f - (Ci_3-alkyl) -C first 3 -alkylsulfonylamino-, C . 3-alkyl-sulfonyl-C 2 .3-alkylamino, alkylsulfonylamino or a C 3 -C 2. 3-alkyl-N- (Ci. 3 alkyl) amino group, a hydroxycarbonyl-C1. 3 alkyl amino group or one N (C b3 alkyl) hydroxy-carbonyl-C | .3-alkylamino, guanidino, wherein hydrogen may be replaced by C-alkyl-B3, the group of formula

- N(R8) - CO - (CH2)n - R9 (II), v ktorom- N (R 8 ) - CO - (CH 2 ) n - R 9 (II) in which

R8 znamená atóm vodíka alebo Ci_3-alkylovú skupinu, n znamená číslo 0, 1,2, alebo 3,R 8 is hydrogen or C 1-3 -alkyl, n is 0, 1, 2, or 3,

R9 znamená skupinu amino-, Ci_3-alkylamino-, di-(C1.3-alkyl)-amino- alebo C[.4-alkoxy-, 5- až 7-člennú cykloalkylénimínovú skupinu, pričom metylénová skupina v polohe 4 piperidínovej skupiny môže byť nahradená skupinou -NH-, -jV(Ci_3-alkyl)- alebo -/V(Ci_3-alkylkarbonyl)-, alebo pokiaľ n znamená číslo 1, 2, alebo 3 môže tiež znamenať atóm vodíka, skupinu vzorcaR 9 represents an amino, a C 3 -alkylamino, di- (C1. 3 alkyl) amino or C [. A 4- alkoxy-, 5- to 7-membered cycloalkyleneimine group, wherein the methylene group at the 4-position of the piperidine group may be replaced by -NH-, -N (C 1-3 -alkyl) - or - N (C 1-3 -alkylcarbonyl) - or when n is 1, 2, or 3 may also be a hydrogen atom, a group of formula

-N(R10) - (CH2)m - (CO)o - R (III), v ktorom-N (R 10 ) - (CH 2 ) m - (CO) o - R (III) in which

R10 znamená atóm vodíka alebo C].3-alkylovú skupinu, m je číslo 1, 2, 3 alebo 4, o je číslo 1 alebo, pokiaľ m znamená číslo 2, 3 alebo 4, tiež číslo 0 aR 10 represents a hydrogen atom or C 1. 3- alkyl, m is 1, 2, 3 or 4, o is 1 or, when m is 2, 3 or 4, also 0; and

R11 znamená skupinu amino-, Ci_3-alkylamino-, di-(Ci_3-alkyl)-amino-, Ci_4-alkoxy- alebo skupinu metoxyC|_3-alkoxy-, alebo 5- alebo 6-člennú cyklo-alkyléniminovú skupinu, pričom metylénová skupina v polohe 4 piperidínovej skupiny môže byť vždy nahradená skupinou -NH-, -jV(Ci.3-alkyl)-, alebo -A(Ci_3-alkyl-karbonyl)-, skupinu azetidino-, pyrolidino-, piperidino-, 2,6-dimetyl-piperidino-, 3,5-di-metyl-piperidino- alebo azepino-, pričom metylénová skupina v polohe 3 pyrolidínovej skupiny môže byť substituovaná skupinou hydroxy, metylénová skupina v polohe 4 piperidínovej skupiny môže byť substituovaná skupinou hydroxy, hydroxyCi_3-alkyl- alebo Ckl- alkoxy-, alebo uvedená metylénová skupina môže byť nahradená atómom kyslíka alebo atómom síry, skupinou sulfinyl-, sulfonyl-, -NH-, -TV(Ci_3-alkyl)-, -TV(C].3-alkyl-karbonyl)-, -A(benzoyl)- alebo -/V(fenyl-C].3-alkyl-karbonyl)-, pričom metylénová skupina viazaná na imínový atóm dusíka pyrolidínovej skupiny, piperidínovej skupiny alebo piperazínovej skupiny môže byť nahradená karbonylovou skupinou, alebo R6 znamená nerozvetvenú C].3-alkylovú skupinu, ktorej koncová časť je substituovaná karboxylovou skupinou alebo skupinou C].3-alkoxy-karbonyl-, skupinu vzorcaR 11 represents amino-, C 1-3 -alkylamino-, di- (C 1-3 -alkyl) -amino-, C 1-4 -alkoxy- or methoxyC 1-3 -alkoxy-, or a 5- or 6-membered cycloalkyleneimine group group, wherein the methylene group at position 4 of the piperidine group can always be replaced by -NH-, -N (Ci. 3 alkyl) -, or -N (C 3 -alkyl-carbonyl) - group azetidino-, pyrrolidino, piperidino-, 2,6-dimethyl-piperidino-, 3,5-dimethyl-piperidino- or azepino-, wherein the methylene group at the 3-position of the pyrrolidine group may be substituted by a hydroxy group, the methylene group at the 4-position of the piperidine group may be substituted hydroxy, hydroxyC 3 alkyl- or C kl - alkoxy, or said methylene group can be replaced by oxygen, S, sulfinyl, sulfonyl, -NH-, -TV (C 3 alkyl) -, - TV (C]. 3 -alkyl-carbonyl) -, -N (benzoyl) - or - / V (phenyl-C]. 3 -alkyl-carbonyl) -, wherein the methylene group is bonded to the imine at m N pyrrolidine, piperidine or piperazine groups may be replaced by a carbonyl group, or R 6 is a straight C]. A 3- alkyl group whose terminal moiety is substituted with a carboxyl group or a C 1 group. A 3- alkoxy-carbonyl- group of formula

-N(R12) - CO - (CH2)p - R13 (IV), v ktorom-N (R 12 ) -CO- (CH 2 ) p -R 13 (IV) wherein

R12 znamená atóm vodíka, C1.3-alkylovú alebo fenyl-Cu-alkylovú skupinu, p je číslo 0, 1 alebo 2 aR 12 represents a hydrogen atom, C 1 . 3- alkyl or phenyl-C 1-6 alkyl, p is 0, 1 or 2;

R13 znamená skupinu amino-, Ci_4-alkylamino-, di-(C].4-alkyl)-amino-, benzyl-amino-, A-(C|.3-alkyl)-benzylamino, Cj.3-alkoxy-Ci.3-alkylamino-, TV-(Ci_3-alkyl)-C|.3-alkoxy-Ci.3-alkyl-amino-, di-(2-metoxy-etyl)-amino-, di-(co-hydroxy-C2.3alkyl)-amino- alebo aminokarbonyl-metyl-V-(metyl)-amino-, prostredníctvom atómu dusíka viazanú, voliteľne C^-alkylovou skupinou substituovanú pyrolylovú skupinu, pyrazolylovú skupinu alebo imidazolylovú skupinu, skupinu pyrolidino-, piperidino-, morfolino-, tiomorfolino- alebo piperazínovú skupinu, ktorá je voliteľne v polohe 4 substituovaná skupinou Ci_3-alkyl-, fenyl-Cj_3-alkyl-, Ci_3-alkyl.karbonyl- alebo Ci_4-alkoxykarbonyl-, pokiaľ n znamená číslo 1 alebo 2, R12 môže tiež znamenať vodíkový atóm, skupinu vzorcaR 13 represents amino-, C 1-4 -alkylamino-, di- (C 1-4 -alkyl) -amino-, benzyl-amino-, N - (C 1-3 -alkyl) -benzylamino, C 1-6 -alkyl; 3- alkoxy-Ci. 3- alkylamino-, N - (C 1-3 -alkyl) -C 1-6 alkyl. 3- alkoxy-Ci. 3-alkyl-amino, di (2-methoxyethyl) amino, di- (co-hydroxy-C 2nd 3 alkyl) amino or aminocarbonyl-methyl-N- (methyl) amino, a nitrogen-bonded, optionally C 1-4 -alkyl substituted pyrrolyl, pyrazolyl or imidazolyl group, a pyrrolidino-, piperidino-, morpholino-, thiomorpholino- or piperazine-group, which is optionally substituted at the 4-position with a C 1-3 -alkyl- , phenyl-C 1-3 -alkyl-, C 1-3 -alkylcarbonyl- or C 1-4 -alkoxycarbonyl-, when n is 1 or 2, R 12 can also be a hydrogen atom, a group of the formula

-N(R14) - (CH2)q - (CO)r - R15 (V), v ktorom-N (R 14 ) - (CH 2 ) q - (CO) r - R 15 (V) in which

R14 znamená atóm vodíka, Ci_4-alkylovú skupinu, Ci_3-alkylkarbonylovú skupinu, fenylkarbonylovú skupinu, fenyl-C[.3-alkylkarbonylovú skupinu, furylkarbonylovú skupinu, pyridinylkarbonylovú skupinu, furyl-C].3-alkyl-karbonylovú skupinu, pyridinyl-Ci_3-alkylkarbonylovú skupinu, Ci_4-alkyl-sulfonylovú skupinu, fenylsulfonylovú skupinu alebo fenyl-Ci_3-alkyl-sulfonylovú skupinu, q je číslo 1, 2 alebo 3, r je číslo 1, alebo pokiaľ q je číslo 2 alebo 3, r znamená tiež číslo 0 aR 14 represents a hydrogen atom, a C 1-4 -alkyl group, a C 1-3 -alkylcarbonyl group, a phenylcarbonyl group, a phenyl-C 1-6 alkyl group, or a C 1-4 alkyl group; 3- alkylcarbonyl, furylcarbonyl, pyridinylcarbonyl, furyl-C 1. 3- alkyl-carbonyl, pyridinyl-C 1-3 -alkylcarbonyl, C 1-4 -alkylsulfonyl, phenylsulfonyl or phenyl-C 1-3 -alkylsulfonyl, q is 1, 2 or 3, r is 1, or when q is 2 or 3, r is also 0 and

R15 znamená skupinu amino-, Ck4-alkylamino-, di-(Ci_4alkyl)-amino-, fenyl-amino-, ,V-(Ck4-alkyl)-fenylamino-, benzylamino- alebo jV-(Ci_4-alkyl)-benzyl-amino-, alebo skupinu vzorcaR 15 is amino-, C 1-4 -alkylamino-, di- (C 1-4 alkyl) -amino-, phenyl-amino-, N - (C 1-4 -alkyl) -phenylamino-, benzylamino- or N - (C 1-4) -alkyl) -benzyl-amino-, or a group of the formula

-N(R16) - SO2 - R17 (VI), v ktorom-N (R 16) - SO 2 - R 17 (VI), wherein

R16 znamená atóm vodíka alebo terminálnu C| j-alkylovú skupinu voliteľne substituovanú skupinou kyano-, trifluórmetyl-karbonyl-amino- alebo jV-(C1.3-alkyl)-trifluórmetyl-karbonyl-amino- aR 16 represents a hydrogen atom or a terminal C 1 j-alkyl optionally substituted by cyano, trifluoromethyl-carbonyl-amino or N- (C first 3 -alkyl) carbonyl-trifluoromethyl-amino and

R17 znamená Ci.3-alkylovú skupinu, pričom všetky pod označením R6 uvedené zvyšky obsahujúce jednoducho viazané alebo nakondenzované fenylové skupiny môžu byť substituované atómom fluóru, chlóru alebo brómu, skupinou metyl-, trifluórmetyl-, metoxy-, nitro- alebo kayno- aR 17 is C 1-6. 3- alkyl, wherein all the R 6 moieties containing single bonded or fused phenyl groups mentioned above may be substituted by fluorine, chlorine or bromine, methyl, trifluoromethyl, methoxy, nitro or kayno-; and

R5 znamená atóm vodíka, pričom v uvedených zvyškoch atóm vodíka viazaný na atóme dusíka môže byť nahradený acetylovou skupinou alebo Zerc-butoxykarbonylovou skupinou,R 5 represents a hydrogen atom, in which the hydrogen atom bonded to the nitrogen atom may be replaced by an acetyl group or a tert-butoxycarbonyl group,

SK 287312 Β6 karboxylové skupiny v uvedených zvyškoch môžu byť aj vo forme terc-butoxykarbonylových prekurzorových skupín a v uvedených zvyškoch obsiahnuté nasýtené alkylové alebo alkoxylové časti, ktoré obsahujú viac ako dva uhlíkové atómy môžu byť nerozvetvené alebo rozvetvené, pokiaľ sa neuvádza inak, ich tautoméry, diastereoméry, enantioméry, ich zmesi a soli.The carboxyl groups in said radicals may also be in the form of tert-butoxycarbonyl precursor groups and in said radicals saturated alkyl or alkoxy moieties containing more than two carbon atoms may be unbranched or branched, unless otherwise indicated, their tautomers, diastereomers , enantiomers, mixtures thereof and salts thereof.

Mimoriadne pozoruhodná podskupina veľmi výhodných zlúčenín vzorca (I) sú zlúčeniny, v ktorýchA particularly notable subset of the highly preferred compounds of formula (I) are those in which

X, R1, R3, a R5 sú určené skôr,X, R 1 , R 3 , and R 5 are as defined above,

R2 znamená nerozvetvenú alebo rozvetvenú Ci.4-alkoxykarbonylovú skupinu alebo fenoxykarbonylovú skupinu, nerozvetvenú alebo rozvetvenú Ci_3-alkoxykarbonylovú skupinu, ktorá v koncovej alkylovej časti môže byť substituovaná skupinou fenyl-, karboxy-, C|.3-alkoxy-karbonyl-, aminokarbonyl-, Ci.3-alkylaminokarbonylalebo di-(C|.3-alkyl)-amino-karbonyl-, alebo nerozvetvenú alebo rozvetvenú C2_3-alkoxy-karbonylovú skupinu, ktorá je v koncovej alkylovej časti substituovaná skupinou hydroxy-, Ci_3-alkoxy-, amino-, C^-alkyl-amino- alebo di-(Ci_3-alkyl)-amino-, R2 is a linear or branched C. A 4- alkoxycarbonyl group or a phenoxycarbonyl group, a straight or branched C 1-3 -alkoxycarbonyl group which in the terminal alkyl moiety may be substituted by a phenyl-, carboxy-, C 1-6 -alkyl group; 3 -alkoxycarbonyl-, aminocarbonyl-; 3- alkylaminocarbonylamino or di- (C 1-3 -alkyl) -amino-carbonyl-, or unbranched or branched C 2-3 -alkoxy-carbonyl, which is substituted in the terminal alkyl moiety by hydroxy, C 1-3 -alkoxy-, amino- , C 1-4 -alkyl-amino- or di- (C 1-3 -alkyl) -amino-,

R4 znamená R7-(n-CI.3-alkyl)-fenylovú skupinu, v ktorejR 4, R 7 - (n C I. 3-alkyl) -phenyl, wherein

R7 znamená skupinu amino-, Ci_6-alkylamino-, di-(C1.4-alkyl)-amino-, o)-hydroxy-C2.3-alkyl-amino-, N-(C\.3-alkyl)-ro-hydroxy-C2.3-alkyl-amino-, di-(a>-hydroxy-C2.3-alkyl)amino- alebo skupinu di-(o)-(C|.3-alkoxy)-C2_3-alkyl)amino-, alebo znamená fenylovú skupinu, ktorá je substituovaná skupinou vzorca (IV)R 7 represents an amino, a C 6 -alkylamino, di- (C first 4 alkyl) -amino-, o) hydroxy-C 2nd 3-alkyl-amino, N- (C \. 3 alkyl) -R-hydroxy-C2. 3-alkyl-amino, di (i> hydroxy-C2. 3 alkyl) amino group or a di (o) - (C |. 3 -alkoxy) -C2_ 3 -alkyl) amino, or means a phenyl group which is substituted with a group of formula (IV)

-N(R12) - CO - (CH2)p - R13 (IV), v ktorom-N (R 12 ) -CO- (CH 2 ) p -R 13 (IV) wherein

R12, p a R13 sú určené skôr, ich tautoméry, diastereoméry, enantioméry, ich zmesi a soli.R 12 , p and R 13 are as defined above, their tautomers, diastereomers, enantiomers, mixtures and salts thereof.

Druhá, mimoriadne pozoruhodná podskupina veľmi výhodných zlúčenín sú zlúčeniny, v ktorýchA second, particularly remarkable subset of the highly preferred compounds are those in which

X, R1, R3, a R5 sú určené skôr,X, R 1 , R 3 , and R 5 are as defined above,

R2 znamená aminokarbonylovú alebo metylaminokarbonylovú skupinu, etylamino-karbonylovú skupinu voliteľne v polohe 2 skupiny etyl- substituovanú skupinou hydroxy- alebo skupinou Ci.3-alkoxy-, alebo pokiaľ R4 neznamená aminosulfonyl-fenylovú skupinu alebo N-(C|.5-alkyl)-C|.3-alkylaminokarbonylovú skupinu R2 znamená tiež di-(Ci_2-alkyl)-aminokarbonylovú skupinu,R 2 represents an aminocarbonyl or methylaminocarbonyl group, an ethylamino-carbonyl group optionally at the 2-position of the ethyl group substituted by a hydroxy- or a C 1-3 -alkoxy- group, or when R 4 is not an aminosulfonyl-phenyl group or N- (C 1-5-) alkyl) -C |. 3- alkylaminocarbonyl R 2 also denotes di- (C 1-2 -alkyl) aminocarbonyl,

R4 znamená R7-(n-Ci_3-alkyl)-fenylovú skupinu, v ktorejR 4 represents R 7 - (n-C 1-3 -alkyl) -phenyl in which

R7 znamená skupinu amino-, C].6-alkylamino-, di-(C1.4-alkyl)-amino-, a>-hydroxy-C2.3-alkyl-amino-, V-(Ci_3-alkyl)-ro-hydroxy-C2.3-alkyl-amino-, di-(<B-hydroxy-C2.3-alkyl)amino- alebo skupinu di-((o-(Ci.3-alkoxy)-C2_3-alkyl)-amino-, alebo znamená fenylovú skupinu, ktorá je substituovaná skupinou vzorca (IV)R 7 is amino-, C 1 -. 6 -alkylamino, di- (C first 4 alkyl) amino, and> hydroxy-C 2nd 3-alkyl-amino, N- (C 3 alkyl) -R C-Hydroxy-second 3-alkyl-amino, di - (<B-hydroxy-C2. 3 alkyl) amino group or a di - ((O (C. 3 -alkoxy) -C2_ 3 -alkyl) amino, or means a phenyl group which is substituted with a group of formula (IV)

-N(R12) - CO - (CH2)p - R13 (IV), v ktorom-N (R 12 ) -CO- (CH 2 ) p -R 13 (IV) wherein

R12, p a R13 sú určené skôr, ich tautoméry, diastereoméry, enantioméry, ich zmesi a soli.R 12 , p and R 13 are as defined above, their tautomers, diastereomers, enantiomers, mixtures and salts thereof.

Najvýhodnejšie zlúčeniny všeobecného vzorca (I) sú zlúčeniny, v ktorýchMost preferred compounds of formula (I) are those in which

X znamená atóm kyslíka,X is an oxygen atom,

R1 a R5 sú každé vodíkový atóm,R 1 and R 5 are each a hydrogen atom,

R2 znamená metoxykarbonylovú skupinu, etoxykarbonylovú skupinu alebo amino-karbonylovú skupinu,R 2 is methoxycarbonyl, ethoxycarbonyl or aminocarbonyl group,

R3 znamená fenylovú skupinu,R 3 represents a phenyl group,

R4 fenylovú skupinu, ktorá je monosubstituovaná skupinou R6, pričomR 4 is a phenyl group which is monosubstituted with R 6 , wherein

R6 znamená N-metyl-imidazol-2-ylovú skupinu, nerozvetvenú alebo rozvetvenú Ci_3-alkylovú skupinu, ktorej koncová časť je substituovaná skupinou Cj.4-alkylamino-, di-(C].4-alkyl)-amino-, piperidino- alebo skupinou 2,6-dimetyl-piperidino-, skupinu vzorca (IV)R 6 represents an N-methyl-imidazol-2-yl group, a straight or branched C 1-3 -alkyl group, the terminal part of which is substituted by C 1-6. 4- alkylamino-, di- (C 1-4 -alkyl) -amino-, piperidino- or 2,6-dimethyl-piperidino-, a group of formula (IV)

-N(R12) - CO - (CH2)p - R13 (IV), v ktorom-N (R 12 ) -CO- (CH 2 ) p -R 13 (IV) wherein

R12 znamená Cj.3-alkylovú skupinu, p je číslo 1 alebo 2 aR 12 is C 1-6. 3 alkyl group, p is 1 or 2 and

R13 znamená di-(Ci_3-alkyl)-aminoskupinu, alebo skupinu vzorca (V)R 13 represents a di- (C 1-3 -alkyl) -amino group or a group of formula (V)

-N(R14) - (CH2)q - (CO)r - R15 (V), v ktorom-N (R 14 ) - (CH 2 ) q - (CO) r - R 15 (V) in which

R14 znamená Ci.3-alkylkarbonylovú skupinu alebo Ci.3-alkylsulfonylovú skupinu q je číslo 1, 2 alebo 3, r je číslo 1, alebo, pokiaľ q je číslo 2 alebo 3, môže byť r číslo 0 a R15 znamená di-(Ci.3-alkyl)-aminoskupinu, pričom uvedené zvyšky obsahujúce nasýtené alkylové časti, ktoré majú viac ako dva uhlíkové atómy môžu byť nerozvetvené alebo rozvetvené, pokiaľ nie je uvedené inak, ich tautoméry, diastereoméry, enantioméry, ich zmesi a soli.R 14 is C 1-3 -alkylcarbonyl or C 1-3 -alkylsulfonyl q is 1, 2 or 3, r is 1, or, if q is 2 or 3, r can be 0 and R 15 is di - (C 1-3 -alkyl) amino, wherein said saturated alkyl moieties having more than two carbon atoms may be unbranched or branched, unless otherwise indicated, their tautomers, diastereomers, enantiomers, mixtures thereof and salts thereof.

Mimoriadne pozoruhodná podskupina najvýhodnejších zlúčenín vzorca (I) sú zlúčeniny, v ktorých X, R1, R3 a R5 sú určené skôr,A particularly remarkable subset of the most preferred compounds of formula (I) are those wherein X, R 1 , R 3, and R 5 are as defined above,

R2 je metoxykarbonyloá skupina alebo etoxykarbonylová skupina a R2 is metoxykarbonyloá or ethoxycarbonyl, and

R4 znamená di-jCuj-alkylj-amino-Ci.j-alkylfenylovú skupinu, alebo fenylovú skupinu substituovanú skupinou vzorca (IV)R 4 represents a di-C 1-6 -alkyl-amino-C 1-6 -alkylphenyl group or a phenyl group substituted with a group of formula (IV)

-N(R12) - CO - (CH2)p - R13 (IV), v ktorom-N (R 12 ) -CO- (CH 2 ) p -R 13 (IV) wherein

R12, p a R13 sú určené skôr, ich tautoméry, diastereoméry, enantioméry, ich zmesi a soli.R 12 , p and R 13 are as defined above, their tautomers, diastereomers, enantiomers, mixtures and salts thereof.

Ako mimoriadne pozoruhodné zlúčeniny všeobecného vzorca (I) možno uviesť:Particularly noteworthy compounds of formula (I) include:

(a) 3 -Z- [ 1 -(4-(piperidin-1 -yl-metyl)anilino)-1 -fenylmetylén] -6-etoxykarbonyl-2-indolinón, (b) 3 -Z- [(1 -(4-(piperidin-1 -yl-metyl)-anilino)-1 -fenyl-metylén] -6-karbamoyl-2-indolinón, (c) 3-Z-[ 1 -(4-(piperidin-1 -yl-metyl)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (d) 3-Z-[ 1 -(4-(dimetylaminometyl)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indoIinón, (e) 3-Z-[ I -(4-((2,6-dimetyl-piperidin-1 -yl)-metyl)-anilino)-1 -fenyl-metylén]-6-etoxy-karbonyl-2-indolinón, (f) 3-Z-[l-(4-(/V-(2-dimetylamino-etyl)-M-acetyl-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (g) 3-Z-[l-(4-(7V-(3-dimetylamino-propyl)-.V-acetyl-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (h) 3-Z-[l-(4-(7V-(2-dimetylamino-etyl)-7V-metylsulfonyl-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (i) 3-Z-[ 1 -(4-(dimetylaminometyl)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (j) 3-Z-[l-(4-(7V-acetyl-jV-dimetylaminokarbonylmetyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (k) 3-Z-[ 1 -(4-etylaminometyl-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (l) 3-Z-[ 1 -(4-( 1 -metyl-imidazol-2-yl)-anilino)-1 -fenylmetylén]-6-metoxykarbonyl-2-indolinón, (m) 3-Z-[ 1 -(4-(N-dimetylaminometylkarbonyl-V-metyl-amino)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (n) 3-Z-[l-(4-(/V-(2-dimetylamino-etyl)-yV-metylsulfonyl-amino)-amlino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (o) 3-Z-[l-(4-( A,-(3-dimetylamino-propyl)-/V-metylsulfonyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (p) 3 -Z-[ 1 -(4-(/V-dimetylaminokarbony lme tyl-A'-mety lsulfonyl-amino)-anil i no)-1 -fenyl-metylén] -6-metoxykarbonyl-2-indolinón, (q) 3-Z-[ 1 -(4-(N-((2-dimetylarmno-etyl)-karbonyl)-A'-metyl-amino)-anilino) -1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (r) 3-Z-[l-(4-(jV-(2-dimetylamino-etyl)-jV-acetyI-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón a (s) 3-Z-[ 1 -(4-metylaminometyl-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, ich tautoméry, ich zmesi a ich soli.(a) 3-Z- [1- (4- (piperidin-1-ylmethyl) anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (b) 3-Z- [(1 - ( 4- (piperidin-1-yl-methyl) -anilino) -1-phenyl-methylene] -6-carbamoyl-2-indolinone, (c) 3-Z- [1- (4- (piperidin-1-yl- (d) 3-Z- [1- (4- (dimethylaminomethyl) anilino) -1-phenylmethylene] -6- (methyl) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone ethoxycarbonyl-2-indolinone, (e) 3-Z- [1- (4 - ((2,6-dimethyl-piperidin-1-yl) -methyl) -anilino) -1-phenyl-methylene] -6-ethoxy -carbonyl-2-indolinone, (f) 3-Z- [1- (4 - (N- (2-dimethylamino-ethyl) -N-acetyl-amino) -anilino) -1-phenyl-methylene] -6 (g) 3-Z- [1- (4- (N - (3-dimethylamino-propyl) - N -acetyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone; -ethoxycarbonyl-2-indolinone, (h) 3-Z- [1- (4- (N - (2-dimethylamino-ethyl) - N -methylsulfonyl-amino) -anilino) -1-phenyl-methylene] -6- ethoxycarbonyl-2-indolinone, (i) 3-Z- [1- (4- (dimethylaminomethyl) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, (j) 3-Z- [1] - (4- (7V-acetyl-N-dimethylaminocarbonylmethyl (amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (k) 3-Z- [1- (4-ethylaminomethyl-anilino) -1-phenylmethylene] -6-methoxycarbonyl -2-indolinone, (1) 3-Z- [1- (4- (1-methyl-imidazol-2-yl) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, (m) 3 -Z- [1- (4- (N-dimethylaminomethylcarbonyl-N-methyl-amino) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, (n) 3-Z- [1 - ( 4- (N - (2-dimethylamino-ethyl) - N -methylsulfonyl-amino) -amino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (o) 3-Z- [1 - ( 4- (N - (3-dimethylaminopropyl) - / V-methylsulphonyl-amino) -anilino) -l-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (p) 3-Z- [1 - (4- (N-dimethylaminocarbonylmethyl-N'-methylsulfonylamino) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, (q) 3-Z- [1- (4- (N - ((2-dimethylarmno-ethyl) -carbonyl) -N'-methyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (r) 3-Z - [l- (4- (N- (2-dimethylamino-ethyl) -N-acetyl-amino) anilino) -l-phenyl-methylene] -6-methoxycarbonyl-2-indolinone and (s) 3-Z- [1- (4-methylaminomethyl-anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, their tautomers, mixtures thereof, and salts thereof.

Ako ďalšiu podskupinu zlúčenín všeobecného vzorca (I) možno uviesť zlúčeniny, v ktorýchAnother subgroup of compounds of formula (I) are those in which:

X znamená atóm kyslíka alebo síry,X is an oxygen or sulfur atom,

R1 znamená atóm vodíka alebo prekurzorovú skupinu, ako je C]_4-alkoxykarbonylová skupina alebo C2.4-alkanoylová skupina,R 1 represents a hydrogen atom or a prodrug group such as a C] _ 4 -alkoxycarbonyl or C 2nd 4- alkanoyl group,

R2 znamená karboxylovú skupinu, nerozvetvenú alebo rozvetvenú C1.6-alkoxy-karbonylovú skupinu, C5.7-cykloalkoxykarbonylovú skupinu alebo fenyl-Ci.3-alkoxykarbonylovú skupinu, aminokarbonylovú aleboR 2 is carboxy, a linear or branched C 1, 6-alkoxy-carbonyl, C5-7-cycloalkoxycarbonyl or phenyl-C. 3- alkoxycarbonyl, aminocarbonyl or

Ci.2-alkylaniinokarbonylovú skupinu, alebo pokiaľ R4 neznamená skupinu aminosulfonylfenyl- alebo N-(Ci_6-alkyl)-C1.3-alkylaminokarbonyl-fenylová skupinu a tiež di-(Ci_2-alkyl)-amiiio-karbonylová skupinu, R3 znamená atóm vodíka, Ci_6-alkylovú skupinu, C3.7-cykloalkylovú skupinu, trifluórmetylová skupinu alebo heteroarylovú skupinu, fenylovú alebo naftylová skupinu, fenylová alebo naftylová skupinu mono- alebo di- substituovaná atómom fluóru, chlóru, brómu alebo jódu, skupinou trifluórmetyl-, Ci_3-alkyl- alebo C].3-alkoxy-, pričom v prípade disubstitácie môžu byť substituenty rovnaké alebo rozdielne a pričom uvedené nesubstituované, ako aj mono- a di- substituované fenylové alebo naftylové skupiny môžu byť navyše substituované skupinou hydroxy-, hydroxy-Ci_3-alkyl- alebo skupinou Ci_3-alkoxy-Ci_3-alkyl-, skupinou kyano-, karboxy-, karboxy-C].3-alkyl-, Ci„3-alkoxykarbonyl-, aminokarbonyl-, C].3-alkylaminokarbonyl- alebo di-(Ci_3-alkyl)-amino-karbonylovou skupinou, skupinou nitro-, skupinou amino-, Ci_3-alkylamino-, di-(Ci_3-alkyl)-amino alebo amino-Ci_3-alkylovou skupinou, skupinou C].3-alkylkarbonylamino-, jV-(Ci.3-alkyl)-C].3-alkylkarbonylamino-, Ci.3-alkylkarbonylamino-Ci.3-alkyl-, 7V-(Ci_3-alkyl)-Cl.3-alkylkarbonylamino- C^-alkyl-, C,.3-alkylsulfonylammo-, C1.3-alkylsulfonylamino-Cb3-alkyl, Aí-(C1.3-alkyl)-Ct_3-alkylsulfonylammo-Cl_3-alkyl- alebo skupinou aryl-C1.3-alkyl-sulfonylamino-, skupinou cykloalkylamino-, cykloalkylénimino-, cykloalkyléniminokarbonyl-, cykloalkylénimino-C|.3-alkyl-, cykloalkyléniminokarbonyl-Cj^-alkyl alebo cykloalkyléniminosulfonyl-Ci_3-alkylovou skupinou vždy so 4 až 7 členmi kruhu, pričom metylénová skupina v polohe 4 šesťčlennej alebo sedem-člennej cykloalkyléniminoskupiny môže byť nahradená atómom kyslíka alebo síry, skupinou sulfmyl-, sulfonyl-, -NH- alebo skupinou -TV(Ci.3-alkyl)-, alebo môže byť substituovaná heteroarylovou skupinou alebo heteroaryl-Cj.j-alkylovou skupinou,Ci. 2 -alkylaniinokarbonylovú group, or when R 4 does not represent aminosulfonylfenyl- or N (Ci_6 alkyl) -C 1-3 alkylaminocarbonyl-phenyl group, and also di- (Ci_2-alkyl) -amiiio-carbonyl, R 3 is H , C 1-6 -alkyl, C 3 . 7- cycloalkyl, trifluoromethyl or heteroaryl, phenyl or naphthyl, phenyl or naphthyl mono- or di- substituted by fluorine, chlorine, bromine or iodine, trifluoromethyl, C 1-3 -alkyl- or C 1 -substituted. 3 -alkoxy, where in the case disubstitácie substituents may be the same or different and wherein the abovementioned unsubstituted as well as mono- and di-substituted phenyl or naphthyl groups may additionally be substituted by hydroxy, hydroxy-C 3 -alkyl-, or a C 3- alkoxy-C 1-3 -alkyl-, cyano-, carboxy-, carboxy-C 1. 3- alkyl-, C 1-3 -alkoxycarbonyl-, aminocarbonyl-, C 1-3 . 3- alkylaminocarbonyl- or di- (C 1-3 -alkyl) amino-carbonyl, nitro-, amino-, C 1-3 -alkylamino-, di- (C 1-3 -alkyl) amino or amino-C 1-3 -alkyl group, group C]. 3- alkylcarbonylamino- N - (C 1-3 -alkyl) -C 1. 3- alkylcarbonylamino-, Ci. 3- alkylcarbonylamino-C 1-6 alkyl; 3- alkyl-, N- (C 1-3 -alkyl) -C 1 . 3- alkylcarbonylamino- C 1-6 -alkyl-, C 1-6 -alkyl-; 3- alkylsulfonylamino-, C 1 . 3 alkylsulfonylamino C-c3-alkyl, and s - (C first 3 alkyl) C t _ -alkylsulfonylammo 3 -C l _ 3 alkyl- or aryl-group 1st 3 -alkylsulfonylamino-, cycloalkylamino-, cycloalkylenimino-, cycloalkyleneiminocarbonyl-, cycloalkylenimino-C1-6-cycloalkyleneimino-; 3 alkyl-, cykloalkyléniminokarbonyl-C-alkyl, or-C cykloalkyléniminosulfonyl 3 -alkyl each having 4 to 7 ring members, wherein the methylene group in the 4-position six-membered or seven-membered cycloalkyleneimino groups may be replaced by O or S, sulfmyl- , sulfonyl-, -NH- or -TV (C 1-3 -alkyl) -, or may be substituted with a heteroaryl group or a heteroaryl-C 1-6 -alkyl group,

R4 znamená C3.7-cykloalkylová skupinu, pričom metylénová skupina v polohe 4 šesťčlennej alebo sedemčlennej cykloalkylovej skupiny môže byť substituovaná skupinou amino-, C|.3-alkylamino- alebo skupinou di-(Ci_3-alkyl)-amino- alebo nahradená skupinou -NH- alebo -/V(C|.3-alkyl)-, alebo znamená fenylová skupinu substituovaná skupinou R6, pričom fenylová skupina môže byť navyše substituovaná atómom fluóru, chlóru, brómu alebo jódu, skupinou C1.5-alkyl-, trifluórmetyl-, C|.3-alkoxy-, karboxy-, Ci_3-alkoxykarbonyl-, aminosulfonyl-, nitro- alebo kyano-, pričomR 4 is C 3. A 7- cycloalkyl group, wherein the methylene group at the 4-position of the six or seven membered cycloalkyl group may be substituted by amino-, C 1-6 -cycloalkyl. 3- alkylamino- or di- (C 1-3 -alkyl) -amino- or replaced by -NH- or - N (C 1-3 -alkyl) -, or represents a phenyl group substituted with R 6 , wherein the phenyl group may additionally be substituted by F, Cl, Br, I, a C 1st 5- alkyl-, trifluoromethyl-; 3- alkoxy-, carboxy-, C 1-3 -alkoxycarbonyl-, aminosulfonyl-, nitro- or cyano-, wherein

R6 znamená atóm vodíka, fluóru, chlóru, brómu alebo jódu, skupinu kyano-, nitro-, amino-, Ci.5-alkyl-, C3.7-cykloalkyl-, trifluórmetyl-, fenyl-, tetrazolyl- alebo heteroarylová skupinu,R 6 represents a hydrogen, fluorine, chlorine, bromine or iodine atom, a cyano-, nitro-, amino-, C 1-5 -alkyl-, C 3 group . 7- cycloalkyl-, trifluoromethyl-, phenyl-, tetrazolyl- or heteroaryl,

Ci_3-alkoxylová skupinu voliteľne substituovaná 1 až 3 atómami fluóru, Ci_3-alkoxy-C1.3-alkoxylová skupinu, fenyl-Ci_3-alkoxylová skupinu, amino-C2.3-alkoxylová skupinu, C].3-alkylamino-C2.3-alkoxylová skupinu, di-(Ci_3-alkyl)-amino-C2-3-alkoxylová skupinu, fenyl-Ci.3-alkylamino-C2_3-alkoxylová skupinu, /V-(Cj.3-alkyl)-fenyl-Ci.3-alkylamino-C2.3-alkoxylová skupinu, C5.7-cykloalkylénimino-C2.3-alkoxylová skupinu alebo skupinu Ci_3-alkylmerkapto-, karboxyskupinu, Ci_4-alkoxykarbonylová skupinu, aminokarbonylová skupinu, C].3-alkylamino-karbonylová skupinu, /V-(C|.5-alkyl)-C|_3-alkylaminokarbonylová skupinu, fenyl-Ci_3-alkylamino-karbonylová skupinu, N-(C[.3-alkyl)-fenyl-Ci.3-alkylamino-karbonylová skupinu, piperazinokarbonylová skupinu alebo /V-(C,_3-alkyljpiperazino-karbonylová skupinu,C 1-3 -alkoxy optionally substituted with 1 to 3 fluorine atoms, C 1-3 -alkoxy-C 1 . 3- alkoxy, phenyl-C 1-3 -alkoxy, amino-C 2 . 3- alkoxy, C 1. 3 -alkylamino-C 2nd 3 -alkoxy group, a di (C 3 alkyl) amino-C 2-3 -alkoxy, phenyl-C. 3- alkylamino-C 2-3 -alkoxy, N - (C 1-3 -alkyl) -phenyl-C 1-6 -alkyloxy; 3 -alkylamino-C 2nd 3- alkoxy, C5. 7-C -cykloalkylénimino second 3- alkoxy or C 1-3 -alkylmercapto-, carboxy, C 1-4 -alkoxycarbonyl, aminocarbonyl, C 1. 3- alkylamino-carbonyl, N - (C 1-5 -alkyl) -C 1-3 -alkylaminocarbonyl, phenyl-C 1-3 -alkylaminocarbonyl, N- (C 1-3 -alkyl) -phenyl- Ci. 3- alkylamino-carbonyl, piperazinocarbonyl or N - (C 1-3 -alkyl ) piperazinocarbonyl,

Ci_3-alkylaminokarbonylová alebo A,-(C|.5-alkyl)-C|.3-alkylaminokarbonylová skupinu, v ktorých je alkylová časť substituovaná karboxylovou skupinou alebo C[.3-alkoxykarbonylovou skupinou, alebo v polohe 2 alebo skupinou di-(C1.3-alkyl)-amino-, skupinou piperazino-, skupinou TV-(C].3-alkyl)-piperazino- alebo štvorčlennou až sedemčlennou cykloalkyléniminovou skupinou, až 7 členná cykloalkylénimínová skupinu, ktorej s iminoskupinou viazaná metylénová skupina môže byť nahradená karbonylovou skupinou alebo sulfonylovou skupinou, ktorej cykloalkylénová časť môže byť kondenzovaná s fenylovým kruhom, alebo jeden alebo dva atómy vodíka môžu byť nahradené C1_3-alkylovou skupinou a/alebo metylénová skupina v polohe 4 šesťčlennej alebo sedemčlennej cykloalkylénimínovej skupiny môže byť substituovaná karboxylovou skupinou, C1.3-alkoxykarbonylovou skupinou, aminokarbonylovou skupinou, C,_3-alkylaminokarbonylovou skupinou, di-(C1.3-alkyl)-aminokarbonylovou skupinou, fenyl-C|.3- alkylamínovou skupinou alebo Ä/-(Ci.3-alkyl)-fenyl-C1.3-alkylaminovou skupinou, alebo môže byť nahradená atómom kyslíka alebo síry, skupinou sulfmyl-, sulfonyl-, -NH-, -ÍV(CI.3-alkyl)-, -N(fenyl)-, -MC|.3-alkyl-karbonyl)- alebo -A'(benzoyl)-,A C 3 -alkylaminokarbonylová or A, - (C |. 5 alkyl) -C |. A 3- alkylaminocarbonyl group in which the alkyl moiety is substituted with a carboxyl group or a C 1-6 alkyl group; 3 alkoxycarbonyl group or in the 2 or the group di- (C1. 3 alkyl) -amino, piperazino group, a group of TV- (C]. 3 alkyl) -piperazino- or a four to seven membered cykloalkyléniminovou group, to 7 membered cykloalkylénimínová group, the imino group is bound to the methylene group can be replaced by a carbonyl group or a sulfonyl group, wherein a cycloalkylene moiety may be fused to a phenyl ring, or one or two hydrogen atoms may be replaced by a C 1 _ 3 -alkyl and / or a methylene group in the 4 cykloalkylénimínovej six or seven membered group is optionally substituted by carboxy, C first 3- alkoxycarbonyl, aminocarbonyl, C 1-3 -alkylaminocarbonyl, di- (C 1-3 -alkyl) aminocarbonyl, phenyl-C 1-4 alkyl; 3 -alkylamino or N - (C 1-3 -alkyl) -phenyl-C 1 . 3 an alkylamino group, or may be replaced by O or S, sulfmyl-, sulfonyl, -NH-, -N (Ci. 3 alkyl) -, -N (phenyl) -, -MC |. 3- alkyl-carbonyl) - or -A '(benzoyl) -,

C].4-alkylová skupinu, pričom môže byť substituovaná skupinou hydroxy- alebo skupinou C].3-alkoxy-, skupinou amino-, Ci_7-alkylamino-, di-fCi^-alkylj-amino-, di-Ä/-(CI.3-alkyl)-amino-C2-3-alkylamino-, Ιή-Ν,Ν,Ν'-(CI.3-alkyl)-amino-C2.3-alkylamino-, fenyl-amino-, /V-fenyl-Ci_3-alkyl-amino-, fenyl-Ci.3-alkylamino-, ?V-(Ci.3-alkyl)-fenyl-Ci_3-alkylamino- alebo di-(fenyl-C1.3-alkyl)-amino-, skupinou C^j-alkylkarbonylamino-, 7V-(Ci.3-alkyl)-Ci.3-alkylkarbobylamino-, Ci_3-alkoxykarbonyl-Ci.3-alkylamino- alebo ^-(Cu-alkylj-Ci.j-alkoxykarbonyl-Ci.j-alkylamino-, skupinou C4.7-cykloalkylamino-, C4.7-cykloalkyl-Ci.3-alkyl-amino- alebo C4.7-cykloalkenylamino-, v ktorých sa poloha 1 kruhu nepodieľa na dvojitej väzbe a pričom uvedené skupiny môžu byť navyše na aminovom atóme dusíka substituované skupinou Ci_3-alkyl-, a vodíkové atómy môžu byť čiastočne alebo celkom nahradené atómami fluóru a môžu byť substituované skupinou C5.7-cykloalkyl-, C2.4-alkyl-, až 7 člennou cykloalkyléniminovou skupinou, v ktorej metylénová skupina, viazaná na imnoskupinu môže byť nahradená karbonylovou skupinou alebo sulfonylovou skupinou, cykloalkylénová časť môže byť kondenzovaná s fenylovou skupinou alebo s voliteľne atómom fluóru, chlóru, brómu alebo jódu, skupinou nitro-, C]_3-alkyl-, C^-alkoxy- alebo amino- substituovanou skupinou oxazolo-. imidazolo-, tiazolo-, pyridino-, pyrazino- alebo pyrimidino-, jeden alebo dva vodíkové atómy môžu byť nahradené C|.3-alkylovou skupinou, C5.7-cykloalkylovou skupinou alebo fenylovou skupinou, metylénová skupina v polohe 4 šesťčlennej alebo sedemčlennej cykloalkylénimínovej skupiny môže byť substituovaná hydroxy-skupinou, skupinou karboxy-, skupinou C1.4-alkoxykarbonyl-, amino-karbonyl-, C^-alkylamino-karbonyl, di-(Ci_3-alkyl)-aminokarbonyl-, fenyl-C].3-alkylamino- alebo M(C|.3-alkyl)-fenyl-Ci.3-alkylamino-, alebo uvedená metylénová skupina môže byť nahradená atómom kyslíka alebo síry, skupinou sulfinyl-, sulfonyl-, -NH-, -/V(Ci_3-alkyl)-, -N- (fenyl)-, -/V(C|_3-alkyl-karbonyl)- alebo -jV(benzoyl)-, skupinou karboxy-, Cu-alkoxykarbonyl-, aminokarbonyl-, Cl.3-alkylamino-karbonyl- alebo di-(C|.3-alkyl)-aminokarbonyl-, alebo substituovaná 4 až 7 člennou cykloalkyléniminovou skupinou, skupinu amino-, pyrolidino-, piperidino-, morfolino-, benzoylamino- alebo jV-(C|.3-alkyl)-benzoylamino-, skupinu TV-(C1.3-alkyl)-C2.4-alkanoylamino-, ktorá je v alkylovej časti navyše substituovaná karboxylovou skupinou alebo C].3-alkoxykarbonylovou skupinou, skupinu vzorca (II)C]. A 4- alkyl group, which may be substituted by a hydroxy- or a C 1 group. 3 -alkoxy, amino group, C 7 -alkylamino, di-FCI ^ -alkylj-amino, di-R / - (Ci. 3 alkyl) amino-C 2 -3-amino- Ιή -Ν, Ν, Ν '- (Ci. 3 alkyl) amino-C2. 3- alkylamino-, phenyl-amino-, N-phenyl-C 1-3 -alkyl-amino-, phenyl-C 1-6 -alkyl- 3 -alkylamino,? N (Ci. 3 alkyl) phenyl-C 3 -alkylamino or di- (phenyl-C1. 3 alkyl) amino, a C ^ J-alkylcarbonylamino, 7V- (Cl. 3 alkyl) -C. 3- alkylcarbobylamino-, C 1-3 -alkoxycarbonyl-C 1-6 -alkylcarbobylamino-; 3 ^ -alkylamino, or - (C-alkyli-CI-CI-alkoxycarbonyl-alkylamino-, a C 4th -cykloalkylamino- 7, C 4.-C 7 -cycloalkyl. 3 -alkyl-amino, or C 4. -cykloalkenylamino- 7, wherein the position of the ring 1 does not participate in the double bond, and wherein the said groups may in addition to the amine nitrogen atom substituted by a C 3 -alkyl-, and the hydrogen atoms may be partially or fully substituted by fluorine, and may be substituted by C 5. 7 -cycloalkyl- C 2nd 4 -alkyl-, and 7 membered cykloalkyléniminovou group, wherein the methylene group attached to imnoskupinu may be replaced by a carbonyl group or a sulfonyl group, a cycloalkylene moiety may be fused with a phenyl group or optionally with a fluorine, chlorine, bromine or iodine atom, a nitro-, C 1-3 -alkyl-, C 1-4 -alkoxy- or amino-substituted by an oxazolo-, imidazolo-, thiazolo-, pyridino-, pyrazino- or pyrimidino group -, one or two in Dikova atoms may be replaced with C |. 3 -alkyl, C 5. 7 -cycloalkyl or a phenyl group, a methylene group in the 4-position six or seven membered cykloalkylénimínovej group may be substituted with a hydroxy group, a carboxy group, a C 1st 4- alkoxycarbonyl-, amino-carbonyl-, C 1-4 -alkylamino-carbonyl, di- (C 1-3 -alkyl) -aminocarbonyl-, phenyl-C]. 3- alkylamino- or M (C 1-3 -alkyl) -phenyl-C 1-6 alkyl; The 3- alkylamino-, or said methylene group may be replaced by an oxygen or sulfur atom, a sulfinyl-, sulfonyl-, -NH-, - (V (C 1-3 ) alkyl) -, -N- (phenyl) -, - / V group. (C | _ 3 -alkyl-carbonyl) - or -N (benzoyl) -, carboxy groups, Cu-alkoxycarbonyl, aminocarbonyl, C l. 3- alkylamino-carbonyl- or di- (C 1-3 -alkyl) -aminocarbonyl-, or substituted by a 4-7 membered cycloalkyleneimine group, an amino-, pyrrolidino-, piperidino-, morpholino-, benzoylamino- or N - (C 1-6) group |. 3 alkyl) -benzoylamino- group, TV- (C1. 3 alkyl) -C2. 4- alkanoylamino-, which is additionally substituted in the alkyl moiety with a carboxyl group or C 1. A 3- alkoxycarbonyl group, a group of formula (II)

- N(R8) - CO - (CH2)n - R9 (II), v ktorom- N (R 8 ) - CO - (CH 2 ) n - R 9 (II) in which

R8 znamená atóm vodíka alebo Ci.3-alkylovú skupinu, n znamená číslo 0, 1,2, alebo 3,R 8 represents a hydrogen atom or C 1-6 alkyl; 3- alkyl, n is 0, 1, 2, or 3,

R9 znamená skupinu amino-, C].4-alkylamino-, fenylamino-, jV-(Ci.4-alkyl)-fenylamino-, benzylamino-, N-(C^-alkylj-benzylamino- alebo di-(C1.4-alkyl)-amino-, 4- až 7-člennú cykloalkylénimínovú skupinu, pričom metylénová skupina v polohe 4 šesťčlennej alebo sedemčlennej cykloalkylénimínovej skupiny môže byť vždy nahradená atómom kyslíka alebo síry, skupinou sulfinyl-, sulfonyl-, -NH-, -7V(Ci.3-alkyl)-, -//(fenyl)-, -/V(C|.3-alkyl-karbonyl)- alebo -/V(benzoyl)-, alebo pokiaľ n znamená číslo 1, 2, alebo 3 môže znamenať tiež atóm vodíka, skupinu vzorca (III)R 9 is amino-, C 1 -. 4 -alkylamino, phenylamino, N- (Ci. 4 alkyl) -fenylamino-, benzylamino, N- (C ^ -alkylj-benzylamino-or di (C1. 4 alkyl) amino, 4 - a 7-membered cycloalkyleneimine group, wherein the methylene group at the 4-position of a 6-membered or 7-membered cycloalkylenimine group may in each case be replaced by an oxygen or sulfur atom, a sulfinyl-, sulfonyl-, -NH-, -7V (C 1-3 -alkyl) - group; - // (phenyl) -, - N (C 1-3 -alkylcarbonyl) - or - N (benzoyl) -, or when n is 1, 2, or 3 may also be hydrogen, a group of the formula (III)

-N(R10) - (CH2)m - (CO)o - R11 (III), v ktorom-N (R 10) - (CH 2) m - (CO) O - R @ 11 (III), wherein

R10 znamená atóm vodíka, Ci_3-alkylovú skupinu, C|.3-alkyl-karbonylovú skupinu, arylkarbonylovú skupinu, fenyl-C|.3-alkyl-karbonylovú skupinu, Ci_3-alkylsulfonylovú skupinu, arylsulfonylovú skupinu alebo fenylCi.3-alkyl-sulfonylovú skupinu, mje číslo 1, 2, 3 alebo 4, o je číslo 0 alebo 1 aR 10 represents a hydrogen atom, a C 1-3 -alkyl group, a C 1-6 alkyl group, or a C 1-3 alkyl group; 3 -alkylcarbonyl, arylcarbonyl, phenyl-C 1-6 alkyl; 3 -alkylcarbonyl, C 1-3 -alkylsulfonyl, arylsulfonyl or phenylCi. 3 -alkylsulfonyl, m is 1, 2, 3 or 4, o is 0 or 1; and

R11 znamená skupinu amino-, Ci_4-alkylamino-, fenylamino-, N-(Ci_4-alkyl)-fenylamino-, benzylamino-, N-(Ci.4-alkyl)-benzylamino- alebo di-(Ci_4-alkyl)-amino-, 4- až 7-člennú cykloalkylénimínovú skupinu, pričom cykloalkylénová časť môže byť kondenzovaná s fenylovým kruhom, alebo metylénová skupina v polohe 4 šesťčlennej alebo sedemčlennej cykloalkylénimínovej skupiny môže byť nahradená atómom kyslíka alebo síry, skupinou sulfinyl-, sulfonyl-, -NH-, -/V(Ci.3-alkyl)-, -7V(fenyl)-, -7V(C|.3-alkyl-karbonyl)- alebo skupinou -Mbenzoyl)-, skupinu Ci_3-alkoxy- alebo v polohe 1 voliteľne Cj.3-alkylovou skupinou substituovanú skupinu di-(Ci_4-alkyl)-amino-C|.3-alkylamino-,R 11 represents an amino, a C 4 -alkylamino, phenylamino, N- (C 4 alkyl) -fenylamino-, benzylamino, N- (Ci. 4 alkyl) -benzylamino- or di- (C 4 - alkyl) -amino-, 4- to 7-membered cycloalkyleneimine group, wherein the cycloalkylene moiety may be fused to the phenyl ring, or the methylene group at the 4-position of a six- or seven-membered cycloalkyleneimine group may be replaced by an oxygen or sulfur atom, sulfinyl-, sulfonyl- , -NH-, - N (C 1-3 -alkyl) -, -7 N (phenyl) -, -7 N (C 1-3 -alkyl-carbonyl) - or -Mbenzoyl) -, C 1-3 -alkoxy- or in position 1 optionally C 1. A di-(C 1-4 -alkyl) amino-C 1-6 -substituted group substituted by an alkyl group. 3 -alkylamino-,

SK 287312 Β6 alebo skupinu V-(Ci.3-alkyl)-C1.5-alkylsulfonylatnino- alebo V-(Cb3-alkyl)-fenyl-sulfonylamino-, v ktorých alkylová časť je navyše substituovaná skupinou kyano- alebo karboxylovou skupinou, pričom všetky pre R6 uvedené zvyšky obsahujúce jednoducho viazané alebo nakondenzované fenylové skupiny môžu byť mono- alebo di- substituované atómom fluóru, chlóru, brómu alebo jódu, skupinou Cj.s-alkyl-, trifluórmetyl-, Ci.3-alkoxy-, karboxy-, Cu-alkoxykarbonyl-, aminosulfonyl-, nitro- alebo kyano-, pričom substituenty môžu byť rovnaké alebo rozdielne, alebo dva susediace vodíkové atómy fenylovej skupiny môžu byť nahradené skupinou metyléndioxy-, aOr a group V- (C 1-3 -alkyl) -C 1 . -Alkylsulfonylatnino- 5 or N (C b 3-alkyl) sulfonylamino-phenyl, wherein the alkyl moiety is additionally substituted by a cyano or carboxyl, each of the R 6 radicals of the easily bonded or fused phenyl groups may be mono- or di- substituted by a fluorine, chlorine, bromine or iodine atom, a C 1-5 -alkyl-, trifluoromethyl-, C 1-6 -alkyl-, C 1-6 -alkyl-, C 1-6 -alkyl-, C 1-6 -alkyl-, C 1-4- 3- alkoxy-, carboxy-, C 1-6 alkoxycarbonyl-, aminosulfonyl-, nitro- or cyano-, wherein the substituents may be the same or different, or two adjacent hydrogen atoms of the phenyl group may be replaced by a methylenedioxy- group, and

R5 znamená atóm vodíka alebo Ci.3-alkylovú skupinu, pričom výrazom arylskupina sa rozumie voliteľne mono- alebo di- substituovaná fenylová alebo naftylová skupina, substituovaná atómom fluóru, chlóru, brómu alebo jódu, skupinou trifluórmetyl-, Ci.3-alkyl- alebo Cp3-alkoxy- a výrazom heteroarylová skupina sa rozumie monocyklická päťčlenná alebo šesťčlenná heteroarylová skupina, voliteľne substituovaná Ci.3-alkylovou skupinou, pričom uvedená šesťčlenná heteroarylová skupina obsahuje jeden, dva alebo tri atómy dusíka a päťčlenná heteroarylová skupina obsahuje iminoskupinu, atóm kyslíka alebo atóm síry, voliteľne substituované Ci.3-alkylovou skupinou, alebo obsahuje voliteľne skupinou C1.3-alkyl- substituovanú iminoskupinu a atóm kyslíka, alebo atóm síry, alebo obsahuje voliteľne C].3-alkylovou skupinou substituovanú iminoskupinu a dva atómy dusíka, a okrem uvedeného môže byť na uvedené monocyklické heterocyklické skupiny cez dva susediace atómy uhlíka nakondenzovaný fenylový kruh, uvedené nasýtené alkylové a alkoxylové časti vpredu určených skupín, ktoré obsahujú viac ako 2 uhlíkové atómy, zahŕňajú, pokiaľ sa neuvádza inak, aj ich rozvetvené izoméry napríklad skupiny izopropyl-, tercbutyl- a izobutyl-, a pričom uvedené karboxylové, amino- a imino- skupiny môžu byť substituované zvyškom, ktorý je odštiepiteľný in vivo, ich izoméry a ich soli.R 5 represents a hydrogen atom or C 1-6 alkyl; 3- alkyl, wherein the term "aryl" refers to an optionally mono- or di-substituted phenyl or naphthyl group substituted by a fluorine, chlorine, bromine or iodine atom, trifluoromethyl-, C 1-6 alkyl; 3- alkyl- or C 3-6 -alkoxy- and the term heteroaryl refers to a monocyclic five- or six-membered heteroaryl group, optionally substituted with C 1-6 alkyl; A 3- alkyl group, said six-membered heteroaryl group containing one, two or three nitrogen atoms and a five-membered heteroaryl group containing an imino group, an oxygen atom or a sulfur atom, optionally substituted with C 1-6 alkyl; 3- alkyl, or optionally containing C 1 . A 3- alkyl-substituted amino group and an oxygen atom or a sulfur atom, or optionally contains C 1. A 3- alkyl-substituted amino group and two nitrogen atoms, and in addition to said monocyclic heterocyclic groups a fused phenyl ring may be fused to two monocyclic heterocyclic groups, said saturated alkyl and alkoxy moieties of the predetermined groups containing more than 2 carbon atoms, unless otherwise indicated, their branched isomers, for example, isopropyl, tert-butyl and isobutyl groups, and wherein said carboxyl, amino and imino groups may be substituted with an in vivo cleavable residue, their isomers and salts thereof.

Nové zlúčeniny podľa vynálezu možno pripraviť napríklad nasledujúcimi, v podstate z literatúry známymi, spôsobmi:The novel compounds of the invention can be prepared, for example, by the following essentially known literature:

a) premenou zlúčeniny všeobecného vzorca (VII)a) converting a compound of formula (VII)

R3 R 3

(VII), v ktorom(VII) in which:

X a R3 sú určené,X and R 3 are identified,

R2' má význam ako R2 uvedené na začiatku,R 2 'is defined as R 2 mentioned in the beginning,

R18 znamená vodíkový atóm alebo ochrannú skupinu pre dusík laktámovej skupiny, pričom jeden zo zvyškov R2' a R18 môže voliteľne cez medzičlen (spacer) vytvárať väzbu s tuhou fázou a druhý z uvedených zvyškov má uvedený význam, aR 18 represents a hydrogen atom or a nitrogen protecting group of the lactam group, wherein one of the radicals R 2 'and R 18 can optionally form a solid-phase bond via a spacer and the other of said radicals as defined above, and

Z1 znamená atóm halogénu, skupinu hydroxy-, alkoxy- alebo arylalkoxy-, napríklad atóm chlóru alebo atóm brómu, skupinu metoxy-, etoxy- alebo benzyloxy-, s amínom všeobecného vzorca (VIII) v ktoromZ 1 represents a halogen atom, a hydroxy-, alkoxy- or arylalkoxy- group, for example a chlorine or bromine atom, a methoxy-, ethoxy- or benzyloxy- group, with an amine of the general formula (VIII) in which:

R4 a R5 sú určené,R 4 and R 5 are intended,

(VIII), a ak sa vyžaduje, následným odštiepením použitej ochrannej skupiny dusíka laktámovej skupiny alebo odštiepením od tuhej fázy.(VIII) and, if desired, subsequent cleavage of the used nitrogen protecting group of the lactam group or cleavage from the solid phase.

Vhodná ochranná skupina dusíka laktámovej skupiny je napríklad acetylová skupina, benzoylová skupina, etoxykarbonylová skupina, terc-butyloxykarbonylová skupina alebo benzyloxykarbonylová skupina a vhodná tuhá fáza je živica, ako je napríklad 4-(2',4'-dimetoxyfenylaminometyl)-fenoxylová živica, pričom väzba účelne nastáva prostredníctvom aminoskupiny, alebo p-benzyloxybenzylalkoholová živica, pričom väzba účelne nastáva prostredníctvom medzičlena, ako je 2,5-dimetoxy-4-hydroxy-benzylderivát.A suitable nitrogen protecting group for the lactam group is, for example, acetyl, benzoyl, ethoxycarbonyl, tert-butyloxycarbonyl or benzyloxycarbonyl, and a suitable solid phase is a resin, such as 4- (2 ', 4'-dimethoxyphenylaminomethyl) -phenoxy resin, the bond conveniently occurs through an amino group, or a p-benzyloxybenzyl alcohol resin, wherein the bond conveniently occurs via an intermediate, such as 2,5-dimethoxy-4-hydroxybenzyl derivative.

Uvedená premena sa účelne uskutoční v prostredí rozpúšťadla, ako je dimetylformamid, toluén, acetonitril, tetrahydrofurán, dimetylsulfoxid, metylénchlorid, alebo v prostredí ich zmesí, voliteľne v prítomnosti inertnej zásady ako je trietylamín, jV-etyl-diizopropylamín alebo hydrogenuhličitan sodný, pri teplotách medzi 20 a 175 °C, pričom použitá ochranná skupina sa môže súčasne odštiepiť v dôsledku amidácie.The conversion is conveniently carried out in a solvent such as dimethylformamide, toluene, acetonitrile, tetrahydrofuran, dimethylsulfoxide, methylene chloride, or mixtures thereof, optionally in the presence of an inert base such as triethylamine, N-ethyl-diisopropylamine or sodium bicarbonate, 20 and 175 ° C, wherein the protecting group used can be simultaneously cleaved off as a result of amidation.

Ak Z1 v zlúčenine všeobecného vzorca (VII) znamená atóm halogénu, potom sa uvedená premena výhodne uskutoční v prítomnosti inertnej zásady pri teplotách medzi 20 a 120 °C.When Z 1 in the compound of formula (VII) is a halogen atom, then said conversion is preferably carried out in the presence of an inert base at temperatures between 20 and 120 ° C.

Ak Z1 v zlúčenine všeobecného vzorca (VII) znamená hydroxylovú skupinu, alkoxylovú skupinu alebo arylalkoxylovú skupinu, potom sa uvedená premena výhodne uskutoční pri teplotách medzi 20 a 200 °C.When Z 1 in the compound of formula (VII) is a hydroxyl group, an alkoxy group or an arylalkoxy group, then said conversion is preferably carried out at temperatures between 20 and 200 ° C.

Prípadné vyžadované následné odštiepenie použitej ochrannej skupiny sa účelne uskutoční alebo hydrolyticky vo vodnom alebo alkoholovom rozpúšťadle, napríklad v metanole/vode, etanole/vode, izopropanole/vode, tetrahydrofuráne/vode, dioxáne/-vode, dimetylformamide/vode, metanole alebo etanole, v prítomnosti hydroxidu alkalického kovu, ako je hydroxid lítny, hydroxid sodný alebo hydroxid draselný, pri teplotách medzi 0 a 100 °C, výhodne pri teplotách medzi 10 a 50 °C, alebo sa výhodne uskutoční amidáciou s organickou zásadou, ako je amoniak, butylamín, dimetylamín alebo piperidín v prostredí rozpúšťadla, ako je metanol, etanol, dimetylformamid a ich zmesi, alebo v nadbytku použitého amínu pri teplotách medzi 0 a 100 °C, výhodne pri teplotách medzi 10 a 50 °C.The optional subsequent cleavage of the protecting group used is conveniently carried out or hydrolytically in an aqueous or alcoholic solvent, for example in methanol / water, ethanol / water, isopropanol / water, tetrahydrofuran / water, dioxane / water, dimethylformamide / water, methanol or ethanol, the presence of an alkali metal hydroxide such as lithium hydroxide, sodium hydroxide or potassium hydroxide at temperatures between 0 and 100 ° C, preferably at temperatures between 10 and 50 ° C, or is preferably carried out by amidation with an organic base such as ammonia, butylamine, dimethylamine or piperidine in a solvent environment such as methanol, ethanol, dimethylformamide and mixtures thereof, or in excess of the amine used at temperatures between 0 and 100 ° C, preferably at temperatures between 10 and 50 ° C.

Odštiepenie použitej tuhej fázy sa výhodne uskutoční pomocou kyseliny trifluóroctovej a vody pri teplotách medzi 0 a 35 °C, výhodne pri teplote miestnosti.The cleavage of the solid phase used is preferably carried out with trifluoroacetic acid and water at temperatures between 0 and 35 ° C, preferably at room temperature.

b) Príprava zlúčeniny všeobecného vzorca (I), v ktorom R2 s výnimkou karboxylovej skupiny je určené ako na začiatku, sa uskutoční premenou zlúčeniny všeobecného vzorca (IX)b) Preparation of the compound of formula (I), wherein R 2 other than the carboxyl group is designated as the beginning, resulting in a conversion of a compound of formula (IX)

(IX), v ktorom(IX) in which:

R1 a R3 až R5 sú určené ako vpredu, alebo jej reaktívneho derivátu so zlúčeninou všeobecného vzorca (X)R 1 and R 3 to R 5 are as defined above, or a reactive derivative thereof with a compound of formula (X)

H - R19 (X), v ktoromH - R 19 (X) in which

R19 znamená Ci.6-alkanol, C4.7-cykloalkanol alebo aromatický alkohol,R 19 is C 1-6. 6 -alkanol, C 4 . 7 -cycloalkanol or aromatic alcohol,

Ci-6-alkanol, ktorý v koncovej alkylovej časti je substituovaný fenylovou skupinou, heteroarylovou skupinou, karboxylovou skupinou, Ci.3-alkoxy-karbonylovou skupinou, aminokarbonylovou skupinou, C|.3-alkylaminokarbonylovou skupinou alebo di-(C].3-alkyl)-aminokarbonylovou skupinou,C 1-6 -alkanol, which in the terminal alkyl moiety is substituted by phenyl, heteroaryl, carboxyl, C 1-6 -alkanol; 3 -alkoxycarbonyl; aminocarbonyl; 3- alkylaminocarbonyl or di- (C 1-3 -alkyl) aminocarbonyl,

Ci-e-alkanol, ktorý je v koncovej alkylovej časti substituovaný atómom chlóru alebo skupinou hydroxy-, C,.3-alkoxy-, amino-, Ci_3-alkylamino- alebo di-(C1.3-alkyl)amino-, aminoskupinu, alebo metylaminoskupinu, etylaminoskupinu alebo di-(Ci_2-alkyl)-aminoskupinu, ktoré môžu byť voliteľne substituované v polohe 2 etylskupiny skupinou hydroxy- alebo Ci_3-alkoxy-.C 1-6 -alkanol substituted in the terminal alkyl moiety with a chlorine atom or a hydroxy-, C 1-6 -alkyl group. 3 -alkoxy, amino, C 3 -alkylamino or di- (C first 3 alkyl) amino, amino, or methylamino, ethylamino or di- (Ci_2-alkyl) amino group which may optionally be substituted in the position 2 of the ethyl group with hydroxy- or C 1-3 -alkoxy-.

Esterifíkácia alebo amidácia sa výhodne uskutoční v prostredí rozpúšťadla, ako je metylénchlorid, dietyléter, tetrahydrofurán, toluén, dioxán, acetonitril, dimetylsulfoxid akebo dimetylformamid, voliteľne v prítomnosti anorganickej alebo terciámej organickej zásady, výhodne pri teplotách medzi 20 °C a teplotou varu pod spätným chladičom použitého rozpúšťadla. Pritom sa premena uskutoční s príslušnou kyselinou, výhodne v prítomnosti vodu odnímajúceho činidla, napríklad v prítomnosti izobutylesteru kyseliny chlórmravčej, tetraetylesteru kyseliny orto-uhličitej, metylesteru kyseliny ortooctovej, 2,2-dimetoxypropánu, tetrametoxysilánu, tionylchloridu, trimetylchlórsilánu, chloridu fosforitého, oxidu fosforečného, 7V,/V-dicyklohexylkarbodiimidu, N, /V-dicyklohexylkarbodiimiduW-hydroxysukcínimidu, N, /V’-dicyklohexylkarbodíimidu/1 -hydroxy-benztriazolu, 2 -(1 H-benzotriazo 1-1 -yl) -1,1,3,3 -tetrametylurónium-tetrafluórborátu, 2 -(1 //-benzo triazo 1-1 -y 1) -1,1,3,3-tetra-metyluróniumtetrafluórborátu/l-hydroxybenztriazolu, /V.M-karbonyldiimidazolu alebo trifenyl -fosfín/chloridu uhličitého a voliteľne s prídavkom zásady, ako je pyridín, 4-dimetylaminopyridín, 7V-metyl-morfolín alebo trietylamín, účelne pri teplotách medzi 0 a 150 °C, výhodne pri teplotách medzi 0 a 100 °C, a acylácia sa uskutoční príslušnou reaktívnou zlúčeninou, ako je anhydrid, ester, imidazolid alebo halogenid voliteľne v prítomnosti terciámej organickej zásady, ako je trietylamín, 7V-etyl-diizopropylamín alebo N-metylmorfolín pri teplotách medzi 0 a 150 °C, výhodne pri teplotách medzi 50 a 100 °C.The esterification or amidation is preferably carried out in a solvent environment such as methylene chloride, diethyl ether, tetrahydrofuran, toluene, dioxane, acetonitrile, dimethylsulfoxide or dimethylformamide, optionally in the presence of an inorganic or tertiary organic base, preferably at temperatures between 20 ° C and boiling point. the solvent used. The conversion is carried out with the appropriate acid, preferably in the presence of a water-withdrawing agent, for example in the presence of isobutyl chloroformate, tetraethyl ortho-carbonate, methyl ortho-acetic acid, 2,2-dimethoxypropane, tetramethoxysilane, thionyl chloride, phosphorochlorite N, N -dicyclohexylcarbodiimide, N, N-dicyclohexylcarbodiimide N-N-N-N-N-dicyclohexylcarbodiimide / 1-hydroxybenzotriazole, 2- (1H-benzotriazo-1-yl) -1,1,3, 3-tetramethyluronium tetrafluoroborate, 2- (1H-benzo-triazol-1-yl) -1,1,3,3-tetramethyluronium tetrafluoroborate / 1-hydroxybenzotriazole, 1H-carbonyldiimidazole or triphenylphosphine / carbon tetrachloride and optionally with the addition of a base such as pyridine, 4-dimethylaminopyridine, N-methylmorpholine or triethylamine, suitably at temperatures between 0 and 150 ° C, preferably at temperatures between 0 and 100 ° C, and the acylation is carried out an appropriate reactive compound such as an anhydride, ester, imidazolide or halide optionally in the presence of a tertiary organic base such as triethylamine, N-ethyl-diisopropylamine or N-methylmorpholine at temperatures between 0 and 150 ° C, preferably at temperatures between 50 and 100 ° C.

c) Príprava zlúčeniny všeobecného vzorca (I), v ktorom R4 znamená Ci_4-alkylovú skupinu, substituovanú skupinou R7, pričomc) Preparation of a compound of formula (I) wherein R 4 is C 1-4 -alkyl substituted with R 7 wherein:

R7 znamená skupinu amino-, Ci^-alkylamino-, di-ÍC^-alkylj-amino-, fenylamino-, TV-fenyl-Ct.j-alkyl-amino-, fenyl-C^j-alkyl-amino-, Äŕ-(C1.3-alkyl)-fenyl-C1.3-alkylamino- alebo di-(fenyl-Ci_3-alkyl)-amino-, skupinu ci)-hydroxy-C2.3-alkylamino-, A^C^-alkylj-o-hydroxy-Cjj-alkyl-amino-, di-(ro-hydroxy-C2.3-alkyl)-amino-, di-(ra-(C1.3-alkoxy)-C2.3-alkyl)-amino- alebo Aľ-(dioxolán-2-yl)-Ci_3-alkyl-amino-, skupinu Ci.3-alkylkarbonylamino-C2_3-alkyl-amino- alebo C|.3-alkylkarbonyl-amino-C2.3-alkyl-/ť-(Cl.3-alkyl)-amino-, skupinu Ci.3-alkylsulfonylamino-, //-(Cu-alkylj-Ci^-alkyl-sulfonylamino-, C1.3-alkylsulfonylamino-C2.3-alkyl-amino- alebo C|.3-alkylsulfonylamino-C2.3-alkyl-A'-(C|.3-alkyl)-amino-, skupinu vzorca (III)R 7 is amino-, C 1-4 -alkylamino-, di-C 1-4 -alkyl-amino-, phenylamino-, N-phenyl-C 1-4 -alkyl-amino-, phenyl-C 1-4 -alkyl-amino-, N - (C 1-3 -alkyl) -phenyl-C 1-3 -alkylamino- or di- (phenyl-C 1-3 -alkyl) -amino-, ci) -hydroxy-C 2-3 -alkylamino- group, alkyl-o-hydroxy-C 1-6 -alkyl-amino-, di- (ω-hydroxy-C 2-3 -alkyl) -amino-, di- (α- (C 1-3 -alkoxy) -C 2,3 -alkyl) - amino- or N 1 - (dioxolan-2-yl) -C 1-3 -alkyl-amino-, a C 1-6 alkyl group; 3 alkylcarbonylamino-C 2 _ 3 -alkyl-amino or C |. 3- alkylcarbonylamino-C2. 3 alkyl- / T- (Art. 3 alkyl) amino group, Ci.3-alkylsulfonylamino, // - (C-alkyli-C-alkyl-sulfonylamino, C 1-3 alkylsulfonylamino-C2 .3-alkyl-amino or C | .3-alkylsulfonylamino-C 2nd 3 -alkyl-N - (C | .3 alkyl) amino, a group of formula (III)

-N^MCHA-tCOjo-R11 (III), v ktoromN ^ MCHA tCOjo-11-R (III) wherein

R10 znamená atóm vodíka, Ci_3-alkylovú skupinu, C[.3-alkyl-karbonylovú skupinu, arylkarbonylovú skupinu, fenyl-Ci.3-alkyl-karbonylovú skupinu, Cl.3-alkylsulfonylovú skupinu, arylsulfonylovú skupinu alebo fenylC1.3-alkylsulfonylovú skupinu, m je číslo 1, 2, 3 alebo 4, oje číslo 1 aR 10 represents a hydrogen atom, a C 1-3 -alkyl group, a C 1-6 alkyl group or a C 1-3 alkyl group; 3 -alkylcarbonyl, arylcarbonyl, phenyl-C 1-6 alkyl; 3-alkyl-carbonyl, C l. 3- alkylsulfonyl, arylsulfonyl or phenylC 1 . 3 alkylsulphonyl group, m is 1, 2, 3 or 4, o is a value 1, and

R11 znamená skupinu amino-, C|.4-alkylamino-, di-(C1.4-alkyl)-amino-, fenylamino-, ÍV-(CI.4-alkyl)-fenylamino-, benzylamino-, M-(Ci.4-alkyl)-benzylamino-, C].4-alkoxy- alebo skupinu Ci.3-alkoxy-Ci_3-alkoxy-, voliteľne skupinou C|.3-alkyl- substituovanú skupinu di-(C|.4-alkyl)-amino-Ci.3-alkylamino- alebo 4- až 7-člennú cykloalkylénimínovú skupinu, pričom cykloalkylénová časť môže byť kondenzovaná s fenylovým kruhom, alebo metylénová skupina v polohe 4 šesťčlennej alebo sedemčlennej cykloalkylénimínovej skupiny môže byť vždy nahradená atómom kyslíka alebo síry, skupinou sulfinyl-, sulfonyl-, -NH-, -TV(Ci.3-alkyl)-, -M/fenyl)-, -TV(C1.3-alkyl-karbonyl)- alebo -7V-(benzoyl)-, skupinu C4.7-cykloalkylamino-, C4.7-cykloalkyl-Ci.3-alkylamino- alebo C4.7-cykloalkenylamino-, v ktorej sa poloha 1 kruhu nezúčastňuje na dvojitej väzbe a pričom uvedené skupiny môžu byť navyše substituované na amínovom atóme dusíka skupinou C5.7-cykloalkyl-, C2.4-alkenyl- alebo C^-alkyl-, alebo 4 až 7 člennú cykloalkylénimínovú skupinu, ktorej cykloalkylénová časť môže byť kondenzovaná s fenylovou skupinou alebo so skupinou oxazolo-, imidazolo-, tiazolo-, pyridino-, pyrazino- alebo pyrimidino-, voliteľne substituovanými atómom fluóru, chlóru, brómu alebo jódu, skupinou nitro-, skupinou C|.3-alkyl-, C[.3-alkoxy alebo aminoskupinou, a ktorej jeden alebo dva atómy vodíka môžu byť nahradené Cj^-alkylovou skupinou, C5.7-cykloalkylovou skupinou alebo fenylovou skupinou, a/alebo ktorej metylénová skupina v polohe 3 päťčlennej cykloalkylénimínovej skupiny môže byť substituovaná hydroxyskupinou, hydroxy-C].3-alkylovou skupinou, skupinou C|.3-alkoxy- alebo Cl.3-alkoxy-Ci_3-alkylovou skupinou, ktorej metylénová skupina v polohe 3 alebo 4 šesťčlennej alebo sedemčlennej cykloalkylénimínovej skupiny môže byť substituovaná hydroxyskupinou, hydroxy-Ci_3-alkylovou skupinou, skupinou C1.3-alkoxy-, Ci.3-alkoxy-Ci.3-alkylovou skupinou, karboxylovou skupinou, skupinou Ci_4-alkoxykarbonyl-, aminokarbonyl-, Ci.3-alkylamino-karbonyl-, di-(Ci.3-alkyl)-aminokarbonyl-, fenyl-Ci.3-alkylamino- alebo 7ť-(C|.3-alkyl)-fenyl-Ci_3-alkylamino-, alebo uvedená metylénová skupina môže byť nahradená atómom kyslíka alebo síry, skupinou sulfinyl-, sulfonyl-, -NH-, -TV(C1.3-alkyl)-, -ÍV(fenyl)-, -ň/(fenyl-C1.3-alkyl)-, -/V'(C|.3-alkyl-karbonyl)-, -TV(C].4-alkoxy-karbonyl)-, -7V(benzoyl)- alebo -A/(fenyl-C|.3-alkyl-karbonyl)-, pričom metylénová skupina, ktorá je viazaná s imínovým atómom dusíka cykloalkylénimínovej skupiny môže byť nahradená karbonylovou skupinou alebo sulfonylovou skupinou, alebo v päťčlennej až sedemčlennej monocyklickej alebo s fenylovou skupinou kondenzovanej cykloalkylénimínovej skupine obidve metylénové skupiny viazané imínovým atómom dusíka môžu byť nahradené karbonylovými skupinami, sa uskutoční premenou zlúčeniny všeobecného vzorca (XI)R 11 is amino-, C 1-6 -alkyl. 4 alkylamino-, di (C1. 4 alkyl) amino, phenylamino, N- (Ci. 4 alkyl) -fenylamino-, benzylamino, N- (Ci. 4 alkyl) benzylamino -, C]. 4- alkoxy- or a C 1-6 alkyl group; 3- alkoxy-C 1-3 -alkoxy-, optionally with C 1-6. A 3- alkyl- substituted di- (C 1-4 -alkyl) amino-C 1-6 alkyl group; A 3- alkylamino- or 4- to 7-membered cycloalkyleneimine group, wherein the cycloalkylene moiety may be fused to the phenyl ring, or the methylene group at the 4-position of a six- or seven-membered cycloalkyleneimine group may be replaced by an oxygen or sulfur atom; , -NH-, -TV (Cl. 3 alkyl) -, -N / phenyl) -, -TV (C1. 3 alkyl-carbonyl) - or -7V- (benzoyl) -, a group of C4. 7 -cycloalkylamino-, C 4 . 7 -cycloalkyl-C 1-3 -alkylamino- or C 4 . 7 -cycloalkenylamino- in which the ring 1 position does not participate in the double bond and wherein said groups may additionally be substituted on the amino nitrogen atom by a C 5 group. 7 -cycloalkyl- C 2nd A 4- alkenyl- or C 1-4 -alkyl-, or 4-7 membered cycloalkyleneimine group, the cycloalkylene moiety of which may be fused with a phenyl group or with an oxazolo-, imidazolo-, thiazolo-, pyridino-, pyrazino- or pyrimidino- group, optionally substituted by a fluorine, chlorine, bromine or iodine atom, a nitro- group, a C 1-6 group. 3- alkyl-; 3 -alkoxy or amino, and wherein one or two hydrogen atoms may be replaced by C ^ -alkyl, C 5. A 7- cycloalkyl or phenyl group, and / or wherein the methylene group at the 3-position of the five-membered cycloalkyleneimine group may be substituted with a hydroxy group, hydroxy-C 1. 3- alkyl, C 1-6. 3 -alkoxy or C l .3-alkoxy-C 3 -alkyl, where the methylene group in the 3- or 4 cykloalkylénimínovej six or seven membered group is optionally substituted by hydroxy, hydroxy-C 3 -alkyl, C first 3- alkoxy-, Ci. 3- alkoxy-C 1-3 -alkyl, carboxyl, C 1-4 -alkoxycarbonyl-, aminocarbonyl-, C 1-4 -alkyl; 3- alkylamino-carbonyl-, di- (C 1-3 -alkyl) -aminocarbonyl-, phenyl-C 1-6 -alkyl- 3- alkylamino- or N - (C 1-3 -alkyl) -phenyl-C 1-3 -alkylamino-, or said methylene group may be replaced by an oxygen or sulfur atom, sulfinyl-, sulfonyl-, -NH-, -TV ( C1. 3 alkyl) -, -N (phenyl) -, -N / (phenyl-C1. 3 alkyl) -, - / V "(C |. 3 -alkyl-carbonyl) -, -TV ( ( 1-4 -alkoxycarbonyl) -, -7 N (benzoyl) - or - N - (phenyl-C 1-3 -alkylcarbonyl) -, wherein the methylene group which is bonded to the imine nitrogen atom of the cycloalkylenimine group may be substituted by carbonyl or sulfonyl, or in a 5- to 7-membered monocyclic or phenyl-fused cycloalkylenimine group, both methylene groups bound by an imine nitrogen atom may be replaced by carbonyl groups, by conversion of a compound of formula (XI)

(XI),(XI),

R18 v ktoromR 18 in which

R1, R5 a X sú určené ako skôr,R 1 , R 5 and X are as previously defined,

R2' má rovnaký význam ako R2 skôr,R 2 'is as R 2 above,

R18 znamená vodíkový atóm alebo ochrannú skupinu pre dusík laktámovej skupiny, pričom jeden zo zvyškov R2' a R18 môže voliteľne vytvárať cez medzičlen (Spacer) väzbu s tuhou fázou a druhý z uvedených zvyškov má uvedený význam, aR 18 represents a hydrogen atom or a nitrogen protecting group of the lactam group, wherein one of R 2 'and R 18 may optionally form a solid phase bond through the Spacer and the other of said radicals is as defined above, and

A znamená CA-alkylovú skupinu aA represents a C 1-6 alkyl group and

Z2 znamená vymeniteľnú skupinu, napríklad alkylovú alebo arylsulfonyloxyskupinu, ako je skupina metyl sulfonyloxy-, etylsulfonyloxy-, p-toluénsulfonyloxy- alebo trifluór-metánsulfonyloxy-, s amínom všeobecného vzorca (XII)Z 2 is an exchangeable group, for example an alkyl or arylsulfonyloxy group such as methyl sulfonyloxy, ethylsulfonyloxy, p-toluenesulfonyloxy or trifluoromethanesulfonyloxy, with an amine of formula (XII)

H-R7“ (XII), v ktoromHR 7 '(XII), in which

R7' má rovnaký význam ako R7 vpredu a ak sa vyžaduje, následné odštiepenie použitej ochrannej skupiny od dusíkového atómu laktámovej skupiny alebo od tuhej fázy.R 7 'has the same meaning as R 7 above and, if desired, subsequent cleavage of the protecting group used from the nitrogen atom of the lactam group or from the solid phase.

Uvedená premena sa účelne uskutoční v prostredí rozpúšťadla, ako je metylénchlorid, tetrahydrofurán, 1,4-dioxán, toluén, acetonitril, dimetylsulfoxid, dimetylformamid, dimetylacetamid, Λ'-metylpyrolidón alebo v prostredí ich zmesí, voliteľne s prídavkom vody ako korozpúšťadla a/alebo s prídavkom inertnej pomocnej zásady, napríklad hydrogenuhličitanu sodného, pyridínu, 2,4,6-trimetyl-pyridínu, chinolínu, trietylamínu, N-etyldiizopropylamínu, /V-etyl-dicyklohexylamínu, l,4-diazobicyklo[2.2.2]oktánu alebo 1,8-diazobicyklo[5.4.0]-undek-7-énu, pri teplotách v rozmedzí medzi -50 a +100 °C, výhodne pri teplotách medzi -10 a +50 °C, pričom použitá ochranná skupina sa súčasne môže v dôsledku amidácie odštiepiť.The conversion is conveniently carried out in a solvent environment such as methylene chloride, tetrahydrofuran, 1,4-dioxane, toluene, acetonitrile, dimethylsulfoxide, dimethylformamide, dimethylacetamide, Λ'-methylpyrrolidone or mixtures thereof, optionally with the addition of water as a co-solvent and / or with the addition of an inert auxiliary base such as sodium bicarbonate, pyridine, 2,4,6-trimethylpyridine, quinoline, triethylamine, N-ethyldiisopropylamine, N-ethyl-dicyclohexylamine, 1,4-diazobicyclo [2.2.2] octane or 1 , 8-diazobicyclo [5.4.0] -undec-7-ene, at temperatures between -50 and +100 ° C, preferably at temperatures between -10 and +50 ° C, while the protective group used can simultaneously amidation cleave.

Prípadne vyžadované odštiepenia použitej ochrannej skupiny dusíka laktámovej skupiny alebo odštiepenie od tuhej fázy sa uskutoční spôsobom, ktorý sa opisuje v bode a.Any desired cleavage of the used nitrogen protecting group of the lactam group or cleavage from the solid phase is carried out as described in a.

Ak pripravená zlúčenina vzorca (I) podľa tohto vynálezu obsahuje alkoxy-karbonylovú skupinu, možno túto zlúčeninu pomocou hydrolýzy premeniť na zodpovedajúcu karboxylovú zlúčeninu, alebo ak pripravená zlúčenina vzorca (I) podľa tohto vynálezu obsahuje skupinu amino- alebo alkylamino-, možo túto zlúčeninu pomocou redukčnej alkylácie premeniť na zodpovedajúcu alkylamino- alebo dialkylaminozlúčeninu, alebo ak pripravená zlúčenina vzorca (I) podľa tohto vynálezu obsahuje skupinu amino- alebo alkylamino-, možno túto zlúčeninu acyláciou alebo sulfonáciou premeniť na príslušnú acyl- alebo sulfonylovú zlúčeninu, alebo ak pripravená zlúčenina vzorca (I) podľa tohto vynálezu obsahuje karboxylovú skupinu, možno túto zlúčeninu esterifíkáciou alebo amidáciou premeniť na zodpovedajúcu esterovú alebo aminokarbonylovú zlúčeninu, alebo ak zlúčenina vzorca (I) obsahuje cykloalkylénimínovú skupinu, v ktorej je jedna metylénová skupina nahradená atómom síry, možno túto zlúčeninu oxidáciou premeniť na zodpovedajúcu sulfínylovú alebo sulfonylovú zlúčeninu, alebo ak zlúčenina vzorca (I) podľa tohto vynálezu obsahuje nitroskupinu, možno túto zlúčeninu redukciou premeniť na zodpovedajúcu aminozlúčeninu, alebo zlúčeninu všeobecného vzorca (I) podľa tohto vynálezu, v ktorej R4 znamená skupinou amino-, alkylamino-, aminoalkyl- alebo A'-alkyl-amino- substituovanú fenylovú skupinu, možno následne premenou s príslušným kyanátom, izokyanátom alebo karbamoylhalogenidom premeniť na zodpovedajúcu močovinovú zlúčeninu všeobecného vzorca (I), alebo zlúčeninu všeobecného vzorca (I) podľa tohto vynálezu, v ktorej R4 znamená skupinou amino-, alkylamino-, aminoalkyl- alebo A-alkyl-amino- substituovanú fenylovú skupinu, možno následne premenou s príslušnou amidíno skupinu prenášajúcou skupinou alebo premenou so zodpovedujúcim nitrilom premeniť na zodpovedajúcu guanidínovú zlúčeninu všeobecného vzorca (I).If the prepared compound of formula (I) of the present invention contains an alkoxycarbonyl group, the compound may be converted to the corresponding carboxyl compound by hydrolysis, or if the prepared compound of formula (I) of the present invention contains an amino- or alkylamino- group, by reductive alkylation to the corresponding alkylamino- or dialkylamino compound, or if the compound of formula (I) of the present invention contains an amino- or alkylamino- group, this compound can be converted by acylation or sulfonation to the corresponding acyl- or sulfonyl compound, or I) according to the invention contains a carboxyl group, this compound can be converted by esterification or amidation to the corresponding ester or aminocarbonyl compound, or if the compound of formula (I) contains a cycloalkyleneimine group in which there is one methylene group the sulfur-substituted pin may be converted to the corresponding sulfinyl or sulfonyl compound by oxidation, or if the compound of formula (I) of the present invention contains a nitro group, the compound may be converted to the corresponding amino compound or formula (I) of the present invention by reduction wherein R 4 represents an amino-, alkylamino-, aminoalkyl- or N'-alkyl-amino-substituted phenyl group, may subsequently be converted to the corresponding urea compound of formula (I) or compound of general formula by conversion with the appropriate cyanate, isocyanate or carbamoyl halide. of formula (I) according to the invention in which R 4 represents an amino-, alkylamino-, aminoalkyl- or N-alkyl-amino-substituted phenyl group can be subsequently converted to the corresponding amidine-transfer group or by conversion with the corresponding nitrile to the corresponding g a uanidine compound of formula (I).

Následná hydrolýza sa uskutoční výhodne v prostredí vodného rozpúšťadla, napríklad v prostredí vody, metanolu/vody, etanolu/vody, izopropanolu/vody, tetra-hydrofuránu/vody alebo dioxánu/vody, v prítomnosti kyeliny, ako je kyselina trifluór-octová, kyselina chlorovodíková alebo kyselina sírová, alebo v prítomnosti hydroxidu alkalického kovu, ako je hydroxid lítny, hydroxid sodný alebo hydroxid draselný pri teplotách medzi 0 a 100 °C, výhodne pri teplotách medzi 10 a 50°C.The subsequent hydrolysis is preferably carried out in an aqueous solvent environment, for example water, methanol / water, ethanol / water, isopropanol / water, tetrahydrofuran / water or dioxane / water, in the presence of an acid such as trifluoroacetic acid, hydrochloric acid or sulfuric acid, or in the presence of an alkali metal hydroxide such as lithium hydroxide, sodium hydroxide or potassium hydroxide at temperatures between 0 and 100 ° C, preferably at temperatures between 10 and 50 ° C.

Následná redukčná alkylácia sa výhodne uskutoční vo vhodnom rozpúšťadle, ako je metanol, metanol/voda, metanol/voda/amoniak, etanol, éter, tetrahydrofurán, dioxán alebo dimetylformamid, voliteľne s prísadou kyseliny, ako je kyselina chlorovodíková v prítomnosti aktívneho vodíka, napríklad vodíka v prítomnosti Raneyovho niklu, platiny alebo paládia na uhlíku, alebo v prítomnosti hydridu kovu, ako je bórhydrid sodný, bórhydrid lítny, kyanobórhydrid sodný alebo hydrid hlinito-lítny, pri teplotách medzi 0 a 100 °C, výhodne pri teplotách medzi 20 a 80 °C.Subsequent reductive alkylation is preferably carried out in a suitable solvent such as methanol, methanol / water, methanol / water / ammonia, ethanol, ether, tetrahydrofuran, dioxane or dimethylformamide, optionally with an acid addition such as hydrochloric acid in the presence of active hydrogen, for example hydrogen in the presence of Raney nickel, platinum or palladium on carbon, or in the presence of a metal hydride such as sodium borohydride, lithium borohydride, sodium cyanoborohydride or lithium aluminum hydride at temperatures between 0 and 100 ° C, preferably between 20 and 80 ° C.

Následná acylácia alebo sulfonácia sa účelne uskutoční príslušnou voľnou kyselinou alebo zodpovedajúcou reaktívnou zlúčeninou, ako je anhydrid, ester, imidazolid alebo halogenid príslušnej kyseliny, výhodne v prostredí rozpúšťadla, ako je metylénchlorid, dietyléter, tetrahydrofurán, toluén, dioxán, acetonitril, dimetylsulfoxid alebo dimetylformamid, voliteľne v prítomnosti anorganickej alebo terciámej organickej zásady pri teplotách medzi -20 a 200 °C, výhodne pri teplotách medzi 20 °C a teplotou varu použitého rozpúšťadla. Premena s voľnou kyselinou sa môže uskutočniť v prítomnosti aktivačného činidla kyseliny alebo v prítomnosti vodu odnímajúceho činidla, napríklad v prítomnosti izobutylesteru kyseliny chlórmravčej, tetraetylesteru kyseliny ortouhličitej, metylesteru kyseliny ortooctovej, 2,2-dimetoxy-propánu, tetrametoxysilánu, tionylchloridu, trimetylchlórsilánu, chloridu fosforitého, oxidu fosforečného, MTV-dicyklohexylkarbodiimidu, A/,N’-dicyklohexylkarbodiimidu/-A/-hydroxysukcínimidu, 7V,7V-dicyklohexylkarbodiimidu/l-hydroxy-benztriazolu, 2-( 1 /7-benzotriazol-1 -yl)-1,1,3,3-tetrametylurónium-tetrafluórborátu, 2-( 1 W-benzo-triazol-1 -yl)-1,1,3,3-tetrametylurónium-tetrafluórborátu/l-hydroxy-benztriazolu, N,IV-karbonyldiimidazolu alebo trifenylfosfín/chloridu uhličitého a voliteľne s prídavkom zásady, ako je pyridín, 4-dimetylaminopyridín, 7V-metyl-morfolín alebo trietylamín, účelne pri teplotách medzi 0 a 150 °C, výhodne pri teplotách medzi 0 a 100 °C. Premena s príslušnou reaktívnou zlúčeninou sa môže uskutočniť v prítomnosti terciámej organickej zásady, ako je trietylamín, 7V-etyl-diizopropylamín, /V-metyl-morfolín alebo pyridín, alebo s použitím anhydridu v prítomnosti príslušnej kyseliny pri teplotách medzi 0 a 150 °C, výhodne pri teplotách medzi 50 a 100 °C.Subsequent acylation or sulfonation is conveniently carried out with the appropriate free acid or the corresponding reactive compound such as the anhydride, ester, imidazolide or halide of the appropriate acid, preferably in a solvent environment such as methylene chloride, diethyl ether, tetrahydrofuran, toluene, dioxane, acetonitrile, dimethylsulfoxide or dimethylsulfoxide. optionally in the presence of an inorganic or tertiary organic base at temperatures between -20 and 200 ° C, preferably at temperatures between 20 ° C and the boiling point of the solvent used. The conversion with the free acid may be carried out in the presence of an acid activating agent or in the presence of a water-withdrawing agent, for example, in the presence of isobutyl chloroformate, tetraethyl carbonate, methyl orthoacetic acid, 2,2-dimethoxypropane, tetramethoxysilane, phosphoryl chloride phosphorus pentoxide, N, N-dicyclohexylcarbodiimide, N, N'-dicyclohexylcarbodiimide / N -hydroxysuccinimide, N, N-dicyclohexylcarbodiimide / 1-hydroxy-benzotriazole, 2- (1/7-benzotriazol-1-yl) -1, 1,3,3-tetramethyluronium tetrafluoroborate, 2- (1H-benzotriazol-1-yl) -1,1,3,3-tetramethyluronium tetrafluoroborate / 1-hydroxybenztriazole, N, IV-carbonyldiimidazole or triphenylphosphine % of carbon tetrachloride and optionally with an addition of a base such as pyridine, 4-dimethylaminopyridine, N-methylmorpholine or triethylamine, suitably at temperatures between 0 and 150 ° C, preferably at temperatures between 0 and 100 C. Conversion with the appropriate reactive compound can be carried out in the presence of a tertiary organic base such as triethylamine, N-ethyl-diisopropylamine, N-methyl-morpholine or pyridine, or using an anhydride in the presence of the appropriate acid at temperatures between 0 and 150 ° C, preferably at temperatures between 50 and 100 ° C.

Následná esterifikácia alebo amidácia sa účelne uskutoční premenou zodpovedajúceho reaktívneho derivátu karboxylovej kyseliny s príslušným alkoholom alebo amínom, čo už bolo uvedené.Subsequent esterification or amidation is conveniently accomplished by conversion of the corresponding reactive carboxylic acid derivative with the appropriate alcohol or amine, as previously described.

Následná oxidácia atómu síry sa výhodne uskutoční v prostredí rozpúšťadla alebo zmesi rozpúšťadiel, napríklad v prostredí vody, vody/pyridínu, acetónu, metylénchloridu, kyseliny octovej, kyseliny octovej/acetanhydridu, zriedenej kyseliny sírovej alebo kyseliny trifluóroctovej, vždy podľa použitého oxidačného činidla pri teplotách medzi -80 a 100 °C.The subsequent oxidation of the sulfur atom is preferably carried out in a solvent or solvent mixture, for example water, water / pyridine, acetone, methylene chloride, acetic acid, acetic acid / acetic anhydride, dilute sulfuric acid or trifluoroacetic acid, depending on the oxidizing agent used. -80 and 100 ° C.

Príprava príslušnej sulfmylovej zlúčeniny všeobecného vzorca (I) sa uskutoční oxidáciou ekvivalentom použitého oxidačného činidla, napríklad peroxidom vodíka v ľadovej kyseline octovej, kyseline trifluóroctovej alebo kyseline mravčej pri 0 °C až 20 °C, alebo v acetóne pri 0 až 60 °C, s peroxykyselinou, ako je kyselina permravčia v ľadovej kyseline octovej alebo v kyseline trifluóroctovej pri 0 až 50 °C, alebo s kyselinou m-chlórperbenzoovou v metylénchloride, chloroforme alebo dioxáne pri -20 až 80 °C, s jodistanom draselným vo vodnom metanole alebo etanole pri -15 až 25 °C, brómom v ľadovej kyseline octovej alebo vodnom roztoku kyseliny octovej v prítomnosti slabej zásady, ako je octan sodný, s 7V-brómsukcínimidom v etanole, s íerc-butylhypochloritom v metanole pri -80 až -30 °C, s jódbenzodichloridom vo vodnom pyridíne pri 0 až 50 °C, s kyselinou dusičnou v ľadovej kyseline octovej pri 0 až 20 °C, kyselinou chrómovou v ľadovej kyseline octovej alebo v acetóne pri 0 až 20 °C a so sulfurylchloridom v metylénchloride pri -70 °C a tak získaný tioéterový-chlórový komplex sa účelne hydrolyzuje v prostredí vodného etanolu.The preparation of the corresponding sulfmyl compound of formula (I) is carried out by oxidation with an equivalent of the oxidizing agent used, for example hydrogen peroxide in glacial acetic acid, trifluoroacetic acid or formic acid at 0 ° C to 20 ° C, or acetone at 0 to 60 ° C, peroxyacid such as permetic acid in glacial acetic acid or trifluoroacetic acid at 0 to 50 ° C, or with m-chloroperbenzoic acid in methylene chloride, chloroform or dioxane at -20 to 80 ° C, with potassium periodate in aqueous methanol or ethanol at -15 to 25 ° C, bromine in glacial acetic acid or aqueous acetic acid in the presence of a weak base such as sodium acetate, with N -bromosuccinimide in ethanol, with tert-butyl hypochlorite in methanol at -80 to -30 ° C, with iodobenzodichloride in aqueous pyridine at 0 to 50 ° C, with nitric acid in glacial acetic acid at 0 to 20 ° C, chromic acid in ice acetic acid or acetone at 0 to 20 ° C and with sulfuryl chloride in methylene chloride at -70 ° C, and the thioether-chlorine complex thus obtained is conveniently hydrolyzed in aqueous ethanol.

Príprava príslušnej sulfonylovej zlúčeniny všeobecného vzorca (I) sa uskutoční oxidáciou, vychádzajúc zo zodpovedajúcej sulfmylovej zlúčeniny, účelne s jedným alebo viac ekvivalentmi použitého oxidačného činidla alebo sa vychádza zo zodpovedajúcej merkaptozlúčeniny, účelne reakciou s dvoma alebo viac ekvivalentmi použitého oxidačného činidla, napríklad s peroxidom vodíka v ľadovej kyseline octovej/acetanhydride, v kyseline trifluóroctovej alebo v kyseline mravčej pri 20 až 100 °C, alebo v acetóne pri 0 až 60 °C, s peroxykyselinou, ako je kyselina permravčia alebo kyseliny m-chlórperbenzoová v ľadovej kyseline octovej, v kyseline trifluóroctovej, metylénchloride alebo chloroforme pri teplotách medzi 0 a 60 °C, s kyselinou dusičnou v ľadovej kyseline octovej pri 0 až 20 °C, s kyselinou chrómovou, jodistanom sodným alebo manganistanom draselným v prostredí kyseliny octovej, vody/kyseliny sírovej alebo v acetóne pri 0 až 20 °C.The preparation of the corresponding sulfonyl compound of formula (I) is carried out by oxidation starting from the corresponding sulfmyl compound, suitably with one or more equivalents of the oxidizing agent used, or starting from the corresponding mercapto compound, conveniently by reaction with two or more equivalents of the oxidizing agent used, for example hydrogen peroxide. in glacial acetic acid / acetic anhydride, in trifluoroacetic acid or in formic acid at 20 to 100 ° C, or in acetone at 0 to 60 ° C, with a peroxyacid such as permetic acid or m-chloroperbenzoic acid in glacial acetic acid, in acid trifluoroacetic acid, methylene chloride or chloroform at temperatures between 0 and 60 ° C, with nitric acid in glacial acetic acid at 0 to 20 ° C, with chromic acid, sodium periodate or potassium permanganate in acetic acid, water / sulfuric acid or acetone at 0-20 ° C .

Následná redukcia nitroskupiny sa výhodne uskutoční hydrogenolyticky, napríklad vodíkom v prítomnosti katalyzátora, ako je paládium na uhlíku alebo Raneyov nikel v prostredí rozpúšťadla, ako je metanol, etanol, etylester kyseliny octovej, dimetylformamíd, dimetylformamid/acetón alebo ľadová kyselina octová, voliteľne s prísadou kyseliny, ako je kyselina chlorovodíková alebo ľadová kyselina octová, pri teplotách medzi 0 a 50 °C, výhodne pri teplote miestnosti a pri tlaku vodíka približne 0,1 až 0,7 MPa (1 až 7 barov), výhodne ale od 0,3 do 5 MPa (od 3 do 5 barov).The subsequent reduction of the nitro group is preferably carried out hydrogenolytically, for example with hydrogen in the presence of a catalyst such as palladium on carbon or Raney nickel in a solvent environment such as methanol, ethanol, ethyl acetate, dimethylformamide, dimethylformamide / acetone or glacial acetic acid optionally. such as hydrochloric acid or glacial acetic acid, at temperatures between 0 and 50 ° C, preferably at room temperature and at a hydrogen pressure of about 1 to 7 bar, but preferably from 0.3 to 7 bar. 5 MPa (from 3 to 5 bars).

Následná príprava zodpovedajúcej močovinovej zlúčeniny všeobecného vzorca (I) sa účelne uskutoční pôsobením anorganického kyanátu alebo príslušného izokyanátu alebo karbamoylchloridu, výhodne v prostredí rozpúšťadla, ako je dimetylformamid a voliteľne v prítomnosti terciámej organickej zásady, ako je trietyl-amín, pri teplotách medzi 0 a 50 °C, výhodne pri teplote miestnosti.The subsequent preparation of the corresponding urea compound of formula (I) is conveniently carried out by treatment with an inorganic cyanate or the corresponding isocyanate or carbamoyl chloride, preferably in a solvent such as dimethylformamide and optionally in the presence of a tertiary organic base such as triethylamine at temperatures between 0 and 50. ° C, preferably at room temperature.

Následná príprava zodpovedajúcej guanidínovej zlúčeniny všeobecného vzorca (I) sa účelne uskutoční premenou so zlúčeninou, ktorá prenáša skupinu amidino-, ako je 3,5-dimetylpyrazol-l-karboxyamidín, výhodne v prostredí rozpúšťadla, ako je dimetylformamid a voliteľne v prítomnosti terciámej organickej zásady, ako je trietylamín pri teplotách medzi 0 a 50 °C, výhodne pri teplote miestnosti.The subsequent preparation of the corresponding guanidine compound of formula (I) is conveniently carried out by conversion with a compound that carries an amidino- group such as 3,5-dimethylpyrazole-1-carboxyamidine, preferably in a solvent environment such as dimethylformamide and optionally in the presence of a tertiary organic base. such as triethylamine at temperatures between 0 and 50 ° C, preferably at room temperature.

V opísaných premenách možno prípadné reaktívne skupiny, ako je karboxy-, hydroxy-, amino-, alkylamino- alebo imino- chrániť počas premeny bežnými ochrannými skupinami, ktoré po premene možno opäť odštiepiť.In the described conversions, optional reactive groups such as carboxy, hydroxy, amino, alkylamino or imino can be protected during the conversion by conventional protecting groups which can be cleaved again after the conversion.

Ako ochranné skupiny pre karboxylovú skupinu možno uviesť napríklad skupinu trimetylsilyl-, metyl-, etyl-, terc -butyl-, benzyl- alebo tetrahydropyranyl- a ochranné skupiny na ochranu skupín hydroxy-, amino-, alkylamino- alebo imino- sú vhodné napríklad skupiny acetyl-, tridluóracetyl-, benzoyl-, etoxykarbonyl-, terc-butoxykarbonyl-, benzyloxykarbonyl-, benzyl-, metoxybenzyl- alebo 2,4-dimetoxy-benzyl- a na ochranu aminoskupiny ešte navyše ftalylová skupina.Examples of carboxyl protecting groups include trimethylsilyl-, methyl-, ethyl-, tert-butyl-, benzyl- or tetrahydropyranyl-, and protecting groups for the protection of hydroxy-, amino-, alkylamino- or imino- groups, for example: acetyl-, trifluoroacetyl-, benzoyl-, ethoxycarbonyl-, tert-butoxycarbonyl-, benzyloxycarbonyl-, benzyl-, methoxybenzyl- or 2,4-dimethoxy-benzyl- and, in addition, a phthalyl group for the protection of the amino group.

Prípadné následné odštiepenie použitej ochrannej skupiny možno uskutočniť napríklad v prostredí vodného rozpúšťadla, napríklad vo vode, izopropanole/vode, tetrahydrofuráne/vode alebo dioxáne/vode, v prítomnosti kyseliny, ako je kyselina trifluóroctová, chlorovodíková alebo sírová, alebo v prítomnosti hydroxidu alkalického kovu, ako je hydroxid lítny, hydroxid sodný alebo hydroxid draselný, pri teplotách medzi 0 a 100 °C, výhodne pri teplotách medzi 10 a 50 °C.Optional subsequent cleavage of the protecting group used can be carried out, for example, in an aqueous solvent environment, for example water, isopropanol / water, tetrahydrofuran / water or dioxane / water, in the presence of an acid such as trifluoroacetic, hydrochloric or sulfuric acid, or alkali metal hydroxide, such as lithium hydroxide, sodium hydroxide or potassium hydroxide at temperatures between 0 and 100 ° C, preferably at temperatures between 10 and 50 ° C.

Odštiepenie skupiny benzyl-, metoxybenzyl- alebo benzyloxykarbonylového zvyšku možno uskutočniť tiež hydrogenolyticky, napríklad vodíkom v prítomnosti katalyzátora, ako je paládium na uhlíku v prostredí rozpúšťadla, ako je metanol, etanol, etylester kyseliny octovej, dimetylformamid, dimetylformamid/acetón alebo ľadová kyselina octová, voliteľne s prídavkom kyseliny, ako je kyselina chlorovodíková alebo ľadová kyselina octová pri teplotách medzi 0 a 50 °C, výhodne ale pri teplote miestnosti, a pod tlakom vodíka približne 0,1 až 0,7 MPa (1 až 7 barov), výhodne 0,3 až 0,5 MPa (3 až 5 barov).The cleavage of the benzyl-, methoxybenzyl- or benzyloxycarbonyl radical can also be carried out by hydrogenolysis, for example with hydrogen in the presence of a catalyst such as palladium on carbon in a solvent such as methanol, ethanol, ethyl acetate, dimethylformamide, dimethylformamide / acetone or glacial acetic acid. optionally with the addition of an acid such as hydrochloric acid or glacial acetic acid at temperatures between 0 and 50 ° C, preferably at room temperature, and under a hydrogen pressure of about 1 to 7 bar, preferably 0 3 to 0.5 MPa (3 to 5 bar).

Odštiepenie metoxybenzylovej skupiny možno uskutočniť tiež v prítomnosti oxidačného činidla, ako je dusičnan amónnocéričitý v prostredí rozpúšťadla, ako je metylénchlorid, acetonitril alebo acetonitril/voda pri teplotách medzi 0 a 50 °C, výhodne ale pri teplote miestnosti.Cleavage of the methoxybenzyl group may also be carried out in the presence of an oxidizing agent such as ammonium cerium nitrate in a solvent such as methylene chloride, acetonitrile or acetonitrile / water at temperatures between 0 and 50 ° C, preferably at room temperature.

Odštiepenie 2,4-dimetoxybenzylového zvyšku možno výhodne uskutočniť v kyseline trifluóroctovej v prítomnosti anizolu.The cleavage of the 2,4-dimethoxybenzyl moiety can preferably be carried out in trifluoroacetic acid in the presence of anisole.

Odštiepenie terc-butylového alebo terc-butyloxykarbonylového zvyšku možno výhodne uskutočniť kyselinou, ako je kyselina trifluóroctová alebo kyselina chlorovodíková, voliteľne s použitím rozpúšťadla, ako je metylénchlorid, dioxán, etylester kyseliny octovej alebo éter.The cleavage of the tert-butyl or tert-butyloxycarbonyl moiety can preferably be carried out with an acid such as trifluoroacetic acid or hydrochloric acid, optionally using a solvent such as methylene chloride, dioxane, ethyl acetate or ether.

Odštiepenie ftalylového zvyšku možno výhodne uskutočniť v prítomnosti hydrazínu alebo niektorého primárneho amínu, ako je metylamín, etylamín alebo n-butylamín v prostredí rozpúšťadla, ako je metanol, etanol, izopropanol, toluén/voda alebo dioxán pri teplotách medzi 20 a 50 °C.The cleavage of the phthalyl residue may preferably be carried out in the presence of hydrazine or a primary amine such as methylamine, ethylamine or n-butylamine in a solvent such as methanol, ethanol, isopropanol, toluene / water or dioxane at temperatures between 20 and 50 ° C.

Pripravené chirálne zlúčeniny všeobecného vzorca (I) možno ďalej rozdeliť na ich enantioméry a/alebo diastereoméry.The prepared chiral compounds of formula (I) may be further subdivided into their enantiomers and / or diastereomers.

Tak napríklad pripravenú zlúčeninu vzorca (I), ktorá je vo forme racemátu možno rozdeliť spôsobmi, ktoré sú samy osebe všeobecne známe (pozri: Allinger N. L. a Eliel E. L. v Topics in Stereochemistry, Vol. 6. Wiley Interscience, 1871), na optické antipódy; zlúčeniny všeobecného vzorca (I) s najmenej 2 asymetrickými atómami uhlíka možno na základe ich rozdielnych fyzikálno-chemických vlastností deliť spôsobmi, ktoré sú samy osebe známe, napríklad chromatograficky a/alebo fŕakčnou kryštalizáciou na ich diastereoméry; v prípade, že sa získajú v racemickej forme možno ich ďalej deliť na ich enantioméry tak, ako sa uvádza.For example, the prepared compound of formula (I), which is in the form of a racemate, can be resolved into optical antipodes by methods generally known per se (see: Allinger NL and Eliel EL in Topics in Stereochemistry, Vol. 6. Wiley Interscience, 1871). ; the compounds of formula (I) having at least 2 asymmetric carbon atoms can be separated into their diastereomers by methods known per se, for example by chromatographic and / or fractional crystallization, owing to their different physicochemical properties; when obtained in racemic form, they can be further resolved into their enantiomers as indicated.

Enantioméme delenie možno výhodne uskutočniť delením na stĺpci chirálnych fáz, alebo rekryštalizáciou z opticky aktívneho rozpúšťadla, alebo premenou s látkou, ktorá s racemickou zlúčeninou tvorí opticky aktívne soli alebo deriváty, najmä s kyselinami alebo s ich aktivovanými derivátmi alebo s alkoholmi a delením týmto spôsobom získaných diastereomémych solí alebo derivátov napríklad na základe ich rozdielnej rozpustnosti, pričom z čistých diastereomémych solí alebo derivátov pôsobením vhodných činidiel možno uvoľniť voľné antipódy. Použiteľné sú najmä opticky aktívne kyseliny, napríklad D- a L- formy kyseliny vínnej, kyseliny dibenzoylvínnej, kyseliny di-o-tolylvínnej, kyseliny jablčnej, kyseliny mandľovej, kyseliny gáforsulfónovej, kyseliny glutamínovej, kyseliny N-acetyl-glutamínovej, kyseliny asparágovej, kyseliny N-acetylas parágovej alebo kyseliny chĺnovej. Vhodné opticky aktívne alkoholy zahŕňajú napríklad (+) alebo (-) mentol a ako opticky aktívny acylový zvyšok v amidoch je vhodná napríklad (+) alebo (-) metyloxykarbonylová skupina.The enantiomeric separation may advantageously be effected by separation on a chiral phase column, or by recrystallization from an optically active solvent, or by conversion with a substance which forms optically active salts or derivatives with the racemic compound, in particular with acids or their activated derivatives or with alcohols, and diastereomeric salts or derivatives, for example because of their different solubility, whereby free antipodes can be released from the pure diastereomeric salts or derivatives by treatment with suitable agents. Particularly useful are optically active acids, for example the D- and L-forms of tartaric acid, dibenzoyltartaric acid, di-o-tolyltartaric acid, malic acid, mandelic acid, camphorsulfonic acid, glutamic acid, N-acetylglutamic acid, aspartic acid, N-acetylase of parageic or cholineic acid. Suitable optically active alcohols include, for example, (+) or (-) menthol, and as the optically active acyl residue in amides, for example, (+) or (-) methyloxycarbonyl is suitable.

Pripravené zlúčeniny všeobecného vzorca (I) možno ďalej premeniť na soli, najmä na farmaceutické použitie na fyziologicky prípustné soli s anorganickými alebo organickými kyselinami. Vhodné sú napríklad kyselina chlorovodíková, kyselina bromovodíková, kyselina sírová, kyselina fosforečná, kyselina fumárová, kyselina jantárová, kyselina mliečna, kyselina citrónová, kyselina vínna, kyselina maleínová alebo kyselina metánsulfónová.The prepared compounds of formula (I) can be further converted into salts, in particular for pharmaceutical use, into physiologically acceptable salts with inorganic or organic acids. Suitable are, for example, hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, fumaric acid, succinic acid, lactic acid, citric acid, tartaric acid, maleic acid or methanesulfonic acid.

Okrem uvedeného možno pripravené nové zlúčeniny vzorca (I) v prípade, že obsahujú karboxylovú skupinu, následne premeniť na ich soli s anorganickými alebo organickými zásadami, najmä na farmaceutické použitie na fyziologicky prípustné soli. Vhodné zásady sú napríklad hydroxid sodný, hydroxid draselný, cyklohexyl-amín, etanolamín, dietanolamín a trietanolamín.In addition, the novel compounds of formula (I), when they contain a carboxyl group, can then be converted into their salts with inorganic or organic bases, in particular for pharmaceutical use, into physiologically acceptable salts. Suitable bases are, for example, sodium hydroxide, potassium hydroxide, cyclohexylamine, ethanolamine, diethanolamine and triethanolamine.

Východiskové látky so všeobecným vzorcom (VII) až (XII) sú alebo známe z literatúry, alebo ich možno pripraviť v literatúre opísanými spôsobmi, lebo ich možno pripraviť spôsobmi, ktoré sa uvádzajú v opise alebo v príkladoch. Napríklad zlúčeniny všeobecného vzorca (IX) sa opisujú v nemeckej patentovej prihláške 198 24 922.5. Ďalej, zlúčeniny všeobecného vzorca (XI) sú dostupné zo zlúčenín všeobecného vzorca (I) v ktorých R4 v alkylovej časti znamená hydroxyskupinou substituovanú Ci.4-alkyl-fenylovú skupinu, napríklad premenou s alkyl- alebo aryl-sulfonylchloridmi.The starting materials of formulas (VII) to (XII) are either known from the literature or can be prepared in the literature by the methods described, or they can be prepared by the methods described in the description or in the examples. For example, compounds of formula (IX) are described in German patent application 198 24 922.5. Further, compounds of formula (XI) are available from compounds of formula (I) wherein R 4 in the alkyl moiety is a hydroxy substituted C 1-6 alkyl. A 4- alkyl-phenyl group, for example by conversion with alkyl- or aryl-sulfonyl chlorides.

Už bolo uvedené, že nové zlúčeniny všeobecného vzorca (I), v ktorých R1 znamená atóm vodíka alebo prekurzorovú skupinu majú cenné farmakologické vlastnosti, najmä inhibičné účinky na rôzne kinázy, najmä receptorové tyrozínové kinázy, ako sú VEGFR2, PDGFRa, PDGFRP, FGFR1, FGFR3, EGFR, HER2, IGF1R a HGFR, ako aj na komplexy od cyklínu závislých kináz (cyclin dependent kinases, CD K), ako sú CDK.1, CDK2, CDK3, CDK4, CDK5, CDK6, CDK7, CDK8 a CDK9 s ich špecifickými cyklínmi (A, BI, B2, C, Dl, D2, D3, E, F, Gl, G2, H, I a K) a na vírusové cyklíny, ďalej na proliferačne kultivované ľudské bunky, najmä na endotelové bunky, napríklad pri angiogenéze, ale aj na proliferáciu iných buniek, najmä nádorových buniek.It has already been mentioned that the novel compounds of formula (I) wherein R1 is a hydrogen atom or a prodrug group have valuable pharmacological properties, particularly inhibitory effects on various kinases, especially receptor tyrosine kinases such as VEGFR2, PDGFR, PDGFR, FGFR1, FGFR3, EGFR, HER2, IGF1R and HGFR, as well as cyclin dependent kinases (CDKs) such as CDK.1, CDK2, CDK3, CDK4, CDK5, CDK6, CDK7, CDK8 and CDK9 with their specific cyclins (A, B1, B2, C, D1, D2, D3, E, F, G1, G2, H, I and K) and viral cyclins, further proliferative cultured human cells, especially endothelial cells, e.g. angiogenesis, but also for the proliferation of other cells, especially tumor cells.

Biologické vlastnosti nových zlúčenín sa skúšali nasledujúcimi štandardnými postupmi.The biological properties of the novel compounds were tested using the following standard procedures.

Endotelové bunky z humánnej pupočnej šnúry (Humane Nabelschnur Endothelzellen, HUVEC) sa kultivovali v prostredí IMDM (Gibco BRL), doplnenom 10 % fetálneho hovädzieho séra (FBS, Sigma), 50 μΜ β-merkaptoetanolu (Fluka), štandardným antibiotikom, 15 pg.mľ1 endotelového rastového faktora /ECGS, Collaborative Biomedical Products) a 100 pg.mľ1 heparínu (Sigma) na želatínou pokrytých kultivačných fľašiach (0,2 %-ná želatína, Sigma) pri 37 °C v atmosfére s 5 % CO2 a nasýtenom vodnou parou.Human umbilical cord endothelial cells (Humane Nabelschnur Endothelzellen, HUVEC) were cultured in IMDM medium (Gibco BRL) supplemented with 10% fetal bovine serum (FBS, Sigma), 50 μΜ β-mercaptoethanol (Fluka), standard antibiotic, 15 pg. ml @ 1 endothelial growth factor / ECGS, Collaborative Biomedical Products) and 100 pg.mľ 1 heparin (Sigma) on gelatin-coated culture flasks (0.2% strength gelatine, Sigma) at 37 ° C in a 5% CO 2, and saturated with water vapor.

Na sledovanie inhibičnej účinnosti zlúčenín z tohto vynálezu sa bunky 16 hodín „vyhladovali“, to znamená že sa udržiavali v kultivačnom prostredí bez rastových faktorov (ECGS + heparín). Bunky sa z kultivačných nádob uvoľnili pomocou trypsínu/EDTA a raz sa premyli v sérovom prostredí. Následne sa očkovali s hustotou 2,5.103 buniek na jamku.To monitor the inhibitory potency of the compounds of this invention, cells were "starved" for 16 hours, i.e., maintained in a culture medium without growth factors (ECGS + heparin). Cells were detached from the culture flasks with trypsin / EDTA and washed once in serum. They were then seeded at a density of 2.5 x 10 3 cells per well.

Množenie buniek sa stimulovalo 5 ng.mľ1 VEGFi65 (vaskulámy endotelový rastový faktor; Weich H., GBF Braunschweig) a 10 pg.mľ' heparínu. Na každej kultivačnej platni bolo vždy šesť nestimulovaných jamiek na kontrolu.Cell proliferation was stimulated with 5 µg / ml VEGF 65 (vascular endothelial growth factor; Weich H., GBF Braunschweig) and 10 µg / ml heparin. There were six unstimulated wells per control in each culture plate.

Zlúčeniny podľa tohto vynálezu sa rozptýlili v 100 %-nom dimetylsulfoxide a pripravili sa rôzne riedenia na trojnásobné vykonávanie skúšok, pričom maximálna koncentrácia dimetylsulfoxidu bola 0,3 %.The compounds of this invention were dispersed in 100% dimethylsulfoxide and various dilutions were prepared for triplicate assays, with a maximum dimethylsulfoxide concentration of 0.3%.

Bunky sa inkubovali 76 hodín pri 37 °C, potom sa na ďalších 16 hodín pridal 3H-tymidín (0,1 μ Ci/jamka, Amersham) na stanovenie syntézy DNA. Rádioaktívne značené bunky sa následne imobilizovali na filtračnej tkanine a pomocou β-čítača sa stanovila zabudovaná rádioaktivita. Na stanovenie inhibičného účinku zlúčenín z tohto vynálezu sa použili stredné hodnoty nestimulovaných buniek, ktoré sa odčítali od stredných hodnôt stimulovaných buniek (v prítomnosti a v neprítomnosti zlúčenín podľa tohto vynálezu).The cells were incubated for 76 hours at 37 ° C, then 3 H-thymidine (0.1 µl Ci / well, Amersham) was added for an additional 16 hours to determine DNA synthesis. The radiolabeled cells were then immobilized on the filter tissue and the incorporated radioactivity was determined using a β-counter. Mean values of unstimulated cells that were subtracted from the mean values of stimulated cells (in the presence and absence of compounds of the invention) were used to determine the inhibitory effect of the compounds of the invention.

Vypočítala sa pomerná proliferácia v percentách kontroly (HUVEC bez inhibítora) a z výsledku sa odvodila účinná koncentrácia, ktorá zníži proliferáciu buniek na 50 % (IC50).The relative proliferation in percent of control (HUVEC without inhibitor) was calculated and the effective concentration was deduced to reduce cell proliferation to 50% (IC 50).

Ako príklad sa uvádzajú výsledky skúšok nasledujúcich zlúčenín (a) až (s) všeobecného vzorca (I):By way of example, test results of the following compounds (a) to (s) of the general formula (I) are given:

(a) 3 -Z- [ 1 -(4-(piperidin-1 -yl-metyl)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (b) 3-Z- [(1 -(4-(piperidin-1 -yl-metyl)-anilino)-1 -fenyl-metylén]-6-karbamoyl-2-indolinón, (c) 3-Z-[l -(4-(piperidin-1 -yl-metyl)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (d) 3-Z-[l-(4-(dimetylaminometyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (e) 3-Z-[ 1 -(4-((2,6-dimetyl-piperidin-1 -yl)-metyl)-anilino)-1 -fenyl-metylén]-6-etoxy-karbonyl-2-indolinón, (Ď 3-Z-[l-l'4-(M-(2-dimetylamino-etyl)-A-acetyl-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (g) 3-Z-[l-(4-(/V-(3-dimetylamino-propyl)-jV-acetyl-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (h) 3-Z-[l-(4-(M-(2-dimetylamino-etyl)-V-metylsulfonyl-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (i) 3-Z-[l-(4-(dimetylaminometyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón,(a) 3-Z- [1- (4- (piperidin-1-ylmethyl) -anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (b) 3-Z- [( 1- (4- (piperidin-1-ylmethyl) -anilino) -1-phenylmethylene] -6-carbamoyl-2-indolinone, (c) 3-Z- [1- (4- (piperidin-1) -yl-methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (d) 3-Z- [1- (4- (dimethylaminomethyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (e) 3-Z- [1- (4 - ((2,6-dimethyl-piperidin-1-yl) -methyl) -anilino) -1-phenyl-methylene] - 6-ethoxy-carbonyl-2-indolinone, (β 3 -Z- [1- 1-4 '- (N- (2-dimethylamino-ethyl) -A-acetyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (g) 3-Z- [1- (4- (N - (3-dimethylamino-propyl) - N -acetyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (h) 3-Z- [1- (4- (N- (2-dimethylamino-ethyl) -N-methylsulfonyl-amino) -anilino) -1-phenyl-methylene] - (I) 3-Z- [1- (4- (dimethylaminomethyl) anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, 6-ethoxycarbonyl-2-indolinone,

Q) 3-Z-[I-(4-(A'-acetyl-W-dimetylaminokarbonylmetyl-amino)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (k) 3 -Z- [ 1 -(4-etylaminometyl-anilino)-1 -fenyl-metylén] -6-metoxykarbonyl-2-indolinón, (l) 3-Z-[ 1 -(4-( 1 -metyl-imidazol-2-yl)-anilino)-1 -fenylmetylén]-6-metoxykarbonyl-2-indolinón, (m) 3-Z-[l-(4-(7V-dimetylaminometylkarbonyl-A-metylamino)anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (n) 3-Z-[l-(4-(Aí-(2-dimetylaminoetyl)-A-metylsulfonylamino)anilino)-l-fenylmetylén]-6-metoxykarbonyl-2-indolinón, (o) 3 -Z- [ 1 -(4-(17-(3 -dimetylamino-propyl)-77-metylsulfonyl-amino)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (p) 3-Z-[l-(4-(JV-dimetylaminokarbonylmetyl-7V-metylsulfonyl-amino)-amlino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (q) 3-Z-[ 1 -(4-(Aí-((2-dimetylamino-etyl)-karbonyl)-N-metyl-amino)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (r) 3-Z-[l-(4-(/V-(2-dimetylamino-etyl)-jV-acetyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón a (s) 3-Z-[l-(4-metylaminometyl-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón.Q) 3-Z- [1- (4- (N'-acetyl-N-dimethylaminocarbonylmethylamino) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, (k) 3 -Z- [1- (4-ethylaminomethyl-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (1) 3-Z- [1- (4- (1-methyl-imidazol-2-yl)) (anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, (m) 3-Z- [1- (4- (N-dimethylaminomethylcarbonyl-N-methylamino) anilino) -1-phenylmethylene] -6 methoxycarbonyl-2-indolinone, (n) 3-Z- [l- (4- (I - (2-dimethylaminoethyl) -N-methylsulfonylamino) anilino) -l-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (o) 3-Z- [1- (4- (17- (3-dimethylamino-propyl) -77-methylsulfonylamino) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, ( p) 3-Z- [1- (4- (N-dimethylaminocarbonylmethyl-N-methylsulfonyl-amino) -amino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (q) 3-Z- [ 1 - (4- (I - ((2-dimethylamino-ethyl) carbonyl) -N-methyl-amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (r) 3 Z- [l- (4 - (/ V- (2-dimethylamino-ethyl) -N-acetyl-amino) anilino) -lf enyl-methylene] -6-methoxycarbonyl-2-indolinone and (s) 3-Z- [1- (4-methylaminomethyl-anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone.

Nasledujúca tabuľka obsahuje stanovené hodnoty:The following table contains the determined values:

Zlúčenina compound IC50 [μΜ]IC 50 [μΜ] (a) (A) 0,04 0.04 (b) (B) 0,35 0.35 (c) (C) 0,01 0.01 (d) (D) 0,02 0.02 (e) (E) 0,05 0.05 (f) (F) 0,01 0.01 (g) (G) 0,003 0,003 (h) (H) 0,01 0.01 (i) (I) 0,03 0.03 (í) (S) 0,02 0.02 (k) (A) 0,03 0.03 (D (D 0,1 0.1 (m) (M) 0,02 0.02 (n) (N) 0,02 0.02 (o) (about) 0,01 0.01 (P) (P) 0,02 0.02 (q) (Q) 0,02 0.02 (r) (L) 0,01 0.01 (s) (with) 0,04 0.04

Na základe svojich inhibičných účinkov na proliferáciu buniek, najmä na proliferáciu endotelových buniek a nádorových buniek, uvedené zlúčeniny všeobecného vzorca (I) sú vhodné na liečbu chorôb, ktoré sú spojené s proliferáciou buniek, najmä endotelových buniek.Because of their inhibitory effects on cell proliferation, particularly on the proliferation of endothelial cells and tumor cells, said compounds of formula (I) are useful in the treatment of diseases associated with cell proliferation, especially endothelial cells.

Napríklad proliferácia endotelových buniek a s tým spojená neovaskularizácia je jeden z rozhodujúcich krokov pri rozvoji nádorových ochorení (Folkman J. a ďalší, Náture 339, 58-61 (1989); Hanahan D. a Folkman J., Celí 86, 353-365 (1996)). Proliferácia endotelových buniek je ďalej významná tiež pri hemangiómoch, pri metastázovaní, reumatickej artritíde, psoriáze a pri očnej neovaskularizácii (Folkman J., Náture Med. 1, 27-31 (1995)). Terapeutická potreba inhibítorov proliferácie endotelových buniek sa preukázala na zvieracom modeli ako zverejnil napríklad O'Reilly a ďalší a Parangi a ďalší (O'Reilly M. S. a ďalší, Celí 88, 277-285 (1997); Parangi S. a ďalší, Proc. Natl. Ac. Sci USA 93, 2002-2007 (1996)).For example, endothelial cell proliferation and associated neovascularization is one of the critical steps in cancer development (Folkman J. et al., Nature 339, 58-61 (1989); Hanahan D. and Folkman J., Cell 86, 353-365 (1996). )). Furthermore, endothelial cell proliferation is also important in hemangiomas, metastasis, rheumatoid arthritis, psoriasis, and ocular neovascularization (Folkman J., Nature Med. 1, 27-31 (1995)). The therapeutic need for endothelial cell proliferation inhibitors has been demonstrated in an animal model as disclosed, for example, by O'Reilly et al. And Parangi et al. (O'Reilly MS et al., Cell 88, 277-285 (1997); Parangi S. et al., Proc. Natl. Ac Sci Sci 93, 2002-2007 (1996)).

Zlúčeniny všeobecného vzorca (I), ich tautoméry, stereoizoméry alebo ich fyziologicky prípustné soli sú preto vhodné napríklad na liečbu nádorov (napríklad karcinómu epitelových doštičiek, astrocytómu, Kaposiho sarkómu, glioblastómu, pľúcnej rakoviny, rakoviny dýchacích ciest, karcinómu hrdla a šije, melanómu, vaječníkového karcinómu, karcinómu prostaty, rakoviny prsníka, polybunkového pľúcneho karcinómu, gliómu, kolorektálnych nádorov, urogenitálnach rakovín, ako je polymyelóm), psoriázy, artritídy (napríklad reumatoidnej artritídy), hemangiómu, abgiofibrómu, očných chorôb (napríklad diabetickej retinopatie), neovaskulámeho zákalu, chorôb obličiek (napríklad glomerulonefrítídy), diabetickej nefropatie, malígnej nefrosklerózy, mikroangiopatického trombického syndrómu, rejekcie transplantov a glomerulopatie, fibrotických ochorení ( napríklad cirhózy pečene), proliferatívnych mesangiabunkových ochorení, artériosklerózy, poškodení nervových tkanív a na potláčanie reoklúzie ciev po ošetrení balónikovým katétrom, pri cievnej protetike alebo po použití mechanických zariadení na otváranie ciev (napríklad stentov), alebo ďalších ochorení, ktoré sa vyznačujú proliferáciou buniek alebo angiogenézou.The compounds of formula (I), their tautomers, stereoisomers or their physiologically acceptable salts are therefore suitable, for example, for the treatment of tumors (e.g. epithelial cell carcinoma, astrocytoma, Kaposi's sarcoma, glioblastoma, lung cancer, respiratory cancer, throat and neck cancer, melanoma, ovarian cancer, prostate cancer, breast cancer, polycellular lung cancer, glioma, colorectal tumors, urogenital cancers such as polymyeloma), psoriasis, arthritis (e.g. rheumatoid arthritis), hemangioma, abgiofibrosis, diabetic retinopathy (eye diseases) kidney diseases (e.g. glomerulonephritis), diabetic nephropathy, malignant nephrosclerosis, microangiopathic thrombosis syndrome, transplant rejection and glomerulopathy, fibrotic diseases (e.g. liver cirrhosis), proliferative mesangiab cell diseases, arteriosclerosis erosion, nerve tissue damage, and for suppressing vascular reocclusion after balloon catheter treatment, vascular orthotics, or mechanical vascular opening devices (e.g., stents), or other diseases characterized by cell proliferation or angiogenesis.

Na základe svojich biologických vlastností možno uvedené zlúčeniny podľa tohto vynálezu užívať samotné, alebo v kombinácii s inými farmakologicky účinnými látkami, napríklad v nádorovej terapii ako monoterapiu alebo ako kombináciu s ďalšími protinádorovými liečivami, napríklad v kombinácii s topoizomerázovými inhibítormi (napríklad s Etoposidom), mitózovými inhibítormi (napríklad s Vinblastínom, Taxolom), so zlúčeninami, ktoré vstupujú do interakcie s nukleovými kyselinami (napríklad s cis-Platínom, Cyklophosphamidom, Adriamycínom), hormónovými antagonistmi (napríklad s Tamoxifénom), inhibítormi metabolických procesov (napríklad s 5-FU a ďalšími), cytokínmi (napríklad s Interferónmi), kinázovými inhibítormi, protilátkami, alebo tiež v kombinácii s liečbou ožarovaním a podobne. Uvedené kombinácie možno užívať alebo simultánne alebo sekvenčne.Because of their biological properties, the compounds of the invention can be used alone or in combination with other pharmacologically active substances, for example in tumor therapy as monotherapy or in combination with other anti-cancer drugs, for example in combination with topoisomerase inhibitors (e.g. Etoposide), mitosis inhibitors (e.g. Vinblastine, Taxol), compounds that interact with nucleic acids (e.g. cis-Platin, Cyclophosphamide, Adriamycin), hormone antagonists (e.g. Tamoxifen), inhibitors of metabolic processes (e.g. 5-FU and others) ), cytokines (e.g., interferons), kinase inhibitors, antibodies, or also in combination with radiation therapy and the like. Said combinations may be used simultaneously or sequentially.

Pri farmaceutickom použití sa zlúčeniny z tohto vynálezu spravidla užívajú u teplokrvných živočíchov, najmä u človeka, v dávkach 0,01 až 100 mg.kg'1 telesnej hmotnosti, výhodne 0,1 až 20 mg.kg'1 telesnej hmotnosti. Zlúčeniny podľa tohto vynálezu sa na podávanie spravidla zapracujú s jedným alebo viacerými bežnými inertnými nosičmi a/alebo riedidlami, napríklad s kukuričným škrobom, mliečnym cukrom, trstinovým cukrom, mikrokryštalickou celulózou, stearanom horečnatým, polyvinylpyrolidónom, kyselinou citrónovou, kyselinou vínnou, s vodou, vodou/etanolom, vodou/glycerolom, vodou/sorbitolom, vodou/polyetylénglykolom, propylénglykolom, stearylalkoholom, karboxymetylcelulózou alebo tuky obsahujúcimi látkami, ako je stužený tuk, alebo s vhodnými zmesami uvedených látok do formy bežného galenického prípravku, ako sú tablety, dražé, kapsuly, prášky, injekčné roztoky, ampulky, suspenzie, roztoky, spreje alebo kvapky.For pharmaceutical use the compounds of the invention generally taking in a warm, in particular humans, in doses of 0.01 to 100 mg.kg "1 of body weight, preferably 0.1 to 20 mg.kg" 1 of body weight. The compounds of the invention are generally formulated for administration with one or more conventional inert carriers and / or diluents, for example, corn starch, milk sugar, cane sugar, microcrystalline cellulose, magnesium stearate, polyvinylpyrrolidone, citric acid, water, tartaric acid, water. / ethanol, water / glycerol, water / sorbitol, water / polyethylene glycol, propylene glycol, stearyl alcohol, carboxymethylcellulose or fat-containing substances such as hardened fat or with suitable mixtures thereof to form a conventional galenic preparation such as tablets, dragees, capsules powders, injectable solutions, ampoules, suspensions, solutions, sprays or drops.

Použité skratky:Abbreviations used:

FMOC = 9-fluórenylmetoxykarbonylFMOC = 9-fluorenylmethoxycarbonyl

HOBt = l-hydroxy-l//-benzotriazolHOBt = 1-hydroxy-1 H -benzotriazole

TBTU = O-benzotriazol-l-yl-WM.M-tetrametylurónium-tetrafluórborátTBTU = O-benzotriazol-1-yl-WMM-tetramethyluronium tetrafluoroborate

DBU = l,8-diazobicyklo[5.4.0]idec-7-én.DBU = 1,8-diazobicyclo [5.4.0] idec-7-ene.

Vynález sa bližšie objasňuje v ďalej uvedených príkladoch.The invention is illustrated by the following examples.

Príklady uskutočnenia vynálezuDETAILED DESCRIPTION OF THE INVENTION

Príprava východiskových zlúčenínPreparation of the starting compounds

Príprava 1 s použitím tuhej fázyPreparation 1 using solid phase

Rinkova živica (MBHA-živica, firma Novabiochem) (2,0 g) sa nechala napučať v 30 ml dimetylformamidu. Potom sa pridalo 40 ml 30 %-ného piperidínu v dimetylformamide a zmes sa 7 minút pretrepávala až sa odštiepila ochranná FMOC-skupina. Živica sa potom niekoľkokrát premyla dimetylformamidom. Potom sa pridalo 0,4 g kyseliny 2-indolinín-6-karboxylovej (pripravená podobne ako uvádza Langenbeck a ďalší, Justus Liebigs Ann. Chem. 499, 201-208 (1932)), 297 mg HOBt, 706 mg TBTU a 0,9 ml /V-etyl-diizopropylamínu v 30 ml dimetylformamidu a reakčná zmes sa hodinu pretrepávala. Roztok sa potom oddelil od živice odsávaním a živica sa premyla päťkrát s 30 ml dimetylformamidu a dva razy s 30 ml metylénchloridu. Sušila sa prefúkovaním dusíkom. Výťažok produktu bol 1,9 g nasýtenej živice.Rink resin (MBHA resin, Novabiochem) (2.0 g) was swelled in 30 ml of dimethylformamide. Then 40 ml of 30% piperidine in dimethylformamide was added and the mixture was shaken for 7 minutes until the FMOC protecting group was cleaved. The resin was then washed several times with dimethylformamide. 0.4 g of 2-indolinine-6-carboxylic acid (prepared similarly to Langenbeck et al., Justus Liebigs Ann. Chem. 499, 201-208 (1932)), 297 mg HOBt, 706 mg TBTU and 0, 9 ml of N-ethyl-diisopropylamine in 30 ml of dimethylformamide and the reaction mixture was shaken for one hour. The solution was then separated from the resin by suction and the resin was washed five times with 30 ml of dimethylformamide and twice with 30 ml of methylene chloride. It was dried by flushing with nitrogen. The product yield was 1.9 g of saturated resin.

Príprava 2 s použitím tuhej fázyPreparation 2 using solid phase

1,9 g v príprave 1 pripravenej živice sa 3 hodiny miešalo s 6 ml anhydridu kyseliny octovej a 6 ml trietylesteru kyseliny ortobenzoovej pri 110 °C. Reakčná zmes sa potom nachala vychladnúť, živica sa premyla dimetylformamidom a potom metylénchloridom. Výťažok: 1,9 g vlhkej živice.1.9 g of Preparation 1 of the prepared resin was stirred with 6 ml of acetic anhydride and 6 ml of triethyl orthobenzoate at 110 ° C for 3 hours. The reaction mixture was then allowed to cool, the resin was washed with dimethylformamide and then with methylene chloride. Yield: 1.9 g wet resin.

Podobne ako v príprave 2 sa pripravili ďalej uvedené nasýtené živice:As in Preparation 2, the following saturated resins were prepared:

(1) živica nasýtená 3-Z-(l-etoxy-metylén)-6-karbamoyl-2-indolinónom; pripravila sa zo živice pripravenej v príklade I premenou s trietylesterom kyseliny ortomravčej, (2) živica nasýtená 3-Z-(l-metoxy-l-metyl-metylén)-6-karbamoyl-2-indolinónom; pripravila sa zo živice pripravenej v príklade I premenou s trimetylesterom kyseliny ortooctovej, (3) živica nasýtená 3-Z-(l-metoxy-l-etyl-metylén)-6-karbamoyl-2-indolinónom; pripravila sa zo živice pripravenej v príklade I premenou s trimetylesterom kyseliny ortopropiónovej, (4) živica nasýtená 3-Z-(l-metoxy-l-propyl-metylén)-6-karbamoyl-2-indolinónom; pripravila sa zo živice pripravenej v príklade I premenou s trimetylesterom kyseliny ortomaslovej.(1) a resin saturated with 3-Z- (1-ethoxy-methylene) -6-carbamoyl-2-indolinone; prepared from the resin prepared in Example I by conversion with triethyl orthoformate, (2) a resin saturated with 3-Z- (1-methoxy-1-methyl-methylene) -6-carbamoyl-2-indolinone; prepared from the resin prepared in Example I by conversion with trimethyl orthoacetate; (3) a resin saturated with 3-Z- (1-methoxy-1-ethyl-methylene) -6-carbamoyl-2-indolinone; prepared from the resin prepared in Example I by conversion with trimethyl orthopropionate; (4) a resin saturated with 3-Z- (1-methoxy-1-propylmethylene) -6-carbamoyl-2-indolinone; It was prepared from the resin prepared in Example I by conversion with trimethyl orthobutyrate.

Príprava 3Preparation

A/-(4-Nitrofenyl)-/V-metyl-metánsulfónamidA / - (4-Nitro-phenyl) - / V-methyl-methanesulfonamide

3,0 g V-metyl-4-nitroanilínu sa rozpustilo v 20 ml pyridínu a po kvapkách sa pri teplote miestnosti pridalo 2,4 g chloridu kyseliny metánsulfónovej. Reakčná zmes sa 12 hodín miešala pri teplote miestnosti. Potom sa zmes naliala do vody a vylúčená zrazenina sa odfiltrovala a vo vákuu pri 50 °C vysušila. Výťažok produktu bol 4,0 g (87 % teoretického výťažku), Rf hodnota: 0,5 (gél kyseliny kremičitej, etylester kyseliny octovej/toluén = 7:3).3.0 g of N-methyl-4-nitroaniline was dissolved in 20 ml of pyridine and 2.4 g of methanesulfonic acid chloride was added dropwise at room temperature. The reaction mixture was stirred at room temperature for 12 hours. The mixture was then poured into water and the precipitate formed was filtered off and dried in vacuo at 50 ° C. Yield: 4.0 g (87% of theory), Rf value: 0.5 (silica gel, ethyl acetate / toluene = 7: 3).

Teplota topenia produktu bola 107 až 108 °C.Mp 107-108 ° C.

Príprava 4 7V-(2-Dimetylamino-etyl)-/V-metylsulfonyl-4-nitroanilínPreparation 4 N- (2-Dimethylamino-ethyl) - N -methylsulfonyl-4-nitroaniline

38,9 g A-Metylsulfonyl-4-nitroanilínu sa rozpustilo v 2,0 litroch acetónu, pridalo sa 51,9 g l-chlór-2-dimetylamino-etánu, 77,4 g uhličitanu draselného a 5,0 g jodidu sodného a zmes sa spolu 4 dni miešala pri 50 °C, pričom sa po 12 hodinách pridalo ďalších 25,9 g l-chlór-2-dimetylamino-etánu, 49,8 g uhličitanu draselného a 5,0 g jodidu sodného v 500 ml acetónu a po 36 hodinách sa pridalo ďalších 26,0 g l-chlór-2-dimetylamino-etánu, 50,0 g uhličitanu draselného a 5,0 jodidu sodného v 100 ml acetónu. Po uvedenom čase sa násada filtrovala a filtrát sa skoncentroval. Zvyšok sa rozmiešal v éteri, filtroval s odsávaním a vysušil pri 40 °C. Výťažok produktu bol 25,3 g (49 % teoretického výťažku),38.9 g of N-methylsulfonyl-4-nitroaniline was dissolved in 2.0 liters of acetone, 51.9 g of 1-chloro-2-dimethylaminoethane, 77.4 g of potassium carbonate and 5.0 g of sodium iodide were added, and the mixture was stirred together at 50 ° C for 4 days, after which an additional 25.9 g of 1-chloro-2-dimethylaminoethane, 49.8 g of potassium carbonate and 5.0 g of sodium iodide in 500 ml of acetone were added after 12 hours and after 36 hours an additional 26.0 g of 1-chloro-2-dimethylaminoethane, 50.0 g of potassium carbonate and 5.0 of sodium iodide in 100 ml of acetone were added. After this time, the batch was filtered and the filtrate was concentrated. The residue was stirred in ether, filtered with suction and dried at 40 ° C. Yield: 25.3 g (49% of theory);

Rf hodnota: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol/amoniak = 9 : 1 : 0,1). C11H17N3O4S Rf value: 0.5 (silica gel, methylene chloride / methanol / ammonia 9: 1: 0.1). C11H17N3O4S

ESI-hmotnostné spektrum: m/z = 288 [M+H]+.ESI-MS: m / z = 288 [M + H] &lt; + &gt;.

Podobne ako v príprave 4 sa pripravili nasledujúce zlúčeniny:Similar to Preparation 4, the following compounds were prepared:

(1) 4-[V-(3-dimetylamino-propyl)-/V-metylsulfonyl-amino]-nitrobenzén, (2) A/-karboxymetyl-A/-metylsulfonyl-4-nitroanilín, (3) N-kyanometyl-N-metylsulfonyl-p-fenyléndiamín, (4) 4-[/V-(2- (V-benzyl-7V-metyl-amino)-etyl)-7V-metylsulfonyl- amino]-nitrobenzén, (5) 4-[iV-(3-ftalimido-2-yl-propyl)-jV-metylsulfonyl-amino]- nitrobenzén, (6) 4-[V-(3- (.V-benzyl-A-metyl-amino)-propyl)-/V-metylsulfonyl-amino]-nitrobenzén.(1) 4- [N- (3-dimethylamino-propyl) - N -methylsulfonylamino] -nitrobenzene, (2) N-carboxymethyl- N -methylsulfonyl-4-nitroaniline, (3) N-cyanomethyl- N-methylsulfonyl-p-phenylenediamine, (4) 4 - [N - (2- (N -benzyl-N -methyl-amino) ethyl) -7-methylsulfonyl-amino] -nitrobenzene, (S) 4- [ N - (3-phthalimido-2-yl-propyl) - N -methylsulfonyl-amino] -nitrobenzene, (6) 4- [N - (3- (N -benzyl-N -methyl-amino) -propyl) - / V-methylsulphonyl-amino] -nitrobenzene.

Príprava 5 7V-(Dimetylaminokarbonyl-metyl)-.V-metylsulfonyl-4-nitro-anilínPreparation 5 N- (Dimethylaminocarbonyl-methyl) - N -methylsulfonyl-4-nitro-aniline

7,0 g Aí-karboxymetyl-A''-metylsulfonyl-4-nitroamlínu, 2,5 g dimetylamino- hydrochloridu, 8,1 g TBTU a EXAMPLE A 7.0 g carboxymethyl-N '- methylsulfonyl-4-nitroamlínu, 2.5 g dimethylamino hydrochloride, 8.1 g of TBTU and

3,9 g HOBT sa rozpustilo v 125 ml dimetylformamidu a pri 0 °C sa pridalo 17,6 ml /V-etyldnzopropylamínu. Reakčná zmes sa 4 hodiny miešala pri teplote miestnosti, zriedila litrom vody a vylúčená zrazenina sa oddelila odsávaním. Po premytí vodou etanolom a éterom sa zvyšok vysušil pri 70 °C s použitím vákua. Výťažok produktu bol 5,3 g (69 % teoretického výťažku),3.9 g of HOBT were dissolved in 125 ml of dimethylformamide and 17.6 ml of N-ethyldisopropylamine was added at 0 ° C. The reaction mixture was stirred at room temperature for 4 hours, diluted with 1 liter of water and the precipitate formed was collected by suction. After washing with water ethanol and ether, the residue was dried at 70 ° C under vacuum. Yield: 5.3 g (69% of theory);

Rf hodnota: 0,40 (gél kyseliny kremičitej, metylénchlorid/metanol = 9 : 1), Rf value: 0.40 (silica gel, methylene chloride / methanol = 9: 1).

CnH^OjSCnH ^ OJS

ESI-hmotnostné spektrum: m/z = 300 [M-H]'.ESI-MS: m / z = 300 [M-H] -.

Podobne ako v príprave 5 sa pripravili nasledujúce zlúčeniny:As in Preparation 5, the following compounds were prepared:

(1) 4-[(/V-dimetylaminokarbonylmetyl)amino]nitrobenzén, pripravený reakciou 4-(7V-karboxymetyl-amino)nitrobenzénu a dimetylaminhydrochloridu, (2) 4-(/V-metylaminokarbonylmetyl-/V-metylsulfonyl-amino)-nitrobenzén, pripravený reakciou /V-karboxymetyl-/V-metylsulfonyl-4-nitroanilínu a metylaminhydrochloridu, (3) 4-[7V-(metylkarbamoyl-metyl)-N-metyl-amino)-metyl]nitrobenzén, pripravený reakciou 4-[(/V-karboxymetyl-A'-metyl-amino)-metyl]-nitrobenzénu a metylamín- hydrochloridu, (4) 4-[7V-(dimetylkarbamoyl-metyl)-/V-metyl-amino)-metyl]nitrobenzén, pripravený reakciou 4-[(7V-karboxymetyl-Ä/-metyl-amino)-metyl]-nitrobenzénu a dimetylamin-hydrochloridu.(1) 4 - [(N-dimethylaminocarbonylmethyl) amino] nitrobenzene, prepared by the reaction of 4- (N-carboxymethyl-amino) nitrobenzene and dimethylamine hydrochloride, (2) 4- (N-methylaminocarbonylmethyl- N -methylsulfonylamino) - nitrobenzene, prepared by the reaction of N-carboxymethyl- N -methylsulfonyl-4-nitroaniline and methylamine hydrochloride, (3) 4- [N - (methylcarbamoyl-methyl) -N-methyl-amino) methyl] nitrobenzene, prepared by the reaction of 4- [ (N-carboxymethyl-N'-methyl-amino) -methyl] -nitrobenzene and methylamine hydrochloride, (4) 4- [N - (dimethylcarbamoyl-methyl) - N -methyl-amino) methyl] nitrobenzene, prepared by reaction of 4 - [(N-carboxymethyl-N-methyl-amino) -methyl] -nitrobenzene and dimethylamine hydrochloride.

Príprava 6 4-[/V-(2-Dimetylamino-etyl)-JV-acetylamino]metyl]nitrobenzénPreparation 6 4- [N - (2-Dimethylamino-ethyl) - N -acetylamino] methyl] nitrobenzene

3,6 g 4-(2-dimetylamino-etylamino)nitrobenzénu (podľa Gabbaya a ďalších, J. Am. Chem. Soc. 91, 5136 (1969)) sa rozpustilo v 50 ml metylénchloridu a pridalo sa 5,0 ml trietylamínu. Do tejto zmesi sa potom pri teplote miestnosti pomaly po kvapkách pridával acetylchlorid (1,3 ml) a zmes sa 2 hodiny miešala pri teplote miestnosti. Potom sa opäť pridal trietylamín (5,0 ml) a acetylchlorid (1,3 ml) a reakčná zmes sa zahrievala na teplotu varu pod spätným chladičom ďalšie dve hodiny. Potom sa odstránilo rozpúšťadlo, zvyšok sa rozmiešal s etylesterom kyseliny octovej a organická fáza sa dva razy premyla vodou. Po sušení nad bezvodým síranom horečnatým a odstránilo rozpúšťadlo a zvyšok sa vysušil vo vákuu.3.6 g of 4- (2-dimethylamino-ethylamino) nitrobenzene (according to Gabbay et al., J. Am. Chem. Soc. 91, 5136 (1969)) was dissolved in 50 ml of methylene chloride and 5.0 ml of triethylamine was added. Acetyl chloride (1.3 mL) was then slowly added dropwise to this mixture at room temperature and the mixture was stirred at room temperature for 2 hours. Then, triethylamine (5.0 mL) and acetyl chloride (1.3 mL) were added again and the reaction mixture was heated at reflux for an additional two hours. The solvent was then removed, the residue was triturated with ethyl acetate and the organic phase was washed twice with water. After drying over anhydrous magnesium sulfate, the solvent was removed and the residue was dried in vacuo.

Výťažok produktu bol 2,0 g (45 % teoretického výťažku),Yield: 2.0 g (45%)

Rf hodnota: 0,55 (gél kyseliny kremičitej, metylénchlorid/metanol/amoniak = 9:1: 0,1),Rf value: 0.55 (silica gel, methylene chloride / methanol / ammonia = 9: 1: 0.1),

C12H17N3O3C12H17N3O3

ESI-hmotnostné spektrum: m/z = 252 [M+H]+.ESI-MS: m / z = 252 [M + H] &lt; + &gt;.

Podobne ako v príprave 6 sa pripravili nasledujúce zlúčeniny:Similar to Preparation 6, the following compounds were prepared:

(1) 4-[N-(3-dimetylamino-propyl)-A/-acetyl-amino]-nitrobenzén, pripravený reakciou 4-(3-dimetylamino-propylaminoj-nitrobenzénu (podľa Gabbaya a ďalších, J. Am. Chem. Soc. 91, 5136 (1969)) a acetylchloridu, (2) 4-[7V-(2-dimetylamino-etyl)-7V-propionyl-amino]-nitrobenzén, pripravený reakciou 4-(2-dimetylamino-etylaminoj-nitrobenzénu a propionylchloridu, (3) 4-[1V-acetyl-A'-(dimetylaminokarbonylmetyl)amino]mtrobenzén, pripravený reakciou 4-[JV-(dimetylaminokarbonylmetyl)-amino]-nitrobenzénu a acetylchloridu, (4) 4-[AA(2-dimetylamino-etyl)-X-butyryl-amino]-nitrobenzén, pripravený reakciou 4-(2-dimetylamino-etylaminoj-nitrobenzénu a butyrylchloridu, (5) 4-[jV-(2-dimetylamino-etyl)-7V-izobutyryl-amino]nitrobenzén, pripravený reakciou 4-(2-dimetylamino-etylaminoj-nitrobenzén a izobutyrylchloridu, (6) 4-[7V-(2-dimetylamino-etyl)-7V-benzoyl-amino]-nitrobenzén, pripravený reakciou 4-(2-dimetylamino-etylaminoj-nitrobenzénu a benzoylchloridu, (7) 4-[7V-(2-dimetylamino-etyl)-7V-acetyl-amino]-l,3-dinitrobenzén, pripravený reakciou 4-(2-dimetylamino-etyl-amino)-l,3- dinitrobenzénu a acetylchloridu, (8) 4-[AL(2-dimetylamino-etyl)-A'-(furán-2-karbonyl)amino]nitrobenzén, pripravený reakciou 4-(2-dimetylamino-etylaminoj-nitrobenzénu a íurán-2-karbonylchloridu, (9) 4-|W-(2-dimetylamino-etyl)-A-(2-metoxy-benzoyl)-amino]-nitrobenzén, pripravený reakciou 4-(2-dimetylamino-etylaminoj-nitrobenzénu a 2-metoxy-benzoylchloridu, (10) 4-[7V-(2-dimetylamino-etyl)-jV-(pyridín-3-karbonyl)amino]nitrobenzén, pripravený reakciou 4-(2-dimetylamino-etylamino)-nitrobenzénu a chloridu kyseliny nikotínovej, (11) 4-[jV-(2-dimetylamino-etyl)-A-(fenyl-acetyl)amino]nitrobenzén, pripravený reakciou 4-(2-dimetylamino-etylamino)-nitrobenzénu a fenylacetylchloridu, (12) 4-[A-(2-dimetylamino-etyl)-A'-acetyl-amino]-3-bróm-nitrobenzén, pripravený reakciou 4-[,V-(2-dimetylamino-etyl)-amino]-3-bróm-nitrobenzénu a acetylchloridu, (13) Aí-akryloyl-A/-metyl-4-nitro-anilín, pripravený reakciou 4-metylamino-nitro-benzénu a chloridu kyseliny akrylovej, (14) JV-akryloyl-/V-izopropyl-4-nitro-anilín, pripravený reakciou 4-izopropylamino-nitrobenzénu a chloridu kyseliny akrylovej, (15) >V-akryloyl-/V-benzyl-4-mtro-anilin, pripravený reakciou 4-benzylamino-nitro-benzénu a chloridu kyseliny akkrylovej, (16) 7V-brómacetyl-7V-metyl-4-nitroanilín, pripravený reakciou 4-metylamino-nitro-benzénu a brómacetyl -chloridu, (17) 7V-brómacetyl-7V-izopropyl-4-nitroanilín, pripravený reakciou 4-izopropylamino-nitrobenzénu a brómacetylchloridu, (18) jV-brómacetyl-V-benzyl-4-nitroanilín, pripravený reakciou 4-benzylamino-nitrobenzénu a brómacetylchloridu,(1) 4- [N- (3-dimethylamino-propyl) - N -acetyl-amino] -nitrobenzene, prepared by the reaction of 4- (3-dimethylamino-propylamino) -nitrobenzene (according to Gabbay et al., J. Am. Chem. Soc., 91, 5136 (1969)) and acetyl chloride, (2) 4- [N - (2-dimethylamino-ethyl) - N -propionyl-amino] -nitrobenzene, prepared by the reaction of 4- (2-dimethylamino-ethylamino) -nitrobenzene and propionyl chloride, (3) 4- [1-acetyl-N - (dimethylaminocarbonylmethyl) amino] nitrobenzene a, prepared by reaction of 4- [J N- (dimethylaminocarbonylmethyl) amino] nitrobenzene and acetyl chloride, (4) 4- [AA ( 2-dimethylamino-ethyl) -X-butyryl-amino] -nitrobenzene, prepared by the reaction of 4- (2-dimethylamino-ethylamino) -nitrobenzene and butyryl chloride, (S) 4- [N- (2-dimethylamino-ethyl) -7H-isobutyryl (amino) nitrobenzene, prepared by the reaction of 4- (2-dimethylamino-ethylamino) -nitrobenzene and isobutyryl chloride, (6) 4- [N- (2-dimethylamino-ethyl) -7-benzoylamino] -nitrobenzene, prepared by the reaction of 4- ( 2-dimethylamino-ethylamino-nitrobenzene and benzoyl chloride, (7) 4- [N- (2-dimethylamino-ethy) l) -N-acetyl-amino] -1,3-dinitrobenzene, prepared by the reaction of 4- (2-dimethylamino-ethylamino) -1,3-dinitrobenzene and acetyl chloride, (8) 4- [A L (2-dimethylamino) (ethyl) -N- (furan-2-carbonyl) amino] nitrobenzene, prepared by the reaction of 4- (2-dimethylamino-ethylamino) -nitrobenzene and furan-2-carbonyl chloride, (9) 4- N - (2-dimethylamino-) ethyl) - N- (2-methoxy-benzoyl) -amino] -nitrobenzene, prepared by reacting 4- (2-dimethylamino-ethylamino) -nitrobenzene and 2-methoxy-benzoyl chloride, (10) 4- [N - (2-dimethylamino- ethyl) -N- (pyridine-3-carbonyl) amino] nitrobenzene, prepared by reacting 4- (2-dimethylamino-ethylamino) -nitrobenzene and nicotinic acid chloride, (11) 4- [N- (2-dimethylamino-ethyl) - N - (phenyl-acetyl) amino] nitrobenzene, prepared by the reaction of 4- (2-dimethylamino-ethylamino) -nitrobenzene and phenylacetyl chloride, (12) 4- [N - (2-dimethylamino-ethyl) - N '-acetyl-amino] 3-bromo-nitrobenzene, prepared by reacting 4 - [, N- (2-dimethylaminoethyl) amino] -3-bromo-nitrobenzene and acetyl chloride (13), and I-acryloyl-a / -methyl-4-nitro (14) N -acryloyl- N -isopropyl-4-nitro-aniline, prepared by reacting 4-isopropylamino-nitrobenzene and acrylic acid, (14) N-acryloyl- N -benzyl-4-nitroaniline, prepared by reaction of 4-benzylamino-nitro-benzene and acrylic acid chloride, (16) N -bromoacetyl-N -methyl-4-nitroaniline, prepared by reaction of 4- (17) N-bromoacetyl-N-isopropyl-4-nitroaniline, prepared by the reaction of 4-isopropylamino-nitrobenzene and bromoacetyl chloride, (18) N-bromoacetyl-N-benzyl-4-nitroaniline, prepared by the reaction of 4-benzylamino-nitrobenzene and bromoacetyl chloride,

Príprava 7 7V-(Dimetylaminometylkarbonyl)-7V-metyl-4-nitroanilínPreparation 7 N - (Dimethylaminomethylcarbonyl) - N -methyl-4-nitroaniline

K 1,8 g dimetylaminohydrochloridu a 5,5 g uhličitanu draselného v 80 ml acetónu sa pridalo pri teplote miestnosti v troch častiach 4,2 g V-brómacetyl-N-metyl-4-nitroanilínu. Reakčná zmes sa 12 hodín miešala pri teplote miestnosti, potom sa filtrovala a filtrát sa skoncentroval. Zvyšok sa rozpustil v etylesteri kyseliny octovej, dva razy premyl vodou, sušil nad bezvodým síranom sodným a nakoniec sa odparil v rotačnej odparke. Výťažok produktu bol 2,8 g (79 % teoretického výťažku),To 1.8 g of dimethylaminohydrochloride and 5.5 g of potassium carbonate in 80 ml of acetone was added 4.2 g of N-bromoacetyl-N-methyl-4-nitroaniline at room temperature in three portions. The reaction mixture was stirred at room temperature for 12 hours, then filtered and the filtrate was concentrated. The residue was dissolved in ethyl acetate, washed twice with water, dried over anhydrous sodium sulfate and finally evaporated in a rotary evaporator. Yield: 2.8 g (79% of theory);

Rf hodnota: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 7:3), teplota topenia produktu bola 121 až 122 °C.Rf value: 0.5 (silica gel, methylene chloride / methanol = 7: 3), mp 121-122 ° C.

Podobne ako v príprave 7 sa pripravili nasledujúce zlúčeniny:Similar to Preparation 7, the following compounds were prepared:

(1) 7V-(piperidin-1 -yl-metylkarbonyl)-7V-metyl-4-nitroanilín, (2) V-(morfolin-4-yl-metylkarbonyl)-iV-metyl-4-mtroamlín, (3) V-[(4-benzyl-piperazin-1 -yl)-metylkarbonyl]-7V-metyl-4-nitroanilín, (4) <V-(pyrolidin-1 -yl-metylkarbonyl)-A/-metyl-4-nitroanilín, (5) M-[(yV-aminokarbonylmetyl-A'-metyl-amino)-metylkarbonyl]-V-metyl-4-nitroanilín, (6) A'-[(A'-benzyl-.V-metyl-amino)-metylkarbonylJ-Af-metyl-4-nitroanilín, (7) /V-[di-(2-metoxyetyl)-amino-metylkarbonyl]-A'-metyl-4-nitroanilín, (8) 7V-(dimetylaminometylkarbonyl)-7V-izopropyl-4-nitroanilín, (9) V-(piperidín-1 -yl-metylkarbonyl)-7V-izopropyl-4-nitroanilín, (10) V-[(4-ŕerc-butoxykarbonylpiperazin-1 -yl)metylkarbonyll-V-izopropyl-4-nitroanilín, (11) N-[(7V-benzyl-Aľ-metyl-amino)-metylkarbonyl]-7V-benzyl-4-nitroamlín, (12) W(dimetylaminornetylkarbonyl)-Ä,-benzyl-4-nitroanilín, (13) N-(piperidin-1 -yl-metylkarbonyl)-V-benzyl-4-nitroanilín, (14) jV-[di-(2-hydroxyetyl)-amino-metylkarbonyl]-M-metyl-4-nitroanilín, (15) A'-[/V-(2-metoxyetyl)-A'-metyl-amino)-metylkarbonyl)-A'-metyl-4-nitroanilín, (16) N- [(7V-(2-dimetylamino-etyl)-V-metylamino)metylkarbonyl] -W-metyl-4-ηitroanilin, (17) N-[(4-metyl-piperazin-1 -yl)-metylkarbonyl]-V-metyl-4-nitroanilín, (18) V-[(imidazol-l-yl)-metylkarbonyl]-JV-metyl-4-nitroanilín, (19) 7V-[(ftalimido-2-yl)metylkarbonyl]-7V-metyl-4-nitroanilín.(1) N - (piperidin-1-ylmethylcarbonyl) - N -methyl-4-nitroaniline, (2) N - (morpholin-4-ylmethylcarbonyl) - N -methyl-4-nitroaniline, (3) V - [(4-benzyl-piperazin-1-yl) -methylcarbonyl] -7V-methyl-4-nitroaniline, (4) <N (pyrrolidin-1-yl-methylcarbonyl) -N- / methyl-4-nitroaniline, (5) N - [(N-aminocarbonylmethyl-N'-methyl-amino) -methylcarbonyl] -N-methyl-4-nitroaniline, (6) N '- [(N'-benzyl-N-methyl-amino) -metylkarbonylJ A-f-methyl-4-nitroaniline, (7) / N [di (2-methoxyethyl) -amino-methylcarbonyl] -N-methyl-4-nitroaniline, (8) 7V- (dimethylamino-methylcarbonyl) - N, N-isopropyl-4-nitroaniline, (9) N - (piperidin-1-ylmethylcarbonyl) - N, N-isopropyl-4-nitroaniline, (10) N - [(4-tert-butoxycarbonylpiperazin-1-yl) methylcarbonyl] - In-isopropyl-4-nitroaniline, (11) N - [(7V-benzyl-N- methyl-amino) -methylcarbonyl] -7V-benzyl-4-nitroamlín, (12) W (dimetylaminornetylkarbonyl) -N, benzyl -4-nitroaniline, (13) N- (piperidin-1-ylmethylcarbonyl) -N-benzyl-4-nitroaniline, (14) N- [di- (2-hydroxyethyl) amino-methylcarbonyl] -N-methyl -4-nitroaniline, (1 5) N - [N - (2-methoxyethyl) - N '-methyl-amino) -methylcarbonyl) - N' -methyl-4-nitroaniline, (16) N - [(N - (2-dimethylamino-ethyl) (N-methylamino) methylcarbonyl] -N-methyl-4-nitroaniline, (17) N - [(4-methyl-piperazin-1-yl) methylcarbonyl] -N-methyl-4-nitroaniline, (18) V - [(imidazol-l-yl) -methylcarbonyl] - J V-methyl-4-nitroaniline, (19) 7V - [(phthalimido-2-yl) methylcarbonyl] -7V-methyl-4-nitroaniline.

Príprava 8 jV-[(2-Dimetylaminoetyl)-karbonyl]-7V-benzyl-4-nitroanilínPreparation 8 N - [(2-Dimethylaminoethyl) -carbonyl] -N-benzyl-4-nitroaniline

V 50 ml metanolu sa rozpustilo 0,5 g hydrochloridu dimetylamínu, 1,1 ml trietylamínu a 1,2 g N-akroyl-N-benzyl-4-nitroanilínu. Roztok sa 24 hodín miešal pri teplote miestnosti. Reakčná zmes sa potom skoncentrovala, zvyšok sa čistil na stĺpci oxidu hlinitého (aktivita oxidu 2 až 3) s použitím metylénchloridu a etanolu (50 : 1) ako elučného činidla.0.5 g of dimethylamine hydrochloride, 1.1 ml of triethylamine and 1.2 g of N-aroyl-N-benzyl-4-nitroaniline were dissolved in 50 ml of methanol. The solution was stirred at room temperature for 24 hours. The reaction mixture was then concentrated, and the residue was purified on an alumina column (2-3 activity) using methylene chloride and ethanol (50: 1) as eluent.

Výťažok produktu bol 1,4 g (98 % teoretického výťažku), Rf hodnota: 0,8 (oxid hlinitý, metylénchlorid/etanol = 20 : 1), teplota topenia produktu bola 73 °C.Yield: 1.4 g (98% of theory); Rf value: 0.8 (alumina, methylene chloride / ethanol = 20: 1); mp 73 DEG C .;

Podobne ako v príprave 8 sa pripravili nasledujúce zlúčeniny:Similar to Preparation 8, the following compounds were prepared:

(1) V-[(2-dimetylamino-etyl)-karbonyl]-N-izopropyl-4-nitroanilín, pripravený reakciou V-akryloyl-W-izopropyl-4-nitroanilínu a dimetylaminhydrochloridu, (2) jV-[(2-dimetylamino-etyl)-karbonyl]-jV-metyl-4-nitroanilín, pripravený reakciou V-akryloyl-N-metyl-4-nitroanilínu a dimetylaminhydrochloridu, (3) V-[(2-(4-íerc-butoxykarbonyl-piperazin-l-yl)-etyl)-karbonyl]-7V-metyl-4-nitroanilin, pripravený reakciou V-akryloyl-V-metyl-4-nitroanilínu a N-terc- butoxykarbonyl-piperazínu, (4) 7V-[(2-(piperidin-l-yl)-etyl)-karbonyl]-V-metyl-4-nitroanilín, pripravený reakciou A,-akryloyl-/V-metyl-4-nitroanilínu a piperidínu, (5) N-[(2-(N-benzyl-N-metyl-amino)-etyl)-karbonyl]-N-metyl-4-nitroanilín, pripravený reakciou Λ'-akryloyl-/V-metyl-4-nitroanilínu a V-benzyl-V-metyl-amínu.(1) N - [(2-dimethylamino-ethyl) -carbonyl] -N-isopropyl-4-nitroaniline, prepared by the reaction of N-acryloyl-N-isopropyl-4-nitroaniline and dimethylamine hydrochloride, (2) N - [(2- dimethylamino-ethyl) -carbonyl] -N-methyl-4-nitroaniline, prepared by the reaction of N-acryloyl-N-methyl-4-nitroaniline and dimethylamine hydrochloride, (3) N - [(2- (4-tert-butoxycarbonylpiperazine) - 1-yl) -ethyl) -carbonyl] -N-methyl-4-nitroaniline, prepared by reacting N-acryloyl-N-methyl-4-nitroaniline and N-tert-butoxycarbonylpiperazine, (4) N - [(2- (piperidin-1-yl) -ethyl) -carbonyl] -N-methyl-4-nitroaniline, prepared by the reaction of N , -acryloyl- N -methyl-4-nitroaniline and piperidine, (5) N - [(2- ( N-benzyl-N-methyl-amino) -ethyl) -carbonyl] -N-methyl-4-nitroaniline, prepared by reacting N'-acryloyl-N-methyl-4-nitroaniline and N-benzyl-N-methyl-amine .

Príprava 9Preparation 9

4-(4-Metyl-piperazin-1 -yl)-nitrobenzén4- (4-Methyl-piperazin-1-yl) -nitrobenzene

Zmes 31,5 g 4-chlór-l-nitrobenzénu a 44,4 ml 1-metylpiperazínu sa spolu 18 hodín miešala pri 90 °C. Potom sa zmes naliala do ľadovej vody a vylúčená zrazenina sa zachytila filtráciou s odsávaním. Zachytený podiel sa premyl vodou a rekryštalizoval z prostredia etanolu a vody (1 : 1). Produkt sa sušil vo vákuu pri 75 °C. Výťažok: 44,0 g (99 % teoretického výťažku), Rf-hodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 10 : 1), teplota topenia produktu bola 108-112 °C.A mixture of 31.5 g of 4-chloro-1-nitrobenzene and 44.4 ml of 1-methylpiperazine was stirred together at 90 ° C for 18 hours. The mixture was then poured into ice water and the precipitate formed was collected by suction filtration. The collected fraction was washed with water and recrystallized from ethanol / water (1: 1). The product was dried under vacuum at 75 ° C. Yield: 44.0 g (99% of theory), Rf value of product: 0.5 (silica gel, methylene chloride / methanol = 10: 1), m.p. 108-112 ° C.

Podobne ako v príprave 9 sa pripravili nasledujúce zlúčeniny:Similar to Preparation 9, the following compounds were prepared:

(1) N-(2-dimetylaminoetyl)-N-metyl-4-nitroanilín, pripravený reakciou l-fluór-4-nitro-benzénu a 1-dimetylamino-2-metylaminoetánu, (2) V-(3-dimetylaminopropyl)-V-metyl-4-nitroanilm, pripravený reakciou l-fluór-4-nitrobenzénu a 1-dimetylamino-3-metylamino-propánu, (3) 4-(7V-karboxymetyl-amino)-nitrobenzén, pripravený reakciou l-fluór-4-nitro-benzénu a glycínu, (4) N-cyklohexyl-p-fenyléndiamín, pripravený reakciou l-fluór-4-nitrobenzénu a cyklohexylamínu, (5) 6-[jV-(2-dimetylamino-etyl)-jV-metylsulfonyl-amino]-3-ftalimido-2-yl-nitrobenzén, pripravený reakciou 2-nitro-4-ftalimido-2-yl-fluórbenénu, V-(2-dimetylamino-etyl)-metánsulfónamidu a hydridu sodného ako zásadou, (6) 6-[7V-(2-dmietylamino-etyl)-N-metylsulfonyl-amino]-l,3-dinitrobenzén, pripravený reakciou 2,4-dinitrochlórbenzénu, N- (2-dimetylamino-etyl)-metánsulfónamidu a hydridu sodného ako zásadou, (7) 4-[V-(2-dimetylamino-etyl)-/V-metylsulfonylaminoj-3-chlómitrobenzén, pripravený reakciou 2-fluór-5-nitro-chlórbenzénu, N-(2-dimetyl-amino-etyl)-metánsulfónamidu a hydridu sodného ako zásadou, (8) 4-(2-dimetylamino-etyl-amino)-l,3-dinitrobenzén, pripravený reakciou l-chlór-2, 4-dinitro-benzénu a N, jV-dimetyletylendiamínu, (9) 4-[V-(2-dimetylamino-etyl)-V-(etylsulfonyl)-amino]-nitrobenzén, pripravený reakciou l-fluór-4-nitro-benzénu, N-(2-dimetylamino-etyl)-etánsulfónamidu a hydridu sodného ako zásadou, (10) 4-[jV-(2-dimetylamino-etyl)-7V-(propylsulfonyl)-amino]-nitrobenzén, pripravený reakciou l-fluór-4-nitro-benzénu, jV-(2-dimetylamino-etyl)-propánsulfónamidu a hydridu sodného ako zásadou, (11) 4-[7V-(2-dimetylamino-etyl)-7V-(butylsulfonyl)-amino]-nitrobenzén, pripravený reakciou l-fluór-4-nitro-benzénu, jV-(2-dimetylamino-etyl)-butánsulfónamidu a hydridu hydridu sodného ako zásadou, (12) 4-[/V-(2-dimetylamino-etyl)-jV-(benzylsulfonyl)-amino]-nitrobenzén, pripravený reakciou l-fluór-4-nitro-benzénu, /V-(2-dimetylaminoetyl)-fenylmetánsulfónamidu a hydridu sodného ako zásadou, (13) 4-[7V-(2-dimetylamino-etyl)-M-(fenylsulfonyl)-amino]-mtrobenzén, pripravený reakciou l-fluór-4-nitro-benzénu, jV-(2-dimetylamino-etyl)-benzénsulfónamidu a hydridu sodného ako zásadou, (14) 4-[7V-(2-dimetylamino-etyl)-/V-(izopropylsulfonyl)-amino]-nitrobenzén, pripravený reakciou l-fluór-4-nitro-benzénu, 7V-(2-dimetylamino-etyl)-izopropylsulfónamidu a hydridu sodného ako zásadou, (15) 4-[/V-(2-dimetylamino-etyl)-amino]-3-bróm-nitrobenzén, pripravený reakciou 2-bróm-l-fluór-4-nitro-benzénu a jV,/V-dimetyl-etylendiamínu, (16) 4-izopropylamino-nitrobenzén, pripravený reakciou l-fluór-4-nitrobenzénu a izopropylamínu, (17) 4-benzylamino-nitrobenzén, pripravený reakciou l-fluór-4-nitrobenzénu a benzylamími.(1) N- (2-dimethylaminoethyl) -N-methyl-4-nitroaniline, prepared by the reaction of 1-fluoro-4-nitro-benzene and 1-dimethylamino-2-methylaminoethane, (2) N- (3-dimethylaminopropyl) - N-methyl-4-nitroanilm, prepared by reaction of 1-fluoro-4-nitrobenzene and 1-dimethylamino-3-methylamino-propane, (3) 4- (N-carboxymethyl-amino) -nitrobenzene, prepared by reaction of 1-fluoro-4 (4) N-cyclohexyl-p-phenylenediamine, prepared by the reaction of 1-fluoro-4-nitrobenzene and cyclohexylamine, (S) 6- [N- (2-dimethylamino-ethyl) -N-methylsulfonyl- amino] -3-phthalimido-2-yl-nitrobenzene, prepared by reacting 2-nitro-4-phthalimido-2-yl-fluorobenene, N- (2-dimethylamino-ethyl) -methanesulfonamide and sodium hydride as a base, (6) 6 - [N - (2-dimethylamino-ethyl) -N-methylsulfonylamino] -1,3-dinitrobenzene, prepared by the reaction of 2,4-dinitrochlorobenzene, N- (2-dimethylamino-ethyl) -methanesulfonamide and sodium hydride as a base, (7) 4- [N - (2-dimethylamino-ethyl) - N -methylsulfonylamino] -3-chloro-mitobenzene, prepared by reaction of 2- Fluoro-5-nitro-chlorobenzene, N- (2-dimethylamino-ethyl) -methanesulfonamide and sodium hydride as base, (8) 4- (2-dimethylamino-ethyl-amino) -1,3-dinitrobenzene, prepared by reaction 1-chloro-2,4-dinitro-benzene and N, N -dimethylethylenediamine, (9) 4- [N - (2-dimethylamino-ethyl) - N - (ethylsulfonyl) amino] nitrobenzene, prepared by the reaction of 1-fluoro 4-nitro-benzene, N- (2-dimethylamino-ethyl) -ethanesulfonamide and sodium hydride as a base, (10) 4- [N - (2-dimethylamino-ethyl) - N - (propylsulfonyl) amino] -nitrobenzene , prepared by the reaction of 1-fluoro-4-nitro-benzene, N - (2-dimethylamino-ethyl) -propanesulfonamide and sodium hydride as a base, (11) 4- [N - (2-dimethylamino-ethyl) -7- (butylsulfonyl) (amino) -nitrobenzene, prepared by reacting 1-fluoro-4-nitro-benzene, N - (2-dimethylamino-ethyl) -butanesulfonamide and sodium hydride hydride as a base, (12) 4- [N - (2-dimethylamino) - ethyl) - N - (benzylsulfonyl) amino] -nitrobenzene, prepared by the reaction of 1-fluoro-4-nitro-benzene, N - (2-dimethylaminoethyl) -phenylmethanes (13) 4- [N - (2-dimethylamino-ethyl) - N - (phenylsulfonyl) amino] -trobenzene, prepared by the reaction of 1-fluoro-4-nitro-benzene, N - (2) (14) 4- [N - (2-dimethylamino-ethyl) - N - (isopropylsulfonyl) amino] nitrobenzene, prepared by the reaction of 1-fluoro-4-nitro-dimethylamino-ethyl) -benzenesulfonamide and sodium hydride as a base; (15) 4- [N - (2-dimethylamino-ethyl) -amino] -3-bromo-nitrobenzene, prepared by the reaction of 2- (2-dimethylamino-ethyl) -isopropylsulfonamide and sodium hydride as the base; (16) 4-isopropylamino-nitrobenzene, prepared by reaction of 1-fluoro-4-nitrobenzene and isopropylamine, (17) 4-benzylamino-nitrobenzene , prepared by reaction of 1-fluoro-4-nitrobenzene and benzylamines.

Príprava 10Preparation 10

4-(Imidazol-4-yl)-1 -nitrobenzén4- (Imidazol-4-yl) -1-nitrobenzene

V 50 ml koncentrovanej kyseliny sírovej sa opatrne rozpustilo 9,5 g 2-fenyl-imidazolu a do tohto roztoku sa pri 0 °C pridalo 5,8 g dusičnanu amónneho. Po 60 minútovom miešaní pri 0 °C sa zmes vyliala do ľadovej vody, upravila do zásaditej reakcie vodným roztokom amoniaku a vylúčená zrazenia sa oddelila filtráciou s odsávaním a rekryštalizovala z prostredia etanolu.9.5 g of 2-phenyl-imidazole were carefully dissolved in 50 ml of concentrated sulfuric acid, and 5.8 g of ammonium nitrate was added to this solution at 0 ° C. After stirring at 0 ° C for 60 minutes, the mixture was poured into ice water, basified with aqueous ammonia solution and the precipitate formed was collected by suction filtration and recrystallized from ethanol.

Výťažok: 8,0 g (64 % teoretického výťažku), Rrhodnota produktu: 0,6 (gél kyseliny kremičitej, etylester kyseliny octovej/etanol = 10 : 1), C9H7N3O2 Yield: 8.0 g (64% of theory), Product value: 0.6 (silica gel, ethyl acetate / ethanol = 10: 1), C 9 H 7 N 3 O 2

Hmotnostné spektrum: m/z =189 [M]+.Mass spectrum: m / z = 189 [M] &lt; + &gt;.

Podobne ako v príprave 10 sa pripravili nasledujúce zlúčeniny:As in Preparation 10, the following compounds were prepared:

(1) 4-(imidazol-2-yl)-nitrobenzén, pripravený reakciou z 4-(imidazol-2-yl)-benzénu, (2) 4-(5-metyl-imidazol-4-yl)-nitrobenzén, pripravený reakciou z 4-metyl-5-fenyl-imidazol (J. Heterocycl. Chem. 1983, 20,1277-1281).(1) 4- (imidazol-2-yl) -nitrobenzene, prepared by reaction from 4- (imidazol-2-yl) -benzene, (2) 4- (5-methyl-imidazol-4-yl) -nitrobenzene, prepared by reaction from 4-methyl-5-phenyl-imidazole (J. Heterocycl. Chem. 1983, 20, 1277-1281).

Príprava 11Preparation 11

4-(2-(Imidazol-4-yl)-etylén)-nitrobenzén4- (2- (imidazol-4-yl) -ethylene) -nitrobenzene

1,5 g 4-nitrobenzaldehydu a 7,45 g (7V-trityl-imidazol-4-yl-metyl)-trifenyl-fosfóniumchloridu sa rozpustilo v 75 ml tetrahydrofuránu a do roztoku sa pri teplote miestnosti pridali po kvapkách 3 ml DBU. Reakčná zmes sa 120 minút miešala pri teplote miestnosti a potom sa naliala do vody, vylúčená zrazenina sa zachytila filtráciou s odsávaním. Produkt sa rozmiešal v 25 ml zriedenej kyseliny chlorovodíkovej (cHci = 1 mol.dm’3) a 4 hodiny s varil pod spätným chladičom. Roztok sa potom neutralizoval roztokom amoniaku, extrahoval etylesterom kyseliny octovej a organická fáza sa premyla vodou, sušila nad bezvodým síranom sodným a odparila. Odparok sa čistil na stĺpci gélu kyseliny kremičitej s použitím metylénchloridu/metanolu 10:1 ako elučným činidlom.1.5 g of 4-nitrobenzaldehyde and 7.45 g of (N-trityl-imidazol-4-ylmethyl) -triphenylphosphonium chloride were dissolved in 75 ml of tetrahydrofuran and 3 ml of DBU were added dropwise to the solution at room temperature. The reaction mixture was stirred at room temperature for 120 minutes and then poured into water, and the precipitate was collected by suction filtration. The product was taken up in 25 ml diluted hydrochloric acid (c = 1 ci H mol.dm '3) and 4 hours, heated to reflux. The solution was then neutralized with ammonia solution, extracted with ethyl acetate, and the organic phase was washed with water, dried over anhydrous sodium sulfate and evaporated. The residue was purified on a silica gel column using 10: 1 methylene chloride / methanol as eluent.

Výťažok: 1,0 g (47 % teoretického výťažku), Rrhodnota produktu: 0,6 (gél kyseliny kremičitej, etylester kyseliny octovej/etanol =10:1), teplota topenia produktu bola 185 až 188 °C.Yield: 1.0 g (47% of theory). Product value: 0.6 (silica gel, ethyl acetate / ethanol = 10: 1), m.p. 185-188 ° C.

Príprava 12Preparation 12

4-(Piperidin-1 -yl-metyl)-nitrobenzén4- (Piperidin-1-yl-methyl) -nitrobenzene

40,0 g 4-nitrobenzylbrómidu sa rozpustilo v 500 ml metylénchloridu, pridalo sa 51,5 ml trietylamínu a po kvapkách sa opatrne pridalo 18,3 ml piperidínu. Po skončení exotermickej reakcie sa reakčná zmes zahrievala ďalších 30 minút na teplotu varu pod spätným chladičom. Po ochladení sa premyla vodou a organická fáza sa sušila nad bezvodým síranom sodným a nakoniec sa odparila.40.0 g of 4-nitrobenzyl bromide was dissolved in 500 ml of methylene chloride, 51.5 ml of triethylamine was added, and 18.3 ml of piperidine was carefully added dropwise. After the exothermic reaction was completed, the reaction mixture was refluxed for an additional 30 minutes. After cooling, it was washed with water and the organic phase was dried over anhydrous sodium sulfate and finally evaporated.

Výťažok: 36,3 g (89 % teoretického výťažku), Rrhodnota produktu: 0,6 (gél kyseliny kremičitej, metylénchlorid/metanol = 9 : 1), Ci2Hi6N2O2 + Yield: 36.3 g (89% of theory), Product value: 0.6 (silica gel, methylene chloride / methanol = 9: 1), C 12 H 6 N 2 O 2 +

Hmotnostné spektrum: m/z = 221 [M]+.Mass spectrum: m / z = 221 [M] &lt; + &gt;.

Podobne ako v príprave 12 sa pripravili nasledujúce zlúčeniny:Similar to Preparation 12, the following compounds were prepared:

(1) 4-[(2,6-dimetyl-piperidin-l-yl)-metyl]-nitrobenzén, (2) 3 -(/V,/V-dimetyl-aminometyl)-mtrobenzén, (3) 4-(/V,V-dimetyl-aminometyl)-nitrobenzén, (4) 4-(2-dimetylamino-etyl)-nitrobenzén, (5) 4-(2-dietylamino-etyl)-nitrobenzén (6) 4-(dietylamino-metyl)-nitrobenzén, (7) 4-(yV-benzyl-N-metyl-aminometyl)-nitrobenzén, (8) 4-(N-etyl-Mmetyl-arninornetyl)-nitrobenzén, (9) 4-[N-(n-hexyl)-7V-metyl-aminometyI)-nitrobenzén, (10) 4-(tiomorpholin-4-yl-metyl)-nitrobenzén, (11) 4-[(4-metyl-piperazin-l-yl)-metyl]-nitrobenzén, (12) 4-(imidazol-1 -yl-metyl)-nitrobenzén, (13) 4-[2-(4-hydroxy-piperidin-1 -yl)-etyl-amino]-nitrobenzén, (14) 4-[(3-hydroxy-pyrrolidin-1 -yl)-metyl]-nitrobenzén, (15) 4-(1,2,4-triazol-1 -yl-metyl)-nitrobenzén, (16) 4-( 1,2,3-triazol-2-yl-metyl)-nitrobenzén, (17) 4-( 1,2,3-triazol-1 -yl-metyl)-nitrobenzén, (18) 4-[(iV-etoxykarbonyl-metyl-/V-metyl-amino)-metyl]nitrobenzén, (19) 4-[(/V-aminokarbonyl-metyl-7V-metyl-amino)-metyl]-nitrobenzén, (20) 4-(azetidin-1 -yl-metyl)-nitrobenzén, (21) 4-[(di-(2-metoxy-etyl)-amino)-metyl]-nitrobenzén, (22) 4-[N-( /V-terc-butoxykarbonyl-3 -amino-propyl)-N-metylami nometyl] -nitrobenzén, (23) 4-[(A'-propyl-jV-metyl-amino)-metyl]-nitrobenzén, (24) 4-[(jV-(2-dimetylamino-etyl)-A'-metyl-amino)-metyl]-mtrobenzén, (25) 4-[(/V-(3-dimetylamino-propyl)-V-metyl-amino)-metyl]-nitrobenzén, (26) 4-[(N-(2-metoxy-etyl)-jV-metyl-amino)-metyl]-nitrobenzén, (27) 4-[(A'-(2-hydroxy-etyl)-/V-metyl-amino)-metyI]-nitrobenzén, (28) 4-[(/V-(dioxolán-2-yl-metyl)-7V-metyl-amino)-metyl]nitrobenzén, (29) 4-(3-oxo-piperazin-1 -yl-metyl)-nitrobenzén.(1) 4 - [(2,6-dimethyl-piperidin-1-yl) -methyl] -nitrobenzene, (2) 3- (N, N -dimethylaminomethyl) -trobenzene, (3) 4- ( N, N -dimethyl-aminomethyl) -nitrobenzene, (4) 4- (2-dimethylamino-ethyl) -nitrobenzene, (S) 4- (2-diethylamino-ethyl) -nitrobenzene (6) 4- (diethylamino-methyl) ) -nitrobenzene, (7) 4- (N-benzyl-N-methyl-aminomethyl) -nitrobenzene, (8) 4- (N-ethyl-methylmethyl-aminomethyl) -nitrobenzene, (9) 4- [N- (n) (10) 4- (thiomorpholin-4-yl-methyl) -nitrobenzene, (11) 4 - [(4-methyl-piperazin-1-yl) -methyl] -hexyl) - N -methyl-aminomethyl) -nitrobenzene; -nitrobenzene, (12) 4- (imidazol-1-yl-methyl) -nitrobenzene, (13) 4- [2- (4-hydroxy-piperidin-1-yl) -ethyl-amino] -nitrobenzene, (14) 4 - [(3-hydroxy-pyrrolidin-1-yl) -methyl] -nitrobenzene, (15) 4- (1,2,4-triazol-1-ylmethyl) -nitrobenzene, (16) 4- (1) (2,3) triazol-2-ylmethyl) nitrobenzene, (17) 4- (1,2,3-triazol-1-ylmethyl) nitrobenzene, (18) 4 - [(N-ethoxycarbonyl- methyl- (N-methyl-amino) -methyl] nitrobenzene, (19) 4 - [(N-aminocarbonyl-methyl-N-methyl-amino) -methyl] -nitrobenzene, (20) 4- (azetidin-1 -) - yl (21) 4 - [(di- (2-methoxy-ethyl) -amino) -methyl] -nitrobenzene, (22) 4- [N- (N-tert-butoxycarbonyl-3-amino) -methyl] -nitrobenzene; (23) 4 - [(N'-propyl-N-methyl-amino) -methyl] -nitrobenzene, (24) 4 - [(N - (2-dimethylamino-) -propyl) -N-methylaminomethyl] -nitrobenzene; (25) 4 - [(N - (3-dimethylamino-propyl) - N -methyl-amino) -methyl] -nitrobenzene, (26) 4 - [(ethyl) -N- (methyl-amino) -methyl] -mtrobenzene; - [(N- (2-methoxy-ethyl) - N -methyl-amino) -methyl] -nitrobenzene, (2 S) 4 - [(N '- (2-hydroxy-ethyl) - N -methyl-amino) (methyl) -nitrobenzene, (2 S) 4 - [(N - (dioxolan-2-ylmethyl) - N -methyl-amino) methyl] nitrobenzene, (2 S) 4- (3-oxo-piperazine-1) yl-methyl) nitrobenzene.

Príprava 13 4-[(/V-Karboxymetyl-/V-metyl-amino)-metyl]-nitrobenzénPreparation 13 4 - [(N-Carboxymethyl- N -methyl-amino) -methyl] -nitrobenzene

7,33 g 4-[(/V-etoxykarbonyl-metyl-/V-metyl-amino)-metyl]-mtrobenzénu sa rozpustilo v 140 ml etanolu, pridalo sa 34,0 ml roztoku hydroxidu sodného (cNa0H = 1 mol.dm3) a zmes sa pol hodiny miešala pri teplote miestnosti. Reakčná zmes sa potom neutralizovala zriedenou kyselinou chlorovodíkovou (cHci= 1 mol.dm3), rozpúšťadlo sa odstránilo, zvyšok sa rozmiešal v metylénchloride a extrahoval vodou. Vodná fáza sa skoncentrovala a zvyšok sa rekryštalizoval z prostredia metylénchloridu.7.33 g of 4 - [(N-ethoxycarbonyl-methyl- N -methyl-amino) -methyl] -trobenzene were dissolved in 140 ml of ethanol, and 34.0 ml of sodium hydroxide solution (c NaOH = 1 mol. dm 3 ) and the mixture was stirred at room temperature for half an hour. The reaction mixture was then neutralized with dilute hydrochloric acid (c H 1 = 1 mol.dm 3 ), the solvent was removed, the residue was stirred in methylene chloride and extracted with water. The aqueous phase was concentrated and the residue was recrystallized from methylene chloride.

Výťažok: 5,43 g (84 % teoretického výťažku),Yield: 5.43 g (84% of theory),

Rf-hodnota produktu: 0,4 (gél kyseliny kremičitej, metylénchlorid/metanol = 2 : 1), C10H12N2O4Rf value of the product: 0.4 (silica gel, methylene chloride / methanol = 2: 1), C10H12N2O4

Hmotnostné spektrum: m/z = 223 [M]+.Mass spectrum: m / z = 223 [M] &lt; + &gt;.

Príprava 14Preparation 14

4-(V-Etyl-aminometyl)-nitrobenzén4- (W-ethyl-aminomethyl) -nitrobenzene

V 25 ml etanolu sa rozpustilo 6,0 g 4-nitrobenzylbrómidu, roztok sa zmiešal s 25 ml 10 %-ného etanolového roztoku etylamínu a reakčná zmes sa 2 hodiny varila pod spätným chladičom. Potom sa roztok odparil v rotačnej odparke, zvyšok sa rozmiešal v metylénchloride a premyl zriedeným roztokom hydroxidu sodného. Nakoniec sa odparila organická fáza.6.0 g of 4-nitrobenzyl bromide was dissolved in 25 ml of ethanol, the solution was mixed with 25 ml of a 10% ethanol solution of ethylamine, and the reaction mixture was refluxed for 2 hours. Then the solution was rotovapped, the residue was stirred in methylene chloride and washed with dilute sodium hydroxide solution. Finally, the organic phase was evaporated.

Výťažok: 2,3 g (46 % teoretického výťažku),Yield: 2.3 g (46% of theory),

Rf-hodnota produktu: 0,2 (gél kyseliny kremičitej, metylénchlorid/metanol = 9 : 1),Rf value of product: 0.2 (silica gel, methylene chloride / methanol = 9: 1),

C9H12N2O2C9H12N2O2

Hmotnostné spektrum: m/z =179 [M-H].Mass spectrum: m / z = 179 [M-H].

Podobne ako v príprave 14 sa pripravili nasledujúce zlúčeniny:Similar to Preparation 14, the following compounds were prepared:

(1) 4-[V-(4-chlórbenzyl)-aminometyl]-nitrobenzén, (2) 4-(N-cyklohexyl-aminometyl)-nitrobenzén, (3) 4-(V-izopropyl-aminometyl)-nitrobenzén, (4) 4-(/V-propyl-aminometyl)-nitrobenzén, (5) 4-(/V-metyl-aminometyl)-nitrobenzén, (6) 4-(N-butyl-aminometyl)-nitrobenzén, (7) 4-(N-metoxykarbonyl-metyl-aminometyl)-nitrobenzén, (8) 4-(N-benzyl-aminometyl)-nitrobenzén, (9) 4-(aminometyl)-nitrobenzén, (10) 4-(pyrolidin-1 -yl-metyl)-nitrobenzén, (11) 4-(morfolin-4-yl-metyl)-nitrobenzén, (12) 4-(hexametyléniminometyl)-nitrobenzén, (13) 4-(4-hydroxy-piperidin-1 -yl-metyl)-nitrobenzén, (14) 4-(4-metoxy-piperidin-1 -yl-metyl)-nitrobenzén,(1) 4- [N- (4-chlorobenzyl) -aminomethyl] -nitrobenzene, (2) 4- (N-cyclohexyl-aminomethyl) -nitrobenzene, (3) 4- (N-isopropyl-aminomethyl) -nitrobenzene, ( 4) 4- (N-propyl-aminomethyl) -nitrobenzene, (5) 4- (N-methyl-aminomethyl) -nitrobenzene, (6) 4- (N-butyl-aminomethyl) -nitrobenzene, (7) 4 - (N-methoxycarbonyl-methyl-aminomethyl) -nitrobenzene, (8) 4- (N-benzyl-aminomethyl) -nitrobenzene, (9) 4- (aminomethyl) -nitrobenzene, (10) 4- (pyrrolidin-1-yl) (11) 4- (morpholin-4-ylmethyl) -nitrobenzene, (12) 4- (hexamethyleniminomethyl) -nitrobenzene, (13) 4- (4-hydroxy-piperidin-1-yl-) -methyl- (14) 4- (4-methoxy-piperidin-1-ylmethyl) -nitrobenzene,

SK 287312 Β6 (15) 4-(4-metyl-piperidin-1 -yl-metyl)-nitrobenzén, (16) 4-(4-etyl-piperidin-1 -yl-metyl)-nitrobenzén, (17) 4-(4-izopropyl-piperidin-1 -yl-metyl)-nitrobenzén, (18) 4-(4-fenyl-piperidin-1 -yl-metyl)-nitrobenzén, (19) 4-(4-benzyl-piperidin-1 -yl-metyl)-nitrobenzén, (20) 4-(4-etoxykarbonyl-piperidin-1 -yl-metyl)-nitrobenzén, (21) 4-(//,jV-dipropyl-ammometyl)-nitrobenzén, (22) 4-(4-íerc-butoxykarbonyl-piperazin-l-yl-metyl)- nitrobenzén, (23) 4-(2-morfolin-4-yl-etyl)-nitrobenzén, (24) 4-(2-pyrolidin-1 -yl-etyl)-nitrobenzén, (25) 4-(2-piperidin-l-yl-etyl)-nitrobenzén, (26) 4-(1V-etyl-A'-benzyl-aminometyl)-nitrobenzén, (27) 4-(7V-propyl-7V-benzyl-aminometyl)-nitrobenzén, (28) 4-[jV-metyl-jV-(4-chlórbenzyl)-aminometyl]-nitrobenzén, (29) 4-[/V-metyl-Aí-(4-brómbenzyl)-aminometyl]-mtrobenzén, (30) 4-[íV-metyl-/V-(4-fluórbenzyl)-ammometyl]-nitrobenzén, (31) 4-[Aľ-metyl-jV-(4-metylbenzyl)-aminometyl]-nitrobenzén, (32) 4-[jV-metyl-Af-(3-chlórbenzyl)-aminometyl]-nitrobenzén, (33) 4-[7V-metyl-7V-(3, 4-dimetoxybenzyl)-aminometyl]-nitrobenzén, (34) 4-[7V-metyl-A/-(4-metoxybenzyl)-aminometyl]-nitrobenzén, (35) 4-(A-2, 2,2-tnfluóretyl-A'-benzyl-aminometyl)nitrobenzén, (3 6) 4-[7V-2, 2,2-trifluóretyl-jV-(4-chlórbenzyl)-aminometyl]nitrobenzén; (37) 4-(tiomorfolin-4-yl-metyl)-nitrobenzén, (38) 4-(azetidión-1 -yl-metyl)-nitrobenzén, (39) 4-(3,4-dihydropyrrolidin-1 -yl-metyl)-nitrobenzén, (40) 4-(3,4-dihydropiperidín-l-yl-metyl)-nitrobenzén, (41) 4-(2-metoxykarbonyl-pyrrolidin-1 -yl-metyl)-nitrobenzén, (42) 4-(3,5-dimetyl-piperidin-l-yl-metyl)-nitrobenzén, (43) 4-(4-fenyl-piperazin-1 -yl-metyl)-nitrobenzén, (44) 4-(4-fenyl-4-hydroxy-piperidin-1 -yl-metyl)-nitrobenzén, (45) 4_[jV_(3 ,4,5-trimetoxybenzyl)-A'-metyl-aminometyl]nitrobenzén, (46) 4- [M(3,4-dimetoxybenzy 1 j-iV-etyl-amino metyl] -nitrobenzén, (47) 4-[7V-((2,6-dichlórbenzyl)-A'-metyl)-aminometyl]-nitrobenzén, (48) 4-[7V-(4-trifluórmetylbenzyl)-/V-metyl)-aminometyl]-nitrobenzén, (49) 4-(jV-benzyl-jV-izopropyl-aminometyl)-nitrobenzén, (50) 4-(<V-benzyl-/V-Zez-c-butyl-aminometyl)-mtrobenzén, (51) 4-(jV,jV-diizopropyl-aminometyl)-nitrobenzén, (5 2) 4-(Λζ Λ'-diizobutyl-aminometyl)-nitrobenzén, (53) 4-(2,3,4,5-tetrahydro-benzo(d)azepin-3-yl-metyl)- nitrobenzén, (54) 4-(2,3-dihydro-izoindol-2-yl-metyl)-nitrobenzén, (55) 4-(6,7-dimetoxy-l,2,3,4-tetrahydro-izochinolin-2-yl-metyl)-nitrobenzén, (56) 4-(1,2,3,4-tetrahydro-izochinoíin-2-yl-metyl)nitrobenzén, (57) 4-[7V-(2-hydroxyetyl)-Aľ-benzyl-aminometyl]-nitrobenzén, (58) 4-[7V-(l-etyl-pentyl)-7V-(pyridin-2-yl-metyl)-aminometyl]-nitrobenzén, (59) 4-(piperidin-l-yl-metyl)-l,3-dinitrobenzén, (60) 4-(7V-fenetyl-/V-metyl-aminometyl)-nitrobenzén, (61) 4-[iV-(3,4-dihydroxy-fenetyl)-jV-metyl-aminometyl]-nitrobenzén, (62) 4- [7V-(3,4,5 -trimetoxy- fenetyl)-7V-mety 1-aminometyl] nitrobenzén, (63) 4- [N-(3,4-di metoxy- renetyl)-/V-metyl-ami nometyl] -nitrobenzén, (64) 4-[7V-(3,4-dimetoxy-benzyl)-jV-metyl-aminometyl]-nitrobenzén, (65) 4-[jV-(4-chlór-benzyl)-7V-metyl-aminometyl]-nitrobenzén, (66) 4-[/V-(4-bróm-benzyl)-/V-metyl-ammometyl]-mtrobenzén, (67) 4-[/V-(4-fluór-benzyl)-/V-metyl-aminometyl]-nitrobenzén, (68) 4-[jV-(4-metyl-benzyl)-7V-metyl-aminometyl]-nitrobenzén, (69) 4-[/V-(4-nitro-fenetyl)-7V-metyl-aminometyl]-nitrobenzén, (70) 4-(A,-fenetyl-/V-benzyl-aminometyl)-nitrobcnzén, (71) 4-(7V-fenetyl-jV-cyklohexyl-aminometyl)-nitrobenzén, (72) 4-[/V-(2-(pyridin-2-yl)-etyl)-7V-metyl-aminometyl]-nitrobenzén, (73) 4-[A-(2-(pyridin-4-yl)-etyl)-jV-metyl-aminometyl]-nitrobenzén, (74) 4-[Aí-(pyridin-4-yl-metyl)-zV-metyl-aminometyl]-nitrobenzén, (75) 4-(A/,/V-dibenzyl-aminometyl)-nitrobenzén, (76) 4-[/V-(4-nitro-fenetyl)-A-propyl-aminometyl]-nitrobenzén, (77) 4-(V-benzyl-/V-(3-kyano-propyl)-aminometyl)-nitrobenzén, (78) 4-(N-benzyl-N-alyl-aminometyl)-nitrobenzén, (79) 4-[/V-benzyl-X-(2,2,2-trifluóretyl)-aminometyl]nitrobenzén, (80) 4-[/V-(2-benzo( 1,3)dioxol-5-yl-metyl)-/V-metyl-aminometyl]-nitrobenzén, (81) 4-(7-chlór-2,3,4,5-tetrahydro-benzo(d)azepin-3-yl-metyl)-nitrobenzén, (82) 4-(7,8-dichlór-2,3,4,5-tetrahydro-benzo (d) azepin-3-yl-metyl)-nitrobenzén, (83) 4-(7-metoxy-2,3,4,5-tetrahydro-benzo (d) azepin-3-yl-metyl)-nitrobenzén, (84) 4-(7-metyl-2,3,4,5-tetrahydro-benzo (d) azepin-3-yl-metyl)-nitrobenzén, (85) 4-(7,8-dimetoxy-2,3,4,5-tetrahydro-benzo (d) azepin-3-yl-metyl)-nitrobenzén, (86) 4-(6,7-dichlór-1,2,3,4-tetrahydro-izochinolin-2-yl-metyl)-nitrobenzén, (87) 4-(6,7-dimetyl-1,2,3,4-tetrahydro-izochinolín-2-yl-metyl)-nitrobenzén, (88) 4-(6-chlór-1,2,3,4-tetrahydro-izochinolin-2-yl-metyl)nitrobenzén, (89) 4-(7-chlór-1,2,3,4-tetrahydro-izochinolin-2-yl-metyl)nitrobenzén, (90) 4-(6-metoxy-l,2,3,4-tetrahydro-izochinolin-2-yl-metyl)nitrobenzén, (91) 4-(7-metoxy-l,2,3,4-tetrahydro-izochinolin-2-yl-metyl)nitrobenzén, (92) 4-[(2,3,4,5-tetrahydro-azepino(4,5-b)pyrazin-3-yl)metyl]-nitrobenzén, (93) 4-[(7-amino-2,3,4,5-tetrahydro-azepino(4,5-b)pyrazin-3yl)-metyl]-nitrobenzén, (94) 4-[(2-amino-5,6,7,8-tetrahydro-azepino(4,5-d) tiazol-6yl)-metyl]-nitrobenzén, (95) 4-[(5,6,7,8-tetrahydro-azepino(4,5-d) tiazol-6-yl)metyl]-nitrobenzén,(15) 4- (4-methyl-piperidin-1-yl-methyl) -nitrobenzene, (16) 4- (4-ethyl-piperidin-1-yl-methyl) -nitrobenzene, (17) 4- (4-isopropyl-piperidin-1-yl-methyl) -nitrobenzene, (18) 4- (4-phenyl-piperidin-1-yl-methyl) -nitrobenzene, (19) 4- (4-benzyl-piperidin-1) (20) 4- (4-ethoxycarbonyl-piperidin-1-ylmethyl) -nitrobenzene, (21) 4- (N, N-dipropyl-aminomethyl) -nitrobenzene, (22) 4- (4-tert-butoxycarbonyl-piperazin-1-yl-methyl) -nitrobenzene, (23) 4- (2-morpholin-4-yl-ethyl) -nitrobenzene, (24) 4- (2-pyrrolidin-1) (25) 4- (2-piperidin-1-yl-ethyl) -nitrobenzene, (26) 4- ( 1 -ethyl-N'-benzylaminomethyl) -nitrobenzene, (27) ) 4- (N-propyl-N-benzyl-aminomethyl) -nitrobenzene, (28) 4- [N-methyl-N- (4-chlorobenzyl) -aminomethyl] -nitrobenzene, (29) 4- [N-methyl] - N - (4-bromobenzyl) aminomethyl] -trobenzene, (30) 4- [N -methyl- N - (4-fluorobenzyl) -ammomethyl] nitrobenzene, (31) 4- [N 1 -methyl- N- (4-methylbenzyl) aminomethyl] -nitrobenzene (32) 4- [N-methyl-N-f - (3-chloro-benzyl) -amino nomethyl] -nitrobenzene, (33) 4- [N-methyl-N - (3,4-dimethoxybenzyl) -aminomethyl] -nitrobenzene, (34) 4- [N-methyl-N- (4-methoxybenzyl) aminomethyl] (35) 4- (N-2,2,2-trifluoroethyl-N'-benzylaminomethyl) nitrobenzene, (36) 4- [N-2,2,2-trifluoroethyl-N - (4)] - nitrobenzene; (chlorobenzyl) aminomethyl] nitrobenzene ; (37) 4- (thiomorpholin-4-yl-methyl) -nitrobenzene, (38) 4- (azetidin-1-yl-methyl) -nitrobenzene, (39) 4- (3,4-dihydropyrrolidin-1-yl- methyl) -nitrobenzene, (40) 4- (3,4-dihydropiperidin-1-ylmethyl) -nitrobenzene, (41) 4- (2-methoxycarbonyl-pyrrolidin-1-ylmethyl) -nitrobenzene, (42) 4- (3,5-dimethyl-piperidin-1-yl-methyl) -nitrobenzene, (43) 4- (4-phenyl-piperazin-1-yl-methyl) -nitrobenzene, (44) 4- (4-phenyl) -4-hydroxy-piperidin-1-yl-methyl) -nitrobenzene, (45) 4- [N - (3,4,5-trimethoxybenzyl) - N'-methyl-aminomethyl] nitrobenzene, (46) 4- [M (3) (47) 4- [N - ((2,6-dichlorobenzyl) -N'-methyl) aminomethyl] nitrobenzene, (48) 4- [4-dimethoxybenzyl] -N-ethyl-aminomethyl] -nitrobenzene, (48) 4- [N - (4-Trifluoromethylbenzyl) - N -methyl) aminomethyl] -nitrobenzene, (49) 4- (N -benzyl-N -isopropyl-aminomethyl) nitrobenzene, (50) 4- (N -benzyl- N-Zez-t-butyl-aminomethyl) -trobenzene, (51) 4- (N, N-diisopropyl-aminomethyl) -nitrobenzene, (5 2) 4- (ΛΛζ'-diisobutyl-aminomethyl) -nitrobenzene, ( 53) 4- (2,3,4,5-tetrahydro-benzo (d) azepin-3-ylmethyl) -nitrile robenzene, (54) 4- (2,3-dihydro-isoindol-2-ylmethyl) -nitrobenzene, (55) 4- (6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinolin-2) -yl-methyl) -nitrobenzene, (56) 4- (1,2,3,4-tetrahydro-isoquinolin-2-yl-methyl) nitrobenzene, (57) 4- [N- (2-hydroxyethyl) -A '] (58) 4- [N - (1-ethyl-pentyl) - N - (pyridin-2-ylmethyl) -aminomethyl] -nitrobenzene, (59) 4- (piperidin-1-yl) -benzyl-aminomethyl] -nitrobenzene; -yl-methyl) -1,3-dinitrobenzene, (60) 4- (N-phenethyl- N -methyl-aminomethyl) nitrobenzene, (61) 4- [N- (3,4-dihydroxy-phenethyl) - N-methyl-aminomethyl] -nitrobenzene, (62) 4- [N - (3,4,5-trimethoxyphenethyl) -7 H -methyl-aminomethyl] nitrobenzene, (63) 4- [N- (3,4) (64) 4- [N- (3,4-dimethoxy-benzyl) - N -methyl-aminomethyl] -nitrobenzene, (65) 4- [N-methoxy-renethyl] - N -methyl-aminomethyl] -nitrobenzene, (65) 4- N - (4-chloro-benzyl) - N -methyl-aminomethyl] -nitrobenzene, (66) 4- [N - (4-bromo-benzyl) - N -methyl-aminomethyl] -trobenzene, (67) 4- [N- (4-fluoro-benzyl) - N -methyl-aminomethyl] -nitrobenzene, (68) 4- [N- (4-methyl-benzyl) -7-methyl-aminomethyl] -nitrobenzene, ( 69) 4- [N - (4-nitro-phenethyl) - N -methyl-aminomethyl] -nitrobenzene, (70) 4- (N , -phenethyl- N -benzylaminomethyl) -nitrobenzene, (71) 4- ( N-phenethyl-N-cyclohexyl-aminomethyl) -nitrobenzene, (72) 4- [N - (2- (pyridin-2-yl) -ethyl) - N -methyl-aminomethyl] -nitrobenzene, (73) 4- [N- (2- (pyridin-4-yl) ethyl) -N-methyl-aminomethyl] -nitrobenzene (74) 4- [I - (pyridin-4-yl-methyl) -zV-methyl-aminomethyl ] nitrobenzene, (75) 4- (A /, / V-dibenzyl-aminomethyl) nitrobenzene, (76) 4 - [/ V- (4-nitro-phenethyl) -N-propyl-aminomethyl] -nitrobenzene, ( 77) 4- (N-benzyl- N - (3-cyano-propyl) -aminomethyl) -nitrobenzene, (78) 4- (N-benzyl-N-allyl-aminomethyl) -nitrobenzene, (79) 4- [ N-benzyl-N - (2,2,2-trifluoroethyl) aminomethyl] nitrobenzene, (80) 4 - [N - (2-benzo (1,3) dioxol-5-ylmethyl)] - N -methyl-aminomethyl] -nitrobenzene, (81) 4- (7-chloro-2,3,4,5-tetrahydro-benzo (d) azepin-3-ylmethyl) -nitrobenzene, (82) 4- (7) , 8-dichloro-2,3,4,5-tetrahydro-benzo (d) azepin-3-ylmethyl) -nitrobenzene, (83) 4- (7-methoxy-2,3,4,5-tetrahydro- benzo (d) azepin-3-ylmethyl) -nitrobenzene, (84 ) 4- (7-methyl-2,3,4,5-tetrahydro-benzo (d) azepin-3-ylmethyl) -nitrobenzene, (85) 4- (7,8-dimethoxy-2,3,4) , 5-tetrahydro-benzo (d) azepin-3-yl-methyl) -nitrobenzene, (86) 4- (6,7-dichloro-1,2,3,4-tetrahydro-isoquinolin-2-yl-methyl) -nitrobenzene, (87) 4- (6,7-dimethyl-1,2,3,4-tetrahydro-isoquinolin-2-ylmethyl) -nitrobenzene, (88) 4- (6-chloro-1,2, 3,4-tetrahydro-isoquinolin-2-ylmethyl) nitrobenzene, (89) 4- (7-chloro-1,2,3,4-tetrahydro-isoquinolin-2-ylmethyl) nitrobenzene, (90) 4 - (6-methoxy-1,2,3,4-tetrahydro-isoquinolin-2-ylmethyl) nitrobenzene, (91) 4- (7-methoxy-1,2,3,4-tetrahydro-isoquinolin-2-one); (92) 4 - [(2,3,4,5-tetrahydro-azepino (4,5-b) pyrazin-3-yl) methyl] nitrobenzene, (93) 4 - [(7-yl) methyl] nitrobenzene; -amino-2,3,4,5-tetrahydro-azepino (4,5-b) pyrazin-3-yl) -methyl] -nitrobenzene, (94) 4 - [(2-amino-5,6,7,8-) - tetrahydro-azepino (4,5-d) thiazol-6-yl) -methyl] -nitrobenzene, (95) 4 - [(5,6,7,8-tetrahydro-azepino (4,5-d) thiazol-6-yl)] ) -methyl] -nitrobenzene.

Príprava 15Preparation 15

4-(1,1 -Dioxo-tiomorfolin-4-yl-metyl)-nitrobenzén4- (1,1-Dioxo-thiomorpholin-4-yl-methyl) -nitrobenzene

V 100 ml metylénchloridu sa rozpustilo 6,0 g 4-(tiomorfolin-4-yl-metyl)-nitrobenzénu a do roztoku sa pomaly pridalo 10,3 g meta-chlórperbenzoovej. Po ďalších 3 hodinách miešania pri teplote miestnosti sa vylúčená zrazenina zachytila na filtri.6.0 g of 4- (thiomorpholin-4-ylmethyl) -nitrobenzene was dissolved in 100 ml of methylene chloride and 10.3 g of meta-chloroperbenzoic acid was slowly added to the solution. After stirring for another 3 hours at room temperature, the precipitate formed was collected on a filter.

Výťažok: 6,2 g (91 % teoretického výťažku),Yield: 6.2 g (91% of theory),

Rf-hodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 1 : 1), C11H14N2O4SRf value of product: 0.5 (silica gel, methylene chloride / methanol = 1: 1), C 11 H 14 N 2 O 4 S

Hmotnostné spektrum: m/z = 270 [M]+.Mass spectrum: m / z = 270 [M] &lt; + &gt;.

Podobne ako v príprave 15 sa pripravila nasledujúca zlúčenina:As in Preparation 15, the following compound was prepared:

(1)4-(1 -oxo-tiomorfolin-4-yl-metyl)-nitrobenzén.(1) 4- (1-Oxo-thiomorpholin-4-ylmethyl) -nitrobenzene.

Príprava 16 4-[Λ,-(3-Amino-propyl)-7Vmetylsulfonyl-aInino]-nitrobenzénPREPARATION 16 4- [Λ, - (3-Amino-propyl) -7V l · methylsulphonyl-amino] nitrobenzene

V 200 ml etanolu sa rozpustilo 9,5 g 4-[A'-(3-ftalimido-2-yl-propyl)-7V-metyl-sulfonyl-amino]-nitrobenzénu, pridalo sa 11,5 ml hydrazinhydrátu a reakčná zmes sa 1,5 hodiny miešala pri 50 °C. Po ochladení sa zvyšok ešte skoncentroval, pridala sa voda a roztok sa extrahoval metylénchloridom. Organická fáza sa sušila, skoncentrovala a čistila na stĺpci gélu kyseliny kremičitej (s použitím metylén-chloridu/metanolu/amoniaku = = 9 : 1 : 0,1 ako elučným činidlom).9.5 g of 4- [N '- (3-phthalimido-2-yl-propyl) -N-methylsulfonyl-amino] -nitrobenzene were dissolved in 200 ml of ethanol, 11.5 ml of hydrazine hydrate were added and the reaction mixture was The mixture was stirred at 50 ° C for 1.5 hours. After cooling, the residue was concentrated, water was added and the solution was extracted with methylene chloride. The organic phase was dried, concentrated and purified on a silica gel column (using methylene chloride / methanol / ammonia = 9: 1: 0.1 as eluent).

Výťažok: 2,5 g (39 % teoretického výťažku),Yield: 2.5 g (39% of theory),

Rf-hodnota produktu: 0,2 (gél kyseliny kremičitej, metylénchlorid/metanol = 9 : 1),Rf value of product: 0.2 (silica gel, methylene chloride / methanol = 9: 1),

C10H15N3O4SC 10 H 15 N 3 O 4 N

Hmotnostné spektrum: m/z = 272 [M-H]’.Mass Spectrum: m / z = 272 [M-H] '.

Podobne ako v príprave 16 sa pripravila zlúčenina:Similar to Preparation 16, a compound was prepared:

(1) 6-[A/-(2-dimetylaminoetyl)-7V-metylsulfonylamino]-3-amino-nitrobenzén, pripravila sa z 6-[7V-(2-dimetylamino-etyl)-/V-metylsulfonylamino]-3-ftalimido-2-yl-nitrobenzénu.(1) 6- [A / - (2-dimethylamino-ethyl) -7V-methylsulfonylamino] -3-amino-nitrobenzene is prepared from 6- [7V- (2-dimethylamino-ethyl) - / V-methylsulfonylamino] -3- phthalimido-2-yl-nitrobenzene.

Príprava 17Preparation 17

4-( 1 -Metyl-imidazol-2-yl)-nitrobenzén4- (1-Methyl-imidazol-2-yl) -nitrobenzene

V 50 ml dimetylsulfoxidu sa rozpustilo 7,5 g 4-(imidazol-2-yl)-nitrobenzénu a pri 0 °C sa pridalo 5,0 g íerc-butylátu draslíka. Po hodine miešania pri teplote miestnosti sa po kvapkách pridalo 2,6 ml metyljodidu a zmes sa hodinu miešala pri teplote miestnosti. Potom sa naliala do ľadovej vody a vytvorená zrazenina sa odsala, premyla vodou a vysušila.7.5 g of 4- (imidazol-2-yl) -nitrobenzene were dissolved in 50 ml of dimethylsulfoxide and 5.0 g of potassium tert-butylate were added at 0 ° C. After stirring at room temperature for one hour, 2.6 ml of methyl iodide was added dropwise and the mixture was stirred at room temperature for one hour. It was then poured into ice water and the precipitate formed was filtered off with suction, washed with water and dried.

Výťažok: 6,1 g (76 % teoretického výťažku), Rrhodnota produktu: 0,6 (gél kyseliny kremičitej, metylénchlorid/metanol = 10 : 1). Teplota topenia produktu bola 186 až 187 °C.Yield: 6.1 g (76% of theory), R f value of the product: 0.6 (silica gel, methylene chloride / methanol = 10: 1). Mp 186-187 ° C.

Podobne ako v príprave 17 sa pripravili nasledujúce zlúčeniny:As in Preparation 17, the following compounds were prepared:

(1) 4-(l-etyl-imidazol-2-yl)-nitrobenzén, pripravený reakciou z 4-(imidazol-2-yl)-nitro-benzénu a etyliodidu, (2) 4-(l-benzyl-imidazol-2-yl)-nitrobenzén, pripravený reakciou z 4-(imidazol-2-yl)-nitrobenzénu a benzylbromidu.(1) 4- (1-ethyl-imidazol-2-yl) -nitrobenzene, prepared by the reaction of 4- (imidazol-2-yl) -nitrobenzene and ethyliodide, (2) 4- (1-benzyl-imidazole- 2-yl) -nitrobenzene, prepared by reaction of 4- (imidazol-2-yl) -nitrobenzene and benzyl bromide.

Príprava 18 4-[(/V-(2-(2-Metoxy-etoxy)-etyl)-V-metyl-amino)-metyl]nitrobenzénPreparation 18 4 - [(N - (2- (2-Methoxy-ethoxy) -ethyl) - N -methyl-amino) -methyl] nitrobenzene

V 30 ml dimetylformamidu sa rozpustilo 5,0 g 4-metylaminometylnitro-benzénu a pridalo sa 4,6 g 2-(2-metoxy-etoxy)-etylchloridu. Po šiestich hodinách miešania pri 100 °C sa odstránilo rozpúšťadlo a zvyšok sa rozmiešal v etylesteri kyseliny octovej. Organická fáza sa premyla vodou a sušila nad bezvodým síranom sodným. Po odstránení rozpúšťadla sa zvyšok čistil na stĺpci s oxidom hlinitým (aktivita oxidu 2 až 3) s použitím toluénu a etylesteru kyseliny octovej (5:1) ako elučným činodlom.5.0 g of 4-methylaminomethylnitrobenzene were dissolved in 30 ml of dimethylformamide and 4.6 g of 2- (2-methoxyethoxy) ethyl chloride were added. After stirring at 100 ° C for six hours, the solvent was removed and the residue was triturated in ethyl acetate. The organic phase was washed with water and dried over anhydrous sodium sulfate. After removal of the solvent, the residue was purified on an alumina column (2-3 activity) using toluene and ethyl acetate (5: 1) as eluent.

Výťažok: 2,3 g (29 % teoretického výťažku), Rrhodnota produktu: 0,5 (oxid hlinitý, toluén/etylester kyseliny octovej = 5:1), C13H20N2O4Yield: 2.3 g (29% of theory), R f value of the product: 0.5 (aluminum oxide, toluene / ethyl acetate = 5: 1) C13H20N2O4

ESI-Hmotnostné spektrum: m/z = 267 [M-H]'.ESI-MS: m / z = 267 [M-H] -.

Príprava 19 4-(A'-Etyl-A-íerc-butoxykarbonyl-aminometyl)-nitrobenzénPreparation 19 4- (N'-Ethyl-N-tert-butoxycarbonyl-aminomethyl) -nitrobenzene

V 50 ml etylesteru kyseliny octovej sa rozpustilo 2,2 g 4-(etylaminometyl)-nitrobenzénu, pridalo sa 2,6 g di-terc-butyl-dikarbonátu (íerc-butoxykarbonyl-anhydridu), zmes sa 30 minút miešala pri teplote miestnosti. Potom sa roztok premyl vodou a skoncentroval.2.2 g of 4- (ethylaminomethyl) nitrobenzene were dissolved in 50 ml of ethyl acetate, 2.6 g of di-tert-butyl dicarbonate (tert-butoxycarbonyl anhydride) were added, and the mixture was stirred at room temperature for 30 minutes. Then the solution was washed with water and concentrated.

Výťažok: 3,4 g,Yield: 3.4 g,

Rrhodnota produktu: 0,3 (gél kyseliny kremičitej, metylénchlorid/metanol = 50 : 1), teplota topenia produktu bola 85 °C. R f value of the product: 0.3 (silica gel, methylene chloride / methanol = 50: 1), melting point: 85 ° C.

Podobne ako v príprave 19 sa pripravili nasledujúce zlúčeniny:As in Preparation 19, the following compounds were prepared:

(1) 4- [V-(4-chlórfenyl-mety l)-/V-terc-butoxykarbony 1-aminometyl] -nitrobenzén, (2) 4-0V-/'erc-butoxykarbonyl-aminometyl)-nitrobenzén, (3) 4-(/V-cyklohexyl-<V-íerc-butoxykarbonyl-aminometyl)-nitrobenzén, (4) 4-(Aľ-izopropyl-7V-/erc-butoxykarbonyl-aminometyl)-nitrobenzén, (5) 4-(7V-metyl-/V-/erc-butoxykarbonyl-aminometyl)-nitrobenzén, (6) 4-(JV-propyl-/V-terc-butoxykarbonyl-aminometyl)-nitrobenzén, (7) 4-(V-butyl-A'-terc-butoxykarbonyl-aminometyl)-nitrobenzén, (8) 4-(jV-metoxykarbonyl-metyl-A,-/erc-butoxykarbonyl-aminometyl)-nitrobenzén, (9) 4-(7V-benzyl-7V-terc-butoxykarbonyl-aminometyl)-nitrobenzén, (10) 4-[N-(3-trifluóracetylaminopropyl)-/V-metylsulfonylamino]nitrobenzén, pripravený reakciou z 4-[/V-(3-amino-propyl)-jV-metylsulfonyl-amino]-nitrobenzénu a anhydridu kyseliny trifluóroctovej, (11) 4-[(4-íerc-butoxykarbonyl-piperazin-1 -yl)-metyl] -nitrobenzén.(1) 4- [N- (4-chlorophenylmethyl) -N-tert-butoxycarbonyl-aminomethyl] nitrobenzene, (2) 4-N-tert-butoxycarbonyl aminomethyl) nitrobenzene, (3) ) 4 - (/ V-cyclohexyl- <W-tert-butoxycarbonyl-aminomethyl) nitrobenzene, (4) 4- (N-isopropyl-7V- I '/ t-butoxycarbonyl-aminomethyl) nitrobenzene, (5) -4- ( N-methyl- N - tert -butoxycarbonyl-aminomethyl) -nitrobenzene, (6) 4- (N -propyl- N - tert -butoxycarbonyl-aminomethyl) -nitrobenzene, (7) 4- (N -butyl-A) "tert-butoxycarbonyl-aminomethyl) nitrobenzene, (8) 4- (N-methoxycarbonylmethyl-A - / t-butoxycarbonyl-aminomethyl) nitrobenzene, (9) 4- (7V-benzyl-7V-tert butoxycarbonyl-aminomethyl) nitrobenzene, (10) 4- [N- (3-trifluoroacetylaminopropyl) - N -methylsulfonylamino] nitrobenzene, prepared by the reaction of 4- [N - (3-amino-propyl) - N -methylsulfonyl-amino] (11) 4 - [(4-tert-butoxycarbonyl-piperazin-1-yl) -methyl] -nitrobenzene] -nitrobenzene and trifluoroacetic anhydride.

Príprava 20Preparation 20

4-(Piperidin-1 -yl-metyl)-anilín4- (Piperidin-1-yl-methyl) -aniline

V 300 ml metanolu sa rozpustilo 37,0 g 4-(piperidin-l-yl-metyl)-nitrobenzénu, pridalo sa 8,0 g Raneyovho niklu. Násada sa 85 minút hydrogenovala pod tlakom približne 0,3 MPa (3 bary) vodíka pri teplote miestnosti. Katalyzátor sa potom odfiltroval a filtrát sa odparil.37.0 g of 4- (piperidin-1-ylmethyl) -nitrobenzene was dissolved in 300 ml of methanol, 8.0 g of Raney nickel were added. The batch was hydrogenated under a pressure of about 3 bar of hydrogen at room temperature for 85 minutes. The catalyst was then filtered off and the filtrate was evaporated.

Výťažok: 24,0 g (75 % teoretického výťažku), Rrhodnota produktu: 0,4 (gél kyseliny kremičitej; metylénchlorid/metanol = 9 : 1), C12H18N2 Yield: 24.0 g (75% of theory), Product value: 0.4 (silica gel; methylene chloride / methanol = 9: 1), C 12 H 18 N 2

ESI-Hmotnostné spektrum: m/z =191 [M+H]+.ESI-MS: m / z = 191 [M + H] &lt; + &gt;.

Podobne ako v príprave 20 sa pripravili nasledujúce zlúčeniny:Similar to Preparation 20, the following compounds were prepared:

(1) 4-[(2,6-dimetyl-piperidin-1 -yl)-metyl]-anilín, (2) N-(2-dimetylamino-etyl)-V-metylsulfonyl-p-fenyléndiamín, (3) 3-(dimetylaminometyl)-anilín, (4) 4-(dimetylaminometyl)-anilín, (5) 4-(2-dimetylamino-etyl)-anilín, (6) 4-[7V-(2-dimetylamino-etyl)-7V-acetyl-amino]-anilín, (7) 4-[V-(3-dimetylamino-propyl)-jV-acetyl-amino]-anilín, (8) 4-[V-(2-dimetylamino-etyl)-7V-benzoyl-ainino]-anilín, (9) 4-[7V-(2-dimetylamino-etyl)-jV-propionyl-amino]-anilín, (10) 4-[V-(2-dimetylamino-etyl)-Af-butyryl-amino]-anilín, (11) 4-[TV-(2-dimetylamino-etyl)-7V-izobutyryl-amino]-anilín, (12) 4-(7V-terc-butoxykarbonyl-aminometyl)-anilín, (13) 4-(V-etyl-V-terc-butoxykarbonyl-aminometyl)-anilín, (14) 4-[ň/-(4-chlórfenyl-metyl)-/V-jerč-butoxykarbonylaminometyl]-anilín, (15) 4-(N-cyklohexyl-N-íerc-butoxykarbonyl-aminometyl)-anilín, (16) 4-(/V-izopropyl-JV-ŕerc-butoxykarbony]-aminometyl)-anilín, (17) 4-(7V-propyl-jV-terc-butoxykarbonyl-aminome tyl)-anil í n, (18) 4-(N-metyWV-íerc-butoxykarbonyl-aminometyl)-anilín, (19) 4-(/V-butyl-W-íďrc-butoxykarbonyl-aminometyl)-anilin, (20) 4-(jV-metoxykarbonyl-metyl-jV-ŕerc-butoxykarbonylaminometyl)-anilín, (21) 4-(/V-benzyl-Af-ŕerc-butoxykarbony 1-aminometyl)-anilín, (22) 4-(pyrolidin-1 -yl-metyl)-anilín, (23) 4-(morfolin-4-yl-metyl)-anilín, (24) 4-(hexametyléniminometyl)-anilín, (25) 4-(4-hydroxy-piperidin-1 -yl-metyl)-anilín, (26) 4-(4-metoxy-piperidin-1 -yl-metyl)-anilín, (27) 4-(4-metyl-piperidin-1 -yl-metyl)-anilín, (28) 4-(4-etyl-piperidin-1 -yl-metyl)-anilín, (29) 4-(4-izopropyl-piperidin-1 -yl-metyl)-anilín, (30) 4-(4-fenyl-piperidin-l-yl-metyl) -anilín, (31) 4-(4-benzyl-piperidin-1 -yl-metyl)-anilín, (32) 4-(4-etoxykarbonyl-piperidm-l-yl-metyl)-anilín, (33) 4-(/V,A-dipropyl-aminometyl)-anilin, (34) 4-(4-Zerc-butoxykarbonyl-piperazin-1 -yl-metyl)-anilín, (35) 4-(2-morfolin-4-yl-etyl)-anilín, (36) 4-(2-pyrolidin-1 -yl-etyl)-anilín, (37) 4-(2-piperidin-1 -yl-etyl)-anilín, (38) 4-(7V-propyl-A'-benzyl-aminometyl)-anilín, (39) 4-(jV-(n-Hexyl)-/V-metyl-aminometyl]-anilín, (40) 4-[7V-metyl-A/-(4-chlórbenzyl)-aminometyl]-anilín, (41) 4-(W-metyl-/V-(4-brómbenzyI)-aminometyl]-anilín, (42) 4-[Aí-metyl-/V-(4-metylbenzyl)-aminometyl]-anilín, (43) 4-[W-metyl-A/-(4-fluórbenzyl)-aminometyl]-anilín, (44) 4- [7V-metyl-jV-(3 -chlórbenzyl)-aminometyl] -anilín, (45) 4-[<V-metyl-/V-(3,4-dimetoxybenzyl)-aminometyl]-anilín, (46) 4-|7V-metyl-A/-(4-metoxybenzyl)-aminometyl]-amlín, (47) 4-(/V-2,2,2-trifluóretyl-/V-benzyl-aminometyl)-anilín, (48) 4-[7V-2,2,2-trifluóretyl-7V-(4-chlórbenzyl)-aminometyl]-anilín, (49) 4-(tiomorfolin-4-yl-metyl)-anilín, (5 0) 4-( 1 -oxo-tiomorfolin-4-yl-metyl)-anilín, (51) 4-( 1,1 -dioxo-tiomorfolin-4-yl-metyl)-anilín, (52) 4-(azetidión-1 -yl-metyl)-anilín, (53) 4-(3,4-dihydropyrolidin-1 -yl-metyl)-anilín, (54) 4-(3,4-dihydropiperidin-l-yl-metyl)-anilín, (55) 4-(2-metoxykarbonyl-pyrolidin-l -yl]-metyl)-anilín, (56) 4-(3, 5-dimetyl-piperidin-l-yl-metyl)-anilín, (57) 4-(4-fenyl-piperazin-1 -yl-metyl)-anilín, (5 8) 4-(4-fenyl-4-hydroxy-piperidm-1 -yl-metyl)-anilín, (59) 4-[jV-(3,4,5-trimetoxy-benzyl)-jV-metyl-aminometyl]anilín, (60) 4-[7V_(3,4-dimetoxy-benzyl)-jV-etyl-aminometyl]-anilm, (61) 4-(/v-benzyl-7v'-etyl-aminometyl)-amlín, (62) 4-[7V-(2,6-dichlórbenzyl)-/V-metyl-aminometyl]-anilín, (63) 4-[W-(4-trifluórmetylbenzyl)-7V-metyl-aminometyl]-anilín, (64) 4-(/V-benzyl-/V-izopropyl-aminometyl)-anilín, (65) 4-(7V-benzyl-Aľ-Zerc-butyl-aminometyl)-anilín, (66) 4-(dietylamino-metyl)-anilín, (67) 4-(2-dietylamino-etyl)-anilín, (68) 4-(/V,/V-diizopropyl-aminometyl)-anilm, (69) 4-(7V,7V-diizobutyl-aminometyl)-anilín, (70) 4-(2,3,4,5-tetrahydro-benzo (d) azepin-3-yl-metyl)-anilín, (71) 4-(2,3-dihydro-izoindol-2-yl-metyl)-anilín, (72) 4-(6,7-dimetoxy-l,2,3,4-tetrahydro-izochinolin-2-yl-metyl)-anilín, (73) 4-(1,2,3,4-tetrahydro-izochinolin-2-yl-metyl)-anilín, (74) 4-[7V-(2-hydroxy-etyl)-/V-benzyl-aminometyl]-anilín, (75) 4-[W-( 1 -etyl-pentyl)-N-(pyridín-2-yl-metyl)-aminometyl]-anilín, (76) 4-(piperidin-l-yl-metyl)-3-nitro-anilín, (77) 4-(piperidin-l-yl-metyl)-3-amino-anilín, (78) 4-(/V-benzyl-/V-metyl-aminometyl)-anilín, (79) 4-(ŤV-etyl-Af-metyl-aminometyl)-anilín, (80) 4-(jV-fenetyl-7V-metyl-ammometyl)-anilín, (81) 4-[íV-(3,4-dihydroxy-fenetyl)-N-metyl-aminometyl]-amlín, (82) 4-[<V-(3,4,5-trimetoxy-fenetyl)-<V-metyl-aminometyl]-anilín, (83) 4-[7V-(3,4-dimetoxy-fenetyl)-Aľ-metyl-aminometyl]-anilín, (84) 4-[7V-(3,4-dimetoxy-benzyl)-7V-metyl-aminometyl]-anilín, (85) 4-[7V-(4-chlór-benzyl)-7V-metyl-aminometyl]-anilín, (86) 4-[7/-(4-bróm-benzyl)-7V-metyl-aminometyl]-anilín, (87) 4-[/V-(4-fluór-benzyl)-ľV-metyl-ammometyl]-anilín, (88) 4- [/V-(4-metyl-benzyl)-/V-mety 1-ammometyl] -anilín, (89) 4-[7V-(4-nitro-fenetyl)-N-metyl-aminometyl]-anilín, (90) 4-(7V-fenetyl-7V-benzyl-aminometyl)-anilín, (91) 4-(N-fenetyl-7V-cyklohexyl-aminometyl)-anilín, (92) 4-|7V-(2-(pyridin-2-yl)-etyl)-/V-metyl-aminometyl]-anilín, (93) 4-[/V-(2-(pyridin-4-yl)-etyl)-A'-metyl-aminometyl]-amlm, (94) 4-[/V-(pyridin-4-yl-metyl)-/V-metyl-aminometyl]-anilín, (95) 4-(7V,7V-dibenzylaminometyl)-anilín, (96) 4-[Aľ-(4-nitro-benzyl)-?/-propyl-aminometyl]-anilín, (97) 4-[7V-benzyl-jV-(3-kyano-propyl)-aminometyll-anilín, (98) 4-(/V-benzyl-/V-alyl-aminometyl)-anilín, (99) 4-[7V-benzyl-jV-(2,2,2-trifluóretyl)-aminometyl]-anilín, (100) 4-[(benzo(l,3)dioxol-5-yl-metyl)-metyl-aminometyl]-anilín, (101) 4-(7-chlór-2,3,4,5-tetrahydro-benzo (d) azepin-3-yl-metyl)-anilín, (102) 4-(7,8-dichlór-2,3,4,5-tetrahydro-benzo(d)azepin-3-yl-metyl)-anilín, (103) 4-(7-metoxy-2,3,4,5-tetrahydro-benzo(d)azepin-3-yl-metyl)-anilín, (104) 4-(7-metyl-2,3,4,5-tetrahydro-benzo(d)azepin-3-yl-metyl)-anilín, (105) 4-(7,8-dimetoxy-2,3,4,5-tetrahydro-benzo(d)azepm-3-yl-metyl)-anilín, (106) 4-(6,7-dichlór-l,2,3,4-tetrahydro-izochinolin-2-yl-metyl)-amlín, (107) 4-(6,7-dimetyl-1, 2,3,4-tetrahydro-izochinolin-2-yl-metyl)-anilín, (108) 4-(6-chlór-1,2,3,4-tetrahydro-izochinolin-2-yl-metyl)-anilín, (109) 4-(7-chlór-l,2,3,4-tetrahydro-izochinolin-2-yl-metyl)-anilín, (110) 4-(6-metoxy-1,2,3,4-tetrahydro-izochinolin-2-yl-metyl)-anilín, (111) 4-(7-metoxy-l,2,3,4-tetrahydro-izochinolin-2-yl-metyl)-anilín, (112) 4-(2,3,4,5-tetrahydro-azepino(4,5-b)pyrazm-3-yl-metyl)-anilín, (113) 4-(7-amino-2,3,4,5-tetrahydro-azepino(4,5-b)pyrazin-3-yl-metyl)-anilín, (114) 4-(2-amino-5,6,7,8-tetrahydro-azepino(4,5-d)tiazol-6-yl-metyl)-anilín, (115) 4-(5,6,7,8-tetrahydro-azepino(4,5-d)tiazol-6-yl-metyl)-anilín, (116) 4-(4-metyl-piperazin-l-yl)-anilín, (117) 4-[7V-(2-dimetylamino-etyl)-/V-metyl-amino]-anilín, (118) 4-[//-(3-dimetylamino-propyl)-/V-metyl-amino]-anilín, (119) N-(3-dimetylamino-propyl)-/V-metylsulfonyl-p-fenyléndiamín, (120) 4-[(A'-dimetylaminokarbonyI-metyl-iV-metylsulfonyl)-amino]-amlín, (121) N-(4-aminofenyl)-jV-metyl-metánsulfonamid, (122) 4-(imidazol-4-yl)-anilín, (123) 4-(tetrazol-5-yl)-anilín, (124) 4-[jV-(2-dimetylamino-etyl)-7V-propionyl-amino]-amlm, (125) <V-(dimetylaminometylkarbonyl)-/v'-metyl-p-fenyléndiamín, (126) 7V-[(2-dimetylamino-etyl)-karbonyl]-7V-metyl-p-fenyléndiamín, (127) 4-(7V-acetyl-7V-(dimetylaminokarbonyl-metyl)-amino)-anilín, (128) N-metylaminokarbonyl-metyl-N-metylsulfonyl-p-fenyléndiamín, (129) TV-aminokarbonyl-metyl-N-metylsulfonyl-p-fenyléndiamín, (130) 4-(imidazolidin-2,4-dión-5-ylidén-metyl)-anilín, (131) 4-(irmdazolidín-2,4-dión-5-yl-metyl)-anilín, (132) 4-(2-oxo-pyrolidin-1 -yl-metyl)-anilín, (133) N-kyanometyl-JV-metylsulfonyl-p-fenyléndiamín, (134) 4-[2-(imidazol-4-yl)-etyl]-anilín, (135) 4-[ (4-metyl-piperazin-l-yl)-metyl]-anilín, (136) 4-[7V-(2-(7V-benzyl-7V-metyl-amino)-etyl)-7V-metylsulfonyl-amino]-anilín, (137) 4-[A/-(3-(//-benzyl-/V-metyl-amino)-propyl)-<V-metylsulfonyl-amino]-anilín, (138) TV-cyklohexyl-p-fenyléndiamín, (139) 4-(pyridin-4-yl-metyl)-anilín, (140) 4-(imidazol-1 -yl-metyl)-anilín, (141) 4-benzyl-anilín, (142) jV-(3-trifluóracetylamino-propyl)-7V-metylsulfonyl-p-fenyléndiamín, (143) terc-butylester kyseliny 4-amino-fenyloctovej, (144) 4-(imidazol-2-yl)-anilín, (145) 4-( 1 -metyl-imidazol-2-yl)-anilín, (146) 4-( 1 -etyl-imidazol-2-yl)-anilín, (147) 4-(1 -benzyl-imidazol-2-yl)-anilin, (148) 4- [N-(2-dimetylamino-etyl)-,V-rnetylsul fonyl-arninol-3 -amino-anilín, (149) 4-[A'-(2-dimetylamino-etyl)-,V-metylsu1fonyl-amino]-3-chlór-anilín, (150) 4-[7V-(2-dimetylamino-etyl)-.V-acetyl-amino]-3-amino-anilm, (151) 4-[7V-(2-dimetylamino-etyl)-A/-acetyl-amino]-3 -bróm-anilín, (152) 4-[2-(4-hydroxy-piperidin-1 -yl)-etyl-amino]-anilín, (153) jV-(2-dimetylamino-etyl)-7V-etylsulfonyl-p- fenyléndiamín, (154) 7V-(2-dimetylamino-etyl)-V-propylsulfonyl-p-fenyléndiamín, (155) 7V-(2-dimetylamino-etyl)-JV-izopiOpylsulfonyl-p-fenyléndiamín, (156) A'-(2-dimetylamino-etyl)-/V-butylsulfonyl-p-fenyléndiamín, (157) A/-(2-dimetylamino-etyl)-/V-benzylsulfonyl-p-fenyléndiamín, (158) 7V-(2-dimetylamino-etyl)-/V-fenylsulfonyl-p-fenyléndiamín, (159) 4-((3-hydroxy-pyrolidín-l-yl)-metyl)-anilín, (160) 4-[7V-(2-dimetylamino-etyl)-.ŕV-(furán-2-karbonyl)-amino]-anilín, (161) 4-|W-(2-dimetylamino-etyl)-/V-(2-metoxy-benzoy1)-amino]-anilín, (162) 4-[N-(2-dimetylamino-etyl)-7V-(pyridín-3-karbonyl)-amino]-anilm, (163) 4-[ľV-(2-dimetylamino-etyl)-7V-(fenyl-acetyl)-amino]-anilín, (164) A/-(piperidin-l-yl-metylkarbonyl)-N-metyl-p-fenyléndiamín, (165) jV-(morfolin-4-yl-metylkarbonyl)-jV-metyl-p-fenyléndiamín, (166) 7V-[(4-benzyl-piperazin-1 -yl)-metylkarbonyl]-7V-metyl-p-fenyléndiamín, (167) jV-(pyrolidin-1 -yl-metylkarbonyl)-7V-metyl-p-fenyléndiamín, (168) 4-(5-metyl-imidazol-4-yl)-anilín, (169) 7V-[(2-dimetylamino-etyl)-karbonyl]-jV-izopropyl-p-fenyléndiamín, (170) A'-[(2-dimetylamino-etyl)-karbonyl]-/V-benzyl-p-fenyléndiamín, (171) jV-(íV-aminokarbonyl-metyl-A,-metylamino)metylkarbonyl)-iV-metyl-p-fenyléndiamín, (172) Af-[(A'-benzyl-/V-metyl-amino)-metylkarbonyl]-A'-metyl-p-fenyléndiamín, (173) A/-[di-(2-metoxyetyl)-amino-metylkarbonyl)-A'-metyl-p-fenyléndiamín, (174) N-[(2-(4-íerc-butoxykarbonyl-piperazin-l-yl)etyl)karbonyl]-7V-metyl-p-fenyléndiamin, (175) /V-[2-(piperidin-1 -yl)-etyl)-karbonyl]-jV-metyl-p-fenyléndiamín, (176) A'-[(2-(JV-benzyl-/V-metyl-amino)-ety])-karbonyl]-Aí-metyl-/)-fenyléndiamín, (177) ;V-(dimetylaminometylkarbonyl)-/V-izopropyl-p-fenyléndiamm, (178) jV-(piperidin-1 -yl-metylkarbony 1)-Λ- izopropyl-p-fenyléndiamín, (179) N-[(4-Zerc-butoxykarbonyl-piperazin-1 -yl)metylkarbonyl]-Mizopropyl-/)-fenyléndiamín, (180) 7V-[(jV-benzyl-jV-metyl-amino)-metylkarbonyl]-7V-benzyl-p-fenyléndiamín, (181) A'-(dimetylaminometylkarbonyl)-//-benzyl-p-fenyléndiamín, (182) ŤV-(piperidin-1 -yl-metylkarbonyl)-7V-benzyl-p-fenyléndiamín, (183) 4-(1,2,4-triazol-1 -yl-metyl-anilín, (184) 4-( 1,2,3-triazol-2-yl-metyl)-anilín, (185) 4-(1,2,3-triazol-1 -yl-metyl)-anilín, (186) 4-[(N-etoxykarbonyl-metyl-7V-metyl-amino)-metyl]anilín, (187) 4-[(<V-aminokarbonyl-metyl-;V-metyl-amino)-metyl]-anilín, (188) 4-(azetidin- l-yl-metyl)-anilín, (189) 4-[(di-(2-metoxy-etyl)-amino)-metyl]-anilín, (190) 4-[(7V-(2-(2-metoxy-etoxy)-etyl)-7V-metyl-amino)-metyl]-anilín, (191) 4- [jV-(/V-íerc-butoxykarbonyl-3 -amino-propyl)-/V-metylaminometyl]-anilín, (192) 4-[(N-(metylkarbamoyl-metyl)-Aľ-metyl-amino)-metyl]-anilín, (193) 4-[(7V-(dimetylkarbamoyl-metyl)-A/-metyl-amino)-metyl]-anilín,(1) 4 - [(2,6-dimethyl-piperidin-1-yl) -methyl] -aniline, (2) N- (2-dimethylamino-ethyl) - N -methylsulfonyl-p-phenylenediamine, (3) 3 - (dimethylaminomethyl) -aniline, (4) 4- (dimethylaminomethyl) -aniline, (5) 4- (2-dimethylamino-ethyl) -aniline, (6) 4- [N - (2-dimethylamino-ethyl) -7V (7) 4- [N- (3-dimethylamino-propyl) -N-acetyl-amino] -aniline, (8) 4- [N- (2-dimethylamino-ethyl) -7H-acetyl-amino] -aniline; (9) 4- [N - (2-dimethylamino-ethyl) - N -propionyl-amino] -aniline, (10) 4- [N - (2-dimethylamino-ethyl) -A] -benzoyl-ainino] -aniline; f butyryl-amino] -aniline (11) 4- [TV- (2-dimethylamino-ethyl) -7V-isobutyryl-amino] -aniline (12) 4- (7V-tert-butoxycarbonyl-aminomethyl) -aniline (13) 4- (N-ethyl-N-tert-butoxycarbonyl-aminomethyl) -aniline, (14) 4- [N - (4-chlorophenylmethyl) - N -tert-butoxycarbonylaminomethyl] -aniline, ( 15) 4- (N-cyclohexyl-N-tert-butoxycarbonyl-aminomethyl) aniline, (16) 4 - (/ V-isopropyl-J-tert-butoxycarbonyl] aminomethyl) aniline, (17) 4- ( N-propyl-N-tert-butoxycarbonyl-aminomethyl) -aniline, (18) 4- (N-methyl-N-tert-butoxy) (19) 4- (N-butyl-N-tert-butoxycarbonyl-aminomethyl) -aniline, (20) 4- (N-methoxycarbonylmethyl-N-tert-butoxycarbonylaminomethyl) -aniline, (21) 4 - (/ V-benzyl-N-tert-butoxycarbonyl-f 1-aminomethyl) -aniline (22) 4- (pyrrolidin-1-yl-methyl) -aniline (23) 4- (morpholin-4 (25) 4- (4-hydroxy-piperidin-1-ylmethyl) -aniline, (26) 4- (4-methoxy-4-methoxy-piperidin-1-ylmethyl) -aniline; piperidin-1-yl-methyl) -aniline, (27) 4- (4-methyl-piperidin-1-yl-methyl) -aniline, (28) 4- (4-ethyl-piperidin-1-yl-methyl) -aniline, (29) 4- (4-isopropyl-piperidin-1-yl-methyl) -aniline, (30) 4- (4-phenyl-piperidin-1-yl-methyl) -aniline, (31) 4- (4-benzyl-piperidin-1-yl-methyl) -aniline, (32) 4- (4-ethoxycarbonyl-piperidin-1-ylmethyl) -aniline, (33) 4- (N, N-dipropyl- aminomethyl) -aniline, (34) 4- (4-tert-butoxycarbonyl-piperazin-1-ylmethyl) -aniline, (35) 4- (2-morpholin-4-yl-ethyl) -aniline, (36) 4- (2-pyrrolidin-1-yl-ethyl) -aniline, (37) 4- (2-piperidin-1-yl-ethyl) -aniline, (38) 4- (N-propyl-N'-benzyl) aminomethyl) aniline, (39) 4- (N- (n-hexyl) - / V-methyl-aminomethyl] -aniline (40) 4- [7V-methyl-A / - (4-chlorobenzyl) aminomethyl ] -aniline (41) 4- (N-methyl- / V- (4-bromobenzyl) aminomethyl] -aniline (42) 4- [N-methyl d / N- (4-methylbenzyl) aminomethyl] aniline, (43) 4- [N-methyl-A / - (4-fluorobenzyl) aminomethyl] -aniline (44) 4- [7V-methyl-N- (3-chlorobenzyl) aminomethyl] aniline, (45) 4 - [<V-methyl- / V- (3,4-dimethoxybenzyl) aminomethyl] -aniline (46) 4- | 7V-methyl-A / - (4-methoxybenzyl) aminomethyl] -amlín (47) 4- (N-2,2,2-trifluoroethyl- N -benzyl-aminomethyl) -aniline, (48) 4- [N-2,2,2-trifluoroethyl-N - (4-chlorobenzyl) (aminomethyl) -aniline, (49) 4- (thiomorpholin-4-yl-methyl) -aniline, (50) 4- (1-oxo-thiomorpholin-4-ylmethyl) -aniline, (51) 4 - (1,1-dioxo-thiomorpholin-4-yl-methyl) -aniline, (52) 4- (azetidin-1-yl-methyl) -aniline, (53) 4- (3,4-dihydropyrrolidin-1 -) - (54) 4- (3,4-dihydropiperidin-1-ylmethyl) -aniline, (55) 4- (2-methoxycarbonyl-pyrrolidin-1-yl] -methyl) -aniline, (56) 4- (3,5-dimethyl-piperidine-1) -yl-methyl) -aniline, (57) 4- (4-phenyl-piperazin-1-yl-methyl) -aniline, (58) 4- (4-phenyl-4-hydroxy-piperidin-1-yl- (59) 4- [N - (3,4,5-trimethoxy-benzyl) - N -methyl-aminomethyl] aniline, (60) 4- [N - (3,4-dimethoxy-benzyl) - N-Ethyl-aminomethyl] -aniline, (61) 4- (N-benzyl-7'-ethyl-aminomethyl) -amine, (62) 4- [N-(2,6-dichlorobenzyl) - N -methyl (63) 4- [N - (4-trifluoromethylbenzyl) - N -methyl-aminomethyl] -aniline, (64) 4- (N -benzyl- N -isopropyl-aminomethyl) -aniline, (65) 4- (N -benzyl-N ' - tert -butyl-aminomethyl) -aniline, (66) 4- (diethylamino-methyl) -aniline, (67) 4- (2-diethylamino-ethyl) -aniline, (68) 4- (N, N -diisopropyl-aminomethyl) -aniline, (69) 4- (N, N -diisobutyl-aminomethyl) -aniline, (70) 4- (2,3,4,5- tetrahydro-benzo (d) azepin-3-yl-methyl) -aniline, (71) 4- (2,3-dihydro-isoindol-2-ylmethyl) -aniline, (72) 4- (6,7- dimethoxy-1,2,3,4-tetrahydro-isoquinolin-2-yl-methyl) -aniline, (73) 4- (1,2,3,4-tetrahydro-isoquinolin-2-yl-methyl) -aniline, (74) 4- [N - (2-hydroxy-ethyl) - N -benzyl-aminomethyl] -anil n, (75) 4- [N- (1-ethyl-pentyl) -N- (pyridin-2-yl-methyl) -aminomethyl] -aniline, (76) 4- (piperidin-1-yl-methyl) - 3-nitro-aniline, (77) 4- (piperidin-1-yl-methyl) -3-amino-aniline, (78) 4- (N-benzyl- N -methyl-aminomethyl) -aniline, (79) ) -4- (TV-ethyl-f-methyl-aminomethyl) -aniline (80) 4- (N-phenethyl-7V-methyl-aminomethyl) -aniline (81) 4- [N- (3,4- dihydroxy-phenethyl) -N-methyl-aminomethyl] -amine, (82) 4- [N - (3,4,5-trimethoxy-phenethyl) - N -methyl-aminomethyl] -aniline, (83) 4- [N - (3,4-dimethoxy-phenethyl) - N 1 -methyl-aminomethyl] -aniline, (84) 4- [N - (3,4-dimethoxy-benzyl) - N -methyl-aminomethyl] -aniline, (85) 4- [N - (4-chloro-benzyl) - N -methyl-aminomethyl] -aniline, (86) 4- [N - (4-bromo-benzyl) -7-methyl-aminomethyl] -aniline (87) 4- [N - (4-fluoro-benzyl) - N -methyl-aminomethyl] -aniline, (88) 4- [N - (4-methyl-benzyl) - N -methyl- (89) 4- [N-(4-nitro-phenethyl) -N-methyl-aminomethyl] -aniline, (90) 4- (N-phenethyl-N-benzylaminomethyl) -aniline, ( 91) 4- (N-phenethyl-N-cyclohexyl-aminomethyl) -aniline, (92) 4- N - (2- (pyridin-2-y) (1) -ethyl) - N -methyl-aminomethyl] -aniline, (93) 4- [N - (2- (pyridin-4-yl) -ethyl) - N -methyl-aminomethyl] -amino, ( 94) 4- [N - (pyridin-4-ylmethyl) - N -methyl-aminomethyl] -aniline, (95) 4- (N, N-dibenzylaminomethyl) -aniline, (96) 4- [A 1 ' - (4-nitro-benzyl) - N -propyl-aminomethyl] -aniline, (97) 4- [N -benzyl-N- (3-cyano-propyl) -aminomethyl] -aniline, (98) 4- ( N-benzyl- N -allyl-aminomethyl) -aniline, (99) 4- [N -benzyl-N- (2,2,2-trifluoroethyl) -aminomethyl] -aniline, (100) 4 - [(benzo) (1,3) dioxol-5-yl-methyl) -methyl-aminomethyl] -aniline, (101) 4- (7-chloro-2,3,4,5-tetrahydro-benzo (d) azepin-3-yl) (102) 4- (7,8-dichloro-2,3,4,5-tetrahydro-benzo (d) azepin-3-ylmethyl) -aniline, (103) 4- (7-methyl) -aniline; -methoxy-2,3,4,5-tetrahydro-benzo (d) azepin-3-yl-methyl) -aniline, (104) 4- (7-methyl-2,3,4,5-tetrahydro-benzo ( (d) azepin-3-yl-methyl) -aniline, (105) 4- (7,8-dimethoxy-2,3,4,5-tetrahydro-benzo (d) azepin-3-yl-methyl) -aniline, (106) 4- (6,7-dichloro-1,2,3,4-tetrahydro-isoquinolin-2-ylmethyl) -amine, (107) 4- (6,7-dimethyl-1,2,3) , 4-tetrahydro-isoquinolin In-2-yl-methyl) -aniline, (108) 4- (6-chloro-1,2,3,4-tetrahydro-isoquinolin-2-ylmethyl) -aniline, (109) 4- (7- chloro-1,2,3,4-tetrahydro-isoquinolin-2-ylmethyl) -aniline, (110) 4- (6-methoxy-1,2,3,4-tetrahydro-isoquinolin-2-yl-methyl) (111) 4- (7-methoxy-1,2,3,4-tetrahydro-isoquinolin-2-ylmethyl) -aniline, (112) 4- (2,3,4,5-tetrahydro) -azepino (4,5-b) pyrazin-3-ylmethyl) -aniline, (113) 4- (7-amino-2,3,4,5-tetrahydro-azepino (4,5-b) pyrazine- 3-yl-methyl) -aniline, (114) 4- (2-amino-5,6,7,8-tetrahydro-azepino (4,5-d) thiazol-6-ylmethyl) -aniline, (115) ) 4- (5,6,7,8-tetrahydro-azepino (4,5-d) thiazol-6-ylmethyl) -aniline, (116) 4- (4-methyl-piperazin-1-yl) - aniline, (117) 4- [N- (2-dimethylamino-ethyl) - N -methyl-amino] -aniline, (118) 4- [N - (3-dimethylamino-propyl) - N -methyl- amino] -aniline, (119) N- (3-dimethylamino-propyl) - N -methylsulfonyl-p-phenylenediamine, (120) 4 - [(N'-dimethylaminocarbonyl-methyl-N -methylsulfonyl) -amino] -amine (121) N- (4-aminophenyl) -N-methyl-methanesulfonamide, (122) 4- (imidazol-4-yl) -aniline, (123) 4- (tetr azol-5-yl) -aniline, (124) 4- [N - (2-dimethylamino-ethyl) - N -propionyl-amino] -amino, (125) N - (dimethylaminomethylcarbonyl) - N -methyl- p-phenylenediamine, (126) N - [(2-dimethylamino-ethyl) -carbonyl] -N-methyl-p-phenylenediamine, (127) 4- (N-acetyl-N - (dimethylaminocarbonylmethyl) amino) - aniline, (128) N-methylaminocarbonyl-methyl-N-methylsulfonyl-p-phenylenediamine, (129) N-aminocarbonyl-methyl-N-methylsulfonyl-p-phenylenediamine, (130) 4- (imidazolidine-2,4-dione- 5-ylidene-methyl) -aniline, (131) 4- (imidazolidin-2,4-dione-5-ylmethyl) -aniline, (132) 4- (2-oxo-pyrrolidin-1-yl-methyl) -aniline, (133) N-cyanomethyl-N-methylsulfonyl-p-phenylenediamine, (134) 4- [2- (imidazol-4-yl) -ethyl] -aniline, (135) 4 - [(4-methyl- piperazin-1-yl) -methyl] -aniline, (136) 4- [N - (2- (N -benzyl-N -methyl-amino) -ethyl) - N -methylsulfonyl-amino] -aniline, (137) 4- [N- (3- (N-benzyl- N -methyl-amino) -propyl) - N -methylsulfonylamino] -aniline, (138) N -cyclohexyl-p-phenylenediamine, (139) 4- (pyridin-4-yl-methyl) -aniline, (140) 4- (imidazol-1-yl-methyl) -aniline n, (141) 4-benzyl-aniline, (142) N- (3-trifluoroacetylamino-propyl) -7H-methylsulfonyl-p-phenylenediamine, (143) 4-amino-phenylacetic acid tert-butyl ester, (144) 4- (145) 4- (1-methyl-imidazol-2-yl) -aniline, (146) 4- (1-ethyl-imidazol-2-yl) -aniline, (147) ) 4- (1-benzyl-imidazol-2-yl) -aniline, (148) 4- [N- (2-dimethylamino-ethyl) -, N-methylsulfonyl-amino-3-amino-aniline, (149) 4- [N '- (2-dimethylamino-ethyl) -, N-methylsulfonyl-amino] -3-chloro-aniline, (150) 4- [N - (2-dimethylamino-ethyl) - N -acetyl-amino] ] -3-amino-aniline A, (151) 4- [7V- (2-dimethylamino-ethyl) -N / N-acetyl-amino] -3-bromo-aniline, (152) 4- [2- (4-hydroxy (153) N- (2-dimethylamino-ethyl) - N -ethylsulfonyl-p-phenylenediamine, (154) N - (2-dimethylamino-ethyl) - N -piperidin-1-yl) ethyl-amino] -aniline; -propylsulfonyl-p-phenylenediamine, (155) N - (2-dimethylamino-ethyl) - N -isopropyl-sulfonyl-p-phenylenediamine, (156) N- (2-dimethylamino-ethyl) - N -butylsulfonyl-p-phenylenediamine (157) N- (2-dimethylamino-ethyl) - N -benzylsulfonyl-p-phenylene diamine, (158) N- (2-dimethylamino-ethyl) - N -phenylsulfonyl-p-phenylenediamine, (159) 4 - ((3-hydroxy-pyrrolidin-1-yl) methyl) -aniline, (160) 4- [N - (2-dimethylamino-ethyl) - N - (furan-2-carbonyl) -amino] -aniline, (161) 4- N - (2-dimethylamino-ethyl) - N - (2) -methoxy-benzoyl) -amino] -aniline, (162) 4- [N- (2-dimethylamino-ethyl) - N - (pyridine-3-carbonyl) -amino] -aniline, (163) 4- [1 '- (2-dimethylamino-ethyl) -N- (phenyl-acetyl) -amino] -aniline, (164) N- (piperidin-1-ylmethylcarbonyl) -N-methyl-p-phenylenediamine, (165) N- (morpholin-4-ylmethylcarbonyl) - N -methyl-p-phenylenediamine, (166) N - [(4-benzyl-piperazin-1-yl) -methylcarbonyl] -7 H -methyl-p-phenylenediamine, (167) N - (pyrrolidin-1-ylmethylcarbonyl) - N -methyl-p-phenylenediamine, (168) 4- (5-methyl-imidazol-4-yl) -aniline, (169) N - [(2-dimethylamino- ethyl) -carbonyl] -N-isopropyl-p-phenylenediamine, (170) N - [(2-dimethylamino-ethyl) -carbonyl] - N -benzyl-p-phenylenediamine, (171) N - (N-aminocarbonyl) -methyl-, -methyl-amino) methylcarbonyl) -N-methyl-p-phenylenediamine, (172) and f - [(N-benzyl - / V-methyl-amino) -methylcarbonyl] -N-methyl-p-phenylenediamine, (173) A / - [di- (2-methoxyethyl) -amino-methylcarbonyl) -N-methyl-p-phenylenediamine, (174) N - [(2- (4-tert-butoxycarbonyl-piperazin-1-yl) ethyl) carbonyl] -N-methyl-p-phenylenediamine, (175) N - [2- (piperidin-1-yl) ) ethyl) carbonyl] -N-methyl-p-phenylenediamine, (176) N - [(2- (benzyl-J V / V-methyl-amino) -ethyl]) - carbonyl] -N I - (177) N - (dimethylaminomethylcarbonyl) - N -isopropyl-p-phenylenediamine, (178) N- (piperidin-1-ylmethylcarbonyl) -N-isopropyl-p-phenylenediamine, (179) N - [(4-tert-butoxycarbonyl-piperazin-1-yl) methylcarbonyl] -Misopropyl-1H-phenylenediamine, (180) N - [(N-benzyl-N-methyl-amino) -methylcarbonyl] - N-benzyl-p-phenylenediamine, (181) N - (dimethylaminomethylcarbonyl) - N -benzyl-p-phenylenediamine, (182) N - (piperidin-1-ylmethylcarbonyl) - N -benzyl-p-phenylenediamine, (183) 4- (1,2,4-triazol-1-yl-methyl-aniline, (184) 4- (1,2,3-triazol-2-ylmethyl) -aniline, (185) 4- (1,2,3-triazol-1-ylmethyl) -aniline, (186) 4 - [(N-etox) (187) 4 - [(N-aminocarbonyl-methyl-; N -methyl-amino) -methyl] -aniline, (188) 4- (azetidine-) -carbonyl-methyl-N-methyl-amino) -methyl] aniline; 1-yl-methyl) -aniline, (189) 4 - [(di- (2-methoxy-ethyl) -amino) -methyl] -aniline, (190) 4 - [(N - (2- (2-methoxy) (191) 4- [N - (N-tert-butoxycarbonyl-3-amino-propyl) - N -methylaminomethyl] -aniline, (ethoxy) -ethyl) - N -methyl-amino) -methyl] -aniline; (192) 4 - [(N- (methylcarbamoyl-methyl) -N & apos methyl-amino) -methyl] -aniline (193) 4 - [(7V- (dimethylcarbamoyl-methyl) -N- / methyl-amino) methyl] aniline,

SK 287312 Β6 (194) 4-[(7V-propyl-jV-metyl-amino)-metyl]-anilín, (195) 4-[(A,-(2-dimetylamino-etyl)-N-metyl-amino)-metyl]-anilín, (196) 4-[(7V-(3-dimetylamino-propyl)-jV-metyl-amino)-metyl]-anilín, (197) 4-[(7V-(2-metoxy-etyl)-7V-metyl-amino)-metyl]-anilín, (198) 4-[(V-(2-hydroxy-etyl)-V-metyl-amino)-metyI]-amlín, (199) 4-[(/V-(dioxolán-2-yl-metyl)-A'-metyl-amino)-metyl]-anilín, (200) 4-(3-oxo-piperazin-1 -yl-metyl)-anilín, (201) N-[di-(2-hydroxyetyl)-amino-metylkarbonyl]-jV-metyl-p-fenyléndiamín, (202) N-[(A'-(2-metoxyetyl)-N-metyl-amino)-metylkarbonyl]-N-metyl-p-fenyléndiamín, (203) V-[(A'-(2-dimetylamino-etyl)-V-metyl-amino)-metylkarbonyl]-N-metyl-p-fenyléndiamín, (204) jV-[(4-metyl-piperazín-l-yl)-metylkarbonyl]-7V-metyl-p-fenyléndiamín, (205) 7V-[(imidazol-l-yl)-metylkarbonyl]-jV-metyl-p-fenyléndiamín, (206) 7V-[(ftalimido-2-yl)-metylkarbonyl]-N-metyl-p-fenyléndiamín.EN 287 312 Β6 (194) 4 - [(7V-propyl-N-methyl-amino) -methyl] -aniline (195) 4 - [(A - (2-dimethylamino-ethyl) -N-methyl-amino) -methyl-aniline, (196) 4 - [(N - (3-dimethylamino-propyl) - N -methyl-amino) -methyl] -aniline, (197) 4 - [(N - (2-methoxy-ethyl) (N-methyl-amino) -methyl] -aniline, (198) 4 - [(N - (2-hydroxy-ethyl) - N -methyl-amino) methyl] -amine, (199) 4 - [( N - (dioxolan-2-yl-methyl) - N '-methyl-amino) -methyl] -aniline, (200) 4- (3-oxo-piperazin-1-yl-methyl) -aniline, (201) N- [di- (2-hydroxyethyl) amino-methylcarbonyl] -N-methyl-p-phenylenediamine, (202) N - [(N '- (2-methoxyethyl) -N-methylamino) methylcarbonyl] - N-methyl-p-phenylenediamine, (203) N - [(N '- (2-dimethylamino-ethyl) - N -methyl-amino) -methylcarbonyl] -N-methyl-p-phenylenediamine, (204) N - [ (4-methyl-piperazin-1-yl) -methylcarbonyl] -N-methyl-p-phenylenediamine, (205) N - [(imidazol-1-yl) -methylcarbonyl] -N-methyl-p-phenylenediamine, (206) N - [(phthalimido-2-yl) methylcarbonyl] -N-methyl-p-phenylenediamine.

Príprava 21 4-(4-Hydroxymetyl-piperidm-1 -yl-metyl-amino)-anilínPreparation 21 4- (4-Hydroxymethyl-piperidin-1-yl-methyl-amino) -aniline

V 15 ml tetrahydrofuránu sa dispergovalo 1,1 g 4-(4-etoxykarbonyl-piperidin-I-yl-metyl-amino)-anilínu. Pri teplote miestnosti sa pridalo 175 mg hydridu boritolítneho a zmes sa 24 hodín miešala. Potom sa pridalo ďalších 175 mg hydridu boritolítneho a reakčná zmes sa miešala ďalších 7,5 hodín. Nasledovalo pridanie 15 ml vody a desaťminútové miešanie. Zmes sa potom 3 razy extrahovala vždy 15 ml etylesteru kyseliny octovej. Spojené organické vrstvy sa premyli vodou a nasýteným vodným roztokom chloridu sodného, sušili nad bezvodým síranom sodným a odparili. Zvyšok sa čistil na stĺpci gélu kyseliny kremičitej s použitím metylén-chloridu/metanolu/amoniaku (4:1: 0,01) ako elučným činidlom.1.1 g of 4- (4-ethoxycarbonyl-piperidin-1-yl-methyl-amino) -aniline was dispersed in 15 ml of tetrahydrofuran. 175 mg of boron hydride were added at room temperature and the mixture was stirred for 24 hours. Then an additional 175 mg of lithium borohydride was added and the reaction stirred for an additional 7.5 hours. This was followed by the addition of 15 ml of water and stirring for 10 minutes. The mixture was then extracted 3 times with 15 ml of ethyl acetate each time. The combined organic layers were washed with water and saturated aqueous sodium chloride solution, dried over anhydrous sodium sulfate and evaporated. The residue was purified on a silica gel column using methylene chloride / methanol / ammonia (4: 1: 0.01) as eluent.

Výťažok: 200 mg (27 % teoretického výťažku),Yield: 200 mg (27% of theory),

Rrhodnota produktu: 0,4 (gél kyseliny kremičitej, metylénchlorid/metanol/amoniak = 4 : 1 : 0,01), teplota topenia produktu bola 157 °C.Product value: 0.4 (silica gel, methylene chloride / methanol / ammonia = 4: 1: 0.01), mp 157 ° C.

Príprava 22Preparation 22

Metylester kyseliny 4-etoxykarbonylmetyl-3-nitro-benzoovej4-Ethoxycarbonylmethyl-3-nitro-benzoic acid methyl ester

V 100 ml dimetylformamidu sa rozpustilo 54,3 g metylesteru kyseliny 3-nitro-benzoovej s 29,0 g metylesteru kyseliny chlóroctovej. Pri -10 °C sa pripravený roztok po kvapkách pridal do roztoku 78,5 g terc-butylátu draslíka v 500 ml dimetylformamidu. Reakčná zmes sa 10 minút miešala a potom sa naliala do roztoku 350 ml koncentrovanej kyseliny chlorovodíkovej v 2 litroch ľadovej vody. Roztok sa 0,5 hodiny miešal, vylúčená zrazenia sa zachytila na filtri s odsávaním a premyla vodou. Produkt sa rekryštalizoval z prostredia metanolu a vysušil vo vákuu pri 40 °C.54.3 g of methyl 3-nitrobenzoate were dissolved in 100 ml of dimethylformamide with 29.0 g of methyl chloroacetate. At -10 ° C, the prepared solution was added dropwise to a solution of 78.5 g of potassium tert-butylate in 500 ml of dimethylformamide. The reaction mixture was stirred for 10 minutes and then poured into a solution of 350 mL concentrated hydrochloric acid in 2 L ice water. The solution was stirred for 0.5 h, the precipitate formed was collected on a suction filter and washed with water. The product was recrystallized from methanol and dried under vacuum at 40 ° C.

Výťažok: 48,3 g (51 % teoretického výťažku),Yield: 48.3 g (51% of theory),

Rrhodnota produktu: 0,7 (gél kyseliny kremičitej, petroléter/etylester kyseliny octovej = 1:1), teplota topenia produktu bola 65 až 73 °C.Product value: 0.7 (silica gel, petroleum ether / ethyl acetate = 1: 1), mp 65-73 ° C.

Podobne ako v príprave 22 sa pripravila nasledujúca zlúčenina:Similar to Preparation 22, the following compound was prepared:

(1) etylester kyseliny 4-metoxykarbonyl-metyl-3-nitrobenzoovej, pripravený reakciou z 4-etylesteru kyseliny tioxykarbonyl-metyl-3-nitro-benzoovej.(1) 4-Methoxycarbonyl-methyl-3-nitrobenzoic acid ethyl ester, prepared by reaction from 4-ethyl-thioxycarbonyl-methyl-3-nitrobenzoic acid 4-ethyl ester.

Príprava 23Preparation 23

Metylester kyseliny 2-indolinón-6-karboxylovej2-Indolinone-6-carboxylic acid methyl ester

V 800 ml koncentrovanej kyseliny octovej sa rozpustilo 48,3 g metylesteru kyseliny 4-etoxykarbonylmetyl-3-nitro-benzoovej, pridalo sa 500 g paládia na uhlíku (10 %-ného) a roztok sa 2,5 hodiny hydrogenoval vodíkom pod tlakom približne 0,35 MPa (50 psi). Po skončení hydrogenácie sa katalyzátor odfiltroval, filtrát sa odparil, odparok sa rozmiešal v 150 ml terc-butylmetyléteru, filtroval a vo vákuu pri 100 °C vysušil. Výťažok: 28,6 g (98 % teoretického výťažku), Rrhodnota produktu: 0,4 (gél kyseliny kremičitej, metylénchlorid/metanol = 10 : 1), teplota topenia produktu bola 208 až 211 °C.48.3 g of 4-ethoxycarbonylmethyl-3-nitro-benzoic acid methyl ester was dissolved in 800 ml of concentrated acetic acid, 500 g of palladium on carbon (10%) were added, and the solution was hydrogenated with hydrogen under a pressure of approximately 0 for 2.5 hours. 35 MPa (50 psi). After completion of the hydrogenation, the catalyst was filtered off, the filtrate was evaporated, the residue was taken up in 150 ml of tert-butyl methyl ether, filtered and dried in vacuo at 100 ° C. Yield: 28.6 g (98% of theory), Product value: 0.4 (silica gel, methylene chloride / methanol = 10: 1), mp 208-211 ° C.

Podobne ako v príprave 23 sa pripravila nasledujúca zlúčenina:As in Preparation 23, the following compound was prepared:

(1) etylester kyseliny 2-indolinón-6-karboxylovej, pripravený reakciou z etylesteru kyseliny 4-metoxykarbonyl-metyl-3-nitro-benzoovej.(1) 2-indolinone-6-carboxylic acid ethyl ester, prepared by reaction from ethyl 4-methoxycarbonylmethyl-3-nitro-benzoate.

SK 287312 Β6SK 287312-6

Príprava 24Preparation 24

-Acetyl-3-( 1 -etoxy-1 -fenyl-metylén)-6-etyloxykarbonyl-2-indolinón-Acetyl-3- (1-ethoxy-1-phenyl-methylene) -6-ethyloxycarbonyl-2-indolinone

15,0 g Etylesteru kyseliny 2-indolinón-6-karboxylovej, 49,6 ml trietylesteru kyseliny ortobenzoovej a 150 ml acetanhydridu sa 4 hodiny miešalo pri 110 °C. Rozpúšťadlo sa potom odstránilo, zvyšok sa rekryštalizoval z prostredia petroléteru a vysušil vo vákuu pri 50 °C.15.0 g of 2-indolinone-6-carboxylic acid ethyl ester, 49.6 ml of triethyl orthobenzoate and 150 ml of acetic anhydride were stirred at 110 ° C for 4 hours. The solvent was then removed, the residue was recrystallized from petroleum ether and dried under vacuum at 50 ° C.

Výťažok: 16,9 g (61 % teoretického výťažku), Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, petroléter/metylénchlorid/etylester kyseliny octovej = = 5:4:1), teplota topenia produktu bola 98 až 100 °C, C22H21NO5.Yield: 16.9 g (61%), R f value of the product: 0.5 (silica gel, petroleum ether / methylene chloride / ethyl acetate = 5: 4: 1), mp = 98-100 ° C 22 H 21 NO 5 .

Podobne ako v príprave 24 sa pripravili nasledujúce zlúčeniny:Similar to Preparation 24, the following compounds were prepared:

(1) l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinón, pripravený reakciou z metylesteru kyseliny 2-indolinón-6-karboxylovej, trietylesteru kyseliny ortobenzoovej a acetanhydridu, (2) l-acetyl-3-(l-etoxy-l-etylmetylén)-6-etoxykarbonyl-2-indolinón, pripravený reakciou z etylesteru kyseliny 2-indolinón-6-karboxylovej, trietylesteru kyseliny ortopropiónovej a acetanhydridu.(1) 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone, prepared by reaction from 2-indolinone-6-carboxylic acid methyl ester, triethyl orthobenzoate and acetic anhydride, (2) 1-acetyl-3- (1-ethoxy-1-ethylmethylene) -6-ethoxycarbonyl-2-indolinone, prepared by reaction from 2-indolinone-6-carboxylic acid ethyl ester, orthopropionic acid triethyl ester and acetic anhydride.

Príprava konečných zlúčenínPreparation of final compounds

Príklad 1Example 1

3-Z-[ 1 -(4-(Piperidin-1 -yl-metyl)-anilino)-1 -fenyl-metylén]-6-karbamoyl-2-indolinón-trifluóracetát3-Z- [1- (4- (Piperidin-1-yl-methyl) -anilino) -1-phenyl-methylene] -6-carbamoyl-2-indolinone trifluoroacetate

300 mg v príprave pripravenej živice sa v dispergovalo v 3 ml dimetyl-formamidu a po pridaní 0,2 g 4-(piperidm-l-yl-metyl)-anilmu sa reakčná zmes 22 hodín pretrepávala pri 70 °C. Nasledovala filtrácia, premývanie živice viac razy metylénchloridom, metanolom a dimetylformamidom. Na odstránenie acetylovej skupiny sa potom na dve hodiny pridal 1 ml metanolového roztoku amoniaku. Po ďalšom premytí sa v priebehu 60 minút pridali 4 ml 10 %-nej kyseliny trifluóroctovej v metylénchloride, oddelila sa živica a roztok sa skoncentroval.300 mg of the prepared resin was dispersed in 3 ml of dimethylformamide and, after addition of 0.2 g of 4- (piperidin-1-ylmethyl) -anilm, the reaction mixture was shaken at 70 ° C for 22 hours. This was followed by filtration, washing the resin several times with methylene chloride, methanol and dimethylformamide. 1 ml of methanolic ammonia solution was then added for two hours to remove the acetyl group. After further washing, 4 ml of 10% trifluoroacetic acid in methylene chloride was added over 60 minutes, the resin was separated and the solution was concentrated.

Výťažok: 69 mg,Yield: 69 mg,

Rrhodnota produktu: 0,1 (gél kyseliny kremičitej, metylénchlorid/metanol = 9 : 1),Product value: 0.1 (silica gel, methylene chloride / methanol = 9: 1),

C28H28N4O2 Hmotnostné spektrum: m/z = 452 [M]+.C 28 H 28 N 4 O 2 Mass spectrum: m / z = 452 [M] + .

Podobne ako v príklade 1 sa pripravili nasledujúce zlúčeniny:As in Example 1, the following compounds were prepared:

(1) 3-Z-( 1 -anilino-1 -fenyl-metylén)-6-karbamoyl-2-indolinón, zlúčenina sa pripravila zo živice pripravenej podobne ako v príklade II a z anilínu, C22Hi7N3O2, hmotnostné spektrum: m/z = 355 [M]+, (2) 3-Z-[l-(4-dimetylaminometyl-anilino)-l-fenyl-metylén]-6-karbamoyl-2-indolinón-trifluóracetát, zlúčenina sa pripravila zo živice pripravenej podobne ako v príprave 2 a z 4-dimetylaminometyl-anilínu, C25H24N4O2, hmotnostné spektrum: m/z = 412 [M]+, (3) 3-Z-[ 1 -(4-(2-dietylamino-etyl)-anilino)-1 -fenyl-metylén]-6-karbamoyl-2-indolinón-trifluóracetát, zo živice podobne ako v príprave 2 a 4-(2-dietylamino-etyl)-anilínu,(1) 3-Z- (1-anilino-1-phenyl-methylene) -6-carbamoyl-2-indolinone, prepared from a resin prepared similar to Example II and from aniline, C 22 H 7 N 3 O 2 , mass spectrum: m / z = 355 [M] + , (2) 3- Z- [1- (4-dimethylaminomethyl-anilino) -1-phenyl-methylene] -6-carbamoyl-2-indolinone trifluoroacetate, prepared from a resin prepared similar to Preparation 2 and from 4-dimethylaminomethyl-aniline, C 25 H 24 N 4 O 2 , mass spectrum: m / z = 412 [M] + , (3) 3-Z- [1- (4) - (2-diethylamino-ethyl) -anilino) -1-phenylmethylene] -6-carbamoyl-2-indolinone trifluoroacetate, from the resin, similar to Preparation 2 and 4- (2-diethylamino-ethyl) -aniline,

C28H30N4O2, hmotnostné spektrum: m/z = 454 [M]+, (4) 3-Z-[l-(4-(morfolin-4-yl-metyl)-anilino)-l-fenyl-metylén]-6-karbamoyl-2-mdolinón-trifluóracetát, zlúčenina sa pripravila zo živice pripravenej podobne ako v príprave 2 a zo 4-(morfolin-4-yl-metyl)-anilmu, Rrhodnota produktu: 0,50 (gél kyseliny kremičitej, metylénchlorid/metanol = 4:1) C27H26N4O3, hmotnostné spektrum: m/z = 454 [M]+, (5) 3-Z-[l -(4-( l-oxo-tiomorpholin-4-yl-metyl)-anilino)-l-fenyl-metylén]-6-karbamoyl-2-indolinón-trifluóracetát, zlúčenina sa pripravila zo živice pripravenej podobne ako v príprave 2 a zo 4-(l-oxo-tiomorpholin-4-yl-metyl)-anilínu,C 28 H 30 N 4 O 2 , mass spectrum: m / z = 454 [M] + , (4) 3-Z- [1- (4- (morpholin-4-ylmethyl) -anilino) -1- phenyl-methylene] -6-carbamoyl-2-indolinone trifluoroacetate, prepared from a resin prepared similar to Preparation 2 and from 4- (morpholin-4-ylmethyl) -anilm, Product Value: 0.50 (gel) silica, methylene chloride / methanol = 4: 1) C 27 H 6 N 4 O 2 3, MS: m / z = 454 [m] +, (5) 3-Z- [l - (4- (l-oxo (thiomorpholin-4-ylmethyl) -anilino) -1-phenylmethylene] -6-carbamoyl-2-indolinone trifluoroacetate, prepared from a resin prepared similar to Preparation 2 and from 4- (1-oxo- tiomorpholin-4-yl-methyl) -aniline,

Rrhodnota produktu: 0,30 (gél kyseliny kremičitej, metylénchlorid/metanol = 9:1) C27H26N4O3S, hmotnostné spektrum: m/z = 486 [M]+, (6) 3-Z-[ 1 -(4-( 1,1 -dioxo-tiomorfolin-4-yl-metyl)-anilín)-1 -fenyl-metylén]-6-karbamoyl-2-indolinón-trifluóracetát,Product value: 0.30 (silica gel, methylene chloride / methanol = 9: 1) C 27 H 26 N 4 O 3 S, mass spectrum: m / z = 486 [M] + , (6) 3-Z- [ 1- (4- (1,1-dioxo-thiomorpholin-4-ylmethyl) -aniline) -1-phenyl-methylene] -6-carbamoyl-2-indolinone trifluoroacetate,

SK 287312 Β6 pripravený reakciou zo živice pripravenej podobne ako v príprave 2 a 4-(l,l-dioxo-tiomorfolin-4-yl-metyl)-anilínu,Prepared by reaction from a resin prepared similar to Preparation 2 and 4- (1,1-dioxo-thiomorpholin-4-ylmethyl) -aniline,

Rf-hodnota produktu: 0,30 (gél kyseliny kremičitej, metylénchlorid/metanol = 9:1), C27H26N4O4S, hmotnostné spektrum: m/z = 502 [M]+, (7) 3-Z-[ 1 -(4-(benzylaminometyl)-anilino)-1 -fenyl-metylén]-6-karbamoyl-2-indolinón-trifluóracetát, zo živice podobne ako v príprave 2 a 4-|W-(fenylmetyl)-jV-íerc-butoxykarbonylamino-metyl]-anilínu, Rrhodnota produktu: 0,40 (gél kyseliny kremičitej, metylénchlorid/metanol = 4 : 1),Rf value of the product: 0.30 (silica gel, methylene chloride / methanol = 9: 1), C27H26N4O4S, mass spectrum: m / z = 502 [M] + , (7) 3-Z- [1- (4-) (benzylaminomethyl) -anilino) -1-phenylmethylene] -6-carbamoyl-2-indolinone trifluoroacetate, from the resin, similar to Preparation 2 and 4- N - (phenylmethyl) -N- tert -butoxycarbonylamino-methyl] - aniline, R r value of the product: 0.40 (silica gel, methylene chloride / methanol = 4: 1).

C30H26N4O2, + hmotnostné spektrum: m/z=474 [M]+, (8) 3-Z-[l-(4-(aminometyl)anilino)-l-fenyl-metylén]-6-karbamoyl-2-indolinón-trifluór-acetát, zlúčenina sa pripravila zo živice pripravenej podobne ako v príprave 2 a zo 4-(<V-terc-butoxykarbonyl-aminometyl)-anilínu,C30H26N4O2, + mass spectrum: m / z = 474 [M] + , (8) 3-Z- [1- (4- (aminomethyl) anilino) -1-phenylmethylene] -6-carbamoyl-2-indolinone- trifluoroacetate, the compound was prepared from a resin prepared similar to Preparation 2 and from 4- (N-tert-butoxycarbonyl-aminomethyl) -aniline,

Rrhodnota produktu: 0,10 (gél kyseliny kremičitej, metylénchlorid/metanol = 4 : 1), R f value of the product: 0.10 (silica gel, methylene chloride / methanol = 4: 1).

C23H20N4O2, hmotnostné spektrum: m/z = 384 [M]+, (9) 3-Z-[ 1 -(4-(2,6-dimetylpiperidin-1 -yl-metyl)-anilino)-1 -fenyl-metylén]-6-karbamoyl-2-indolinón-trifluóracetát, zlúčenina sa pripravila zo živice pripravenej podobne ako v príprave 2 a z 4-(2,6-dimetylpiperidin-1-yl-metyl)-anilínu,C23H20N4O2, mass spectrum: m / z = 384 [M] + , (9) 3- Z- [1- (4- (2,6-dimethylpiperidin-1-ylmethyl) -anilino) -1-phenylmethylene -6-carbamoyl-2-indolinone trifluoroacetate, the compound was prepared from a resin prepared similar to Preparation 2 and from 4- (2,6-dimethylpiperidin-1-ylmethyl) -aniline,

Rrhodnota produktu: 0,45 (gél kyseliny kremičitej, metylénchlorid/metanol = 4 : 1), C30H32N4O2, hmotnostné spektrum: m/z = 480 [M]+, (10) 3-Z-[ 1 -(4-(pyrolidin-1 -yl-metyl)anilino)-1 -fenylmetylén]-6-karbamoyl-2-indolinón-trifluóracetát, zlúčenina sa pripravila zo živice pripravenej podobne ako v príprave 2 a zo 4-(pyrolidín-l-yl-metyl)-anilínu, Rrhodnota produktu: 0,15 (gél kyseliny kremičitej, metylénchlorid/metanol = 4 : 1), C27H26N4O2, hmotnostné spektrum: m/z = 438 [M]+, (11) 3-Z-[l-(3-(dimetylaminometyl)anilino)-l-fenyl-metylén]-6-karbamoyl-2-indolinón-trifluóracetát, zlúčenina sa pripravila zo živice pripravenej podobne ako v príprave 2 a z 3-dimetylaminometyl-amlínu, Rrhodnota produktu: 0,23 (gél kyseliny kremičitej, metylénchlorid/metanol = 4 : 1), C25H24N4O2, hmotnostné spektrum: m/z = 412 [M]+, (12) 3-Z-[l-(3-(/V-metyl-/V-etyl-ammometyl)-anilm)-l-fenyl-metylén]-6-karbarnoyl-2-indolinón-triŕluóracetát, zo živice pripravenej podobne ako v príprave 2 a S-jV-inetyl-Metyl-aminometylj-anilínu,Product value: 0.45 (silica gel, methylene chloride / methanol = 4: 1), C30H32N4O2, mass spectrum: m / z = 480 [M] + , (10) 3-Z- [1- (4- (pyrrolidine) -1-ylmethyl) anilino) -1-phenylmethylene] -6-carbamoyl-2-indolinone trifluoroacetate, prepared from a resin prepared similar to Preparation 2 and from 4- (pyrrolidin-1-ylmethyl) - Aniline, Product Value: 0.15 (silica gel, methylene chloride / methanol = 4: 1), C27H26N4O2, mass spectrum: m / z = 438 [M] + , (11) 3-Z- [1- (3-) (dimethylaminomethyl) anilino) -1-phenylmethylene] -6-carbamoyl-2-indolinone trifluoroacetate, prepared from a resin prepared similar to Preparation 2 and from 3-dimethylaminomethylamine, Product Value: 0.23 (acid gel) silica, methylene chloride / methanol = 4: 1), C 25 H 24 N 4 O 2, mass spectrum: m / z = 412 [M] + , (12) 3-Z- [1- (3- (N-methyl-) N -ethyl- (aminomethyl) -anilino) -1-phenylmethylene] -6-carbarnoyl-2-indolinone-trifluoroacetate, from a resin prepared similarly and ko in preparation 2 and N-N-ethyl-methyl-aminomethyl-aniline,

Rrhodnota produktu; 0,23 (gél kyseliny kremičitej, metylénchlorid/metanol = 4 : 1), C26H26N4O2, hmotnostné spektrum: m/z = 426 [M]+, (13) 3-Z-[l-(3-(metylaminometyl)-anilino)-l-fenyl-metylén]-6-karbamoyl-2-indolinón-trifluóracetát, zlúčenina sa pripravila zo živice pripravenej podobne ako v príprave 2 a zo 4-(Aľ-íerc-butoxykarbonyl-X-metyl-aminometyl)-anilínu,Product Value; 0.23 (silica gel, methylene chloride / methanol = 4: 1), C 26 H 26 N 4 O 2, mass spectrum: m / z = 426 [M] + , (13) 3-Z- [1- (3- ( methylaminomethyl) anilino) -l-phenyl-methylene] -6-carbamoyl-2-indolinone-trifluoroacetate prepared from the resin prepared as in preparation 2 and 4- (S I '-tert-butoxycarbonyl-methyl-X aminomethyl) aniline,

Rrhodnota produktu: 0,06 (gél kyseliny kremičitej, metylénchlorid/metanol = 4 : 1), C24H22N4O2, hmotnostné spektrum: m/z = 399 [M+H]+, (14) 3-Z- [ 1 -(3 -hydroxymetyl-anilino)-1 -fenyl-metylén]-6-karbamoyl-2-indolinón, zlúčenina sa pripravila zo živice pripravenej podobne ako v príprave 2 a z 3-amino-benzylalkoholu, Rrhodnota produktu: 0,7 (gél kyseliny kremičitej, metylénchlorid/metanol = 4:1) C23H19N3O3, hmotnostné spektrum: m/z = 385 [M]+, (15) 3-Z-[ 1 -(4-(metoxykarbonylmetylaminometyl)anilino)-1 -fenyl-metylén]-6-karbamoyl-2-indolinón-trifluóracetát, zlúčenina sa pripravila zo živice pripravenej podobne ako v príprave 2 a zo 4-(/V-metoxykarbonyl-metyl-7V-terc-butoxykarbonyl-aminometylj-anilínu,Product value: 0.06 (silica gel, methylene chloride / methanol = 4: 1), C24H22N4O2, mass spectrum: m / z = 399 [M + H] + , (14) 3-Z- [1- (3- hydroxymethyl-anilino) -1-phenyl-methylene] -6-carbamoyl-2-indolinone, the compound was prepared from a resin prepared similar to that of Preparation 2 and from 3-aminobenzyl alcohol, Product Value: 0.7 (silica gel, methylene chloride) (methanol = 4: 1) C 23 H 19 N 3 O 3, mass spectrum: m / z = 385 [M] + , (15) 3-Z- [1- (4- (methoxycarbonylmethylaminomethyl) anilino) -1-phenylmethylene] -6- carbamoyl-2-indolinone trifluoroacetate, the compound was prepared from a resin prepared similar to Preparation 2 and from 4- (N-methoxycarbonyl-methyl-N-tert-butoxycarbonyl-aminomethyl) aniline,

Rrhodnota produktu: 0,40 (gél kyseliny kremičitej, metylénchlorid/metanol = 9:1) C26H24N4O4, hmotnostné spektrum: m/z = 457 [M+H]+, (16) 3-Z-[l-(4-(/V-metylsulfonyl-7V-(dimetylaminokarbonyl-metyl)-amino)-anilino)-l-fenyl-metylén]-6-karbamoyl-2-indolinón, zlúčenina sa pripravila zo živice pripravenej podobne ako v príprave 2 a zo 4-(jV-metylsulfonyl-7V-(dimetylaminokarbonyl-metyl)-amino) anilínu,Product value: 0.40 (silica gel, methylene chloride / methanol = 9: 1) C 26 H 24 N 4 O 4, mass spectrum: m / z = 457 [M + H] + , (16) 3-Z- [1- (4- ( N-methylsulfonyl-N- (dimethylaminocarbonyl-methyl) -amino) -anilino) -1-phenyl-methylene] -6-carbamoyl-2-indolinone, prepared from a resin prepared similar to Preparation 2 and from 4- ( N-methylsulfonyl-N- (dimethylaminocarbonylmethyl) amino) aniline,

Rf-hodnota produktu: 0,40 (gél kyseliny kremičitej, metylénchlorid/metanol = 9:1)Rf value of the product: 0.40 (silica gel, methylene chloride / methanol = 9: 1)

C27H27N5O5S, hmotnostné spektrum: m/z = 533 [M]+, (17) 3 -Z-[ 1 -(4-(jV-acetylaminometyl)anilino)-1 -fenylmetylén]-6-karbamoyl-2-indolinón, zlúčenina sa pripravila zo živice pripravenej podobne ako v príprave 2 a zo 4-(/V-acetyl-aminornetyl)-anilínu, Rf-hodnota produktu: 0,70 (gél kyseliny kremičitej, metylénchlorid/metanol = 4:1) C25H22N4O3, hmotnostné spektrum: m/z = 426 [M]+, (18) 3-Z-[ 1 -(3,4-dimetoxy-anilino)-1 -fenyl-metylén] -6-karbamoyl-2-indolinón, zlúčenina sa pripravila zo živice pripravenej podobne ako v príprave 2 a z 3,4-dimetoxy-anilínu,C27H27N5O5S, mass spectrum: m / z = 533 [M] + , (17) 3 -Z- [1- (4- (N-acetylaminomethyl) anilino) -1-phenylmethylene] -6-carbamoyl-2-indolinone, compound was prepared from a resin prepared similar to Preparation 2 and from 4- (N-acetyl-aminomethyl) -aniline, Rf value of the product: 0.70 (silica gel, methylene chloride / methanol = 4: 1) C 25 H 22 N 4 O 3 , mass spectrum: m / z = 426 [M] + , (18) 3-Z- [1- (3,4-dimethoxy-anilino) -1-phenyl-methylene] -6-carbamoyl-2 -indolinone, the compound was prepared from a resin prepared similar to Preparation 2 and from 3,4-dimethoxy-aniline,

Rrhodnota produktu: 0,40 (gél kyseliny kremičitej, metylénchlorid/metanol = 9 : 1), R f value of the product: 0.40 (silica gel, methylene chloride / methanol = 9: 1).

C24H21N3O4, hmotnostné spektrum: m/z = 415 [M]+, (19) 3-Z-[ 1 -(4-(morfolin-4-yl)anilino)-1 -fenylmetylén]-6-karbamoyl-2-indolinóntrifluór-acetát, zlúčenina sa pripravila zo živice pripravenej podobne ako v príprave 2 a zo 4-morfolin-4-yl-anilínu, Rf-hodnota produktu: 0,20 (gél kyseliny kremičitej, metylénchlorid/metanol = 9:1) C26H24N4O3, hmotnostné spektrum: m/z = 440 [M]+, (20) 3-Z-l-(4-acetylamino-amlino)-I-fenyl-metylén]-6-karbamoyl-2-indolinón, zlúčenina sa pripravila zo živice pripravenej podobne ako v príprave 2 a z 4-acetylamino-anilínu, Rrhodnota produktu: 0,25 (gél kyseliny kremičitej, metylénchlorid/metanol = 9 : 1) C24H20N4O3, hmotnostné spektrum: m/z = 412 [M]+, (21) 3 -Z- [ 1 -(4-amino-anilino)-1 -fenyl-metylén] -6-karbamoyl-2-indolinón, zlúčenina sa pripravila zo živice pripravenej podobne ako v príprave 2 a zo 4-amino-anilínu, Rf-hodnota produktu: 0,40 (gél kyseliny kremičitej, metylénchlorid/metanol = 9:1) C22Hi8N4O2, hmotnostné spektrum: m/z = 370 [M]+, (22) 3-Z-[ 1 -(4-A/-metyl-/V-acetylaminoanilino)-1 -fenylmetylén]-6-karbamoyl-2-indolinón, zlúčenina sa pripravila zo živice pripravenej podobne ako v príprave 2 a z 4-(/V-metyl-jV-acetyl-amino)-anilínu,C 24 H 21 N 3 O 4 , mass spectrum: m / z = 415 [M] + , (19) 3-Z- [1- (4- (morpholin-4-yl) anilino) -1-phenylmethylene] - 6-carbamoyl-2-indolinone trifluoroacetate, the compound was prepared from a resin prepared similar to Preparation 2 and from 4-morpholin-4-yl-aniline, Rf product value: 0.20 (silica gel, methylene chloride / methanol = 9: 1) C 26 H 24 N 4 O 3 , mass spectrum: m / z = 440 [M] + , (20) 3-Z1- (4-acetylamino-amino) -1-phenyl-methylene] -6- carbamoyl-2-indolinone prepared from the resin prepared as in preparation 2 and 4-acetylamino-aniline, R r value of the product: 0.25 (silica gel, methylene chloride / methanol = 9: 1) C 2 H 20 N 4 4 O 3 , mass spectrum: m / z = 412 [M] + , (21) 3 -Z- [1- (4-amino-anilino) -1-phenyl-methylene] -6-carbamoyl-2-indolinone, the compound was prepared from a resin prepared similar to Preparation 2 and from 4-amino-aniline, Rf value of the product: 0.40 (silica gel, methylene chloride / methanol = 9): 1) C 22 H 8 N 4 O 2, mass spectrum: m / z = 370 [M] + , (22) 3-Z- [1- (4-N - methyl- N -acetylaminoanilino) -1-phenylmethylene ] -6-carbamoyl-2-indolinone, the compound was prepared from a resin prepared similar to Preparation 2 and 4- (N-methyl-N-acetyl-amino) -aniline,

C25H22N4O3, hmotnostné spektrum: m/z = 426 [M]+, (23) 3-Z-[l-(4-etoxykarbonyl-anilino)-l-fenyl-metylén]-6-karbamoyl-2-indolinón, zlúčenina sa pripravila zo živice pripravenej podobne ako v príprave 2 a z etylesteru kyseliny 4-amino-benzoovej, 2 C 5 H 22 N 4 O 3 MS: m / z = 426 [M] +, (23) 3-Z- [l- (4-ethoxycarbonyl-anilino) -l-phenyl-methylene] -6-carbamoyl -2-indolinone, the compound was prepared from a resin prepared similar to Preparation 2 and from ethyl 4-aminobenzoate,

C25H21N3O4, hmotnostné spektrum: m/z = 427 [M]+, (24) 3-Z-[l-(4-karboxy-anilmo)-I-fenyl-metylén]-6-karbamoyl-2-indolinón, zlúčenina sa pripravila zo živice pripravenej podobne ako v príprave 2 a z kyseliny 4-amino-benzoovej, Rrhodnota produktu: 0,11 (gél kyseliny kremičitej, metylénchlorid/metanol = 9 : 1), 2 C 5 H 21 N 3 O 4, MS: m / z = 427 [M] +, (24) 3-Z- [l- (4-carboxy-anilino) -I-phenyl-methylene] -6-carbamoyl 2-indolinone prepared from the resin prepared as in preparation 2 and 4-amino-benzoic acid, R f value of the product: 0.11 (silica gel, methylene chloride / methanol = 9: 1).

C23Hi7N3O4, hmotnostné spektrum: m/z = 398 (M-H)', (25) 3-Z-[ 1 -(4-benzylkarbamoyl-anilino)-1 -fenyl-metylén]-6-karbamoyl-2-indolinón, zlúčenina sa pripravila zo živice pripravenej podobne ako v príprave 2 a z benzylamidu kyseliny 4-amino-benzoovej,C2 3 H 7 N 3 O 4 , mass spectrum: m / z = 398 (MH) -, (25) 3-Z- [1- (4-benzylcarbamoyl-anilino) -1-phenyl-methylene] -6-carbamoyl -2-indolinone, the compound was prepared from a resin prepared similar to Preparation 2 and from 4-aminobenzoic acid benzylamide,

Rrhodnota produktu: 0,21 (gél kyseliny kremičitej, metylénchlorid/metanol = 9:1) C3oH24N403, * hmotnostné spektrum: m/z = 488 [M] , (26) 3-Z-[l-(cyklohexyl-amino)-l-fenyl-metylén]-6-karbamoyl-2-indolinón, zlúčenina sa pripravila zo živice pripravenej podobne ako v príprave 2 a z cyklohexylamínu, R f value of the product: 0.21 (silica gel, methylene chloride / methanol = 9: 1) C 3 oH 24 N 4 0 3 * MS: m / z = 488 [M], (26) 3-Z- [1- (cyclohexylamino) -1-phenyl-methylene] -6-carbamoyl-2-indolinone, prepared from a resin prepared similar to Preparation 2 and from cyclohexylamine,

Rrhodnota produktu: 0,60 (gél kyseliny kremičitej, metylénchlorid/metanol = 9 : 1),Product value: 0.60 (silica gel, methylene chloride / methanol = 9: 1),

C22H23N3O2, hmotnostné spektrum: m/z = 361 [M]+, (27) 3-Z-[l-(4-amino-cyklohexyl-amino)-l-fenyl-metylén]-6-karbamoyl-2-indolinón-trifluóracetát, zlúčenina sa pripravila zo živice pripravenej podobne ako v príprave 2 a zo 4-amino-cyklohexylamínu, C22H24N4O2, hmotnostné spektrum: m/z = 376 [M]+, (28) 3-Z-[l-(jV-metyl-piperidm-4-yI-amino)-l-fenyl-metylén]-6-karbamoyl-2-indolmón-trifluóracetát, zlúčenina sa pripravila zo živice pripravenej podobne ako v príprave 2 a zo 4-amino-l-metyl-piperidinu, Rrhodnota produktu: 0,15 (gél kyseliny kremičitej, metylénchlorid/metanol = 4:1) C22H24N4O2, hmotnostné spektrum: m/z = 376 [M]+, (29) 3-Z-[l-(4-(piperidin-l-yl-metyl)anilino)-l-metylmetylén]-6-karbamoyl-2-indoli-nón-trifluóracetát, zlúčenina sa pripravila zo živice pripravenej podobne ako v príprave 2 (2) a zo 4-(piperidin-l-yl-metyl)-anilínu,C 22 H 23 N 3 O 2 , mass spectrum: m / z = 361 [M] + , (2 S) 3-Z- [1- (4-amino-cyclohexylamino) -1-phenyl-methylene] -6 -carbamoyl-2-indolinone trifluoroacetate, the compound was prepared from a resin prepared similar to Preparation 2 and from 4-amino-cyclohexylamine, C 22 H 24 N 4 O 2 , mass spectrum: m / z = 376 [M] + , (28) 3-Z- [1- (N-methyl-piperidin-4-yl-amino) -1-phenyl-methylene] -6-carbamoyl-2-indolmonium trifluoroacetate, prepared from a resin prepared similarly to that described in preparation 2 and 4-amino-l-methyl-piperidine, R r value of the product: 0.15 (silica gel, methylene chloride / methanol = 4: 1) C 22 H 24 N 4 O 2 MS: m / z = 376 [M] + , (29) 3-Z- [1- (4- (piperidin-1-ylmethyl) anilino) -1-methylmethylene] -6-carbamoyl-2-indolinone trifluoroacetate, compound prepared from a resin prepared similar to Preparation 2 (2) and from 4- (piperidin-1-ylmethyl) -aniline,

Rrhodnota produktu: 0,30 (gél kyseliny kremičitej, metylénchlorid/metanol = 4 : 1),Product value: 0.30 (silica gel, methylene chloride / methanol = 4: 1),

C23H26N4O2, hmotnostné spektrum: m/z = 390 [M]+, (30) 3-Z-[l-(3-dimetylaminometyl-anilino)-l-metyl-metylén]-6-karbamoyl-2-indolinón-trifluóracetát, zlúčenina sa pripravila zo živice pripravenej podobne ako v príprave 2 (2) a z 3-dimetylaminometyl-anilínu, Rrhodnota produktu: 0,51 (gél kyseliny kremičitej, metylénchlorid/metanol = 4 : 1), C20H22N4O2, hmotnostné spektrum: m/z = 351 [M+H]+, (31) 3-Z-[ 1 -(4-(/V-metyl-/V-benzylaminometyl)-anilino)-1 -metyl-metylén]-6-karbamoyl-2-indolinón-trifluóracetát, zlúčenina sa pripravila zo živice pripravenej podobne ako v príprave 2 (2) a z 4-(7V-metyl-Aľ-benzyl-aminometyl)-anilínu,C 23 H 26 N 4 O 2 , mass spectrum: m / z = 390 [M] + , (30) 3- Z- [1- (3-dimethylaminomethyl-anilino) -1-methyl-methylene] -6-carbamoyl -2-indolinone trifluoroacetate, prepared from a resin prepared similar to Preparation 2 (2) and from 3-dimethylaminomethyl-aniline, Product Value: 0.51 (silica gel, methylene chloride / methanol = 4: 1), C 20 H 22 N 4 O 2 , mass spectrum: m / z = 351 [M + H] + , (31) 3-Z- [1- (4- (N-methyl- N -benzylaminomethyl) -anilino) - 1-methyl-methylene] -6-carbamoyl-2-indolinone-trifluoroacetate prepared from the resin prepared as in preparation 2 (2) and 4- (7V-methyl-N- benzyl-aminomethyl) -aniline,

Rrhodnota produktu: 0, 73 (gél kyseliny kremičitej, metylénchlorid/metanol = 4:1) C26H26N4O2, hmotnostné spektrum: m/z = 426 [M]+, (32) 3-Z-[l-(4-(/V-metylsulfonyl-7V-(2-dimetylaminoetyl)amino)amlino)-l-metyl-metylén]-6-karbamoyl-2-indolinón- trifluoracetát, zlúčenina sa pripravila zo živice pripravenej podobne ako v príprave 2 (2) a z 4-(/V-rnetylsulfonyl-/V-(2-dimetylamino-etyl)-amino)-anilínu,Rf value of the product: 0, 73 (silica gel, methylene chloride / methanol = 4: 1) 2 C 6 H 26 N 4 O 2 MS: m / z = 426 [M] +, (32) 3-Z- [l - (4- (N-methylsulfonyl-N- (2-dimethylaminoethyl) amino) amino) -1-methylmethylene] -6-carbamoyl-2-indolinone trifluoroacetate, the compound was prepared from a resin prepared similar to Preparation 2 (2) from 4- (N-methylsulfonyl- N - (2-dimethylamino-ethyl) -amino) -aniline,

C22H27N5O4S, hmotnostné spektrum: m/z = 458 [M+H]+, (33) 3-Z-[l-(4-chlór-anilmo)-l-metyl-metylén]-6-karbamoyl-2-indolinón, zlúčenina sa pripravila zo živice pripravenej podobne ako v príprave 2 (2) a z 4-chlór-anilínu,C 22 H 27 N 5 O 4 S, mass spectrum: m / z = 458 [M + H] + , (33) 3-Z- [1- (4-chloro-anilmo) -1-methyl-methylene] - 6-carbamoyl-2-indolinone, the compound was prepared from a resin prepared similar to Preparation 2 (2) and from 4-chloroaniline,

Rrhodnota produktu: 0, 10 (gél kyseliny kremičitej, metylénchlorid/metanol = 9:1), C17H14C1N3O2, hmotnostné spektrum: m/z = 327/329 [M]+, (34) 3-Z-[l-(3-chlór-anilino)-1 -metyl-metylén]-6-karbamoyl-2-indolinón, zlúčenina sa pripravila zo živice pripravenej podobne ako v príprave 2 (2) a z 3-chlór-anilínu, R f value of the product: 0, 10 (silica gel, methylene chloride / methanol = 9: 1), C 17 H 14 C1N 2 O 3, MS: m / z = 327/329 [M] +, (34) 3 -Z- [1- (3-chloro-anilino) -1-methyl-methylene] -6-carbamoyl-2-indolinone, prepared from a resin prepared similar to Preparation 2 (2) and from 3-chloro-aniline,

Rrhodnota produktu: 0,11 (gél kyseliny kremičitej, metylénchlorid/metanol = 9:1), C[7H14C1N3O2, hmotnostné spektrum: m/z = 327/329 [M]+, (35) 3-Z-[l-(4-metoxykarbonyl-anilino)-l-metyl-metylén]-6-karbamoyl-2-indolinón, zlúčenina sa pripravila zo živice pripravenej podobne ako v príprave 2 (2) a z metylesteru kyseliny 4-amino-benzoovej,Product value: 0.11 (silica gel, methylene chloride / methanol = 9: 1), C [ 7 H 14 ClN 3 O 2 , mass spectrum: m / z = 327/329 [M] + , (35) 3- Z- [1- (4-Methoxycarbonyl-anilino) -1-methyl-methylene] -6-carbamoyl-2-indolinone, prepared from a resin prepared similar to Preparation 2 (2) and from 4-amino-benzoic acid methyl ester .

Rrhodnota produktu: 0,11 (gél kyseliny kremičitej, metylénchlorid/metanol = 9:1), Ci9H17N3O4, hmotnostné spektrum: m/z = 351 [M]+, (36) 3-Z-[l-(4-karboxy-anilino)-l-metyl-metylén]-6-karbamoyl-2-indolinón, zlúčenina sa pripravila zo živice pripravenej podobne ako v príprave 2 (2) a z kyseliny 4-amino-benzoovej,Product value: 0.11 (silica gel, methylene chloride / methanol = 9: 1), C 19 H 17 N 3 O 4 , mass spectrum: m / z = 351 [M] + , (36) 3-Z- [ 1- (4-carboxy-anilino) -1-methyl-methylene] -6-carbamoyl-2-indolinone, prepared from a resin prepared similar to Preparation 2 (2) and from 4-aminobenzoic acid,

C28H15N3O4, hmotnostné spektrum: m/z = 336 [M-H]', (37) 3-Z-[ 1 -(4-metyl-3-nitro-anilino)-1 -metyl-metylén]/6-karbamoyl-2-indolinón, zlúčenina sa pripravila zo živice pripravenej podobne ako v príprave 2 (2) a z 4-metyl-3-nitro-amlínu, Rphodnota produktu: 0,82 (gél kyseliny kremičitej, metylénchlorid/metanol = 4 : 1), C18H26N4O, hmotnostné spektrum: m/z = 352 [M]+, (3 8) 3-Z-[ 1 -(4-(piperidin-1 -yl-metyl)-anilino)-1 -propyl-metylén]-6-karbamoyl-2-indolinón-trifluóracetát, zo živice pripravenej podobne ako v príprave 2 (4) a 4-(piperidin-l-yl-metyl)-anilínu,C 28 H 15 N 3 O 4 , mass spectrum: m / z = 336 [MH] -, (37) 3-Z- [1- (4-methyl-3-nitro-anilino) -1-methyl-methylene] [6-carbamoyl-2-indolinone, the compound was prepared from a resin prepared similar to Preparation 2 (2) and from 4-methyl-3-nitro-amine, Product Value: 0.82 (silica gel, methylene chloride / methanol = 4) : 1), C 18 H 26 N 4 O, mass spectrum: m / z = 352 [M] + , (38) 3-Z- [1- (4- (piperidin-1-ylmethyl) -anilino) -1-propylmethylene] -6-carbamoyl-2-indolinone trifluoroacetate, from a resin prepared similar to Preparation 2 (4) and 4- (piperidin-1-ylmethyl) aniline,

Rphodnota produktu: 0,37 (gél kyseliny kremičitej, metylénchlorid/metanol = 4 : 1), C25H30N4O2, hmotnostné spektrum: m/z = 418 [M]+, (39) 3-Z-[l-(3-dimetylaminometyl-anilino)-l-propylmetylén]-6-karbamoyl-2-indolinón-trifluóracetát, zo živice pripravenej podobne ako v príprave 2 (4) a 3-dimetylaminometyl-anilínu, Rphodnota produktu: 0,42 (gél kyseliny kremičitej, metylénchlorid/metanol = 4 : 1),Rphodnota product: 0.37 (silica gel, methylene chloride / methanol = 4: 1), 2 C 5 H 30 N 4 O 2 MS: m / z = 418 [M] +, (39) 3-Z- [l - (3-dimethylaminomethyl-anilino) -1-propylmethylene] -6-carbamoyl-2-indolinone trifluoroacetate, from a resin prepared similar to Preparation 2 (4) and 3-dimethylaminomethyl-aniline, Rf: 0.42 (gel) silicic acid, methylene chloride / methanol = 4: 1),

C22H26N4O2, hmotnostné spektrum: m/z = 378 [M]+, (40) 3-Z-[l-(4-(/V-metyl-/V-benzylaminometyl)anilino)-l-propyl-metylén]-6-karbamoyl-2-indolinón-trifluóracetát, zo živice pripravenej podobne ako v príprave 2 (4) a 4-[A-metyl-A'-benzyl]-aminometyl]-anilínu, Rphodnota produktu: 0,81 (gél kyseliny kremičitej, metylénchlorid/metanol = 4 : 1), C28H30N4O2, hmotnostné spektrum: m/z = 454 [M]+, (41) 3-Z-[l-(4-(7V-metylsulfonyl-Aľ-(2-dimetylaminoetyl)amino)anilino)-l-propyl-metylén]-6-karbamoyl-2-indolinón-trifluóracetát, zo živice pripravenej podobne ako v príprave 2 (4) a 4-[;V-metylsu1fonyl-A'-(2-dimetylamino-etyl)-amino)-anilínu,C 22 H 26 N 4 O 2 , mass spectrum: m / z = 378 [M] + , (40) 3-Z- [1- (4- (N-methyl- N -benzylaminomethyl) anilino) -1 -propylmethylene] -6-carbamoyl-2-indolinone trifluoroacetate, from a resin prepared similarly to Preparation 2 (4) and 4- [N-methyl-N'-benzyl] aminomethyl] -aniline, Product Value: 0 , 81 (silica gel, methylene chloride / methanol = 4: 1), C 28 H 30 N 4 O 2 , mass spectrum: m / z = 454 [M] + , (41) 3-Z- [1- (4) - (N-methylsulfonyl-N ' - (2-dimethylaminoethyl) amino) anilino) -1-propylmethylene] -6-carbamoyl-2-indolinone trifluoroacetate, from a resin prepared similar to Preparation 2 (4) and 4- [, W-metylsu1fonyl N - (2-dimethylamino-ethyl) amino) -aniline,

Rphodnota produktu: 0,59 (gél kyseliny kremičitej, metylénchlorid/metanol = 4:1),Product value: 0.59 (silica gel, methylene chloride / methanol = 4: 1),

C24H31N5O4S, hmotnostné spektrum: m/z = 486 [M+H]+, (42) 3-Z-[l-(4-chlór-anilino)-l-propyl-metylén]-6-karbamoyl-2-indolinón, zo živice pripravenej podobne ako v príprave 2 (4) a 4-chlór-anilínu,C 24 H 31 N 5 O 4 S, mass spectrum: m / z = 486 [M + H] + , (42) 3-Z- [1- (4-chloro-anilino) -1-propyl-methylene] - 6-carbamoyl-2-indolinone, from a resin prepared similar to Preparation 2 (4) and 4-chloroaniline,

Rphodnota produktu: 0,17 (gél kyseliny kremičitej, metylénchlorid/metanol = 9:1),Product value: 0.17 (silica gel, methylene chloride / methanol = 9: 1),

C19H18C1N3O2, hmotnostné spektrum: m/z = 355/357 [M]+, (43) 3-Z-[ 1 -(3-chlór-anilino)-1 -propyl-metylén]-6-karbamoyl-2-indolinón, zo živice pripravenej podobne ako v príprave 2 (4) a 3-chlór-anilínu,C 19 H 18 ClN 3 O 2 , mass spectrum: m / z = 355/357 [M] + , (43) 3-Z- [1- (3-chloro-anilino) -1-propylmethylene] -6 -carbamoyl-2-indolinone, from a resin prepared similar to Preparation 2 (4) and 3-chloroaniline,

Rphodnota produktu: 0, 12 (gél kyseliny kremičitej, metylénchlorid/metanol = 9 : 1),Product value: 0.12 (silica gel, methylene chloride / methanol = 9: 1),

C19H18C1N3O2, hmotnostné spektrum: m/z = 355/357 [M]+, (44) 3-Z-[ 1 -(4-metoxykarbonyl-anilino)-1 -propyl-metylén] -6-karbamoyl-2-indolinón, zo živice pripravenej podobne ako v príprave 2 (4) a metylesteru kyseliny 4-amino-benzoovej,C 19 H 18 ClN 3 O 2 , mass spectrum: m / z = 355/357 [M] + , (44) 3-Z- [1- (4-methoxycarbonyl-anilino) -1-propyl-methylene] -6 -carbamoyl-2-indolinone, from a resin prepared similar to Preparation 2 (4) and 4-aminobenzoic acid methyl ester,

Rf-hodnota produktu: 0,8 (gél kyseliny kremičitej, metylénchlorid/metanol = 4 : 1),Rf value of the product: 0.8 (silica gel, methylene chloride / methanol = 4: 1),

C21H21N3O4, hmotnostné spektrum: m/z = 379 [M]+, (45) 3-Z-[l-(4-karboxy-anilino)-l-propyl-metylén]-6-karbamoyl-2-indolinón, zo živice pripravenej podobne ako v príprave 2 (4) a z kyseliny 4-amino-benzoovej,C 21 H 21 N 3 O 4 , mass spectrum: m / z = 379 [M] + , (45) 3-Z- [1- (4-carboxy-anilino) -1-propyl-methylene] -6-carbamoyl -2-indolinone, from a resin prepared similar to Preparation 2 (4) and from 4-aminobenzoic acid,

C2oH[9N304, hmotnostné spektrum: m/z = 364 [M-H]+, (46) 3-Z-[l-(4-metyl-3-nitro-anilino)-l-propyl-metylén]-6-karbamoyl-2-indolmón, zo živice pripravenej podobne ako v príprave 2 (4) a z 4-metyl-3-nitro-anilínu,C 20 H 9 N 3 0 4 , mass spectrum: m / z = 364 [MH] + , (46) 3-Z- [1- (4-methyl-3-nitro-anilino) -1-propyl-methylene -6-carbamoyl-2-indolmone, from a resin prepared similar to Preparation 2 (4) and from 4-methyl-3-nitroaniline,

Rphodnota produktu: 0,86 (gél kyseliny kremičitej, metylénchlorid/metanol = 4 : 1), C20H20N4O4, hmotnostné spektrum: m/z = 380 [M]+.Rphodnota product: 0.86 (silica gel, methylene chloride / methanol = 4: 1), C 20 H 20 N 4 O 4, MS: m / z = 380 [M] +.

Príklad 2 3-Z-[l-(3-(Piperidin-l-yl-metyl)-anilino)-l-fenyl-metylén]-6-karbamoyl-2-indolinón-trifluóracetátExample 2 3-Z- [1- (3- (Piperidin-1-ylmethyl) -anilino) -1-phenyl-methylene] -6-carbamoyl-2-indolinone trifluoroacetate

2,0 g 3-Aminobenzylalkoholu v 20 ml difenylformamidu podobne ako v príklade 1 sa spolu s 2,0 g živice pripravenej podobne ako v príprave 2 22 hodín pretrepávalo pri 70 °C. Rozpúšťadlo sa potom odstránilo odsávaním a živica sa niekoľko razy premyla dimetylformamidom a metylénchloridom. Nasýtená živica (200 mg) sa potom dispergovala v 2 ml metylénchloridu a po pridaní 0,2 ml chloridu kyseliny metánsulfónovej a 0,1 ml trietylamínu sa zmes nechala 2 hodiny stať pri teplote miestnosti. Živica sa potom viac razy premyla metylénchloridom, dispergovala v 2 ml metylénchloridu a pridali sa 0,2 ml piperidínu. Po hodine sa živica premyla metylénchloridom a dimetylformamidom a potom sa spracovala ako v príklade 1.2.0 g of 3-Aminobenzyl alcohol in 20 ml of diphenylformamide, similar to Example 1, was shaken at 70 ° C for 22 hours along with 2.0 g of a resin prepared similar to Preparation 2. The solvent was then removed by suction and the resin was washed several times with dimethylformamide and methylene chloride. The saturated resin (200 mg) was then dispersed in 2 ml of methylene chloride and after addition of 0.2 ml of methanesulfonic acid chloride and 0.1 ml of triethylamine the mixture was allowed to stand at room temperature for 2 hours. The resin was then washed several times with methylene chloride, dispersed in 2 ml of methylene chloride, and 0.2 ml of piperidine was added. After one hour, the resin was washed with methylene chloride and dimethylformamide and then worked up as in Example 1.

Výťažok: 15 mg, Rf-hodnota produktu: 0,30 (gél kyseliny kremičitej, metylénchlorid/metanol = 4 : 1), C28H28N4O2,Yield: 15 mg, Rf value of the product: 0.30 (silica gel, methylene chloride / methanol = 4: 1), C28H28N4O2,

Hmotnostné spektrum: m/z = 452 [M]+.Mass spectrum: m / z = 452 [M] &lt; + &gt;.

Podobne ako v príklade 2 sa pripravili nasledujúce zlúčeniny:As in Example 2, the following compounds were prepared:

(1) 3-Z-[ 1 -(3-(dietylaminometyl)anilino)-1 -fenyl-metylén]-6-karbamoyl-2-indolinón-trifluóracetát, zlúčenina sa pripravila zo živice pripravenej podobne ako v príprave 2 a z dietylamínu, Rf-hodnota produktu: 0,80 (gél kyseliny kremičitej, metylénchlorid/metanol = 4 : 1), C27H28N4O2, hmotnostné spektrum: m/z = 440 [M]+, (2) 3-Z-[ 1 -(3-(benzylaminometyl)-anilino)-1 -fenyl-metylén] -6-karbamoyl-2-indolinón-trifluóracetát, zlúčenina sa pripravila zo živice pripravenej podobne ako v príprave 2 a z benzyl-amínu, Rrhodnota produktu: 0,80 (gél kyseliny kremičitej, metylénchlorid/metanol = 4:1),(1) 3-Z- [1- (3- (diethylaminomethyl) anilino) -1-phenylmethylene] -6-carbamoyl-2-indolinone trifluoroacetate, prepared from a resin prepared similar to Preparation 2 and from diethylamine, Rf value of product: 0.80 (silica gel, methylene chloride / methanol = 4: 1), C27H28N4O2, mass spectrum: m / z = 440 [M] +, (2) 3-Z- [1- (3-) (benzylamino-methyl) anilino) -1-phenyl-methylene] -6-carbamoyl-2-indolinone-trifluoroacetate prepared from the resin prepared as in preparation 2 and benzylamine, the product, R f value: 0.80 (gel silicic acid, methylene chloride / methanol = 4: 1),

C30H26N4O2, hmotnostné spektrum: m/z = 474 [M]+, (3) 3-Z-[l-(3-(JV-metyl-N-benzyl-aminometyl)-anilino)-l-fenyl-metylén]-6-karbamoyl-2-indolinón-trifluóracetát, zlúčenina sa pripravila zo živice pripravenej podobne ako v príprave 2 a z /V-metyl-benzylamínu, Rrhodnota produktu: 0,80 (gél kyseliny kremičitej, metylénchlorid/metanol = 4:1),C30H26N4O2, mass spectrum: m / z = 474 [M] &lt; + &gt;, (3) 3-Z- [1- (3- (N-methyl-N-benzylaminomethyl) anilino) -1-phenyl-methylene] - 6-carbamoyl-2-indolinone trifluoroacetate, the compound was prepared from a resin prepared similarly to Preparation 2 and N, N-methyl-benzylamine, Product Value: 0.80 (silica gel, methylene chloride / methanol = 4: 1),

C31H28N4O2, hmotnostné spektrum: m/z = 488 [M]+, (4) 3-Z-[l-(3-(butylaminometyl)-anilino)-l-fenyl-metylén]-6-karbamoyl-2-indolinón-trifluóracetát, zlúčenina sa pripravila zo živice pripravenej podobne ako v príprave 2 a z butylamínu, Rrhodnota produktu: 0,40 (gél kyseliny kremičitej, metylénchlorid/metanol = 4 : 1),C 31 H 28 N 4 O 2 , mass spectrum: m / z = 488 [M] + , (4) 3-Z- [1- (3- (butylaminomethyl) anilino) -1-phenylmethylene] -6 -carbamoyl-2-indolinone trifluoroacetate, the compound was prepared from a resin prepared similar to Preparation 2 and from butylamine, Product Value: 0.40 (silica gel, methylene chloride / methanol = 4: 1),

C27H28N4O2, hmotnostné spektrum: m/z = 440 [M]+, (5) 3-Z-[l-(3-(aminometyl)-anilino)-l-fenyl-metylén]-6-karbamoyl-2-indolinón-trifluór-acetát, zlúčenina sa pripravila zo živice pripravenej podobne ako v príprave 2 a z amoniaku, C23H20N4O2, hmotnostné spektrum: m/z = 385 [M+H]+, (6) 3 -Z-[ 1 -(3-(A-(3 -di mety laminopropylj-N-mety laminomety l)anilino)-1 -fenyl-metylén]-6-karbamoyl-2-indolinón-trifluóracetát, zlúčenina sa pripravila zo živice pripravenej podobne ako v príprave 2 a z l-dimetylamino-3-metylaminopropánu,C27H28N4O2, mass spectrum: m / z = 440 [M] + , (S) 3-Z- [1- (3- (aminomethyl) anilino) -1-phenylmethylene] -6-carbamoyl-2-indolinone- trifluoroacetate, the compound was prepared from a resin prepared similar to Preparation 2 and ammonia, C 23 H 20 N 4 O 2 , mass spectrum: m / z = 385 [M + H] + , (6) 3 -Z- [ 1- (3- (N- (3-dimethylaminopropyl) -N-methylaminomethyl) anilino) -1-phenylmethylene] -6-carbamoyl-2-indolinone trifluoroacetate, prepared from a resin prepared similarly to preparation of 2 to 1-dimethylamino-3-methylaminopropane,

Rrhodnota produktu: 0,67 (gél kyseliny kremičitej, metylénchlorid/metanol = 4 : 1), C29H33N5O, hmotnostné spektrum: m/z = 484 [M+H]+, (7) 3-Z-[l-(3-(AL(2-dimetylaminoetyl)-/V-metyl-aminometyl)-anilino)-l-fenyl-metylén]-6-karbamoyl-2-indolinón-trifluóracetát, zlúčenina sa pripravila zo živice pripravenej podobne ako v príprave 2 a z l-dimetylamino-2-metylaminoetánu,Product value: 0.67 (silica gel, methylene chloride / methanol = 4: 1), C 29 H 33 N 5 O, mass spectrum: m / z = 484 [M + H] + , (7) 3-Z- [1- (3- (A L (2-Dimethylaminoethyl) - N -methyl-aminomethyl) -anilino) -1-phenylmethylene] -6-carbamoyl-2-indolinone trifluoroacetate, prepared from a resin prepared similarly as in preparation 2 and 1-dimethylamino-2-methylaminoethane,

Rrhodnota produktu: 0,40 (gél kyseliny kremičitej, metylénchlorid/metanol = 4 : 1), C28H31N5O2, hmotnostné spektrum: m/z = 470 [M+H]+.Product value: 0.40 (silica gel, methylene chloride / methanol = 4: 1), C 28 H 31 N 5 O 2 , mass spectrum: m / z = 470 [M + H] + .

Príklad 3Example 3

3-Z-[ 1 -(4-(Piperidin-1 -yl-metyl)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón3-Z- [1- (4- (Piperidin-1-yl-methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone

1,5 g 1-Acetyl-3-(l-etoxy-l-fenyl-metylén)-6-etoxykarbonyl-2-indolinónu a 1,1 g 4-(piperidín-l-yl-metyl)-anilínu sa rozpustilo v 15 ml dimetylformamidu a roztok sa 45 minút miešal pri 100 °C. Po ochladení sa pridalo 5,0 ml piperidínu a reakčná zmes sa pri teplote miestnosti miešala ďalšie tri hodiny. Po odstránení rozpúšťadla sa zvyšok čistil na stĺpci oxidu hlinitého (aktivita oxidu 2 až 3) s použitím metylén-chloridu a etanolu (100 : 3) ako elučným činidlom.1.5 g of 1-Acetyl-3- (1-ethoxy-1-phenyl-methylene) -6-ethoxycarbonyl-2-indolinone and 1.1 g of 4- (piperidin-1-ylmethyl) -aniline were dissolved in 15 ml of dimethylformamide and the solution was stirred at 100 ° C for 45 minutes. After cooling, 5.0 mL of piperidine was added and the reaction mixture was stirred at room temperature for an additional three hours. After removal of the solvent, the residue was purified on an alumina column (2 to 3 oxide activity) using methylene chloride and ethanol (100: 3) as eluent.

Výťažok: 1,1 g (58 % teoretického výťažku), Rrhodnota produktu: 0,5 (oxid hlinitý, metylénchlorid/etanol =100:3) C3oH31N303, hmotnostné spektrum: m/z = 481 [M]+ .Yield: 1.1 g (58% of theory), Product value: 0.5 (aluminum oxide, methylene chloride / ethanol = 100: 3) C 3 H 31 N 3 0 3 , mass spectrum: m / z = 481 [M] ] + .

Podobne ako v príklade 3 sa pripravili nasledujúce zlúčeniny:As in Example 3, the following compounds were prepared:

(1) 3-Z-[l-(4-bróm-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(1 -etoxy-1 -fenyl-metylén)-6-etoxykarbonyl-2-indolinónu a 4-brómanilínu,(1) 3-Z- [1- (4-bromo-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenyl- methylene) -6-ethoxycarbonyl-2-indolinone and 4-bromoaniline,

Rrhodnota produktu: 0,4 (gél kyseliny kremičitej, toluén/etylester kyseliny octovej = 5:1), C24H i9BrN2O3, hmotnostné spektrum: m/z = 462/464 [M]+, (2) 3-Z-[l-(3-(dimetylaminometyl)anilino)-l-fenylmetylén]-6-etoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(I-etoxy-l-fenyl-metylén)-6-etoxykarbonyl-2-indolinónu a 3-(dimetylaminometyl)-anilínu,Product value: 0.4 (silica gel, toluene / ethyl acetate = 5: 1), C 24 H 19 BrN 2 O 3 , mass spectrum: m / z = 462/464 [M] + , (2) 3- Z- [1- (3- (dimethylaminomethyl) anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-ethoxycarbonyl -2-indolinone and 3- (dimethylaminomethyl) aniline,

Rrhodnota produktu: 0,5 (oxid hlinitý, metylénchlorid/etanol = 30 : 1),Product value: 0.5 (alumina, methylene chloride / ethanol = 30: 1),

C27H27N3O3,C 27 H 27 N 3 O 3

ESI-hmotnostné spektrum: m/z = 442 [M+H]+, (3) 3-Z-[ 1 -(4-(dimetylaminometyl)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l -etoxy- l-fenyl-metylén)-6-etoxykarbonyl-2-indolinónu a 4-(dimetylaminometyl)-anilínu,ESI-MS: m / z = 442 [M + H] + , (3) 3-Z- [1- (4- (dimethylaminomethyl) anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2- indolinone, prepared by reacting 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-ethoxycarbonyl-2-indolinone and 4- (dimethylaminomethyl) aniline,

Rrhodnota produktu: 0,7 (oxid hlinitý, etylester kyseliny octovej/etanol = 20 : 1),Product value: 0.7 (alumina, ethyl acetate / ethanol = 20: 1),

C27H27N3O3,C 27 H 27 N 3 O 3

ESI-hmotnostné spektrum: m/z = 442 [M+H]+, (4) 3-Z-[ 1 -(4-[(2,6-dimetyl-piperidin-1 -yl)-metyl]-anilino)-1 -fenyl-metylén]-6-etoxy-karbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-etoxykarbonyl-2-indolinónu a 4-[(2,6-dimetyl-piperidin-1-yl) metyl]-anilínu,ESI-MS: m / z = 442 [M + H] + , (4) 3-Z- [1- (4 - [(2,6-dimethyl-piperidin-1-yl) -methyl] -anilino) 1-Phenylmethylene] -6-ethoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-ethoxycarbonyl-2-indolinone and 4 - [( 2,6-dimethyl-piperidin-1-yl) methyl] -aniline,

Rrhodnota produktu: 0,6 (gél kyseliny kremičitej, metylénchlorid/etanol = 5:1),Product value: 0.6 (silica gel, methylene chloride / ethanol = 5: 1),

C32H35N3O3, hmotnostné spektrum: m/z=5O9 [M]+, (5) 3-Z-[ 1 -(4-(2-dimetylamino-etyl)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-etoxykarbonyl-2-indolinónu a 4-(2-dimetylamino-etyl)-anilínu,C 32 H 35 N 3 O 3 , mass spectrum: m / z = 5O9 [M] + , (S) 3-Z- [1- (4- (2-dimethylamino-ethyl) -anilino) -1-phenyl- methylene] -6-ethoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-ethoxycarbonyl-2-indolinone and 4- (2-dimethylamino-ethyl) -aniline .

Rrhodnota produktu: 0,2 (gél kyseliny kremičitej, metylénchlorid/etanol = 5:1),Product value: 0.2 (silica gel, methylene chloride / ethanol = 5: 1),

C28H29N3O3, hmotnostné spektrum: m/z=44 [M]+, (6) 3-Z-[ 1 -(4-(7V-(2-dimetylamino-etyl)-7V-acetyl-amino)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-etoxykarbonyl-2-indolinónu a 4-(/V-(2-dimetylamino-etyl)-A'-acetyl-amino)-anilínu,C 28 H 29 N 3 O 3 , mass spectrum: m / z = 44 [M] + , (6) 3-Z- [1- (4- (N - (2-dimethylamino-ethyl) -7 H -acetyl- amino) -anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, prepared by reacting 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-ethoxycarbonyl-2-indolinone and 4 - (/ V- (2-dimethylamino-ethyl) -N-acetyl-amino) -aniline,

Rrhodnota produktu: 0,4 (oxid hlinitý, metylénchlorid/etanol = 20 : 1),Product value: 0.4 (alumina, methylene chloride / ethanol = 20: 1),

C3oH32N404, hmotnostné spektrum: m/z=512 [M]+, (7) 3-Z-[l-(4-terc-butyloxykarbonyl-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-etoxykarbonyl-2-indolinónu a 4-terc-butyloxykarbonyl-anilínu,C 3 H 32 N 4 O 4 , mass spectrum: m / z = 512 [M] + , (7) 3-Z- [1- (4-tert-butyloxycarbonyl-anilino) -1-phenyl-methylene] -6 -ethoxycarbonyl-2-indolinone, prepared by reacting 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-ethoxycarbonyl-2-indolinone and 4-tert-butyloxycarbonyl-aniline,

Rrhodnota produktu: 0,4 (oxid hlinitý, metylénchlorid/etanol = 40 : 1),Product value: 0.4 (alumina, methylene chloride / ethanol = 40: 1),

C29H28N2O5, hmotnostné spektrum: m/z=484 [M]+, (8) 3-Z-[l-(4-(jV-(3-dimetylammo-propyl)-A'-acetyl-ammo)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-etoxykarbonyl-2-indolinónu a 4-(7V-(3-dimetylamino-propyl)-7V-acetyl-amino)-anilínu,C 29 H 28 N 2 O 5 , mass spectrum: m / z = 484 [M] + , (8) 3-Z- [1- (4- (N - (3-dimethylaminopropyl) -N-acetyl) -amino-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-ethoxycarbonyl-2-indolinone and 4- (7V- (3-dimethylaminopropyl) -7V-acetyl-amino) -aniline,

Rf-hodnota produktu: 0,2 (oxid hlinitý, metylénchlorid/etanol = 40 : 1),Rf value of product: 0.2 (alumina, methylene chloride / ethanol = 40: 1),

C31H34N4O4, hmotnostné spektrum: m/z=526 [M]+, (9) 3-Z-[l-(4-(/V-(2-dimetylaminoetyl)-/V-metylsulfonylamino)anilino)-l-fenylmetylén]-6-etoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-etoxykarbonyl-2-indolinónu a /V-(2-dimetylamino-etyl)-A'-metylsulfonyl-/)-fenyléndiamínu,C31H34N4O4, mass spectrum: m / z = 526 [M] &lt; + &gt;, (9) 3-Z- [1- (4- (N - (2-dimethylaminoethyl) - N -methylsulfonylamino) anilino) -1-phenylmethylene] 6-ethoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-ethoxycarbonyl-2-indolinone and N - (2-dimethylamino-ethyl) - N ' methylsulphonyl - /) - phenylenediamine,

Rf-hodnota produktu: 0,3 (oxid hlinitý, metylénchlorid/etanol = 40 : 1),Rf value of the product: 0.3 (alumina, methylene chloride / ethanol = 40: 1),

C29H32N4O5S, hmotnostné spektrum: m/z = 548 [M]+, (10) 3-Z-[ 1 -(4-(4-metyl-piperazin-1 -yl)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, pripravený reakciou 1 -acetyl-3 -(1 -etoxy-1 -fenyl-metylén)-6-etoxykarbonyl-2-indoIinónu a 4-(4-metyl-piperazin-1 -y 1) -anilínu,C29H32N4O5S, mass spectrum: m / z = 548 [M] &lt; + &gt;, (10) 3-Z- [1- (4- (4-methyl-piperazin-1-yl) -anilino) -1-phenyl-methylene] - 6-ethoxycarbonyl-2-indolinone, prepared by reacting 1-acetyl-3- (1-ethoxy-1-phenyl-methylene) -6-ethoxycarbonyl-2-indolinone and 4- (4-methyl-piperazin-1-yl) aniline,

Rf-hodnota produktu: 0,3 (oxid hlinitý, etylester kyseliny octovej),Rf value of product: 0.3 (alumina, ethyl acetate),

C29H30N4O3,C29H30N4O3.

ESI-hmotnostné spektrum: m/z = 483 [M+H]+, (11) 3-Z-[ 1 -(4-(/V-(2-dimetylamino-etyl)-/V-metyl-amino)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-etoxykarbonyl-2-indolinónu a 4-(/V-(2-dimetylamino-etyl)-/V-metyl-amino)-anilínu,ESI-MS: m / z = 483 [M + H] + , (11) 3-Z- [1- (4 - (N - (2-dimethylamino-ethyl) - N -methyl-amino) - anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-ethoxycarbonyl-2-indolinone and 4 - (/ N- (2-dimethylamino-ethyl) - / V-methyl-amino) -aniline,

Rf-hodnota produktu: 0,5 (oxid hlinitý, metylénchlorid/etanol = 20 : 1),Rf value of product: 0.5 (alumina, methylene chloride / ethanol = 20: 1),

C29H32N4O3,C 29 H 3 N 4 O 3 ,

ESI-hmotnostné spektrum: m/z = 485 [M+H]+, (12) 3-Z-[l-(4-(/V-(3-dimetylamino-propyl)-jV-metyl]-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-etoxykarbonyl-2-indolinónu a 4-(//-(3-dimetylamino-propyl)-7V-metyl-amino)-anilínu,ESI-MS: m / z = 485 [M + H] + , (12) 3-Z- [1- (4 - (N - (3-dimethylamino-propyl) - N -methyl] -amino) - anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-ethoxycarbonyl-2-indolinone and 4 - (/ / - (3-dimethylaminopropyl) -7V-methyl-amino) -aniline,

Rrhodnota produktu: 0,5 (oxid hlinitý, etylester kyseliny octovej),R r value of the product: 0,5 (alumina, ethyl acetate),

C30H34N4O3,C30H34N4O3.

ESI-hmotnostné spektrum: m/z = 499 [M+H]+, (13) 3-Z-[ 1 -(4-(7V-metyl-acetylamino)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-etoxykarbonyl-2-indolinónu a 4-amino-/V-metyl-acetanilidu,ESI-MS: m / z = 499 [M + H] &lt; + &gt;, (13) 3-Z- [1- (4- (N-methyl-acetylamino) -anilino) -1-phenyl-methylene] -6- ethoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-ethoxycarbonyl-2-indolinone and 4-amino- N -methyl-acetanilide,

Rrhodnota produktu: 0,3 (gél kyseliny kremičitej, metylénchlorid/etanol = 15 : 1), C27H25N3O3, hmotnostné spektrum: m/z = 455 [M]+, (14) 3-Z-[ 1 -(4-(/V-metyl-metylsulfonylamino)anilino)-1 -fenylmetylén]-6-etoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-1-fenyl-metylén)-6-etoxykarbonyl-2-indolinónu a 7V-(4-aminofenyl)-Ä/-metyl-metánsulfónamidu,Product Rf value: 0.3 (silica gel, methylene chloride / ethanol = 15: 1), C 7 H 25 N 2 O 3 3 MS: m / z = 455 [M] +, (14) 3-Z- [1 - (4- (N -methyl-methylsulfonylamino) anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6- ethoxycarbonyl-2-indolinone and N - (4-aminophenyl) - N -methyl methanesulfonamide,

Rrhodnota produktu: 0,8 (oxid hlinitý, etylester kyseliny octovej),Product value: 0.8 (alumina, ethyl acetate),

C26H25N3O5S, hmotnostné spektrum: m/z = 491 [M]+, (15) 3-Z-[l-(4-(/V-(3-dimetylamino-propyl)-/V-metylsulfonyl-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-etoxykarbonyl-2-indolinónu a /V-(3-dimetylamino-propyl)-/V-metylsulfonyl-p-fenyléndiamínu,C 26 H 25 N 3 O 5 S, mass spectrum: m / z = 491 [M] + , (15) 3-Z- [1- (4 - (N - (3-dimethylaminopropyl) -) (methylsulfonyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenyl-methylene) -6-ethoxycarbonyl-2- indolinone and N - (3-dimethylamino-propyl) - N -methylsulfonyl-p-phenylenediamine,

Rrhodnota produktu: 0,6 (gél kyseliny kremičitej, metylénchlorid/etanol/amoniak = 5:2: 0,01),Product value: 0.6 (silica gel, methylene chloride / ethanol / ammonia = 5: 2: 0.01),

C30H34N4O5S,C30H34N4O5S.

ESI-hmotnostné spektrum: m/z = 563 [M+H]+, (16) 3-Z-[ 1 -(4-(WdimetylaminokarbonyI-metyl-7/-metylsulfonylamino)anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-etoxykarbonyl-2-indolinónu a 4-(JV-dimetylaminokarbonyl-metyl-íV-metylsulfonyl)-amino)-anilínu,ESI-MS: m / z = 563 [M + H] + , (16) 3- Z- [1- (4- (N-dimethylaminocarbonyl-methyl-7-methylsulfonylamino) anilino) -1-phenylmethylene] - 6-ethoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-ethoxycarbonyl-2-indolinone and 4- ( N -dimethylaminocarbonylmethyl-N-methylsulfonyl) amino) aniline,

Rrhodnota produktu: 0,6 (gél kyseliny kremičitej, metylénchlorid/etanol = 10 : 1), C29H30N4O6S, ESI-hmotnostné spektrum: m/z = 561 [M-H]', (17) 3-Z-[ 1 -(4-(imidazol-4-yl)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-etoxykarbonyl-2-indolinónu a 4-(imidazol-4-yl)-anilínu,Product Rf value: 0.6 (silica gel, methylene chloride / ethanol = 10: 1), 2 C 9 H 30 N 4 O6S, ESI-MS: m / z = 561 [MH] ', (17) 3-Z- [1- (4- (Imidazol-4-yl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenyl-methylene) ) -6-ethoxycarbonyl-2-indolinone and 4- (imidazol-4-yl) aniline,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/etanol/amoniak =10:1: 0,01), c27h22n4o3, hmotnostné spektrum: m/z = 450 [M]+, (18) 3-Z-[ 1 -(4-(tetrazol-5-yl)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-etoxykarbonyl-2-indolinónu a 4-(tetrazol-5-yl)-anilínu, R f value of the product: 0.5 (silica gel, methylene chloride / ethanol / ammonia 10: 1: 0.01), C 27 H 22 N 4 O 3 MS: m / z = 450 [M] +, (18) 3-Z- [1- (4- (tetrazol-5-yl) -anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, prepared by reaction of 1-acetyl-3- (1- ethoxy-1-phenyl-methylene) -6-ethoxycarbonyl-2-indolinone and 4- (tetrazol-5-yl) -aniline,

Rf-hodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/etanol = 5:1),Rf value of product: 0.5 (silica gel, methylene chloride / ethanol = 5: 1),

C25H20N6O3,C 25 H 20 N 6 O 3

ESI-hmotnostné spektrum: m/z = 451 [M-H], (19) 3-Z-[ 1 -(4-(7V-benzyl-jV-metylaminometyl)anilino)-1 -fenylmetylén]-6-etoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-etoxykarbonyl-2-indolinónu a 4-(/V-benzyl-A-metyl-aminometyl)-anilínu,ESI-MS: m / z = 451 [MH], (19) 3- Z- [1- (4- (N-benzyl-N-methylaminomethyl) anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2- indolinone, prepared by reacting 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-ethoxycarbonyl-2-indolinone and 4- (N-benzyl-N-methyl-aminomethyl) aniline,

Rrhodnota produktu: 0,4 (gél kyseliny kremičitej, metylénchlorid/etanol = 10 : 1), C33H31N3O3, ESI-hmotnostné spektrum: m/z = 516 [M-H], (20) 3-Z-[ 1 -(4-(A/-(2-dimetylamino-etyl)-7V-propionyl-amino)-anilín)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-etoxykarbonyl-2-indolinónu a 4-[A-(2-dimetylamino-etyl)-/V-propionyI-amino]-anilínu, R f value of the product: 0.4 (silica gel, methylene chloride / ethanol = 10: 1), C 33 H 31 N 3 O 3; ESI-MS: m / z = 516 [MH], (20) 3- Z- [1 - (4- (A / - (2-dimethylamino-ethyl) -7V-propionyl-amino) -aniline) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, prepared by reaction of l-acetyl -3- (1-ethoxy-1-phenyl-methylene) -6-ethoxycarbonyl-2-indolinone and 4- [N- (2-dimethylamino-ethyl) - N -propionylamino] -aniline,

Rrhodnota produktu: 0,2 (gél kyseliny kremičitej, metylénchlorid/etanol = 5:1),Product value: 0.2 (silica gel, methylene chloride / ethanol = 5: 1),

C3iH34N4O4,C 3 iH 34 N 4 O 4 ,

ESI-hmotnostné spektrum: m/z = 525 [M-H], (21) 3 -Z- [ 1 -(4-(pyrolidin-1 -yl-metyl)-anilino)-1 -fenyl-metylén] -6-etoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-etoxykarbonyl-2-indolinónu a 4-(pyrolidín-l-yl-metyl)-anilínu,ESI-MS: m / z = 525 [MH], (21) 3 -Z- [1- (4- (pyrrolidin-1-ylmethyl) -anilino) -1-phenylmethylene] -6-ethoxycarbonyl -2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenyl-methylene) -6-ethoxycarbonyl-2-indolinone and 4- (pyrrolidin-1-ylmethyl) aniline,

Rrhodnota produktu: 0,1 (gél kyseliny kremičitej, metylénchlorid/etanol = 5:1),Product value: 0.1 (silica gel, methylene chloride / ethanol = 5: 1),

C29H29N3O3,C 29 H 9 N 3 O 2 3,

ESI-hmotnostné spektrum: m/z = 466 [M-H]', (22) 3-Z-[ 1 -(4-(7V-metyl-/V-fenetyl-aminometyl)-anilino)-1 -fenylmetylén]-6-etoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-etoxykarbonyl-2-indolinónu a 4-(7V-fenetyl-jV-metyl-aminometyl)-anilínu,ESI-MS: m / z = 466 [MH] -, (22) 3-Z- [1- (4- (N-methyl- N -phenethylaminomethyl) anilino) -1-phenylmethylene] -6 -ethoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenyl-methylene) -6-ethoxycarbonyl-2-indolinone and 4- (N-phenethyl-N-methyl-aminomethyl) -aniline .

Rrhodnota produktu: 0,4 (gél kyseliny kremičitej, metylénchlorid/etanol = 10 : 1),Product value: 0.4 (silica gel, methylene chloride / ethanol = 10: 1),

C34H33N3O3,C 34 H 33 N 3 O 3

ESI-hmotnostné spektrum: m/z = 530 [M-H], (23) 3-Z-[l-(4-(7V-dimetylaminometylkarbonyl-/V-metylamino)anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-etoxykarbonyl-2-indolinónu a /V-dimetylaminometylkarbonyl-yV-metyl-/j-fenyléndiamínu,ESI-MS: m / z = 530 [MH], (23) 3-Z- [1- (4- (N-dimethylaminomethylcarbonyl- N -methylamino) anilino) -1-phenylmethylene] -6-ethoxycarbonyl -2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-ethoxycarbonyl-2-indolinone and N-dimethylaminomethylcarbonyl-N-methyl- N -phenylenediamine,

Rrhodnota produktu: 0,1 (gél kyseliny kremičitej, metylénchlorid/etanol = 10 : 1),Product value: 0.1 (silica gel, methylene chloride / ethanol = 10: 1),

C29H3oN404,C 29 H 3 oN 4 0 4

ESI-hmotnostné spektrum: m/z = 497 [M-H]', (24) 3-Z-[l-(4-(/V-(2-dimetylaminoetyl)-7V-etyIsulfonylamino)anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-etoxykarbonyl-2-indolinónu a N-(2-dimetylamino-etyl)-jV-etylsulfonyl-p-fenyléndiamínu,ESI-MS: m / z = 497 [MH] -, (24) 3-Z- [1- (4- (N - (2-dimethylaminoethyl) -N-ethylsulfonylamino) anilino) -1-phenylmethylene ] -6-ethoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-ethoxycarbonyl-2-indolinone and N- (2-dimethylamino-ethyl) -N- ethylsulfonyl-p-phenylenediamine,

Rrhodnota produktu: 0,6 (gél kyseliny kremičitej, metylénchlorid/etanol = 5:1),R r value of the product: 0.6 (silica gel, methylene chloride / ethanol = 5: 1),

C30H34N4O5S,C30H34N4O5S.

ESI-hmotnostné spektrum: m/z = 561 [M-H]', (25) 3-Z-[ 1 -(4-(7V-terc-butoxykarbonyl-A'-etyl-aminometyl)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-etoxykarbonyl-2-indolinónu a 4-(/V-terc-butoxykarbonyl-/V-etylaminometyl)-anilínu,ESI-MS: m / z = 561 [MH] -, (25) 3-Z- [1- (4- (N-tert-butoxycarbonyl-N'-ethyl-aminomethyl) -anilino) -1-phenyl- methylene] -6-ethoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-ethoxycarbonyl-2-indolinone and 4- (N-tert-butoxycarbonyl-) V-ethylaminomethyl) -aniline,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 10 : 1),R r value of the product: 0.5 (silica gel, methylene chloride / methanol = 10: 1),

C32H35N3O5,C32H35N3O5.

ESI-hmotnostné spektrum: m/z = 540 [M-H]’, (26) 3-Z-[ 1 -(4-(piperidin-1 -ylmetyl)anilino)-1 -etylmetylén]-6-etoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-etyl-metylén)-6-etoxykarbonyl-2-indolinónu a 4-(piperidin-l-yl-metyl)-anilínu,ESI-MS: m / z = 540 [MH] -, (26) 3-Z- [1- (4- (piperidin-1-ylmethyl) anilino) -1-ethylmethylene] -6-ethoxycarbonyl-2-indolinone prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-ethyl-methylene) -6-ethoxycarbonyl-2-indolinone and 4- (piperidin-1-ylmethyl) -aniline,

Rrhodnota produktu: 0,9 (gél kyseliny kremičitej, metylénchlorid/etanol = 5:1),R r value of the product: 0.9 (silica gel, methylene chloride / ethanol = 5: 1),

C26H3iN3O3,C 26 H 3 N 3 O 3 ,

ESI-hmotnostné spektrum: m/z = 432 [M-H]‘, (27) 3-Z-[l-(4-(7V-(2-dimetylaminoetyl)-/V-metylsulfonylamino)anilino)-l-etyl-metylén]-6-etoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-etyl-metylén)-6-etoxykarbonyl-2-indolinónu a ?V-(2-dimetylamino-etyl)-jV-metylsulfonyl-p-fenyléndiamínu,ESI-MS: m / z = 432 [MH] +, (2 S) 3-Z- [1- (4- (N - (2-dimethylaminoethyl) - N -methylsulfonylamino) anilino) -1-ethylmethylene 6-ethoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-ethylmethylene) -6-ethoxycarbonyl-2-indolinone and N - (2-dimethylamino-ethyl) - N -. methylsulphonyl-p-phenylenediamine,

Rrhodnota produktu: 0,3 (gél kyseliny kremičitej, metylénchlorid/etanol = 5:1),R r value of the product: 0.3 (silica gel, methylene chloride / ethanol = 5: 1),

C25H32N4O5S,C 25 H3 2 N 4 O 5 S

ESI-hmotnostné spektrum: m/z = 499 [M-H]’, (28) 3-Z-[l-(4-(dimetylaminometyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenylmetylén)-6-metoxykarbonyl-2-indolinónu a 4-(dimetylaminometyl)-anilínu,ESI-MS: m / z = 499 [MH] -, (28) 3-Z- [1- (4- (dimethylaminomethyl) anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, prepared by reacting 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4- (dimethylaminomethyl) aniline,

Rrhodnota produktu: 0,6 (gél kyseliny kremičitej, metylénchlorid/metanol = 5:1), C26H25N3O3, ESI-hmotnostné spektrum: m/z = 428 [M+H]+, (29) 3-Z-[ 1 -(4-[(2,6-dimetyl-piperidin-1 -yl)-metyl]-anilino)-1 -fenyl-metylén]-6-metoxy-karbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-[(2,6-dimetyl-piperidín-1 -yl)-metyl] -anilínu,Product value: 0.6 (silica gel, methylene chloride / methanol = 5: 1), C26H25N3O3, ESI mass spectrum: m / z = 428 [M + H] + , (29) 3-Z- [1 - ( 4 - [(2,6-dimethyl-piperidin-1-yl) -methyl] -anilino) -1-phenyl-methylene] -6-methoxy-carbonyl-2-indolinone, prepared by reaction of 1-acetyl-3- (1 -ethoxy-1-phenyl-methylene) -6-methoxycarbonyl-2-indolinone and 4 - [(2,6-dimethyl-piperidin-1-yl) -methyl] -aniline,

Rrhodnota produktu: 0,5 (reverzná fáza RP 8, metanol/päťpercentný vodný roztok chloridu sodného = 4 : 1), C31H33N3O3,Product value: 0.5 (reverse phase RP 8, methanol / 5% aqueous sodium chloride = 4: 1), C31H33N3O3,

ESI-hmotnostné spektrum: m/z = 496 [M+H]+, (30) 3-Z-[l-(4-(/V-(2-dimetylamino-etyl)-7V-metylsulfonylamino)anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a A/-(2-dimetylamino-etyl)-/V-metylsulfonyl-p-fenyléndiamínu,ESI-MS: m / z = 496 [M + H] &lt; + &gt;, (30) 3-Z- [1- (4 - (N - (2-dimethylamino-ethyl) -7-methylsulfonylamino) anilino) -1 phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared by reaction of l-acetyl-3- (l-ethoxy-l-phenyl-methylene) -6-methoxycarbonyl-2-indolinone and a / - (2-dimethylamino ethyl) - / V-methylsulfonyl-p-phenylenediamine,

Rrhodnota produktu: 0,6 (gél kyseliny kremičitej, metylénchlorid/metanol = 5:1),Product value: 0.6 (silica gel, methylene chloride / methanol = 5: 1),

C28H3oN405S,C2 8 H 3 oN 4 0 5 S

ESI-hmotnostné spektrum: m/z = 533 [M-H]’, (31) 3-Z-[ 1 -(4-(.'V-(3-dimetylamino-propyl)-/V-metylsulfonyl-amino)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 7V-(3-dimetylamino-propyl)-/V-metylsulfonyl-p-fenyléndiamínu,ESI-MS: m / z = 533 [MH] -, (31) 3-Z- [1- (4 - (N - (3-dimethylamino-propyl) - N -methylsulfonyl-amino) -anilino) -1-Phenylmethylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and N - (3- dimethylaminopropyl) - / V-methylsulfonyl-p-phenylenediamine,

Rrhodnota produktu: 0,5 (oxid hlinitý, metylcnchlorid/metanol = 30 : 1),Product value: 0.5 (alumina, methyl chloride / methanol = 30: 1),

C29H32N4O5S,C29H 3 2N 4 O 5 S

ESI-hmotnostné spektrum: m/z = 547 [M-H]’, (32) 3-Z-[l-(4-(7'/-dimetylaminokarbonyl-metyl-M-metylsulfonyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-((<V-dimetylaminokarbonyl-metyl-/V-metylsulfonyl)-amino)-anilínu,ESI-MS: m / z = 547 [MH] -, (32) 3-Z- [1- (4- (7'-dimethylaminocarbonyl-methyl-N-methylsulfonyl-amino) -anilino) -1-phenyl -methylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4 - ((N-dimethylaminocarbonyl-methyl) - / V-methylsulfonyl) amino) aniline,

Rf-hodnota produktu: 0,5 (oxid hlinitý, metylénchlorid/metanol = 20 : 1),Rf value of product: 0.5 (alumina, methylene chloride / methanol = 20: 1),

C28H28N4O6S,C 2 8H 2 8N 4 O 6 S

ESI-hmotnostné spektrum: m/z = 547 [M-H]’, (33) 3-Z-[ 1 -(4-(A'-acetyl-A,-dimetylammokarbonyl-metyl-amino)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-((,V-acetyl-.A/-dimetylaminokarbonylmetyl)-amino)-anilínu,ESI-mass spectrum: m / z = 547 [MH] -, (33) 3-Z- [1- (4- (N'-acetyl-N , -dimethylaminocarbonyl-methylamino) -anilino) -1-phenyl -methylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4 - ((N-acetyl-). N -dimethylaminocarbonylmethyl) amino-aniline,

Rf-hodnota produktu: 0,6 (gél kyseliny kremičitej, metylénchlorid/metanol = 10 : 1),Rf value of the product: 0.6 (silica gel, methylene chloride / methanol = 10: 1),

C29H28N4O5,C 2 9H 28 N 4 O 5

ESI-hmotnostné spektrum: m/z = 511 [M-H]', (34) 3-Z-[ 1 -(4-(Ä''-dimetylaminokarbonyl-metyl-amino)-amlino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-((7V-dimetylaminokarbonyl-metyl)-amino)-anilínu,ESI-MS: m / z = 511 [MH] -, (34) 3-Z- [1- (4- (N '- dimethylaminocarbonyl-methyl-amino) -amino) -1-phenyl-methylene] - 6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4 - ((N-dimethylaminocarbonylmethyl) amino) - aniline

Rrhodnota produktu: 0,6 (oxid hlinitý, metylénchlorid/metanol = 30 : 1),R r value of the product: 0.6 (alumina, methylene chloride / methanol = 30: 1),

C27H26N4O4,C 27 H 26 N 4 O 4 ,

ESI-hmotnostné spektrum: m/z = 469 [M-H]‘, (35) 3-Z-[l-(4-(7V-(3-dimetylamino-propyl)-7V-acetyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a /v'-(3-dimetylamino-propyl)-7V-acetyl-p-fenyléndiamínu,ESI-MS: m / z = 469 [MH] -, (35) 3- Z- [1- (4- (N - (3-dimethylamino-propyl) -7-acetyl-amino) -anilino) -1 -phenylmethylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and N '- (3-dimethylamino) propyl) -7V-acetyl-p-phenylenediamine,

Rrhodnota produktu: 0,5 (oxid hlinitý, metylénchlorid/metanol = 20 : 1),Product value: 0.5 (alumina, methylene chloride / methanol = 20: 1),

C30H32N4O4,C 30 H 32 N 4 O 4

ESI-hmotnostné spektrum: m/z = 511 [M-H]’, (36) 3-Z-[l-(4-(/V-metylaminokarbonyl-metyl-/V-metylsulfonylamino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a jV-metylaminokarbonyl-metyl-TV-metylsulfonyl-p-fenyléndiamínu,ESI-MS: m / z = 511 [MH] -, (36) 3-Z- [1- (4- (N-methylaminocarbonyl-methyl- N -methylsulfonylamino) -anilino) -1-phenyl-methylene 6-Methoxycarbonyl-2-indolinone, prepared by reacting 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and N-methylaminocarbonyl-methyl-N-methylsulfonyl-p- phenylenediamine,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 10 : 1),Product value: 0.5 (silica gel, methylene chloride / methanol = 10: 1),

C27H26N4O6S,C 27 H 26 N 4 O 6 S

ESI-hmotnostné spektrum: m/z = 533 [M-H]‘, (37) 3-Z-[l-(4-((imidazolidin-2,4-dión-5-ylidén)metyl)amlino)-l-fenylmetylén]-6-metoxy-karbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-((imidazolidín-2,4-dión-5-ylidén)-metyl)-anilínu,ESI-MS: m / z = 533 [MH] -, (37) 3-Z- [1- (4 - ((imidazolidin-2,4-dione-5-ylidene) methyl) amino) -1-phenylmethylene 6-Methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4 - ((imidazolidine-2,4-) dione-5-ylidene) methyl) aniline,

Rrhodnota produktu: 0,4 (gél kyseliny kremičitej, metylénchlorid/metanol = 10 : 1),Product value: 0.4 (silica gel, methylene chloride / methanol = 10: 1),

C27H20N4O5,C 27 H 20 N 4 O 5

ESI-hmotnostné spektrum: m/z = 479 [M-H]‘, (38) 3-Z-[l-(4-(1V-((2-dimetylamino-etyl)-karbonyl)-/V-metyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 7V-((2-dimetylamino-etyl)-karbonyl)-7V-metyl-p-fenyléndiamínu,ESI-MS: m / z = 479 [MH] -, (38) 3-Z- [1- (4- ( 1 N - ((2-dimethylamino-ethyl) -carbonyl) - N -methyl-amino) (1-Anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and N, N- ((2-dimethylamino-ethyl) carbonyl) -7V-methyl-p-phenylenediamine,

Rrhodnota produktu: 0,5 (oxid hlinitý, metylénchlorid/metanol = 20 : 1),Product value: 0.5 (alumina, methylene chloride / methanol = 20: 1),

C29H30N4O4,C 29 H 30 N 4 O 4

ESI-hmotnostné spektrum: m/z = 497 [M-H]', (39) 3-Z-[ 1 -(4-(/V-/erc-butoxykarbonyl-aminometyl)anilino)-1 -fenylmetylén]-6-metoxy-karbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(N-terc-butoxykarbonylaminometylj-anilínu,ESI-MS: m / z = 497 [MH] -, (39) 3-Z- [1- (4- (N-tert-butoxycarbonylaminomethyl) anilino) -1-phenylmethylene] -6-methoxy -carbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4- (N-tert-butoxycarbonylaminomethyl) aniline,

Rrhodnota produktu: 0,3 (oxid hlinitý, metylénchlorid/metanol = 20 : 1),Product value: 0.3 (alumina, methylene chloride / methanol = 20: 1),

C29H29N3O5,C29H29N3O5.

ESI-hmotnostné spektrum: m/z = 498 [M-H]', (40) 3-Z-[l-(4-(2-oxopyrolidin-l-ylmetyl)anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(2-oxo-pyrolidin-l-yl-metyl) anilínu,ESI-MS: m / z = 498 [MH] -, (40) 3- Z- [1- (4- (2-oxopyrrolidin-1-ylmethyl) anilino) -1-phenylmethylene] -6-methoxycarbonyl -2-indolinone prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4- (2-oxo-pyrrolidin-1-ylmethyl) aniline,

Rrhodnota produktu: 0,3 (gél kyseliny kremičitej, metylénchlorid/metanol = 20 : 1), C28H25N3O4, ESI-hmotnostné spektrum: m/z = 466 [M-H]', (41) 3-Z-[l-(4-(7V-aminokarbonyl-/V-metylsulfonyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený z l-acetyl-3-(l-etoxy-l-fenylmetylén)-6-metoxykarbonyl-2-indolinónu a TV-aminokarbonylmetyl-7V-metylsulfonyl-p-fenyléndiamínu,Product value: 0.3 (silica gel, methylene chloride / methanol = 20: 1), C28H25N3O4, ESI mass spectrum: m / z = 466 [MH] -, (41) 3-Z- [1- (4-) (N-aminocarbonyl- N -methylsulfonyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared from 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6 -methoxycarbonyl-2-indolinone and N-aminocarbonylmethyl-N-methylsulfonyl-p-phenylenediamine,

Rrhodnota produktu: 0,7 (gél kyseliny kremičitej, metylénchlorid/metanol = 5:1), C26H24N4O6S, ESI-hmotnostné spektrum: m/z = 519 [M-H]', (42) 3-Z-[l-(4-(tiomorfolin-4-yl-metyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(tiomorfolín-4-yl-metyl)-anilínu,Product Rf value: 0.7 (silica gel, methylene chloride / methanol = 5: 1), C 6 H 24 N 2 O 6 S 4, ESI-MS: m / z = 519 [MH] ', (42) 3- Z- [1- (4- (thiomorpholin-4-ylmethyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared by reaction of 1-acetyl-3- (1-ethoxy-1) -phenyl-methylene) -6-methoxycarbonyl-2-indolinone and 4- (thiomorpholin-4-ylmethyl) -aniline,

Rrhodnota produktu: 0,4 (gél kyseliny kremičitej, metylénchlorid/metanol =15:1),Product value: 0.4 (silica gel, methylene chloride / methanol = 15: 1),

C28H27N3O3S,C 28 H2 7 N 3 O 3 S

ESI-hmotnostné spektrum: m/z = 484 [M-H]', (43) 3-Z-[ 1 -(4-( 1,1 -dioxo-tiomorfolin-4-yl-metyl)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(l,l-dioxo-tiomorfolin-4-yl-metyl)-anilínu,ESI-MS: m / z = 484 [MH] -, (43) 3-Z- [1- (4- (1,1-dioxo-thiomorpholin-4-ylmethyl) -anilino) -1-phenyl -methylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4- (1,1-dioxo-thiomorpholine) 4-yl-methyl) -aniline,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 10 : 1), C28H27N3O5S, ESI-hmotnostné spektrum: m/z = 516 [M-H]', (45) 3-Z-[ 1 -(4-(Ä'-ŕerc-butoxykarbonyl-etylaminometyl)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(7V-etyl-7V-ŕerc-butoxykarbonylaminometylj-anilínu,Product value: 0.5 (silica gel, methylene chloride / methanol = 10: 1), C 28 H 27 N 3 O 5 S, ESI mass spectrum: m / z = 516 [MH] -, (45) 3- Z- [1- (4- (N-tert-butoxycarbonyl-ethylaminomethyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared by reaction of 1-acetyl-3- (1-ethoxy- 1-phenyl-methylene) -6-methoxycarbonyl-2-indolinone and 4- (N-ethyl-N-tert-butoxycarbonylaminomethyl) aniline,

Rrhodnota produktu: 0,6 (gél kyseliny kremičitej, metylénchlorid/metanol = 10 : 1),Product value: 0.6 (silica gel, methylene chloride / methanol = 10: 1),

C31H33N3 O5,C 31 H 33 N 3 O 5

ESI-hmotnostné spektrum: m/z = 526 [M-H]',ESI-MS: m / z = 526 [M-H] -,

3-Z-[l-(4-(/V-benzyl-/V-metyl-aminometyl)-anilino)-l-fenyl-metylén]-6-metoxy-karbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(A'-benzyl-Aí-metyl-aminometyl)anilínu,3-N- [1- (4 - (N-benzyl- N -methyl-aminomethyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared by reaction of 1-acetyl- 3- (l-ethoxy-l-phenyl-methylene) -6-methoxycarbonyl-2-indolinone and 4- (N-benzyl-s-methyl-aminomethyl) aniline,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 10 : 1),Product value: 0.5 (silica gel, methylene chloride / methanol = 10: 1),

C32H29N3O3,C 32 H 29 N 3 O 3

ESI-hmotnostné spektrum: m/z = 502 [M-H]', (47) 3-Z-[ 1 -(4-( 1 -oxo-tiomorfolin-4-yl-metyl)-anilino)-1 -fenyl-metylén]-6-metoxy-karbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(l-oxo-tiomorfolin-4-yl-metyl)-anilínu,ESI-MS: m / z = 502 [MH] -, (47) 3-Z- [1- (4- (1-oxo-thiomorpholin-4-ylmethyl) -anilino) -1-phenyl-methylene 6-Methoxycarbonyl-2-indolinone, prepared by reacting 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4- (1-oxo-thiomorpholine-4) yl-methyl) -aniline,

Rrhodnota produktu: 0,7 (gél kyseliny kremičitej, metylénchlorid/metanol = 10 : 1),Product value: 0.7 (silica gel, methylene chloride / methanol = 10: 1),

C28H27N3O4S, ,C 28 H 27 N 3 O 4 S,,

ESI-hmotnostné spektrum: m/z = 500 [M-H]', (48) 3-Z-[l-(4-(2-(imidazol-4-yl)-etyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu, a 4-(2-(imidazol-4-yl)-etyl)-anilínu,ESI-MS: m / z = 500 [MH] -, (48) 3- Z- [1- (4- (2- (imidazol-4-yl) ethyl) -anilino) -1-phenylmethylene 6-Methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone, and 4- (2- (imidazol-4-yl) ) ethyl) aniline,

Rrhodnota produktu: 0,4 (gél kyseliny kremičitej, metylénchlorid/metanol = 5 : 1),Product value: 0.4 (silica gel, methylene chloride / methanol = 5: 1),

C28H24N4O3,C 28 H 24 N 4 O 3

ESI-hmotnostné spektrum: m/z = 463 [M-H]', (49) 3-Z-[ 1 -(4-(morfolin-4-yl-metyl)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(morfolin-4-yl-metyl)-anilínu,ESI-MS: m / z = 463 [MH] -, (49) 3-Z- [1- (4- (morpholin-4-ylmethyl) -anilino) -1-phenylmethylene] -6- methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenyl-methylene) -6-methoxycarbonyl-2-indolinone and 4- (morpholin-4-ylmethyl) -aniline,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 10 : 1), C28H27N3O4, ESI-hmotnostné spektrum: m/z = 468 [M-H]', (50) 3-Z-[ 1 -(4-(4-metylpiperazin-l-yl)metyl)anilino)-1 -fenylmetylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-((4-metyl-piperazin-1 -yl)-metyl)-anilínu,Product value: 0.5 (silica gel, methylene chloride / methanol = 10: 1), C28H27N3O4, ESI mass spectrum: m / z = 468 [MH] -, (50) 3-Z- [1- (4-) (4-methylpiperazin-1-yl) methyl) anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl -2-indolinone and 4 - ((4-methyl-piperazin-1-yl) -methyl) -aniline,

Rrhodnota produktu: 0,4 (gél kyseliny kremičitej, metylénchlorid/metanol 5:1),Product value: 0.4 (silica gel, methylene chloride / methanol 5: 1),

C29H30N4O3,C29H30N4O3.

ESI-hmotnostné spektrum: m/z = 481 [M-H]', (51) 3-Z-[l-(4-((2-(/V-benzyl-7V-nietyl-amino)-etyl)-/V-metylsulfonyl-amino)-anilmo)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(7V-(2-(A-benzyl-7V-metyl-amino)-etyl)-jV-metylsulfonyl-amino)-anilínu,ESI-MS: m / z = 481 [MH] -, (51) 3-Z- [1- (4 - ((2 - (N-benzyl-7 H -methylamino) ethyl)) - N -methylsulfonyl-amino) -anilino-1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenyl-methylene) -6-methoxycarbonyl-2- indolinone and 4- (N - (2- (N -benzyl-N -methyl-amino) -ethyl) - N -methylsulfonyl-amino) -aniline,

Rrhodnota produktu: 0,7 (gél kyseliny kremičitej, metylénchlorid/metanol = 10 : 1),Product value: 0.7 (silica gel, methylene chloride / methanol = 10: 1),

C34H34N4O5S,C34H34N4O5S.

ESI-hmotnostné spektrum: m/z = 609 [M-H]’, (52) 3-Z-[l-(4-cyklohexylaminoanilino)-l-fenylmetylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a /V-cyklohexyl-p-fenyléndiaminu,ESI-MS: m / z = 609 [MH] -, (52) 3-Z- [1- (4-cyclohexylaminoanilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, prepared by reaction of 1-acetyl- 3- (1-ethoxy-1-phenyl-methylene) -6-methoxycarbonyl-2-indolinone and N-cyclohexyl-p-phenylenediamine,

Rrhodnota produktu: 0,8 (gél kyseliny kremičitej, metylénchlorid/metanol = 10 : 1),Product value: 0.8 (silica gel, methylene chloride / methanol = 10: 1),

C29H28N2O3,C29H28N2O3.

ESI-hmotnostné spektrum: m/z = 451 [M-H]’, (53) 3-Z-[l-(4-(pyridin-4-yl-metyl)-amlino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(pyridin-4-yl-metyl)-anilínu,ESI-MS: m / z = 451 [MH] -, (53) 3- Z- [1- (4- (pyridin-4-ylmethyl) amino) -1-phenyl-methylene] -6- methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenyl-methylene) -6-methoxycarbonyl-2-indolinone and 4- (pyridin-4-ylmethyl) -aniline,

Rrhodnota produktu: 0,6 (gél kyseliny kremičitej, metylénchlorid/metanol/amoniak = 5:1: 0,01), C29H23N3O3,Product value: 0.6 (silica gel, methylene chloride / methanol / ammonia = 5: 1: 0.01), C29H23N3O3,

ESI-hmotnostné spektrum: m/z = 460 [M-H]', (54) 3-Z-[l-(4-(imidazol-l-yl-metyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(imidazol-l-yl-metyl)-anilínu,ESI-MS: m / z = 460 [MH] -, (54) 3- Z- [1- (4- (imidazol-1-ylmethyl) -anilino) -1-phenyl-methylene] -6- methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenyl-methylene) -6-methoxycarbonyl-2-indolinone and 4- (imidazol-1-ylmethyl) -aniline,

Rrhodnota produktu: 0,4 (gél kyseliny kremičitej, metylénchlorid/metanol/amoniak = 10 : 1 : 0,01), C27H22N4O3,Product value: 0.4 (silica gel, methylene chloride / methanol / ammonia = 10: 1: 0.01), C27H22N4O3,

ESI-hmotnostné spektrum: m/z = 449 [M-H]‘, (55) 3-Z-[ 1 -(4-(imidazol-l-yl-metyl)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(imidazol-l-yl-metyl)-anilínu,ESI-MS: m / z = 449 [MH] -, (55) 3- Z- [1- (4- (imidazol-1-ylmethyl) -anilino) -1-phenyl-methylene] -6- methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenyl-methylene) -6-methoxycarbonyl-2-indolinone and 4- (imidazol-1-ylmethyl) -aniline,

Rrhodnota produktu: 0,4 (gél kyseliny kremičitej, metylénchlorid/metanol/amoniak = 10 : 1 : 0,01), C27H22N4O3,Product value: 0.4 (silica gel, methylene chloride / methanol / ammonia = 10: 1: 0.01), C 27 H 22 N 4 O 3 ,

ESI-hmotnostné spektrum: m/z = 449 [M-H]', (5 6) 3 -Z- [ 1 -(jV-metyl-piperidin-4-yl-amino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-índolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-amino-l-metyl-piperidínu,ESI-MS: m / z = 449 [MH] -, (S) 3 -Z- [1- (N-Methyl-piperidin-4-ylamino) -1-phenyl-methylene] -6-methoxycarbonyl -2-indolinone, prepared by reacting 1-acetyl-3- (1-ethoxy-1-phenyl-methylene) -6-methoxycarbonyl-2-indolinone and 4-amino-1-methyl-piperidine,

Rrhodnota produktu: 0,3 (gél kyseliny kremičitej, metylénchlorid/metanol = 5:1),Product value: 0.3 (silica gel, methylene chloride / methanol = 5: 1),

C23H25N3O3,C23H25N3O3.

ESI-hmotnostné spektrum: m/z = 390 [M-H]', (57) 3-Z-[ 1 -(4-(imidazol-4-yl-metyl)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(imidazol-4-yl-metyl)-anilínu,ESI-MS: m / z = 390 [MH] -, (57) 3-Z- [1- (4- (imidazol-4-ylmethyl) -anilino) -1-phenyl-methylene] -6- methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenyl-methylene) -6-methoxycarbonyl-2-indolinone and 4- (imidazol-4-ylmethyl) -aniline,

Rrhodnota produktu: 0,2 (gél kyseliny kremičitej, metylénchlorid/metanol = 5:1),Product value: 0.2 (silica gel, methylene chloride / methanol = 5: 1),

SK 287312 Β6SK 287312-6

C27H22N4O3,C 27 H 22 N 4 O 3

ESI-hmotnostné spektrum: m/z = 449 [M-H]', (5 8) 3-Z-[l -(4-((4-hydroxy-piperidin-1 -yl)-metyl)-anilino)-1 -fenyl-metylén]-6-metoxy-karbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-((4-hydroxy-piperidin-1 -yl)-metyl)-anilínu,ESI-MS: m / z = 449 [MH] -, (58) 3-Z- [1- (4 - ((4-hydroxy-piperidin-1-yl) -methyl) -anilino) -1- phenylmethylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4 - ((4-hydroxy -piperidin-1-yl) -methyl) -aniline,

Rrhodnota produktu: 0,1 (gél kyseliny kremičitej, metylénchlorid/metanol = 10 : 1),R r value of the product: 0.1 (silica gel, methylene chloride / methanol = 10: 1),

C29H29N3O3,C 29 H 29 N 3 O 3

ESI-hmotnostné spektrum: m/z = 482 [M-H]', (59) 3-Z-[l-(4-((4-metoxy-piperidin-l-yl)-metyl)-anilino)-l-fenyl-metylén]-6-metoxy-karbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-((4-metoxy-piperidin-1 -yl)-metyl)-anilínu,ESI-MS: m / z = 482 [MH] -, (59) 3- Z- [1- (4 - ((4-methoxy-piperidin-1-yl) -methyl) -anilino) -1-phenyl -methylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4 - ((4-methoxy- piperidin-1-yl) -methyl) -aniline,

Rrhodnota produktu: 0,4 (gél kyseliny kremičitej, metylénchlorid/metanol = 10 : 1),R r value of the product: 0.4 (silica gel, methylene chloride / methanol = 10: 1),

C30H31N3O4,C 30 H 31 N 3 O 4

ESI-hmotnostné spektrum: m/z = 496 [M-H]-, (60) 3-Z-[l-(4-benzyl-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-benzyl-anilínu,ESI-MS: m / z = 496 [MH] - , (60) 3- Z- [1- (4-Benzyl-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared by reaction 1-acetyl-3- (1-ethoxy-1-phenyl-methylene) -6-methoxycarbonyl-2-indolinone and 4-benzyl-aniline,

Rrhodnota produktu: 0,6 (gél kyseliny kremičitej, metylénchlorid/metanol = 10 : 1),Product value: 0.6 (silica gel, methylene chloride / methanol = 10: 1),

C3oH24N203, teplota topenia produktu bola: 224 °C.C 3 H 24 N 2 O 3 , mp 224 ° C.

(61) 3-Z-[l-(4-(IV-(3-trifluóracetylaminopropyl)-A,-metylsulfonylamino)anilino)-l-fcnyl-metylén]-6-mctoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a jV-(3-trifluóracetylamino-propyl)-/V-metylsulfonyl-p-fenyléndiamínu,(61) 3-Z- [l- (4- (I, N- (3-trifluóracetylaminopropyl) -N, -metylsulfonylamino) anilino) -l-phenyl-methylene] -6-Methoxycarbonyl-2-indolinone, prepared by reaction of l- acetyl-3- (1-ethoxy-1-phenyl-methylene) -6-methoxycarbonyl-2-indolinone and N - (3-trifluoroacetylamino-propyl) - N -methylsulfonyl-p-phenylenediamine,

Rrhodnota produktu: 0,5 (oxid hlinitý, metylénchlorid/metanol = 20 : 1),Product value: 0.5 (alumina, methylene chloride / methanol = 20: 1),

C29H27F3N4O6S,C 29 H 27 F 3 N 4 O 6 S

ESI-hmotnostné spektrum: m/z = 615 [M-H]’, (62) 3-Z-[ 1 -(4-terc-butoxykarbonyl-metyl-anilino)-1 -fenyl-metylén] -6-etoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a terc-butylesteru kyseliny 4-aminofenyloctovej,ESI-MS: m / z = 615 [MH] -, (62) 3-Z- [1- (4-tert-butoxycarbonyl-methyl-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2- indolinone, prepared by reacting 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4-aminophenylacetic acid tert-butyl ester,

Rrhodnota produktu: 0,5 (oxid hlinitý, etylester kyseliny octovej),Product value: 0.5 (alumina, ethyl acetate),

C3oH3oN205,C 3 oH 3 oN 2 0 5

ESI-hmotnostné spektrum: m/z = 497 [M-H], (63) 3-Z-[l-(4-terc-butoxykarbonyl-anilino)-l-etyl-metylén]-6-etoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-etyl-metylén)-6-etoxykarbonyl-2-indolinónu a 4-terc-butoxykarbonyl-anilínu,ESI-MS: m / z = 497 [MH], (63) 3- Z- [1- (4-tert-butoxycarbonyl-anilino) -1-ethyl-methylene] -6-ethoxycarbonyl-2-indolinone, prepared by reacting 1-acetyl-3- (1-ethoxy-1-ethyl-methylene) -6-ethoxycarbonyl-2-indolinone and 4-tert-butoxycarbonyl-aniline,

Rrhodnota produktu: 0,4 (oxid hlinitý, metylénchlorid/etanol = 20 : 1),Product value: 0.4 (alumina, methylene chloride / ethanol = 20: 1),

C25H29N2O5,C 25 H 29 N 2 O 5

ESI-hmotnostné spektrum: m/z = 435 [M-H], (64) 3-Z- [ 1 -(4-(4-rerc-butoxykarbonyl-piperazin-1 -yl-metyl)-anilino)-1 -fenyl-metylén] -6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(4-/erc-butoxykarbonyl-piperazin-1 -yl-metyl)-anilínu,ESI-MS: m / z = 435 [MH], (64) 3- Z- [1- (4- (4-tert-butoxycarbonyl-piperazin-1-ylmethyl) -anilino) -1-phenyl- methylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4- (4- tert -butoxycarbonyl-piperazine) -1-yl-methyl) -aniline,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 10 : 1), C33H36N4O5, ESI-hmotnostné spektrum: m/z = 567 [M-H], (65) 3-Z-[l-(4-(l-metyl-inidazol-2-yl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(l-metyl-imidazol-2-yl)-anilínu,Product value: 0.5 (silica gel, methylene chloride / methanol = 10: 1), C 33 H 36 N 4 O 5 , ESI mass spectrum: m / z = 567 [MH], (65) 3-Z- [1- (4- (1-Methyl-inidazol-2-yl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared by reaction of 1-acetyl-3- (1-ethoxy-1) -phenyl-methylene) -6-methoxycarbonyl-2-indolinone and 4- (1-methyl-imidazol-2-yl) -aniline,

Rrhodnota produktu: 0,6 (gél kyseliny kremičitej, metylénchlorid/metanol = 5 : 1),Product value: 0.6 (silica gel, methylene chloride / methanol = 5: 1),

C27H22N4O3,C 27 H 22 N 4 O 3

ESI-hmotnostné spektrum: m/z = 449 [M-H], (66) 3-Z-[l-(4-(/V-(2-dimetylaminoetyl)-jV-metylsulfonylamino)-3-nitroanilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 6-(Ar-(2-dimetylamino-etyl)- A/-metylsulfonyl-amino)-3-amino-nitrobenzénu,ESI-MS: m / z = 449 [MH], (66) 3- Z- [1- (4- (N - (2-dimethylaminoethyl) - N -methylsulfonylamino) -3-nitroanilino) -1-phenyl methylene] -6-methoxycarbonyl-2-indolinone, prepared by reaction of l-acetyl-3- (l-ethoxy-l-phenyl-methylene) -6-methoxycarbonyl-2-indolinone and 6- (N - (2-dimethylamino ethyl) - A / methylsulphonyl-amino) -3-amino-nitrobenzene,

Rrhodnota produktu: 0,6 (gél kyseliny kremičitej, metylénchlorid/metanol = 5:1),Product value: 0.6 (silica gel, methylene chloride / methanol = 5: 1),

C28H29N5O7S,C28H29N5O7S.

ESI-hmotnostné spektrum: m/z = 578 [M-H]', (67) 3-Z-[ 1 -(4-(/V-(2-dimetylamino-etyl)-/V-metylsulfonyl-amino)-3-amino-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(Af-(2-dimetylamino-etyl)-/V-metylsulfonyl-amino)-3-amino-anilmu,ESI-MS: m / z = 578 [MH] -, (67) 3-Z- [1- (4 - (N - (2-dimethylamino-ethyl) - N -methylsulfonylamino) -3- amino-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4- (A f - (2-dimethylamino-ethyl) - / V-methylsulfonyl-amino) -3-amino-aniline,

Rrhodnota produktu: 0,5 (oxid hlinitý, metylénchlorid/metanol = 20 : 1),Product value: 0.5 (alumina, methylene chloride / methanol = 20: 1),

C28H31N5O5S,C 28 H 31 N 5 O 5 S

ESI-hmotnostné spektrum: m/z = 548 [M-H]', (68) 3-Z-[l-(4-((3-(Aí-benzyl-A/-metylamino)-propyl)-A-metyl-sulfonyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(7V-(3-(/V-benzyl-jV-metyl-amino)-propyl)-/V-metylsulfonyl-amino)-anilínu,ESI-MS: m / z = 548 [MH] ', (68) 3-Z- [l- (4 - ((3- (BENZYL-A / -methyl-amino) propyl) -N-methyl (sulfonyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenyl-methylene) -6-methoxycarbonyl-2- indolinone and 4- (N - (3- (N-benzyl-N-methyl-amino) -propyl) - N -methylsulfonyl-amino) -aniline,

Rrhodnota produktu: 0,6 (gél kyseliny kremičitej, metylénchlorid/metanol = 10 : 1),Product value: 0.6 (silica gel, methylene chloride / methanol = 10: 1),

C35H36N4O5S,C 35 H 36 N 4 O 5 S

ESI-hmotnostné spektrum: m/z = 623 [M-H]', (69) 3-Z-[l-(4-(A,-(2-dimetylaminoetyl)-A,-metylsulfonylamino)-3-chlóranilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenylmetylén)-6-metoxykarbonyl-2-indolinónu a 4-(A'-(2-dimetylamino-etyl)-A,-metylsuIfonyl-amino)-3-chlór-anilínu,ESI-MS: m / z = 623 [MH] ', (69) 3-Z- [l- (4- (N - (2-dimethylamino-ethyl) -N, -metylsulfonylamino) -3-chloroanilino) -l -phenylmethylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4- (N '- (2-dimethylamino) -ethyl) - N , -methylsulfonyl-amino) -3-chloro-aniline,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 10 : 1),Product value: 0.5 (silica gel, methylene chloride / methanol = 10: 1),

C28H29C1N4O5S,C 28 H 29 C1N 4 O 5 S

ESI-hmotnostné spektrum: m/z = 567/569 [M-H]‘, (70) 3-Z-[l-(4-(/V-dimetylaminometylkarbonyl-jV-metylamino)anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a A+dimetylaminometylkarbonyl-A'-metyl-p-fenyléndiamínu,ESI-MS: m / z = 567/569 [MH] -, (70) 3-Z- [1- (4- (N-dimethylaminomethylcarbonyl-N-methylamino) anilino) -1-phenyl-methylene] - 6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and N + dimethylaminomethylcarbonyl-N'-methyl-p-phenylenediamine,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9 : 1), C28H28N4O4, ESI-hmotnostné spektrum: m/z = 483 [M-H]', (71) 3-Z-[l-(4-(/V-(2-dimetylamino-etyl)-/V-acetyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(A,-(2-dimetylamino-etyl)-N-acetyl-amino)-anilinu,Product value: 0.5 (silica gel, methylene chloride / methanol = 9: 1), C 28 H 28 N 4 O 4 , ESI mass spectrum: m / z = 483 [MH] -, (71) 3-Z- [ 1- (4- (N - (2-dimethylamino-ethyl) - N -acetyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared by reaction of 1-acetyl-3 - (l-ethoxy-l-phenyl-methylene) -6-methoxycarbonyl-2-indolinone and 4- (N - (2-dimethylamino-ethyl) -N-acetyl-amino) -aniline,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9 : 1),Product value: 0.5 (silica gel, methylene chloride / methanol = 9: 1),

C29H3oN404,C 2 9H 3 oN 4 0 4

ESI-hmotnostné spektrum: m/z = 497 [M-H]', (72) 3-Z-[l-(4-(A/-(2-dimetylamino-etyl)-Mpropionyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(/V-(2-dimetylamino-etyl)-jV-propionyl-amino)-anilínu,ESI-MS: m / z = 497 [MH] ', (72) 3-Z- [l- (4- (A / - (2-dimethylamino-ethyl) -Mpropionyl-amino) anilino) -l- phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4 - (N - (2- dimethylamino-ethyl) -N-propionyl-amino) -aniline,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9 : 1),Product value: 0.5 (silica gel, methylene chloride / methanol = 9: 1),

C3oH32N404,C 3 oH 32 N 4 0 4

ESI-hmotnostné spektrum: m/z = 511 [M-H]-, (73) 3-Z-[l-(4-(/V-(2-dimetylamino-etyl)-7V-butyryl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(/V-(2-dimetylamino-etyl)-A/-butyryl-amino)-anilínu,ESI-MS: m / z = 511 [MH] - , (73) 3-Z- [1- (4 - (N - (2-dimethylamino-ethyl) -7-butyryl-amino) -anilino) - 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenyl-methylene) -6-methoxycarbonyl-2-indolinone and 4 - (N - ( 2-dimethylamino-ethyl) -N / butyryl-amino) -aniline,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 8:1),Product value: 0.5 (silica gel, methylene chloride / methanol = 8: 1),

C31H34N4O4,C31H34N4O4.

ESI-hmotnostné spektrum: m/z = 525 [M-H]', (74) 3-Z-[l-(4-(7V-(2-dimetylamino-etyl)-/V-izobutyryl-amino)anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(7V-(2-dimetylamino-etyl) /V-izobutyryl-ammo)-anilínu,ESI-MS: m / z = 525 [MH] -, (74) 3-Z- [1- (4- (N - (2-dimethylamino-ethyl) - N -isobutyryl-amino) anilino) -1 -phenylmethylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4- (N, N- (2- dimethylamino-ethyl) -N-isobutyryl-amino-aniline,

Rphodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9:1),Product value: 0.5 (silica gel, methylene chloride / methanol = 9: 1),

C32H34N4O4,C32H34N4O4.

ESI-hmotnostné spektrum: m/z = 525 [M-H]’, (75) 3-Z-[l-(4-(Ar-(2-dimetylamino-etyl)-Är-benzoyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(7V-(2-dimetylamino-etyl)-/V-benzoyl-amino)-anilínu,ESI-MS: m / z = 525 [MH] ', (75) 3-Z- [l- (4- (N - (2-dimethylamino-ethyl) -N-benzoyl-amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4- (N - ( 2-dimethylamino-ethyl) - / V-benzoyl-amino) -aniline,

Rphodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9:1),Product value: 0.5 (silica gel, methylene chloride / methanol = 9: 1),

C34H32N4O4,C34H32N4O4.

ESI-hmotnostné spektrum: m/z = 559 [M-H]', (76) 3-Z-[l-(4-(A/-(2-dimetylamino-etyl)-Aľ-acetyl-amino)-3-amino-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(/V-(2-dimetylammo-etyl)-7V-acetyl-amino)-3-amino-anilínu,ESI-MS: m / z = 559 [MH] -, (76) 3-Z- [1- (4- (N - (2-dimethylamino-ethyl) - N 1 -acetyl-amino) -3- amino-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4- (/ V- (2-dimethylamino-ethyl) -7V-acetyl-amino) -3-amino-aniline,

Rphodnota produktu: 0,5 (oxid hlinitý, metylénchlorid/metanol = 20 : 1),Product value: 0.5 (alumina, methylene chloride / methanol = 20: 1),

C29H31N5O4,C29H31N5O4.

ESI-hmotnostné spektrum: m/z = 512 [M-H]', (77) 3-Z-[l-(4-(4-hydroxymetylpiperidin-l-ylmetyl)amlino)-l-fenylmetylén]-6-metoxy-karbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(4-hydroxymetyl-piperidin-1 -yl-metyl-amino)-anilínu,ESI-MS: m / z = 512 [MH] -, (77) 3- Z- [1- (4- (4-hydroxymethylpiperidin-1-ylmethyl) amino) -1-phenylmethylene] -6-methoxycarbonyl -2-indolinone, prepared by reacting 1-acetyl-3- (1-ethoxy-1-phenyl-methylene) -6-methoxycarbonyl-2-indolinone and 4- (4-hydroxymethyl-piperidin-1-yl-methyl-amino) aniline,

Rf -hodnota produktu: 0,3 (gél kyseliny kremičitej, metylénchlorid/metanol = 5:1), Rf Rf value of the product: 0.3 (silica gel, methylene chloride / methanol = 5: 1).

C30H31N3O4,C30H31N3O4.

ESI-hmotnostné spektrum: m/z = 496 [M-H]', (7 8) 3 -Z- [ 1 -(4-(2-(4-hydroxy-piperidin-1 -yl)-etyl)-anilino)-1 -fény 1-metylén] -6-metoxy-karbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(2-(4-hydroxy-piperidin-1 -yl)-etyl-amino)-anilínu,ESI-MS: m / z = 496 [MH] &lt; - &gt;, (7 &lt; 8 &gt;) 3 - Z - [1- (4- (2- (4-hydroxy-piperidin-1-yl) -ethyl) -anilino) - 1-Phenyl 1-methylene] -6-methoxycarbonyl-2-indolinone, prepared by reacting 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4- (2 - (4-hydroxy-piperidin-1-yl) -ethyl-amino) -aniline,

Rphodnota produktu: 0, 3 (gél kyseliny kremičitej, metylénchlorid/metanol = 5 : T), C3oH31N304,Rphodnota product: 0, 3 (silica gel, methylene chloride / methanol = 5: T), C3oH 31 N 30 4,

ESI-hmotnostné spektrum: m/z = 496 [M-H]', (79) 3-Z-[l-(4-(7V-(2-dimetylamino-etyl)-/V-propylsulfonylamino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a /V-(2-dimetylamino-etyl)-jV-propylsulfonyl-p-fenyléndiamínu,ESI-MS: m / z = 496 [MH] -, (79) 3- Z- [1- (4- (N - (2-dimethylamino-ethyl) - N -propylsulfonylamino) -anilino) -1- phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and N - (2-dimethylamino-ethyl) ) -N-propylsulfonyl-p-phenylenediamine,

Rphodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9 : 1),Product value: 0.5 (silica gel, methylene chloride / methanol = 9: 1),

C3oH34N205S,C 3 oH 3 4 N 2 0 5 S,

ESI-hmotnostné spektrum: m/z = 561 [M-H]', (80) 3-Z-[ 1 -(4-(7/-(2-dimetylaminoetyl)-7V-butylsulfonylamino)anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 7V-(2-dimetylamino-etyl)-/V-butylsulfonyl-p-fenyléndiammu,ESI-MS: m / z = 561 [MH] -, (80) 3-Z- [1- (4- (N - (2-dimethylaminoethyl) -N-butylsulfonylamino) anilino) -1-phenylmethylene 6-Methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and N - (2-dimethylamino-ethyl) - N butylsulfonyl-p-phenylenediamine,

Rphodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9 : 1),Product value: 0.5 (silica gel, methylene chloride / methanol = 9: 1),

C3iH36N4O5S,C3iH 36 N 4 O 5 S

ESI-hmotnostné spektrum: m/z = 575 [M-H]', (81) 3-Z-[l-(4-(7V-(2-dimetylamino-etyl)-/V-fenylsulfonyl-amino)-amlino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a M-(2-dimetylamino-etyl)-./V-fenylsulfonyl-p-fenyléndiammu,ESI-MS: m / z = 575 [MH] -, (81) 3- Z- [1- (4- (N - (2-dimethylamino-ethyl) - N -phenylsulfonyl-amino) -amino) - 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenyl-methylene) -6-methoxycarbonyl-2-indolinone and N- (2-dimethylamino- ethyl) -. / V-phenylsulfonyl-p-phenylenediamine,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9 : 1),Product value: 0.5 (silica gel, methylene chloride / methanol = 9: 1),

C33H32N4O5S,C33H32N4O5S.

ESI-hmotnostné spektrum: m/z = 595 [M-H]', (82) 3-Z-[l-(4-(7V-(2-dimetylamino-etyl)-7V-benzylsulfonylamino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 7V-(2-dimetylamino-etyl)-7V-benzylsulfonyl-p-fenyléndiamínu,ESI-MS: m / z = 595 [MH] +, (82) 3- Z- [1- (4- (N - (2-dimethylamino-ethyl) -7-benzylsulfonylamino) -anilino) -1-phenyl -methylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and N - (2-dimethylamino-ethyl) - 7V-benzylsulfonyl-p-phenylenediamine,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9:1),Product value: 0.5 (silica gel, methylene chloride / methanol = 9: 1),

C34H34N4O5S,C34H34N4O5S.

ESI-hmotnostné spektrum: m/z = 609 [M-H]', (83) 3-Z-[l-(4-(/V-(2-dimetylaminoetyl)-jV-etylsulfonylamino)anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a /V-(2-dimetylamino-etyl)-7V-etyl-sulfbnyl-p-fenyléndiamínu,ESI-MS: m / z = 609 [MH] -, (83) 3-Z- [1- (4 - (N - (2-dimethylaminoethyl) - N -ethylsulfonylamino) anilino) -1-phenylmethylene 6-Methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and N - (2-dimethylamino-ethyl) -7H ethyl-sulfonyl-p-phenylenediamine,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9:1), C29H32N4O5S,Product value: 0.5 (silica gel, methylene chloride / methanol = 9: 1), C29H32N4O5S,

ESI-hmotnostné spektrum: m/z - 547 [M-H]’, (84) 3-Z-[l-(4-((imidazolidin-2,4-dión-5-yl)-metyl)-amlino)-l-fenyl-metylén]-6-metoxy-karbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-((imidazolidin-2,4-dión-5-yl)metyl)-anilínu,ESI-MS: m / z - 547 [MH] -, (84) 3-Z- [1- (4 - ((imidazolidin-2,4-dione-5-yl) -methyl) -amino) -1 -phenylmethylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4 - ((imidazolidine- 2,4-dione-5-yl) methyl) aniline,

Rrhodnota produktu: 0,6 (gél kyseliny kremičitej, metylénchlorid/metanol = 5:1),Product value: 0.6 (silica gel, methylene chloride / methanol = 5: 1),

C27H22N4O5,C27H22N4O5.

ESI-hmotnostné spektrum: m/z = 481 [M-H]’, (85) 3-Z-[l-(4-((3-hydroxy-pyrolidin-l-yl)-metyl)-anilino)-l-fenyl-metylén]-6-metoxy-karbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-((3-hydroxy-pyrolidin-1 -yl)-metyl)-anilínu,ESI-MS: m / z = 481 [MH] -, (85) 3- Z- [1- (4 - ((3-hydroxy-pyrrolidin-1-yl) -methyl) -anilino) -1-phenyl -methylene] -6-methoxycarbonyl-2-indolinone, prepared by reacting 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4 - ((3-hydroxy- pyrrolidin-1-yl) -methyl) -aniline,

Rrhodnota: 0,1 (gél kyseliny kremičitej, metylénchlorid/metanol = 10 : 1),Value: 0.1 (silica gel, methylene chloride / methanol = 10: 1),

C28H27N3O4,C28H27N3O4.

ESI-hmotnostné spektrum: m/z = 468 [M-H]‘, (86) 3-Z-[l-(4-(cyklohexyl-metyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(cyklohexyl-metyl)-anilínu (Eur. J. Med. Chem. Chim. Ther. 27, 537-544 (1992)),ESI-MS: m / z = 468 [MH] -, (86) 3- Z- [1- (4- (cyclohexylmethyl) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2- indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4- (cyclohexylmethyl) aniline (Eur. J. Med. Chem. Chim. Ther., 27, 537-544 (1992)),

Rrhodnota produktu: 0,6 (gél kyseliny kremičitej, metylénchlorid/metanol = 10 : 1),Product value: 0.6 (silica gel, methylene chloride / methanol = 10: 1),

C30H30N2O3,C30H30N2O3.

ESI-hmotnostné spektrum: m/z = 465 [M-H]', (87) 3-Z-[l-(4-(cyklohexyl-karbonyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(cyklohexyl-karbonyl)-anilínu,ESI-MS: m / z = 465 [MH] +, (87) 3- Z- [1- (4- (cyclohexylcarbonyl) anilino) -1-phenylmethylene] -6-methoxycarbonyl-2- indolinone, prepared by reacting 1-acetyl-3- (1-ethoxy-1-phenyl-methylene) -6-methoxycarbonyl-2-indolinone and 4- (cyclohexylcarbonyl) -aniline,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 10 : 1), C30H28N2O4,Product value: 0.5 (silica gel, methylene chloride / methanol = 10: 1), C30H28N2O4,

ESI-hmotnostné spektrum: m/z = 479 [M-H]', (88) 3-Z-[l-(4-dietylaminometyl-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(dietylamino-metyl)-anilínu,ESI-MS: m / z = 479 [MH] -, (88) 3-Z- [1- (4-diethylaminomethyl-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared by reaction 1-acetyl-3- (1-ethoxy-1-phenyl-methylene) -6-methoxycarbonyl-2-indolinone and 4- (diethylamino-methyl) -aniline,

Rrhodnota produktu: 0,4 (gél kyseliny kremičitej, metylénchlorid/metanol = 10 : 1), C28H29N3O3, ESI-hmotnostné spektrum: m/z = 454 [M-H]', (89) 3-Z-[l-(4-(/V-(«-hexyl)-IV-metyl-aminometyl)-amlino)-l-fcnyl-metylén]-6-metoxy-karbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(/V-(«-hexyl)-/V-metyl-amino-metyl)-anilínu,Product value: 0.4 (silica gel, methylene chloride / methanol = 10: 1), C28H29N3O3, ESI mass spectrum: m / z = 454 [MH] -, (89) 3-Z- [1- (4-) (/ V - ( «- hexyl) - I-N-methyl-aminomethyl) -amlino) -l-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared by reaction of l-acetyl-3- (l-ethoxy - 1-phenyl-methylene) -6-methoxycarbonyl-2-indolinone and 4 - (N - (N-hexyl) - N -methyl-aminomethyl) -aniline,

Rrhodnota produktu: 0,6 (gél kyseliny kremičitej, metylénchlorid/metanol = 10 : 1),Product value: 0.6 (silica gel, methylene chloride / methanol = 10: 1),

C31H35N3O3,C31H35N3O3.

ESI-hmotnostné spektrum: m/z = 496 [M-H]', (90) 3-Z-[ 1 -(4-(A,-(2-dimetylamino-etyl)-/V-(furán-2-karbonyl)-amino)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(jV-(2-dimetylamino-etyl)-jV-(furán-2-karbonyl)-amino)-anilínu,ESI-MS: m / z = 496 [MH] ', (90) 3-Z- [1 - (4- (N - (2-dimethylamino-ethyl) - / V- (furan-2-carbonyl) (amino) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone, and 4- (N- (2-dimethylamino-ethyl) -N- (furan-2-carbonyl) amino) aniline,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9:1),R r value of the product: 0.5 (silica gel, methylene chloride / methanol = 9: 1),

C32H30N4O5,C32H30N4O5.

ESI-hmotnostné spektrum: m/z = 549 [M-H], (91) 3-Z-[l-(4-(M-(2-dimetylaminoetyl)-7V-(2-metoxy-benzoyl)-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(AL(2-dimetylamino-etyl)-/V-(2-metoxy-benzoyl)-arnino)-anilínu,ESI-MS: m / z = 549 [MH], (91) 3- Z- [1- (4- (N- (2-dimethylaminoethyl) -N- (2-methoxybenzoyl) amino) amino) anilino -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared by reacting 1-acetyl-3- (1-ethoxy-1-phenyl-methylene) -6-methoxycarbonyl-2-indolinone and 4- (A L) (2-dimethylamino-ethyl) - / V- (2-methoxy-benzoyl) -amino) aniline,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9:1),Product value: 0.5 (silica gel, methylene chloride / methanol = 9: 1),

C35H34N4O5,C35H34N4O5.

ESI-hmotnostné spektrum: m/z = 589 [M-H], (92) 3-Z-[l-(4-(7V-(2-dimetylarmnoetyl)-jV-(pyridín-3-karbonyl)amino)anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(;V-(2-dimetylamino-etyl)-/V-(pyridín-3-karbonyl)-amino)-anilínu,ESI-MS: m / z = 589 [MH], (92) 3- [1- (4- (N - (2-dimethylarmnoethyl) - N - (pyridine-3-carbonyl) amino) anilino) - 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared by reacting 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4 - (; N - ( 2-dimethylamino-ethyl) - / V- (pyridin-3-carbonyl) amino) aniline,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9 : 1),Product value: 0.5 (silica gel, methylene chloride / methanol = 9: 1),

C33H31N5O4,C33H31N5O4.

ESI-hmotnostné spektrum: m/z = 560 [M-H]', (93) 3-Z-[l-(4-(V-(2-dimetylamino-etyl)-AL(fenyl-acetyl)-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(/V-(2-dimetylamino-etyl)-/V-(fenyl-acetyl)-amino)-anilínu,ESI-MS: m / z = 560 [MH] -, (93) 3-Z- [1- (4- (N - (2-dimethylamino-ethyl) -A L (phenyl-acetyl) amino) - anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4 - (/ N- (2-dimethylamino-ethyl) - / V- (phenyl-acetyl) amino) -aniline,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9 : 1),Product value: 0.5 (silica gel, methylene chloride / methanol = 9: 1),

C35H34N4O4,C35H34N4O4.

ESI-hmotnostné spektrum: m/z = 573 [M-H], (94) 3-Z-[l-(4-(/V-etyl-7V-metylaminometyl)anilino)-l-fenylmetylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(7V-etyl-7V-metyl-aminometyl)-anilínu,ESI-MS: m / z = 573 [MH], (94) 3-Z- [1- (4- (N-ethyl-N-methylaminomethyl) anilino) -1-phenylmethylene] -6-methoxycarbonyl-2 -indolinone prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenyl-methylene) -6-methoxycarbonyl-2-indolinone and 4- (N-ethyl-N-methyl-aminomethyl) -aniline,

Rrhodnota produktu: 0,3 (gél kyseliny kremičitej, metylénchlorid/metanol = 10 : 1),Product value: 0.3 (silica gel, methylene chloride / methanol = 10: 1),

C27H27N3O3,C 27 H 27 N 3 O 3

ESI-hmotnostné spektrum: m/z = 440 [M-H]‘, (95) 3-Z-[l-(4-(imidazol-2-yl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(imidazol-2-yl)-anilínu,ESI-MS: m / z = 440 [MH] -, (95) 3- Z- [1- (4- (imidazol-2-yl) -anilino) -1-phenylmethylene] -6-methoxycarbonyl- 2-indolinone, prepared by reacting 1-acetyl-3- (1-ethoxy-1-phenyl-methylene) -6-methoxycarbonyl-2-indolinone and 4- (imidazol-2-yl) -aniline,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol =10:1),Product value: 0.5 (silica gel, methylene chloride / methanol = 10: 1),

C26H20N4O3,C26H20N4O3.

ESI-hmotnostné spektrum: m/z = 435 [M-H]', (96) 3-Z-[ 1-(4-(1-etyl-imidazol-2-yl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(l-etyl-imidazol-2-yl)-anilínu,ESI-MS: m / z = 435 [MH] -, (96) 3- Z- [1- (4- (1-ethyl-imidazol-2-yl) -anilino) -1-phenyl-methylene] - 6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4- (1-ethyl-imidazol-2-yl) - aniline

Rrhodnota produktu: 0,4 (gél kyseliny kremičitej, metylénchlorid/metanol = 10 : 1), C28H24N4O3, ESI-hmotnostné spektrum: m/z = 463 [M-H], (97) 3-Z- [1-(4-(1 -benzyl-imidazol-2-yl)-anilino)-1 -fenyl metylén] -6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(l-benzyl-imidazol-2 -yl) -anilínu,Product value: 0.4 (silica gel, methylene chloride / methanol = 10: 1), C28H24N4O3, ESI mass spectrum: m / z = 463 [MH], (97) 3-Z- [1- (4- ( 1-benzyl-imidazol-2-yl) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6- methoxycarbonyl-2-indolinone and 4- (1-benzyl-imidazol-2-yl) -aniline,

Rrhodnota produktu: 0,3 (gél kyseliny kremičitej, metylénchlorid/metanol = 20 : 1),Product value: 0.3 (silica gel, methylene chloride / methanol = 20: 1),

C33H26N4O3,C33H26N4O3.

ESI-hmotnostné spektrum: m/z = 525 [M-H], (98) 3-Z-[l-(4-(/V-(2-dimetylamino-etyl)-jV-izopropylsulfonyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolínon, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 7V-(2-dimetylamino-etyl)-jV-izopropylsulfonyl-p-fenyléndiamínu,ESI-MS: m / z = 525 [MH], (98) 3- Z- [1- (4 - (N - (2-dimethylamino-ethyl) - N -isopropylsulfonyl-amino) -anilino) -1 -phenylmethylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and N - (2-dimethylaminoethyl) ) -N-isopropylsulfonyl-p-phenylenediamine,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9 : 1),Product value: 0.5 (silica gel, methylene chloride / methanol = 9: 1),

C30H34N4O5S,C 30 H 34 N 4 O 5 S

ESI-hmotnostné spektrum: m/z = 561 [M-H]‘, (99) 3-Z-[l-(4-(jV-(piperidin-l-yl-metylkarbonyl)-/V-metylamino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a //-(piperriín-l-yl-metylkarbonyl)-7V-metyl-p-fenyléndiamínu,ESI-MS: m / z = 561 [MH] -, (99) 3- Z- [1- (4- (N - (piperidin-1-ylmethylcarbonyl) - N -methylamino) -anilino) - 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and N - (piperriin-1) yl-methylcarbonyl) -7V-methyl-p-phenylenediamine,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9:1),Product value: 0.5 (silica gel, methylene chloride / methanol = 9: 1),

C31H32N4O4,C 31 H 32 N 4 O 4 ,

ESI-hmotnostné spektrum: m/z = 523 [M-H]‘, (100) 3-Z-[ 1 -(4-(7V-(morfolin-4-yl-metylkarbonyl)-/V-metylamino)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu, a /V-(morfolin-4-yl-metylkarbonyl)-/V-metyl-p-fenyléndiamínu,ESI-MS: m / z = 523 [MH] -, (100) 3- Z - [1- (4- (N - (morpholin-4-ylmethylcarbonyl) - N -methylamino) -anilino) - 1-Phenylmethylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone, and N - (morpholine- 4-yl-methylcarbonyl) - / V-methyl-p-phenylenediamine,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9:1), C3oH3oN405, ESI-hmotnostné spektrum: m/z = 525 [M-H]‘, (101) 3-Z-[ 1 -(4-(/V-((4-benzyl-piperazm-1 -ylj-metylkarbonylj-V-metyl-ammoj-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 7V-((4-benzyl-piperazin-1 -yl)-metylkarbonyl)-jV-metyl-p-fenyléndiamínu,Product Rf value: 0.5 (silica gel, methylene chloride / methanol = 9: 1), C 3 oH 3 oN 0 4 5, ESI-MS: m / z = 525 [MH] +, (101) 3-Z - [1- (4 - (N - ((4-Benzyl-piperazin-1-yl) -methylcarbonyl] -N-methyl-amino-anilino) -1-phenyl-methylene) -6-methoxycarbonyl-2-indolinone, prepared by reacting 1-acetyl-3- (1-ethoxy-1-phenyl-methylene) -6-methoxycarbonyl-2-indolinone and N - ((4-benzyl-piperazin-1-yl) -methylcarbonyl) -N-methyl-p phenylenediamine,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9: 1),Product value: 0.5 (silica gel, methylene chloride / methanol = 9: 1),

C37H37N5O4,C 37 H 37 N 5 O 4

ESI-hmotnostné spektrum: m/z = 614 [M-H]', (102) 3-Z-[l-(4-(7V-(pyrolidin-1 -yl-metylkarbonylj-M-metylaminoj-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a /V-(pyrolidin-l-yl-metylkarbonyl)-/V-metyl-p-fenyléndiamínu,ESI-MS: m / z = 614 [MH] -, (102) 3- Z- [1- (4- (N - (pyrrolidin-1-ylmethylcarbonyl) -N-methylamino-anilino) -1-phenyl) -methylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and N - (pyrrolidin-1-yl-) - methylcarbonyl) - / V-methyl-p-phenylenediamine,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9 : 1), c30h30n4o4,Product value: 0.5 (silica gel, methylene chloride / methanol = 9: 1), c 30 h 30 n 4 o 4 ,

ESI-hmotnostné spektrum: m/z = 509 [M-H] j (103) 3-Z-[l-(4-(jV-(2-dimetylamino-etyl)-/V-acetyl-amino)-3-bróm-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2 -indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(7V-(2-dimetylarnmo-etyl)-.'V-acetyl-amino)-3-bróm-anilmu,ESI-MS: m / z = 509 [MH] + (103) 3- Z- [1- (4- (N - (2-dimethylamino-ethyl) - N -acetyl-amino) -3-bromo- anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4- (7H) - (2-ethyl-dimetylarnmo) -. "N-acetyl-amino) -3-bromo-aniline,

Rrhodnota produktu: 0,6 (gél kyseliny kremičitej, metylénchlorid/metanol = 5:1),Product value: 0.6 (silica gel, methylene chloride / methanol = 5: 1),

C29H29BrN4O4,C 2 9H 29 BrN 4 O 4

ESI-hmotnostné spektrum: m/z = 575/577 [M-H]‘, (104) 3-Z-[ 1 -(4-(5-metyl-imidazol-4-yl)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(5-metyl-imidazol-4-yl)-anilínu,ESI-MS: m / z = 575/577 [MH] -, (104) 3-Z- [1- (4- (5-methyl-imidazol-4-yl) -anilino) -1-phenyl-methylene 6-Methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4- (5-methyl-imidazol-4-yl) ) aniline,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol/amoniak =10:1: 0,01),Product value: 0.5 (silica gel, methylene chloride / methanol / ammonia = 10: 1: 0.01),

C27H22N4O3,C 27 H 22 N 4 O 3

ESI-hmotnostné spektrum: m/z = 449 [M-H]', (105) 3-Z-[l-(4-(M-((2-dimetylaminoetyl)karbonyl)-?/-izopropylamino)anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolmónu a /v-((2-dimetylamino-etyl)-karbonyl)-xV-izopropyl-p-fenyléndiamínu,ESI-MS: m / z = 449 [MH] -, (105) 3-Z- [1- (4- (N - ((2-dimethylaminoethyl) carbonyl) - R -isopropylamino) anilino) -1- phenylmethylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolmone and N - ((2-dimethylamino- ethyl) carbonyl) -XV-isopropyl-p-phenylenediamine,

Rrhodnota produktu: 0,1 (gél kyseliny kremičitej, metylénchlorid/metanol = 10 : 1),Product value: 0.1 (silica gel, methylene chloride / methanol = 10: 1),

C3iH34N4O4,C 3 iH 34 N 4 O 4 ,

SK 287312 Β6SK 287312-6

ESI-hmotnostné spektrum: m/z = 525 [M-H]’, (106) 3 -Z- [ 1 -(4-(/V-((2-dimetylamino-etyl)-karbonyl)-JV-benzyl-amino)-anilino)-1 -fenyl-metylén] -6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a /V-((2-dimetylamino-etyl)-karbonyl)-jV-benzyl-p-fenyléndiamínu,ESI-MS: m / z = 525 [MH] -, (106) 3 -Z- [1- (4 - (N - ((2-dimethylamino-ethyl) -carbonyl) -N-benzylamino)) (anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and N, N- ((2-dimethylamino-ethyl) carbonyl) -N-benzyl-p-phenylenediamine,

Rrhodnota produktu: 0,1 (gél kyseliny kremičitej, metylénchlorid/metanol = 10 : 1),Product value: 0.1 (silica gel, methylene chloride / methanol = 10: 1),

C31H34N4O4,C31H34N4O4.

ESI-hmotnostné spektrum: m/z = 525 [M-H]', (107) 3-Z- [ 1 -(4-(7V-butyl-7V-íerc-butoxykarbonylaminometyl)anilino)-1 -fenyl-metylén] -6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(7V-butyl-7V-Zerc-butoxykarbonylaminometyl)-anilínu,ESI-MS: m / z = 525 [MH] -, (107) 3-Z- [1- (4- (N-butyl-N-tert-butoxycarbonylaminomethyl) anilino) -1-phenylmethylene] -6 -methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4- (N-butyl-N-tert-butoxycarbonylaminomethyl) -aniline .

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9 : 1),Product value: 0.5 (silica gel, methylene chloride / methanol = 9: 1),

C33H37N3O5,C 33 H 3 7N 3 O 5

ESI-hmotnostné spektrum: m/z = 554 [M-H]', (108) 3-Z-[ 1 -(4-(M((A-aminokarbonyl-metyl-X-metyl-amino)-metylkarbonyl)-7V-metyl-amino)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 7V-(7V-aminokarbonyl-metyl-A,-metylamino)metylkarbonyl)-/V-metyl-p-fenylén-diamínu,ESI-MS: m / z = 554 [MH] -, (108) 3-Z- [1- (4- (M ((N-aminocarbonyl-methyl-X-methyl-amino) -methylcarbonyl) -7-) - methyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and N - (N-aminocarbonyl-methyl-N , -methylamino) methylcarbonyl) - N -methyl-p-phenylene diamine,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9 : 1),Product value: 0.5 (silica gel, methylene chloride / methanol = 9: 1),

C29H29N5O5,C 29 H 29 N 5 O 5

ESI-hmotnostné spektrum: m/z = 526 [M-H]', (109) 3-Z-[ 1 -(4-(N-((X-benzyl-/V-metyl-amino)-metylkarbonyl)-/V-metylamino)anilino)-1 -fenyl- metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 7V-((/V-benzyl-7V-metyl-amino)-metylkarbonyl)-Aľ-metyl-/t-fenyléndiamínu,ESI-MS: m / z = 526 [MH] -, (109) 3-Z- [1- (4- (N - ((X-benzyl- N -methyl-amino) -methylcarbonyl) - N) (methylamino) anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 7H - ((/ V-benzyl-7V-methyl-amino) -methylcarbonyl) -N-methyl-L / t-phenylenediamine,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9 : 1),Product value: 0.5 (silica gel, methylene chloride / methanol = 9: 1),

C34H32N4O4,C34H32N4O4.

ESI-hmotnostné spektrum: m/z = 559 [M-H]', (110) 3-Z-[l-(4-(/V-(di-(2-metoxyetyl)-amino-metylkarbonyl)-Aľ-metyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 7V-(di-(2-metoxyetyl)-aminometylkarbonyl)-V-metyl-p-fenyléndiamínu, Rrhodnota produktu: 0, 5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9:1),ESI-MS: m / z = 559 [MH] -, (110) 3- Z- [1- (4 - (N - (di- (2-methoxyethyl) -amino-methylcarbonyl)) - N 1 -methyl (amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and N - (di- (2-methoxyethyl) -aminomethylcarbonyl) - N -methyl-p-phenylenediamine, Product value: 0.5 (silica gel, methylene chloride / methanol = 9: 1),

C32H36N4O4,C 32 H 36 N 4 O 4

ESI-hmotnostné spektrum: m/z = 571 [M-H]', (111) 3-Z-[ 1 -(4-(7V-((2-(4-terc-butoxykarbonyl-piperazin-1 -yl)-etyl)-karbonyl)-/V-metyl-amino)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indoIinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a /V-((2-(4-terc-butoxykarbonyl-piperazin-l-yl)etyl)karbonyl)-7V-metyl-p-fenylén-diaminu,ESI-MS: m / z = 571 [MH] -, (111) 3-Z- [1- (4- (7H - ((2- (4-tert-butoxycarbonyl-piperazin-1-yl)) -ethyl) (carbonyl) - N -methyl-amino) -anilino-1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenyl-methylene) 6-methoxycarbonyl-2-indolinone and N - ((2- (4-tert-butoxycarbonylpiperazin-1-yl) ethyl) carbonyl) -N-methyl-p-phenylene diamine,

Rrhodnota produktu: 0,8 (gél kyseliny kremičitej, metylénchlorid/metanol = 5:1),Product value: 0.8 (silica gel, methylene chloride / methanol = 5: 1),

C36H41N5O6,C36H41N 5 O 6

ESI-hmotnostné spektrum: m/z = 638 [M-H]', (112) 3-Z-[ 1 -(4-(Af-((2-(piperidin-1 -yl)-etyl)-karbonyl)-/V-metyl-amino)-anilmo)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 7V-((2-(piperidin-1 -yl)-etyl)-karbonyl)-/V-metyl-p-fenyléndiamínu,ESI-MS: m / z = 638 [MH] +, (112) 3-Z- [1 - (4- (f - ((2- (piperidin-1-yl) ethyl) carbonyl) - (N-Methylamino) -anilino-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl- 2-indolinone and N - ((2- (piperidin-1-yl) ethyl) carbonyl) - N -methyl-p-phenylenediamine,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 5:1),Product value: 0.5 (silica gel, methylene chloride / methanol = 5: 1),

C32H34N4O4,C 32 H34N 4 O4

ESI-hmotnostné spektrum: m/z = 537 [M-H]', (113) 3-Z-[l-(4-(jV-((2-(/V-benzyl-jV-metylamino)etyl)karbonyl)-jV-metylamino)anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 7V-((2-(7V-benzyl-7V-metyl-amino)-etyl)-karbonyl)-/V-metyl-p-fenyléndiamínu,ESI-MS: m / z = 537 [MH] -, (113) 3- Z- [1- (4- (N - ((2- (N-benzyl-N-methylamino) ethyl) carbonyl)) - N-methylamino) anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 7V - ((2- (7V-benzyl-7V-methyl-amino) ethyl) carbonyl) - / V-methyl-p-phenylenediamine,

Rrhodnota produktu: 0,4 (gél kyseliny kremičitej, metylénchlorid/metanol - 10 : 1),Product value: 0.4 (silica gel, methylene chloride / methanol - 10: 1),

C35H34N4O4,C35H34N4O4.

ESI-hmotnostné spektrum: m/z = 573 [M-H]', (114) 3-Z-[l-(4-(7V-dimetylaminometylkarbonyl-/V-izopropyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 7V-(dimetylaminometylkarbonyl)-7V-izopropyl-p-fenyléndiamínu,ESI-MS: m / z = 573 [MH] -, (114) 3-Z- [1- (4- (N-dimethylaminomethylcarbonyl- N -isopropyl-amino) -anilino) -1-phenyl-methylene] 6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and N - (dimethylaminomethylcarbonyl) - N -isopropyl-p-phenylenediamine .

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9 : 1),Product value: 0.5 (silica gel, methylene chloride / methanol = 9: 1),

C30H32N4O4,C 30 H 32 N 4 O 4

ESI-hmotnostné spektrum: m/z = 511 [M-H]', (115) 3-Z- [ 1 -(4-(M(pipendin-1 -yl-metylkarbonyl)-7V-izopropyl-amino)-anilino)-1 -fenyl-metylén] -6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a jV-(piperidin-l-yl-metylkarbonyl)-JV-izopropyl-p-fenyléndiamínu,ESI-MS: m / z = 511 [MH] -, (115) 3-Z- [1- (4- (N (piperidin-1-ylmethylcarbonyl) -N-isopropyl-amino) -anilino) - 1-Phenylmethylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and N - (piperidin-1- yl-methylcarbonyl) -N-isopropyl-p-phenylenediamine,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9 : 1),Product value: 0.5 (silica gel, methylene chloride / methanol = 9: 1),

C33H36N4O4,C 33 H 36 N 4 O 4 ,

ESI-hmotnostné spektrum: m/z = 551 [M-H]', (116) 3 -Z- [ 1 -(4-(JV-((4-terc-butoxykarbonyl-piperazin-1 -yl)-metylkarbonyl)-/V- izo-propyl-amino)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-mdolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a Af-((4-terc-butoxykarbonylpiperazin-l-yl)metylkarbonyl)-jV-izopropyl-/2-fenyléndiamínu,ESI-MS: m / z = 551 [MH] -, (116) 3 -Z- [1- (4- (N - ((4-tert-butoxycarbonyl-piperazin-1-yl) -methylcarbonyl) -) N-iso-propyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenyl-methylene) -6-methoxycarbonyl -2-indolinone and a f - ((4-tert-butoxycarbonyl-l-yl) methylcarbonyl) -N-isopropyl / 2-phenylenediamine,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9:1),Product value: 0.5 (silica gel, methylene chloride / methanol = 9: 1),

C37H43N5O6,C 37 H 43 N 5 O 6

ESI-hmotnostné spektrum: m/z = 652 [M-H]', (117) 3-Z-[ 1 -(4-(Af-((/V-benzyl-A'-metylamino)metylkarbonyl)-A/-benzylamino)anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 7V-((/V-benzyl-jV-metyl-amino)-metylkarbonyl)-/V-benzyl-p-fenyléndiamínu,ESI-MS: m / z = 652 [MH] +, (117) 3-Z- [1 - (4- (f - ((/ V-benzyl-N-methyl-amino) methylcarbonyl) -N / - benzylamino) anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and N, N- ((/ V-benzyl-N-methyl-amino) -methylcarbonyl) - / V-benzyl-p-phenylenediamine,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9 : 1),Product value: 0.5 (silica gel, methylene chloride / methanol = 9: 1),

C4oH36N404,C 4 oH 36 N 4 0 4 ,

ESI-hmotnostné spektrum: m/z = 635 [M-H]', (118) 3-Z-[ 1 -(4-(7V-dimetylaminometylkarbonyl-/V-benzyl-amino)-anilmo)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 7V-( dime tylami nometylkarbonyl)-/V-benzyl-p-fenyléndiamínu,ESI-MS: m / z = 635 [MH] -, (118) 3-Z- [1- (4- (N-dimethylaminomethylcarbonyl- N -benzylamino) -anilino) -1-phenylmethylene] 6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and N - (dimethylaminomethylcarbonyl) - N -benzyl- p-phenylenediamine,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9 : 1),Product value: 0.5 (silica gel, methylene chloride / methanol = 9: 1),

C34H32N4O4,C 34 H 32 N 4 O 4 ,

ESI-hmotnostné spektrum: m/z = 559 [M-H]', (119) 3-Z-[ 1 -(4-(/V-(piperidin-1 -yl-metylkarbonyl)-/V-benzyl-amino)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(5-metyl-imidazol-4-yl)-anilínu,ESI-MS: m / z = 559 [MH] -, (119) 3-Z- [1- (4 - (N - (piperidin-1-ylmethylcarbonyl) - N -benzylamino) - anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4- (5 methyl-imidazol-4-yl) -aniline,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9:1),Product value: 0.5 (silica gel, methylene chloride / methanol = 9: 1),

C37H36N4O4,C 37 H 36 N 4 O 4

ESI-hmotnostné spektrum: m/z = 599 [M-H]', (120) 3-Z-[ 1 -(4-( 1,2,4-triazol-2-yl-metyl)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-( 1,2,4-triazol-1 -yl-metyl)-anilínu,ESI-MS: m / z = 599 [MH] -, (120) 3- Z- [1- (4- (1,2,4-triazol-2-ylmethyl) -anilino) -1-phenyl -methylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4- (1,2,4-triazole) -1-yl-methyl) -aniline,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 10 : 1),Product value: 0.5 (silica gel, methylene chloride / methanol = 10: 1),

C26H2iN5O3,C 2 6H 2 iN 5 O 3 ,

ESI-hmotnostné spektrum: m/z = 450 [M-H]',ESI-MS: m / z = 450 [M-H] -,

SK 287312 Β6 (121) 3-Z-[ 1 -(4-( 1,2,3-triazol-2-yl-metyl)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(l,2,3-triazol-2-yl-metyl)-anilínu,(121) 3-Z- [1- (4- (1,2,3-triazol-2-ylmethyl) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenyl-methylene) -6-methoxycarbonyl-2-indolinone and 4- (1,2,3-triazol-2-ylmethyl) -aniline,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 20 : 1),Product value: 0.5 (silica gel, methylene chloride / methanol = 20: 1),

C26H21N5O3,C26H21N5O3.

ESI-hmotnostné spektrum: m/z = 450 [M-H]’, (12 2) 3-Z- [ 1 -(4-( 1,2,3-triazol-1 -yl-metyl)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-1 -fényl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(l,2,3-triazol-1 -yl-metyl)-anilínu,ESI-MS: m / z = 450 [MH] -, (12 2) 3-Z- [1- (4- (1,2,3-triazol-1-ylmethyl) -anilino) -1- phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared by reacting 1-acetyl-3- (1-ethoxy-1-phenyl-methylene) -6-methoxycarbonyl-2-indolinone and 4- (1,2,3- triazol-1-yl-methyl) -aniline,

Rrhodnota produktu: 0,4 (gél kyseliny kremičitej, metylénchlorid/metanol = 9:1),Product value: 0.4 (silica gel, methylene chloride / methanol = 9: 1),

C26H21N5O3,C26H21N 5 O 3

ESI-hmotnostné spektrum: m/z = 450 [M-H]', (123) 3-Z-[l-(4-((/V-aminokarbonyl-metyl-/V-metyl-amino)-metyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-((JV-aminokarbonyl-metyl-/V-metyl-amino)-metyl)-anilínu,ESI-MS: m / z = 450 [MH] -, (123) 3-Z- [1- (4 - ((N-aminocarbonyl-methyl- N -methyl-amino) -methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4 - ((JV- aminocarbonyl-methyl- / V-methyl-amino) methyl) aniline,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9 : 1),Product value: 0.5 (silica gel, methylene chloride / methanol = 9: 1),

C27H26N4O4,C 27 H 26 N 4 O 4 ,

ESI-hmotnostné spektrum: m/z = 469 [M-H]’, (124) 3-Z-[ 1 -(4-((di-(2-metoxy-etyl)-amino)-metyl)anilino)-1 -fenyl-metylén]-6-metoxy-karbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-((di-(2-metoxy-etyl)-amino)-metyl)-anilínu,ESI-MS: m / z = 469 [MH] -, (124) 3-Z- [1- (4 - ((di- (2-methoxy-ethyl) amino) methyl) anilino) -1- phenyl-methylene] -6-methoxy-carbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenyl-methylene) -6-methoxycarbonyl-2-indolinone and 4 - ((di- ( 2-methoxy-ethyl) amino) methyl) aniline,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9 : 1),Product value: 0.5 (silica gel, methylene chloride / methanol = 9: 1),

C3oH33N305,C 3 o 33 N 3 05,

ESI-hmotnostné spektrum: m/z = 514 [M-H]’, (125) 3-Z-[l-(4-(pyrolidin-l-yl]-metyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(pyrolidin-l-yl-metyl)-anilínu,ESI-MS: m / z = 514 [MH] -, (125) 3- Z- [1- (4- (pyrrolidin-1-yl) -methyl) -anilino) -1-phenyl-methylene] -6 -methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenyl-methylene) -6-methoxycarbonyl-2-indolinone and 4- (pyrrolidin-1-ylmethyl) -aniline,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9 : 1),Product value: 0.5 (silica gel, methylene chloride / methanol = 9: 1),

C28H27N3O3,C 28 H 27 N 3 O 3

ESI-hmotnostné spektrum: m/z = 452 [M-H]', (126) 3-Z-[l-(4-((di-(2-hydroxy-etyl)-amino)metyl)anilino)-l-fenylmetylén]-6-metoxy-karbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-((di-(2-hydroxy-etyl)-amino)-metyl)-anilínu,ESI-MS: m / z = 452 [MH] -, (126) 3-Z- [1- (4 - ((di- (2-hydroxyethyl) amino) methyl) anilino) -1-phenylmethylene 6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4 - ((di- (2-hydroxy) ethyl) amino) methyl) aniline,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9 : 1),Product value: 0.5 (silica gel, methylene chloride / methanol = 9: 1),

C^H^N/Os,C ^ H ^ N / Os.

ESI-hmotnostné spektrum: m/z = 486 [M-H]’, (127) 3-Z-[l-(4-((7V-etoxykarbonyl-metyl-7V-metyl-amino)-metyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyI-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-((7V-etoxykarbonyl-metyl-7V-metyl-amino)-metyl)-anilínu,ESI-MS: m / z = 486 [MH] -, (127) 3- Z- [1- (4 - ((N-ethoxycarbonyl-methyl-N-methyl-amino) -methyl) -anilino) -1 -phenylmethylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4 - ((N-ethoxycarbonyl- methyl-7V-methyl-amino) methyl) aniline,

Rrhodnota produktu: 0,5 (oxid hlinitý, metylénchlorid/etanol = 40 : 1),Product value: 0.5 (alumina, methylene chloride / ethanol = 40: 1),

C29H29N3O5,C 2 9H 2 9N 3 O5

ESI-hmotnostné spektrum: m/z = 498 [M-H]', (12 8) 3 -Z-[ 1 -(4-(azetidin-1 -yl-metyl)-anilino)-1 -fenyl-metylén] -6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy- l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(azetidin-1-yl-metyl)-anilínu,ESI-MS: m / z = 498 [MH] -, (12 8) 3 -Z- [1- (4- (azetidin-1-ylmethyl) -anilino) -1-phenylmethylene] -6 -methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenyl-methylene) -6-methoxycarbonyl-2-indolinone and 4- (azetidin-1-ylmethyl) -aniline,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol/amoniak = 9:1: 0,5,Product value: 0.5 (silica gel, methylene chloride / methanol / ammonia = 9: 1: 0.5,

C27H25N3O3,C 27 H 2 5N3O 3,

ESI-hmotnostné spektrum: m/z = 438 [M-H]', (129) 3-Z-[l-(4-(/V-propyl-A-terc-butoxykarbonylaminometyl)anilino)-l-fenyI-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(/V-propyl-M -íerc-butoxykarbonylaminometyl)-anilínu,ESI-MS: m / z = 438 [MH] -, (129) 3-Z- [1- (4- (N-propyl-N-tert-butoxycarbonylaminomethyl) anilino) -1-phenyl-methylene] - 6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4- (N-propyl-N-tert-butoxycarbonylaminomethyl) aniline,

Rf-hodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9 : 1),Rf value of product: 0.5 (silica gel, methylene chloride / methanol = 9: 1),

C32H35N3O5,C32H35N3O5.

ESI-hmotnostné spektrum: m/z = 540 [M-H]', (130) 3-Z-[ 1 -(4((íV-(2-(2-metoxy-etoxy)-etyl)-/V-metylamino)-metyl)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(N-(2-(2-mctoxy-etoxy)etyl)-/V-metyl-amino)-metyl)-anilínu,ESI-MS: m / z = 540 [MH] -, (130) 3-Z- [1- (4 (( N - (2- (2-methoxy-ethoxy) ethyl)) - N -methylamino) (1-Methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4- (N- (2- (2-methoxy-ethoxy) ethyl) - N -methyl-amino) -methyl) -aniline,

Rrhodnota produktu: 0,4 (gél kyseliny kremičitej, metylénchlorid/metanol = 9:1),Product value: 0.4 (silica gel, methylene chloride / methanol = 9: 1),

C30H33N3O5,C30H33N3O5.

ESI-hmotnostné spektrum: m/z = 514 [M-H]’, (131) 3-Z-[ 1 -(4-((/V-(íerc-butoxykarbonyl-3-amino-propyl)-/V-metyl-amino)-metyl)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(N-(N-terc-biitoxykarbonyl-3-amino-propyl)-/V-metyl-aminometyl)-amlinu,ESI-MS: m / z = 514 [MH] -, (131) 3-Z- [1- (4 - ((N - (tert -butoxycarbonyl-3-aminopropyl)) - N -methyl- amino) -methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenyl-methylene) -6-methoxycarbonyl-2- indolinone and 4- (N- (N-tert-biithoxycarbonyl-3-amino-propyl) - N -methyl-aminomethyl) -amine,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9:1),Product value: 0.5 (silica gel, methylene chloride / methanol = 9: 1),

C33H38N4O5,C 33 H 38 N 4 O 5

ESI-hmotnostné spektrum: m/z = 571 [M-H]', (132) 3-Z-[l-(4-((7V-(metylkarbamoyl-metyl)-7V-metyl-amino)-metyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-((/V-(metylkarbamoyl-metyl)-jV-metyl-amino)-metyl)-anilínu,ESI-MS: m / z = 571 [MH] -, (132) 3-Z- [1- (4 - ((N - (methylcarbamoyl-methyl) - N -methyl-amino) -methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4 - ((R) - (methylcarbamoyl-methyl) -N-methyl-amino) methyl) aniline,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9:1),Product value: 0.5 (silica gel, methylene chloride / methanol = 9: 1),

C28H28N4O4,C28H28N4O4.

ESI-hmotnostné spektrum: m/z = 483 [M-H]’, (133) 3-Z-[l-(4-((7V-(dimetylkarbamoyl-metyl)-/V-metyl-amino)-metyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-((?V-(dimetylkarbamoyl-metyl)-/V-metyl-amino)-metyl)-anilínu, Rrhodnota produktu: 0,3 (gél kyseliny kremičitej, metylénchlorid/metanol = 10:1),ESI-MS: m / z = 483 [MH] -, (133) 3-Z- [1- (4 - ((N - (dimethylcarbamoyl-methyl) - N -methyl-amino) -methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared by reacting 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4 - ((? N - (dimethylcarbamoyl-methyl) - N -methyl-amino) -methyl) -aniline, Product value: 0.3 (silica gel, methylene chloride / methanol = 10: 1),

C29H3oN404,C29H 3 oN 4 04

ESI-hmotnostné spektrum: m/z = 497 [M-H]', (134) 3-Z-[ 1 -(4-metyl-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-metyl-anilínu,ESI-MS: m / z = 497 [MH] -, (134) 3-Z- [1- (4-methyl-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared by reaction 1-acetyl-3- (1-ethoxy-1-phenyl-methylene) -6-methoxycarbonyl-2-indolinone and 4-methyl-aniline,

Rrhodnota produktu: 0,4 (gél kyseliny kremičitej, metylénchlorid/metanol = 9 : 1),Product value: 0.4 (silica gel, methylene chloride / methanol = 9: 1),

C24H20N2O3,C 24 H 20 N 2 O 3

ESI-hmotnostné spektrum: m/z = 383 [M-H], (135) 3-Z-[l-(4-((7V-propyl-/V-metyl-amino)-metyl)-anilino)-l-fenyl-metylén]-6-metoxy-karbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-((7V-propyl-jV-metyl-amino)-metyl)-anilínu,ESI-MS: m / z = 383 [MH], (135) 3- Z- [1- (4 - ((N-propyl- N -methyl-amino) -methyl) -anilino) -1-phenyl -methylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4 - ((N-propyl- N-methyl-amino) methyl) aniline,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9 : 1),Product value: 0.5 (silica gel, methylene chloride / methanol = 9: 1),

C28H29N3O3,C 28 H 29 N 3 O 3

ESI-hmotnostné spektrum: m/z = 454 [M-H]', (136) 3-Z-[l-(4-((/V-(2-hydroxy-etyl)-N-metyl-amino)-metyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-((77-(2-hydroxy-etyl)-jV-metyl-amino)-metyl)-anilínu,ESI-MS: m / z = 454 [MH] -, (136) 3-Z- [1- (4 - ((N - (2-hydroxy-ethyl) -N-methylamino) methyl)) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared by reacting 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4- ( (77- (2-hydroxyethyl) -N-methyl-amino) methyl) aniline,

Rrhodnota produktu: 0,5 (oxid hlinitý, metylénchlorid/etanol = 40 : 1),Product value: 0.5 (alumina, methylene chloride / ethanol = 40: 1),

C27H27N3O4,C 27 H 27 N 3 O 4

ESI-hmotnostné spektrum: m/z = 456 [M-H],ESI-MS: m / z = 456 [M-H]

SK 287312 Β6 (137) 3-Z-[l-(4-((/V-(2-dimetylamino-etyl)-7V-metyl-amino)-metyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-((7V-(2-dimetylamino-etyl)-/V-metyl-amino)-metyl)-anilínu,(137) 3-Z- [1- (4 - ((N - (2-dimethylamino-ethyl) - N -methyl-amino) -methyl) -anilino) -1-phenyl-methylene] -6 -methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4 - ((N - (2-dimethylaminoethyl)) -. N-methyl-amino) methyl) aniline,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9 : 1),R r value of the product: 0.5 (silica gel, methylene chloride / methanol = 9: 1),

C29H32N4O3,C29H32N4O3.

ESI-hmotnostné spektrum: m/z = 483 [M-H]', (138) 3-Z-[ 1 -(4-((JV-(3-dimetylamino-propyl)-/V-metyl-amino)-metyl)-anilino)-l -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-((/V-(3-dimetylamino-propyl)-7V-metyl-amino)-metyl)-anilínu,ESI-MS: m / z = 483 [MH] -, (138) 3-Z- [1- (4 - ((N - (3-dimethylamino-propyl) - N -methyl-amino) -methyl)) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4- ( (/ V- (3-dimethylaminopropyl) -7V-methyl-amino) methyl) aniline,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9:1),R r value of the product: 0.5 (silica gel, methylene chloride / methanol = 9: 1),

C30H34N4O3,C 30 H34N 4 O 3

ESI-hmotnostné spektrum: m/z = 497 [M-H]’, (139) 3-Z-[ 1 -(4-(3-oxo-piperazin-1 -yl-metyl)-anilino)-1 -fenylmetylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou l-acetyl-3-(l-etoxy-l-fenyl-metylén)-6-metoxykarbonyl-2-indolinónu a 4-(3-oxo-piperazin-1 -yl-metyl)-anilínu,ESI-MS: m / z = 497 [MH] -, (139) 3-Z- [1- (4- (3-oxo-piperazin-1-ylmethyl) -anilino) -1-phenylmethylene] - 6-methoxycarbonyl-2-indolinone, prepared by the reaction of 1-acetyl-3- (1-ethoxy-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone and 4- (3-oxo-piperazin-1-ylmethyl) ) aniline,

Rrhodnota produktu: 0,46 (gél kyseliny kremičitej, metylénchlorid/metanol = 9:1),Product value: 0.46 (silica gel, methylene chloride / methanol = 9: 1),

C28H26N4O4, ESI-hmotnostné spektrum: m/z = 481 [M-H]’.C 28 H 26 N 4 O 4 , ESI mass spectrum: m / z = 481 [MH] -.

Príklad 4Example 4

3-Z-[l-(4-Karboxy-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón3-Z- [l- (4-carboxy-anilino) -l-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone

485 mg 3-Z-[l-(4-terc-butoxykarbonyl-anilino)-l-fenyl-metylén]-6-etoxy-karbonyl-2-indolinónu sa rozpustilo v 15 ml metylénchloridu a pridalo sa 6,0 ml kyseliny trifluóroctovej. Reakčná zmes sa 2 hodiny miešala pri teplote miestnosti. Rozpúšťadlo sa potom odstránilo a zvyšok sa rekryštalizoval z prostredia éteru. Výťažok: 375 mg (87 % teoretického výťažku),485 mg of 3-Z- [1- (4-tert-butoxycarbonyl-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone was dissolved in 15 ml of methylene chloride and 6.0 ml of trifluoroacetic acid was added. . The reaction mixture was stirred at room temperature for 2 hours. The solvent was then removed and the residue was recrystallized from ether. Yield: 375 mg (87% of theory),

Rrhodnota produktu: 0,3 (gél kyseliny kremičitej, metylénchlorid/metanol =10:1)Product value: 0.3 (silica gel, methylene chloride / methanol = 10: 1)

C25H20N2O5, hmotnostné spektrum: m/z = 428 [M]+ .C 25 H 20 N 2 O 5, mass spectrum: m / z = 428 [M] + .

Podobne ako v príklade 4 sa pripravili nasledujúce zlúčeniny:As in Example 4, the following compounds were prepared:

(1) 3-Z-[ 1 -(4-aminometyl-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený z 3-Z-[ 1 -(4-(/V-ŕerc-butoxykarbonyl-aminometyl)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinónu,(1) 3-Z- [1- (4-Aminomethyl-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared from 3-Z- [1- (4 - (N - tert-butyl)] (butoxycarbonyl-aminomethyl) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol/amoniak = 5:1: 0,01), C24H2iN3O3,Product value: 0.5 (silica gel, methylene chloride / methanol / ammonia = 5: 1: 0.01), C 24 H 2 iN 3 O 3 ,

ESI-hmotnostné spektrum: m/z = 398 [M-H]', (2) 3-Z-[ 1 -(4-etylaminometyl-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený z 3 -Z- [ 1 -(4-(7V-/erc-butoxykarbonyl-etylaminometyl)-anilino)-1 -fenyl-metylén] -6-metoxykarbonyl-2-indolinónu,ESI-MS: m / z = 398 [MH] -, (2) 3-Z- [1- (4-ethylaminomethyl-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared from 3-Z- [1- (4- (N-tert-butoxycarbonyl-ethylaminomethyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone,

Rrhodnota produktu: 0,4 (gél kyseliny kremičitej, metylénchlorid/metanol/amoniak =10:1: 0,01), C26H25N3O3,Product value: 0.4 (silica gel, methylene chloride / methanol / ammonia = 10: 1: 0.01), C 26 H 25 N 3 O 3 ,

ESI-hmotnostné spektrum: m/z = 426 [M-H]', (3) 3-Z-[l-(4-karboxymetyl-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, pripravený z 3-Z-[l-(4-íerc-butoxykarbonyl-metyl-anilino)-l-fenyl-metylén]-6-etoxy-karbonyl-2-indolinónu, Rrhodnota produktu: 0,1 (oxid hlinitý, metylénchlorid/etanol/amoniak= 5:1: 0,01),ESI-MS: m / z = 426 [MH] -, (3) 3-Z- [1- (4-carboxymethyl-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, prepared from 3-Z- [1- (4-tert-butoxycarbonyl-methyl-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, Product Value: 0.1 (aluminum oxide, methylene chloride / ethanol) ammonia = 5: 1: 0.01)

C26H22N2O5,C 26 H 22 N 2 O 5

ESI-hmotnostné spektrum: m/z = 441 [M-H]', (4) 3-Z-[l-(4-karboxy-anilino)-l-etyl-metylén]-6-etoxykarbonyl-2-indolinón, pripravený z 3-Z-[ 1 -(4-íerc-butoxykarbonyl-anilino)-1 -etyl-metylén]-6-etoxykarbonyl-2-indolinónu, Rrhodnota produktu: 0,1 (oxid hlinitý, metylénchlorid/etanol = 20 : 1),ESI-MS: m / z = 441 [MH] -, (4) 3-Z- [1- (4-carboxy-anilino) -1-ethyl-methylene] -6-ethoxycarbonyl-2-indolinone, prepared from 3-Z- [1- (4-tert-butoxycarbonyl-anilino) -1-ethyl-methylene] -6-ethoxycarbonyl-2-indolinone, Product value: 0.1 (aluminum oxide, methylene chloride / ethanol = 20: 1) .

C21H20N2O5,C 21 H 20 N 2 O 5 ,

ESI-hmotnostné spektrum: m/z = 379 [M-H]',ESI-MS: m / z = 379 [M-H] -,

SK 287312 Β6 (5) 3-Z-[l-(4-(piperazin-l-yl-metyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený z 3-Z-[l-(4-(4-rerc-butoxykarbonyl-piperazin-l-yl-metyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinónu,(5) 3-Z- [1- (4- (piperazin-1-ylmethyl) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, prepared from 3-Z- [l- (4- (4-tert-butoxycarbonyl-piperazin-l-yl-methyl) anilino) -l-phenyl-methylene] -6-methoxycarbonyl-2-indolinone,

Rrhodnota produktu: 0,1 (gél kyseliny kremičitej, metylénchlorid/metanol/amoniak = 10 : 1 : 0,01), C28H28N4O3,Product value: 0.1 (silica gel, methylene chloride / methanol / ammonia = 10: 1: 0.01), C28H28N4O3,

ESI-hmotnostné spektrum: m/z = 469 [M+H]+, (6) 3-Z-[l-(4-butylaminometylanilino)-l-fenylmetylén]-6-metoxykarbonyl-2-indolinón, pripravený z 3-Z-[ 1 -(4-(7V-butyl-7V-rerc-butoxykarbonyl-aminometyl)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinónu,ESI-MS: m / z = 469 [M + H] + , (6) 3- Z- [1- (4-butylaminomethylanilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, prepared from 3- N- [1- (4- (N-butyl-N-tert-butoxycarbonyl-aminomethyl) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9:1),Product value: 0.5 (silica gel, methylene chloride / methanol = 9: 1),

C28H29N3O3,C28H29N3O3.

ESI-hmotnostné spektrum: m/z = 454 [M-H]', (7) 3-Z-[l-(4-etylaminometyl-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, pripravený z 3-Z-[l-(4-(A'-/e/c-butoxykarbonyl-A'-etylaminometyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinónu,ESI-MS: m / z = 454 [MH] -, (7) 3-Z- [1- (4-ethylaminomethyl-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, prepared from 3-Z- [l- (4- (N - / e / c-butoxycarbonyl-N-ethylaminomethyl) -anilino) -l-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone,

Rrhodnota produktu: 0,3 (gél kyseliny kremičitej, metylénchlorid/metanol/amoniak =10:1:0, 01),Product value: 0.3 (silica gel, methylene chloride / methanol / ammonia = 10: 1: 0, 01),

C27H27N3O3,C 27 H 27 N 3 O 3

ESI-hmotnostné spektrum: m/z = 442 [M+H]+, (8) 3-Z-[ 1 -(4-etylaminometyl-anilino)-1 -fenyl-metylén]-6-karbamoyl-2-indolinón, pripravený z 3-Z-[ 1 -(4-(7V-ŕerc-butoxykarbonyl-etylaminometyl)-anilino)-1 -fenyl-metylén]-6-karbamoyl-2-indolinónu,ESI-MS: m / z = 442 [M + H] + , (8) 3-Z- [1- (4-ethylaminomethyl-anilino) -1-phenyl-methylene] -6-carbamoyl-2-indolinone, prepared from 3-N- [1- (4- (N-tert-butoxycarbonyl-ethylaminomethyl) -anilino) -1-phenyl-methylene] -6-carbamoyl-2-indolinone,

Rrhodnota produktu: 0,2 (gél kyseliny kremičitej, metylénchlorid/metanol/amoniak = 5:1: 0,01),Product value: 0.2 (silica gel, methylene chloride / methanol / ammonia = 5: 1: 0.01),

C25H24N4O2,C25H24N4O2.

ESI-hmotnostné spektrum: m/z = 411 [M-H]’, (9) 3 -Z-[ 1 -(4-(/V-(piperazm-1 -yl-metylkarbonyl)-?V-izopropyl-amino)-anilino)-1 -fenyl-metylén] -6-metoxykarbonyl-2-indolinón, pripravený z 3-Z-[l-(4-(7V-((4-Zerc-butoxykarbonylpiperazin-l-yl)-metylkarbonyl)-7V-izopropyl-amino)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinónu,ESI-MS: m / z = 411 [MH] -, (9) 3 -Z- [1- (4 - (N - (piperazin-1-ylmethylcarbonyl) - N -isopropylamino) - anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared from 3-Z- [1- (4- (N - ((4-tert-butoxycarbonylpiperazin-1-yl) -methylcarbonyl) -7V) -isopropyl-amino) -anilino-1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone,

Rrhodnota produktu: 0,35 (gél kyseliny kremičitej, metylénchlorid/metanol = 9 : 1),Product value: 0.35 (silica gel, methylene chloride / methanol = 9: 1),

C32H35N5O4,C32H35N5O4.

ESI-hmotnostné spektrum: m/z = 552 [M-H]', (10) 3-Z-[ 1 -(4-(/V-((2-(piperazin-1 -yl)-etyl)-karbonyl)-A'-metyl-amino)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený z 3-Z-[l-(4-(7V-((2-(4-ŕerc-butoxykarbonylpiperazin-l-yl)-etyl)-karbonyl)-/V-metyl-amino)-anilino)-fenyl-metylén]-6-metoxykarbonyl-2-indolinónu,ESI-MS: m / z = 552 [MH] -, (10) 3-Z- [1- (4 - (N - ((2- (piperazin-1-yl) ethyl) -carbonyl)) - N'-methyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared from 3-Z- [1- (4- (7H - ((2- (4-tert- butoxycarbonyl-l-yl) ethyl) carbonyl) - / V-methyl-amino) anilino) -phenyl-methylene] -6-methoxycarbonyl-2-indolinone,

Rrhodnota produktu: 0,4 (gél kyseliny kremičitej, metylénchlorid/metanol/amoniak = 5:1: 0,01),Product value: 0.4 (silica gel, methylene chloride / methanol / ammonia = 5: 1: 0.01),

C31H33N5O4,C31H33N5O4.

ESI-hmotnostné spektrum: m/z = 540 [M+H]+, (11) 3-Z-[l-(4-(/V-propyl-aminometyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený z 3-Z-[ 1 -(4-(/V-propyl-7V-Zerc-butoxykarbonylaminometyl)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinónu,ESI-MS: m / z = 540 [M + H] + , (11) 3-Z- [1- (4- (N-propyl-aminomethyl) -anilino) -1-phenyl-methylene] -6 -methoxycarbonyl-2-indolinone prepared from 3-N- [1- (4- (N-propyl-N-tert-butoxycarbonylaminomethyl) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone,

Rrhodnota produktu: 0,35 (gél kyseliny kremičitej, metylénchlorid/metanol = 9 : 1),Product value: 0.35 (silica gel, methylene chloride / methanol = 9: 1),

C27H27N3O3,C 27 H 27 N 3 O 3 ,

ESI-hmotnostné spektrum: m/z = 440 [M-H]', (12) 3-Z-[l-(4-(7V-(3-amino-propyl)-7V-metyl-amino)-metyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený z 3-Z-[l-(4-((7V-(rerc-butoxykarbonyl-3-aminopropyl)-jV-metyl-amino)-metyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyI-2-indolinónu,ESI-MS: m / z = 440 [MH] -, (12) 3- Z- [1- (4- (N - (3-amino-propyl) - N -methyl-amino) -methyl) -anilino -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared from 3-Z- [1- (4 - ((N - (tert -butoxycarbonyl-3-aminopropyl) - N -methyl-amino) -) methyl) anilino) -l-phenyl-methylene] -6-methoxycarbonyl-2-indolinone,

Rrhodnota produktu: 0,35 (gél kyseliny kremičitej, metylénchlorid/metanol = 9:1),Product value: 0.35 (silica gel, methylene chloride / methanol = 9: 1),

C28H30N4O3,C28H30N4O3.

ESI-hmotnostné spektrum: m/z = 471 [M+H]+.ESI-MS: m / z = 471 [M + H] &lt; + &gt;.

Príklad 5Example 5

3-Z-[ 1 -(4-Metylaminometyl-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón3-Z- [1- (4-Methylaminomethyl-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone

V 20 ml etanolu sa rozpustilo 100 mg 3-Z-[l-(4-(W-benzyl-A'-metyl-amino-metyl)-amlino)-l-fenylmetylén]-6-etoxykarbonyl-2-indolinónu, pridalo sa 0,2 ml kyseliny chlorovodíkovej (cHcl = 1 mol.dm’3) a reakčná zmes sa 70 minút hydrogenovala pri teplote miestnosti pod tlakom vodíka 0,35 MPa (50 psi). Po hydrogenácii sa zmes filtrovala a filtrát sa odparil v rotačnej odparke. Zvyšok sa vysušil vo vákuu pri 100 °C. Výťažok: 50 mg (53 % teoretického výťažku),100 mg of 3-Z- [1- (4- (N-benzyl-N'-methyl-amino-methyl) -amino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone was dissolved in 20 ml of ethanol, added 0.2 ml of HCl (c = 1 HCl mol.dm '3), and the mixture is hydrogenated for 70 minutes at room temperature under a hydrogen pressure of 0.35 MPa (50 psi). After hydrogenation, the mixture was filtered and the filtrate was evaporated in a rotary evaporator. The residue was dried under vacuum at 100 ° C. Yield: 50 mg (53% of theory),

Rrhodnota produktu: 0,3 (gél kyseliny kremičitej, metylénchlorid/etanol/amoniak = 5:1: 0,01), C26H25N3O3,Product value: 0.3 (silica gel, methylene chloride / ethanol / ammonia = 5: 1: 0.01), C26H25N3O3,

ESI-hmotnostné spektrum: m/z = 426 [M-H]’.ESI-MS: m / z = 426 [M-H] -.

Podobne ako v príklade 5 sa pripravili nasledujúce zlúčeniny:As in Example 5, the following compounds were prepared:

(1) 3-Z-[ 1 -(4-metylaminometylanilino)-1 -fenylmetylén]-6-metoxykarbonyl-2-indolinón, pripravený z 3-Z-[ 1 -(4-(N-benzyl-V-metyl-aminometyl)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinónu,(1) 3-Z- [1- (4-methylaminomethylanilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, prepared from 3-Z- [1- (4- (N-benzyl-N-methyl- aminomethyl) anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone,

Rrhodnota produktu: 0,2 (gél kyseliny kremičitej, metylénchlorid/metanol/amoniak =10:1:0, 01), C25H23N3O3,Product value: 0.2 (silica gel, methylene chloride / methanol / ammonia = 10: 1: 0, 01), C25H23N3O3,

ESI-hmotnostné spektrum: m/z =412 [M-H]‘, (2) 3-Z-[l-(4-(V-(2-metylaminoetyl)-/V-metylsulfonyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-indolinón, pripravený z 3 -Z-[ 1 -(4-((2-(/V-benzy 1-TV-metyl-amino)-etyl)-N-metylsulfonyl-amino)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinónu,ESI-MS: m / z = 412 [MH] -, (2) 3-Z- [1- (4- (N - (2-methylaminoethyl) - N -methylsulfonylamino) -anilino) -1- phenyl-methylene] -6-methoxycarbonyl-indolinone, prepared from 3-Z- [1- (4 - ((2- (N-benzyl-N-benzylamino) ethyl) -N-methylsulfonyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone,

Rrhodnota produktu: 0,3 (gél kyseliny kremičitej,metylénchlorid/metano 1/amoniak = 10 : 1 : 0, 01), C27H28N4O5S,Product value: 0.3 (silica gel, methylene chloride / methanol 1 / ammonia = 10: 1: 0, 01), C 27 H 28 N 4 O 5 S,

ESI-hmotnostné spektrum: m/z = 519 [M-H]-, (3) 3-Z-[l-(4-(N-(2-amino-etyl)-N-metylsulfonyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený z 3-Z-[l-(4-(V-kyanometyl-N-metylsulfonyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinónu,ESI-MS: m / z = 519 [MH] - , (3) 3-Z- [1- (4- (N- (2-amino-ethyl) -N-methylsulfonyl-amino) -anilino) -1 -phenylmethylene] -6-methoxycarbonyl-2-indolinone, prepared from 3-Z- [1- (4- (N -cyanomethyl-N-methylsulfonylamino) -anilino) -1-phenylmethylene] -6- methoxycarbonyl-2-indolinone,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol/amoniak = 5:1: 0,01), C26H26N4O5S,Product value: 0.5 (silica gel, methylene chloride / methanol / ammonia = 5: 1: 0.01), C 26 H 26 N 4 O 5 S,

ESI-hmotnostné spektrum: m/z = 505 [M-H]’, (4) 3-Z-[l-(4-(/V-(3-metylamino-propyl)-A-metylsulfonyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený z 3-Z-[ 1 -(4-(V-(3-(N-benzyl-JV-metyl-amino)-propyl)-V-metylsulfonyl-amino)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinónu,ESI-MS: m / z = 505 [MH] -, (4) 3-Z- [1- (4 - (N - (3-methylamino-propyl) - N -methylsulfonyl-amino) -anilino) - 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared from 3-Z- [1- (4- (N - (3- (N-benzyl-N-methyl-amino)) -propyl) -N- methylsulfonyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone,

Rrhodnota produktu: 0,3 (gél kyseliny kremičitej, metylénchlorid/metanol/amoniak = 5:1: 0,01), C28H30N4O5S,Product value: 0.3 (silica gel, methylene chloride / methanol / ammonia = 5: 1: 0.01), C 28 H 30 N 4 O 5 S,

ESI-hmotnostné spektrum: m/z = 533 [M-H]‘, (5) 3-Z-[ 1 -(4-(N-(piperazin-1 -yl-metylkarbonyl)-W-metylamino)anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón pripravený z 3-Z-[l-(4-(N-((4-benzyl-piperazin-l-yl)metylkarbonyl)-V-metyl-amino)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyI-2-indolinónu,ESI-MS: m / z = 533 [MH] -, (S) 3-Z- [1- (4- (N- (piperazin-1-ylmethylcarbonyl) -N-methylamino) anilino) -1- phenyl-methylene] -6-methoxycarbonyl-2-indolinone prepared from 3-Z- [1- (4- (N - ((4-benzyl-piperazin-1-yl) methylcarbonyl) -N-methyl-amino) -anilino -1-Phenylmethylene] -6-methoxycarbonyl-2-indolinone

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 9:1),Product value: 0.5 (silica gel, methylene chloride / methanol = 9: 1),

C3oH3iN504,C 3 oH 3 iN 5 0 4 ,

ESI-hmotnostné spektrum: m/z = 524 [M-H]‘, (6) 3-Z-[ 1 -(4-(V-(metylamino-metylkarbonyl)-V-metylamino)anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený z 3-Z-[l-(4-(/V-((A'-benzyl-/V-metylamino)metylkarbonyl)-/V-metyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinónu,ESI-MS: m / z = 524 [MH] -, (6) 3-Z- [1- (4- (N- (methylamino-methylcarbonyl) -N-methylamino) anilino) -1-phenyl-methylene] 6-methoxycarbonyl-2-indolinone, prepared from 3-N- [1- (4 - (N - ((N'-benzyl- N -methylamino) methylcarbonyl) - N -methylamino) -anilino) -l-phenyl-methylene] -6-methoxycarbonyl-2-indolinone,

Rrhodnota produktu: 0,3 (gél kyseliny kremičitej, metylénchlorid/metanol = 9:1),Product value: 0.3 (silica gel, methylene chloride / methanol = 9: 1),

C27H2f,N4O4, ESI-hmotnostné spektrum: m/z = 469 [M-H]’, (7) 3-Z-[l-(4-(jV-((2-metylamino-etyl)-karbonyl)-ALmetyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón,C 27 H 21 F, N 4 O 4 , ESI mass spectrum: m / z = 469 [MH] -, (7) 3-Z- [1- (4- (N - ((2-methylaminoethyl)) (carbonyl) - ( L- methyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone,

SK 287312 Β6 pripravený z 3-Z-[l-(4-(A,-((2-(A,-benzy]-A,-metylamino)etyl)karbonyl)-A-metylamino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinónu,Prepared from 3-Z- [1- (4- (N , - ((2- (N , -benzyl) - N , -methylamino) ethyl) carbonyl) - N -methylamino) -anilino) -1- phenyl-methylene] -6-methoxycarbonyl-2-indolinone,

Rrhodnota produktu: 0,3 (gél kyseliny kremičitej, metylénchlorid/metanol/amoniak = 5:1: 0,01), C28H28N4O4,Product value: 0.3 (silica gel, methylene chloride / methanol / ammonia = 5: 1: 0.01), C28H28N4O4,

ESI-hmotnostné spektrum: m/z = 483 [M-H]-.ESI-MS: m / z = 483 [MH] - .

Príklad 6 3-Z-[l-(4-Ureidometyl-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinónExample 6 3-Z- [1- (4-Ureidomethyl-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone

V 15 ml metanolu sa rozpustilo 300 mg 3-Z-[l-(4-aminometyl-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinónu a pridalo sa 200 ml trietylamínu. Potom sa pridalo 400 mg kyanátu draselného v 5 ml vody. Po dvoch dňoch miešania pri teplote miestnosti sa reakčná zmes odparila v rotačnej odparke, zvyšok sa rozmiešal v metylénchloride a premyl raz vodou a raz nasýteným vodným roztokom chloridu sodného. Organická fáza sa sušila nad bezvodým síranom sodným a odparila. Zvyšok sa sušil pri 100 °C vo vákuu. Výťažok: 100 mg (21 % teoretického výťažku),300 mg of 3-Z- [1- (4-aminomethyl-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone was dissolved in 15 ml of methanol and 200 ml of triethylamine was added. Then 400 mg of potassium cyanate in 5 ml of water was added. After stirring at room temperature for two days, the reaction mixture was rotary evaporated, the residue was stirred in methylene chloride and washed once with water and once with saturated aqueous sodium chloride solution. The organic phase was dried over anhydrous sodium sulfate and evaporated. The residue was dried at 100 ° C under vacuum. Yield: 100 mg (21% of theory),

Rf-hodnota produktu: 0,7 (gél kyseliny kremičitej, metylénchlorid/metanol = 5:1),Rf value of product: 0.7 (silica gel, methylene chloride / methanol = 5: 1),

C25H22N4O4, ·C25H22N4O4, ·

ESI-hmotnostné spektrum: m/z = 441 [M-H]-.ESI-MS: m / z = 441 [MH] - .

Príklad 7Example 7

-Z-[ 1 -(4-Guanidinometyl-anilino)-1 -fenyl-metylén] -6-metoxykarbonyl-indolinón-Z- [1- (4-Guanidinomethyl-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-indolinone

V 5 ml dimetylformamidu sa rozpustilo 300 mg 3-Z-[l-(4-aminometyl-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinónu a pridalo sa 300 ml trietylamínu. Potom sa pridalo 700 mg amidínu kyseliny 3,5-dimetylpyrazol-1-karboxylovej v 5 ml dimetylformamidu. Po jednodňovom miešaní pri teplote miestnosti sa reakčná zmes odparila v rotačnej odparke. Zvyšok sa vysušil pri 100 °C vo vákuu.300 mg of 3-Z- [1- (4-aminomethyl-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone was dissolved in 5 ml of dimethylformamide and 300 ml of triethylamine was added. Then 700 mg of 3,5-dimethylpyrazole-1-carboxylic acid amidine in 5 ml of dimethylformamide was added. After stirring at room temperature for one day, the reaction mixture was evaporated in a rotary evaporator. The residue was dried at 100 ° C under vacuum.

Výťažok: 200 mg (87 % teoretického výťažku),Yield: 200 mg (87% of theory),

Rrhodnota produktu: 0,1 (reverzná fáza RP8, metanol/5%-ný roztok chloridu sodného = 6:4), C25H23N5O3,Product value: 0.1 (reverse phase RP8, methanol / 5% sodium chloride solution = 6: 4), C25H23N5O3,

Hmotnostné spektrum: m/z = 441 [M]+.Mass spectrum: m / z = 441 [M] &lt; + &gt;.

Príklad 8Example 8

3-Z-[l-(4-Acetylaminometyl-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón3-Z- [l- (4-acetylamino-anilino) -l-phenyl-methylene] -6-methoxycarbonyl-2-indolinone

V 5 ml ľadovej kyseliny octovej sa rozpustilo 100 mg 3-Z-[l-(4-aminometyl-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinónu, pridalo sa 0,1 ml anhydridu kyseliny octovej a zmes sa 10 minút miešala pri teplote miestnosti. Reakčná zmes sa potom naliala do nasýteného vodného roztoku uhličitanu sodného a štyri razy extrahovala metylénchloridom. Spojené organické vrstvy sa premyli nasýteným vodným roztokom chloridu sodného, sušili nad bezvodým síranom sodným a odparili. Zvyšok sa vysušil pri 100 °C vo vákuu. Výťažok: 20 mg (23 % teoretického výťažku),100 mg of 3-Z- [1- (4-aminomethyl-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone was dissolved in 5 ml of glacial acetic acid, 0.1 ml of acetic anhydride was added and the mixture was stirred at room temperature for 10 minutes. The reaction mixture was then poured into a saturated aqueous sodium carbonate solution and extracted four times with methylene chloride. The combined organic layers were washed with saturated aqueous sodium chloride solution, dried over anhydrous sodium sulfate and evaporated. The residue was dried at 100 ° C under vacuum. Yield: 20 mg (23% of theory),

Rrhodnota produktu: 0,4 (gél kyseliny kremičitej, metylénchlorid/metanol = 10 : 1),Product value: 0.4 (silica gel, methylene chloride / methanol = 10: 1),

G26H23N3O4, ESI-hmotnostné spektrum: m/z = 440 [M-H]’.G26H23N3O4, ESI-MS: m / z = 440 [M-H] &lt; + &gt;.

Podobne ako v príklade 8 sa pripravili nasledujúce zlúčeniny:As in Example 8, the following compounds were prepared:

(1) 3-Z-[l-(4-(jV-metylsulfonylammometyl)anilino)-l-fenylmetylén]-6-metoxykarbonyl-2-indolinón, pripravený reakciou 3-Z-[l-(4-aminometylanilino)-l-fenylmetylén]-6-metoxykarbonyl-2-indolinónu a metánsulfonylchloridu/trietylamínu,(1) 3-Z- [1- (4- (N-methylsulfonylammomethyl) anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, prepared by the reaction of 3-Z- [1- (4-aminomethylanilino) -1] -phenylmethylene] -6-methoxycarbonyl-2-indolinone and methanesulfonyl chloride / triethylamine,

Rrhodnota produktu: 0,7 (gél kyseliny kremičitej, metylénchlorid/metanol = 5:1),Product value: 0.7 (silica gel, methylene chloride / methanol = 5: 1),

C25H23N3O5S,C 25 H 2 3N 3 O 5 S,

ESI-hmotnostné spektrum: m/z = 476 [M-H]’, (2) 3-Z-[l-(4-(4-benzoyl-piperazin-l-yl-metyl)-anilino)-l-fenyl-metylén]-6-metoxy-karbonyl-2-indolinón, pripravený reakciou 3-Z-[ 1 -(4-(piperazin-1 -yl-metyl)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinónu a benzoylchloridu,ESI-MS: m / z = 476 [MH] -, (2) 3-Z- [1- (4- (4-benzoyl-piperazin-1-ylmethyl) -anilino) -1-phenyl-methylene 6-Methoxy-carbonyl-2-indolinone prepared by the reaction of 3-Z- [1- (4- (piperazin-1-ylmethyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2- indolinone and benzoyl chloride,

Rrhodnota produktu: 0,7 (gél kyseliny kremičitej, metylénchlorid/metanol = 10 : 1) C35H32N4O4, ESI-hmotnostné spektrum: m/z = 571 [M-H]-, (3) 3-Z-[l-(4-((/V-(3-acetylamino-propyl)-/V-metyl-amino)-metyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený z 3-Z-[ 1 -(4-((A-(3-amino-propyl)-/V-metyl-amino)-metyl)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinónu,Product value: 0.7 (silica gel, methylene chloride / methanol = 10: 1) C35H32N4O4, ESI mass spectrum: m / z = 571 [MH] - , (3) 3-Z- [1- (4- ( (N - (3-Acetylamino-propyl) - N -methyl-amino) -methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, prepared from 3-Z- [1- (4 - ((N- (3-amino-propyl) - N -methyl-amino) -methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone,

Rrhodnota produktu: 0,3 (gél kyseliny kremičitej, metylénchlorid/metanol = 9:1),Product value: 0.3 (silica gel, methylene chloride / methanol = 9: 1),

C30H32N4O4, ESI-hmotnostné spektrum: m/z = 511 [M-H]'.C30H32N4O4, ESI mass spectrum: m / z = 511 [M-H] -.

Príklad 9Example 9

3-Z-[l-(4-(Piperidin-l-yl-metyl)-anilino)-l-fenyl-metylén]-6-karboxy-2-indolinón3-Z- [l- (4- (piperidin-l-yl-methyl) anilino) -l-phenyl-methylene] -6-carboxy-2-indolinone

V 30 ml etanolu sa rozpustilo 0,8 g 3-Z-[l-(4-(piperidin-l-yl-metyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinónu, pridalo sa 8,3 ml roztoku hydroxidu sodného (cNa0H = 1 mol.dm'3) a reakčná zmes sa hodinu miešala pri 80 °C. Po ochladení sa zmes neutralizovala zriedenou kyselinou chlorovodíkovou (8,3 ml, cHC1 = 1 mol.dm'3). Vylúčená zrazenina sa zachytila filtráciou s odsávaním, premyla vodou, etanolom a éterom a pri 100 °C vysušila vo vákuu.0.8 g of 3-Z- [1- (4- (piperidin-1-ylmethyl) -anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone was dissolved in 30 ml of ethanol, 8.3 ml of sodium hydroxide solution (c NaOH = 1 mol.dm &lt; 3 &gt; ) and the reaction mixture was stirred at 80 [deg.] C. for 1 hour. After cooling, the mixture was neutralized with dilute hydrochloric acid (8.3 mL, c HCl = 1 mol.dm 3 ). The precipitate formed was collected by suction filtration, washed with water, ethanol and ether and dried at 100 ° C under vacuum.

Výťažok: 0,7 g (89 % teoretického výťažku),Yield: 0.7 g (89% of theory),

Rf-hodnota produktu: 0,2 (gél kyseliny kremičitej, metylénchlorid/metanol = 5:2),Rf value of product: 0.2 (silica gel, methylene chloride / methanol = 5: 2),

C26H27N3O3, *C26H27N3O3, *

Hmotnostné spektrum: m/z = 453 [M]+.Mass Spectrum: m / z = 453 [M] &lt; + &gt;.

Podobne ako v príklade 9 sa pripravili nasledujúce zlúčeniny:As in Example 9, the following compounds were prepared:

(1) 3-Z-[ 1 -(4-bróm-anilino)-1 -fenyl-metylén] -6-karboxy-2-indolinón, pripravený z 3-Z-[l-(4-bróm-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinónu, Rrhodnota produktu: 0,4 (gél kyseliny kremičitej, toluén/etylester kyseliny octovej = 5:1), C22Hi5BrN2O3,(1) 3-Z- [1- (4-bromo-anilino) -1-phenyl-methylene] -6-carboxy-2-indolinone, prepared from 3-Z- [1- (4-bromo-anilino) - l-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, R r value of the product: 0.4 (silica gel, toluene / ethyl acetate = 5: 1), C 22 H 5 BrN 2 O 3,

ESI-hmotnostné spektrum: m/z = 435/437 [M+H]+, (2) 3-Z-[ 1 -(3-(dimetylaminometyl)-anilino)-1 -fenyl-metylén]-6-karboxy-2-indolinón, pripravený z 3-Z-[l-(3-(dimetylaminometyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinónu, Rrhodnota produktu: 0,7 (reverzná fáza RP8, metanol/päťpercentný roztok chloridu sodného = 4:1), C25H23N3O3,ESI-MS: m / z = 435/437 [M + H] + , (2) 3- Z- [1- (3- (dimethylaminomethyl) anilino) -1-phenylmethylene] -6-carboxy- 2-indolinone, prepared from 3-Z- [1- (3- (dimethylaminomethyl) -anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, Product value: 0.7 (reverse phase RP8, methanol) / 5% sodium chloride solution = 4: 1), C25H23N3O3,

ESI-hmotnostné spektrum: m/z = 414 [M+H]+, (3) 3-Z-[l-(4-(dimetylaminometyl)-anilino)-l-fenyl-metylén]-6-karboxy-2-indolinón, pripravený z 3-Z-[ 1 -(4-(dimetylaminometyl)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinónu, Rrhodnota produktu: 0,7 (reverzná fáza RP8, metanol/5 %-ný vodný roztok chloridu sodného = 4 : 1), C25H23N3O3,ESI-MS: m / z = 414 [M + H] + , (3) 3-Z- [1- (4- (dimethylaminomethyl) anilino) -1-phenylmethylene] -6-carboxy-2- indolinone, prepared from 3-Z- [1- (4- (dimethylaminomethyl) -anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, Product value: 0.7 (reverse phase RP8, methanol / 5) % aqueous sodium chloride solution = 4: 1), C25H23N3O3,

ESI-hmotnostné spektrum: m/z = 412 [M-H]', (4) 3-Z-[l-(4-[ (2,6-dimetyl-piperidin-l-yl)-metyl]-anilino)-l-fenyl-metyIén]-6-karboxy-2-indolinón, pripravený z 3-Z-[l-(4-[(2,6-dimetyl-piperidin-l-yl)-metyl]-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinónu,ESI-MS: m / z = 412 [MH] -, (4) 3-Z- [1- (4 - [(2,6-dimethyl-piperidin-1-yl) -methyl] -anilino) -1 -phenyl-methylene] -6-carboxy-2-indolinone, prepared from 3-Z- [1- (4 - [(2,6-dimethyl-piperidin-1-yl) -methyl] -anilino) -1-phenyl methylene] -6-ethoxycarbonyl-2-indolinone,

Rrhodnota produktu: 0,6 (reverzná fáza RP8, metanol/päťpercentný vodný roztok chloridu sodného = 4:1), CjoHnNjOj,Product value: 0.6 (reverse phase RP8, methanol / 5% aqueous sodium chloride = 4: 1), C 10 H 11 N 3 O 3,

ESI-hmotnostné spektrum: m/z = 482 [M+H]+, (5) 3-Z-[ 1 -(4-( 1 -metyl-imidazol-2-yl)-anilino)-1 -fenyl-metylén]-6-karboxy-2-indolinón, pripravený z 3-Z-[ 1 -(4-( 1 -metyl-imidazol-2-yl)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinónu, Rrhodnota produktu: 0,6 (reverzná fáza RP8, metanol/päťpercentný vodný roztok chloridu sodného = 4:1), C26H20N4O3,ESI-MS: m / z = 482 [M + H] + , (S) 3-Z- [1- (4- (1-methyl-imidazol-2-yl) -anilino) -1-phenyl-methylene 6-Carboxy-2-indolinone, prepared from 3-Z- [1- (4- (1-methyl-imidazol-2-yl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2- indolinone, Product value: 0.6 (reverse phase RP8, methanol / 5% aqueous sodium chloride = 4: 1), C26H20N4O3,

ESI-hmotnostné spektrum: m/z = 435 [M-H]', (6) 3-Z-[l-(4-(/V-acetyl-/V-dimetylaminokarbonylmetylamino)anilino)-l-fenyl-metylén]-6-karboxy-2-indolinón, pripravený z 3-Z-[l-(4-(N-acetyl-/V-dimetylaminokarbonyl-metyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinónu,ESI-MS: m / z = 435 [MH] -, (6) 3-Z- [1- (4- (N-acetyl- N -dimethylaminocarbonylmethylamino) anilino) -1-phenylmethylene] -6 -carboxy-2-indolinone prepared from 3-Z- [1- (4- (N-acetyl- N -dimethylaminocarbonyl-methyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2- indolinone,

Rrhodnota produktu: 0,3 (gél kyseliny kremičitej, metylénchlorid/metanol = 10 : 1),Product value: 0.3 (silica gel, methylene chloride / methanol = 10: 1),

C28H26N4O5,C28H26N4O5.

ESI-hmotnostné spektrum: m/z = 497 [M-H]‘, (7) 3-Z-[l-(4-etylaminometyl-anilino)-l-fenyl-metylén]-6-karboxy-2-indolinón, pripravený z 3-Z-[ 1 -(4-etylaminometyl-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinónu, Rrhodnota produktu: 0,6 (reverzná fáza RP8, metanol/päťpercentný vodný roztok chloridu sodného = 4 : 1), C25H23N3O3,ESI-MS: m / z = 497 [MH] -, (7) 3-Z- [1- (4-ethylaminomethyl-anilino) -1-phenyl-methylene] -6-carboxy-2-indolinone, prepared from 3-Z- [1- (4-ethylaminomethyl-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, Product value: 0.6 (reverse phase RP8, methanol / 5% aqueous sodium chloride solution = 4 : 1), C25H23N3O3

ESI-hmotnostné spektrum: m/z = 412 [M-H]', (8) 3-Z-[l-(4-(/V-dimetylaminometylkarbonyl-/V-metylamino)anilino)-l-fenyl-metylén]-6-karboxy-2-indolinón, pripravený z 3-Z-[ 1 -(4-(/V-dimetylaminometylkarbonyl-N-metyl-amino)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinónu,ESI-MS: m / z = 412 [MH] -, (8) 3-Z- [1- (4- (N-dimethylaminomethylcarbonyl- N -methylamino) anilino) -1-phenyl-methylene] -6 -carboxy-2-indolinone, prepared from 3-Z- [1- (4- (N-dimethylaminomethylcarbonyl-N-methylamino) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone,

Rrhodnota produktu: 0,6 (reverzná fáza RP8, metanol/päťpercentný vodný roztok chloridu sodného = 4:1), C27H26N4O4,Product value: 0.6 (reverse phase RP8, methanol / 5% aqueous sodium chloride solution = 4: 1), C 27 H 26 N 4 O 4 ,

ESI-hmotnostné spektrum: m/z = 469 [M-H]‘, (9) 3-Z-[l-(4-(/V-terc-butoxykarbonyl-etylaminometyl)-anilino)-l-fenyl-metylén]-6-karboxy-2-indolinón, pripravený z 3-Z-[l-(4-(N-ŕerc-butoxykarbonyl-etylaminometyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinónu,ESI-MS: m / z = 469 [MH] -, (9) 3-Z- [1- (4- (N-tert-butoxycarbonyl-ethylaminomethyl) -anilino) -1-phenyl-methylene] -6 -carboxy-2-indolinone, prepared from 3-Z- [1- (4- (N-tert-butoxycarbonyl-ethylaminomethyl) -anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone,

Rrhodnota produktu: 0,4 (gél kyseliny kremičitej, metylénchlorid/metanol = 10 : 1),Product value: 0.4 (silica gel, methylene chloride / methanol = 10: 1),

C30H31N3O5,C 30 H 31 N 3 O 5 ,

ESI-hmotnostné spektrum: m/z = 512 [M-H], (10) 3-Z-[l-(4-((/V-karboxymetyl-jV-metyl-amino)-inetyl)-amlino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, pripravený z 3-Z-[ 1 -(4-((/V-etoxykarbonyl-metyl-jV-metylamino)-metyl)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl 2-indolinónu,ESI-MS: m / z = 512 [MH], (10) 3- Z- [1- (4 - ((N-carboxymethyl-N -methyl-amino) -inetyl) -amino) -1-phenyl -methylene] -6-methoxycarbonyl-2-indolinone, prepared from 3-Z- [1- (4 - ((N-ethoxycarbonyl-methyl-N-methylamino) -methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl of 2-indolinone,

Rf-hodnota produktu: 0,4 (gél kyseliny kremičitej, metylénchlorid/metanol = 6 : 1),Rf value of product: 0.4 (silica gel, methylene chloride / methanol = 6: 1),

C27H25N3O5, ESI-hmotnostné spektrum: m/z = 470 [M-H]'.C 27 H 25 N 3 O 5 , ESI mass spectrum: m / z = 470 [MH] -.

Príklad 10 3-Z-[l-(4-(Piperidin-l-yl-metyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinónExample 10 3-N- [1- (4- (Piperidin-1-yl-methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone

V 35 ml dimetylformamidu sa rozmiešalo 0,9 g 3-Z-[l-(4-(piperidin-l-yl-metyl)-anilino)-l-fenyl-metylén]-6-karboxy-2-indolinónu a pridalo sa 0,4 g karbonyl-diimidazolu. Zmes sa 14 hodín miešala pri teplote miestnosti. Potom sa pridalo 20 ml metanolu a znova sa zmes miešala 3 hodiny pri 50 °C. Rozpúšťadlo sa odstránilo a zvyšok sa čistil na stĺpci gélu kyseliny kremičitej s použitím metylénchloridu/metanolu ako elučným činidlom.0.9 g of 3-Z- [1- (4- (piperidin-1-ylmethyl) -anilino) -1-phenyl-methylene] -6-carboxy-2-indolinone was stirred in 35 ml of dimethylformamide and added. 0.4 g of carbonyl-diimidazole. The mixture was stirred at room temperature for 14 hours. Then 20 ml of methanol were added and the mixture was again stirred at 50 ° C for 3 hours. The solvent was removed and the residue was purified on a silica gel column using methylene chloride / methanol as eluent.

Výťažok: 0,5 g (49 % teoretického výťažku), Rrhodnota produktu: 0,5 (oxid hlinitý, metylénchlorid/metanol = 30 : 1), C^HjgNjOj,Yield: 0.5 g (49% of theory), Product value: 0.5 (alumina, methylene chloride / methanol = 30: 1), C C ^HjgNjOj,

ESI-hmotnostné spektrum: m/z = 468 [M+H]+.ESI-MS: m / z = 468 [M + H] &lt; + &gt;.

Podobne ako v príklade 10 sa pripravili nasledujúce zlúčeniny:As in Example 10, the following compounds were prepared:

(1) 3-Z-[ 1 -(4-(piperidin-1 -yl-metyl)-anilino)-1 -fenyl-metylén]-6-benzyloxykarbonyl-2-indolinón, pripravený reakciou l-fenyl-metylén]-6-karboxy-2-indolinónu a benzylalkoholu,(1) 3-Z- [1- (4- (piperidin-1-yl-methyl) -anilino) -1-phenyl-methylene] -6-benzyloxycarbonyl-2-indolinone, prepared by reaction of 1-phenyl-methylene] - 6-carboxy-2-indolinone and benzyl alcohol,

Rrhodnota produktu: 0,6 (oxid hlinitý, metylénchlorid/metanol = 30 : 1)Product value: 0.6 (aluminum oxide, methylene chloride / methanol = 30: 1)

C35H33N3O3, hmotnostné spektrum: m/z = 543 [M]+, (2) 3-Z-[ 1 -(4-(piperidin-1 -yl-metyl)-anilino)-1 -fenyl-metylén]-6-izopropyloxykarbonyl-2-indolinón, pripravený reakciou 3-Z-[l-(4-(piperidin-l-ylmetyl)anilino)-l-fenylmetylén]-6-karboxy-2-indolinónu a izopropanolu,C 35 H 33 N 3 O 3 , mass spectrum: m / z = 543 [M] + , (2) 3-Z- [1- (4- (piperidin-1-ylmethyl) -anilino) -1- phenyl-methylene] -6-isopropyloxycarbonyl-2-indolinone, prepared by the reaction of 3-Z- [1- (4- (piperidin-1-ylmethyl) anilino) -1-phenylmethylene] -6-carboxy-2-indolinone and isopropanol,

Rrhodnota produktu: 0,4 (oxid hlinitý, metylénchlorid/izopropanol = 30 : 1),Product value: 0.4 (alumina, methylene chloride / isopropanol = 30: 1),

C31H33N3O3, hmotnostné spektrum: 95 [M]+, (3) 3-Z-[ 1 -(4-(piperidin-1 -yl-metyl)-anilino)-1 -fenyl-metylén]-6-propyloxykarbonyl-2-indolinón, pripravený reakciou 3-Z-[l-(4-(piperidin-l-yl-metyl)-anilino)-l-fenylmetylén]-6-karboxy-2-indolinónu a n-propanolu,C31H 33 N 3 O 3 MS: 95 [M] +, (3) 3-Z- [1 - (4- (piperidin-1-ylmethyl) anilino) -1-phenyl-methylene] -6- propyloxycarbonyl-2-indolinone, prepared by reacting 3-Z- [1- (4- (piperidin-1-ylmethyl) -anilino) -1-phenylmethylene] -6-carboxy-2-indolinone and n-propanol,

Rrhodnota produktu: 0,7 (gél kyseliny kremičitej, metylénchlorid/metanol = 5 : 1),Product value: 0.7 (silica gel, methylene chloride / methanol = 5: 1),

C31H33N3O3, hmotnostné spektrum: m/z = 495 [M]+, (4) 3-Z-[ 1 -(4-(piperidin-1 -yl-metyl)-anilino)-1 -fenyl-metylén]-6-butyloxykarbonyl-2-indolinón, pripravený reakciou 3-Z-[l-(4-(piperidin-l-yl-metyl)-anilino)-l-fenyl-metylén]-6-karboxy-2-indolinónu a n-butanolu,C31H33N3O3, mass spectrum: m / z = 495 [M] &lt; + &gt;, (4) 3-Z- [1- (4- (piperidin-1-ylmethyl) -anilino) -1-phenylmethylene] -6- butyloxycarbonyl-2-indolinone, prepared by reacting 3-Z- [1- (4- (piperidin-1-ylmethyl) -anilino) -1-phenylmethylene] -6-carboxy-2-indolinone and n-butanol,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 10 ; 1),Product value: 0.5 (silica gel, methylene chloride / methanol = 10; 1),

SK 287312 Β6SK 287312-6

C32H35N3O3, + hmotnostné spektrum: m/z = 509 [M]+, (5) 3-Z-[ 1 -(4-bróm-anilino)-1 -fenyl-metylén]-6-karbamoyl-2-indolinón, pripravený reakciou 3-Z-[l-(4-bróm-anilino)-l-fenyl-metylén]-6-karboxy-2-indolinónu a amoniaku, Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 10 : 1), C22H16BrN2O3, hmotnostné spektrum: m/z = 432/434 [M-H]’, (6) 3-Z-[ 1 -(4-(piperidin-1 -ylmetyljanilino)-1 -fenylmetylén]-6-etylkarbamoyl-2-indolinón, pripravený reakciou 3-Z-[ 1 -(4-(piperidin-1 -yl-metyl)-anilino)-1 -fenyl-metylén]-6-karboxy-2-indolinónu a plynného etylamínu,C32H35N3O3, + mass spectrum: m / z = 509 [M] + , (S) 3-Z- [1- (4-bromo-anilino) -1-phenyl-methylene] -6-carbamoyl-2-indolinone, prepared by reaction of 3-Z- [1- (4-bromo-anilino) -1-phenyl-methylene] -6-carboxy-2-indolinone and ammonia, Product Value: 0.5 (silica gel, methylene chloride / methanol = 10: 1), C 22 H 16 BrN 2 O 3 , mass spectrum: m / z = 432/434 [MH] -, (6) 3-Z- [1- (4- (piperidin-1-ylmethyl) anilino) -1- phenylmethylene] -6-ethylcarbamoyl-2-indolinone, prepared by the reaction of 3-Z- [1- (4- (piperidin-1-ylmethyl) -anilino) -1-phenylmethylene] -6-carboxy-2-indolinone and ethylamine gas,

Rrhodnota produktu: 0,6 (gél kyseliny kremičitej, metylénchlorid/metanol = 5:1),Product value: 0.6 (silica gel, methylene chloride / methanol = 5: 1),

C30H32N4O2, hmotnostné spektrum: m/z = 480 [M]+, (7) 3-Z-[l-(4-(dimetylaminometyl)-anilino)-l-fenyl-metylén]-6-[(2-metyloxy-etoxy)-karbonyl]-2-indolinón, pripravený reakciou 3-Z-[l-(4-(dimetylaminometyl)-anilino)-l-fenyl-metylén]-6-karboxy-2-indolinónu a metylglykolu,C 30 H 32 N 4 O 2 , mass spectrum: m / z = 480 [M] + , (7) 3-Z- [1- (4- (dimethylaminomethyl) anilino) -1-phenyl-methylene] -6 - [(2-methyloxy-ethoxy) -carbonyl] -2-indolinone, prepared by the reaction of 3-Z- [1- (4- (dimethylaminomethyl) -anilino) -1-phenyl-methylene] -6-carboxy-2-indolinone and methyl glycol,

Rrhodnota produktu: 0,8 (gél kyseliny kremičitej, metylénchlorid/metanol = 4:1),Product value: 0.8 (silica gel, methylene chloride / methanol = 4: 1),

C25H23N3O3 2 C 5 H 23 N3O3

ESI-hmotnostné spektrum: m/z = 470 [M-H]’, (8) 3-Z-[l-(4-(dimetylaminometyl)anilino)-l-fenylmetylén]-6-[(2-dimetylamino-etoxy)-karbonyl]-2-indolinón, pripravený reakciou 3-Z-[l-(4-(dimetylaminometyl)-anilino)-l-fenyl-metylén]-6-karboxy-2-indolinónu a 2-dimetylaminoetanolu,ESI-MS: m / z = 470 [MH] -, (8) 3-Z- [1- (4- (dimethylaminomethyl) anilino) -1-phenylmethylene] -6 - [(2-dimethylaminoethoxy) - carbonyl] -2-indolinone, prepared by reacting 3-Z- [1- (4- (dimethylaminomethyl) -anilino) -1-phenylmethylene] -6-carboxy-2-indolinone and 2-dimethylaminoethanol,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 5:2),Product value: 0.5 (silica gel, methylene chloride / methanol = 5: 2),

C29H32N4O3,C 29 H 32 N 4 O 3

ESI-hmotnostné spektrum: m/z = 483 [M-H]', (9) 3-Z-[l-(4-(dimetylaminometyl)amlino)-l-fenylmetylén]-6-[(2-/V-terc-butoxykarbonyl-amino-etoxy)-karbonyl]-2-indolinón, pripravený reakciou 3-Z-[l-(4-(dimetylaminometyl)-anilino)-l-fenyl-metylén]-6-karboxy-2-indolinónu a 2-7V-ŕerc-butoxykarbonyl-amino-etanolu,ESI-MS: m / z = 483 [MH] -, (9) 3-Z- [1- (4- (dimethylaminomethyl) amino) -1-phenylmethylene] -6 - [(2- N -t-tert-) butoxycarbonyl-amino-ethoxy) -carbonyl] -2-indolinone, prepared by reacting 3-Z- [1- (4- (dimethylaminomethyl) -anilino) -1-phenyl-methylene] -6-carboxy-2-indolinone and 2- 7V-tert-butoxycarbonyl-amino-ethanol,

Rrhodnota produktu: 0,8 (gél kyseliny kremičitej, metylénchlorid/metanol = 5:2),Product value: 0.8 (silica gel, methylene chloride / methanol = 5: 2),

C32H36N4O5,C 32 H 36 N 4 O 5

ESI-hmotnostné spektrum: m/z = 412 [M-H]', (10) 3-Z-[l-(4-(dimetylaminometyl)-anilino)-l-fenyl-metylén]-6-[(2,2,2-trifluóretoxy)-karbonyl]-2-indolinón, pripravený reakciou 3-Z- [ 1 -(4-(dimetylaminometyl)-anilino)-1 -fenyl-metylén] -6-karboxy-2-indolinónu, a 2,2,2-trifluóretanolu,ESI-MS: m / z = 412 [MH] -, (10) 3-Z- [1- (4- (dimethylaminomethyl) anilino) -1-phenylmethylene] -6 - [(2,2, 2-trifluoroethoxy) carbonyl] -2-indolinone, prepared by reacting 3-Z- [1- (4- (dimethylaminomethyl) anilino) -1-phenylmethylene] -6-carboxy-2-indolinone, and 2,2 , 2-trifluoroethanol,

Rrhodnota produktu: 0, 5 (gél kyseliny kremičitej, metylénchlorid/metanol = 5:1),Product value: 0.5 (silica gel, methylene chloride / methanol = 5: 1),

C27H24F3N3O3,C 27 H 24 F 3 N 3 O 3 ,

ESI-hmotnostné spektrum: m/z = 494 [M-H]',ESI-MS: m / z = 494 [M-H] -,

Príklad 11Example 11

3-Z-[l-(4-(Piperidin-1 -yl-metyl)-anilino)-1 -fenyl-metylén]-6-karbamoyl-2-indolinón3-Z- [1- (4- (Piperidin-1-yl-methyl) -anilino) -1-phenyl-methylene] -6-carbamoyl-2-indolinone

V 25 ml dimetylformamidu sa rozmiešalo 0,9 g 3-Z-[l-(4-(piperidin-l-yl-metyl)-anilino)-l-fenyl-metylén]-6-karboxy-2-indolinónu, 0,8 g TBTU a 0,4 g HOBT a pridal sa 1,0 ml trietylamínu. Zmes sa 15 minút miešala pri teplote miestnosti. Pri 10 až 15 °C sa potom privádzal plynný amoniak (15 minút) a zmes sa potom 1,5 hodiny miešala pri teplote miestnosti. Vylúčená zrazenina sa zachytila na filtri s odsávaním, premyla vodou, etanolom a éterom a vysušila pri 100 °C vo vákuu.0.9 g of 3-Z- [1- (4- (piperidin-1-yl-methyl) -anilino) -1-phenyl-methylene] -6-carboxy-2-indolinone, 0.95 g, was stirred in 25 ml of dimethylformamide. 8 g TBTU and 0.4 g HOBT and 1.0 ml triethylamine was added. The mixture was stirred at room temperature for 15 minutes. Ammonia gas (15 minutes) was then added at 10-15 ° C and the mixture was then stirred at room temperature for 1.5 hours. The precipitate formed was collected on a suction filter, washed with water, ethanol and ether and dried at 100 ° C under vacuum.

Výťažok: 0,6 g (64 % teoretického výťažku), Rrhodnota produktu: 0,4 (reverzná fáza RP8, metanol/päťpercentný vodný roztok chloridu sodného = 6:4), C28H28N4O2,Yield: 0.6 g (64% of theory), Product value: 0.4 (reverse phase RP8, methanol / 5% aqueous sodium chloride solution = 6: 4), C 28 H 28 N 4 O 2 ,

ESI-hmotnostné spektrum: m/z = 453 [M+H]+.ESI-MS: m / z = 453 [M + H] &lt; + &gt;.

Podobne ako v príklade 11 sa pripravili nasledujúce zlúčeniny:As in Example 11, the following compounds were prepared:

(1) 3-Z-[ 1 -(4-(piperidin-1 -yl-metyl)-anilino)-1 -fenyl-metylén]-6-dimetylkarbamoyl-2-indolinón, pripravený reakciou 3-Z-[ 1 -(4-(piperidin-1 -yl-metyl)-anilino)-1 -fenyl-metylén]-6-karboxy-2-indolinónu a dimetylaminhydrochloridu/diizopropyletylamínu,(1) 3-Z- [1- (4- (piperidin-1-yl-methyl) -anilino) -1-phenyl-methylene] -6-dimethylcarbamoyl-2-indolinone, prepared by the reaction of 3-Z- [1- (4- (piperidin-1-ylmethyl) -anilino) -1-phenylmethylene] -6-carboxy-2-indolinone and dimethylamine hydrochloride / diisopropylethylamine,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol = 5 : 1),Product value: 0.5 (silica gel, methylene chloride / methanol = 5: 1),

C30H32N4O2,C3 0 H 32 N 4 O 2

ESI-hmotnostné spektrum: m/z = 481 [M+H]+, (2) 3-Z-[ 1 -(4-(piperidin-1 -yl-metyl)-anilino)-1 -fenyl-metylén]-6-(/V-etyl-/V-metyl-karbamoyl)-2-indolmón, pripravený reakciou 3-Z-[l-(4-(piperidin-l-ylmetyl)anilino)-l-fenylmetylén]-6-karboxy-2-indolinónu a N-etyl-jV-metylamínu,ESI-MS: m / z = 481 [M + H] &lt; + &gt;, (2) 3-Z- [1- (4- (piperidin-1-ylmethyl) -anilino) -1-phenyl-methylene] - 6- (N-ethyl- N -methyl-carbamoyl) -2-indolmone prepared by the reaction of 3-Z- [1- (4- (piperidin-1-ylmethyl) anilino) -1-phenylmethylene] -6-carboxy -2-indolinone and N-ethyl-N-methylamine,

Rrhodnota produktu: 0,5 (oxid hlinitý, metylénchlorid/etanol = 20 : 1),Product value: 0.5 (alumina, methylene chloride / ethanol = 20: 1),

C3iH34N4O2,C 3 iH 34 N 4 O2,

ESI-hmotnostné spektrum: m/z = 495 [M+H]+, (3) 3-Z-[ 1 -(4-(piperidin-1 -yl-metyl)-anilino)-1 -fenyl-metylén]-6-metylkarbamoyl-2-indolinón, pripravený reakciou 3 -Z- [ 1 -(4-(piperidin-1 -yl-metyl)-anilino)-1 -fenyl-metylén]-6-karboxy-2-indolinónu a metylamínhydrochloridu/diizopropyletylammu,ESI-MS: m / z = 495 [M + H] + , (3) 3-Z- [1- (4- (piperidin-1-ylmethyl) -anilino) -1-phenylmethylene] - 6-methylcarbamoyl-2-indolinone, prepared by the reaction of 3-Z- [1- (4- (piperidin-1-ylmethyl) -anilino) -1-phenylmethylene] -6-carboxy-2-indolinone and methylamine hydrochloride] diizopropyletylammu.

Rrhodnota produktu: 0,3 (oxid hlinitý, metylénchlorid/etanol = 20 : 1),Product value: 0.3 (alumina, methylene chloride / ethanol = 20: 1),

C29H30N4O2,C29H30N4O2.

ESI-hmotnostné spektrum: m/z = 467 [M+H]+, (4) 3-Z-[l-(3-(dimetylaminometyl)-anilino)-l-fenyl-metylén]-6-metylkarbamoyl-2-indolinón, pripravený reakciou 3-Z-[l-(3-(dimetylaminometyl)-anilino)-l-fenyl-metylén]-6-karboxyl-2-indolinónu a metylamínhydrochloridu/trietylamínu,ESI-MS: m / z = 467 [M + H] + , (4) 3-Z- [1- (3- (dimethylaminomethyl) anilino) -1-phenylmethylene] -6-methylcarbamoyl-2- indolinone, prepared by reacting 3-Z- [1- (3- (dimethylaminomethyl) -anilino) -1-phenylmethylene] -6-carboxyl-2-indolinone and methylamine hydrochloride / triethylamine,

Rrhodnota produktu: 0,3 (gél kyseliny kremičitej, metylénchlorid/etanol = 2:1),Product value: 0.3 (silica gel, methylene chloride / ethanol = 2: 1),

C26H26N4O2, hmotnostné spektrum: m/z = 426 [M]+, (5) 3-Z-[l-(4-(piperidin-l-yl-metyl)-anilino)-l-fenyl-metylén]-6-(2-hydroxyetyl-karbamoyl)-2-indolinón, pripravený reakciou 3-Z-[ 1 -(4-(piperidin-l -yl-metyl)-anilino)-1 -fenyl-metylén]-6-karboxy-2-indolinónu a etanolamínu/diizopropyletylamínu,C26H26N4O2, mass spectrum: m / z = 426 [M] &lt; + &gt;, (S) 3-Z- [1- (4- (piperidin-1-ylmethyl) -anilino) -1-phenyl-methylene] -6- (2-hydroxyethylcarbamoyl) -2-indolinone, prepared by the reaction of 3-Z- [1- (4- (piperidin-1-ylmethyl) -anilino) -1-phenylmethylene] -6-carboxy-2- indolinone and ethanolamine / diisopropylethylamine,

Rrhodnota produktu: 0,5 (oxid hlinitý, metylénchlorid/metanol = 20 : 1),Product value: 0.5 (alumina, methylene chloride / methanol = 20: 1),

C3oH32N403,C 3 o 32 N40 3 ,

ESI-hmotnostné spektrum: m/z = 495 [M-H]’, (6) 3-Z-[l-(4-(piperidin-l-yl-metyl)-anilino)-l-fenyl-metylén]-6-dietylkarbamoyl-2-indolinón, pripravený reakciou 3-Z-[l-(4-(piperidin-l-yl-metyl)-anilino)-l-fenylmetylén]-6-karboxy-2-indolinónu a dietylamínhydrochloridu/diizopropyletylamínu,ESI-MS: m / z = 495 [MH] -, (6) 3-Z- [1- (4- (piperidin-1-ylmethyl) -anilino) -1-phenyl-methylene] -6- diethylcarbamoyl-2-indolinone, prepared by the reaction of 3-Z- [1- (4- (piperidin-1-ylmethyl) -anilino) -1-phenylmethylene] -6-carboxy-2-indolinone and diethylamine hydrochloride / diisopropylethylamine,

Rrhodnota produktu: 0,8 (oxid hlinitý, metylénchlorid/metanol = 10 : 1),Product value: 0.8 (alumina, methylene chloride / methanol = 10: 1),

C32H36N4O2,C 32 H 36 N 4 O2

ESI-hmotnostné spektrum: m/z = 509 [M+H]+, (7) 3-Z-[l-(4-(/V-Zerc-butoxykarbonyl-etylaminometyl)-anilino)-l-fenyl-metylén]-6-karbamoyl-2-indolinón, pripravený z 3-Z-[l-(4-(íV-terc-butoxykarbonyletylaminometyl)-anilino)-l-fenyl-metylén]-6-karboxy-2-indolinónu,ESI-MS: m / z = 509 [M + H] + , (7) 3- Z- [1- (4- (N-tert-butoxycarbonyl-ethylaminomethyl) -anilino) -1-phenyl-methylene] -6-carbamoyl-2-indolinone, prepared from 3-Z- [1- (4- ( N -tert-butoxycarbonylethylaminomethyl) -anilino) -1-phenylmethylene] -6-carboxy-2-indolinone,

Rrhodnota produktu: 0,3 (gél kyseliny kremičitej, toluén/etylester kyseliny octovej/-etanol = 4:2:1), C3oH32N404,Product value: 0.3 (silica gel, toluene / ethyl acetate / ethanol = 4: 2: 1), C 30 H 32 N 4 O 4 ,

ESI-hmotnostné spektrum: m/z = 511 [M-H]’, (8) 3-Z-[l-(4-(/V-dimetylaminometylkarbonyl-/V-metyl-amino)anilino)-l-fenylmetylén]-6-karbamoyl-2-indolinón, pripravený z 3-Z-[ 1 -(4-(A,-dimetylaminometylkarbonyl-/'/-metyl-amino)-anilino)-1 -fenyl-metylén]-6-karboxy-2-indolinónu,ESI-MS: m / z = 511 [MH] -, (8) 3-Z- [1- (4- (N-dimethylaminomethylcarbonyl- N -methylamino) anilino) -1-phenylmethylene] -6 -carbamoyl-2-indolinone, prepared from 3-Z- [1- (4- (N , -dimethylaminomethylcarbonyl- N -methyl-amino) -anilino) -1-phenyl-methylene] -6-carboxy-2- indolinone,

Rrhodnota produktu: 0,5 (gél kyseliny kremičitej, metylénchlorid/metanol/amoniak = 5:1: 0,01),Product value: 0.5 (silica gel, methylene chloride / methanol / ammonia = 5: 1: 0.01),

C27H27N5O3,C 27 H 27 N 5 O 3

ESI-hmotnostné spektrum: m/z = 468 [M-H]'.ESI-MS: m / z = 468 [M-H] -.

Príklad 12Example 12

3-Z-[l-(4-(/V-Dimetylaminometylkarbonyl-/V-metyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, soľ s kyselinou citrónovou3-Z- [1- (4- (N-Dimethylaminomethylcarbonyl- N -methylamino) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, citric acid salt

Do roztoku 3,25 g monohydrátu kyseliny citrónovej v 50 ml metanolu sa pri teplote miestnosti pridalo 5,0 g 3-Z- [ 1 -(4-(/V-dimetylaminometylkarbonyl-JV-metyl-amino)-ani 1 ino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinónu. Roztok sa potom skoncentroval, zvyšok sa premyl éterom a rekryštalizoval z prostredia etylesteru kyseliny octovej.To a solution of 3.25 g of citric acid monohydrate in 50 ml of methanol at room temperature was added 5.0 g of 3-Z- [1- (4- (N-dimethylaminomethylcarbonyl-N-methyl-amino) -anilino) - 1-Phenylmethylene] -6-methoxycarbonyl-2-indolinone. The solution was then concentrated, the residue washed with ether and recrystallized from ethyl acetate.

Výťažok: 6,3 g (90 % teoretického výťažku),Yield: 6.3 g (90% of theory),

Rf-hodnota produktu: 0,6 (gél kyseliny kremičitej, metylénchlorid/metanol/amoniak = 5 : 1 : 0,01), teplota topenia produktu bola 198 °C,Rf value of product: 0.6 (silica gel, methylene chloride / methanol / ammonia = 5: 1: 0.01), mp 198 ° C,

C28H28N4O5 x c6h8o7,C 28 H 28 N 4 O 5 xc 6 h 8 o 7

ESI-hmotnostné spektrum: m/z = 483 [M-H]', analýza: vypočítané zloženie 60,34 % C, 5,37 % H, 8,28 % N;ESI-MS: m / z = 483 [M-H] -, analysis: calculated C, 60.34; H, 5.37; N, 8.28;

stanovené zloženie 59,98 % C, 5,25 % H, 8,13 % N.calculated C 59.98%, H 5.25%, 8.13% N.

Podobne ako v príklade 12 sa pripravila nasledujúca zlúčenina:As in Example 12, the following compound was prepared:

(1) 3-Z-[l-(4-(dimetylaminometyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón x kyselina metánsulfónová, pripravená reakciou 3-Z-[ 1 -(4-(dimetylamino-metyl)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinónu a kyseliny metán-sulfónovej,(1) 3-Z- [1- (4- (dimethylaminomethyl) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone x methanesulfonic acid prepared by the reaction of 3-Z- [1- (4- (dimethylamino-methyl) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone and methanesulfonic acid,

Rf-hodnota produktu: 0,6 (gél kyseliny kremičitej, metylénchlorid/metanol/amoniak = 5:1: 0,01), teplota topenia produktu bola: 275 °C,Rf value of product: 0.6 (silica gel, methylene chloride / methanol / ammonia = 5: 1: 0.01), melting point: 275 ° C,

C26H25N3O2xCH4O3S,C 26 H 25 N 3 O 2 x CH 4 O 3 S,

ESI-hmotnostné spektrum: m/z = 426 [M-H]’, analýza: vypočítané zloženie 61,92 % C, 5,59 % H, 8,03 % N, 6,12 % S; stanovené zloženie 61,43 % C, 5,87 % H, 7,85 % N, 5,39 % S.ESI-MS: m / z = 426 [M-H] -, analysis: calculated C 61.92%, H 5.59%, N 8.03%, S 6.12%; calculated C 61.43%, H 5.87%, N 7.85%, S 5.39%.

Podobne ako v uvedených príkladoch možno pripraviť nasledujúce zlúčeniny:As in the examples, the following compounds can be prepared:

(1) 3-Z-( 1 -anilino-1 -fenyl-metylén)-6-etoxykarbonyl-2-indolinón, (2) 3-Z-[l-(4-nitro-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (3) 3-Z-[l-(4-fluór-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (4) 3-Z-[l-(4-chlór-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (5) 3-Z-[l-(4-jód-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (6) 3-Z- [ 1 -(4-kyano-anilino)-1 -fenyl-metylén] -6-etoxykarbonyl-2-indolinón, (7) 3-Z-[ 1 -(4-metoxy-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (8) 3-Z-[l-(4-etoxy-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (9) 3-Z-[l-(4-trifluórmetyl-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (10) 3-Z-( 1 -(4-metyl-anilino)-1 -fenyl-metylén] -6-etoxykarbonyl-2-indolinón, (11) 3-Z-[l-(4-metylmerkapto-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (12) 3-Z-[ 1 -(4-aminometyl-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (13) 3-Z-[l-(4-(izopropylaminometyl)-anilino)-l-fenyl-methylén]-6-etoxykarbonyl-2-indolinón, (14) 3-Z-[l-(4-(anilinometyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (15) 3-Z-[l-(4-(propylaminometyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (16) 3-Z-[l-(4-(butylaminometyl)anilino)-l-fenylmetylén]-6-etoxykarbonyl-2-indolinón, (17) 3-Z-[ 1 -(4-(izobutylaminometyl)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (18) 3-Z-[ 1 -(4-(cyklohexylaminometyl)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (19) 3-Z-[ 1 -(4-(benzylaminometyl)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (20) 3-Z-[l-(4-((7V-etyl-/V-metyl-amino)-metyl)-anilino)-l-fenyl-metylén]-6-etoxy-karbonyl-2-indolinón, (21) 3-Z-[ 1 -(4-((Aľ-metyl-jV-propyl-amino)-metyl)-anilino)-1 -fenyl-metylén]-5-etoxy-karbonyl-2-indolinón, (22) 3-Z-[ 1 -(4-((V-izopropyl-V-metyl-amino)-metyl)-anilmo)-1 -fenyl-metylén]-5-etoxy-karbonyl-2-indolinón, (23) 3-Z-[l-(4-((7V-etyl-/V-propyl-amino)-metyl)-anilino)-l-fenyl-metylén]-5-etoxy-karbonyl-2-indolinón, (24) 3-Z-[l-(4-((/V-etyl-V-izopropyl-amino)-metyl)-anilino)-l-fenyl-metylén]-6-etoxy-karbonyl-2-indolinón, (25) 3-Z-[l-(4-(dipropylaminometyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (26) 3-Z-[l-(4-(diizopropylaminometyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (27) 3-Z-[ 1 -(4-((7V-benzyl-7V-etyl-amino)-metyl)-anilino)-1 -fenyl-metylén]-6-etoxy-karbonyl-2-indolinón, (28) 3-Z-[l-(4-(dibenzylaminometyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (29) 3-Z-[ 1-(4-(3,6-dihydro-277-pyridin-l-yl-metyl)-anilino)l-fenyl-metylén]-6-etoxy-karbonyl-2-indolinón, (30) 3-Z-[l-(4-(3,5-dimetyl-piperidin-l-yl-metyl-anilino)l-fenyl-metylén]-5-etoxy-karbonyl-2-indolinón, (31) 3-Z-[l-(4-(azepan-l-yl-metyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (32) 3-Z-[l-(4-(piperazin-l-yl-metyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (33) 3-Z-[l-(4-(morfolin-4-yl-metyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (34) 3-Z-[l-(4-(tiomorfolin-4-yl-metyl)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (35) 3-Z-[l-(4-(l-oxo-tiomorfolin-4-yl-metyl)-anilino)- l-fenyl-metylén]-6-etoxy-karbonyl-2-indolinón, (36) 3-Z-[ 1 -(4-( 1,1 -dioxo-tiomorfolin-4-yl-metyl)-anilino)-1 -fenyl-metylén]-6-etoxy-karbonyl-2-indolinón, (37) 3-Z-[l-(4-( acetylamino-metyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (38) 3-Z-[ 1 -(4-(2-amino-etyl)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (39) 3-Z-[l-(4-(2-metylamino-etyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (40) 3-Z-[l-(4-(2-etylamino-etyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (41) 3-Z-[l-(4-(2-dietylamino-etyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (42) 3-Z-[ 1 -(4-(2-piperidin-1 -yl-etyl)-anilino)-1 -fenyl-metylén] -6-etoxykarbonyl-2-indolinón, (43) 3-Z-[ 1 -(4-(2-acetylamino-etyl)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (44) 3-Z-[ 1 -(4-(3-amino-propyl)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (45) 3-Z-[l-(4-(3-dimetylamino-propyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (46) 3-Z-[l -(4-(/V-aminometylkarbonyl-A'-metyl-amino)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (47) 3-Z-[l-(4-(7V-metylaminometylkarbonyl-N-metyl-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (48) 3-Z-[l-(4-(A/-etylaminometylkarbonyl-iV-metyl-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (49) 3-Z-[l-(4-(/V-dietylaminometylkarbonyl-A7-metyl-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-(1) 3-Z- (1-anilino-1-phenyl-methylene) -6-ethoxycarbonyl-2-indolinone, (2) 3-Z- [1- (4-nitro-anilino) -1-phenyl-methylene (3) 3-Z- [1- (4-fluoro-anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (4) 3-Z-] -6-ethoxycarbonyl-2-indolinone; [1- (4-Chloro-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (S) 3-Z- [1- (4-iodo-anilino) -1-phenyl-methylene] 6-ethoxycarbonyl-2-indolinone, (6) 3-Z- [1- (4-cyano-anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (7) 3-Z- [ 1- (4-Methoxy-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (8) 3-Z- [1- (4-ethoxy-anilino) -1-phenyl-methylene] - 6-ethoxycarbonyl-2-indolinone, (9) 3-Z- [1- (4-trifluoromethyl-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (10) 3-Z- (1) - (4-methyl-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (11) 3-Z- [1- (4-methylmercapto-anilino) -1-phenyl-methylene] -6 -ethoxycarbonyl-2-indolinone, (12) 3-Z- [1- (4-aminomethyl-anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (13) 3-Z- [1- (4- (isopropylamino) -anil Ino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (14) 3-Z- [1- (4- (anilinomethyl) -anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2 (15) 3-Z- [1- (4- (propylaminomethyl) -anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (16) 3-Z- [1- (4) - (butylaminomethyl) anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (17) 3-Z- [1- (4- (isobutylaminomethyl) anilino) -1-phenylmethylene] -6-ethoxycarbonyl -2-indolinone, (18) 3-Z- [1- (4- (cyclohexylaminomethyl) -anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (19) 3-Z- [1- (4- (benzylaminomethyl) -anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (20) 3-Z- [1- (4 - ((N-ethyl- N -methyl-amino) (methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (21) 3-Z- [1- (4 - ((N ' -methyl-N-propylamino) (methyl) -anilino) -1-phenyl-methylene] -5-ethoxycarbonyl-2-indolinone, (22) 3-Z- [1- (4 - ((N-isopropyl-N-methyl-amino)) (methyl) -anilino) -1-phenyl-methylene] -5-ethoxycarbonyl-2-indolinone, (2S) 3-Z- [1- (4 - ((N-ethyl-N-propylamino)) methyl) anilino) -lf enyl-methylene] -5-ethoxycarbonyl-2-indolinone, (2S) 3-Z- [1- (4 - ((N-ethyl-N-isopropyl-amino) -methyl) -anilino) -1- phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (2S) 3-Z- [1- (4- (dipropylaminomethyl) anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (26) 3-Z- [1- (4- (diisopropylaminomethyl) -anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (27) 3-Z- [1- (4 - (( N-benzyl-N-ethyl-amino) -methyl) -anilino) -1-phenyl-methylene] -6-ethoxy-carbonyl-2-indolinone, (2 S) 3-Z- [1- (4- (dibenzylaminomethyl)) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (2 S) 3-Z- [1- (4- (3,6-dihydro-277-pyridin-1-ylmethyl) - (30) 3-Z- [1- (4- (3,5-dimethyl-piperidin-1-yl-methyl-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone -phenyl-methylene] -5-ethoxy-carbonyl-2-indolinone, (3 S) 3-Z- [1- (4- (azepan-1-ylmethyl) -anilino) -1-phenyl-methylene] -6 -ethoxycarbonyl-2-indolinone, (2 S) 3-Z- [1- (4- (piperazin-1-ylmethyl) -anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (33) 13-Z- [1- (4- (Morpholin-4-ylmethyl) -anilino) -1-phe (34) 3- Z- [1- (4- (thiomorpholin-4-ylmethyl) -anilino) -1-phenylmethylene] -6-ethoxycarbonyl- 2-indolinone, (3 S) 3-N- [1- (4- (1-oxo-thiomorpholin-4-ylmethyl) -anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (36) 3-Z- [1- (4- (1,1-dioxo-thiomorpholin-4-ylmethyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (37) 3-Z- [1- (4- (acetylamino-methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (38) 3-Z- [1- (4- (2-Amino-ethyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (39) 3-Z- [1- (4- (2-methylamino-ethyl) -anilino) - 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (40) 3-Z- [1- (4- (2-ethylamino-ethyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2-indolinone, (4 S) 3-Z- [1- (4- (2-diethylamino-ethyl) -anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (42) 3-Z- [1- (4- (2-Piperidin-1-yl-ethyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (43) 3-Z- [1- (4- ( 2-acetylamino-ethyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbones 1-2-indolinone, (44) 3- Z - [1- (4- (3-amino-propyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (45) 3- Z- [1- (4- (3-dimethylamino-propyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (46) 3-Z- [1- (4 - (V) (47) 3-Z- [1- (4- (N-methylaminomethylcarbonyl-N-methyl) -aminomethylcarbonyl-N'-methyl-amino) -anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (48) 3- Z- [1- (4- (N -ethylaminomethylcarbonyl-N-methyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (49) 3-Z- [1- (4- (N-diethylaminomethylcarbonyl- 7 7 -methylamino) -anilino) -1-phenyl- methylene] -6-ethoxycarbonyl-2-

-indolinón, (50) 3-Z-[l-(4-(/V-(piperidin-l-yl-metylkarbonyl)-A'’-metylamino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-(50) 3-Z- [1- (4 - (N - (piperidin-1-ylmethylcarbonyl) - N '- methylamino) -anilino) -1-phenylmethylene] -6-ethoxycarbonyl -2-

-indolinón, (51) 3-Z-[ 1 -(4-(A-(morfolin-4-yl-mety]karbonyl)-A/-metyl-amino)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (52) 3-Z-[ 1 -(4-(iV-(piperazin-1 -yl-mety lkarbonyl)-/V- metylamino] -anilino)-1 -fenyl-metylén] -6-etoxykarbonyl-(51) 3-Z- [1- (4- (N- (morpholin-4-ylmethylcarbonyl) -N - methyl-amino) -anilino) -1-phenylmethylene] -6 -ethoxycarbonyl-2-indolinone, (52) 3-Z- [1- (4- (N - (piperazin-1-ylmethylcarbonyl) - N -methylamino] anilino) -1-phenylmethylene] - 6-ethoxycarbonyl-

-2-indolinón, (53) 3-Z-[l-(4-(/V-(2-amino-etylkarbonyl)-/V-metyl-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (54) 3-Z-[ 1 -(4-(7V-(2-metylamino-etylkarbonyl)-7V-metyl-amino)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (55) 3-Z-[l-(4-(7V-(2-dietylamino-etylkarbonyl)-JV-metyl-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl--2-indolinone, (53) 3- Z - [1- (4 - (N - (2-amino-ethylcarbonyl) - N -methyl-amino) -anilino) -1-phenyl-methylene] -6- ethoxycarbonyl-2-indolinone, (54) 3- Z - [1- (4- (N - (2-methylamino-ethylcarbonyl) - N -methyl-amino) -anilino) -1-phenylmethylene] -6-ethoxycarbonyl -2-indolinone, (3 S ) 3-N- [1- (4- (N - (2-diethylamino-ethylcarbonyl) - N -methyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl -

-2-indolinón, (56) 3-Z-[l-(4-(<V-acetyl-/V-(2-aminoetyl)-amino)-anilino)-l-fenyl-metylén]-6-etoxy-karbonyl-2-indolinón, (57) 3-Z-[l-(4-(7V-acetyl-7'/-(2-metylamino-etyl)-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolín, (58) 3-Z-[l-(4-(77-acetyl-lV-(2-metylamino-propyl)-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (59) 3-Z-[l-(4-(./V-acetyl-7V-(2-piperidin-1 -yl-etyl)-amino)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (60) 3-Z-[l -(4-(jV-acetyl-/V-(aminokarbonyl-metyl)-amino)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (61) 3-Z-[l-(4-(7V-acetyl-7V-(dimetylaminokarbonyl-metyl)-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (62) 3-Z-[ 1 -(4-(/V-acetyl-/V-(pipendin-1 -yl-karbonyl-metyl)- amino)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (63) 3-Z-[l-(4-(N-metyl-N-(aminokarbonyl)-amino)-anilino)-l-fenyl-metylén]-6-etoxykaŕbonyl-2-indolinón, (64) 3-Z-[l-(4-(A-metyl-A/-(metylaminokarbonyl)-amino)-amlino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (65) 3-Z-[l-(4-(7V-metyl-7V-(dimetylaminokarbonyl)-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (66) 3-Z-[l -(4-(jV-metyl-/V-(piperidin-1 -yl-karbonyl)-amino)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (67) 3-Z-[l-(4-(jV-(2-aminoetyl)-7V-metylsulfonyl-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (68) 3-Z-[l-(4-(7V-(2-metylamino-etyl)-7V-metylsulfonyl-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (69) 3-Z-[ 1 -(4-(iV-(2-etylamino-etyl)-iV-metylsulfonyl-amino)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (70) 3-Z-[l-(4-(ÄL(2-dietylamino-etyl)-7V-metylsulfonyl-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl--2-indolinone, (2S) 3-Z- [1- (4 - (N-acetyl- N - (2-aminoethyl) amino) anilino) -1-phenylmethylene] -6-ethoxy- carbonyl-2-indolinone, (57) 3- Z - [1- (4- (N-acetyl-7 '- (2-methylamino-ethyl) -amino) -anilino) -1-phenyl-methylene] -6 -ethoxycarbonyl-2-indoline, (58) 3-Z- [1- (4- (77-acetyl-1H- (2-methylamino-propyl) -amino) -anilino) -1-phenyl-methylene] -6- ethoxycarbonyl-2-indolinone, (59) 3- Z - [1- (4 - (N -acetyl-N - (2-piperidin-1-yl-ethyl) -amino) -anilino) -1-phenyl- methylene] -6-ethoxycarbonyl-2-indolinone, (60) 3-Z- [1- (4- (N-acetyl- N - (aminocarbonylmethyl) amino) anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (2 S) 3-N- [1- (4- (N-acetyl-N - (dimethylaminocarbonylmethyl) amino) anilino) -1-phenylmethylene] -6- ethoxycarbonyl-2-indolinone, (62) 3-Z- [1- (4- (N-acetyl- N - (piperidin-1-ylcarbonylmethyl) amino) anilino) -1-phenyl- methylene] -6-ethoxycarbonyl-2-indolinone, (63) 3-Z- [1- (4- (N-methyl-N- (aminocarbonyl) amino) anilino) -1-phenylmethylene] -6- ethoxycarbonyl-2-indolinone (64) 3-Z- [l- (4- (N-methyl-A / - (methylaminocarbonyl) amino (amino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (2S) 3-Z- [1- (4- (N-methyl-N - (dimethylaminocarbonyl) amino) -anilino) - 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (66) 3-Z- [1- (4- (N-methyl- N - (piperidin-1-yl-carbonyl) amino) -anilino -1-Phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (67) 3-Z- [1- (4- (N - (2-aminoethyl) -N-methylsulfonyl-amino) -anilino) -1 -phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (68) 3- Z- [1- (4- (N - (2-methylamino-ethyl) -7 H -methylsulfonyl-amino) -anilino) -1- phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (69) 3- Z- [1- (4- (N - (2-ethylamino-ethyl) - N -methylsulfonyl-amino) -anilino) -1-phenyl methylene] -6-ethoxycarbonyl-2-indolinone (70) 3-Z- [l- (4- (R L (2-diethylamino-ethyl) -7V-methylsulphonyl-amino) -anilino) -l-phenyl- methylene] -6-ethoxycarbonyl-

-2-indolinón, (71) 3-Z-[ 1 -(4-(jV-(2-pyrolidin-1 -yl-etyl)-7V-metylsulfonylamino)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl--2-indolinone, (71) 3-Z- [1- (4- (N - (2-pyrrolidin-1-yl-ethyl) - N -methylsulfonylamino) -anilino) -1-phenyl-methylene] -6- ethoxycarbonyl-

-2-indolinón, (72) 3-Z-[l-(4-(jV-(2-piperidm-l-yl-etyl)-./V-metylsulfonyl-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón,-2-indolinone, (72) 3- Z- [1- (4- (N - (2-piperidin-1-yl-ethyl) - N -methylsulfonyl-amino) -anilino) -1-phenyl-methylene ] -6-ethoxycarbonyl-2-indolinone,

SK 287312 Β6 (73) 3-Z-[l-(4-(A'-(2-piperazin-l-yl-etyl)-V-metylsulfonyl-amino)-amlino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (74) 3-Z-[l-(4-(7V-(2-(morfolin-4-yl)-etyl)-jV-metylsulfonylamino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (75) 3-Z-[l-(4-(7V-(aminokarbonyl-metyl)-N-nietylsuIfonyl-amino)-aniIino)-l-fenyLmetylén]-6-etoxykarbonyl-2-indolinón, (76) 3-Z-[l-(4-(Ar-(metylaminokarbonyl-metyl)-JV-metylsulfonyl-amino)-anilmo)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (77) 3-Z-[l-(4-(N-(etylaminokarbonyl-metyl)-X-metylsulfonyl-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (78) 3-Z-[l-(4-(jV-(7V_(2-dimetylamino-etyl)-Aľ-metyl-amino)-karbonyl-metyl)-N-metyl-sulfonyl-amino)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (79) 3-Z-[l-(4-(7V-(dietylaminokarbonyl-metyl)-7V-metylsulfonyI-amino)-anilino)-I-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (80) 3-Z-[ 1 -(4-(JV-(pyrolidin-1 -yl-karbonyl-metyl)-W-metylsulfonyl-amino)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (81) 3-Z-[ 1 -(4-(/V-(piperidin-1 -yl-karbonyl-metyl)-/V-metylsul fonyl-amino)-anili no)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (82) 3-Z-[l-(4-(/V-(piperazín-l-yl-karbonyl-metyl)-A,-metylsulfonyl-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (83) 3-Z-[l-(4-(A'-((morfolin-4-yl)-karbonyl-metyl)-N-metylsulfonyl-amino)-amlino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (84) 3-Z-[l-(4-(2-dimetylamino-etoxy)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (85) 3-Z-[l-(4-(3-dimetylamino-propoxy)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (86) 3-Z-[I-(4-(aminokarbonyl-metyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (87) 3-Z-[l-(4-(2-aminokarbonyl-etyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (88) 3-Z-[l-(4-(pyridin-2-yl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (89) 3-Z-[l-(4-(pyridin-3-yl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (90) 3-Z-[l-(4-(pyridin-4-yl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (91) 3-Z-[l-(4-(JV-acetyl-Ň-metyl-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (92) 3-Z-[l-(4-(7V-etylkarbonyl-7V-(dimetylaminokarbonylmetyl)-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (93) 3-Z-[l-(karbamoyl-metyl-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (94) 3-Z-[l-(4-dimetylkarbamoyl-metyl-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (95) 3-Z-[l-(4-(piperidin-l-yl-metyl)-anilino)-metylén]-6-etoxykarbonyl-2-indolinón, (96) 3-Z-[l-(4-(piperidin-l-yl-metyl)-anilino)-propylidén]-6-etoxykarbonyl-2-indolinón, (97) 3-Z-[I-(4-(piperidm-l-yl-metyl)-anilino)-butylidén]-6-etoxykarbonyl-2-indolinón, (98) 3-Z-[I-(4-(7V-(3-dimetylamino-propyl)-/V-acetyl-amino)-anilino)-metylén]-6-etoxy-karbonyl-2-indolinón, (99) 3-Z-[l-(4-(jV-(3-dimetylamino-piOpyl)-A'-acetyl-amino)-anilino)-etylidén]-6-etoxy-karbonyl-2-indolinón, (100) 3-Z-[l-(4-(X-(3-dimetylamino-propyl)-Aľ-acetyl-amino)-anilino)-propylidén]-6-etoxykarbonyl-2-indolinón, (101) 3-Z-[ 1 -(4-(7V-(3-dimetylamino-propyl)-7V-acetyl-amino)-anilino)-butylidén]-6-etoxykarbonyl-2-indolinón, (102) 3-Z-[l-(4-(jV-(2-dimetylamino-etyl)-/V-metylsulfonyl-amino)-anilino)-metylén]-6-etoxykarbonyl-2-indolinón, (103) 3-Z-[l-(4-(jV-(2-dimetylamino-etyl)-7V-metylsulfonyl-amino)-amlino)-propylidén]-6-etoxykarbonyl-2-indolinón, (104) 3-Z-[ 1 -(4-(JV-(2-dimetylamino-etyl)-7V-metylsulfonyl-amino)-aniIino)-butylidén]-6-etoxykarbonyl-2-indolinón, (105) 3-Z-[l-(4-tetrazol-5-yl-anilino)-metylén]-6-etoxykarbonyl-2-indolinón, (106) 3-Z-[l-(4-tetrazol-5-yl-anilino)-etyIidén]-6-etoxykarbonyl-2-indolinón, (107) 3-Z-[l-(4-tetrazol-5-yl-anilino)-propylidén]-6-etoxykarbonyl-2-indolinón, (108) 3-Z-[ 1 -(4-tetrazol-5-yl-anilino)-butylidén]-6-etoxykarbonyl-2-indolinón, (109) 3-Z-[l-(4-karboxy-anilino)-metylén]-6-etoxykarbonyI-2-indolinón, (110) 3-Z-[ 1 -(4-karboxy-anilino)-propylidén]-6-etoxykarbonyl-2-indolinón, (111) 3-Z-[l-(4-karboxy-anilino)-butylidén]-6-etoxykarbonyl-2-indolinón, (112) 3-Z-[l-(4-(N-(3-dimetylamino-propionyl)-/V-dimetylaminokarbonylmetyl-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (113) 3-Z-[ 1 -(4-(jV-(4-dimetylamino-butyryl)-/V-dimetylaminokarbonyl-metyl-amino)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyI-2-indolinón, (114) 3-Z-[ 1 -(4-(7V-dimetylaminokarbonyl-metyl-?/-(2-dimetylamino-etyIsulfonyl)-amino)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (115) 3-Z-[l-(4-(/V-dimetylaminokarbonyl-metyl-íV-('3-dimetylamino-propylsulfonyl)-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (116) 3-Z-[l-(4-((2-hydroxy-etyl)-amino-metyl)-anilino)-l-fenyl-metylén]-6-etoxy-karbonyl-2-indolinón, (117) 3-Z-[l-(4-((2-metoxy-etyl)-amino-metyl)-anilino)-l-fenyl-metylén]-6-etoxy-karbonyl-2-indolinón, (118) 3-Z-[l-(4-((2-dimetylamino-etyl)-amino-metyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (119) 3-Z-[l-(4-((3-dimetylamino-propyl)-amino-metyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (120) 3-Z-[ 1 -(4-((7V-íerc-butoxykarbonyl-2-amino-etyl)-aminometyl)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (121) 3-Z-[ 1 -(4-((7V-Zerc-butoxykarbonyl-3-amino-propyl)-aminometyl)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (122) 3 -Z- [ 1 -(4-((2-amino-etyl)-amino-metyl)-anilino)-1 -fenyl-metylén] -6-etoxy-karbonyl-2-indolinón, (123) 3-Z-[l-(4-((3-amino-propyl)-amino-metyl)-anilino)-l-fenyl-metylén]-6-etoxy-karbonyl-2-indolinón, (124) 3-Z-[ 1 -(4-((2-acetylamino-etyl)-amino-metyl)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (125) 3-Z-[l-(4-((3-acetylamino-propyl)-amino-metyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (126) 3-Z-[l-(4-((2-metylsulfonylamino-etyl)-amino-metyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (127) 3-Z-[ 1 -(4-((3-metylsulfonylamino-propyl)-amino-metyl)-anilino)-1 -fenyl-metylén] -6-etoxykarbonyl-2-indolinón, (128) 3-Z-[ 1 -(4-(JV-(jV-ŕerc-butoxykarbonyl-2-amino-etyl)-7V-metyl-amino-metyl)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (129) 3-Z-[ 1 -(4-(7V-(2-amino-etyl)-A'-metyl-amino-metyl)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (130) 3 -Z- [ 1 -(4-(N-(2-acetylami no-ety l)-7V-mety l-amino-metyl)-anilino)-1 -fenyl-metylén] -6-etoxykarbonyl-2-indolinón, (131) 3-Z-[ 1 -(4-(/V-(2-metylsulfonylamino-etyl)-/v-metyl-amino-metyl)-anilino)-1 -fenyl-metylén] -6-etoxykarbonyl-2-indolinón, (132) 3-Z-[l-(4-(karboxymetyl-amino-metyl)-anilino)-l-fenyl-metylén]-6-etoxy-karbonyl-2-indolinón, (133) 3-Z-[l-(4-(etoxykarbonyI-metyl-amino-metyl)-anilino)-l-fenyl-metylén]-6-etoxy-karbonyl-2-indolinón, (134) 3-Z-[l-(4-(karbamoyl-metyl-amino-metyl)-anilino)-l-fenyl-metylén]-6-etoxy-karbonyl-2-indolinón, (135) 3-Z-[ 1 -(4-(dimetylkarbamoyl-metyl-amino-metyl)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (136) 3-Z-[ 1 -(4-(metylkarbamoyl-metyl-amino-metyl)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (137) 3-Z-[l-(4-(A/-dimetylaminometylkarbonyl-A'-metyl-amino)-3-amino-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (138) 3-Z-[ 1 -(4-( V-dime tylaminome ty lkarbonyl -;V-metyl-amino)-3 -nitro-anilino)-1 -fenyl-metylén] -6-etoxykarbonyl- 2-indolinón, (139) 3-Z-[l-(4-(7V-dimetylaminometylkarbonyl-7V-metyl-amino)-3-acetylamino-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (140) 3-Z-[l-(4-(7V-dimetylaminometylkarbonyl-7V-metyl- amino)-3-metylsulfonyl-amino-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (141) 3-Z-[ 1 -(4-(jV-dimetylaminometylkarbonyl-7V-metyl-amino)-3-kyano-amlino)-1 -fenyl-metylén]-6-etoxykarbonyl-2 -indolinón, (142) 3-Z-[l-(4-(/V-dimetylaminometylkarbonyl-/V-metyl-amino)-3-hydrc>xy-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (143) 3-Z-[l-(4-(M-dimetylaminometylkarbonyl-7V-metyl-amino)-3-metoxy-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (144) 3-Z-[ 1 -(4-(7V-dimetylaminometylkarbonyl-Ä/-metyl-amino)-3-etoxykarbonyl-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (145) 3-Z-[l-(4-(N-dimetylaminometylkarbonyl-N-metyl-amino)-3-karboxy-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (146) 3-Z-[ 1 -(4-(jV-dimetylaminometylkarbonyl-7V-metyl-amino)-3-karbamoyl-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (147) 3-Z-[ 1 -(4-(A+dimetylaminometylkarbonyl-/V-metyl-amino)-3-chlór-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2 - indolinón,(73) 3-Z- [1- (4- (N '- (2-piperazin-1-yl-ethyl) - N -methylsulfonyl-amino) -amino) -1-phenyl-methylene] -6 -ethoxycarbonyl-2-indolinone, (74) 3- Z- [1- (4- (N - (2- (morpholin-4-yl) ethyl) - N -methylsulfonylamino) -anilino) -1-phenylmethylene ] -6-ethoxycarbonyl-2-indolinone, (75) 3- [1- (4- (N - (aminocarbonylmethyl) -N-methylsulfonylamino) -amino) -1-phenylmethylene] -6-ethoxycarbonyl -2-indolinone (76) 3-Z- [l- (4- (N - (methylaminocarbonyl-methyl) -N-methylsulphonyl-amino) -anilmo) -l-phenyl-methylene] -6-ethoxycarbonyl-2 (77) 3-Z- [1- (4- (N- (ethylaminocarbonyl-methyl) -X-methylsulfonyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (78) 3-Z- [1- (4- (N - (N - (2-dimethylamino-ethyl) - N 1 -methyl-amino) -carbonyl-methyl) -N-methylsulfonyl-amino) -anilino) -1-Phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (79) 3- Z- [1- (4- (N - (diethylaminocarbonylmethyl) - N -methylsulfonyl-amino) -anilino) -1- phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (80) 3-Z- [1- (4- ( N - (pyrrolidin-1-yl-carbonyl-methyl) - N -methylsulfonyl-amino) (1-Anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (81) 3-Z- [1- (4 - (N - (piperidin-1-yl-carbonyl-methyl)) -] N-methylsulfonyl-amino) -anilino-1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (82) 3-Z- [1- (4 - (N - (piperazin-1-yl)]) -carbonyl-methyl) - N , -methylsulfonyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (83) 3-Z- [1- (4- (A '- ( (morpholin-4-yl) -carbonyl-methyl) -N-methylsulfonyl-amino) -amino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (84) 3-Z- [1- (4) - (2-dimethylamino-ethoxy) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (85) 3- Z- [1- (4- (3-dimethylamino-propoxy) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (86) 3- Z- [1- (4- (aminocarbonylmethyl) -anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2 (87) 3-Z- [1- (4- (2-aminocarbonyl-ethyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (88) 3-Z- [ 1- (4- (pyridin-2-yl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (89) 3- Z- [1- (4- (pyridin-3-yl) ) anilino) -l-phenyl-methylene] -6-ethoxycarbonyl onyl-2-indolinone, (90) 3-Z- [1- (4- (pyridin-4-yl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (91) 3- N- [1- (4- (N-acetyl-N-methyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (92) 3-Z- [1- (4) - (N-ethylcarbonyl-N - (dimethylaminocarbonylmethyl) -amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (93) 3-Z- [1- (carbamoyl-methyl-anilino)] -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (94) 3-Z- [1- (4-dimethylcarbamoyl-methyl-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (95) 3-Z- [1- (4- (piperidin-1-yl-methyl) -anilino) -methylene] -6-ethoxycarbonyl-2-indolinone, (96) 3-Z- [1- (4) - (piperidin-1-yl-methyl) -anilino) -propylidene] -6-ethoxycarbonyl-2-indolinone, (97) 3-Z- [1- (4- (piperidin-1-ylmethyl) -anilino) -butylidene] -6-ethoxycarbonyl-2-indolinone, (98) 3- Z - [1- (4- (N - (3-dimethylamino-propyl) - N -acetyl-amino) -anilino) -methylene] - 6-ethoxy-carbonyl-2-indolinone, (99) 3- Z- [1- (4- (N - (3-dimethylamino-piperidin) -N'-acetyl-amino) -anilino) -ethylidene] -6- ethoxycarbonyl-2-indolinone, ( 100) 3-Z- [1- (4- (X- (3-dimethylamino-propyl) - N ' -acetyl-amino) -anilino) -propylidene] -6-ethoxycarbonyl-2-indolinone, (101) 3- N- [1- (4- (N - (3-dimethylamino-propyl) - N -acetyl-amino) -anilino) -butylidene] -6-ethoxycarbonyl-2-indolinone, (102) 3-Z- [1- (4- (N - (2-dimethylamino-ethyl) - N -methylsulfonyl-amino) -anilino) -methylene] -6-ethoxycarbonyl-2-indolinone, (103) 3-Z- [1- (4- ( N - (2-dimethylamino-ethyl) - N -methylsulfonyl-amino) -amino) -propylidene] -6-ethoxycarbonyl-2-indolinone, (104) 3-Z- [1- (4- (N 2 -) - dimethylamino-ethyl) - N -methylsulfonyl-amino) -aniol) -butylidene] -6-ethoxycarbonyl-2-indolinone, (105) 3-Z- [1- (4-tetrazol-5-yl-anilino) -methylene] -6-ethoxycarbonyl-2-indolinone, (106) 3-Z- [1- (4-tetrazol-5-yl-anilino) -ethylidene] -6-ethoxycarbonyl-2-indolinone, (107) 3-Z- [ 1- (4-Tetrazol-5-yl-anilino) -propylidene] -6-ethoxycarbonyl-2-indolinone, (108) 3-Z- [1- (4-tetrazol-5-yl-anilino) -butylidene] - 6-ethoxycarbonyl-2-indolinone, (109) 3-Z- [1- (4-carboxy-anilino) -methylene] -6-ethoxycarbonyl-2-indolinone, (110) 3-Z- [1- (4-) carboxy γ-anilino) -propylidene] -6-ethoxycarbonyl-2-indolinone, (111) 3-Z- [1- (4-carboxy-anilino) -butylidene] -6-ethoxycarbonyl-2-indolinone, (112) 3- N- [1- (4- (N- (3-dimethylamino-propionyl) - N -dimethylaminocarbonylmethyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (113) 3- N- [1- (4- (N - (4-dimethylamino-butyryl) - N -dimethylaminocarbonyl-methyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (114) 3-N- [1- (4- (N-dimethylaminocarbonyl-methyl-N- (2-dimethylamino-ethylsulfonyl) -amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, ( 115) 3-N- [1- (4- (N-dimethylaminocarbonyl-methyl-N - ('3-dimethylamino-propylsulfonyl) -amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2- (116) 3-Z- [1- (4 - ((2-hydroxy-ethyl) -amino-methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, ( 117) 3-Z- [1- (4 - ((2-methoxy-ethyl) -amino-methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (118) 3 Z- [l- (4 - ((2-dimethylamino-ethyl) -methyl-amino) anilino) -l-phenyl-methylene] -6-ethoxy carbonyl-2-indolinone, (119) 3-Z- [1- (4 - ((3-dimethylamino-propyl) amino-methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (120) 3-Z- [1- (4 - ((N-tert-butoxycarbonyl-2-amino-ethyl) -aminomethyl) -anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (121) 3-Z- [1- (4 - ((N-tert-butoxycarbonyl-3-amino-propyl) -aminomethyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, ( 122) 3-Z- [1- (4 - ((2-amino-ethyl) -amino-methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (123) 3 -Z- [1- (4 - ((3-Amino-propyl) -amino-methyl) -anilino) -1-phenyl-methylene] -6-ethoxy-carbonyl-2-indolinone, (124) 3-Z- [1- (4 - ((2-acetylamino-ethyl) -amino-methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (125) 3-Z- [1- (4) - ((3-acetylamino-propyl) amino-methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (126) 3-Z- [1- (4 - ((2- methylsulfonylamino-ethyl) -amino-methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (127) 3-Z- [1- (4 - ((3-methylsulfonylamino-propyl) - amino-methyl (1) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (128) 3-Z- [1- (4- (N - (N-tert-butoxycarbonyl-2-amino-ethyl)) (N-methyl-amino-methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (129) 3- Z- [1- (4- (N-2-amino-ethyl) (N-Methyl-amino-methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (130) 3-Z- [1- (4- (N- (2-acetylami)) N-ethyl-N-methyl-1-amino-methyl) -anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (131) 3-Z- [1- (4 - (V) - (2-methylsulfonylamino-ethyl) - (N-methyl-amino-methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (132) 3-Z- [1- (4- (carboxymethyl-amino-methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (133) 3- Z- [1- (4- (ethoxycarbonyl-methyl-amino-methyl)) -anilino) -1-phenyl-methylene] -6-ethoxy-carbonyl-2-indolinone, (134) 3-Z- [1- (4- (carbamoyl-methyl-amino-methyl) -anilino) -1-phenyl -methylene] -6-ethoxycarbonyl-2-indolinone, (135) 3-Z- [1- (4- (dimethylcarbamoyl-methyl-amino-methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl -2-indolin (136) 3-Z- [1- (4- (methylcarbamoyl-methyl-amino-methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (137) 3-Z- [l- (4- (A / -dimetylaminometylkarbonyl-N-methyl-amino) -3-amino-anilino) -l-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (138) 3-Z- [ 1- (4- (N-dimethylaminomethylcarbonyl-; N -methylamino) -3-nitroanilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (139) 3-Z- [1- (4- (N-dimethylaminomethylcarbonyl-N-methyl-amino) -3-acetylamino-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (140) 3-Z- [1- (4- (N-dimethylaminomethylcarbonyl-N-methyl-amino) -3-methylsulfonyl-amino-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (141) 3-Z- [1 - ( 4- (N-dimethylaminomethylcarbonyl-N-methyl-amino) -3-cyano-amino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (142) 3-Z- [1- (4- ( (N-dimethylaminomethylcarbonyl- N -methyl-amino) -3-hydroxy-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (143) 3-Z- [1- (4- (N-dimethylamino-methylcarbonyl-7V-methyl-amino) -3-methoxy-anilino) -l-phenyl phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (144) 3-Z- [1 - (4- (7V-dimethylamino-methylcarbonyl-R / N-methyl-amino) -3-ethoxycarbonyl-anilino) -1-phenyl methylene] -6-ethoxycarbonyl-2-indolinone, (145) 3-Z- [1- (4- (N-dimethylaminomethylcarbonyl-N-methylamino) -3-carboxy-anilino) -1-phenyl-methylene] - 6-ethoxycarbonyl-2-indolinone, (146) 3- Z - [1- (4- (N-dimethylaminomethylcarbonyl-N-methyl-amino) -3-carbamoyl-anilino) -1-phenylmethylene] -6-ethoxycarbonyl -2-indolinone, (147) 3- [1- (4- (N + dimethylaminomethylcarbonyl- N -methylamino) -3-chloroanilino) -1-phenylmethylene] -6-ethoxycarbonyl-2 - indolinone,

SK 287312 Β6 (148) 3-Z-[ 1 -(4-(7V-dimetylaminometylkarbonyl-7V-metyl-amino)-3-fluór-anilino)-1 -fenyl-metylén] -6-etoxykarbonyl-2-indolinón, (149) 3-Z-[ 1 -(4-(A,-dimetylaminometylkarbonyl-A'-mety 1-amino)-3-bróm-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (150) 3-Z-[l-(4-(7V-dimetylaminometylkarbonyl-/V-metyl-amino)-3-metyl-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (151) 3-Z-[ 1 -(4-(iV-dimetylaminometylkarbonyl-<V-metyl-ammo)-3-trifluórmetyl-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (152) 3-Z-[l-(4-(7V-dimetylaminometylkarbonyl-/V-metylamino)-3,5-dibróm-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (153) 3-Z-[l-(4-(7V-dimetylaminometylkarbonyl-jV-metyl-amino)-3,5-dichlór-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (154) 3-Z-[ 1 -(4-(dimetylaminometyl)-3-amino-anilino)-l -fenyl-metylén]-6-etoxy-karbonyl-2-indolinón, (155) 3-Z-[l-(4-(dimetylaminometyl)-3-nitroanilino)-l-fenylmetylén]-6-etoxykarbonyl-2-indolinón, (156) 3-Z-[ 1 -(4-(dimetylaminometyl)-3-acetylamino-anilino)-1 -fenyl-metylén]-6-etoxy-karbonyl-2-indolinón, (157) 3-Z-[l-(4-(dimetylaminometyl)-3-(metylsulfonylamino)anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (158) 3-Z-[l-(4-(dimetylaminometyl)-3-kyano-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (159) 3-Z-[l-(4-(dimetylaminometyl)-3-hydroxy-anilino)-l-fenyl-metylén]-6-etoxy-karbonyl-2-indolinón, (160) 3-Z-[ 1 -(4-(dimetylaminometyl)-3-metoxy-anilino)-1 -fenyl-metylén]-6-etoxy-karbonyl-2-indolinón, (161) 3-Z-[ 1 -(4-(dimetylaminometyl)-3-(etoxykarbonyl)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (162) 3-Z-[l-(4-(dimetylaminometyl)-3-karboxy-anilino)-l-fenyl-metylén]-6-etoxy-karbonyl-2-indolinón, (163) 3-Z-[l-(4-(dimetylaminometyl)-3-karbamoyl-anilino)-l-fenyl-metylén]-6-etoxy-karbonyl-2-indolinón, (164) 3-Z-[l -(4-(dimetylaminometyl)-3-chlór-anilino)-l -fenyl-metylén]-6-etoxy-karbonyl-2-indolinón, (165) 3-Z-[l-(4-(dimetylaminometyl)-3-fluór-anilino)-l-fenyl-metylén]-6-etoxy-karbonyl-2-indolinón, (166) 3-Z-[l-(4-(dimetylaminometyl)-3-bróm-anilino)-l-fenyl-metylén]-6-etoxy-karbonyl-2-indolinón, (167) 3-Z-[l-(4-(dimetylaminometyl)-3-metyl-anilino)-l-fenyl-metylén]-6-etoxy-karbonyl-2-indolinón, (168) 3-Z-[ 1 -(4-(dimetylaminometyl)-3 -trifluórmetyl-anilino)-1 -fenyl-metylén] -6-etoxy-karbonyl-2-indolinón, (169) 3-Z-[l-(4-(dimetylaminometyl)-3,5-dibróm-anilino)-l-fenyl-metylén]-6-etoxy-karbonyl-2-indolinón, (170) 3-Z-[l-(4-(dimetylaminometyl)-3,5-dichlór-anilino)-l-fenyl-metylén]-6-etoxy-karbonyl-2-indolinón, (171) 3-Z-[ 1 -(4-(;V-((4-metyl-piperazin-1 -yl)-metylkarbonyl)-7V-metyl-amino)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (172) 3-Z-[ 1 -(4-(Ar-(imidazo-1 -yl-metylkarbonyl)-7V-metyl-amino)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (173) 3-Z-[ 1 -(4-(Af-(ftalimido-2-yl-metylkarbonyl)-7V-metyl-amino)-anilino)-1-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (174) 3-Z-[ 1 -(4-(7V-aminometylkarbonyl-jV-metyl-amino)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (175) 3-Z- [ 1 -(4-(/V-acetylaminometylkarbony I-/V- metyl-amino)-anilino)-1 -fenyl-metylén] -6-etoxykarbonyl-2-indolinón, (176) 3-Z-[ 1 -(4-(/V-metylsulfonylaminometylkarbonyl-jV-metylamino)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (177) 3-Z-[ 1 -(4-(7V-((/V-(2-metoxyetyl)-Ar-metyl-amino) metylkarbonyl)-.V-metyl-amino)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (178) 3-Z-[l-(4-(?/-((X-(2-dimetylaminoetyl)-7V-metyl-amino)-metylkarbonyl)-/V-metyl-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (179) 3-Z-[l-(4-(jV-((di-(2-hydroxyetyl)-amino)-metylkarbonyl)-7V-metyl-amino)-anilino)-l -fenyl-metylén]6-etoxykarbonyl-2-indolinón, (180) 3-Z-[l-(4-(Af-dimetylaminometylkarbonyl-jV-metyl-amino)-anilino)-metylén]-6-etoxykarbonyl-2-indolinón, (181) 3-Z-[ 1 -(4-(7V-dimetylaminometylkarbonyl-Af-metyl-amino)-anilino)-etylidén]-6-etoxykarbonyl-2-indolinón, (182) 3-Z-[ 1 -(4-(7V-dimetylaminometylkarbony 1-V-rnety 1-amino)-anilino)-propylidén] -6-etoxykarbonyl-2-indolinón, (183) 3-Z-[l-(4-( N-dimetylaminomctylkarbonyl-7V-metyl-amino)-amlino)-butylidén]-6-etoxykarbonyl-2-indolinón, (184) 3-Z-[l-(4-(dimetylaminometyl)-anilino)-metylén]-6-etoxykarbonyl-2-indolinón, (185) 3-Z-[l-(4-(dimetylaminometyl)-anilino)-etylidén]-6-etoxykarbonyl-2-indolinón, (186) 3-Z-[l-(4-(dimetylaminometyl)-anilino)-propylidén]-6-etoxykarbonyl-2-indolinón, (187) 3-Z-[l-(4-(dimetylaminometyl)-anilino)-butylidén]-6-etoxykarbonyl-2-indolinón, (188) 3-Z-[ l-(4-(7V-dimetylaminokarbonyl-metyl-amino)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (189) 3-Z-[ 1 -(4-(jV-(3-dimetylamino-propyl)-7/-acetyl-amino)anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (190) 3-Z-[l-(4-((imidazolidín-2,4-dión-5-ylidén)-metyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (191) 3-Z-[ 1 -(4-(7/-((2-dimetylaniino-etyl)-karbonyl)-/V-metyl-amino)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (192) 3-Z- [ 1 -(4-(/V-/erc-butoxykarbonyl-aminometyl)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (193) 3 -Z- [ 1 -(4-(2-oxo-pyrolidin-1 -yl-metyl)-anilino)-1 -fenyl-metylén] -6-etoxy-karbonyl-2-indolinón, (194) 3-Z-[l -(4-(/V-aminokarbonyl-metyl-/V-metylsulfonyl-ammo)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (195) 3-Z-[ 1 -(4-(7/-kyanometyl-7/-metylsulfonyl-amino)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (196) 3-Z-[l -(4-(2-(imidazol-4-yl)-etyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (197) 3-Z-[l-(4-((2-(7/-benzyl-77-metyl-amino)-etyl)-7/-metylsulfonyl-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (198) 3-Z-[ 1 -(4-cyklohexylamino-amlino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (199) 3-Z-[ 1 -(4-(imidazol-1 -yl-metyl)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (200) 3-Z-[l-(4-(imidazol-l-yl-metyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (201) 3-Z-[ 1 -(/V-metyl-piperidin-4-yl-amino)-1 -fenyl-metylén-6-etoxykarbonyl-2-indolinón, (202) 3-Z-[l-(4-(imidazol-4-yl-metyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (203) 3-Z-[ 1 -(4-((4-hydroxy-piperidin-1 -yl)-metyl)-anilino)-1 -fenyl-metylén]-6-etoxy-karbonyl-2-mdolinón, (204) 3-Z-[l-(4-((4-metoxy-piperidin-l-yl)-metyl)-anilino)-l-fenyl-metylén]-6-etoxy-karbonyl-2-indolinón, (205) 3-Z-[l-(4-benzyl-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (206) 3-Z-[l-(4-(7V-(3-trifluoracetylamino-propyl)-A-metylsulfonyl-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (207) 3-Z-[l-(4-(4-terc-butoxykarbonyl-piperazin-l-yl-metyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (208) 3-Z-[ 1 -(4-( 1 -metyl-imidazol-2-yl)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indo!inón, (209) 3-Z-[ 1 -(4-( 1 -metyl-imidazol-2-yl)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (210) 3-Z-[l-(4-(Af-(2-dimetylamino-etyl)-7/-metylsulfonylamino)-3-amino-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (211) 3-Z-[l-(4-((3-(Ar-benzyl-IV-metyl-amino)-propyl)-íV-metylsulfonyl-amino)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (212) 3-Z-[l-(4-(7V-(2-dimetylamino-etyl)-jV-acetyl-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (213) 3-Z-[ 1 -(4-(A/-(2-dimetylamino-etyl)-/V-butyryl-amino)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (214) 3-Z-[l-(4-(7/-(2-dimetylamino-etyl)-7/-izobutyryl-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (215) 3-Z-[ 1 -(4-(7/-(2-dimetylamino-etyl)-jV-benzoyl-amino)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (216) 3-Z-[l-(4-(7/-(2-dimetylamino-etyl)-/V-acetyl-amino)-3- amino-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (217) 3-Z-[ 1 -(4-(4-hydroxymetyl-piperidin-1 -yl-metyl)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (218) 3-Z-[l-(4-(2-(4-hydroxy-piperidin-1 -yl)-etyl)-anilino)-1 -fenyl-metylén]-6-etoxy-karbonyl-2-indolinón, (219) 3-Z-[ 1 -(4-(7/-(2-dimetylamino-etyl)-/V-propylsulfonyl-ammo)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (220) 3-Z-[l-(4-(/V-(2-dimetylamino-etyl)-A'-butylsulfonyl-amino)-amlino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (221) 3 -Z- [ 1 -(4-(7/-(2-dimetylamino-etyl)-7V-fenylsulfonyl-amino)-anilino)-1 -fenyl-metylén] -6-etoxykarbonyl-2-indolinón, (222) 3-Z-[l-(4-(7/-(2-dimetylamino-etyl)-7/-benzylsulfonyl-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (223) 3-Z-[ 1 -(4-((imidazolidín-2,4-dión-5-yl)-metyl)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (224) 3-Z-[l-(4-((3-hydroxy-pyroliiín-l-yl)-metyl)-amlino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (225) 3-Z-[l-(4-(cyklohexyl-metyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (226) 3-Z-[l-(4-(cyklohexyl-karbonyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (227) 3-Z-[ 1 -(4-dietylaminometyl-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (228) 3-Z-[l-(4-(A,-(n-hexyl)-?/-metyl-aminometyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (229) 3-Z-[l-(4-(7V-(2-dimetylamino-etyl)-7V-(furán-2-karbonyl)-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (230) 3-Z-[l-(4-(Aľ-(2-dimetylamino-etyl)-7V-(2-metoxy-benzoyl)-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (231) 3-Z-[l-(4-(7V-(2-dimetylamino-etyl)-7V-(pyridín-3-karbonyl)-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (232) 3-Z-[l-(4-(7V-(2-dimetylamino-etyl)-V-(fenyl-acetyl)-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (233) 3-Z-[l-(4-(imidazol-2-yl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (234) 3-Z-[ 1 -(4-( 1 -etyl-imidazol-2-yl)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (235) 3-Z-[l-(4-(l-benzyl-imidazol-2-yl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (236) 3-Z-[l-(4-(/V-(2-dimetylamino-etyl)-/V-izopropylsulfonyl-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (237) 3-Z-[l-(4-(jV-((4-benzyl-piperazin-l-yl)-metylkarbonyl)-JV-metyl-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (238) 3-Z-[ 1 -(4-(7V-(pyrolidin-1 -yl-metylkarbonyl)-A'-metyl-amino)-anilino)-1 -fény 1-metylén]-6-etoxykarbonyl-2-indolinón, (239) 3-Z-[l-(4-(7V-(2-dimetylamino-etyl)-7V-acetyl-amino)-3-bróm-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (240) 3-Z-[l-(4-(5-metyl-imidazol-4-yl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (241) 3 -Z- [ 1 -(4-(7V-((2-dimetylamino-etyl)-karbonyl)-A/-izopropyl-amino)-anilino)-1 -fenyl-metylén] -6-etoxykarbonyl-2-indolinón, (242) 3-Z-[l-(4-(7V-((2-dimetylamino-etyl)-karbonyl)-7V-benzyl-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (243) 3-Z-[l-(4-(7V-butyl-7V-íerc-butoxykarbonyl-aminometyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (244) 3-Z-[ 1 -(4-(N-((Aľ-aminokarbonyl-metyl-ALmetyl-amino)-metylkarbonyl)-/V-metyl-amino)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (245) 3-Z-[l-(4-(7V-((7/-benzyl-7V-metyl-amino)-metylkarbonyl)-JV-metyl-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (246) 3-Z-[l-(4-(7V-(di-(2-metoxyetyl)-amino-metylkarbonyl)-7V-metyl-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (247) 3-Z-[ 1 -(4-(7V-((2-(4-íerc-butoxykarbonyl-piperazin-1 -yl)-etyl)-karbonyl)-7V-metyl-amino)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (248) 3-Z-[l-(4-(Á-((2-(piperidin-l-yl)-etyl)-karbonyl)-7V-metyl-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (249) 3-Z- [ 1 -(4-( V-((2-(/V-benzyl-JV-mety l-amino)-ety l)-karbony l)-/V-mety l-amino)-ani lino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (250) 3-Z-[l-(4-(A,-dimetylaminometylkarbonyl-/V-izopropyl-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (251) 3-Z-[ 1 -(4-(/V-(piperidin-1 -yl-metylkarbonyl)-A'-izopropyl-amino)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (252) 3-Z- [ 1 -(4-(jV-(4-Zerc-butoxykarbonyl-piperazin-1 -yl)-metylkarbony Ϊ)-Ν- izopropyl-amino)-anil ino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (253) 3-Z-[1 -(4-(//-((jV-benzyl-/V-metyl-amino)-metylkarbonyl)-7V-benzyl-amino)-anilino)-l-fenyl-metylén] 6-etoxykarbonyl-2-indolinón, (254) 3-Z-[l-(4-(7V-dimetylaminometylkarbonyl-jV-benzyl-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (255) 3-Z-[l-(4-(7V-(piperidin-l-yl-metylkarbonyl)-/V-benzylamino)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (256) 3-Z-[l-(4-( 1,2,4-triazol-2-yl-metyl)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (257) 3-Z-[l-(4-(l,2,3-triazol-2-yl-metyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (258) 3-Z-[l-(4-(l,2,3-triazol-l-yl-metyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (259) 3-Z-[l-(4-((//-aminokarbonyl-metyl-//-metyl-amino)-metyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (260) 3-Z-[ 1 -(4-((di-(2-metoxy-etyl)-amino)-metyl)-anilino)-1 -fenyl-metylén]-6-etoxy-karbonyl-2-indolinón, (261) 3-Z-[l-(4-((di-(2-hydroxy-etyl)-amino)-metyl)-anilino)-l-fenyl-metylén]-6-etoxy-karbonyl-2-indolinón, (262) 3-Z-[ 1 -(4-((N-etoxykarbonyl-metyl-A'-metyl-amino)-metyl)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-(148) 3-Z- [1- (4- (N-dimethylaminomethylcarbonyl-N-methyl-amino) -3-fluoro-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (149) 3-Z- [1- (4- (N , -dimethylaminomethylcarbonyl-N'-methyl-amino) -3-bromoanilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (150) 3-N- [1- (4- (N-dimethylaminomethylcarbonyl- N -methyl-amino) -3-methyl-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (151) ) 3-N- [1- (4- (N-dimethylaminomethylcarbonyl- N -methyl-amino) -3-trifluoromethyl-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (152) 3 -Z- [1- (4- (N-dimethylaminomethylcarbonyl- N -methylamino) -3,5-dibromo-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (153) 3-Z - [1- (4- (N-dimethylaminomethylcarbonyl-N-methyl-amino) -3,5-dichloro-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (154) 3-Z- [1- (4- (dimethylaminomethyl) -3-amino-anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (155) 3-Z- [1- (4- (dimethylaminomethyl)) 3-nitrophenyl) -l-phenyl-methylene] -6-ethoxycarbonyl-2-in dolinone, (156) 3-Z- [1- (4- (dimethylaminomethyl) -3-acetylamino-anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (157) 3-Z- [1- (4- (dimethylaminomethyl) -3- (methylsulfonylamino) anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (158) 3- Z- [1- (4- (dimethylaminomethyl)) - 3-cyano-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (159) 3- Z- [1- (4- (dimethylaminomethyl) -3-hydroxy-anilino) -1-phenyl- methylene] -6-ethoxycarbonyl-2-indolinone, (160) 3-Z- [1- (4- (dimethylaminomethyl) -3-methoxy-anilino) -1-phenylmethylene] -6-ethoxycarbonyl- 2-indolinone, (161) 3-Z- [1- (4- (dimethylaminomethyl) -3- (ethoxycarbonyl) -anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (162) 3- Z- [1- (4- (dimethylaminomethyl) -3-carboxy-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (163) 3-Z- [1- (4- ( dimethylaminomethyl) -3-carbamoyl-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (164) 3-Z- [1- (4- (dimethylaminomethyl) -3-chloro-anilino) -1-phenyl-methylene] -6-ethoxy-carbonyl-2-indolinone, (165) 3-Z- [1- (4- (dimethyl) aminomethyl) -3-fluoro-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (166) 3-Z- [1- (4- (dimethylaminomethyl) -3-bromo-anilino) -1-phenyl-methylene] -6-ethoxy-carbonyl-2-indolinone, (167) 3-Z- [1- (4- (dimethylaminomethyl) -3-methyl-anilino) -1-phenyl-methylene] -6 -ethoxycarbonyl-2-indolinone, (168) 3-Z- [1- (4- (dimethylaminomethyl) -3-trifluoromethyl-anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (169) 3-Z- [1- (4- (dimethylaminomethyl) -3,5-dibromo-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (170) 3-Z- [1- (4- (dimethylaminomethyl) -3,5-dichloro-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (171) 3-Z- [1- (4- ( N - ((4-methyl-piperazin-1-yl) -methylcarbonyl) -N-methyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (172) 3-Z - [1 - (4- (N - (imidazol-1-yl-methylcarbonyl) -7V-methyl-amino) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (173) 3 -Z- [1 - (4- (f - (phthalimido-2-yl-methylcarbonyl) -7V-methyl-amino) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indole (174) 3-Z- [1- (4- (N-aminomethylcarbonyl-N-methyl-amino) -anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (175) 3- N- [1- (4- (N-acetylaminomethylcarbonyl- N -methylamino) -anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (176) 3-Z- [1] - (4- (N-methylsulfonylaminomethylcarbonyl- N -methylamino) -anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (177) 3-Z- [1- (4- (7 N - ( (/ V- (2-methoxyethyl) -N-methyl-amino) methylcarbonyl) -. V-methyl-amino) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (178) 3 Z- [l- (4 - (? / - ((X- (2-dimethylamino-ethyl) -7V-methyl-amino) -methylcarbonyl) - / V-methyl-amino) -anilino) -l-phenyl-methylene] 6-ethoxycarbonyl-2-indolinone, (179) 3-Z- [1- (4- (N - ((di- (2-hydroxyethyl) amino) methylcarbonyl) -7-methyl-amino) -anilino) -l-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (180) 3-Z- [l- (4- (f -dimetylaminometylkarbonyl-N-methyl-amino) anilino) methylene] -6-ethoxycarbonyl 2-indolinone (181) 3-Z- [1 - (4- (7V-dimethylamino-methylcarbonyl and f-methyl-amino) anilino) ethyl dene] -6-ethoxycarbonyl-2-indolinone, (182) 3-Z- [1- (4- (N-dimethylaminomethylcarbonyl-1-methyl-1-amino) -anilino) -propylidene] -6-ethoxycarbonyl-2- (183) 3-Z- [1- (4- (N-dimethylaminomethylcarbonyl-N-methyl-amino) -amino) -butylidene] -6-ethoxycarbonyl-2-indolinone, (184) 3-Z- [1] - (4- (dimethylaminomethyl) -anilino) -methylene] -6-ethoxycarbonyl-2-indolinone, (185) 3-Z- [1- (4- (dimethylaminomethyl) anilino) ethylidene] -6-ethoxycarbonyl-2 -indolinone, (186) 3-Z- [1- (4- (dimethylaminomethyl) -anilino) -propylidene] -6-ethoxycarbonyl-2-indolinone, (187) 3-Z- [1- (4- (dimethylaminomethyl)) -anilino) -butylidene] -6-ethoxycarbonyl-2-indolinone, (188) 3-Z- [1- (4- (N-dimethylaminocarbonyl-methyl-amino) -anilino) -1-phenyl-methylene] -6- ethoxycarbonyl-2-indolinone, (189) 3- Z - [1- (4- (N - (3-dimethylamino-propyl) -7 H -acetyl-amino) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl -2-indolinone, (190) 3-Z- [1- (4 - ((imidazolidin-2,4-dione-5-ylidene) -methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2-indolinone, (191) 3-Z- [1- (4- (7H - ((2-dimethylanii)) (1-ethyl-carbonyl) - N -methyl-amino) -anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (192) 3-Z- [1- (4 - (V) - (tert-butoxycarbonyl-aminomethyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (193) 3-Z- [1- (4- (2-oxo-pyrrolidin-1-yl) (methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (194) 3-Z- [1- (4- (N-aminocarbonyl-methyl) - N -methylsulfonyl- (amino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (195) 3-Z- [1- (4- (7-cyanomethyl-7 H -methylsulfonyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (196) 3- Z- [1- (4- (2- (imidazol-4-yl) ethyl) -anilino) -1-phenyl- methylene] -6-ethoxycarbonyl-2-indolinone, (197) 3-Z- [1- (4 - ((2- (1H-benzyl-77-methyl-amino) -ethyl) -7 H -methylsulfonyl-amino) (-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (198) 3- Z- [1- (4-cyclohexylamino-amino) -1-phenylmethylene] -6-ethoxycarbonyl-2 (199) 3-Z- [1- (4- (imidazol-1-yl-methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (200) 3-Z - [l- (4- (imidazo (11-yl-methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (201) 3-Z- [1- (N-methyl-piperidin-4-ylamino) - 1-Phenyl-methylene-6-ethoxycarbonyl-2-indolinone, (202) 3-Z- [1- (4- (imidazol-4-ylmethyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl -2-indolinone, (203) 3-Z- [1- (4 - ((4-hydroxy-piperidin-1-yl) -methyl) -anilino) -1-phenyl-methylene] -6-ethoxy-carbonyl- 2-indolinone, (204) 3-Z- [1- (4 - ((4-methoxy-piperidin-1-yl) -methyl) -anilino) -1-phenyl-methylene] -6-ethoxy-carbonyl-2 -indolinone, (205) 3- Z- [1- (4-benzyl-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (206) 3- Z- [1- (4- ( N - (3-Trifluoroacetylamino-propyl) - N -methylsulfonyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (207) 3- Z- [1- (4- (4) (tert-butoxycarbonyl-piperazin-1-yl-methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (208) 3-Z- [1- (4- (1-methyl- imidazol-2-yl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indinone, (209) 3-Z- [1- (4- (1-methyl-imidazol-2-yl) (-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2-indolinone (210) 3-Z- [l- (4- (f - (2-dimethylamino-ethyl) -7 / -metylsulfonylamino) -3-amino-anilino) -l-phenyl-methylene] -6 ethoxycarbonyl-2-indolinone (211) 3-Z- [l- (4 - ((3- (N-benzyl-I-N-methyl-amino) propyl) -N-methylsulphonyl-amino) anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (212) 3- Z- [1- (4- (N - (2-dimethylamino-ethyl) - N -acetyl-amino) -anilino) - 1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (213) 3-Z- [1- (4- (N - (2-dimethylamino-ethyl) - N -butyrylamino) -anilino) -1-Phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (214) 3-Z- [1- (4- (N - (2-dimethylamino-ethyl) -7 H -isobutyryl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (215) 3-Z- [1- (4- (N - (2-dimethylamino-ethyl) - N -benzoylamino) amino] anilino -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (216) 3-Z- [1- (4- (N - (2-dimethylamino-ethyl) - N -acetyl-amino) - 3-Amino-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (217) 3- Z- [1- (4- (4-hydroxymethyl-piperidin-1-ylmethyl) -anilino) -1-Phenylmethylene] -6-ethoxycarbonyl-2-indoline n, (218) 3- Z- [1- (4- (2- (4-hydroxy-piperidin-1-yl) -ethyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2 (219) 3-Z- [1- (4- (N - (2-dimethylamino-ethyl) - N -propylsulfonyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2-indolinone, (220) 3-Z- [1- (4- (N - (2-dimethylamino-ethyl) - N '-butylsulfonyl-amino) -amino) -1-phenyl-methylene] -6-ethoxycarbonyl -2-indolinone, (221) 3-Z- [1- (4- (N - (2-dimethylamino-ethyl) - N -phenylsulfonyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl -2-indolinone, (222) 3- Z- [1- (4- (N - (2-dimethylamino-ethyl) -7 H -benzylsulfonyl-amino) -anilino) -1-phenyl-methylene] -6- ethoxycarbonyl-2-indolinone, (223) 3-Z- [1- (4 - ((imidazolidin-2,4-dione-5-yl) methyl) -anilino) -1-phenylmethylene] -6-ethoxycarbonyl -2-indolinone, (224) 3-Z- [1- (4 - ((3-hydroxy-pyrrolin-1-yl) -methyl) -amino) -1-phenyl-methylene] -6-ethoxycarbonyl-2- indolinone, (225) 3-Z- [1- (4- (cyclohexyl-methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (226) 3-Z- [1- ( 4- (cyclohexyl-carbonyl) -anilino) -l-phenyl-methylene] -6-e Toxicarbonyl-2-indolinone, (227) 3-Z- [1- (4-diethylaminomethyl-anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (228) 3-Z- [1- ( 4- (n - (n-hexyl) -? / - methyl-aminomethyl) anilino) -l-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone (229) 3-Z- [l- (4 - (N - (2-dimethylamino-ethyl) - N - (furan-2-carbonyl) -amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (230) 3-Z- [1- (4- (N ' - (2-dimethylamino-ethyl) - N - (2-methoxy-benzoyl) -amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, ( 231) 3-N- [1- (4- (N - (2-dimethylamino-ethyl) - N - (pyridine-3-carbonyl) -amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl- 2-indolinone, (232) 3- [1- (4- (N - (2-dimethylamino-ethyl) -N- (phenyl-acetyl) -amino) -anilino) -1-phenyl-methylene] -6 -ethoxycarbonyl-2-indolinone, (233) 3-Z- [1- (4- (imidazol-2-yl) -anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (234) 3 -Z- [1- (4- (1-ethyl-imidazol-2-yl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (235) 3-Z- [1- ( 4- (l-benzyl-imidazol-2-yl) anilino) -l-phenyl-methylene 6-ethoxycarbonyl-2-indolinone, (236) 3- [1- (4 - (N - (2-dimethylamino-ethyl) - N -isopropylsulfonyl-amino) -anilino) -1-phenyl- methylene] -6-ethoxycarbonyl-2-indolinone, (237) 3-Z- [1- (4- (N - ((4-benzyl-piperazin-1-yl) -methylcarbonyl) -N-methyl-amino) - anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (238) 3-Z- [1- (4- (N - (pyrrolidin-1-ylmethylcarbonyl)--'-methyl-amino) (-anilino) -1-phenyl-1-methylene] -6-ethoxycarbonyl-2-indolinone, (239) 3-Z- [1- (4- (N - (2-dimethylamino-ethyl) -7H-acetyl-amino) (3-Bromo-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (240) 3-Z- [1- (4- (5-methyl-imidazol-4-yl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (241) 3-Z- [1- (4- (N - ((2-dimethylamino-ethyl) -carbonyl) - N -isopropyl- amino) -anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (242) 3- Z- [1- (4- (7H - ((2-dimethylamino-ethyl)) -carbonyl) -7H (benzyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (243) 3-Z- [1- (4- (N-butyl-N-tert-butoxycarbonyl-aminomethyl)) anilino) -l-phenyl-methylene] -6-e methoxycarbonyl-2-indolinone (244) 3-Z- [1 - (4- (N - ((aminocarbonyl and L-methyl-N- methyl-amino) -methylcarbonyl) - / V-methyl-amino) -aniline -1-Phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (245) 3-Z- [1- (4- (N - ((N-benzyl-N-methyl-amino) -methylcarbonyl)) - (N -methyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (246) 3-Z- [1- (4- (N - (di- (2-methoxyethyl)) (amino-methylcarbonyl) - N -methyl-amino) -anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (247) 3-Z- [1- (4- (7H - ((2) - (4-tert-butoxycarbonyl-piperazin-1-yl) -ethyl) -carbonyl-N-methyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (248) 3 Z- [l- (4- (N - ((2- (piperidin-l-yl) ethyl) carbonyl) -7V-methyl-amino) -anilino) -l-phenyl-methylene] -6-ethoxycarbonyl -2-indolinone, (249) 3-Z- [1- (4- (N - ((2 - (N-benzyl- N -methyl-amino) ethyl)) carbonyl) -N (250-methyl-1-amino) -amino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone; (250) 3-Z- [1- (4- (N , -dimethylaminomethylcarbonyl- N -isopropyl- amino) anilino) -l-phenyl-methylene] -6-ethoxycarbonyl 1-2-indolinone, (251) 3- Z - [1- (4 - (N - (piperidin-1-ylmethylcarbonyl) - N '-isopropyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (252) 3-Z- [1- (4- (N - (4-tert-butoxycarbonyl-piperazin-1-yl) -methylcarbonyl) -1-isopropyl-amino) - anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (253) 3-Z- [1- (4 - (N - ((N-benzyl- N -methylamino)) - methylcarbonyl-N-benzyl-amino) -anilino-1-phenyl-methylene] 6-ethoxycarbonyl-2-indolinone, (254) 3- Z- [1- (4- (N-dimethylaminomethylcarbonyl-N-benzylamino) (-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (255) 3- Z- [1- (4- (N - (piperidin-1-ylmethylcarbonyl) - N -benzylamino)] - (-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (256) 3- Z- [1- (4- (1,2,4-triazol-2-ylmethyl) -anilino) -1-Phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (257) 3- Z- [1- (4- (1,2,3-triazol-2-ylmethyl) -anilino) -1 -phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (258) 3- Z- [1- (4- (1,2,3-triazol-1-ylmethyl) -anilino) -1-phenyl- methylene] -6-ethoxycarbonyl-2-indolinone, (259) 3 -Z- [1- (4 - ((1H-aminocarbonyl-methyl-1H-methyl-amino) -methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (260) 3-Z- [1- (4 - ((di- (2-methoxy-ethyl) -amino) -methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (261 13-Z- [1- (4 - ((di- (2-hydroxy-ethyl) -amino) -methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, ( 262) 3-Z- [1- (4 - ((N-ethoxycarbonyl-methyl-N'-methylamino) -methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-

-2-indolinón, (263) 3-Z-[ 1 -(4-(azetidin-1 -yl-metyl)-anilmo)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (264) 3-Z-[l -(4-(A'-propyl-7V-terc-butoxykarbonyl-aminometyl)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (265) 3-Z-[ 1 -(4-((jV-(2-(2-metoxy-etoxy)-etyl)-/V-metyl-amino)-metyl)-anilmo)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (266) 3-Z- [ 1 -(4-((AL(/erc-butoxykarbonyl-3 -amino-propyl)-jV-metyl-amino)-metyl)-anilino)-1 -fenyl-metylén] -6-etoxykarbonyl-2-indolinón, (267) 3-Z-[l-(4-((jV-(metylkarbamoyl-metyl)-jV-metyl-amino)-metyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (268) 3-Z-[l-(4-((7V-(dimetylkarbamoyl-metyl)-7V-metyl-amino)-metyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (269) 3-Z-[l-(4-((ALpropyl-7V-metyl-amino)-metyl)-anilino)-l-fenyl-metylén]-6-etoxy-karbonyl-2-indolinóii, (270) 3-Z-[l-(4-((7V-(2-dimetylaimno-etyl)-jV-metyl-amino)-metyl)-aniliiio)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (271) 3-Z-[l-(4-((IV-(3-dimetylamino-propyl)-/v'-metyl-amino)-metyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (272) 3-Z-[l-(4-((N-(2-metoxy-etyl)-N-metyl-amino)-metyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (273) 3-Z-[l-(4-((/V-(2-hydroxy-etyl)-7V-metyl-amino)-metyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2--2-indolinone, (263) 3-Z- [1- (4- (azetidin-1-ylmethyl) -anilmo) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (264) 3 -Z- [1- (4- (N'-propyl-N-tert-butoxycarbonylaminomethyl) -anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (265) 3-Z- [ 1- (4 - ((N - (2- (2-methoxy-ethoxy) -ethyl) - N -methyl-amino) -methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2- indolinone, (266) 3-Z- [1- (4 - ((N - (tert -butoxycarbonyl-3-amino-propyl) - N -methyl-amino) -methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (2 S) 3-Z- [1- (4 - ((N - (methylcarbamoyl-methyl) - N -methyl-amino) -methyl) -anilino) -1-phenyl-methylene ] -6-ethoxycarbonyl-2-indolinone, (268) 3- Z- [1- (4 - ((N - (dimethylcarbamoyl-methyl) - N -methyl-amino) -methyl) -anilino) -1-phenyl- methylene] -6-ethoxycarbonyl-2-indolinone (269) 3-Z- [l- (4 - ((me 7V- ALpropyl-ethyl-amino) methyl) anilino) -l-phenyl-methylene] -6 -ethoxy-carbonyl-2-indolinolium, (270) 3-Z- [1- (4 - ((N - (2-dimethylaminoimethyl) - N -methyl-amino) methyl) -anilio) -1-phenyl -methylene] -6-ethoxycarbonyl-2-indolinone, (271) 3-Z - [l- (4 - ((I, N- (3-dimethylaminopropyl) - / -N'-methyl-amino) methyl) anilino) -l-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (272) 3-Z- [1- (4 - ((N- (2-methoxy-ethyl) -N-methyl-amino) -methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2 -indolinone, (273) 3-Z- [1- (4 - ((N - (2-hydroxy-ethyl) - N -methyl-amino) -methyl) -anilino) -1-phenyl-methylene] -6 ethoxycarbonyl-2-

-indolinón, (274) 3-Z-[l-(4-((7V-(dioxolán-2-yl-metyl)-jV-metyl-amino)-metyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (275) 3-Z-[ 1 -(4-(3-oxo-piperazin-1 -yl-metyl)-anilino)-1 -fenyl-metylén] -6-etoxykarbonyl-2-indolinón, (276) 3-Z-[l-(4-(A/-(piperazin-l-yl-metylkarbonyl)-jV-izopropyl-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (277) 3-Z-[l-(4-(7V-((2-(piperazin-l-yl)-etyl)-karbonyl)-iV-metyl-ainino)-anilino)-l -fenyl-metylén] -6-etoxykarbonyl-2-indolinón, (278) 3-Z-[ 1 -(4-((7V-(3-amino-propyl)-jV-metyl-amino)-metyl)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (279) 3-Z-[l-(4-(7V-(3-metylamino-propyl)-7V-metylsulfonyl-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (280) 3-Z-[l-(4-ureidometyl-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (2 81) 3 -Z- [ 1 -(4-guanidinometyI-anilino)-1 -fenyl-metylén] -6-etoxykarbonyl-2-indolinón, (282) 3-Z-[ 1 -(4-(7V-metylsulfonyl-aminometyl)-anilino)-1 -fenyl-metylén]-6-etoxykarbo-nyl-2-indolmón, (283) 3-Z-[l-(4-(4-benzoyl-piperazin-l-yl-metyl)-anilino)-l-fenyl-metylén]-6-etoxy-karbonyl-2-indolinón, (284) 3-Z-[ 1 -(4-((7V-(3-acetylamino-propyl)-jV-metyl-amino)-metyl)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (285) 3-Z-[l-(4-((<V-(3-metylsulfonylamino-propyl)-Mmetyl-amino)-metyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (286) 3-Z-[l-(4-((A'-karboxymetyl-/V-metyl-amino)-metyl)-anilmo)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (287) 3-Z-( 1 -anilino-1 -fenyl-metylén)-6-metoxykarbonyl-2-indolinón, (288) 3-Z- [ 1 -(4-nitro-anilino)-1 -fenyl-metylén] -6-metoxykarbonyl-2-indolinón, (289) 3-Z-[l-(4-fluór-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolmón, (290) 3-Z-[l-(4-chlór-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (291) 3 -Z- [ 1 -(4-bróm-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (292) 3-Z-[l-(4-jód-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (293) 3-Z-[l-(4-kyano-anilino)-l-fenyl-metyíén]-6-metoxykarbonyl-2-indolinón, (294) 3-Z-[l-(4-karboxy-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (295) 3-Z-[ 1 -(4-metoxy-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (296) 3-Z-[l-(4-etoxy-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (297) 3-Z-[ 1 -(4-trifluórmetyl-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (298) 3-Z-[l-(4-metylmerkapto-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (299) 3-Z-[l-(4-(izopropylaminometyl)-anilino)-I-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (300) 3-Z-[l-(4-(anilinometyl)anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (301) 3-Z-[ 1 -(4-(izobutylaminometyl)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (302) 3-Z-[l-(4-(cyklohexylaminometyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (303) 3-Z-[l-(4-(t’enzylaminornetyl)-anilino)-l’fenyl'rnetylén]-6-metoxykarbonyl-2-indolinón,-indolinone, (274) 3- Z - [1- (4 - ((N - (dioxolan-2-ylmethyl) - N -methyl-amino) methyl) -anilino) -1-phenyl-methylene] - 6-ethoxycarbonyl-2-indolinone, (275) 3-Z- [1- (4- (3-oxo-piperazin-1-ylmethyl) -anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2 -indolinón, (276) 3-Z- [l- (4- (A / - (piperazin-l-yl-methylcarbonyl) -N-isopropyl-amino) -anilino) -l-phenyl-methylene] -6-ethoxycarbonyl -2-indolinone, (277) 3- Z - [1- (4- (N - ((2- (piperazin-1-yl) -ethyl) -carbonyl) - N -methyl-amino) -anilino) -1 -phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (278) 3-Z- [1- (4 - ((N - (3-amino-propyl) - N -methyl-amino) -methyl) -anilino) ) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (279) 3- Z- [1- (4- (N - (3-methylamino-propyl) -7 H -methylsulfonyl-amino) -anilino)) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (280) 3-Z- [1- (4-ureidomethyl-anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, ( 2 81) 3-Z- [1- (4-guanidinomethyl-anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (282) 3-Z- [1- (4- (N-methylsulfonyl)] (aminomethyl) -anilino) -1-phenyl-met ylene] -6-ethoxycarbonyl-2-indolmone, (283) 3-Z- [1- (4- (4-benzoyl-piperazin-1-ylmethyl) -anilino) -1-phenyl-methylene] - 6-ethoxy-carbonyl-2-indolinone, (284) 3-Z- [1- (4 - ((N - (3-acetylamino-propyl) - N -methyl-amino) -methyl) -anilino) -1- phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (285) 3-Z- [1- (4 - ((N - (3-methylsulfonylamino-propyl) -methyl-amino) -methyl) -anilino) - 1-Phenylmethylene] -6-ethoxycarbonyl-2-indolinone, (286) 3-Z- [1- (4 - ((N'-carboxymethyl- N -methylamino) methyl) -anilmo) -1 -phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (287) 3-Z- (1-anilino-1-phenylmethylene) -6-methoxycarbonyl-2-indolinone, (288) 3-Z- [1] - (4-nitro-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (289) 3-Z- [1- (4-fluoro-anilino) -1-phenyl-methylene] -6 -methoxycarbonyl-2-indolmone, (290) 3-Z- [1- (4-chloro-anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, (291) 3-Z- [1- (4-Bromo-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (292) 3- Z- [1- (4-iodo-anilino) -1-phenyl-methylene] -6- methoxycarbonyl-2-indolinone, (29 3) 3-Z- [1- (4-cyano-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (294) 3-Z- [1- (4-carboxy-anilino) - 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (295) 3-Z- [1- (4-methoxy-anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, (296) 13-Z- [1- (4-ethoxy-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (297) 3-Z- [1- (4-trifluoromethyl-anilino) -1 -phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (298) 3- Z- [1- (4-methylmercapto-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (299) 3-Z- [1- (4- (isopropylaminomethyl) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, (300) 3- Z- [1- (4- (anilinomethyl) anilino)] -1-Phenylmethylene] -6-methoxycarbonyl-2-indolinone, (301) 3-Z- [1- (4- (isobutylaminomethyl) anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone (302) 3-Z- [1- (4- (cyclohexylaminomethyl) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, (303) 3-Z- [1- ( 4 - ( t 'enz yl am i nornet yl) - but an ili) -l'f en yl' rnet ylene] -6-methoxycarbonyl-2-indolinone,

SK 287312 Β6 (304) 3-Z-[ 1 -(4-((Ar-metyl-A/-propyl-amino)-metyl)-anilino)-1 -fenyl-metylén]-6-metoxy-karbonyl-2-indolinón, (305) 3-Z-[ 1 -(4-((7V- izopropyl-7V-metyl-amino)-metyl)-anil ino)-1 -fenyl-metylén] -6-metoxykarbonyl-2-indolinón, (306) 3-Z-[l-(4-((A/-etyl-N-propyl-amino)-metyl)-amlino)-l-fenyl-metylén]-6-metoxy-karbonyl-2-indolinón, (307) 3-Z-[ 1 -(4-((7V-etyl-7V-izopropyl-amino)-metyl)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (308) 3-Z-[l-(4-(dipropylaminometyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (309) 3-Z-[l-(4-(diizopropylaminometyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (310) 3-Z-[ 1 -(4-((7V-benzyl-/V-etyl-amino)-metyl)-anilino)-1 -fenyl-metylén]-6-metoxy-karbonyl-2-mdolinón, (311) 3-Z-[l-(4-(dibenzylaminometyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (312) 3-Z-[ 1 -(4-(3,6-dihydro-2/7-pyridin-1 -yl-metyl)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (313) 3-Z-[ 1 -(4-(3,5-dimetyl-piperidin-l -yl-metyl)-anilino)-1 -fenyl-metylén]-6-metoxy-karbonyl-2-indolinón, (314) 3 -Z-[ 1 -(4-(azepan-1 -yl-metyl)-anilino)-1 -fenyl-metylén] -6-metoxykarbonyl-2-indolinón, (315) 3-Z-[ 1 -(4-(2-aminoetyl)anilino)-1 -fenylmetylén]-6-metoxykarbonyl-2-indolinón, (316) 3-Z-[l-(4-(2-metylamino-etyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (317) 3-Z-[l-(4-(2-etylamino-etyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (318) 3-Z- [ 1 -(4-(2-dimetylamino-etyl)-anilino)-1 -fenyl-metylén] -6-metoxykarbonyl-2-indolinón, (319) 3-Z-[l-(4-(2-dietylamino-etyl)-anilino)-l-fenyI-metylén]-6-metoxykarbonyl-2-indolmón, (320) 3-Z-[l-(4-(2-piperidin-l-yl-etyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (321) 3-Z-[l-(4-(2-acetylammo-etyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-mdolinón, (322) 3-Z-[l-(4-(3-amino-propyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (323) 3-Z-[l-(4-(3-dimetylamino-propyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (324) 3-Z-[l-(4-(7V-aminometylkarbonyl-jV-metyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (325) 3-Z-[l-(4-(N-etylaminometylkarbonyl-7V-metyl-amino)-amlino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (326) 3-Z-[l-(4-(N-dietylaminometyíkarbonyI-/V-metyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (327) 3-Z-[l-(4-(7V-dipropylaminometylkarbonyl-Ar-metyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (328) 3-Z-[l-(4-(N-((7V-etyl-N-metyl-amino)-metylkarbonyl)-7V-metyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (329) 3-Z-[l-(4-(A'-((jV-etyl-Aľ-propyl-ammo)-metylkarbonyl)-jV-metyl-amino)-anilmo)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (330) 3-Z-[l-(4-(7V-((A,-metyl-7V-propyl-amino)-metylkarbonyl)-7V-metyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (331) 3 -Z-[ 1 -(4-(IV-dimetylaminometylkarbonyl-jV-etyl-amino)-ani 1 ino)-1 -fenyl-metylén] -6-metoxykarbonyl-2-indolinón, (332) 3-Z-[l-(4-(Aľ-dimetylaminometylkarbonyl-N-propyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (333) 3-Z-[l-(4-(JV-dimetylaminometylkarbonyl-7V-butyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (334) 3-Z-[l-(4-(/V-(2-amino-etylkarbonyl)-7V-metyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (335) 3-Z-[l-(4-(jV-(2-dietylamino-etylkarbonyl)-N-metyl-ammo)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (336) 3-Z-[ 1 -(4-(ALacetyl-A/-(2-aminoetyl)-amino)-anilino)-1 -fenyl-metylén]-6-metoxy-karbonyl-2-indolinón, (337) 3-Z-[l-(4-(Af-acetyl-N-(2-metylamino-etyl)-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (338) 3-Z-[l-(4-(jV-acetyl-7V-(3-metylamino-propyl)-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (339) 3-Z- [ 1 -(4-(jV-acetyl-7V-(2-piperidin-1 -yl-etyl)-amino)-anilino)-1 -fenyl-metylén] -6-metoxykarbonyl-2-indolinón, (340) 3-Z-[l-(4-(jV-acetyl-7V-(aminokarbonyl-metyl)-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (341) 3-Z-[ 1 -(4-(lV-acetyl-A-(piperidin-1 -yl-karbonyl-metyl)-amino)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (342) 3-Z-[l-(4-(/V-metyl-IV-(armnokarbonyl)-amino)-anilmo)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (343) 3-Z-[ 1 -(4-(jV-metyl-.íV-(metylaminokarbonyl)-amino)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (344) 3-Z-[l-(4-(77-metyl-/V-(dimetylaminokarbonyl)-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (345) 3-Z-[l-(4-(jV-metyl-jV-(piperidin-1 -yl-karbonyl)-amino)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (346) 3-Z-[l-(4-(Af-(2-etylaminoetyl)-A'-metylsulfonylamino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (347) 3-Z-[l-(4-(7V-(2-dietylamino-etyl)-?/-metylsulfonyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (348) 3-Z-[l-(4-(7V-(2-pyrolidin-l-yl-etyl)-jV-metylsulfonyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (349) 3-Z-[l-(4-(/V-(2-piperidm-l-yl-etyl)-A'-metylsulfonylamino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (350) 3-Z- [ 1 -(4-(jV-(2-piperazin-1 -yl-etyl)-A,-metylsulfonylamino)-anilino)-1 -fenyl-metylén] -6-metoxykarbonyl-2-indolinón, (351) 3 -Z-[ 1 -(4-(jV-(2-(4-morfolin-1 -yl)-etyl)-N-metylsul fonyl-ami no)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (352) 3-Z-[l-(4-(7V-(etylaminokarbonyl-metyl)-7V-metylsulfonyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (353) 3-Z-[l-(4-(/v-(dietylaminokarbonyl-metyl)-/V-metylsulfonyl-amino)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (354) 3-Z-[ 1 -(4-(/V-(pyrolidin-1 -yl-karbonyl-metyl)-<V-metylsulfonyl-amino)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (355) 3-Z-[ 1 -(4-(/V-(piperidin-1 -yl-karbonyl-metyl)-A/-metylsulfonyl-amino)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (356) 3-Z-[l-(4-(7V-(piperazin-l-yl-karbonyl-metyl)-jV-metylsulfonyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (357) 3-Z-[l-(4-(W-((morfolin-4-yl)-karbonyl-metyl)-/V-metylsulfonyl-amino)-amlino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (358) 3-Z-[l-(4-(2-dimetylamino-etoxy)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (359) 3-Z-[l-(4-(3-dimetylamino-propoxy)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (360) 3-Z-[l-(4-(aminokarbonyl-metyl)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (361) 3-Z-[l-(4-(2-aminokarbonyl-etyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (362) 3-Z-[ 1 -(4-(pyridin-2-yl)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (363) 3-Z-[l-(4-(pyridin-3-yl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (364) 3-Z-[l-(4 ((/V-fenetyl-7V-metylamino)metyl)-anilino)-I-fenyl-metylén]-6-metoxy-karbonyl-2-indolinón, (365) 3-Z-[l-(4-(7V-acetyl-jV-metyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (366) 3-Z-[l-(4-(/V-etylkarbonyl-7V-(dimetylaminokarbonyl-metyl)-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (367) 3-Z-[l -(4-( N-metyl-N-metylsulfonyl-amino)-anilino)-l-fenyl-metylén]-6-metoxy-karbonyl-2-indolinón, (368) 3-Z-[l-(4-karboxymetylanilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (3 69) 3-Z-[ 1 -(4-karbamoyl-metyl-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (370) 3-Z-[l-(4-dimetylkarbamoyl-metyl-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (371) 3-Z-[l-(4-tetrazol-5-yl-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (372) 3-Z-[l-(4-(piperidin-l-yl-metyl)-anilino)-metylén]-6-metoxykarbonyl-2-indolmón, (373) 3-Z-[l-(4-(piperidin-l-yl-metyl)-anilino)-etylidén]-6-metoxykarbonyl-2-indolinón, (374) 3-Z- [ 1 -(4-(piperidin-1 -yl-metyl)-anilino)-propylidén] -6-metoxykarbonyl-2-indolinón, (375) 3-Z-[l-(4-(piperidin-l-yl-metyl)-anilino)-butylidén]-6-metoxykarbonyl-2-indolinón, (376) 3-Z-(l-(4-(7V-(3-dimetylamino-propyl)-jV-acetyl-amino)-anilino)-metylén]-6-metoxykarbonyl-2-indolinón, (377) 3-Z-[l-(4-(Aľ-(3-dimetylamino-propyl)-Aľ-acetyl-amino)-anilino)-etylidén]-6-metoxykarbonyl-2-indolinón, (378) 3-Z-[l-(4-(jV-(3-dimetylamino-piOpyl)-ýV-acetyl-amino)-anilino)-propylidén]-6-metoxykarbonyl-2-indolinón, (379) 3-Z-[l-(4-(A'-(3-dimetylamino-propyl)-7V-acetyl-amino)-amlino)-butylidén]-6-metoxykarbonyl-2-indolinón, (380) 3-Z-[l-(4-(7V-(2-dimetylamino-etyl)-jV-metylsulfonylamino)-anilino)-metylén]-6-metoxykarbonyl-2-indolinón, (381) 3-Z-[l-(4-(7V-(2-dimetylamino-etyl)-/V-metylsulfonylamino)-anilino)-etylidén]-6-metoxykarbonyl-2-indolinón, (382) 3-Z-[l-(4-(AL(2-dimetylamino-etyl)-7V-metylsulfonylamino)-anilino)-propylidén]-6-metoxykarbonyl-2-indolinón, (383) 3-Z-[l-(4-(V-(2-dimetylamino-etyl)-?/-metylsulfonylamino)-anilino)-butylidén]-6-metoxykarbonyl-2-EN 287 312 Β6 (304) 3-Z- [1 - (4 - ((N-methyl-A / propyl-amino) methyl) anilino) -1-phenyl-methylene] -6-methoxycarbonyl- 2-indolinone, (305) 3-N- [1- (4 - ((N-isopropyl-N-methyl-amino) -methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2- indolinone, (306) 3-N- [1- (4 - ((N-ethyl-N-propylamino) -methyl) -amino) -1-phenyl-methylene] -6-methoxy-carbonyl-2- (307) 3-Z- [1- (4 - ((N-ethyl-N-isopropyl-amino) -methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, ( 308) 3-Z- [1- (4- (dipropylaminomethyl) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, (309) 3-Z- [1- (4- (diisopropylaminomethyl)) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (310) 3-Z- [1- (4 - ((N-benzyl- N -ethyl-amino) -methyl) -anilino) -1-Phenylmethylene] -6-methoxycarbonyl-2-indolinone, (311) 3-Z- [1- (4- (dibenzylaminomethyl) anilino) -1-phenylmethylene] -6-methoxycarbonyl- 2-indolinone, (312) 3- [1- (4- (3,6-dihydro-2H-pyridin-1-ylmethyl) -anilino) -1-phenylmethylene] -6-methoxycarbonyl -2-indolinone, (313) 3-Z- [1- (4- (3,5-Dimethyl-piperidin-1-yl-methyl) -anilino) -1-phenyl-methylene] -6-methoxy-carbonyl-2-indolinone, (314) 3-Z- [1- (4- ( azepan-1-yl-methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (315) 3-Z- [1- (4- (2-aminoethyl) anilino) -1- phenylmethylene] -6-methoxycarbonyl-2-indolinone, (316) 3-Z- [1- (4- (2-methylamino-ethyl) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, (317) 3-Z- [1- (4- (2-ethylamino-ethyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (318) 3-Z- [1 - ( 4- (2-dimethylamino-ethyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (319) 3- [1- (4- (2-diethylamino-ethyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolmone, (320) 3-Z- [1- (4- (2-piperidin-1-yl-ethyl) -anilino) -1-phenyl-methylene -6-methoxycarbonyl-2-indolinone, (321) 3- [1- (4- (2-acetylaminomethyl) anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, ( 322) 3-Z- [1- (4- (3-amino-propyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (323) 3-Z- [1- (4) - (3-dimethylaminopropyl) anilino) -l- phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (324) 3- Z- [1- (4- (N-aminomethylcarbonyl-N-methyl-amino) -anilino) -1-phenyl-methylene] -6- methoxycarbonyl-2-indolinone, (325) 3-Z- [1- (4- (N-ethylaminomethylcarbonyl-N-methyl-amino) -amino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, ( 326) 3-Z- [1- (4- (N-diethylaminomethylcarbonyl- N -methyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (327) 3-Z- [l- (4- (7V-dipropylaminometylkarbonyl-N-methyl-amino) -anilino) -l-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (328) 3-Z- [l- (4- (N - ((N-ethyl-N-methyl-amino) -methylcarbonyl) -N-methyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (329) 3-Z - [l- (4- (N - ((N-ethyl-N- propyl-amino) -methylcarbonyl) -N-methyl-amino) -anilmo) -l-phenyl-methylene] -6-methoxycarbonyl-2 -indolinone, (330) 3-N- [1- (4- (N - ((N , -methyl-N-propylamino) -methylcarbonyl) -7-methyl-amino) -anilino) -1-phenyl- methylene] -6-methoxycarbonyl-2-indolinone, (331) 3 -Z- [1- (4- (4-dimethylaminomethylcarbonyl-N-ethylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (332) 3-Z- [1- (4- (N ' -dimethylaminomethylcarbonyl-N-propylamino) -anilino) -1-phenyl-methylene 6-Methoxycarbonyl-2-indolinone, (333) 3-Z- [1- (4- (N-dimethylaminomethylcarbonyl-N-butyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2 -indolinone, (334) 3-Z- [1- (4- (N - (2-amino-ethylcarbonyl) - N -methyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2 (335) 3- Z- [1- (4- (N - (2-diethylamino-ethylcarbonyl) -N-methyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2- indolinone (336) 3-Z- [1 - (4- (acetyl L-A / - (2-aminoethyl) amino) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2- indolinone (337) 3-Z- [l- (4- (f-acetyl-N- (2-methylamino-ethyl) -amino) anilino) -l-phenyl-methylene] -6-methoxycarbonyl-2- (338) 3-N- [1- (4- (N-acetyl-N - (3-methylamino-propyl) -amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (339) 3-N- [1- (4- (N-acetyl-N- (2-piperidin-1-yl-ethyl) -amino) -anilino) -1-phenylmethylene] -6-methoxycarbonyl- 2-indoline (340) 3-N- [1- (4- (N-acetyl-N - (aminocarbonylmethyl) amino) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, ( 341) 3-N- [1- (4- ( N -acetyl-N- (piperidin-1-yl-carbonyl-methyl) -amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2 -indolinón, (342) 3-Z- [l- (4 - (/ V-methyl-I, N (armnokarbonyl) amino) -anilmo) -l-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (343) 3-N- [1- (4- (N-methyl-N - (methylaminocarbonyl) amino) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, (344) 3 -Z- [1- (4- (77-methyl- N - (dimethylaminocarbonyl) amino) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, (345) 3-Z- [ 1- (4- (N-methyl-N - (piperidin-1-yl-carbonyl) -amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (346) 3-Z- [l- (4- (f - (2-methylaminoethyl) -N-methylsulfonylamino) anilino) -l-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (347) 3-Z- [l- (4- (N - (2-diethylamino-ethyl) - N -methylsulfonyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (348) 3-Z- [1- (4- (7V- (2-pyrrolidin (1-yl-ethyl) - N -methylsulfonyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (349) 3-Z- [1- (4 - (N -) - (2-Piperidin-1-yl-ethyl) - N '-methylsulfonylamino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (350) 3-Z- [1- (4- ( N - (2-piperazin-1-yl-ethyl) - N , -methylsulfonylamino) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, (351) 3 -Z- [1- (4) - (N- (2- (4-morpholin-1-yl) ethyl) -N-methylsulfonyl-amino) anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, (352) 3-Z- [1- (4- (N - (ethylaminocarbonyl-methyl) - N -methylsulfonyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (353) 3-Z - [1- (4 - (N - (diethylaminocarbonylmethyl) - N -methylsulfonylamino) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, (354) 3-Z- [1- (4- (N - (pyrrolidin-1-yl-carbonyl-methyl) - (N -methylsulfonyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (355 13-Z- [1- (4 - (N - (piperidin-1-yl-carbonyl-methyl) - N -methylsulfonyl-amino) -anilino) -1-phenyl-methylene] -6-methoxy Rbonyl-2-indolinone, (356) 3- Z - [1- (4- (N - (piperazin-1-yl-carbonyl-methyl) - N -methylsulfonyl-amino) -anilino) -1-phenyl-methylene] 6-Methoxycarbonyl-2-indolinone, (357) 3- [1- (4- (N - ((morpholin-4-yl) -carbonylmethyl) - N -methylsulfonyl-amino) -amino) - 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (358) 3-Z- [1- (4- (2-dimethylamino-ethoxy) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl- 2-indolinone, (359) 3-Z- [1- (4- (3-dimethylamino-propoxy) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (360) 3-Z- [1- (4- (aminocarbonyl-methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (361) 3-Z- [1- (4- (2-aminocarbonyl-ethyl)) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (362) 3-Z- [1- (4- (pyridin-2-yl) -anilino) -1-phenyl-methylene] - 6-methoxycarbonyl-2-indolinone, (363) 3- [1- (4- (pyridin-3-yl) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, (364) 3-Z- [1- (4 ((N-phenethyl-N-methylamino) methyl) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, (365) 3-Z- [l- (4- (7V-acetyl-N-me (366) 3-Z- [1- (4- (N-ethylcarbonyl) -N- (dimethylaminocarbonyl-methyl) - (1-phenyl-methylamino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (367) 3- Z- [1- (4- (N-methyl-N-methylsulfonyl-amino) -anilino) -1 -phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (368) 3-Z- [1- (4-carboxymethylanilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, (369) 13-Z- [1- (4-carbamoyl-methyl-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (370) 3-Z- [1- (4-dimethylcarbamoyl-methyl-) anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (371) 3-Z- [1- (4-tetrazol-5-yl-anilino) -1-phenyl-methylene] -6-methoxycarbonyl -2-indolinone, (372) 3-Z- [1- (4- (piperidin-1-ylmethyl) -anilino) -methylene] -6-methoxycarbonyl-2-indolmone, (373) 3-Z- [ 1- (4- (piperidin-1-yl-methyl) -anilino) -ethylidene] -6-methoxycarbonyl-2-indolinone, (374) 3- Z- [1- (4- (piperidin-1-yl-methyl) (-anilino) -propylidene] -6-methoxycarbonyl-2-indolinone, (375) 3-Z- [1- (4- (piperidin-1-ylmethyl) -anilino) -butyl lidene] -6-methoxycarbonyl-2-indolinone, (376) 3- Z - (1- (4- (N - (3-dimethylamino-propyl) - N -acetyl-amino) -anilino) -methylene] -6- methoxycarbonyl-2-indolinone, (377) 3- Z- [1- (4- (N ' - (3-dimethylamino-propyl) - N ' -acetyl-amino) -anilino) -ethylidene] -6-methoxycarbonyl-2 (378) 3-Z- [1- (4- (N - (3-dimethylamino-piperidin) -N-acetyl-amino) -anilino) -propylidene] -6-methoxycarbonyl-2-indolinone, (379) 13-Z- [1- (4- (N '- (3-dimethylamino-propyl) - N -acetyl-amino) -amino) -butylidene] -6-methoxycarbonyl-2-indolinone, (380) 3-Z - [1- (4- (N - (2-dimethylamino-ethyl) - N -methylsulfonylamino) -anilino) -methylene] -6-methoxycarbonyl-2-indolinone, (381) 3-Z- [1- (4- (N - (2-dimethylamino-ethyl) - N -methylsulfonylamino) -anilino) -ethylidene] -6-methoxycarbonyl-2-indolinone, (382) 3-Z- [1- (4- (AL (2-dimethylamino) (383) 3-Z- [1- (4- (N- (2-dimethylamino-ethyl) -R-methylsulfonylamino) -anilino) -propylidene] -6-methoxycarbonyl-2-indolinone; methylsulfonylamino) anilino) -butylidene] -6-methoxycarbonyl-2-

-indolinón, (384) 3-Z-[l-(4-tetrazol-5-yl-anilino)-metylén]-6-metoxykarbonyl-2-indolinón, (385) 3-Z-[l-(4-tetrazol-5-yl-anilino)-etylidén]-6-metoxykarbonyl-2-indolinón, (386) 3-Z-[l-(4-tetrazol-5-yl-anilino)-propylidén]-6-metoxykarbonyl-2-indolinón, (387) 3-Z-[l-(4-tetrazol-5-yl-amlmo)-butylidén]-6-metoxykarbonyl-2-indolinón, (388) 3-Z-[l-(4-karboxy-anilino)-metylén]-6-metoxykarbonyl-2-indolinón, (389) 3-Z-[l-(4-karboxy-anilino)-etylidén]-6-metoxykarbonyl-2-indolinón, (390) 3-Z-[l-(4-karboxy-anilino)-propylidén]-6-metoxykarbonyl-2-indolinón, (391) 3-Z-[ 1 -(4-karboxy-anilino)-butylidén]-6-metoxykarbonyl-2-indolinón, (392) 3-Z-[l-(4-(7V-benzyl-V-metylaminometyl)-anilino)-l-metyl-metylén]-6-metoxy-karbonyl-2-mdolinón, (393) 3-Z-[l-(4-(2,3,4,5-tetrahydro-benzo(d)azepin-3-yl-metyl)-anilino)-l-metyl-metylén]-6-metoxykarbonyl-2-indolinón, (394) 3-Z-[l-(4-((benzo(l,3)dioxol-5-yl-metyl)-metyl-aminometyl)-anilino)-l-metyl-metylén]-6-metoxykarbonyl-2-indolinón, (395) 3-Z-[l-(4-(TV-fenetyl-A/-metyl-aminometyl)-anilino)-l-metyl-metylén]-6-metoxy-karbonyl-2-indolinón, (396) 3-Z-[l-(4-(jV-(3,4-dimetoxy-benzyl)-jV-metyI-aininometyl)-anilino)-l-metyl-metylén]-6-metoxykarbonyl-2-indolinón, (397) 3-Z-[ 1 -(4-(jV-(4-chlór-benzyl)-7V-metyl-amino-metyl)-anilino)-1 -metyl-metylén]-6-metoxykarbonyl-2-indolinón, (398) 3-Z-[l-(4-(/V-(4-metylbenzyl)-A'-metyl-amino-metyl)-amlino)-l-metyl-metylén]-6-metoxykarbonyl-2--indolinone, (384) 3- Z- [1- (4-tetrazol-5-yl-anilino) -methylene] -6-methoxycarbonyl-2-indolinone, (385) 3- Z- [1- (4-tetrazole) (5-yl-anilino) -ethylidene] -6-methoxycarbonyl-2-indolinone, (386) 3-Z- [1- (4-tetrazol-5-yl-anilino) -propylidene] -6-methoxycarbonyl-2- (387) 3-Z- [1- (4-tetrazol-5-yl-amino) -butylidene] -6-methoxycarbonyl-2-indolinone, (388) 3-Z- [1- (4-carboxy- anilino) -methylene] -6-methoxycarbonyl-2-indolinone, (389) 3-Z- [1- (4-carboxy-anilino) ethylidene] -6-methoxycarbonyl-2-indolinone, (390) 3-Z- [1- (4-Carboxy-anilino) -propylidene] -6-methoxycarbonyl-2-indolinone, (391) 3- Z - [1- (4-Carboxy-anilino) -butylidene] -6-methoxycarbonyl-2-indolinone (392) 3-Z- [1- (4- (N-benzyl-N-methylaminomethyl) -anilino) -1-methyl-methylene] -6-methoxycarbonyl-2-indolinone, (393) 3-Z - [1- (4- (2,3,4,5-tetrahydro-benzo (d) azepin-3-ylmethyl) -anilino) -1-methyl-methylene] -6-methoxycarbonyl-2-indolinone, ( 394) 3-N- [1- (4 - ((benzo (1,3) dioxol-5-ylmethyl) -methyl-aminomethyl) -anilino) -1-methyl-methylene] -6-methoxycarbonyl-2- indolinone, (395) 3-Z- [ 1- (4- (N-phenethyl-N-methyl-aminomethyl) -anilino) -1-methyl-methylene] -6-methoxycarbonyl-2-indolinone, (396) 3-Z- [1- (4) - (N - (3,4-dimethoxy-benzyl) - N -methyl-aininomethyl) -anilino) -1-methyl-methylene] -6-methoxycarbonyl-2-indolinone, (397) 3-Z- [1 - ( 4- (N - (4-chloro-benzyl) - N -methyl-amino-methyl) -anilino) -1-methyl-methylene] -6-methoxycarbonyl-2-indolinone, (398) 3-Z- [1- (4 - (/ V- (4-methylbenzyl) -N-methyl-amino-methyl) -amlino) -l-methyl-methylene] -6-methoxycarbonyl-2-

-indolinón, (399) 3-Z-[l-(4-(AL(4-fluór-benzyl)-Aľ-metyl-amino-metyl)-anilino)-l-metyl-metylén]-6-metoxykarbonyl-2--indolinone, (399) 3-Z- [1- (4- (N (4-fluoro-benzyl) - N 1 -methyl-amino-methyl) -anilino) -1-methyl-methylene] -6-methoxycarbonyl- 2

-indolinón, (400) 3-Z-[l-(4-(JV-(4-bróm-benzyl)-7V-metyl-amino-metyl)-anilino)-l-metyl-metylén]-6-metoxykarbonyl-2-indolinón, (401) 3-Z-[ 1 -(4-(A'-(3-dimetylamino-propionyl)-A/-dimetylaminokarbonylmetyl-amino)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (402) 3-Z-[l-(4-(/V-(4-dimetylamino-butyryl)-A,-dimetylaminokarbonylmetyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (403) 3-Z-[l-(4-(7V-dimetylaminokarbonylmetyl-/V-(2-dimetylamino-etylsulfonyl)-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (404) 3-Z-[l-(4-(jV-dimetylaminokarbonylmetyl-A'-(3-dimetylamino-propylsulfonyl)-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (405) 3-Z-[l-(4-((2-hydroxy-etyl)-amino-metyl)-anilino)-l-fenyl-metylén]-6-metoxy-karbonyl-2-indolinón, (406) 3-Z-[l-(4-((2-metoxy-etyl)-amino-metyl)-anilino) fenyl-metylén]-6-metoxy-karbonyl-2-indolinón, (407) 3-Z-[l-(4-((2-dimetylamino-etyl)-amino-metyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (408) 3-Z-[l-(4-((3-dimetylamino-propyl)-amino-metyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (409) 3-Z-[l-(4-((7Y-ŕerc-butoxykarbonyl-2-amino-etyl)-aminometyl)-amlmo)-í-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (410) 3-Z-[l-(4-((/V-terc-butoxykarbonyl-3-amino-propyl)-aminometyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (411) 3-Z-[l-(4-((2-amino-etyl)-amino-metyl)-anilino)-l-fenyl-metylén]-6-metoxy-karbonyl-2-indolinón, (412) 3-Z-[l-(4-((3-amino-propyl)-amino-metyl)-anilino)-l-fenyl-metylén]-6-metoxy-karbonyl-2-indolinón, (413) 3-Z-[ 1 -(4-((2-acetylaminoetyl)amino-metyl)-anilino)-1 -fenyl-metylén]-6-metoxy-karbonyl-2-indolmón, (414) 3-Z-[l-(4-((3-acetylamino-propyl)-amino-metyl)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (415) 3-Z-[ 1 -(4-((2-metylsulfonylamino-etyl)-amino-metyl)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (416) 3-Z-[ 1 -(4-((3-metylsulfonylamino-propyl)-amino-metyl)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (417) 3-Z-[l-(4-(A-(A'-terc-butoxykarbonyl-2-amino-etyl)-/V-metyl-ammo-metyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (418) 3-Z-[ 1 -(4-(7V-(2-amino-etyl)-7V-metyl-amino-metyl)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (419) 3-Z-[ 1 -(4-(W-(2-acetylamino-etyl)-,V-metyl-amino-metyl)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (420) 3-Z-[ 1 -(4-(7V-(2-metylsulfonylamino-etyl)-Aľ-metyl-amino-metyl)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (421) 3-Z-[i-(4-(karboxymetyl-amino-metyl)-anilino)-1 -fenyl-metylén]-6-metoxy-karbonyl-2-indolinón, (422) 3-Z-[l-(4-(etoxykarbonyl-metyl-amino-metyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (423) 3-Z- [ 1 -(4-(karbamoyl-metyl-amino-metyl)-anilino)-1 -fenyl-metylén]-6-metoxy-karbonyl-2-indolinón, (424) 3-Z-[ 1 -(4-(dimetylkarbamoyl-metyl-amino-metyl)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (425) 3-Z-[l -(4-(metylkarbamoyl-metyl-amino-metyl)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (426) 3-Z-[l-(4-(7V-dimetylaminometylkarbonyl-/V-metylamino)-3-amino-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (427) 3-Z-[l-(4-(A'-dimetylaminometylkarbonyl-/V-metyl-amino)-3-nitro-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (428) 3-Z-[l-(4-(/v-dimetylaminometylkarbonyl-/V-metyl-amino)-3-acetylamino-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (429) 3-Z-[l-(4-(7V-dimetylaminometylkarbonyl-jV-metyl-amino)-3-metylsulfonyl-amino-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (430) 3-Z-[l-(4-(A-dimetylaminometylkarbonyl-A,-metyl-ammo)-3-kyano-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (431) 3-Z-[l-(4-(jV-dimetylaminometylkarbonyl-7V-metyl-amino)-3-hydroxy-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (432) 3-Z-[ 1 -(4-(/V-dimetylaminometylkarbonyl-yV-metyl-amino) -3-metoxy-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (433) 3-Z-[l-(4-(/V-dimetylaminometyľkarbonyl-A'-metyl-amino)-3-etoxykarbonyl-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (434) 3-Z-[l-(4-(/V-dimetylaminometylkarbonyl-iV-metyl-ammo)-3-karboxy-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (435) 3-Z-[l-(4-(7V-dimetylaminometylkarbonyl-7V-metyl-aniino)-3-karbamoyl-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (43 6) 3-Z- [ 1 -(4-(?/-dimetylaininometylkarbonyl-jV-metyl-amino)-3 -chlór-anilino)-1 -fenyl-metylén] -6-metoxykarbonyl-2-indolinón, (437) 3-Z-[ 1 -(4-(/V-dimetylaminometylkarbonyl-/V-metylamino)-3-fluór-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (438) 3-Z-[l-(4-(7V-dimetylarninometylkarbonyl-iV-metylamino)-3-bróm-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (439) 3-Z-[l-(4-(?v-dimetylaminometylkarbonyl-Ar-metyl-amino)-3-metyl-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (440) 3-Z-[l-(4-(JV-dimetylaminometylkarbonyl-/V-metyl-amino)-3-trifluórmetyl-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (441) 3-Z-[ 1 -(4-(7V-dimetylaminometylkarbonyl-jV-metylamino)-3,5-dibróm-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (442) 3-Z-[l-(4-(7V-dimetylaminometylkarbonyl-A/-metyl-amino)-3,5-dichlór-anilmo)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (443) 3-Z-[l-(4-(dimetylaminometyl)-3-amino-anilino)-l-fenyl-metylén]-6-metoxy-karbonyl-2-indolinón, (444) 3-Z-[l-(4-(dimetylaminometyl)-3-nitro-anilino)-l-fenyl-metylén]-6-metoxy-karbonyl-2-indolinón, (445) 3-Z-[l-(4-(dimetylammometyl)-3-acetylamino-anilino)-l-fenyí-metylén]-6-metoxykarbonyl-2-indolinón, (446) 3-Z-[l-(4-(dimetylammometyl)-3-metylsulfonylamino-anilino)-l-fenyl-rnetylén]-6-metoxykarbonyl-2-indolinón, (447) 3-Z-[l-(4-(dimetylaminometyl)-3-kyano-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (448) 3-Z-[l-(4-(dimetylaminometyl)-3-hydroxy-anilino)-l-fenyl-metylén]-6-metoxy-karbonyl-2-indolinón, (449) 3-Z-[l-(4-(dimetylaminometyl)-3-metoxy-anilino)-l-fenyl-metylén]-6-metoxy-karbonyl-2-indolinón, (450) 3-Z-[ 1 -(4-(dimetylaminometyl)-3-etoxykarbonylanilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (451) 3-Z-[l -(4-(dimetylaminometyl)-3-karboxy-anilino)-1 -fenyl-metylén]-6-metoxy-karbonyl-2-indolinón, (452) 3-Z-[l-(4-(dimetylaminometyl)-3-karbamoylanilino)-l-fenyl-metylén]-6-metoxy-karbonyl-2-indolinón, (453) 3-Z-[l-(4-(dimetylaminometyl)-3-chlór-anilino)-l-fenyl-metylén]-6-metoxy-karbonyl-2-indolinón, (454) 3-Z-[l-(4-(dimetylaminometyl)-3-fluór-anilino)-l-fenyl-metylén]-6-metoxy-karbonyl-2-indolinón, (455) 3-Z-[l-(4-(dimetylaminometyl)-3-bróm-anilino)-l-fenyl-metylén]-6-metoxy-karbonyl-2-indolinón, (456) 3-Z-[l-(4-(dimetylaminometyl)-3-metyl-anilino)-l-fenyl-metylén]-6-metoxy-karbonyl-2-indolinón, (457) 3-Z-[l-(4-(dimetylarninometyl)-3-tnfluórmetyl-anilino)-l-fenyl-metyIén]-6-metoxykarbonyl-2-indolinón, (458) 3-Z-[l-(4-dimetylaminometyl-3,5-dibróm-anilino)-l-fenyl-metylén]-6-metoxy-karbonyl-2-indolinón, (459) 3-Z-[l-(4-(dimetylaminometyl)-3,5-dichlór-anilino)-l-fenyl-metylén]-6-metoxy-karbonyl-2-indolinón, (460) 3-Z-[l-(4-(dimetylaminometyl)-anilino)-l-fenyl-metylén]-6-[(2-hydroxy-etoxy)-karbonyl]-2-indolinón, (461) 3-Z-[l-(4-(dimetylaminometyl)-anilino)-l-fenyl-metylén]-6-[(etoxykarbonyl-metoxy)-karbonyl]-2-indolinón, (462) 3-Z-[l-(4-(dimetylaminometyl)-anilmo)-l-fenyl-metylén]-6-[(karboxy-metoxy)-karbonyl]-2-indolinón, (463) 3-Z-[l-(4-(dimetylaminometyl)anilino)-l-fenyl-metylén]-6-[(karbamoyl-metoxy)-karbonyl]-2-indolinón, (464) 3-Z-[l-(4-(7V-dimetylaminometylkarbonyl-7V-metyl-amino)-anilino)-l-fenyl-metylén]-6-[(2-hydroxy-etoxy) -karbony 1] -2 -indolinón, (465) 3-Z-[l-(4-(Aľ-dimetylaminometylkarbonyl-7V-metyl-amino)-anilino)-l-fenyl-metylén]-6-[(etoxykarbonyl metoxy)-karbonyl] -2-indolinón, (466) 3-Z-[l-(4-(/V-dimetylaminometylkarbonyl-/V-metyl-amino)-anilino)-l-fenyl-metylén]-6-[(karboxy-metoxy)-karbonyl]-2-indolinón, (467) 3-Z-[l-(4-(7V-dimetylaminometylkarbonyl-A-metyl-amino)-anilino)-l-fenyl-metylén]-6-[(karbamoyl-metoxy)-karbonyl]-2-indolinón, (468) 3-Z-[l-(4-(jV-dimetylaminometylkarbonyl-jV-metyl-amino)-anilino)-l-fenyl-metylén]-6-[(2-metoxy-etoxy)-karbonyl]-2-indolinón, (469) 3-Z-[l-(4-(/V-dimetylaminometylkarbonyl-7V-metyl-amino)-anilino)-l-fenyl-metylén]-6-[(2-dimetylaminoetoxy)-karbonyl] -2 -indolinón, (470) 3-Z-[l-(4-(JV-dimetylaminometylkarbonyl-n-metyl-amino)-anilino)-l-fenyl-metylén]-6-[(2-(7V-ŕerc-butoxykarbonyl-amino)-etoxy)-karbonyl]-2-indolinón, (471) 3-Z-[l-(4-(7V-dimetylaminometylkarbonyl-7V-metyl-amino)-anilino)-l-fenyl-metylén]-6-[(2-amino-etoxy)-karbonyl]-2-indolinón, (472) 3-Z-[l-(4-(/V-dimetylaminometylkarbonyl-A,-metyl-amino)-amlino)-l-fcnyl-metylén]-6-[(2,2,2-trifluóretoxy) -karbony 1] -2 -indolinón, (473) 3-Z-[l-(4-(V-((4-metyl-piperazin-l-yl)-metylkarbonyl)-/V-metyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (474) 3-Z-[l-(4-(JV-(imidazo-1 -yl-metylkarbonyl)-N-metyl-amino)-anilino)-l -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (475) 3-Z-[l-(4-(7V-(ftalimido-2-yl-metylkarbonyl)-7V-metylamino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2 -indolinón, (476) 3-Z-[l-(4-(7V-aminometylkarbonyl-7V-metyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (477) 3-Z-[ 1 -(4-(jV-acetylaminometylkarbonyl-jV-metyl-amino)-anilino)-1 -fenyl-metylén] -6-metoxykarbonyl-2-indolinón, (478) 3-Z-[l-(4-(7V-metylsulfonylaminometylkarbonyl-/V-metyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (479) 3-Z-[l-(4-(jV-((A/-(2-metoxyetyl)-X-metylamino)metylkarbonyl)-7V-metyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (480) 3-Z-[l-(4-(7V-((/V-(2-dimetylaminoetyl)-/V-metyl-amino)-metylkarbonyl)-M-metyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (481) 3-Z-[l-(4-(M-((di-(2-hydroxyetyl)-amino)-metylkarbonyl)-,V-metyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (482) 3-Z-[l-(4-íerc-butoxykarbonyl-metyl-anilino)-l-fenyl-metylén]-6-metoxy-karbonyl-2-indolinón, (483) 3-Z-[l-(4-(7V-dimetylaminometyIkarbonyl-jV-metyl-amino)-anilino)-metylén]-6-metoxykarbonyl-2-indolinón, (484) 3-Z-[l-(4-(/V-dimetylaminometylkarbonyl-A'-metyl-ammo)-anilmo)-etylidén]-6-metoxykarbonyl-2-indolinón, (485) 3-Z-[l-(4-(V-dimetylaminometylkarbonyl-Aľ-metyl-amino)-anilino)-propylidén]-6-metoxykarbonyl-2-indolinón, (486) 3-Z-[l-(4-(7V-dimetylaminometylkarbonyl-/V-metyl-amino)-anilino)-butylidén]-6-metoxykarbonyl-2-indolinón, (487) 3-Z-[l-(4-(dimetylaminometyl)-anilino)-metylén]-6-metoxykarbonyl-2-indolinón, (488) 3-Z-[l-(4-(dimetylaminometyl)-anilino)-etylidén]-6-metoxykarbonyl-2-indolinón, (489) 3-Z-[ 1 -(4-(dimetylaminometyl)-anilino)-propylidén]-6-metoxykarbonyl-2-indolinón, (490) 3-Z-[l-(4-(dimetylaminometyl)anilino)butylidén]-6-metoxykarbonyl-2-indolinón, (491) 3-Z-[ 1 -(4-íerc-butyloxykarbonyl-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (492) 3-Z-[l-(4-(N-(2-dimetylamino-etyl)-N-metyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2--indolinone, (400) 3-N- [1- (4- (N - (4-bromo-benzyl) - N -methyl-amino-methyl) -anilino) -1-methyl-methylene] -6-methoxycarbonyl- 2-indolinone, (401) 3-Z- [1- (4- (N '- (3-dimethylamino-propionyl) - N -dimethylaminocarbonylmethyl-amino) -anilino) -1-phenylmethylene] -6-methoxycarbonyl -2-indolinone, (402) 3-Z- [1- (4- (N - (4-dimethylamino-butyryl) - N , -dimethylaminocarbonylmethyl-amino) -anilino) -1-phenyl-methylene] -6- methoxycarbonyl-2-indolinone, (403) 3- [1- (4- (N-dimethylaminocarbonylmethyl- N - (2-dimethylamino-ethylsulfonyl) -amino) -anilino) -1-phenyl-methylene] -6- methoxycarbonyl-2-indolinone, (404) 3-Z- [1- (4- (N-dimethylaminocarbonylmethyl-N '- (3-dimethylamino-propylsulfonyl) -amino) -anilino) -1-phenyl-methylene] -6- methoxycarbonyl-2-indolinone, (405) 3-Z- [1- (4 - ((2-hydroxy-ethyl) -amino-methyl) -anilino) -1-phenyl-methylene] -6-methoxy-carbonyl-2 -indolinone, (406) 3-Z- [1- (4 - ((2-methoxy-ethyl) -amino-methyl) -anilino) phenyl-methylene] -6-methoxy-carbonyl-2-indolinone, (407) 3-Z- [l- (4 - ((2-dimethylamino-ethyl) -methyl-amino) anilino) -l-phenyl-methylene] -6-methoxy- ycarbonyl-2-indolinone, (408) 3-Z- [1- (4 - ((3-dimethylamino-propyl) -amino-methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (409) 3-Z- [1- (4 - ((7Y-tert-butoxycarbonyl-2-amino-ethyl) -amino-methyl) -amino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (410) 3-Z- [1- (4 - ((N-tert-butoxycarbonyl-3-amino-propyl) -aminomethyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (411) 3-Z- [1- (4 - ((2-amino-ethyl) -amino-methyl) -anilino) -1-phenyl-methylene] -6-methoxy-carbonyl-2-indolinone, (412) 3-Z- [1- (4 - ((3-Amino-propyl) -amino-methyl) -anilino) -1-phenyl-methylene] -6-methoxy-carbonyl-2-indolinone, (413) 3-Z - [1- (4 - ((2-acetylaminoethyl) amino-methyl) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolmone, (414) 3-Z- [1- (4) - ((3-acetylamino-propyl) amino-methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (415) 3-Z- [1- (4 - ((2- methylsulfonylamino-ethyl) -amino-methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (416) 3-Z- [1- (4 - ((3-methylsulfonylamino-propyl) - amino-methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (417) 3-Z- [1- (4- (N - (N '- tert -butoxycarbonyl-2-amino-ethyl)) - (N-methyl-aminomethyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (418) 3-Z- [1- (4- (N-2-amino-ethyl) (N-methyl-amino-methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (419) 3-Z- [1- (4- (N - (2-acetylamino- ethyl) -, N-methyl-amino-methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (420) 3-Z- [1- (4- (N - (2- methylsulfonylamino-ethyl) - N '- ( methyl-amino-methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (421) 3-Z- [1- (4- (carboxymethyl-amino) (methyl) -anilino) -1-phenyl-methylene] -6-methoxy-carbonyl-2-indolinone, (422) 3- Z- [1- (4- (ethoxycarbonyl-methyl-amino-methyl) -anilino) - 1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (423) 3-Z- [1- (4- (carbamoyl-methyl-amino-methyl) -anilino) -1-phenyl-methylene] -6- methoxy-carbonyl-2-indolinone, (424) 3-Z- [1- (4- (dimethylcarbamoyl-methyl-amino-methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indoline (425) 3-Z- [1- (4- (methylcarbamoyl-methyl-amino-methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (426) 3-Z- [1- (4- (N-dimethylaminomethylcarbonyl- N -methylamino) -3-amino-anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, (427) 3-Z- [1- ( 4- (N'-dimethylaminomethylcarbonyl- N -methyl-amino) -3-nitro-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (428) 3-Z- [1- (4) - (N-dimethylaminomethylcarbonyl- N -methyl-amino) -3-acetylamino-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (429) 3-Z- [1- (4- (N-dimethylaminomethylcarbonyl-N-methyl-amino) -3-methylsulfonyl-amino-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (430) 3-Z- [1- (4- ( N-dimethylaminomethylcarbonyl-N , -methyl-amino-3-cyano-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (431) 3-Z- [1- (4- (N, -) dimethylaminomethylcarbonyl-N-methyl-amino) -3-hydroxy-anilino-1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, (432) 3-Z- [1- (4- (N-dimethylaminomethylcarbonyl) N-methyl-amino) -3-methoxy-anilino-1-phenyl-met ylene] -6-methoxycarbonyl-2-indolinone, (433) 3-Z- [1- (4- (N-dimethylaminomethylcarbonyl-N'-methylamino) -3-ethoxycarbonyl-anilino) -1-phenyl-methylene 6-Methoxycarbonyl-2-indolinone, (434) 3- [1- (4- (N-dimethylaminomethylcarbonyl-N-methyl-amino) -3-carboxy-anilino) -1-phenyl-methylene] - 6-methoxycarbonyl-2-indolinone, (435) 3-N- [1- (4- (N-dimethylaminomethylcarbonyl-N-methyl-amino) -3-carbamoyl-anilino) -1-phenyl-methylene] -6-methoxycarbonyl -2-indolinone, (436) 3-Z- [1- (4- (N-dimethylaininomethylcarbonyl-N-methyl-amino) -3-chloro-anilino) -1-phenyl-methylene] -6-methoxycarbonyl- 2-indolinone, (437) 3-Z- [1- (4- (N-dimethylaminomethylcarbonyl- N -methylamino) -3-fluoro-anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone (438) 3-N- [1- (4- (N-dimethylarninomethylcarbonyl-N-methylamino) -3-bromo-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (439) 3 Z- [l- (4 - (? in-dimethylamino-methylcarbonyl-N-methylamino) -3-methyl-anilino) -l-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (440) 3- Z- [1- (4- ( N, N-dimethylaminomet (441) 3-Z- [1- (4- (N, N-dimethylaminomethylcarbonyl) -ylcarbonyl- N -methyl-amino) -3-trifluoromethyl-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone N-methylamino) -3,5-dibromo-anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, (442) 3-Z- [1- (4- (N-dimethylaminomethylcarbonyl-N ) - methyl-amino) -3,5-dichloro-amino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (443) 3-Z- [1- (4- (dimethylaminomethyl) -3-amino- anilino) -1-phenyl-methylene] -6-methoxy-carbonyl-2-indolinone, (444) 3-Z- [1- (4- (dimethylaminomethyl) -3-nitro-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (445) 3- [1- (4- (dimethylammomethyl) -3-acetylamino-anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, (446) 3-Z- [1- (4- (dimethylammomethyl) -3-methylsulfonylamino-anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, (447) 3-Z- [1- ( 4- (dimethylaminomethyl) -3-cyano-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (448) 3-Z- [1- (4- (dimethylaminomethyl) -3-hydroxy-anilino) ) -l-phenyl-methylene] -6-methoxycarbonyl-2-indole (449) 3-Z- [1- (4- (dimethylaminomethyl) -3-methoxy-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (450) 3-Z- [1- (4- (dimethylaminomethyl) -3-ethoxycarbonylanilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, (451) 3-Z- [1- (4- (dimethylaminomethyl) -3-carboxy) -anilino) -1-phenyl-methylene] -6-methoxy-carbonyl-2-indolinone, (452) 3-Z- [1- (4- (dimethylaminomethyl) -3-carbamoylanilino) -1-phenyl-methylene] - 6-methoxy-carbonyl-2-indolinone, (453) 3-Z- [1- (4- (dimethylaminomethyl) -3-chloro-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (454) 3-Z- [1- (4- (dimethylaminomethyl) -3-fluoro-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (455) 3-Z- [ 1- (4- (dimethylaminomethyl) -3-bromo-anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, (456) 3-Z- [1- (4- (dimethylaminomethyl) - 3-methyl-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (457) 3-Z- [1- (4- (dimethylarninomethyl) -3-trifluoromethyl-anilino) -1- phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (458) 3-Z- [1- (4-dimethylaminomethyl-3,5-di) bromo-anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (459) 3-Z- [1- (4- (dimethylaminomethyl) -3,5-dichloro-anilino) -1- phenyl-methylene] -6-methoxy-carbonyl-2-indolinone, (460) 3-Z- [1- (4- (dimethylaminomethyl) anilino) -1-phenyl-methylene] -6 - [(2-hydroxy- ethoxy) carbonyl] -2-indolinone, (461) 3-Z- [1- (4- (dimethylaminomethyl) -anilino) -1-phenylmethylene] -6 - [(ethoxycarbonylmethoxy) carbonyl] -2 -indolinone, (462) 3-Z- [1- (4- (dimethylaminomethyl) anilino) -1-phenylmethylene] -6 - [(carboxymethoxy) carbonyl] -2-indolinone, (463) 3 -Z- [1- (4- (dimethylaminomethyl) anilino) -1-phenylmethylene] -6 - [(carbamoylmethoxy) carbonyl] -2-indolinone, (464) 3-Z- [1- (4) - (N-dimethylaminomethylcarbonyl-N-methyl-amino) -anilino) -1-phenyl-methylene] -6 - [(2-hydroxy-ethoxy) -carbonyl] -2-indolinone, (465) 3-Z- [ 1- (4- (N ' -dimethylaminomethylcarbonyl-N-methyl-amino) -anilino) -1-phenyl-methylene] -6 - [(ethoxycarbonylmethoxy) carbonyl] -2-indolinone, (466) 3-Z- [l- (4 - (/ V-dimetylaminometylkarbonyl- / V-methyl-amino) -anilino) -l-phenyl-methylene] -6 - [(carboxy-methoxy) -ka Rbonyl] -2-indolinone, (467) 3-Z- [1- (4- (N-dimethylaminomethylcarbonyl-N-methylamino) -anilino) -1-phenylmethylene] -6 - [(carbamoyl-methoxy) -carbonyl] -2-indolinone, (468) 3- [1- (4- (N-dimethylaminomethylcarbonyl-N-methyl-amino) -anilino) -1-phenyl-methylene] -6 - [(2-methoxy) (ethoxy) -carbonyl] -2-indolinone, (469) 3- [1- (4- (N-dimethylaminomethylcarbonyl-N-methyl-amino) -anilino) -1-phenyl-methylene] -6- [ (2-dimethylaminoethoxy) carbonyl] -2-indolinone, (470) 3-Z- [1- (4- (N-dimethylaminomethylcarbonyl-n-methyl-amino) -anilino) -1-phenyl-methylene] -6- [(2- (N-tert-butoxycarbonyl-amino) -ethoxy) -carbonyl] -2-indolinone, (471) 3-Z- [1- (4- (N-dimethylaminomethylcarbonyl-N-methyl-amino) -anilino] -1-phenyl-methylene] -6 - [(2-amino-ethoxy) -carbonyl] -2-indolinone, (472) 3-Z- [1- (4- (N-dimethylaminomethylcarbonyl-N , -methyl)] - (amino) -amino) -1-phenyl-methylene] -6 - [(2,2,2-trifluoroethoxy) carbonyl] -2-indolinone, (473) 3-Z- [1- (4- (V) - ((4-methyl-piperazin-1-yl) -methylcarbonyl) - N -methyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (474 13-Z- [1- (4- (N - (imidazo-1-yl-methylcarbonyl) -N-methyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, ( 475) 3-N- [1- (4- (N - (phthalimido-2-ylmethylcarbonyl) -N-methylamino) anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, (476) 13-Z- [1- (4- (N-aminomethylcarbonyl-N-methyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (477) 3-Z- [1] - (4- (N-acetylaminomethylcarbonyl-N-methyl-amino) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, (478) 3-Z- [1- (4- (7-methyl-amino) carbonyl] -2-indolinone; metylsulfonylaminometylkarbonyl- / V-methyl-amino) -anilino) -l-phenyl-methylene] -6-methoxycarbonyl-2-indolinone (479) 3-Z- [l- (4- (N - ((A / - ( 2-methoxyethyl) - N -methylamino) methylcarbonyl-N-methyl-amino) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, (480) 3-Z- [1- (4- (7V - ((/ V- (2-dimethylamino-ethyl) - / V-methyl-amino) -methylcarbonyl) -N-methyl-amino) -anilino) -l-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (481) 3-Z- [1- (4- (N - ((di- (2-hydroxyethyl) amino) methylcarbonyl) -, N -methyl-amino) -anilino) -1-phenylmethyl (482) 3- [1- (4-tert-butoxycarbonylmethyl-anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, (483) 3-Z- [1- (4- (N-dimethylaminomethylcarbonyl-N-methyl-amino) -anilino) -methylene] -6-methoxycarbonyl-2-indolinone, (484) 3-Z- [1- ( 4 - (N-dimethylaminomethylcarbonyl-N'-methyl-amino) -anilino) ethylidene] -6-methoxycarbonyl-2-indolinone, (485) 3-Z- [1- (4- (N-dimethylaminomethylcarbonyl-A ')) (methyl-amino) -anilino) -propylidene] -6-methoxycarbonyl-2-indolinone, (486) 3- Z- [1- (4- (N-dimethylaminomethylcarbonyl- N -methyl-amino) -anilino) -butylidene 6-Methoxycarbonyl-2-indolinone, (487) 3-Z- [1- (4- (dimethylaminomethyl) -anilino) -methylene] -6-methoxycarbonyl-2-indolinone, (488) 3-Z- [1] - (4- (dimethylaminomethyl) -anilino) -ethylidene] -6-methoxycarbonyl-2-indolinone, (489) 3-Z- [1- (4- (dimethylaminomethyl) -anilino) -propylidene] -6-methoxycarbonyl-2 -indolinone, (490) 3-Z- [1- (4- (dimethylaminomethyl) anilino) butylidene] -6-methoxycarbonyl-2-indolinone, (491) 3-Z- [1- (4-tert-butyloxycarbonyl-anilino) ) -1 -phenyls 1-methylene] -6-methoxycarbonyl-2-indolinone, (492) 3-Z- [1- (4- (N- (2-dimethylamino-ethyl) -N-methylamino) -anilino) -1-phenyl methylene] -6-methoxycarbonyl-2-

-indolinón, (493) 3-Z-[l-(4-(jV-(3-dimetylamino-propyl)-7V-metyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (494) 3-Z-[ 1 -(4-(jV-metyl-acetylamino)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (495) 3-Z-[l-(4-(imidazol-4-yl)anilino)-1 -fenylmetylén]-6-metoxykarbonyl-2-indolinón, (496) 3-Z-[ 1 -(4-((IV-(dioxolán-2-yl-metyl)-/V-metyl-amino)-metyl)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (497) 3-Z-[l-(4-(7V-benzyl-7V-metyl-amino-metyl)-anilino)-1 -metyl-metylén]-6-karbamoyl-2-indolinón, (498) 3-Z-[l-(4-(2,3,4,5-tetrahydro-benzo(d)azepin-3-yl-metyl)-anilino)-l-metyl-metylén]-6-karbamoyl-2-indolinón, (499) 3-Z-[ 1 -(4-((benzo( 1,3)dioxol-5-yl-metyl)-metyl-aminometyl)-anilino)-1 -metyl-metylén]-6-karbamoyl-2-indolinón, (500) 3-Z-[l-(4-(N-fenetyl-V-metyl-amino-metyl)-anilino)-l-metyl-metylén]-6-karbamoyl-2-indolinón, (501) 3-Z-[l-(4-(M-(3,4-dimetoxy-benzyl)-<V-metyl-aminometyl)-anilino)-l-metyl-metylén]-6-karbamoyl-2-indolinón, (502) 3-Z-[l-(4-(N-(4-chlór-benzyl)-A,-metyl-ainino-metyl)-anilino)-l-metyl-metylén]-6-karbamoyl-2-mdo-linón, (503) 3-Z-[l-(4-(7V-(4-metyl-benzyl)-jV-metyl-amino-metyl)-amlino)-l-metyl-metylén]-6-karbamoyl-2-indolinón, (504) 3-Z-[l-(4-(7V-(4-fluór-benzyl)-7V-metyl-amino-metyl)-anilino)-l-metyl-metylén]-6-karbamoyl-2-indo- linón, (505) 3-Z-[l-(4-(7V-(4-bróm-benzyl)-7V-metyl-amino-metyl)-anilino)-l-metyl-metylén]-6-karbamoyl-2-indolinón, (506) 3-Z-[l-(4-((A/-(2-metoxy-etyl)-7V-metyl-amino)-metyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (507) 3-Z-[l-(4-(dimetylaminometyl)-anilino)-l-fenyl-metylén]-6-[(2-amino-etoxy)-karbonyl]-2-indolinón, (508) 3-Z-[l-(4-((/'/-(3-metylsulfonylamino-propyl)-A,-metyl-amino)-metyl)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón.(493) 3-N- [1- (4- (N - (3-dimethylamino-propyl) - N -methyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2- (494) 3-Z- [1- (4- (N-methyl-acetylamino) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, (495) 3-Z- [1] - (4- (imidazol-4-yl) anilino) -1 -phenyl-] -6-methoxycarbonyl-2-indolinone (496) 3-Z- [1 - (4 - ((I, N- (dioxolan-2 (49-methyl-N- (N-methyl-amino) -methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, benzyl-N-methyl-amino-methyl) -anilino) -1-methyl-methylene] -6-carbamoyl-2-indolinone, (498) 3-Z- [1- (4- (2,3,4,5) -tetrahydro-benzo (d) azepin-3-yl-methyl) -anilino) -1-methyl-methylene] -6-carbamoyl-2-indolinone, (499) 3-Z- [1- (4 - ((benzo) (1,3) dioxol-5-yl-methyl) -methyl-aminomethyl) -anilino) -1-methyl-methylene] -6-carbamoyl-2-indolinone, (500) 3-Z- [1- (4-) (N-Phenethyl-N-methyl-amino-methyl) -anilino) -1-methyl-methylene] -6-carbamoyl-2-indolinone, (501) 3-Z- [1- (4- (M- (3) , 4-dimethoxy-benzyl) - <N-methyl-aminomethyl) anilino) -l-methyl-methylene] -6-carbamoyl-2-indole (502) 3-Z- [1- (4- (N- (4-chloro-benzyl) - N , -methyl-amino-methyl) -anilino) -1-methyl-methylene] -6-carbamoyl- 2-indolinone, (503) 3-N- [1- (4- (N - (4-methyl-benzyl) - N -methyl-amino-methyl) -amino) -1-methyl-methylene] -6 -carbamoyl-2-indolinone, (504) 3- [1- (4- (N - (4-fluoro-benzyl) -N-methyl-amino-methyl) -anilino) -1-methyl-methylene] - 6-carbamoyl-2-indolinone, (505) 3- Z- [1- (4- (N - (4-bromo-benzyl) -7 H -methyl-amino-methyl) -anilino) -1-methyl- methylene] -6-carbamoyl-2-indolinone (506) 3-Z- [l- (4 - ((A / - (2-methoxy-ethyl) -7V-methyl-amino) methyl) anilino) - 1-Phenylmethylene] -6-methoxycarbonyl-2-indolinone, (507) 3-Z- [1- (4- (dimethylaminomethyl) anilino) -1-phenylmethylene] -6 - [(2-amino- ethoxy) carbonyl] -2-indolinone, (508) 3-Z- [1- (4 - ((N - (3-methylsulfonylamino-propyl) - N , -methyl-amino) -methyl) -anilino) -l-phenyl-methylene] -6-methoxycarbonyl-2-indolinone.

Príklad 13Example 13

Suché ampulky s 75 mg účinnej látky na 10 mlDry ampoules with 75 mg of active substance per 10 ml

Zloženie: účinná látka 75,0 mg manitol 50,0 mg voda na injekčné účely do 10,0 mlIngredients: active substance 75.0 mg mannitol 50.0 mg water for injections up to 10.0 ml

Príprava: účinná látka a manitol sa rozpustili vo vode, po naplnení ampuliek sa vysušili vymrazovaním.Preparation: The active substance and mannitol were dissolved in water, freeze-dried after filling the ampoules.

Rozpustenie na roztok vhodný na použitie sa uskutoční vodou na injekčné účely.Dissolution to a solution suitable for use is carried out with water for injection purposes.

Príklad 14Example 14

Suché ampulky s 35 mg účinnej látky na 2 mlDry ampoules with 35 mg of active substance per 2 ml

Zloženie: účinná látka 35,0 mg manitol 100,0 mg voda na injekčné účely do 2,0 mlIngredients: active substance 35.0 mg mannitol 100.0 mg water for injections up to 2.0 ml

Príprava: účinná látka a manitol sa rozpustili vo vode, po naplnení ampuliek sa vysušili vymrazovaním.Preparation: The active substance and mannitol were dissolved in water, freeze-dried after filling the ampoules.

Rozpustenie na roztok vhodný na použitie sa uskutoční vodou na injekčné účely.Dissolution to a solution suitable for use is carried out with water for injection purposes.

Príklad 15Example 15

Tablety s 50 mg účinnej látkyTablets containing 50 mg of the active substance

55 Zloženie: (1) účinná látka Composition: (1) active substance 50,0 mg 50.0 mg (2) mliečny cukor (2) milk sugar 98,0 mg 98.0 mg (3) kukuričný škrob (3) corn starch 50,0 mg 50.0 mg (4) polyvinylpyrolidón (4) polyvinylpyrrolidone 15,0 mg 15.0 mg (5) stearan horečnatý (5) magnesium stearate 2,0 mg 2.0 mg 60 spolu 60 together 215,0 mg 215.0 mg

Príprava: Zložky (1), (2) a (3) sa zmiešajú a granulujú pomocou vodného roztoku zložky (4). Vysušený granulát sa zmieša so zložkou (5). Z tejto zmesi sa lisujú biplanáme tablety s obojstrannou fazetou a jednostrannou ryhou. Priemer tabliet 9 mm.Preparation: Components (1), (2) and (3) are mixed and granulated with an aqueous solution of component (4). The dried granulate is mixed with component (5). From this mixture, biplanar tablets with bilateral facets and one-sided score are compressed. Tablet diameter 9 mm.

Príklad 16Example 16

Tablety s 350 mg účinnej látkyTablets with 350 mg of the active substance

Zloženie: (1) účinná látka 350,0 mg (2) mliečny cukor 136,0 mg (3) kukuričný škrob 80,0 mg (4) polyvinylpyrolidón 30,0 mg (5) stearan horečnatý 4,0 mg spolu 600,0 mgIngredients: (1) active substance 350.0 mg (2) milk sugar 136.0 mg (3) corn starch 80.0 mg (4) polyvinylpyrrolidone 30.0 mg (5) magnesium stearate 4.0 mg total 600.0 mg

Príprava: Zložky (1), (2) a (3) sa zmiešajú a granulujú pomocou vodného roztoku zložky (4). Vysušený granulát sa zmieša so zložkou (5). Z tejto zmesi sa lisujú biplanáme tablety s obojstrannou fazetou a jednostrannou ryhou. Priemer tabliet 12 mm.Preparation: Components (1), (2) and (3) are mixed and granulated with an aqueous solution of component (4). The dried granulate is mixed with component (5). From this mixture, biplanar tablets with bilateral facet and unilateral groove are compressed. Tablet diameter 12 mm.

Príklad 17Example 17

Kapsuly s 50 mg účinnej látkyCapsules containing 50 mg of the active substance

Zloženie: (1) účinná látka 50,0 mg (2) sušený kukuričný škrob 58,0 mg (3) práškový mliečny cukor 50,0 mg (4) stearan horečnatý 2,0 mg spolu 160,0 mgIngredients: (1) active ingredient 50.0 mg (2) dried corn starch 58.0 mg (3) powdered milk sugar 50.0 mg (4) magnesium stearate 2.0 mg total 160.0 mg

Príprava: zložka (1) sa rozotrie spolu so zložkou (2). Do rozotretej zmesi sa pridá za intenzívneho miešania zmes zložiek (2) a (4). Prášková zmes sa v plničke kapsúl plní do kapsúl z tvrdej želatíny veľkosť 3.Preparation: component (1) is rubbed together with component (2). A mixture of components (2) and (4) is added to the comminuted mixture with vigorous stirring. The powder mixture is filled into hard gelatin size 3 capsules in a capsule filler.

Príklad 18Example 18

Kapsuly s 350 mg účinnej látkyCapsules with 350 mg of the active substance

Zloženie: (1) účinná látka 350,0mg (2) sušený kukuričný škrob 46,0 mg (3) práškový mliečny cukor 30,0 mg (4) stearan horečnatý ______4,0mg spolu 430,0mgIngredients: (1) active ingredient 350.0mg (2) dried corn starch 46.0 mg (3) powdered milk sugar 30.0 mg (4) magnesium stearate ______ 4.0mg total 430.0mg

Príprava: zložka (1) sa rozotrie spolu so zložkou (2). Do rozotretej zmesi sa pridá za intenzívneho miešania zmes zložiek (2) a (4). Prášková zmes sa v plničke kapsúl plní do kapsúl z tvrdej želatíny veľkosť 0.Preparation: component (1) is rubbed together with component (2). A mixture of components (2) and (4) is added to the comminuted mixture with vigorous stirring. The powder mixture is filled into hard gelatin size 0 capsules in a capsule filler.

Príklad 19Example 19

Capíky s obsahom 100 mg účinnej látky čapík obsahuje: účinná látka 100,0 mg polyetylénglykol (mol. hmotn. 1500) 600,0 mg polyetylénglykol (mol. hmotn. 6000) 460,0 mg polyetylénsorbitan monostearát 840,0 mg spolu 2000,0 mgCaps containing 100 mg of active ingredient suppository contains: active ingredient 100.0 mg polyethylene glycol (mol. Wt. 1500) 600.0 mg polyethylene glycol (mol. Wt. 6000) 460.0 mg polyethylene sorbitan monostearate 840.0 mg total 2000.0 mg

Príprava: polyetylénglykoly sa spolu s monostearátom polyetylénsorbitanu roztopia. Do taveniny sa pri 40 °C homogénne disperguje účinná látka. Ochladí sa na 38 °C a vylieva sa do vopred mierne vychladených čapíkových foriem.Preparation: The polyethylene glycols are melted together with the polyethylene sorbitan monostearate. The active ingredient is dispersed homogeneously into the melt at 40 ° C. Cool to 38 ° C and pour into pre-chilled suppository molds.

Claims (10)

1. Indolinóny substituované v polohe 6 všeobecného vzorca (I) R3 An indolinone substituted in the 6-position of the general formula (I) R 3 I /R’ (I), v ktoromI / R '(I) in which X znamená atóm kyslíka alebo síry,X is an oxygen or sulfur atom, R1 znamená atóm vodíka alebo Ci.4-alkoxykarbonylovú alebo C2.4-alkanoylovú skupinu,R 1 represents a hydrogen atom or C 1-6 alkyl; 4 -alkoxycarbonyl or C 2 .4-alkanoyl, R2 znamená karboxylovú skupinu, nerozvetvenú alebo rozvetvenú C]_6-alkoxy-karbonylovú skupinu, C4.7-cykloalkoxy-karbonylovú skupinu alebo aryloxy-karbonylovú skupinu, nerozvetvenú alebo rozvetvenú C].6-alkoxy-karbonylovú skupinu, ktorá je v koncovej alkylovej časti substituovaná fenylovou skupinou, heteroarylovou skupinou, karboxylovou skupinou, C1.3-alkoxy-karbonylovou skupinou, aminokarbonylovou skupinou, Ci_3-alkylamino-karbonylovou skupinou alebo di-(Ci.3-alkyl)-amino-karbonylovou skupinou, nerozvetvenú alebo rozvetvenú C2_6-alkoxy-karbonylovú skupinu, ktorá je v koncovej alkylovej časti substituovaná atómom chlóru alebo skupinou hydroxy-, C].3-alkoxy-, amino-, Ci.3-alkylamino- alebo di-(C1.3-alkyl)-amino-skupinou, aminokarbonylovú alebo metylaminokarbonylovú skupinu, etylaminokarbonylovú skupinu voliteľne v polohe 2 skupiny etyl- substituovanú skupinou hydroxy- alebo Ci.3-alkoxy-skupinou,R 2 is carboxy, a linear or branched C] _ 6 alkoxy-carbonyl, C 4. 7- cycloalkoxycarbonyl or aryloxycarbonyl, unbranched or branched C 1. 6 alkoxy-carbonyl group which is in the terminal alkyl-substituted phenyl, heteroaryl, carboxyl, C first 3 -alkoxy-carbonyl, aminocarbonyl, Ci_3-alkylamino-carbonyl or di- (Ci. 3 alkyl) amino-carbonyl, linear or branched C 2 _6-alkoxy-carbonyl group which is in the terminal alkyl substituted with a chlorine atom or a hydroxy-, C 1 - group. 3- alkoxy-, amino-, C 1-6 -alkyl; 3 -alkylamino or di- (C1. 3 alkyl) amino radical, an aminocarbonyl or methylaminocarbonyl group, an ethylaminocarbonyl group optionally in the 2-ethyl group substituted by hydroxy or C. 3- alkoxy, R3 znamená atóm vodíka, C|.6-alkylovú skupinu, C3.7-cykloalkylovú skupinu, trifluór-metylovú skupinu alebo heteroarylovú skupinu, fenylovú alebo naftylovú skupinu, fenylovú alebo naftylovú skupinu mono- alebo di- substituovanú atómom fluóru, chlóru, brómu alebo jódu, skupinou trifluórmetyl-, C|.3-alkyl- alebo C|.3-alkoxy-, pričom v prípade disubstitúcie môžu byť substituenty rovnaké alebo rozdielne a pričom uvedené nesubstituované, ako aj mono- a di- substituované fenylové alebo naftylové skupiny môžu byť navyše substituované skupinou hydroxy-, hydroxy-C].3-alkyl- alebo skupinou Ci_3-alkoxy-Ci.3-alkyl-, skupinou kyano-, karboxy-, karboxy-C|.3-alkyl-, Cj^-alkoxykarbonyl-, amino-karbonyl-, C|.3-alkylaminokarbonyl- alebo di-(Ci_3-alkyl)-aminokarbonylovou skupinou, skupinou nitro-, skupinou amino-, Ci.3-alkylamino-, di-(Cj.3-alkyl)-amino alebo amino-Ci.3-alkylovou skupinou, skupinou Ct-3-alkylkarbonylamino-, A-(C!.3-alkyl)-C1.3-alkylkarbonylamino-, Cj.3-alkylkarbonylamino-C1.3-alkyl-, N-(Ci.3-alkyl)-C1.3-alkylkarbonylamino- Ci.3-alkyl-, Cj.3-alkylsulfonylamino-, Cj^-alkylsulfonylamino-Ci.3-alkyl, /V-(C|.3-alkyl)-C|.3-alkylsulfonylamino-C|.3-alkyl- alebo skupinou aryl-C1.3-alkyl-sulfonylamino-, skupinou cykloalkylamino-, cykloalkylénimino-, cykloalkyléniminokarbonyl-, cykloalkylénimino-C|.3-alkyl-, cykloalkyléniminokarbonyl-Ci.3-alkyl alebo cykloalkyléniminosulfonyl-Ci.3-alkylovou skupinou vždy so 4 až 7 členmi kruhu, pričom metylénová skupina v polohe 4 šesťčlennej alebo sedemčlennej cykloalkyléniminoskupiny môže byť nahradená atómom kyslíka alebo síry, skupinou sulfinyl-, sulfonyl-, -NH- alebo -N-(C[_3-alkyl)- skupinou, alebo môže byť substituovaná heteroarylovou skupinou alebo heteroaryl-Ci.3-alkylovou skupinou,R 3 is H, C |. 6- alkyl, C 3 . 7- cycloalkyl, trifluoromethyl or heteroaryl, phenyl or naphthyl, phenyl or naphthyl mono- or di-substituted by fluorine, chlorine, bromine or iodine, trifluoromethyl-, C1-6alkoxy; 3- alkyl- or C 1-6 -alkyl; 3 alkoxy-, wherein in the case of disubstitution the substituents may be the same or different and wherein the abovementioned unsubstituted as well as mono- and di-substituted phenyl or naphthyl groups may additionally be substituted by hydroxy, hydroxy-C]. 3- alkyl- or C 1-3 -alkoxy-C 1-6 alkyl; 3- alkyl-, cyano-, carboxy-, carboxy-C1-6alkyl. 3- alkyl-, C 1-6 -alkoxycarbonyl-, amino-carbonyl-, C 1-6 -alkyl-; 3- alkylaminocarbonyl- or di- (C 1-3 -alkyl) -aminocarbonyl, nitro-, amino-, C 1-3 -alkylamino-, di- (C 1-3 -alkyl) -amino or amino-C 1-6 -alkyl; 3 -alkyl, a C 3-alkylcarbonylamino, N- (Cl. 3 alkyl) -C1. 3- alkylcarbonylamino-, C 1-3 -alkylcarbonylamino-C 1-3 -alkyl-, N- (C 1-3 -alkyl) -C 1 . 3- alkylcarbonylamino-C 1-6 alkyl; 3- alkyl-; 3- alkylsulfonylamino-, C 1-6 -alkylsulfonylamino-C 1-6 alkylsulfonylamino-; 3- alkyl, N - (C 1-3 -alkyl) -C 1-6 alkyl; 3- alkylsulfonylamino-C1-6alkyl; 3- alkyl- or aryl-C 1 . 3 -alkylsulfonylamino-, cycloalkylamino-, cycloalkylenimino-, cycloalkyleneiminocarbonyl-, cycloalkylenimino-C1-6-cycloalkyleneimino-; 3- alkyl-, cycloalkyleneiminocarbonyl-C 1-3 -alkyl or cycloalkyleneiminosulfonyl-C 1-3. A 3- alkyl group having from 4 to 7 ring members, the methylene group in the 4-position of the 6 or 7 membered cycloalkyleneimino group being replaced by an oxygen or sulfur atom, a sulfinyl-, sulfonyl-, -NH- or -N- (C 1-3 alkyl) group -, or may be substituted with a heteroaryl group or a heteroaryl-C 1-6 alkyl group; 3- alkyl, R4 znamená C3.7-cykloalkylovú skupinu, pričom metylénová skupina v polohe 4 šesťčlennej alebo sedemčlennej cykloalkylovej skupiny môže byť nahradená skupinou amino-, C!.3-alkylamino- alebo skupinou di-(Ci.3-alkyl)-amino-, alebo môže byť nahradená skupinou -NH- alebo -jV(Ci.3-alkyl)-, alebo znamená fenylovú skupinu substituovanú skupinou R6, pričom fenylová skupina môže byť navyše mono- alebo di- substituovaná atómom fluóru, chlóru, brómu alebo jódu, skupinou Cj.5-alkyl-, trifluórmetyl-, hydroxy-, Ci.3-alkoxy-, karboxy-, C|.3-alkoxykarbonyl-, amino-, acetylamino-, Ci.3-alkyl-sulfonyl-amino-, aminokarbonyl-, Ci.3-alkyl-aminokarbonyl-, di-(C].3-alkyl)-aminokarbonyl-, amino-sulfonyl-, Ci.3-alkylaminosulfonyl-, di-(Cj.3-alkyl)-aminosulfonyl-, nitro- alebo kyano-, pričom substituenty môžu byť rovnaké alebo rozdielne a pričomR 4 is C 3. A 7- cycloalkyl group, wherein the methylene group at the 4-position of the six- or seven-membered cycloalkyl group may be replaced by amino-, C 1-3 -alkylamino- or di- (C 1-3 -alkyl) -amino-, or may be replaced by -NH- or -N (C 1-3 -alkyl) -, or is a phenyl group substituted with R 6 , wherein the phenyl group may additionally be mono- or di- substituted with a fluorine, chlorine, bromine or iodine atom, with a Cj group. 5- alkyl-, trifluoromethyl-, hydroxy-, C 1-6 alkyl; 3 -alkoxy-, carboxy-, C1-6alkoxy-; 3- alkoxycarbonyl-, amino-, acetylamino-, C 1-3 -alkylsulfonyl-amino-, aminocarbonyl-, C 1-6 -alkyloxycarbonyl-; 3- alkyl-aminocarbonyl-, di- (C 1-3 -alkyl) -aminocarbonyl-, amino-sulfonyl-, C 1 -C 3 -alkyl; 3- alkylaminosulfonyl-, di- (C 1-3 -alkyl) -aminosulfonyl-, nitro- or cyano-, wherein the substituents may be the same or different and wherein R6 znamená atóm vodíka, fluóru, chlóru, brómu alebo jódu, skupinu kyano-, nitro-, amino-, Ci_5-alkyl-, C3.7-cykloalkyl-, trifluórmetyl-, fenyl-, tetrazolyl- alebo heteroarylovú skupinu, skupinu vzorca v ktorom atómy vodíka viazané na dusíkovom atóme môžu byť vzájomne nezávisle od seba nahradené C1.3-alkylovou skupinou,R 6 represents a hydrogen, fluorine, chlorine, bromine or iodine atom, a cyano-, nitro-, amino-, C 1-5 -alkyl-, C 3 group . A 7- cycloalkyl-, trifluoromethyl-, phenyl-, tetrazolyl- or heteroaryl group, a group of the formula in which the hydrogen atoms attached to the nitrogen atom can be replaced independently of one another by a C 1-3 -alkyl group, Ci.3-alkoxylovú skupinu, CI_3-alkoxy-Cl.3-alkoxylovú skupinu, fenyl-Cj.3-alkoxylovú skupinu, amino-C2.3-alkoxylovú skupinu, C1.3-alkylamino-C2.3-alkoxylovú skupinu, di-(C1.3-alkyl)-amino-C2.3-alkoxylovú skupinu, fenyl-C].3-alkylamino-C2.3-alkoxylovú skupinu, /V-(C|.3-alkyl)-fenyl-C|_3-alkylamino-C2_3-alkoxylovú skupinu, C5.7-cyklo-alkylénimino-C2.3-alkoxyovú skupinu alebo skupinu Ci_3-alkylmerkapto-, karboxylovú skupinu, C ^-alkoxykarbonylovú skupinu, aminokarbonylofú skupinu, C].3-alkylamino-karbonylovú skupinu, 77-(Ci.5-alkyl)-C1.3-alkylaminokarbonylovú skupinu, fenyl-C^-alkylamino-karbonylovú skupinu, 7V-(Ci_3-alkyl)-fenyl-Ci.3-alkyl-aminokarbonylovú skupinu, piperazinokarbonylovú skupinu alebo 7V-(Ci_3-alkyl)-piperazinokarbonylovú skupinu,Ci. 3 -alkoxy, C I _ 3 alkoxy-C l. A 3- alkoxy group; 3 -alkoxy, amino-C 2nd 3 -alkoxy, C first 3 -alkylamino-C 2nd 3 -alkoxy, di- (C first 3 alkyl) amino-C 2nd 3- alkoxy, phenyl-C 1. 3 -alkylamino-C 2nd 3 -alkoxy, / V- (C |. 3-alkyl) -phenyl-C | _ 3 alkylamino-C 2 _ 3 alkoxy group, C 5. 7 cyclo-alkylene imino-C 2nd A 3- alkoxy group or a C 1-3 -alkylmercapto-, carboxyl group, a C 1-4 -alkoxycarbonyl group, an aminocarbonyl group, a C 1-6 group. 3- alkylaminocarbonyl, 77- (C 1-5 -alkyl) -C 1 . 3- alkylaminocarbonyl, phenyl-C 1-4 -alkylamino-carbonyl, N - (C 1-3 -alkyl) -phenyl-C 1-6 -alkylaminocarbonyl; 3- alkyl-aminocarbonyl, piperazinocarbonyl or N - (C 1-3 -alkyl) -piperazinocarbonyl, Ci.3-alkylaminokarbonylovú alebo 7V-(Ci.5-alkyl)-Ci.3-alkylaminokarbonylovú skupinu, v ktorých je alkylová časť substituovaná karboxylovou skupinou alebo Cjj-alkoxykarbonylovou skupinou, alebo v polohe 2 aleboCi.3-alkylaminocarbonyl or 7V- (Ci. 5 alkyl) -C. A 3- alkylaminocarbonyl group in which the alkyl moiety is substituted with a carboxyl group or a C 1-6 -alkoxycarbonyl group, or in the 2-position; or 3 skupinou di-(Ci_3-alkyl)-amino-, skupinou piperazino-, skupinou TV-(Ci.3-alkyl)-piperazino- alebo štvorčlennou až sedemčlennou cykloalkyléniminovou skupinou,3 di- (C 1-3 -alkyl) -amino-, piperazino-, N- (C 1-3 -alkyl) -piperazino- or a 4- to 7-membered cycloalkyleneimine group, C3.7-cykloalkyl-karbonylovú skupinu, pričom metylénová skupina v polohe 4 šesťčlennej alebo sedemčlennej cykloalkylovej časti môže byť substituovaná skupinou amino-, Ci_3-alkyl-amino- alebo skupinou di-(Ci.3-alkyl)-amino-, alebo nahradená skupinou -NH- alebo skupinou -7V(Ci_3-alkyl)-,C 3 . A 7- cycloalkyl-carbonyl group, wherein the methylene group at the 4-position of the six- or seven-membered cycloalkyl moiety may be substituted by amino-, C 1-3 -alkyl-amino- or di- (C 1-3 -alkyl) -amino-, or replaced by -NH- or -7V (C 1-3 -alkyl) -, 4 až 7 člennú cykloalkylénimínovú skupinu, ktorej s iminoskupinou viazaná metylénová skupina môže byť nahradená karbonylovou skupinou alebo sulfonylovou skupinou, ktorej cykloalkylénová časť môže byť kondenzovaná s fenylovým kruhom, alebo jeden alebo dva atómy vodíka môžu byť nahradené Cj.3-alkylovou skupinou a/alebo metylénová skupina v polohe 4 šesťčlennej alebo sedemčlennej cyklo-alkylénimínovej skupiny môže byť substituovaná karboxylovou skupinou, C|.3-alkoxykarbonylovou skupinou, aminokarbonylovou skupinou, C].3-alkyl-aminokarbonylovou skupinou, di-(Ci_3-alkyl)-aminokarbonylovou skupinou, fenyl-Ci.3-alkylamínovou skupinou alebo jV-(Ci_3-alkyl)-fenyl-Ci.3-alkyl-amínovou skupinou, alebo môže byť nahradená atómom kyslíka alebo síry, skupinou sulfmyl-, sulfonyl-, -NH-, -MC|j-alkyl)-, -MTenyl)-, -/V(C1.3-alkyl-karbonyl)- alebo -TV(benzoyl)-Ci_4-alkylovú skupinu substituovanú skupinou R7, pričomA 4 to 7 membered cycloalkyleneimine group in which the methylene-bonded methylene group may be replaced by a carbonyl group or a sulfonyl group in which the cycloalkylene moiety may be fused to a phenyl ring, or one or two hydrogen atoms may be replaced by C 1-6. The 3- alkyl group and / or the methylene group at the 4-position of the 6-membered or 7-membered cycloalkyleneimine group may be substituted with a carboxyl group, C 1-6. 3- alkoxycarbonyl, aminocarbonyl, C 1. 3- alkyl-aminocarbonyl, di- (C 1-3 -alkyl) aminocarbonyl, phenyl-C 1-6 alkyl; 3- alkylamino or N - (C 1-3 -alkyl) -phenyl-C 1-6 alkyl; 3 -alkyl-amino, or may be replaced by O or S, sulfmyl-, sulfonyl, -NH-, -MC | j-alkyl) -, -MTenyl) -, - / V (C first 3 - alkyl-carbonyl) - or -TV (benzoyl) -C 1-4 alkyl substituted by R 7 , wherein: R7 znamená C3_7-cykloalkylovú skupinu, pričom metylénová skupina v polohe 4 šesťčlennej alebo sedem-člennej cykloalkylovej skupiny môže byť substituovaná aminoskupinou, C^-alkylamínovou skupinou, di-(Cl.3-alkyl)-amínovou skupinou, alebo nahradená skupinou -NH- alebo skupinou -/V(Ci_3-alkyl)-, v päť až sedemčlennej cykloalkylovej skupine môže byť jedna skupina -(CH2)2- nahradená skupinou -CO-NH-, skupina -(CH2)3- skupinou -NH-CO-NH- alebo skupinou -CO-NH-CO-, alebo skupina -(CH2)4- môže byť nahradená skupinou -NH-CO-NH-CO-, pričom atóm vodíka viazaný na atóme dusíka môže byť nahradený C^-alkylovou skupinou, arylovú alebo heteroarylovú skupinu, skupinu hydroxy- alebo C μ3-alkoxy-, skupinu amino-, C^-j-alkylamino-, di-(Ci.7-alkyl)-amino-, fenylamino-, /V-fenyl-Ci_3-alkyl-amino-, fenyl-C|_3-alkyl-amino-, //-(Ci^-alkylj-fcnyl-Cj^-alkyl-amino- alebo di-(fenyl-C|.3-alkyl)-amino-, skupinu w-hydroxy-C2_3-alkylamino-, /V-(C1.3-alkyl)-ro-hydroxy-C2.3-alkyl-amino-, di-(o)-hydroxy-C2.3-alkylj-amino-, di-(co-(Ci.3-alkoxy)-C2.3-alkyl)-amino- alebo /V-(dioxolán-2-yl)-C|.3-alkyl-amino-, skupinu C|.3-alkylkarbonylamino-C2.3-alkyl-amino- alebo Ci_3-alkylkarbonyl-amino-C2.3-alkyl-/V-(Ci_3-alkyl)-amino-, skupinu Ci.3-alkylsulfonylamino-, A,-(C|.3-alkyl)-C|_3-alkyl-sulfonylamino-, C|_3-alkylsulfonylamino-C2_3-alkyl-amino- alebo C1.3-alkylsulfonylamino-C2.3-alkyl-/V-(Ci.3-alkyl)-amino-, skupinu hydroxykarbonyl-Ci.j-alkylamino- alebo /V-(C|.3-alkyl)-hydroxy-karbonyl-C|.3-alkyl-amino-, guanidínovú skupinu, v ktorej jeden alebo dva atómy vodíka môžu byť každý nahradený C|.3-alkylovou skupinou, skupinu vzorcaR 7 is C 3 _ 7 cycloalkyl group wherein a methylene group in the 4-position six-membered or seven-membered cycloalkyl group may be substituted with amino, C ^ -alkylamino, di (C l. 3-alkyl) -amino group, or replaced by -NH- or - V (C 1-3 -alkyl) -, in a 5-7 membered cycloalkyl group, one - (CH 2 ) 2 - group can be replaced by -CO-NH-, - (CH 2 ) 3 -NH-CO-NH- or -CO-NH-CO-, or - (CH 2 ) 4 - may be replaced by -NH-CO-NH-CO-, wherein the hydrogen atom bound to the nitrogen atom may be replaced by a C 1-4 -alkyl group, an aryl or a heteroaryl group, a hydroxy- or a C 1-3 -alkoxy- group, an amino-, C 1-4 -alkylamino-, di- (C 1-7 -alkyl) -amino-, phenylamino- N-phenyl-C 1-3 -alkyl-amino-, phenyl-C 1-3 -alkyl-amino-, N - (C 1-4 -alkyl) -phenyl-C 1-3 -alkyl-amino- or di- (phenyl- C |. 3 alkyl) amino group, N-hydroxy-C 2 _ 3 -alkylamino- / N (C first 3 alkyl) -R C-Hydroxy-second 3-alkyl-amino, di (o) hydroxy-C 2nd -Alkylj 3-amino, di- (co (C. 3 -alkoxy) -C 2. 3-alkyl) amino and / or N- (dioxolan-2-yl) C |. 3- alkyl-amino-; 3-alkylcarbonylamino C 2 .3-alkyl-amino, or a C 3 alkylcarbonyl-amino-C 2nd 3- alkyl- N - (C 1-3 -alkyl) -amino-; 3 -alkylsulfonylamino-, A, - (C |. 3 alkyl) C | _ 3-alkyl-sulfonylamino, C | _ 3 alkylsulfonylamino-C 2 _ 3 alkyl or amino-C1. 3-C alkylsulfonylamino second 3- alkyl- N - (C 1-3 -alkyl) -amino-, hydroxycarbonyl-C 1-8 -alkylamino- or N - (C 1-3 -alkyl) -hydroxy-carbonyl-C 1-8 -alkyl-; A 3- alkyl-amino-, guanidino group in which one or two hydrogen atoms may each be replaced by C 1-6. 3- alkyl, a group of formula -N(R8) - CO - (CH2)n - R9 (II), v ktorom-N (R 8 ) -CO- (CH 2 ) n -R 9 (II) wherein R8 znamená atóm vodíka alebo C|.3-alkylovú skupinu, n znamená číslo 0, 1,2, alebo 3,R 8 represents a hydrogen atom or C 1-6 alkyl; 3- alkyl, n is 0, 1, 2, or 3, R9 znamená skupinu amino-, C1.4-alkylamino-, di-(Ci_4-alkyl)-amino-, fenyl-amino-, /V-(C|.4-alkyl)-fenylamino-, benzylamino-, /V-(C|.4-alkyl)-benzylamino- alebo C|.4-alkoxy-, 4- až 7-člennú cykloalkylénimínovú skupinu, pričom metylénová skupina v polohe 4 šesťčlennej alebo sedemčlennej cyklo-alkylénimínovej skupiny môže byť nahradená atómom kyslíka alebo síry, skupinou sulfinyl-, sulfonyl-, -NH-, -TV(C|.3-alkyl)-, -N(fenyl)-, -JV(Ci_3-alkyl-karbonyl)- alebo -7V(benzoyl)-, alebo pokiaľ n znamená číslo 1, 2, alebo 3 môže znamenať tiež atóm vodíka, skupinu vzorcaR 9 is amino-, C 1 . 4- alkylamino-, di- (C 1-4 -alkyl) -amino-, phenyl-amino-, N - (C 1-4 -alkyl) -phenylamino-, benzylamino-, N - (C 1-4 -alkyl) ) -benzylamino- or C 1-6 -benzylamino-; A 4- alkoxy-, 4- to 7-membered cycloalkyleneimine group, wherein the methylene group at the 4-position of the 6- or 7-membered cycloalkyleneimine group may be replaced by an oxygen or sulfur atom, a sulfinyl-, sulfonyl-, -NH-, -TV (C) ( 3- alkyl) -, -N (phenyl) -, - N (C 1-3 -alkylcarbonyl) - or -7 N (benzoyl) -, or when n is 1, 2, or 3 may also be hydrogen , a group of formula -N(R10) - (CH2)m - (CO)o - R11 (III), v ktorom-N (R 10) - (CH 2) m - (CO) O - R @ 11 (III), wherein R10 znamená atóm vodíka, Ci_3-alkylovú skupinu, C].3-alkyl-karbonylovú skupinu, arylkarbonylovú skupinu, fenyl-Ci_3-alkyl-karbonylovú skupinu, C!.3-alkylsulfonylovú skupinu, arylsulfonylovú skupinu alebo fenylC].3-alkyl-sulfonylovú skupinu, m je číslo 1, 2, 3 alebo 4, oje číslo 1, alebo, pokiaľ m znamená číslo 2, 3 alebo 4, o môže byť tiež číslo 0 aR 10 is hydrogen, C 1-3 -alkyl, C 1-6. 3 -alkylcarbonyl, arylcarbonyl, phenyl-C 1-3 -alkylcarbonyl, C 1-6 -alkylcarbonyl; 3- alkylsulfonyl, arylsulfonyl or phenylC1. 3 -alkylsulfonyl, m is 1, 2, 3 or 4, o is 1, or, when m is 2, 3 or 4, o can also be 0 and R11 znamená skupinu amino-, C1.4-alkylamino-, di-(Ci_4-alkyl)-amino-, fenyl-amino-, W-(C1.4-alkyl)-fenylamino-, benzylamino-, 7V-(Ci_4-alkyl)-benzylamino-, C1.4-alkoxy- alebo skupinu CI.3-alkoxy-C1.3-alkoxy-, voliteľne skupinou C].3-alkyl- v polohe 1 substituovanú skupinu di- (Cl.4-alkyl)-amino-C]_3-alkylamino- alebo 4- až 7-člennú cykloalkylén-imínovú skupinu, pričom cykloalkylénová časť môže byť kondenzovaná s fenylovým kruhom, alebo metylénová skupina v polohe 4 šesťčlennej alebo sedemčlennej cykloalkylénimínovej skupiny môže byť nahradená atómom kyslíka alebo síry, skupinou sulfinyl-, sulfonyl-, -NH-, -/V(C|_3-alkyl)-, -N(fenyl)-, -/V(Cl.3-alkyl-karbonyl)- alebo -/V(benzoyl)-, skupinu C4.7-cykloalkylamino-, C4.7-cykloalkyl-Ci.3-alkylamino- alebo C4.7-cykloalkenylamino-, v ktorej sa poloha 1 kruhu nezúčastňuje na dvojitej väzbe a pričom uvedené skupiny môžu byť navyše substituované na amínovom atóme dusíka skupinou C5.7-cykloalkyl-, C2.4-alkenyl- alebo Ci_4-alkyl-,R 11 is amino-, C 1 . 4 -alkylamino, di- (C 4 alkyl) amino, phenyl-amino, N- (C first 4 alkyl) -fenylamino-, benzylamino, 7V- (C 4 alkyl) -benzylamino- , C 1 . 4- alkoxy- or C 1 . 3 -alkoxy-C first 3- alkoxy, optionally with C 1. 3 at the 1-alkyl-substituted group di- (C l. 4 alkyl) amino-C] _ 3 -alkylamino or a 4- to 7-membered cycloalkylene-imino group, wherein the cycloalkylene moiety may be fused to the phenyl ring , or the methylene group at the 4-position of a six- or seven-membered cycloalkyleneimine group may be replaced by an oxygen or sulfur atom, a sulfinyl-, sulfonyl-, -NH-, - V (C 1-3 -alkyl) -, -N (phenyl) - , - / V (Art. 3 -alkyl-carbonyl) - or - / V (benzoyl) -, a group of C4. 7 -cycloalkylamino-, C 4 . 7 -cycloalkyl-Ci. 3- alkylamino- or C 4 . 7 -cycloalkenylamino- in which the ring 1 position does not participate in the double bond and wherein said groups may additionally be substituted on the amino nitrogen atom by a C 5 group. 7 -cycloalkyl- C 2nd 4- alkenyl- or C 1-4 -alkyl-, 4 až 7 člennú cykloalkylénimínovú skupinu, ktorej cykloalkylénová časť môže byť kondenzovaná s fenylovou skupinou alebo so skupinou oxazolo-, imidazolo-, tiazolo-, pyridino-, pyrazino- alebo pyrimidino-, voliteľne substituovanými atómom fluóru, chlóru, brómu alebo jódu, skupinou nitro-, skupinou C^-alkyl-, Ci_3-alkoxy alebo aminoskupinou, a/alebo ktorej jeden alebo dva atómy vodíka môžu byť nahradené Ci_3-alkylovou skupinou, C5.7-cykloalkylovou skupinou alebo fenylovou skupinou, a/alebo ktorej metylénová skupina v polohe 3 päťčlennej cykloalkylénimínovej skupiny môže byť substituovaná hydroxyskupinou, hydroxy-C].3-alkylovou skupinou, skupinou C].3-alkoxy- alebo Ci.3-alkoxy-Ci_3-alkylovou skupinou, ktorej metylénová skupina v polohe 3 alebo 4 šesťčlennej alebo sedemčlennej cykloalkylénimínovej skupiny môže byť substituovaná hydroxyskupinou, hydroxy-Ci.3-alkylovou skupinou, skupinou C]_3-aIkoxy- alebo Cj^-alkoxy-Ci-a-alkylovou skupinou, karboxylovou skupinou, skupinou Ci_4-alkoxykarbonyl-, aminokarbonyl-, C].3-alkyl-aminokarbonyl-, di-(C|.3-alkyl)-aminokarbonyl-, fenyl-C1.3-alkylamino- alebo /V-(C]_3-alkyl)fenyl-C^j-alkylamino-, alebo uvedená metylénová skupina môže byť nahradená atómom kyslíka alebo síry, skupinou sulfinyl-, sulfonyl-, -NH-, -7V(C].3-alkyl)-, -7V(fenyl)-, W(fenyl-C1.3-alkyl)-, -7V(C].3-alkylkarbonyl)-, -/V(C1.4-hydroxykarbonyl)-, -jV(Ci_4-alkoxykarbonyl)-, -/V(benzoyl)- alebo -7V(fenyl-Ci_3-alkyl-karbonyl)-, pričom metylénová skupina, ktorá je viazaná s imínovým atómom dusíka cykloalkylénimínovej skupiny môže byť nahradená karbonylovou skupinou alebo sulfonylovou skupinou, alebo v päťčlennej až sedemčlennej monocyklickej alebo s fenylovou skupinou kondenzovanej cykloalkylénimínovej skupine obidve metylénové skupiny, viazané imínový atóm dusíka, môžu byť nahradené karbonylovou skupinou, alebo R6 znamená Ci_4-alkylovú skupinu, ktorá je substituovaná karboxylovou skupinou, Ci_3-alkoxykarbonylovou skupinou, aminokarbonylovou skupinou, Ci_3-alkylaminokarbonylovou skupinou alebo di-(C1.3-alkyl)-aminokarbonylovou skupinou alebo 4 až 7 člennou cykloalkyléniminokarbonylovou skupinou, skupinu 7V-(Ci-3-alkyl)-C2.4-alkanoylamino-, ktorá je alkylovej časti navyše substituovaná karboxylovou skupinou alebo Ci_3-alkoxykarbonylovou skupinou, skupinu vzorcaA 4 to 7 membered cycloalkyleneimine group, the cycloalkylene moiety of which may be fused to a phenyl group or oxazolo-, imidazolo-, thiazolo-, pyridino-, pyrazino- or pyrimidino- group, optionally substituted by a fluorine, chlorine, bromine or iodine atom, a nitro group -, a group of Cl alkyl, C 3 -alkoxy or amino, and / or wherein one or two hydrogen atoms may be replaced by a C 3 -alkyl, C 5. A 7- cycloalkyl or phenyl group, and / or wherein the methylene group at the 3-position of the five-membered cycloalkyleneimine group may be substituted with a hydroxy group, hydroxy-C 1. 3- alkyl, C 1. 3- alkoxy- or C 1-6 -alkyl; A 3- alkoxy-C 1-3 -alkyl group in which the methylene group at the 3- or 4-position of a six- or seven-membered cycloalkyleneimine group may be substituted by a hydroxy group, hydroxy-C 1-6 -alkyl; 3- alkyl, C 1-3 -alkoxy- or C 1-4 -alkoxy-C 1-8 -alkyl, carboxyl, C 1-4 -alkoxycarbonyl-, aminocarbonyl-, C 1-4 -alkyl. 3- alkyl-aminocarbonyl-, di- (C 1-3 -alkyl) aminocarbonyl-, phenyl-C 1 . 3- alkylamino- or N - (C 1-3 -alkyl) phenyl-C 1-4 -alkylamino-, or said methylene group may be replaced by an oxygen or sulfur atom, sulfinyl-, sulfonyl-, -NH-, -7V (C]. 3 alkyl) -, -7V (phenyl) -, N (phenyl-C1. 3 alkyl) -, -7V (C]. 3 -alkylcarbonyl) -, - / V (C1. 4 -hydroxycarbonyl) -, N - (C 1-4 -alkoxycarbonyl) -, N - (benzoyl) - or -7 N (phenyl-C 1-3 -alkylcarbonyl) -, wherein the methylene group which is bonded to the imine nitrogen atom of the cycloalkylenimine group may be replaced by a carbonyl or sulfonyl group, or in a 5- to 7-membered monocyclic or phenyl-fused cycloalkylenimine group, both methylene groups bound by an imine nitrogen atom may be replaced by a carbonyl group, or R 6 represents a C 1-4 -alkyl group which is substituted carboxyl, C 1-3 -alkoxycarbonyl, aminocarbonyl, C 1-3 -alkylaminocarbonyl it or di (C first 3 alkyl) -aminokarbonylovou group or a 4-7 membered cykloalkyléniminokarbonylovou group, a group of 7V- (C 3 alkyl) -C2.4-alkanoylamino which is additionally substituted alkyl or carboxy A C 1-3 -alkoxycarbonyl group, a group of the formula -N(R12) - CO - (CH2)„ - R13 (IV), v ktorom-N (R 12 ) -CO- (CH 2 ) n -R 13 (IV) wherein R12 znamená atóm vodíka, C^g-alkylovú alebo C3.7-cykloalkylovú skupinu, alebo terminálnu Ci_3-alkylovú skupinu, substituovanú fenylovou skupinou, heteroarylovou skupinou, trifluórmetylovou skupinou, hydroxyskupinou, Ci_3-alkoxyskupinou, aminokarbonylovou skupinou, C1.4-alkylamino-karbonylovou skupinou, di-(Ci_4-alkyl)aminokarbonylovou skupinou, Cj.3-alkyl-karbonylovou skupinou, Ci_3-alkyl-sulfonyl-amino skupinou, V-(C1.3-alkyl)-C1.3-alkyl-sulfonyl-amino skupinou, C1.3-alkyl-aminosulfonylovou skupinou alebo di-(C|.3-alkyl)-aminosulfonylovou skupinou a p je číslo 0, 1, 2 alebo 3 aR 12 is H, C ^ g alkyl or C 3. 7- cycloalkyl, or terminal C 1-3 -alkyl substituted by phenyl, heteroaryl, trifluoromethyl, hydroxy, C 1-3 -alkoxy, aminocarbonyl, C 1 . A 4- alkylamino-carbonyl group, a di- (C 1-4 -alkyl) aminocarbonyl group, a C 1-6 alkyl group; 3-alkyl-carbonyl, C 3 -alkyl-sulfonyl-amino, N- (C first 3 alkyl) -C first A 3 -alkylsulfonyl-amino group, C 1 . 3- alkyl-aminosulfonyl or di- (C 1-3 -alkyl) -aminosulfonyl and p is 0, 1, 2 or 3; and R13 má rovnaký význam ako určená skupina R7, alebo, pokiaľ číslo p je 1,2 alebo 3, R13 môže znamenať vodíkový atóm, skupinu vzorcaR 13 has the same meaning as R 7 , or, when p is 1, 2 or 3, R 13 may be hydrogen, a group of the formula -N(R14) - (CH2)q - (CO)r - R15 (V), v ktorom-N (R 14 ) - (CH 2 ) q - (CO) r - R 15 (V) in which R14 znamená atóm vodíka, C1.4-alkylovú skupinu, Ci_3-alkylkarbonylovú skupinu, arylkarbonylovú skupinu, fenyl-Ci_3-alkylkarbonylovú skupinu, heteroarylkarbonylovú skupinu, heteroaryl-C[.3-alkylkarbonylovú skupinu, Ci.4alkylsulfonylovú skupinu, arylsulfonylovú skupinu, fenyl-Ci_3-alkyl-sulfonylovú skupinu, heteroarylsulfonylovú skupinu alebo heteroaryl-C1.3-alkyl-sulfonylovú skupinu, q je číslo 1, 2, 3 alebo 4, r je číslo 1, alebo pokiaľ q je číslo 2, 3 alebo 4, r znamená tiež číslo 0 aR 14 represents a hydrogen atom, C 1 . 4- alkyl, C 1-3 -alkylcarbonyl, arylcarbonyl, phenyl-C 1-3 -alkylcarbonyl, heteroarylcarbonyl, heteroaryl-C 1. 3- alkylcarbonyl, C 1-6 alkyl; An alkylsulfonyl group, an arylsulfonyl group, a phenyl-C 1-3 -alkylsulfonyl group, a heteroarylsulfonyl group or a heteroaryl-C 1 group . 3 -alkylsulfonyl, q is 1, 2, 3 or 4, r is 1, or when q is 2, 3 or 4, r is also 0; and R15 má rovnaký význam ako určená skupina R7, skupinu vzorcaR 15 has the same meaning as R 7 , the group of formula -N(R16) - SO2 - R17 (VI), v ktorom-N (R 16) - SO 2 - R 17 (VI), wherein R16 znamená atóm vodíka alebo terminálnu C|.4-alkylovú skupinu voliteľne substituovanú skupinou kyano-, trifluórmetyl-karbonyl-amino- alebo TV-jCj^-alkylj-trifluórmetyl-karbonyl-amino- aR 16 represents a hydrogen atom or a terminal C 1. A 4- alkyl group optionally substituted by cyano-, trifluoromethyl-carbonyl-amino- or N-C 1-6 -alkyl-trifluoromethyl-carbonyl-amino-; R17 znamená Ci_3-alkylovú skupinu, aminoskupinu, substituovanú skupinou di-(C1.3-alkyl)-amino-C1.3-alkyl-karbonyl- alebo di-(Ci.3-alkyl)-amino-C[.3-alkyl-sulfonyl- a skupinou di-(Ci.3-alkyl)-amino-karbonyl-Ci_3-alkyl-, alebo skupinu A'-ÍCu-alkylj-CM-alkylsulfonylamino- alebo V-(C1.3-alkyl)-fenyl-sulfonylamino-, v ktorých alkylová časť je navyše substituovaná skupinou kyano- alebo karboxy-, pričom všetky pre R6 uvedené zvyšky obsahujúce jednoducho viazané alebo nakondenzované fenylové skupiny môžu byť mono- alebo di- substituované atómom fluóru, chlóru, brómu alebo jódu, skupinou C^-alkyl-, trifluórmetyl-, hydroxy-, Ci_3-alkoxy-, karboxy-, C).3-alkoxykarbonyl-, aminokarbonyl-, Ci_4-alkylamino-karbonyl-, di-(Ci_4-alkyl)-amino-karbonyl-, aminosulfonyl-, C]_3-alkyl-aminosulfonyl-, di-(Ci_3-alkyl)-aminosulfonyl-, Ci.3-alkyl-sulfonylamino-, nitro- alebo kyano-, pričom substituenty môžu byť rovnaké alebo rozdielne, alebo dva susediace vodíkové atómy fenylovej skupiny môžu byť nahradené skupinou metyléndioxy-, aR 17 represents a C 3 alkyl group, an amino group substituted by a di- (C first 3 alkyl) amino-C first 3- alkyl-carbonyl- or di- (C 1-3 -alkyl) -amino-C 1. 3-alkyl-sulfonyl group and a di- (Ci. 3 alkyl) aminocarbonyl-C 3 alkyl-, or a group N-ICU-alkyli-alkylsulfonylamino or CM-N (C1. 3 - alkyl) -phenylsulfonylamino- in which the alkyl moiety is additionally substituted by cyano- or carboxy-, wherein all of the R 6 moieties mentioned containing single bonded or fused phenyl groups may be mono- or di-substituted by fluorine, chlorine, bromine or iodine, C 1-6 -alkyl-, trifluoromethyl-, hydroxy-, C 1-3 -alkoxy-, carboxy-, C 1-6-. 3- alkoxycarbonyl-, aminocarbonyl-, C 1-4 -alkylamino-carbonyl-, di- (C 1-4 -alkyl) -amino-carbonyl-, aminosulfonyl-, C 1-3 -alkyl-aminosulfonyl-, di- (C 1-3 -alkyl) 1-Aminosulfonyl-, C 1-6 -alkyl; 3 -alkylsulfonylamino-, nitro- or cyano-, wherein the substituents may be the same or different, or two adjacent hydrogen atoms of the phenyl group may be replaced by a methylenedioxy- group, and R5 znamená atóm vodíka alebo Ci_3-alkylovú skupinu, pričom výrazom arylskupina sa rozumie mono- alebo di- substituovaná fenylová alebo naftylová skupina, voliteľne substituovaná atómom fluóru, chlóru, brómu alebo jódu, skupinou kyano-, trifluórmetyl-, nitro-, karboxy-, aminokarbonyl-, Ci_3-alkyl- alebo Cb3-alkoxy- a výrazom heteroarylová skupina sa rozumie monocyklická päť- alebo šesťčlenná heteroarylová skupina, v uhlíkatom zvyšku voliteľne substituovaná C1.3-alkylovou skupinou, pričom uvedená šesťčlenná heteroarylová skupina obsahuje jeden, dva alebo tri atómy dusíka a päťčlenná heteroarylová skupina obsahuje iminoskupinu voliteľne substituovanú C[.3-alkylovou alebo fenylCj-3-alkylovou skupinou, atóm kyslíka alebo síry, alebo iminoskupinu voliteľne substituovanú C1.3-alkylovou alebo fenyl-C[.3-alkylovou skupinou, alebo atóm kyslíka alebo síry, a okrem toho atóm dusíka, alebo iminoskupinu voliteľne substituovanú C^-alkylovou alebo fenyl-Ci_3-alkylovou skupinou a dva atómy dusíka, a okrem uvedeného môže byť na uvedené monocyklické heterocyklické skupiny cez dva susediace atómy uhlíka nakondenzovaný fenylový kruh a nastáva väzba cez dusíkový atóm alebo cez atóm uhlíka heterocyklickej časti alebo nakondenzovaného fenylového kruhu, atómy vodíka v uvedených alkylových a alkoxylových skupinách alebo v alkylových častiach určených skupín všeobecného vzorca (I) môžu byť čiastočne alebo celkom nahradené atómami fluóru, a ktorákoľvek karboxylová skupina nachádzajúca sa v uvedených skupinách môže byť nahradená terc.-butoxykarbonylovou prekurzorovou skupinou, aR 5 represents a hydrogen atom or a C 1-3 -alkyl group, the term aryl being a mono- or di-substituted phenyl or naphthyl group optionally substituted by a fluorine, chlorine, bromine or iodine atom, cyano-, trifluoromethyl-, nitro-, carboxy -, aminocarbonyl, C 3 alkyl- or alkoxy-C B3, and the term heteroaryl means a monocyclic five or six membered heteroaryl group, the carbonaceous residue, optionally substituted C first A 3- alkyl group, wherein said six-membered heteroaryl group contains one, two or three nitrogen atoms and the five-membered heteroaryl group contains an imino group optionally substituted with C 1-6 alkyl; A 3- alkyl or phenylC 1-3 -alkyl group, an oxygen or sulfur atom, or an imino group optionally substituted with C 1 . 3- alkyl or phenyl-C 1. 3 -alkyl, or O or S, and also N, or NH optionally substituted by C ^ -alkyl or phenyl-C 3 -alkyl, and two nitrogen atoms, and in addition to that it may be said monocyclic heterocyclic groups via two adjacent carbon atoms of the fused phenyl ring and the bond occurs through the nitrogen atom or through the carbon atom of the heterocyclic moiety or the fused phenyl ring, the hydrogen atoms in said alkyl and alkoxy groups or in the alkyl moieties of the specified groups of formula I may be partially or fully replaced by fluorine atoms , and any carboxyl group present in said groups may be replaced by a tert-butoxycarbonyl precursor group, and každý z atómov vodíka naviazaných na atóm dusíka môže byť nahradený hydroxyskupinou, benzoylovou, pyridinoylová, formylovou, acetylovou, propionylovou, butanoylovou, pentanoylovou, hexanoylovou, alyloxykarbonylovou, metoxykarbonylovou, etoxykarbonylovou, propoxykarbonylovou, izopropoxykarbonylovou, butoxykarbonylovou, /erc-butoxykarbonylovou, pentoxykarbonylovou, hexyloxykarbonylovou, oktyloxykarbonylovou, nonyloxykarbonylovou, decyloxykarbonylovou, undecyloxykarbonylovou, dodecyloxykarbonylovou, hexadecyloxykarbonylovou, benzyloxykarbonylovou, fenyletoxykarbonylovou, fenylpropoxykarbonylová, C1.3-alkylsulfonyl-C2.4-alkoxykarbonylovou, Ci.3-alkoxy-C2.4-alkoxy-C2.4-alkoxykarbonylovou skupinou alebo ReCO-O-(RfCR8)-O-CO- skupinou, v ktorejeach of the hydrogen atoms attached to the nitrogen atom can be replaced by hydroxy, benzoyl, pyridinoyl, formyl, acetyl, propionyl, butanoyl, pentanoyl, hexanoyl, allyloxycarbonyl, methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, isopropoxycarbonyl, isopropoxycarbonyl, isopropoxycarbonyl, octyloxycarbonyl, nonyloxycarbonyl, decyloxycarbonyl, undecyloxycarbonyl, dodecyloxycarbonyl, hexadecyloxycarbonyl, benzyloxycarbonyl, phenylethoxycarbonyl, phenylpropoxycarbonyl, C 1 . 3 -alkylsulfonyl-C 2nd 4- alkoxycarbonyl, Ci. 3 -alkoxy-C 2nd 4 -alkoxy-C 2nd A 4- alkoxycarbonyl group or a R e CO-O- (R f CR 8 ) -O-CO- group in which Re znamená C,_8-alkylovú skupinu, C5.7-cykloalkylovú skupinu, fenylovú alebo fenyl-Ci_3-alkylovú skupinu, Rf znamená atóm vodíka, C].3-alkylovú skupinu, C5.7-cykloalkylovú skupinu alebo fenylovú skupinu a Rs znamená atóm vodíka alebo C].3-alkylovú skupinu, ich tautoméry a ich soli.R e is C, _8 alkyl, C 5-7 cycloalkyl, phenyl or phenyl-Ci_3-alkyl, R f is H, C] .3 alkyl, C 5. 7 cycloalkyl group or a phenyl group and R is H or C]. A 3- alkyl group, tautomers and salts thereof. 2. Indolinóny všeobecného vzorca (I) podľa nároku 1, v ktorýchThe indolinones of general formula (I) according to claim 1, in which R1 a R3 sú určené skôr aR 1 and R 3 are as defined above and X je atóm kyslíka,X is an oxygen atom, R2 je karboxylová skupina, nerozvetvená alebo rozvetvená Ci.6-alkoxy-karbonylová skupina, C5.7-cykloalkoxykarbonylová skupina alebo fenoxykarbonylová skupina, nerozvetvená alebo rozvetvená Ci_3-alkoxy-karbonylová skupina, ktorá v koncovej alkylovej časti je substituovaná skupinou fenyl-, heteroaryl-, karboxy-, C[.3-alkoxy-karbonyl-, aminokarbonyl-, Cu-alkylammokarbonyl- alebo di-(Ci_3-alkyl)-amino-karbonylovou skupinou, nerozvetvená alebo rozvetvená C2.3-alkoxy-karbonylová skupinu, ktorá je v alkylovej koncovej časti substituovaná atómom chlóru, skupinou hydroxy-, Ci_3-alkoxy-, amino-, C1.3-alkylamino- alebo di-CC^-alkyl)-amino-, aminokarbonylová alebo metylaminokarbonylová skupina, etylaminokarbonylová skupina voliteľne v polohe 2 etylovej skupiny substituovaná skupinou hydroxy- alebo C|.3-alkoxy-,R 2 is a carboxyl group, unbranched or branched C 1-6; 6 -alkoxycarbonyl, C 5 . 7- cycloalkoxycarbonyl or phenoxycarbonyl, unbranched or branched C 1-3 -alkoxycarbonyl, which in the terminal alkyl moiety is substituted by phenyl-, heteroaryl-, carboxy-, C 1-6 -alkyl; 3- alkoxy-carbonyl-, aminocarbonyl-, C 1-6 -alkylaminocarbonyl- or di- (C 1-3 -alkyl) -amino-carbonyl, straight or branched-chain C 2 . A 3 -alkoxycarbonyl group, which is substituted in the alkyl terminal part by a chlorine atom, a hydroxy-, C 1-3 -alkoxy-, amino-, C 1 - group ; A 3- alkylamino- or di (C 1-6 -alkyl) -amino-, aminocarbonyl or methylaminocarbonyl group, an ethylaminocarbonyl group optionally at the 2-position of the ethyl group substituted with a hydroxy- or C 1-6 -alkyl group; 3 -alkoxy-, R4 znamená C3.7-cykloalkylovú skupinu, pričom metylénová skupina v polohe 4 šesťčlennej alebo sedemčlennej cykloalkylovej skupiny môže byť nahradená skupinou amino-, C1.3-alkyl-amino- alebo skupinou di-(C1.3-alkyl)-amino-, alebo môže byť nahradená skupinou -NH- alebo -MC|.3-alkyl)-, alebo skupinou R6 substituovanú fenylovú skupinu, ktorá môže byť navyše mono- alebo di-substituovaná atómom fluóru, chlóru alebo brómu, skupinou Ci_3-alkyl-, trifluórmetyl-, hydroxy-, C[.3-alkoxy-, karboxy-, Cl.3-alkoxykarbonyl-, amino-, acetyl-amino-, aminokarbonyl-, Ci_3-alkyl-aminokarbonyl-, di-(Ci_3-alkyl)-aminokarbonyl-, nitro- alebo kyano-, pričom substituenty môžu byť rovnaké alebo rozdielne a pričom R6 znamená atóm vodíka, fluóru, chlóru, brómu alebo jódu, skupinu kyano-, nitro-, amino-, C1.5-alkyl-, C3.7-cykloalkyl-, trifluórmetyl-, fenyl-, tetrazolyl- alebo heteroarylovú skupinu, skupinu vzorca v ktorom atóm vodíka, viazaný na dusíkový atóm môže byť nahradený C1.3-alkylovou skupinou, skupinu Ci.3-alkoxy-, amino-C2.3-alkoxy-, Ci_3-alkylamino-, C2.3-alkoxy-, di-(Ci.3-alkyl)-amino-C2.3-alkoxy-, fenyl-Ci.3-alkylamino-C2.3-alkoxy-, A-(Ci.3-alkyl)-fenyl-CI.3-alkylamino-C2.3-alkoxy-, pyrolidino-C2.3-alkoxy-, piperidino-C2.3-alkoxy- alebo Ci_3-alkylmerkapto-, karboxylovú skupinu, skupinu C].4-alkoxykarbonyl-, aminokarbonyl-, C1_3-alkyl-ammo-karbonyl-, fenyl-Ci_3-alkylamino-karbonyl- alebo jV-(Ci_3-alkyl)-fenyl-C].3-alkyl-amino-karbonyl-, skupinu C3.7-cykloalkyl-karbonyl-, pričom metylénová skupina v polohe 4 šesťčlennej alebo sedemčlennej cykloalkylovej časti môže byť nahradená skupinou -NH- alebo -MC|.;.-alkyl)-,R 4 is C 3. 7 cycloalkyl group wherein a methylene group in the 4-position six or seven membered cycloalkyl group can be replaced by amino, C first 3-alkyl-amino group or a di (C1. 3 alkyl) amino, or can be replaced by -NH- or-MC |. 3- alkyl) -, or a phenyl-substituted phenyl group which may additionally be mono- or di-substituted by a fluorine, chlorine or bromine atom, a C 1-3 -alkyl-, trifluoromethyl-, hydroxy-, C 1-6 -alkyl group. 3 -alkoxy, carboxy, C l. 3- alkoxycarbonyl-, amino-, acetyl-amino-, aminocarbonyl-, C 1-3 -alkyl-aminocarbonyl-, di- (C 1-3 -alkyl) -aminocarbonyl-, nitro- or cyano-, wherein the substituents may be the same or different and wherein R 6 represents a hydrogen, fluorine, chlorine, bromine or iodine atom, a cyano-, nitro-, amino-, C 1 - group . 5- alkyl-, C 3 . 7 -cycloalkyl-, trifluoromethyl, phenyl, tetrazolyl or heteroaryl group of formula wherein the hydrogen atom bonded to the nitrogen atom may be replaced by C first A 3- alkyl group; 3 -alkoxy, amino-C 2nd 3- alkoxy-, C 1-3 -alkylamino-, C 2 . 3- alkoxy-, di- (C 1-3 -alkyl) -amino-C 2 . 3- alkoxy-, phenyl-C 1-6 alkyl; 3 -alkylamino-C 2nd 3 -alkoxy, N- (Cl. 3 alkyl) -phenyl-C. 3 -alkylamino-C 2nd 3 alkoxy-, C-pyrrolidino second 3 alkoxy-, piperidino-C 2nd A 3- alkoxy- or C 1-3 -alkylmercapto-, carboxyl group, a C 1 group. 4 -alkoxycarbonyl-, aminocarbonyl-, C 1 _ 3 alkyl-amino-carbonyl, phenyl-C 3 -alkylamino-carbonyl or N- (C 3 -alkyl) phenyl-C]. 3-alkyl-amino-carbonyl group, C 3. 7- cycloalkyl-carbonyl-, wherein the methylene group at the 4-position of the 6-membered or 7-membered cycloalkyl moiety may be replaced by -NH- or -MC (alkyl) -, 4 až 7 člennú cykloalkylénimínovú skupinu, v ktorej môže byť metylénová skupina viazaná na iminoskupinu nahradená karbonylovou alebo sulfonylovou skupinou, alebo jeden alebo dva atómy vodíka môžu byť každý nahradené Cb:i-alkylovou skupinou a/alebo metylénová skupina v polohe 4 šesťčlennej alebo sedemčlennej cyklo-alkylénimínovej skupiny môže byť substituovaná karboxylovou skupinou, C]_3-alkoxykarbonylovou skupinou, aminokarbonylovou skupinou, Ci_3-alkyl-aminokarbonylovou skupinou, di-(Ci_3-alkyl)-aminokarbonylovou skupinou, fenyl-Ci_3-alkylamínovou skupinou alebo /V-(C1_3-alkyl)-fenyl-Ci.3-alkyl-amínovou skupinou, alebo môže byť nahradená atómom kyslíka alebo síry, skupinou sulfinyl-, sulfonyl-, -NH- alebo -7V(Ci.3-alkyl)-, terminálovú CM-alkylovú skupinu, substituovanú skupinou R7, pričom4-7 membered cykloalkylénimínovú group in which the methylene group can be attached to the imino group substituted by a carbonyl or sulfonyl group, or one or two hydrogen atoms may each be replaced by C p i -alkyl and / or the methylene group in the 4-position six or seven membered the cycloalkylenimine group may be substituted by carboxyl, C 1-3 -alkoxycarbonyl, aminocarbonyl, C 1-3 -alkylaminocarbonyl, di- (C 1-3 -alkyl) aminocarbonyl, phenyl-C 1-3 -alkylamino or / N- (C 1 _3-alkyl) -phenyl-C. A 3 -alkylamino group, or may be replaced by an oxygen or sulfur atom, a sulfinyl-, sulfonyl-, -NH- or -7V (C 1-3 -alkyl) -, terminal C 1-4 -alkyl group substituted with R 7 , while R7 znamená C5_7-cykloalkylovú skupinu, pričom metylénová skupina v polohe 4 šesťčlennej alebo sedem-člennej cykloalkylovej skupiny môže byť nahradená skupinou -NH- alebo -/V(Ci_3-alkyl)-, alebo v päťčlennej až sedemčlennej cykloalkylovej skupine môže byť nahradená skupina -(CH2)2- skupinou -CO-NH-, skupina -(CH2)3- skupinou -NH-CO-NH-, alebo skupina -(CH2)4- skupinou -NH-CO-NH-CO-, pričom vodíkový atóm viazaný na atóme dusíka môže byť vždy nahradený C[.3-alkylovou skupinou, fenylovú alebo heteroarylovú skupinu, skupinu hydroxy- alebo Ci.3-alkoxy-, skupinu amino-, C|.6-alkylamino-, di-(C1.6-alkyl)-amino-, fenylamino-, /V-fenyl-Ci_3-alkyl-amino-, fenyl-C|.3-alkylamino-, A,-(C|.3-alkyl)-feny]-C|.3-alkylamino- alebo di-(fenyl-C1.3-alkyl)-amino-, skupinu co-hydroxy-C2.3-alkyl-amino-, 7V-(Ci_3-alkyl)-a>-hydroxy-C2.3-alkyl-amino-, di-(to-hydroxy-C2.3-alkyl)-amino-, di-(ro-(C1.3-alkoxy)-C2.3-alkyl)-amino- alebo /V-(dioxolán-2-yl)-Ci.3-alkyl-amino-, skupinu C1.3-alkylkarbonylamino-C2.3-alkyl-amino- alebo Ci.3-alkylkarbonyl-amino-C2.3-alkyl-/V-(Ci.3-alkyl)-amino-, skupinu Ci.3-alkylsulfonylamino-, A,-(C1.3-alkyl)-Ci_3-alkyl-sulfonylamino-, C1.3-alkylsulfonylamino-C2.3-alkyl-amino- alebo Ci.3-alkylsulfonylamino-C2.3-alkyl-7V-(Ci_3-alkyl)-amino-, skupinu hydroxykarbonyl-C1.3-alkylamino- alebo M(Ci.3-alkyl)-hydroxy-karbonyl-C1.3-alkyl-amino-, guanidínovú skupinu, v ktorej atóm vodíka môže byť nahradený C].3-alkylovou skupinou, skupinu vzorcaR 7 is C 5 _7 cycloalkyl group wherein a methylene group in the 4-position six or seven membered cycloalkyl group can be replaced by -NH- or - / V (C 3 alkyl) -, or a five to seven membered cycloalkyl group may be be replaced by - (CH 2 ) 2 - by -CO-NH-, - (CH 2 ) 3 - by -NH-CO-NH-, or - (CH 2 ) 4 by -NH-CO-NH -CO-, wherein the hydrogen atom bonded to the nitrogen atom can always be replaced by C 1-6. 3- alkyl, phenyl or heteroaryl, hydroxy- or C 1-6 -alkyl; 3- alkoxy-, amino-, C1-6alkoxy-; 6 -alkylamino, di- (C1. 6 alkyl) amino, phenylamino, / V-phenyl-C 3 -alkyl-amino, phenyl-C |. 3 -alkylamino, A, - (C |. 3 alkyl) -phenyl] C | .3-alkylamino or di- (phenyl-C1. 3 alkyl) amino, CO-hydroxy-C 2 . 3- alkyl-amino- N - (C 1-3 -alkyl) - N -hydroxy-C 2 . 3-alkyl-amino, di (a-hydroxy-C second 3-alkyl) amino, di (ro- (C first 3 -alkoxy) -C second 3-alkyl) amino, or / N- (dioxolan-2-yl) -C. 3-alkyl-amino, C first 3-alkylcarbonylamino C 2nd 3- alkyl-amino- or C 1-6 alkyl; 3 -alkylcarbonyl-amino-C 2nd 3 alkyl- / N (Cl. 3 alkyl) amino group, Ci.3-alkylsulfonylamino, A, - (C1. 3 alkyl) -Ci_ 3 -alkyl-sulfonylamino, C1. 3-C alkylsulfonylamino second 3- alkyl-amino- or C 1-6 alkyl; 3-C alkylsulfonylamino second 3- alkyl-N - (C 1-3 -alkyl) -amino-, hydroxycarbonyl-C 1 . 3- alkylamino- or M (C 1-3 -alkyl) -hydroxy-carbonyl-C 1 . A 3- alkyl-amino-, guanidino group in which the hydrogen atom can be replaced by C 1. 3- alkyl, a group of formula -N(R8) - CO - (CH2)n - R9 (II), v ktorom-N (R 8 ) -CO- (CH 2 ) n -R 9 (II) wherein R8 znamená atóm vodíka alebo C|.3-alkylovú skupinu, n znamená číslo 0, 1,2, alebo 3,R 8 represents a hydrogen atom or C 1-6 alkyl; 3- alkyl, n is 0, 1, 2, or 3, R9 znamená skupinu amino-, C1.3-alkylamino-, di-(C|.--alkyl)-amino-, fenylamino-, benzylamino- alebo C|_4-alkoxy-, 5- až 7-člennú cyklo-alkylénimínovú skupinu, pričom metylénová skupina v polohe 4 piperidínovej skupiny môže byť nahradená atómom kyslíka alebo síry, skupinou -NH-, -A'/C^-alkyl)-, -N(fenyl)-, -7V(Ci_3-alkyl-karbonyl)- alebo -Mbenzoyl)-, alebo, pokiaľ n znamená číslo 1, 2, alebo 3, R9 môže znamenať tiež atóm vodíka, skupinu vzorcaR 9 is amino-, C 1 . 3 -alkylamino, di- (C | .-- alkyl) amino, phenylamino, benzylamino or C | _ 4 -alkoxy, a 5- to 7-membered cycloalkyl alkyleneimine group, the methylene group at position 4 the piperidine group may be replaced by an oxygen or sulfur atom, the group -NH-, -A '(C 1-6 -alkyl) -, -N (phenyl) -, -7 N (C 1-3 -alkylcarbonyl) - or -Menzoyl) -, or, when n is 1, 2, or 3, R 9 can also be a hydrogen atom, a group of the formula -N(R10) - (CH2)m - (CO)o - R11 (III), v ktorom-N (R 10) - (CH 2) m - (CO) O - R @ 11 (III), wherein R10 znamená atóm vodíka, Ci_3-alkylovú skupinu, C1.3-alkylkarbonylovú skupinu, C1.3-alkylsulfonylovú skupinu, mje číslo 1, 2 alebo 3, o je číslo 1 alebo, pokiaľ m znamená číslo 2 alebo 3, o môže znamenať tiež číslo 0 aR 10 represents a hydrogen atom, a C 1-3 -alkyl group, C 1 . 3- alkylcarbonyl, C 1 . A 3- alkylsulfonyl group, m is 1, 2 or 3, o is 1 or, when m is 2 or 3, o may also be 0 and R11 znamená skupinu amino-, Ci.3-alkylamino-, di-(Ci_3-alkyl)-amino-, alebo skupinu Ci_3-alkoxy-Ci_3-alkoxy-, alebo päťčlennú až sedem-člennú cykloalkylénimínovú skupinu, pričom metylénová skupina v polohe 4 piperidínovej skupiny môže byť nahradená atómom kyslíka alebo síry, skupinou -NH-, -/V(C].3-alkyl)-, -N(fenyl)-, -/V(Ci.3-alkyl-karbonyl)- alebo -Mbenzoyl)-, skupinu C4_7-cykloalkylamino- alebo C4.7-cykloalkenylamino-, v ktorej sa poloha 1 kruhu nezúčastňuje na dvojitej väzbe,R 11 represents amino-, C 1-6 alkyl; 3- alkylamino-, di- (C 1-3 -alkyl) -amino-, or a C 1-3 -alkoxy-C 1-3 -alkoxy- group, or a 5- to 7-membered cycloalkyleneimine group, wherein the methylene group at the 4-position of the piperidine group may be replaced oxygen or sulfur atom, -NH-, - N (C 1-3 -alkyl) -, -N (phenyl) -, - N (C 1-3 -alkylcarbonyl) - or -Mbenzoyl) -, C 4 - 7 -cycloalkylamino- or C 4 - . 7 -cycloalkenylamino- in which position 1 of the ring does not participate in the double bond, 4 až 7 člennú cykloalkylénimínovú skupinu, v ktorej cykloalkylénová časť môže byť kondenzovaná s fenylovou skupinou alebo, jeden alebo dva atómy vodíka môžu byť každý nahradené Ci_3-alkylovou skupinou, a/alebo A 4 to 7 membered cycloalkyleneimine group in which the cycloalkylene moiety may be fused to a phenyl group or, one or two hydrogen atoms may each be replaced by a C 1-3 -alkyl group, and / or SK 287312 Β6 metylénová skupina v polohe 3 pyrolidínovej skupiny môže byť substituovaná hydroxyskupinou alebo skupinou C|.3-alkoxy-, metylénová skupina v polohe 4 šesťčlennej alebo sedemčlennej cykloalkylénimínovej skupiny môže byť substituovaná hydroxy-skupinou, hydroxy-Ci_3-alkylovou skupinou, skupinou C,.3-alkoxy-, karboxy-, C].3-alkoxykarbonyl-, aminokarbonyl-, Cj^-alkylamino-karbonyl, di-(C1_3-alkyl)-aminokarbonyl-, fenyl-Ci_3-alkylamino- alebo jV-(C1.3-alkyl)-fenyl-Ci.3-alkylamino-, alebo uvedená metylénová skupina môže byť nahradená atómom kyslíka alebo síry, skupinou sulfinyl-, sulfonyl-, -NH-, -A(Ci.3-alkyl)-, -<V(fenyl)-, -jV(fenyl-Ci_3-alkyl)-, -jV(C].3-alkyl-karbonyl)-, -MCi-4-alkoxy-karbonyl)-, -7V(benzoyl)- alebo -TV(fenyl-Ci.3-alkyl-karbonyl)-, pričom metylénová skupina, ktorá je viazaná s iminovým atómom dusíka cykloalkylénimínovej skupiny môže byť nahradená karbonylovou skupinou alebo sulfonylovou skupinou, alebo v päťčlennej až šesťčlennej monocyklickej alebo s fenylovou skupinou kondenzovanej cykloalkylénimínovej skupine obidve metylénové skupiny viazané na imínový atóm dusíka môžu byť každá nahradené karbonylovou skupinou, alebo R6 znamená Ci_4-alkylovú skupinu, ktorá je na koncovej časti substituovaná karboxylovou skupinou, skupinou Cj^-alkoxykarbonyl-, aminokarbonyl-, C1.3-alkyl-aminokarbonyl- alebo di-(Ci.3-alkyl)-aminokarbonyl- alebo 4 až 7 člennou cyklo-alkyléniminokarbonylovou skupinou, skupinu vzorcaThe methylene group at the 3-position of the pyrrolidine group may be substituted with a hydroxy group or a C 1 group. The 3- alkoxy-, methylene group at the 4-position of a 6-membered or 7-membered cycloalkyleneimine group may be substituted by a hydroxy group, a hydroxy-C 1-3 -alkyl group, a C 1-6 group. 3- alkoxy-, carboxy-, C1-8. 3 -alkoxycarbonyl-, aminocarbonyl, C ^ alkylamino-carbonyl, di (C 1 _3-alkyl) aminocarbonyl-, phenyl-C 3 -alkylamino or N- (C first 3-alkyl) -phenyl-C . 3- alkylamino-, or said methylene group may be replaced by an oxygen or sulfur atom, a sulfinyl-, sulfonyl-, -NH-, -A (C 1-3 -alkyl) -, - (V) phenyl, -, N ( phenyl-C 1-3 -alkyl) -, N - (C 1-3 -alkyl-carbonyl) -, -MC 1-4 -alkoxy-carbonyl) -, -7 N (benzoyl) - or -TV (phenyl-C 1-3 - wherein the methylene group bonded to the imine nitrogen atom of the cycloalkylenimine group may be replaced by a carbonyl group or a sulfonyl group, or in a 5- to 6-membered monocyclic or phenyl-fused cycloalkyleneimine group, both methylene imines may be bound to the methylene imine groups each be replaced by a carbonyl group, or R 6 is a C 4 alkyl group, which is the end portion substituted by carboxy, C ^ alkoxycarbonyl- group, aminocarbonyl, C first A 3- alkyl-aminocarbonyl- or di- (C 1-3 -alkyl) -aminocarbonyl- or a 4 to 7-membered cycloalkyleneiminocarbonyl group, a group of the formula -N(R12) - CO - (CH2)p - R13 (IV), v ktorom-N (R 12 ) -CO- (CH 2 ) p -R 13 (IV) wherein R12 znamená atóm vodíka, C|.3-alkylovú alebo C5.7-cykloalkylovú skupinu, fenyl-Ci_3-alkylovú alebo heteroaryl-C].3-alkylovú skupinu a p je číslo 0, 1, 2 alebo 3 aR 12 represents a hydrogen atom, C 1-6. 3 alkyl or C 5 .7-cycloalkyl, phenyl-C 3 -alkyl, or heteroaryl-C]. The 3- alkyl group and p is the number 0, 1, 2 or 3 a R13 má rovnaký význam ako určená skupina R7, alebo, pokiaľ číslo p je 1, 2 alebo 3, R13 môže znamenať vodíkový atóm, skupinu vzorcaR 13 has the same meaning as R 7 , or, when p is 1, 2 or 3, R 13 can be hydrogen, a group of the formula -N(R14) - (CH2)q - (CO)r - R15 (V), v ktorom-N (R 14 ) - (CH 2 ) q - (CO) r - R 15 (V) in which R14 znamená atóm vodíka, Cj^-alkylovú skupinu, Ci_3-alkylkarbonylovú skupinu, fenylkarbonylovú skupinu, fenyl-Cj-3-alkylkarbonylovú skupinu, heteroarylkarbonylovú skupinu, heteroaryl-C|.3-alkylkarbonylovú skupinu, Cj-4-alkylsulfonylovú skupinu, fenylsulfonylovú skupinu, fenyl-C].3-alkyl-sulfonylovú skupinu, heteroarylsulfonylovú skupinu alebo heteroaryl-Ci_3-alkyl-sulfonylovú skupinu, q je číslo 1, 2, 3 alebo 4, r je číslo 1, alebo, pokiaľ q je číslo 2, 3 alebo 4, r znamená tiež číslo 0 aR 14 represents a hydrogen atom, a C 1-6 -alkyl group, a C 1-3 -alkylcarbonyl group, a phenylcarbonyl group, a phenyl-C 1-3 -alkylcarbonyl group, a heteroarylcarbonyl group, a heteroaryl-C 1-6 group. 3- alkylcarbonyl, C 1-4 -alkylsulfonyl, phenylsulfonyl, phenyl-C 1. 3 -alkylsulfonyl, heteroarylsulfonyl or heteroaryl-C 1-3 -alkylsulfonyl, q is 1, 2, 3 or 4, r is 1, or when q is 2, 3 or 4, r is also number 0 and R15 má rovnaký význam ako určená skupina R7, skupinu vzorcaR 15 has the same meaning as R 7 , the group of formula -N(R16) - SO2 - R17 (VI), v ktorom-N (R 16) - SO 2 - R 17 (VI), wherein R16 znamená atóm vodíka alebo terminálnu C].4-alkylovú skupinu voliteľne substituovanú skupinou kyano-, trifluórmetylkarbonylamino- alebo 7V-(C|.3-alkyl)-trifluórmetylkarbonylamino- aR 16 represents a hydrogen atom or a terminal C 1. A 4- alkyl group optionally substituted by cyano-, trifluoromethylcarbonylamino- or N - (C 1-3 -alkyl) -trifluoromethylcarbonylamino- and R17 znamená Ci_3-alkylovú skupinu, aminoskupinu, substituovanú skupinou di-(C|.3-alkyl)-amino-C|.3-alkyl-karbonyl- alebo di-(Ci.3-alkyl)-amino-Ct.3-alkyl-sulfonyl- a skupinou di-jCi^-alkylj-amino-karbonyl-Cj^-alkyl, pričom všetky pre R6 uvedené zvyšky obsahujúce jednoducho viazané alebo nakondenzované fenylové skupiny môžu byť mono- alebo di- substituované atómom fluóru, chlóru alebo brómu, skupinou C].3-alkyl-, trifluórmetyl-, hydroxy-, Ci_3-alkoxy-, karboxy-, C].3-alkoxykarbonyl-, aminokarbonyl-, Ci_3-alkylaminokarbonyl-, aminosulfonyl-, Ci_3-alkyl-aminosulfonyl-, nitro- alebo kyano-, pričom substituenty môžu byť rovnaké alebo rozdielne, alebo dva susediace vodíkové atómy fenylovej skupiny môžu byť nahradené skupinou metyléndioxy-, aR 17 is C 1-3 -alkyl, amino substituted with di- (C 1-3 -alkyl) -amino-C 1-6 -alkyl. 3- alkyl-carbonyl- or di- (C 1-3 -alkyl) -amino-C 1-6 alkyl; 3 -alkylsulfonyl- and di-C 1-6 -alkyl-amino-carbonyl-C 1-6 -alkyl, all of the radicals mentioned for R 6 containing single bonded or fused phenyl groups may be mono- or di-substituted by fluorine, chlorine or bromine, group C 1. 3- alkyl-, trifluoromethyl-, hydroxy-, C 1-3 -alkoxy-, carboxy-, C 1-3 . 3- alkoxycarbonyl-, aminocarbonyl-, C 1-3 -alkylaminocarbonyl-, aminosulfonyl-, C 1-3 -alkyl-aminosulfonyl-, nitro- or cyano-, wherein the substituents may be the same or different, or two adjacent hydrogen atoms of the phenyl group may be replaced by a group methylenedioxy-, a R5 znamená atóm vodíka alebo Ci_3-alkylovú skupinu, pričom uvedený výraz heteroarylová skupina znamená voliteľne v uhlíkovom skelete Ci_3-alkylovou skupinou substituovanú skupinu pyridinyl-, pyrazinyl-, pyrimidinyl-, pyridazinyl-, pyrolyl-, furyl-, tienyl-, oxazolyl-, tiazolyl-, pyrazolyl-, imidazolyl- alebo triazolyl-, v ktorých jeden atóm vodíka, viazaný na dusíkový atóm môže byť nahradený Ci_3-alkylovou alebo fenyl-Ci_3-alkylovou skupinou a pričom päťčlenné heteroarylové skupiny, ktoré obsahujú najmenej jednu iminoskupinu sú viazané cez atóm uhlíka alebo dusíka, R 5 represents a hydrogen atom or a C 1-3 -alkyl group, said heteroaryl group being optionally substituted in the carbon skeleton by a C 1-3 -alkyl group substituted by pyridinyl-, pyrazinyl-, pyrimidinyl-, pyridazinyl-, pyrrolyl-, furyl-, thienyl-, oxazolyl-, thiazolyl-, pyrazolyl-, imidazolyl- or triazolyl- in which one hydrogen atom attached to the nitrogen atom can be replaced by a C 1-3 -alkyl or a phenyl-C 1-3 -alkyl group and wherein the five-membered heteroaryl groups containing at least one the imino group is bonded via a carbon or nitrogen atom, SK 287312 Β6 v uvedených skupinách môže byť atóm vodíka, ktorý je viazaný na atóm dusíka, nahradený hydroxyskupinou, benzoylovou, pyridinoylová, formylovou, acetylovou, propionylovou, butanoylovou, pentanoylovou, hexanoylovou, alyloxykarbonylovou, metoxykarbonylovou, etoxykarbonylovou, propoxykarbonylovou, izopropoxykarbonylovou, butoxykarbonylovou, Zerc-butoxykarbonylovou, pentoxykarbonylovou, hexyloxykarbonylovou, oktyloxykarbonylovou, nonyloxykarbonylovou, decyloxykarbonylovou, undecyloxykarbonylovou, dodecyl-oxykarbonylovou, hexadecyloxykarbonylovou, benzyloxykarbonylovou, fenyletoxykarbonylovou, fenylpropoxykarbonylová, C1.3-alkylsulfonyl-C2.4-alkoxykarbonylovou, C1.3-alkoxy-C2.4-alkoxy-C2.4-alkoxykarbonylovou skupinou alebo ReCO-O-(RfCRg)-O-CO- skupinou, v ktorejIn said groups, the hydrogen atom which is bonded to the nitrogen atom may be replaced by hydroxy, benzoyl, pyridinoyl, formyl, acetyl, propionyl, butanoyl, pentanoyl, hexanoyl, allyloxycarbonyl, methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, propoxycarbonyl, propoxycarbonyl, propoxycarbonyl, propoxycarbonyl, propoxycarbonyl, t-butoxycarbonyl, pentoxycarbonyl, hexyloxycarbonyl, octyloxycarbonyl, nonyloxycarbonyl, decyloxycarbonyl, undecyloxycarbonyl, dodecyl-oxycarbonyl, hexadecyloxycarbonyl, benzyloxycarbonyl, phenylethoxycarbonyl, phenylpropoxycarbonyl, C first 3 -alkylsulfonyl-C 2 .4-alkyloxycarbonyl, C1-3-alkoxy-C2-4-alkoxy-C2-4-alkoxycarbonyl, or R e CO-O- (R f CR g) -O-CO- group, in which Re znamená Ci.8-alkylovú skupinu, C5.7-cykloalkylovú skupinu, fenylovú alebo fenyl-C ,.3-alkylovú skupinu, Rf znamená atóm vodíka, C^-alkylovú skupinu, C5.7-cykloalkylovú skupinu alebo fenylovú skupinu a R8 znamená atóm vodíka alebo Ci.3-alkylovú skupinu, alebo ktorýkoľvek dusík aminoskupiny môže tvoriť súčasť ftalimidoskupiny, alebo ktorákoľvek karboxylová skupina nachádzajúca sa v uvedených skupinách môže byť nahradená terc-butoxykabonylovou prekurzorovou skupinou, a vodíkové atómy v uvedených alkylových a alkoxylových skupinách, alebo v alkylových častiach určených skupín všeobecného vzorca (I) môžu byť celkom alebo čiastočne nahradené atómami fluóru a ich tautoméry a ich soli.R e represents C 1-8 -alkyl, C 5-7 -cycloalkyl, phenyl or phenyl-C 1-3 -alkyl, R f represents hydrogen, C 1-4 -alkyl, C 5. 7 -cycloalkyl or phenyl; and R 8 represents a hydrogen atom or C 1-6 alkyl. The 3- alkyl group or any amino nitrogen may form part of the phthalimido group, or any carboxyl group present in said groups may be replaced by a tert-butoxycarbonyl precursor group, and hydrogen atoms in said alkyl and alkoxy groups, or in alkyl portions of designated groups of formula (I) may be replaced, in whole or in part, by fluorine atoms and tautomers and salts thereof. 3. Indolinóny všeobecného vzorca (I) podľa nároku 1, v ktorýchThe indolinones of general formula (I) according to claim 1, in which X znamená atóm kyslíka, R1 znamená atóm vodíka, R2 znamená karboxylovú skupinu, nerozvetvenú alebo rozvetvenú C].4-alkoxy-karbonylovú skupinu alebo fenoxykarbonylovú skupinu, nerozvetvenú alebo rozvetvenú Ct.3-alkoxy-karbonylovú skupinu, ktorá je v koncovej alkylovej časti substituovaná fenylovou, karboxylovou, CI.3-alkoxykarbonylovou, aminokarbonylovou, C1.3-alkylaminokarbonylovou alebo di-(Ci.3-alkyl)-amino-karbonylovou skupinou, nerozvetvenú alebo rozvetvenú C2.3-alkoxy-karbonylovú skupinu, ktorá je v koncovej alkylovej časti substituovaná skupinou hydroxy-, C!.3-alkoxy-, amino-, Ci.3-alkyl-amino- alebo di-(Ci_3-alkyl)-amino-, aminokarbonylovú alebo metylaminokarbonylovú skupinu, etylaminokarbonylovú skupinu, ktorá môže byť voliteľne substituovaná v polohe 2 v etylovej skupine skupinou hydroxy- alebo Ci.3-alkoxy-,X is O, R 1 is H, R 2 is carboxyl, straight-chain or branched C]. 4-alkoxy-carbonyl or phenoxycarbonyl group, a linear or branched C i. 3 -alkoxy-carbonyl, which is the terminal alkyl-substituted phenyl, carboxyl, C. 3- alkoxycarbonyl, aminocarbonyl, C 1 . 3 -alkylaminokarbonylovou or di- (Ci. 3 alkyl) amino-carbonyl, linear or branched C2. A 3 -alkoxycarbonyl group which is substituted in the terminal alkyl moiety by a hydroxy-, C1-alkyl group; 3- alkoxy-, amino-, C 1-6 -alkyl; A 3- alkyl-amino- or di- (C 1-3 -alkyl) -amino-, aminocarbonyl or methylaminocarbonyl group, an ethylaminocarbonyl group, which may optionally be substituted at the 2-position in the ethyl group with a hydroxy- or C 1-6 -alkyl group. 3 -alkoxy-, R3 znamená Ci.4-alkylovú skupinu alebo fenylovú skupinu, ktorá môže byť substituovaná atómom fluóru, chlóre alebo brómu, skupinou trifluórmetyl-, C|_3- alkyl-, hydroxy- alebo Ci.3-alkoxy-,R 3 is C 1-6. 4- alkyl or phenyl, which may be substituted by fluorine, chlorine or bromine, trifluoromethyl-, C 1-3 -alkyl-, hydroxy- or C 1-6 -alkyl; 3 -alkoxy-, R4 znamená C5.6-cykloalkylovú skupinu, pričom metylénová skupina v polohe 4 cyklohexylovej skupiny môže byť substituovaná skupinou amino-, Cf-3-alkylamino- alebo di-(C|.3-alkyl)-amino-, alebo nahradená skupinou -NH- alebo -jV(Ci_3-alkyl)-, fenylovú skupinu, fenylovú skupinu disubstituovanú skupinami C].3-alkyl-, Ci.3-alkoxy- alebo nitro-, pričom substituenty môžu byť rovnaké alebo rozdielne, alebo fenylovú skupinu substituovanú skupinou R6, pričom uvedená fenylová skupina môže byť navyše substituovaná atómom fluóru, chlóre alebo brómu alebo skupinou amino- alebo nitro-, pričom R6 znamená atóm fluóru, chlóru alebo brómu,R 4 is C 5. A 6- cycloalkyl group, wherein the methylene group at the 4-position of the cyclohexyl group may be substituted by amino-, C 1-3 -alkylamino- or di- (C 1-3 -alkyl) -amino-, or replaced by -NH- or -J- (C 1-3 -alkyl) -, phenyl, phenyl disubstituted with C 1 groups. 3- alkyl-; 3- alkoxy- or nitro-, wherein the substituents may be the same or different, or a phenyl group substituted by R 6 , wherein said phenyl group may additionally be substituted by a fluorine, chlorine or bromine atom, or an amino- or nitro- group, wherein R 6 represents a fluorine, chlorine or bromine atom, C|.3-alkylovú skupinu, Cj.3-alkoxylovú skupinu, nitroskupinu, aminoskupinu alebo C5.6-cykloalkylovú skupinu, prostredníctvom uhlíkového atómu viazanú pyrolylovú skupinu, pyrazolylovú skupinu, imidazolylovú skupinu, triazolylovú skupinu alebo tetrazolylovú skupinu, pričom uvedené heteroaromatické skupiny môžu byť v uhlíkovom skeletu substituované Ci.3-alkylovou skupinou, alebo jeden vodíkový atóm viazaný na dusíkovom atóme môže byť nahradený Ci_3-alkylovou skupinou alebo fenyl-Ci_3-alkylovou skupinou, skupinu vzorca skupinu karboxy-, C].4-alkoxykarbonyl-, fenyl-C1.3-alkyl-amino-karbonyl- alebo C5.7-cykloalkyl-karbonyl-, päťčlennú alebo šesťčlennú cykloalkylénimínovú skupinu, pričom metylénová skupina v polohe 4 piperidínovej skupiny môže byť nahradená atómom kyslíka alebo atómom síry, skupinou -NH- alebo skupinou -<V(C|.3-alkyl)-, nerozvetvenú Ci.3-alkylovú skupinu, v koncovej časti substituovanú skupinou R7, pričomC |. A 3- alkyl group, e.g. 3- alkoxy, nitro, amino or C 5 . A 6- cycloalkyl group, a pyrrolyl group, a pyrazolyl group, an imidazolyl group, a triazolyl group or a tetrazolyl group bonded via a carbon atom, said heteroaromatic groups being optionally substituted in the carbon skeleton by C 1-6 alkyl; The 3- alkyl group or one hydrogen atom bonded to the nitrogen atom may be replaced by a C 1-3 -alkyl group or a phenyl-C 1-3 -alkyl group, a group of the formula carboxy-, C 1 -alkyl. 4 -alkoxycarbonyl-, phenyl-C first 3- alkyl-amino-carbonyl- or C 5 . A 7- cycloalkyl-carbonyl-, 5- or 6-membered cycloalkyleneimine group, wherein the methylene group at the 4-position of the piperidine group may be replaced by an oxygen or sulfur atom, an -NH- group or a --V (C 1-3 -alkyl) - group, unbranched Ci. A 3- alkyl group, substituted at the terminal portion with R 7 , wherein R7 znamená C5_7-cykloalkylovú skupinu, pričom v päťčlennej alebo šesťčlennej cykloalkylovej skupine môže byť -(CH2)2- skupina nahradená skupinou -CO-NH-, skupina -(CH2)3- môže byť nahradená skupinou -NH-CO-NH- a skupina -(CH2)4- skupinou -NH-CO-NH-CO-, pričom vodíkový atóm viazaný na atóme dusíka môže byť vždy nahradený C].3-alkylovou skupinou, fenylovú alebo pyridinylovú skupinu, alebo prostredníctvom uhlíkového atómu alebo dusíkového atómu viazanú pyrolylovú skupinu, pyrazolylovú skupinu, imidazolylovú skupinu alebo triazolylovú skupinu, pričom uvedené hetero-arylové skupiny môžu byť v uhlíkovom skeletu substituované C1.3-alkylovou skupinou, alebo vodík viazaný na atóme dusíka môže byť nahradený C|_3-alkylovou skupinou, skupinu hydroxy- alebo C[.3-alkoxy-, skupinu amino-, C1.6-alkylamino-, di-(Ci_6-alkyl)-amino-, fenylamino-, jV-fenyl-Ci_3-alkyl-amino-, fenyl-Ci_3-alkylamino- alebo V-(C|.3-alkyl)-fenyl-C|_3-alkyl-amino-, skupinu o)-hydroxy-C2_3-alkylammo-, N-(Ci.3-alkyl)-ro-hydroxy-C2.3-alkyl-amino-, di-(co-hydroxy-C2.3-alkyl)-amino- alebo di-(<o-(Ci.3-alkoxy)-C2.3-alkyl)-amino-, skupinu Ci_3-alkylkarbonylamino-C2_3-alkyl-amino- alebo Ci_3-alkylkarbonyl-amino-C2.3-alkyl-jV-(Ci_3-alkyl)-amino-, skupinu Cl.3-alkylsulfonylamino-, /V-ÍC.-j-alkylj-Co-alkylsuIfonylamino-, C).3-alkylsulfonylamino-C2.3-alkyl-amino-, alebo C1.3-alkylsulfonylamino-C2.3-alkyl-V-(Ci.3-alkyl)-amino-, skupinu hydroxykarbonyl-C]_3-alkyl-amino- alebo A-(C1.3-alkyl)-hydroxy-karbonyl-Ci_3-alkyl-amino-, guanidínovú skupinu, v ktorej môže byť vodík nahradený skupinou C].3-alkyI-, skupinu vzorcaR 7 represents a C 5-7 -cycloalkyl group, wherein in a 5- or 6-membered cycloalkyl group, the - (CH 2 ) 2 - group may be replaced by -CO-NH-, - (CH 2 ) 3 - may be replaced by -NH-CO -NH- and - (CH 2 ) 4 - -NH-CO-NH-CO-, wherein the hydrogen atom bonded to the nitrogen atom can always be replaced by C 1. 3- alkyl, phenyl or pyridinyl, or a pyrrolyl, pyrazolyl, imidazolyl or triazolyl group bonded via a carbon atom or a nitrogen atom, said heteroaryl groups may be C 1 -substituted in the carbon skeleton. The 3- alkyl group or the hydrogen bonded to the nitrogen atom can be replaced by a C 1-3 -alkyl group, a hydroxy- or a C 1-6 -alkyl group. 3 -alkoxy, an amino, C first 6- alkylamino-, di- (C 1-6 -alkyl) -amino-, phenylamino-, N -phenyl-C 1-3 -alkyl-amino-, phenyl-C 1-3 -alkylamino- or N - (C 1-3 -alkyl) phenyl-C | _ 3 -alkyl-amino, a group of) hydroxy-C 2 _ 3 -alkylammo-, N- (Cl. 3 alkyl) -R-hydroxy-C 2. 3-alkyl-amino, di- (co-hydroxy-C2. 3 alkyl) amino or di - (<o (C. 3 -alkoxy) -C second 3-alkyl) amino, alkylcarbonylamino group, a C 3 -C 2 _ 3 -alkyl-amino, or a C 3 alkylcarbonyl-amino-C 2nd 3-alkyl-N- (C 3 alkyl) amino, C l. 3- alkylsulfonylamino-, N-C 1-6 -alkyl- C 0-6 alkylsulfonylamino-, C ) . 3-C alkylsulfonylamino second 3- alkyl-amino-, or C 1 . 3-C alkylsulfonylamino second 3-alkyl-N- (Cl. 3 alkyl) amino group, a hydroxycarbonyl-C] _ 3 -alkyl-amino or N- (C1. 3 alkyl) hydroxy-carbonyl-C 3 alkyl- an amino-, guanidino group in which hydrogen can be replaced by C 1 . 3- alkyl-, a group of formula -N(R8) - CO - (CH2)n - R9 (II), v ktorom-N (R 8 ) -CO- (CH 2 ) n -R 9 (II) wherein R8 znamená atóm vodíka alebo C[.3-alkylovú skupinu, n znamená číslo 0, 1,2, alebo 3,R 8 represents a hydrogen atom or C 1-6 alkyl; 3- alkyl, n is 0, 1, 2, or 3, R9 znamená skupinu amino-, Ci_3-alkylamino-, di-(Ci_3-alkyl)-amino- alebo C1.4-alkoxy-, 5- až 7-člennú cykloalkylénimínovú skupinu, pričom metylénová skupina v polohe 4 piperidínovej skupiny môže byť nahradená skupinou -NH-, -TV(Ci_3-alkyl)- alebo -jV(C!.3-alkyl-karbonyl)-, alebo pokiaľ n znamená číslo 1, 2, alebo 3, R9 môže znamenať tiež atóm vodíka, skupinu vzorcaR 9 is amino-, C 1-3 -alkylamino-, di- (C 1-3 -alkyl) amino or C 1 . A 4- alkoxy-, 5- to 7-membered cycloalkyleneimine group, wherein the methylene group at the 4-position of the piperidine group may be replaced by -NH-, -TV (C 1-3 -alkyl) - or -N (C 1-3 -alkyl-) carbonyl) - or, when n is 1, 2, or 3, R 9 can also be hydrogen, a group of the formula -N(Rl0)-(CH2)m-(CO)o-R (III), v ktorom-N (I0), - (CH 2) m - (CO) a R (III) wherein R10 znamená atóm vodíka alebo Cb3-alkylovú skupinu, m je číslo 1, 2, alebo 3, o je číslo 1 alebo, pokiaľ m znamená číslo 2, alebo 3, o môže znamenať tiež číslo 0 aR 10 is H or C b3 alkyl group, m is 1, 2, or 3, o is 1 or, when m is 2, or 3, o denotes 0, and also R11 znamená skupinu amino-, Ci_3-alkylamino-, di-(Ci_3-alkyl)-amino-, Ci_4-alkoxy- alebo skupinu metoxyCi_3-alkoxy-, alebo 5- alebo 6-člennú cykloalkylénimínovú skupinu, pričom metylénová skupina v polohe 4 piperidínovej skupiny môže byť vždy nahradená skupinou -NH-, -TV(Ci_3-alkyl)-, alebo -7V(Ci_3-alkyl-karbonyľ)-, skupinu azetidino-, pyrolidino-, piperidino-, 2,6-dimetyl-piperidino-, 3,5-di-metyl-piperidino- alebo azepino-, pričom metylénová skupina v polohe 3 pyrolidínovej skupiny môže byť substituovaná skupinou hydroxy, metylénová skupina v polohe 4 piperidínovej skupiny môže byť subs-tituovaná skupinou hydroxy, hydroxyCi_3-alkyl- alebo C^-alkoxy-, alebo metylénová skupina môže byť nahradená atómom kyslíka alebo atómom síry, skupinou sulfmyl-, sulfonyl-, -NH-, -/V(C|.3-alkyl)-, -/V(C].3-alkyl-karbonyl)-, -Mbenzoyl)- alebo -Mfenyl-C|.3-alkyl-karbonyl)-, pričom metylénová skupina viazaná na imínový atóm dusíka pyrolidínovej skupiny, piperidínovej skupiny alebo piperazínovej skupiny môže byť nahradená karbonylovou skupinou, alebo R6 znamená nerozvetvená C!.3-alkylovú skupinu, ktorej koncová časť je substituovaná karboxylovou alebo Ci_3-alkoxy-karbonylovou skupinou, skupinu vzorcaR 11 represents an amino-, C 1-3 -alkylamino-, di- (C 1-3 -alkyl) -amino-, C 1-4 -alkoxy- or methoxyC 1-3 -alkoxy-, or a 5- or 6-membered cycloalkyleneimine group, wherein the methylene group is the 4-position of the piperidine group may in each case be replaced by -NH-, -TV (C 1-3 -alkyl) -, or -7V (C 1-3 -alkylcarbonyl) -, azetidino-, pyrrolidino-, piperidino-, 2, 6-dimethyl-piperidino-, 3,5-dimethyl-piperidino- or azepino-, wherein the methylene group at the 3-position of the pyrrolidine group may be substituted by a hydroxy group, the methylene group at the 4-position of the piperidine group may be substituted by a hydroxy group, the hydroxyC 1-3 -alkyl- or C 1-4 -alkoxy-, or the methylene group may be replaced by an oxygen or sulfur atom, a sulfmethyl-, a sulfonyl-, -NH-, - N (C 1-3 -alkyl) -, - / In (C 1-3 -alkyl-carbonyl) -, -M-benzoyl) - or -M-phenyl-C 1 -. 3-alkyl-carbonyl) -, wherein the methylene group is bonded to the imine nitrogen atom of the pyrrolidine, piperidine or piperazine groups may be replaced by a carbonyl group, or R 6 is a straight-chain C !. A 3- alkyl group whose terminal moiety is substituted by a carboxyl or a C 1-3 -alkoxycarbonyl group, a group of the formula -N(R12) - CO - (CH2)p - R13 (IV), v ktorom-N (R 12 ) -CO- (CH 2 ) p -R 13 (IV) wherein R12 znamená atóm vodíka, Ci_3-alkylovú alebo fenyl-Ci_3-alkylovú skupinu, p je číslo 0, 1 alebo 2 aR 12 represents a hydrogen atom, a C 1-3 -alkyl or a phenyl-C 1-3 -alkyl group, p is 0, 1 or 2 and R13 znamená skupinu amino-, Ci_4-alkylamino-, di-(C1.4-alkyl)-amino-, benzyl-amino-, <V-(C|.3-alkyl)-benzylamino, C1.3-alkoxy-Ci.3-alkylamino-, 7V-(C1.3-alkyl)-Ci.3-alkoxy-Ci_3-alkyl-amino-, di-(2-metoxy-etyl)-amino-, di-(ro-hydroxy-C2.3alkyl)-amino- alebo aminokarbonyl-metyl-V-(metyl)-amino-, prostredníctvom atómu dusíka viazanú, voliteľne Ci_3-alkylovou skupinou substituovanú, pyrolylovú skupinu, pyrazolylovú skupinu alebo imidazolylovú skupinu, skupinu pyrolidino-, piperidino-, morfolino-, tiomorfolino- alebo piperazínovú skupinu, ktorá je voliteľne v polohe 4 substituovaná skupinou C|.3-alkyl-, fenyl-C1.3-alkyl-, C1.3-alkyl.karbonyl- alebo C1.4-alkoxy-karbonyl-, alebo, pokiaľ n znamená číslo 1 alebo 2, R12 môže tiež znamenať vodíkový atóm, skupinu vzorcaR 13 represents an amino, a C 4 -alkylamino, di- (C1. 4 alkyl) amino, benzyl amino, <N- (C |. 3 alkyl) benzylamino, C1. 3- alkoxy-Ci. 3 alkylamino-, 7V- (C1. 3 alkyl) -C. 3 -alkoxy-C 3 -alkyl-amino, di- (2-methoxyethyl) amino, di- (hydroxy-ro-C 2nd 3 alkyl) amino or aminocarbonyl-methyl-N- (methyl ) -amino-, nitrogen-bonded, optionally C 1-3 -alkyl substituted, pyrrolyl, pyrazolyl or imidazolyl, pyrrolidino-, piperidino-, morpholino-, thiomorpholino- or piperazine-group, which is optionally substituted at the 4-position group C |. 3- alkyl-, phenyl-C 1 . 3 -alkyl-, C first Or C 3 -alkyl.karbonyl- first 4- alkoxy-carbonyl- or, when n is 1 or 2, R 12 may also be a hydrogen atom, a group of the formula -N(R14) - (CH2)q - (CO)r - R15 (V), v ktorom-N (R 14 ) - (CH 2 ) q - (CO) r - R 15 (V) in which R14 znamená atóm vodíka, C].4-alkylovú skupinu, Ci_3-alkylkarbonylovú skupinu, fenylkarbonylovú skupinu, fenyl-Ci.3-alkylkarbonylovú skupinu, furyl-karbonylovú skupinu, pyridinylkarbonylovú skupinu, ŕúryl-Cj.3-alkyl-karbonylovú skupinu, pyridinyl-Ci_3-alkylkarbonylovú skupinu, Ci_4-alkyl-sulfonylovú skupinu, fenylsulfonylovú skupinu alebo fenyl-C|.3-alkyl-sulfonylovú skupinu, q je číslo 1, 2 alebo 3, r je číslo 1, alebo, pokiaľ q je číslo 2 alebo 3, r znamená tiež číslo 0 aR 14 represents a hydrogen atom, C 1. 4- alkyl, C 1-3 -alkylcarbonyl, phenylcarbonyl, phenyl-C 1-6 alkyl; 3- alkylcarbonyl, furyl-carbonyl, pyridinylcarbonyl, t-butyl. 3- alkyl-carbonyl, pyridinyl-C 1-3 -alkylcarbonyl, C 1-4 -alkylsulfonyl, phenylsulfonyl or phenyl-C 1-6 alkyl. A 3 -alkylsulfonyl group, q is 1, 2 or 3, r is 1, or, when q is 2 or 3, r is also 0 and R15 znamená skupinu amino-, Ci.4-alkylamino-, di-(C1_4alkyl)-amino-. fenyl-amino-, V-(C|.4-alkyl)-fenylamino-, benzylamino- alebo TV-(C|.4-alkyl)-benzyl-amino-, alebo skupinu vzorcaR 15 represents an amino, Ci.4-alkylamino, di- (C 1 _ 4 alkyl) amino. phenyl-amino-, N - (C 1-4 -alkyl) -phenylamino-, benzylamino- or N - (C 1-4 -alkyl) -benzyl-amino-, or a group of the formula -N(R16) - SO2 - R17 (VI), v ktorom-N (R 16) - SO 2 - R 17 (VI), wherein R16 znamená atóm vodíka alebo terminálnu Ci_3-alkylovú skupinu voliteľne substituovanú skupinou kyano-, trifluórmetyl-karbonyl-amino- alebo V-(Cl.3-alkyl)-trifluórmetyl-karbonyl-amino- aR 16 is H or a terminal a C 3 alkyl group optionally substituted by a cyano, trifluoromethyl-carbonyl-amino or N- (C l. 3-alkyl) carbonyl-trifluoromethyl-amino and R17 znamená Ci_3-alkylovú skupinu, pričom všetky pod označením R6 uvedené zvyšky, obsahujúce jednoducho viazané alebo nakondenzované fenylové skupiny môžu byť substituované atómom fluóru, chlóru alebo brómu, skupinou metyl-, trifluórmetyl-, metoxy-, nitro- alebo kayno- aR 17 represents a C 1-3 -alkyl group, all of the radicals mentioned under R 6 containing single-bonded or fused phenyl groups may be substituted by a fluorine, chlorine or bromine atom, a methyl, trifluoromethyl, methoxy, nitro or kayno- and R5 znamená atóm vodíka, pričom v uvedených zvyškoch môže byť atóm vodíka, viazaný na atóme dusíka nahradený acetylovou skupinou alebo íerc-butoxykarbonylovou skupinou, karboxylové skupiny v uvedených zvyškoch môžu byť aj vo forme íerc-butoxykarbonylových prekurzorových skupín a ich tautoméry a ich soli.R @ 5 represents a hydrogen atom, wherein in said radicals the hydrogen atom bound to the nitrogen atom may be replaced by an acetyl or tert-butoxycarbonyl group, the carboxyl groups in said radicals may also be in the form of tert-butoxycarbonyl precursor groups and tautomers and salts thereof. 4. Indolinóny všeobecného vzorca (I) podľa nároku 1, v ktorýchThe indolinones of general formula (I) according to claim 1, in which X znamená atóm kyslíka,X is an oxygen atom, R1 a R5 sú každé vodíkový atóm,R 1 and R 5 are each a hydrogen atom, R2 znamená metoxykarbonylovú skupinu, etoxykarbonylovú skupinu alebo aminokarbonylovú skupinu,R 2 is methoxycarbonyl, ethoxycarbonyl or aminocarbonyl, R3 znamená fenylovú skupinu,R 3 represents a phenyl group, R4 znamená fenylovú skupinu, ktorá je monosubstituovaná skupinou R6, pričomR 4 represents a phenyl group which is monosubstituted by R 6 , wherein R6 znamená V-metyl-imidazol-2-ylovú skupinu, nerozvetvenú alebo rozvetvenú C|.3-alkylovú skupinu, ktorej koncová časť je substituovaná skupinou CM-alkylamino-, di-(C].4-alkyl)-amino-, piperidino- alebo 2,6-dimetyl-piperidino-, skupinu vzorca (IV)R 6 is N-methyl-imidazol-2-yl, straight or branched C 1-6. A 3- alkyl group whose terminal moiety is substituted by a C 1-4 -alkylamino-, di- (C 1-4 -alkyl) -amino-, piperidino- or 2,6-dimethyl-piperidino- group, a group of formula (IV) -N(R12) - CO - (CH2)p - R13 (IV), v ktorom-N (R 12 ) -CO- (CH 2 ) p -R 13 (IV) wherein R12 znamená Ci_3-alkylovú skupinu, p je číslo 1 alebo 2 aR 12 represents a C 1-3 -alkyl group, p is the number 1 or 2 a R13 znamená di-(Ci.3-alkyl)-aminoskupinu, alebo skupinu vzorca (V)R 13 represents a di- (C 1-3 -alkyl) amino group or a group of formula (V) -N(R14) - (CH2)q - (CO)r - R15 (V), v ktorom-N (R 14 ) - (CH 2 ) q - (CO) r - R 15 (V) in which R14 znamená Ci_3-alkylkarbonylovú skupinu alebo Ci.3-alkylsulfonylovú skupinu, q je číslo 1, 2 alebo 3, r je číslo 1, alebo, pokiaľ q je číslo 2 alebo 3, môže byť r tiež číslo 0 aR 14 represents C 1-3 -alkylcarbonyl or C 1-6 -alkylcarbonyl; 3- alkylsulfonyl, q is 1, 2 or 3, r is 1, or, if q is 2 or 3, r can also be 0 and R15 znamená di-(Ci_3-alkyl)-aminoskupinu, ich tautoméry a ich soli.R 15 represents di- (C 1-3 -alkyl) amino, their tautomers and salts thereof. 5. Substituované indolinóny všeobecného vzorca (I) podľa nároku 1, ktoré sú vybrané zo skupiny zahrnujúcej:The substituted indolinones of formula (I) according to claim 1, selected from the group consisting of: (a) 3-Z-[ 1 -(4-(piperidin-1 -yl-metyl)-anilino)-1 -fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (b) 3 -Z- [(1 -(4-(piperidin-1 -yl-metyl)-anilino)-1 -fenyl-metylén]-6-karbamoyl-2-indolinón, (c) 3-Z-[ 1 -(4-(piperidin-1 -yl-metyl)-anilino)-1 -fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (d) 3-Z-[l-(4-(dimetylaminometyl)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (e) 3-Z-[l-(4-((2,6-dimetyl-piperidin-l-yl)-metyl)-anilino)-l-fenyl-metylén]-6-etoxy-karbonyl-2-indolinón, (f) 3-Z-[l-(4-(W-(2-dimetylamino-etyl)-jV-acetyl-amino)-anilino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (g) 3-Z-[l-(4-(7V-(3-dimetylamino-propyl)-jV-acetyl-amino)-amlino)-l-fenyl-metylén]-6-etoxykarbonyl-2-indolinón, (h) 3-Z-[l-(4-(N-(2-dimetylaminoetyl)-/V-metylsulfonylamino)anilino)-l-fenylmetylén]-6-etoxykarbonyl-2-indolinón, (i) 3 -Z- [ 1 -(4-(dimetylaminometyl)-anilino)-1 -fenyl-metylén] -6-metoxykarbonyl-2-indolinón, (j) 3-Z-[ 1 -(4-(/V-acetyl-TV-dimetylaminokarbonylmetyl-ammo)-anilino)-1 -fenylmetylén]-6-metoxykarbonyl-2-indolinón, (k) 3-Z-[l-(4-etylaminometyl-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (l) 3-Z-[l-(4-(l-metyl-imidazol-2-yl)-anilino)-l-fenylmetylén]-6-rnetoxykarbonyl-2-indolinón, (m) 3-Z-[l-(4-(/V-dimetylaminometylkarbonyl-V-metylamino)-anilino)-l-fenylmetylén]-6-metoxykarbonyl-2-indolinón, (n) 3-Z-[ 1 -(4-(/V-(2-dimetylaminoetyl)-7V-metylsulfonylamino)anilino)-1 -fenylmetylén]-6-metoxykarbonyl-2indolinón, (o) 3-Z-[l-(4-(Ar-(3-dimetylamino-propyl)-V-metylsulfonyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (p) 3-Z-[l-(4-(Y-dimetylaminokarbonylmetyl-7V-metylsulfonyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (q) 3-Z-[l-(4-(/V-((2-dimetylamino-etyl)-karbonyl)-/V-metyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (r) 3-Z-[l-(4-(/V-(2-dimetylamino-etyl)-V-acetyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, (s) 3-Z-[l-(4-metylaminometyl-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón, a (t) 3-Z-[l-(4-(V-((4-metyl-piperazín-l-yl)-metylkarbonyl)-V-metyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón ich tautoméry a ich soli.(a) 3-Z- [1- (4- (piperidin-1-yl-methyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (b) 3-Z- [( 1- (4- (piperidin-1-ylmethyl) -anilino) -1-phenylmethylene] -6-carbamoyl-2-indolinone, (c) 3-Z- [1- (4- (piperidin-1) -yl-methyl) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (d) 3-Z- [1- (4- (dimethylaminomethyl) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (e) 3-Z- [1- (4 - ((2,6-dimethyl-piperidin-1-yl) -methyl) -anilino) -1-phenyl-methylene] - 6-ethoxy-carbonyl-2-indolinone, (f) 3-Z- [1- (4- (N - (2-dimethylamino-ethyl) - N -acetyl-amino) -anilino) -1-phenyl-methylene] -6-ethoxycarbonyl-2-indolinone, (g) 3-Z- [1- (4- (N - (3-dimethylamino-propyl) - N -acetyl-amino) -amino) -1-phenyl-methylene] - 6-ethoxycarbonyl-2-indolinone, (h) 3-Z- [1- (4- (N- (2-dimethylaminoethyl) - N -methylsulfonylamino) anilino) -1-phenylmethylene] -6-ethoxycarbonyl-2-indolinone (i) 3-Z- [1- (4- (dimethylaminomethyl) anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, (j) 3-Z- [1- (4- ( / V-acetyl-TV-dimethylaminocarbonylmethyl-amino) -I lino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, (k) 3-Z- [1- (4-ethylaminomethyl-anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, ( l) 3-Z- [1- (4- (1-methyl-imidazol-2-yl) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, (m) 3-Z- [1- (4- (N-dimethylaminomethylcarbonyl-N-methylamino) -anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone, (n) 3-Z- [1- (4 - (N - (2- dimethylamino-ethyl) -7V-methylsulfonylamino) anilino) -1 -phenyl-] -6-methoxycarbonyl-2indolinón, (o) 3-Z- [l- (4- (N - (3-dimethylaminopropyl) -V-methylsulfonyl amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (β) 3-Z- [1- (4- (N-dimethylaminocarbonylmethyl-N-methylsulfonyl-amino) -anilino) -1 -phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (q) 3-Z- [1- (4 - (N - ((2-dimethylamino-ethyl) -carbonyl) - N -methyl-amino)) (anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (R) 3-Z- [1- (4- (N - (2-dimethylamino-ethyl) -N-acetyl-amino)) (anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, (s) 3-Z- [1- (4-methylaminomethyl-anilino)] -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone, and (1) 3-Z- [1- (4- (N - ((4-methyl-piperazin-1-yl) -methylcarbonyl) -v) (methyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone tautomers and salts thereof. 6. Substituovaný indolinón všeobecného vzorca (I) podľa nároku 1, ktorým je 3-Z-[l-(4-(7V-((4-metyl-piperazin-l-yl)-metylkarbonyl)-N-metyl-amino)-anilino)-l-fenyl-metylén]-6-metoxykarbonyl-2-indolinón alebo jeho farmaceutický prijateľná soľ.The substituted indolinone of formula (I) according to claim 1 which is 3-Z- [1- (4- (N - ((4-methyl-piperazin-1-yl) methylcarbonyl) -N-methyl-amino)) (anilino) -1-phenylmethylene] -6-methoxycarbonyl-2-indolinone or a pharmaceutically acceptable salt thereof. 7. Fyziologicky prípustné soli substituovaných indolinónov podľa nárokov 1 až 6.Physiologically acceptable salts of substituted indolinones according to claims 1 to 6. 8. Farmaceutický prostriedok, vyznačujúci sa tým, že obsahuje indolinón podľa aspoň jedného z nárokov 1 až 6 alebo soľ podľa nároku 7 voliteľne s jedným alebo viacerými nosičmi a/alebo riedidlami.Pharmaceutical composition, characterized in that it comprises an indolinone according to at least one of claims 1 to 6 or a salt according to claim 7, optionally with one or more carriers and / or diluents. 9. Spôsob prípravy farmaceutického prostriedku podľa nároku 8, vyznačujúci sa tým, že sa indolinón podľa aspoň jedného z nárokov 1 až 6 alebo soľ podľa nároku 7 nechemickou cestou zapracuje do jedného alebo viacerých inertných nosičov a/alebo riedidiel.Process for the preparation of a pharmaceutical composition according to claim 8, characterized in that the indolinone according to at least one of claims 1 to 6 or the salt according to claim 7 is incorporated into one or more inert carriers and / or diluents in a non-chemical manner. 10. Spôsob prípravy indolinónov podľa nárokov 1 až 6, alebo soli podľa nároku 7, vyznačujúci sa tým, že (a) na zlúčeninu všeobecného vzorca (VII)A process for the preparation of indolinones according to claims 1 to 6 or a salt according to claim 7, characterized in that (a) to the compound of the general formula (VII) R3 v ktoromR 3 in which X a R3 sú určené v nárokoch 1 až 5,X and R 3 are as defined in claims 1 to 5, R2' má význam ako R2 uvedený v nárokoch 1 až 5,R 2 'is defined as R 2 in claim 1 to 5, R18 znamená vodíkový atóm alebo ochrannú skupinu pre dusík laktámovej skupiny, pričom jeden zo zvyškov R2' a R18 môže voliteľne cez medzičlen (Spacer) vytvárať väzbu s tuhou fázou a druhý z uvedených zvyškov má hore uvedený význam, aR 18 represents a hydrogen atom or a nitrogen protecting group of the lactam group, wherein one of R 2 'and R 18 may optionally form a solid phase bond via a Spacer and the other of said radicals as defined above, and Z1 znamená atóm halogénu, skupinu hydroxy-, alkoxy- alebo arylalkoxy-, sa pôsobí amínom všeobecného vzorca (VIII) (VIII), v ktoromZ 1 is a halogen atom, a hydroxy-, alkoxy- or arylalkoxy- group, is treated with an amine of formula (VIII) (VIII) in which: R4 a R5 sú určené v nárokoch 1 až 5, a ak sa vyžaduje, následne sa odštiepi použitá ochranná skupina dusíka laktámovej skupiny alebo nasleduje odštiepenie od tuhej fázy, (b) na prípravu zlúčeniny všeobecného vzorca (I), v ktoromR 4 and R 5 are as defined in claims 1 to 5 and, if desired, subsequently cleavage of the nitrogen protecting group of the lactam group or followed by cleavage from the solid phase, (b) for the preparation of a compound of formula (I) in which R2 je s výnimkou karboxylovej skupiny určené v nárokoch 1 až 5, sa uskutoční premena zlúčeniny všeobecného vzorca (IX)R 2 is a carboxyl group other than specified in claims 1 to 5, resulting in a conversion of a compound of formula (IX) R3 R 3 R;: R ;: yC — j» V=O yC - j » V O = ''''r '' R HOOC HOOC 'N ] 'N ] v ktorom R1 a R3 až R5 sú určené v nárokoch 1 až 5, alebo jej reaktívneho derivátu so zlúčeninou všeobecného vzorca (X)wherein R 1 and R 3 to R 5 are as defined in claims 1 to 5, or a reactive derivative thereof with a compound of formula (X) R1 R 1 (ix), (Ix)
H-R19 (X), v ktoromHR 19 (X) in which R19 znamená C|.6-alkanol, C4.7-cykloalkanol alebo aromatický alkohol,R 19 is C 1-6 -alkanol, C 4 . 7 -cycloalkanol or aromatic alcohol, C].6-alkanol, ktorý je v koncovej alkylovej časti substituovaný fenylovou skupinou, heteroarylovou skupinou, karboxylovou skupinou, Ci_3-alkoxykarbonylovou skupinou, aminokarbonylovou skupinou, Ci_3-alkylaminokarbonylovou skupinou alebo di-(Ci_3-alkyl)-aminokarbonylovou skupinou,C]. 6 -alkanol substituted in the terminal alkyl moiety with phenyl, heteroaryl, carboxyl, C 1-3 -alkoxycarbonyl, aminocarbonyl, C 1-3 -alkylaminocarbonyl or di- (C 1-3 -alkyl) aminocarbonyl, C|.6-alkanol, ktorý je v koncovej alkylovej časti substituovaný atómom chlóru alebo skupinou hydroxy-, Ci_3-alkoxy-, amino-, Ci.3-alkylamino- alebo di-(C1.3-alkyl)amino-, aminoskupina, alebo metylaminoskupina, etylaminoskupina ktorá voliteľne môže byť substituované v poloheC |. 6 -alkanol substituted in the terminal alkyl moiety with a chlorine atom or a hydroxy-, C 1-3 -alkoxy-, amino-, C 1-6 -alkyl group; 3 -alkylamino or di- (C first 3 alkyl) amino, amino, or methylamino, ethylamino which optionally can be substituted in the 2 etylskupiny skupinou hydroxy- alebo Ci_3-alkoxy-, alebo di-(C|.2-alkyl)-aminoskupina, alebo (c) na prípravu zlúčeniny všeobecného vzorca (I) v ktorom R4 znamená Ct.4-alkylovú skupinu, substituovanú skupinou R7, pričom2-hydroxy ethyl group or a group of a C 3 -alkoxy or di- (C |. 2 alkyl) amino, or (c) for the preparation of a compound of formula (I) wherein R 4 is C i. 4- alkyl, substituted with R 7 , wherein R7 znamená skupinu amino-, Ci_7-alkylamino-, di-(Ci.7-alkyl)-amino-, fenyl-amino-, jV-fenyl-C].3-alkyl-amino-, fenyl-Ci_3-alkyl-amino-, A'-(Ci_3-alkyl)-fenyl-C1_3-alkylamino- alebo di-(fenyl-C1.3-alkyl)-amino-, skupinu o)-hydroxy-C2.3-alkyl-amino-, jV-(C|.3-alkyl)-ro-hydroxy-C2.3-alkyl-amino-, di-(ro-hydroxy-C2.3-alkyl)-amino-, di-(o)-(C|.3-alkoxy)-C2.3-alkyl)-amino- alebo A-(dioxolán-2-yl)-C1.3-alkyl-amino-, skupinu Ci_3-alkylkarbonylamino-C2.3-alkyl-amino- alebo Ci.3-alkylkarbonyl-amino-C2.3-alkyl-TV-(C1_3-alkyl)-amino-, skupinu Ci.3-alkylsulfonylamino-, /V-(C|.3-alkyl)-C|.3-alkylsulfonylamino-, Ci_3-alkylsulfonylamino-C2.3-alkyl-amino- alebo C).3-alkylsulfonylamino-C2.3-alkyl-jV-(C1.3-alkyl)-amino-, skupinu vzorca (III)R 7 is amino-, C 1-7 -alkylamino-, di- (C 1-7 -alkyl) -amino-, phenyl-amino-, N -phenyl-C 1. 3-amino-alkyl, phenyl-C 3 -alkyl-amino, N - (C 3 -alkyl) phenyl-C 1 _ 3 -alkylamino or di- (phenyl-C first 3 alkyl) - amino, a group of) hydroxy-C 2nd 3- alkyl-amino- N - (C 1-3 -alkyl) -ro-hydroxy-C 2 . 3-alkyl-amino, di (ro-hydroxy-C2. 3 alkyl) amino, di (o) - (C |. 3 -alkoxy) -C2. 3-alkyl) -amino or N- (dioxolan-2-yl) -C first 3-amino-alkyl group, a C 3 -C alkylcarbonylamino second 3- alkyl-amino- or C 1-6 alkyl; 3 -alkylcarbonyl-amino-C 2nd 3-TV-alkyl (C 1 _ 3 alkyl) amino, a C. 3 -alkylsulfonylamino-, / V- (C |. 3 alkyl) C | .3-alkylsulfonylamino, C 3 -C 2 alkylsulfonylamino .3-alkyl-amino or C), 3-alkylsulfonylamino-C 2. 3-alkyl-N- (C1 .3 alkyl) amino, a group of formula (III) -N(R10) - (CH2)m - (CO)o - R11 (III) v ktorom-N (R 10 ) - (CH 2 ) m - (CO) o - R 11 (III) wherein R10 znamená atóm vodíka, Ci_3-alkylovú skupinu, Ck3-alkyl-karbonylovú skupinu, arylkarbonylovú skupinu, fenyl-C|.3-alkyl-karbonylovú skupinu, C|.3-alkylsulfonylovú skupinu, arylsulfonylovú skupinu alebo fenylC!.3-alkylsulfonylovú skupinu, m je číslo 1, 2, 3 alebo 4, oje číslo 1 aR 10 is H, C 3 alkyl group, a C k3 alkyl-carbonyl, arylcarbonyl, phenyl-C |. 3 -alkylcarbonyl, C 1-6 alkyl; 3- alkylsulfonyl, arylsulfonyl or phenylC1. 3 alkylsulphonyl group, m is 1, 2, 3 or 4, o is a value 1, and R11 znamená skupinu amino-, Ci_4-alkylamino-, di-(Ci_4-alkyl)-amino-, fenylamino-, ARCi^-alkylj-fenylamino-, benzylamino-, A'-(Ck4-alkyl)-benzylamino-, Ci_4-alkoxy- alebo skupinu Ci_3-alkoxy-Ci.3-alkoxy-, voliteľne skupinou C].3-alkyl- v polohe 1 substituovanú skupinu di- (C1.4-alkyl)-amino-Ci.3-alkylamino- alebo 4až 7-člennú cykloalkylén-imínovú skupinu, pričom cykloalkylénová časť môže byť kondenzovaná s fenylovým kruhom, alebo metylénová skupina v polohe 4 šesťčlennej alebo sedemčlennej cykloalkylénimínovej skupiny môže byť nahradená atómom kyslíka alebo síry, skupinou sulfmyl-, sulfonyl-, -NH-, -/V(Ck3-alkyl)-, -N(fenyl)-, -/v(C|.3-alkyl-karbonyl)- alebo -?V(benzoyl)-, skupinu C4_7-cykloalkylamino-, C4.7-cykloalkyl-C1.3-alkylamino- alebo C4.7-cykloalkenylamino-, v ktorej sa poloha 1 kruhu nezúčastňuje na dvojitej väzbe a pričom uvedené skupiny môžu byť navyše substituované na amínovom atóme dusíka skupinou C5.7-cykloalkyl-, C2.4-alkenyl- alebo Ci.4-alkyl-, alebo 4 až 7 člennú cykloalkylénimínovú skupinu, ktorej cykloalkylénová časť môže byť kondenzovaná s fenylovou skupinou, alebo so skupinou oxazolo-, imidazolo-, tiazolo-, pyridino-, pyrazino- alebo pyrimidino- voliteľne substituovanými atómom fluóru, chlóru, brómu alebo jódu, skupinou nitro-, skupinou C|.3-alkyl-, C,.3-alkoxy alebo aminoskupinou, a ktorej jeden alebo dva atómy vodíka môžu byť nahradené C|.3-alkylovou skupinou, C5.7-cykloalkylovou skupinou alebo fenylovou skupinou, a/alebo ktorej metylénová skupina v polohe 3 päťčlennej cykloalkylénimínovej skupiny môže byť substituovaná skupinou hydroxy-, hydroxy-Ci_3-alkylovou skupinou, skupinou Ck3-alkoxy- alebo Ci_3-alkoxy-Ci.3-alkylovou skupinou, ktorej metylénová skupina v polohe 3 alebo 4 šesťčlennej alebo sedemčlennej cykloalkylénimínovej skupiny môže byť substituovaná hydroxyskupinou, hydroxy-C].3-alkylovou skupinou, skupinou Ci_3-alkoxy-, C]_3-alkoxy-C].3-alkylovou skupinou, Ci_4-alkoxykarbonyl-, aminokarbonyl-, Ci_3-alkylaminokarbonyl-, di-(C]_3-alkyl)-amino-karbonyl-, fenyl-Ci_3-alkylamino- alebo jV-(C1.3-alkyl)-fenyl-Cl.3-alkyl-amino-, alebo uvedená metylénová skupina môže byť nahradená atómom kyslíka alebo síry, skupinou sulfmyl-, sulfonyl-, -NH-, -JV(C1.3-alkyl)-, -JV(fenyl)-, -A(fenyl-Ci_3-alkyl)-, -7V(Ci_3-alkyl-karbonyl)-, -MCk4-alkoxy-karbonyl)-, -vV/benzoyl)- alebo -jV(fenyl-C1.3-alkyl-karbonyl)pričom metylénová skupina, ktorá je viazaná s imínovým atómom dusíka cykloalkylénimínovej skupiny môže byť nahradená karbonylovou skupinou alebo sulfonylovou skupinou, alebo v päťčlennej až sedemčlennej monocyklickej alebo s fenylovou skupinou kondenzovanej cykloalkylénimínovej skupine obidve metylénové skupiny viazané imínovým atómom dusíka môžu byť nahradené karbonylovými skupinami, sa premení zlúčenina všeobecného vzorca (XI) v ktoromR 11 is amino-, C 1-4 -alkylamino-, di- (C 1-4 -alkyl) -amino-, phenylamino-, N-C 1-4 -alkyl-phenylamino-, benzylamino-, N '- (C 1-4 -alkyl) -benzylamino -, C 1-4 -alkoxy- or a C 1-3 -alkoxy-C 1 group. 3- alkoxy, optionally with C 1. 3 at the 1-alkyl-substituted group di- (C 1. 4 alkyl) amino-C. A 3- alkylamino- or 4- to 7-membered cycloalkylene-imine group, wherein the cycloalkylene moiety may be fused to the phenyl ring, or the methylene group at the 4-position of a six- or seven-membered cycloalkyleneimine group may be replaced by an oxygen or sulfur atom; -NH-, - / V (C k3 alkyl) -, -N (phenyl) -, - / in (C |. 3 -alkyl-carbonyl) - or -? V (benzoyl) -, C 4 _7- cycloalkylamino-, C 4 . 7 -cycloalkyl-C 1 . 3- alkylamino- or C 4 . 7 -cycloalkenylamino- in which the ring 1 position does not participate in the double bond and wherein said groups may additionally be substituted on the amino nitrogen atom by a C 5 group. 7 -cycloalkyl- C 2nd 4- alkenyl- or C 1-6 -alkenyl; A 4- alkyl- or 4- to 7-membered cycloalkyleneimine group, the cycloalkylene moiety of which may be fused with a phenyl group or with an oxazolo-, imidazolo-, thiazolo-, pyridino-, pyrazino- or pyrimidino- group optionally substituted by a fluorine, chlorine, bromine or iodine, nitro-, C 1-6. 3- alkyl-; 3- alkoxy or amino, and in which one or two hydrogen atoms may be replaced by C 1-6. 3- alkyl, C 5 . 7 -cycloalkyl or phenyl, and / or wherein a methylene group in position 3 of five cykloalkylénimínovej group may be substituted by hydroxy, hydroxy-C 3 -alkyl, C k3 -alkoxy or a C 3 -alkoxy-C. A 3- alkyl group in which the methylene group at the 3- or 4-position of a six- or seven-membered cycloalkyleneimine group may be substituted by a hydroxy group, hydroxy-C 1. 3- alkyl, C 1-3 -alkoxy-, C 1-3 -alkoxy-C 1. 3- alkyl, C 1-4 -alkoxycarbonyl-, aminocarbonyl-, C 1-3 -alkylaminocarbonyl-, di- (C 1-3 -alkyl) -amino-carbonyl-, phenyl-C 1-3 -alkylamino- or N - (C 1-6 -alkylaminocarbonyl ) ; 3- alkyl) -phenyl-C 1 . 3 -alkyl-amino, or said methylene group can be replaced by O or S, sulfmyl-, sulfonyl, -NH-, - J V (C first 3 alkyl) -, -N (phenyl) -, -N (phenyl-C 3 alkyl) -, -7V (C 3 -alkyl-carbonyl) -, K4 -MC-alkoxy-carbonyl) -, -v / benzoyl) - or -N (phenyl-C first 3 wherein the methylene group bonded to the imine nitrogen atom of the cycloalkyleneimine group may be replaced by a carbonyl group or a sulfonyl group, or in a 5- to 7-membered monocyclic or phenyl-fused cycloalkyleneimine group, both methylene groups may be substituted by an imine nitrogen atom carbonyl groups, is converted to a compound of formula (XI) wherein R1, R5 a X sú určené v nárokoch 1 až 5,R 1 , R 5 and X are as defined in claims 1 to 5, R2' má rovnaký význam ako R2 v nárokoch 1 až 5,R 2 'has the same meaning as R 2 in claims 1 to 5, R18 znamená vodíkový atóm alebo ochrannú skupinu pre dusík laktámovej skupiny, pričom jeden zo zvyškov R2' a R18 môže voliteľne cez medzičlen (Spacer) vytvárať väzbu s tuhou fázou a druhý z uvedených zvyškov má uvedený význam, aR 18 represents a hydrogen atom or a nitrogen protecting group of the lactam group, wherein one of R 2 'and R 18 may optionally form a solid phase bond via a Spacer and the other of said radicals is as defined above, and A znamená Ci_4-alkylovú skupinu aA represents a C 1-4 -alkyl group and Z2 znamená vymeniteľnú skupinu, s amínom všeobecného vzorca (XII)Z 2 is a displaceable group, with an amine of formula (XII) H - R7' (XII), v ktoromH - R 7 '(XII) wherein R7' má rovnaký význam ako R7 skôr a ak sa vyžaduje, nasleduje odštiepenie použitej ochrannej skupiny od dusíkového atómu laktámovej skupiny alebo od tuhej fázy;R 7 'has the same meaning as R 7 above and, if desired, cleavage of the protecting group used from the nitrogen atom of the lactam group or from the solid phase; ak pripravená zlúčenina vzorca (I) obsahuje alkoxykarbonylovú skupinu, možno túto zlúčeninu pomocou hydrolýzy premeniť na zodpovedajúcu karboxylovú zlúčeninu, alebo ak pripravená zlúčenina vzorca (I) obsahuje skupinu amino- alebo alkylamino-, možno túto zlúčeninu premeniť pomocou redukčnej alkylácie na zodpovedajúcu alkylamino- alebo dialkylamino- zlúčeninu, alebo ak pripravená zlúčenina vzorca (I) obsahuje skupinu amino- alebo alkylamino-, možno túto zlúčeninu acyláciou alebo sulfonáciou premeniť na príslušnú acyl- alebo sulfonylovú zlúčeninu, alebo ak pripravená zlúčenina vzorca (I) obsahuje karboxylovú skupinu, možno túto zlúčeninu esterifíkáciou alebo amidáciou premeniť na zodpovedajúcu esterovú alebo aminokarbonylovú zlúčeninu, alebo ak pripravená zlúčenina vzorca (I) obsahuje cykloalkylénimínovú skupinu, v ktorej je jedna metylénová skupina nahradená atómom síry, možno túto zlúčeninu oxidáciou premeniť na zodpovedajúcu sulfinylovú alebo sulfonylovú zlúčeninu, alebo ak pripravená zlúčenina vzorca (I) obsahuje nitroskupinu, možno túto zlúčeninu redukciou premeniť na zodpovedajúcu aminozlúčeninu, alebo pripravenú zlúčeninu všeobecného vzorca (I), v ktorej R4 znamená skupinou amino-, alkylamino-, aminoalkyl- alebo TV-alkyl-amino- substituovanú fenylovú skupinu, možno následne premenou s príslušným kyanátom, izokyanátom alebo karbamoyl-halogenidom premeniť na zodpovedajúcu močovinovú zlúčeninu všeobecného vzorca (I), alebo pripravenú zlúčeninu všeobecného vzorca (I), v ktorej R4 znamená skupinou amino-, alkylamino-, aminoalkyl- alebo ŤV-alkyl-amino- substituovanú fenylovú skupinu, možno následne premenou s príslušnou amidínoskupinu prenášajúcou skupinou alebo premenou so zodpovedajúcim nitrilom premeniť na zodpovedajúcu guanidínovú zlúčeninu všeobecného vzorca (I), alebo ak sa vyžaduje, odštiepi sa ochranná skupina, použitá počas premeny na ochranu reaktívnych skupín, alebo ak sa vyžaduje, pripravená zlúčenina všeobecného vzorca (I) sa následne rozdelí na jej strereoizoméry, alebo pripravená zlúčenina všeobecného vzorca sa premení na jej soli, najmä na farmaceutické použitie na fyziologicky prípustné soli s anorganickou alebo organickou kyselinou alebo zásadou.if the prepared compound of formula (I) contains an alkoxycarbonyl group, it may be converted to the corresponding carboxyl compound by hydrolysis, or if the prepared compound of formula (I) contains an amino- or alkylamino- group, the compound may be converted by reductive alkylation to the corresponding alkylamino- or a dialkylamino compound, or if the compound of formula (I) contains an amino- or alkylamino- group, this compound can be converted by acylation or sulfonation to the corresponding acyl- or sulfonyl compound, or if the compound of formula (I) contains a carboxyl group, by esterification or amidation to convert to the corresponding ester or aminocarbonyl compound, or if the compound of formula (I) produced contains a cycloalkyleneimine group in which one methylene group is replaced by a sulfur atom, the compound may be converted by oxidation n and the corresponding sulfinyl or sulfonyl compound or, if the compound of formula (I) contains a nitro group, this compound can be converted to the corresponding amino compound or a compound of formula (I) in which R 4 is amino-, alkylamino-, aminoalkyl- or a N-alkyl-amino-substituted phenyl group, may be subsequently transformed with the appropriate cyanate, isocyanate or carbamoyl halide to the corresponding urea compound of formula (I), or the prepared compound of formula (I) in which R 4 is amino the alkylamino-, aminoalkyl- or N-alkyl-amino-substituted phenyl group may be subsequently converted to the corresponding guanidine compound of formula (I) by treatment with the appropriate amidine transfer group or the corresponding nitrile or, if desired, cleavage of the protective group group, pou during the conversion to protect the reactive groups or, if desired, the prepared compound of formula (I) is subsequently separated into its stereoisomers, or the prepared compound of formula is converted into its salts, in particular for pharmaceutical use into physiologically acceptable salts with inorganic or organic acid or base.
SK646-2002A 1999-10-13 2000-10-09 6-Position substituted indoline, production and use thereof as a medicament SK287312B6 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19949208A DE19949208A1 (en) 1999-10-13 1999-10-13 New 3-(amino-methylene)-2-indolinone derivatives are kinase inhibitors and cell proliferation inhibitors useful e.g. for treating tumors, metastasis, rheumatoid arthritis or psoriasis
DE2000142696 DE10042696A1 (en) 2000-08-31 2000-08-31 New 3-(amino-methylene)-2-indolinone derivatives are kinase inhibitors and cell proliferation inhibitors useful e.g. for treating tumors, metastasis, rheumatoid arthritis or psoriasis
PCT/EP2000/009867 WO2001027081A1 (en) 1999-10-13 2000-10-09 6-position substituted indoline, production and use thereof as a medicament

Publications (2)

Publication Number Publication Date
SK6462002A3 SK6462002A3 (en) 2002-08-06
SK287312B6 true SK287312B6 (en) 2010-06-07

Family

ID=26006858

Family Applications (1)

Application Number Title Priority Date Filing Date
SK646-2002A SK287312B6 (en) 1999-10-13 2000-10-09 6-Position substituted indoline, production and use thereof as a medicament

Country Status (42)

Country Link
EP (2) EP1224170B9 (en)
JP (2) JP4021664B2 (en)
KR (2) KR100857734B1 (en)
CN (1) CN100455568C (en)
AR (1) AR026036A1 (en)
AT (1) ATE439342T1 (en)
AU (1) AU781939B2 (en)
BE (1) BE2015C018I2 (en)
BG (1) BG65983B1 (en)
BR (1) BRPI0014735B8 (en)
CA (1) CA2387013C (en)
CO (1) CO5261488A1 (en)
CY (2) CY1110067T1 (en)
CZ (1) CZ301073B6 (en)
DE (1) DE50015711D1 (en)
DK (1) DK1224170T5 (en)
EA (1) EA006080B1 (en)
EE (1) EE05427B1 (en)
EG (1) EG25931A (en)
ES (1) ES2331459T3 (en)
FR (1) FR15C0024I2 (en)
HK (1) HK1052505B (en)
HR (1) HRP20020306B1 (en)
HU (2) HU230416B1 (en)
IL (2) IL148756A0 (en)
LU (1) LU92681I2 (en)
ME (1) MEP45408A (en)
MX (1) MXPA02002799A (en)
MY (1) MY127956A (en)
NL (1) NL300725I2 (en)
NO (3) NO322746B1 (en)
NZ (1) NZ518489A (en)
PE (1) PE20010671A1 (en)
PL (1) PL207445B1 (en)
PT (1) PT1224170E (en)
RS (1) RS51013B (en)
SA (1) SA01210704B1 (en)
SI (1) SI1224170T1 (en)
SK (1) SK287312B6 (en)
TW (1) TWI268922B (en)
UA (1) UA75054C2 (en)
WO (1) WO2001027081A1 (en)

Families Citing this family (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19816624A1 (en) * 1998-04-15 1999-10-21 Boehringer Ingelheim Pharma Novel substituted indolinones, their preparation and their use as pharmaceuticals
ES2318649T3 (en) 2000-10-20 2009-05-01 EISAI R&amp;D MANAGEMENT CO., LTD. PROCEDURE FOR PREPARATION OF DERIVATIVES OF 4-FENOXI QUINOLINAS.
US6638965B2 (en) 2000-11-01 2003-10-28 Boehringer Ingelheim Pharma Kg Substituted indolinones, preparation thereof and their use as pharmaceutical compositions
DE10117204A1 (en) 2001-04-06 2002-10-10 Boehringer Ingelheim Pharma Indolinones substituted in the 6-position, their preparation and their use as medicaments
US7678805B2 (en) 2001-06-29 2010-03-16 Ab Science Use of tyrosine kinase inhibitors for treating inflammatory bowel diseases (IBD)
JP2005500041A (en) 2001-06-29 2005-01-06 アブ サイエンス Potent, selective and non-toxic C-KIT inhibitor
US20030091974A1 (en) * 2001-06-29 2003-05-15 Alain Moussy Method for screening compounds capable of depleting mast cells
ATE330608T1 (en) 2001-06-29 2006-07-15 Ab Science THE USE OF N-PHENYL-2-PYRIMIDINE-AMINE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES
US7700610B2 (en) 2001-06-29 2010-04-20 Ab Science Use of tyrosine kinase inhibitors for treating allergic diseases
US20050176687A1 (en) * 2001-06-29 2005-08-11 Alain Moussy Use of tyrosine kinase inhibitors for treating autoimmune diseases
US6765012B2 (en) * 2001-09-27 2004-07-20 Allergan, Inc. 3-(Arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
US20030187026A1 (en) 2001-12-13 2003-10-02 Qun Li Kinase inhibitors
US6797825B2 (en) 2001-12-13 2004-09-28 Abbott Laboratories Protein kinase inhibitors
WO2003057690A1 (en) 2001-12-27 2003-07-17 Theravance, Inc. Indolinone derivatives useful as protein kinase inhibitors
SE0302546D0 (en) 2003-09-24 2003-09-24 Astrazeneca Ab New compounds
ITBO20020198A1 (en) * 2002-04-12 2003-10-13 Univ Bologna DERIVATIVES 2, 5 BIS DIAMMINO 1, 4 BENZOCHENIONIC USEFUL FOR THE TREATMENT OF ALZHEIMER DISEASE, METHOD FOR THEIR PREPARATION AND
US7169936B2 (en) 2002-07-23 2007-01-30 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinone derivatives substituted in the 6-position, their preparation and their use as medicaments
US7514468B2 (en) 2002-07-23 2009-04-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions
DE10233500A1 (en) 2002-07-24 2004-02-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg 3-Z- [1- (4- (N - ((4-methyl-piperazin-1-yl) -methylcarbonyl) -N-methyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl- 2-indolinone monoethanesulfonate and its use as a medicament
US20040204458A1 (en) 2002-08-16 2004-10-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of Lck inhibitors for treatment of immunologic diseases
DE10237423A1 (en) * 2002-08-16 2004-02-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Treating immunological (or related) diseases, e.g. inflammatory bowel disease, rheumatoid arthritis or psoriasis, comprises administration of 3-methylene-2-indolinone derivative or quinazoline compound
US7148249B2 (en) * 2002-09-12 2006-12-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments
JP4879492B2 (en) * 2002-11-27 2012-02-22 アラーガン、インコーポレイテッド Kinase inhibitors for the treatment of diseases
US20050043233A1 (en) * 2003-04-29 2005-02-24 Boehringer Ingelheim International Gmbh Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis
JP4303726B2 (en) 2003-11-11 2009-07-29 エーザイ・アール・アンド・ディー・マネジメント株式会社 Urea derivative and method for producing the same
SE0401790D0 (en) * 2004-07-07 2004-07-07 Forskarpatent I Syd Ab Tamoxifen response in pre- and postmenopausal breast cancer patients
US20060058311A1 (en) * 2004-08-14 2006-03-16 Boehringer Ingelheim International Gmbh Combinations for the treatment of diseases involving cell proliferation
EP2364699A1 (en) 2004-09-13 2011-09-14 Eisai R&D Management Co., Ltd. Joint use of sulfonamide based compound with angiogenesis inhibitor
US8772269B2 (en) 2004-09-13 2014-07-08 Eisai R&D Management Co., Ltd. Use of sulfonamide-including compounds in combination with angiogenesis inhibitors
ES2322175T3 (en) 2004-09-17 2009-06-17 EISAI R&amp;D MANAGEMENT CO., LTD. MEDICINAL COMPOSITION WITH IMPROVED STABILITY AND REDUCED GELIFICATION.
PE20060777A1 (en) * 2004-12-24 2006-10-06 Boehringer Ingelheim Int INDOLINONE DERIVATIVES FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
US9006240B2 (en) 2005-08-02 2015-04-14 Eisai R&D Management Co., Ltd. Method for assay on the effect of vascularization inhibitor
WO2007057397A1 (en) * 2005-11-15 2007-05-24 Boehringer Ingelheim International Gmbh Treatment of cancer
CN104706637A (en) 2006-05-18 2015-06-17 卫材R&D管理有限公司 Antitumor agent for thyroid cancer
EP1870400A1 (en) * 2006-06-08 2007-12-26 Boehringer Ingelheim Pharma GmbH & Co. KG Salts and crystalline salt forms of an 2-indolinone derivative
EP2065372B1 (en) 2006-08-28 2012-11-28 Eisai R&D Management Co., Ltd. Antitumor agent for undifferentiated gastric cancer
WO2008093855A1 (en) 2007-01-29 2008-08-07 Eisai R & D Management Co., Ltd. Composition for treatment of undifferentiated-type of gastric cancer
EP2167465A1 (en) * 2007-06-12 2010-03-31 Boehringer Ingelheim International GmbH Indolinone derivatives and their use in treating disease-states such as cancer
CA2687909C (en) 2007-06-21 2015-09-15 Janssen Pharmaceutica Nv Indolin-2-ones and aza-indolin-2-ones
EP2218712B1 (en) 2007-11-09 2015-07-01 Eisai R&D Management Co., Ltd. Combination of anti-angiogenic substance and anti-tumor platinum complex
UY31506A1 (en) * 2007-12-03 2009-08-03 INDOLINONE DERIVATIVES AND PROCEDURE FOR PREPARATION
CL2008003598A1 (en) * 2007-12-03 2010-02-12 Boehringer Ingelheim Int Procedure for the preparation of 3-z- [1- (4- (n - ((4-methyl-piperazine-1-yl) -methylcarbonyl) -n-methyl-amino) -anilino) -1-phenyl-methylene] - 6-methoxycarbonyl-2-indolinone by dechloroacetylation in basic medium of one of the intermediate compounds.
PL2293795T3 (en) 2008-06-06 2016-01-29 Boehringer Ingelheim Int Pharmaceutical combination
US8853420B2 (en) * 2008-07-29 2014-10-07 Boehringer Ingelheim International Gmbh Compounds
US20120157472A1 (en) 2009-01-14 2012-06-21 Boehringer Ingelheim International Gmbh Method for treating colorectal cancer
US8802384B2 (en) 2009-03-12 2014-08-12 Boehringer Ingelheim International Gmbh Method or system using biomarkers for the monitoring of a treatment
WO2010108503A1 (en) 2009-03-24 2010-09-30 Life & Brain Gmbh Promotion of neuronal integration in neural stem cell grafts
JP2012526766A (en) 2009-05-14 2012-11-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング A novel combination therapy in the treatment of neoplastic and fibrotic diseases
US20120107304A1 (en) 2010-04-27 2012-05-03 Boehringer Ingelheim International Gmbh Combination therapy in treatment of oncological and fibrotic diseases
JP5898074B2 (en) 2010-06-25 2016-04-06 エーザイ・アール・アンド・ディー・マネジメント株式会社 Antitumor agent by combined use of compounds having kinase inhibitory action
WO2012068441A2 (en) 2010-11-19 2012-05-24 Ratiopharm Gmbh Intedanib salts and solid state forms thereof
CA2828946C (en) 2011-04-18 2016-06-21 Eisai R&D Management Co., Ltd. Therapeutic agent for tumor
EP2714937B1 (en) 2011-06-03 2018-11-14 Eisai R&D Management Co., Ltd. Biomarkers for predicting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds
WO2013059740A1 (en) 2011-10-21 2013-04-25 Foundation Medicine, Inc. Novel alk and ntrk1 fusion molecules and uses thereof
EP3604307A1 (en) 2012-01-26 2020-02-05 Angion Biomedica Corp. Anti-fibrotic compounds and uses thereof
EP2914621B1 (en) 2012-11-05 2023-06-07 Foundation Medicine, Inc. Novel ntrk1 fusion molecules and uses thereof
AU2013337264B2 (en) 2012-11-05 2018-03-08 Foundation Medicine, Inc. Novel fusion molecules and uses thereof
CN104936944B (en) 2012-12-06 2017-09-12 山东亨利医药科技有限责任公司 It is used as the dihydroindole ketone derivate of tyrosine kinase inhibitor
KR20150098605A (en) 2012-12-21 2015-08-28 에자이 알앤드디 매니지먼트 가부시키가이샤 Amorphous form of quinoline derivative, and method for producing same
WO2014113729A2 (en) 2013-01-18 2014-07-24 Foundation Mecicine, Inc. Methods of treating cholangiocarcinoma
US20140350022A1 (en) 2013-05-10 2014-11-27 Boehringer Ingelheim International Gmbh Efficacious treatment of NSCLC and predictive clinical marker of the responsiveness of a tumour to a treatment
WO2014185540A1 (en) 2013-05-14 2014-11-20 Eisai R&D Management Co., Ltd. Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds
CN104003925B (en) * 2013-06-05 2016-03-30 四川大学 Oxindole compounds or derivatives thereof and uses thereof
WO2015009889A1 (en) * 2013-07-18 2015-01-22 Concert Pharmaceuticals, Inc. Deuterated intedanib derivatives and their use for the treatment of proliferative disorders
WO2015017728A1 (en) 2013-07-31 2015-02-05 Windward Pharma, Inc. Aerosol tyrosine kinase inhibitor compounds and uses thereof
KR102329681B1 (en) 2014-08-28 2021-11-23 에자이 알앤드디 매니지먼트 가부시키가이샤 High-purity quinoline derivative and method for manufacturing same
CN104262232B (en) * 2014-09-09 2016-05-04 苏州明锐医药科技有限公司 The preparation method of Ni Taidani
CA2976325C (en) 2015-02-25 2023-07-04 Eisai R&D Management Co., Ltd. Method for suppressing bitterness of quinoline derivative
KR20240064733A (en) 2015-03-04 2024-05-13 머크 샤프 앤드 돔 코포레이션 Combination of a pd-1 antagonist and a vegfr/fgfr/ret tyrosine kinase inhibitor for treating cancer
WO2016178064A1 (en) 2015-05-06 2016-11-10 Suven Life Sciences Limited Polymorph of nintedanib ethanesulphonate, processes and intermediates thereof
CN104844499B (en) * 2015-06-05 2017-03-08 北京康立生医药技术开发有限公司 One kettle way prepares the synthetic method of Nintedanib
CN108135737B (en) 2015-06-06 2021-11-05 拨云生物医药科技(广州)有限公司 Compositions and methods for treating pterygium
RU2729936C2 (en) 2015-06-16 2020-08-13 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Anticancer agent
CN105126909B (en) * 2015-07-13 2018-01-23 淮海工学院 Application of the immobilized palladium catalyst in the synthesis of the nitrobenzene methyl of 4 phenylacetylene base 3
CZ308695B6 (en) 2015-07-29 2021-03-03 Zentiva, K.S. Process for preparing methyl (Z) -3 - [[4- [methyl [2- (4-methyl-1-piperazinyl) acetyl] amino] phenyl] amino] phenylmethylene) -oxindole-6-carboxylate (intedanib, nintedanib)
CN106467500A (en) * 2015-08-14 2017-03-01 廊坊百瑞化工有限公司 A kind of one pot synthesis synthesize the new method of Nintedanib key intermediate
PL3722291T3 (en) * 2015-12-24 2023-11-27 Respivert Limited Indolinone compounds and their use in the treatment of fibrotic diseases
CZ2016104A3 (en) 2016-02-24 2017-09-06 Zentiva, K.S. Crystalline modifications of methyl (3Z)-3- {[(4-{methyl[(4-methylpiperazin-1yl)acetyl]amino}phenyl)amino](phenyl)methylidene}-2oxo-2,3-dihydro-1H-indole-6-carboxylate and the methods of their preparation
CN109153666B (en) 2016-03-08 2021-07-16 莱斯彼维特有限公司 Indole derivatives and their use as protein kinase inhibitors
WO2017178428A1 (en) 2016-04-13 2017-10-19 Boehringer Ingelheim International Gmbh Pharmaceutical combination of nintedanib, trifluridine and tipiracil for treating colorectal cancer
EP3246029A1 (en) 2016-05-19 2017-11-22 Boehringer Ingelheim International Gmbh Pharmaceutical combination of nintedanib and capecitabine for the treatment of colorectal cancer
US20190275032A1 (en) 2016-05-27 2019-09-12 Boehringer Ingelheim International Gmbh Use of ecm biomarkers for determining the treatment onset with nintedanib and pirfenidone
US20190275033A1 (en) 2016-06-01 2019-09-12 Boehringer Ingelheim International Gmbh Use of ecm biomarkers for determining the treatment onset with nintedanib and pirfenidone
KR20220080222A (en) 2016-06-02 2022-06-14 에이디에스 테라퓨틱스 엘엘씨 Compositions and methods of using nintedanib for treating ocular diseases with abnormal neovascularization
WO2018022771A1 (en) 2016-07-29 2018-02-01 Oncternal Therapeutics, Inc. Uses of indolinone compounds
CN106748960A (en) * 2016-11-30 2017-05-31 瑞阳制药有限公司 The potential impurity compound of Nintedanib, preparation method, using and its detection method
CN106748961A (en) * 2016-11-30 2017-05-31 瑞阳制药有限公司 The impurity compound of Nintedanib, preparation method, using and its detection method
CN110062625A (en) 2016-12-12 2019-07-26 勃林格殷格翰国际有限公司 Nintedanib by giving the method for treating interstitial lung disease with Ao Dateluo altogether
CN110573161A (en) 2017-03-28 2019-12-13 勃林格殷格翰国际有限公司 Nintedanib for use in a method of treating muscular dystrophy
IL309150A (en) 2017-10-23 2024-02-01 Boehringer Ingelheim Int New combination of active agents for the treatment of progressive fibrosing interstitial lung diseases (pf-ild)
JP7382317B2 (en) 2017-11-17 2023-11-16 フェルミオン オサケ ユキチュア Synthesis of 2-indolinone derivatives known as intermediates for producing nintedanib
JP7061310B2 (en) * 2018-04-05 2022-04-28 国立大学法人 大分大学 Pharmaceuticals for the prevention and treatment of chronic fatty diseases
CN108358827A (en) * 2018-05-07 2018-08-03 日照市普达医药科技有限公司 It is a kind of to treat psoriasic 2- oxo-indoles analog derivative and preparation method thereof
JP7101311B2 (en) * 2018-10-05 2022-07-14 イクノス サイエンシズ エスエー Indolinone compounds for use as MAP4K1 inhibitors
CN115361950A (en) 2020-04-01 2022-11-18 勃林格殷格翰国际有限公司 Use of biomarkers in the treatment of fibrotic disorders
CN111848490B (en) * 2020-08-24 2021-09-24 江西国药有限责任公司 Preparation method of high-purity ethanesulfonic acid nintedanib
CN112574094B (en) * 2020-12-14 2022-07-01 成都大学 Indolone derivatives and pharmaceutical use thereof
KR20220107973A (en) 2021-01-25 2022-08-02 주식회사 나이벡 Peptides for prevention and treatment of fibrosis
EP4098246A1 (en) 2021-05-31 2022-12-07 Lotus Pharmaceutical Co., Ltd. Formulation of nintedanib
CN115703758B (en) * 2021-08-12 2024-03-26 中国医学科学院药物研究所 Compounds used as kinase inhibitors, preparation method and application thereof
WO2024037982A1 (en) 2022-08-16 2024-02-22 Boehringer Ingelheim International Gmbh Pharmaceutical formulations of nintedanib for intraocular use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE558210A (en) * 1956-06-08
JP2742333B2 (en) * 1994-05-06 1998-04-22 アルコン ラボラトリーズ,インコーポレイテッド Use of vitamin E tocopheryl derivatives in ophthalmic compositions
US5880141A (en) * 1995-06-07 1999-03-09 Sugen, Inc. Benzylidene-Z-indoline compounds for the treatment of disease
ATE243034T1 (en) * 1996-01-17 2003-07-15 Taiho Pharmaceutical Co Ltd INTIMAL THICKENING INHIBITORS
GB9718913D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives
DE19815020A1 (en) * 1998-04-03 1999-10-07 Boehringer Ingelheim Pharma New substituted indolinones, their production and their use as medicines
DE19816624A1 (en) * 1998-04-15 1999-10-21 Boehringer Ingelheim Pharma Novel substituted indolinones, their preparation and their use as pharmaceuticals
DE19824922A1 (en) * 1998-06-04 1999-12-09 Boehringer Ingelheim Pharma Novel substituted indolinones, their preparation and their use as pharmaceuticals
GB9904933D0 (en) * 1999-03-04 1999-04-28 Glaxo Group Ltd Compounds

Also Published As

Publication number Publication date
NO2023033I1 (en) 2023-09-05
FR15C0024I2 (en) 2016-08-26
TWI268922B (en) 2006-12-21
WO2001027081A1 (en) 2001-04-19
SI1224170T1 (en) 2009-12-31
BRPI0014735B8 (en) 2021-07-06
NO20021719L (en) 2002-04-11
IL148756A0 (en) 2002-09-12
FR15C0024I1 (en) 2015-04-17
BE2015C018I2 (en) 2019-10-23
HRP20020306A2 (en) 2003-10-31
EA200200380A1 (en) 2002-10-31
EP1224170A1 (en) 2002-07-24
KR20070095996A (en) 2007-10-01
YU26602A (en) 2004-11-25
NL300725I2 (en) 2017-07-13
CA2387013C (en) 2009-12-29
LU92681I2 (en) 2015-05-18
HUS1600022I1 (en) 2017-02-28
LU92681I9 (en) 2019-01-03
PE20010671A1 (en) 2001-06-28
MY127956A (en) 2007-01-31
CZ20021410A3 (en) 2002-07-17
DE50015711D1 (en) 2009-09-24
CY2015009I2 (en) 2016-12-14
BG65983B1 (en) 2010-08-31
HUP0204587A3 (en) 2004-07-28
HRP20020306B1 (en) 2010-09-30
CZ301073B6 (en) 2009-10-29
HK1052505A1 (en) 2003-09-19
RS51013B (en) 2010-10-31
KR100857734B1 (en) 2008-09-10
MXPA02002799A (en) 2003-02-27
CY2015009I1 (en) 2016-12-14
DK1224170T3 (en) 2009-12-07
SK6462002A3 (en) 2002-08-06
EG25931A (en) 2012-10-24
PL355433A1 (en) 2004-04-19
SA01210704B1 (en) 2006-12-05
EP1224170B9 (en) 2017-11-22
AR026036A1 (en) 2002-12-26
JP2007302697A (en) 2007-11-22
CA2387013A1 (en) 2001-04-19
ATE439342T1 (en) 2009-08-15
AU781939B2 (en) 2005-06-23
EE05427B1 (en) 2011-06-15
EA006080B1 (en) 2005-08-25
EP1224170B1 (en) 2009-08-12
CN1391557A (en) 2003-01-15
CN100455568C (en) 2009-01-28
CO5261488A1 (en) 2003-03-31
BRPI0014735B1 (en) 2012-07-10
HK1052505B (en) 2009-06-26
KR100835546B1 (en) 2008-06-09
PT1224170E (en) 2009-10-01
JP4021664B2 (en) 2007-12-12
HU230416B1 (en) 2016-05-30
KR20020038949A (en) 2002-05-24
AU1023301A (en) 2001-04-23
ES2331459T3 (en) 2010-01-05
BRPI0014735A (en) 2002-07-16
UA75054C2 (en) 2006-03-15
DK1224170T5 (en) 2018-01-22
JP2003511441A (en) 2003-03-25
NO2015009I1 (en) 2015-03-30
CY1110067T1 (en) 2015-01-14
NO322746B1 (en) 2006-12-04
NO2015009I2 (en) 2015-03-18
IL148756A (en) 2007-10-31
PL207445B1 (en) 2010-12-31
NZ518489A (en) 2005-05-27
MEP45408A (en) 2011-02-10
EE200200197A (en) 2003-06-16
HUP0204587A2 (en) 2003-05-28
NO20021719D0 (en) 2002-04-11
BG106587A (en) 2003-01-31
EP2157081A1 (en) 2010-02-24

Similar Documents

Publication Publication Date Title
SK287312B6 (en) 6-Position substituted indoline, production and use thereof as a medicament
US6762180B1 (en) Substituted indolines which inhibit receptor tyrosine kinases
JP3952369B2 (en) Novel substituted indolinones, their production and their use as pharmaceuticals
EP1551830B1 (en) Heterocyclically substituted indolinones and their use as receptor tyrosine kinase inhibators
US20040044222A1 (en) New substituted indolinones, preparation thereof and their use as pharmaceutical compositions
MXPA04012937A (en) Indoline derivatives substituted in position 6, production and use thereof as medicaments.
JP2005537276A (en) 6-substituted indolinone derivatives, their preparation and use as pharmaceutical compositions
DE10042696A1 (en) New 3-(amino-methylene)-2-indolinone derivatives are kinase inhibitors and cell proliferation inhibitors useful e.g. for treating tumors, metastasis, rheumatoid arthritis or psoriasis
DE19940829A1 (en) New 3-(anilino-methylidene)-2-indolinone derivatives, are kinase inhibitors and cell proliferation inhibitors, useful e.g. for treating tumors, metastasis, rheumatoid arthritis or psoriasis
DE19949208A1 (en) New 3-(amino-methylene)-2-indolinone derivatives are kinase inhibitors and cell proliferation inhibitors useful e.g. for treating tumors, metastasis, rheumatoid arthritis or psoriasis
DE10029285A1 (en) New 3-(anilino-methylidene)-2-indolinone derivatives, are kinase inhibitors and cell proliferation inhibitors, useful e.g. for treating tumors, metastasis, rheumatoid arthritis or psoriasis
DE10242350A1 (en) New 3-aminomethylene-indoline-2-(thi)one derivatives, are kinase inhibitors useful for treating proliferative diseases e.g. tumors, rheumatoid arthritis, neovascular glaucoma and arteriosclerosis
DE10252969A1 (en) New 3-aminomethylene-indoline-2-(thi)one derivatives, are kinase inhibitors useful for treating proliferative diseases e.g. tumors, rheumatoid arthritis, neovascular glaucoma and arteriosclerosis

Legal Events

Date Code Title Description
SPCF Filing of an spc

Free format text: PRODUCT NAME: NINTEDANIB, JEHO TAUTOMERY A JEHO FYZIOLOGICKY PRIJATELNE SOLI, KONKRETNE NINTEDANIB ESILAT; REGISTRATION NO/DATE: EU/1/14/954/001 - EU/1/14/954/004 20141121

Spc suppl protection certif: 1-2015

Filing date: 20150316

SPCG Grant of an spc

Free format text: PRODUCT NAME: NINTEDANIB, JEHO TAUTOMERY A JEHO FYZIOLOGICKY PRIJATELNE SOLI, KONKRETNE NINTEDANIB ESILAT; REGISTRATION NO/DATE: EU/1/14/954/001 - EU/1/14/954/004 20141121

Spc suppl protection certif: 188 1-2015

Filing date: 20150316

Extension date: 20251010

MK4A Patent expired

Expiry date: 20201009